data_2mk2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mk2 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 4.3 p-90 -85.41 -1.13 56.7 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.966 -0.459 . . . . 0.0 110.761 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -107.33 113.57 27.04 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -173.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.512 ' HE2' HD22 ' A' ' 37' ' ' LEU . 1.9 p80 -138.97 109.95 6.78 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.518 1.127 . . . . 0.0 108.76 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -86.73 26.82 1.06 Allowed 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 124.17 0.988 . . . . 0.0 110.634 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -160.39 25.31 0.16 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.295 0.638 . . . . 0.0 111.098 -162.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 20.0 tp -108.99 -49.09 3.18 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.675 -0.64 . . . . 0.0 111.63 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.4 t 80.08 153.23 0.12 Allowed 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 124.856 1.262 . . . . 0.0 109.869 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.469 ' HB2' ' NH1' ' A' ' 39' ' ' ARG . 74.5 ttt180 -64.21 -38.87 92.6 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 118.019 0.372 . . . . 0.0 111.512 -168.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.57 -54.82 23.56 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 123.652 0.595 . . . . 0.0 110.752 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.77 -22.55 43.02 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.9 -57.08 4.13 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 123.206 0.602 . . . . 0.0 111.542 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.423 ' HG3' HG12 ' A' ' 58' ' ' VAL . 36.7 tt0 -57.76 -37.08 73.03 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.076 1.351 . . . . 0.0 111.26 173.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -71.05 -38.18 72.53 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.365 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -55.13 -43.76 74.43 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.285 0.634 . . . . 0.0 110.083 173.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.547 HD21 ' HB3' ' A' ' 35' ' ' SER . 82.8 mt -71.92 -42.31 66.84 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 123.485 0.49 . . . . 0.0 110.413 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.36 -37.32 71.65 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.543 0.737 . . . . 0.0 112.21 -174.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.7 mtp180 -82.16 -50.56 8.89 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.024 0.53 . . . . 0.0 111.325 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.414 ' HB2' HG13 ' A' ' 109' ' ' VAL . . . -66.41 -46.8 75.35 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.559 0.344 . . . . 0.0 110.314 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.38 125.84 0.0 OUTLIER Glycine 0 CA--C 1.538 1.515 0 N-CA-C 118.854 2.302 . . . . 0.0 118.854 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 177.66 103.22 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 165.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -62.44 149.92 41.36 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -154.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.409 ' HA2' ' SG ' ' A' ' 103' ' ' CYS . . . 89.56 17.45 54.77 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -161.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.547 ' HB3' HD21 ' A' ' 27' ' ' LEU . 17.2 m -71.81 130.59 41.44 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 124.434 1.094 . . . . 0.0 108.895 -177.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -141.74 155.14 45.65 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.118 0.485 . . . . 0.0 111.034 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.512 HD22 ' HE2' ' A' ' 15' ' ' HIS . 0.8 OUTLIER -158.58 153.47 25.0 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.612 166.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.6 t -105.28 117.41 50.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.523 ' HG3' ' HB3' ' A' ' 49' ' ' ALA . 2.1 ptm180 -113.58 168.49 9.72 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 122.168 0.985 . . . . 0.0 110.816 -178.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -54.44 127.91 29.57 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 113.122 -1.854 . . . . 0.0 110.838 165.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.0 m -74.48 143.99 44.38 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 162.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -78.48 83.58 4.67 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.3 m 67.29 -75.51 0.06 Allowed 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 126.201 1.8 . . . . 0.0 111.785 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.469 HG21 ' H ' ' A' ' 45' ' ' ALA 0.317 35.1 m 39.21 -84.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 126.996 2.118 . . . . 0.0 113.743 -167.335 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.469 ' H ' HG21 ' A' ' 44' ' ' VAL . . . -156.6 29.48 0.33 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.147 0.979 . . . . 0.0 109.309 -175.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.48 49.64 7.98 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.532 -175.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.53 176.51 5.01 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.455 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 59.0 m-85 -114.67 157.19 23.45 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.437 1.495 . . . . 0.0 107.447 174.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.523 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . . . -128.87 147.05 50.79 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.391 0.676 . . . . 0.0 110.098 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.4 tp -125.84 113.3 17.06 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.27 1.028 . . . . 0.0 108.577 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 52.6 t -100.58 123.23 44.51 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 35' ' ' SER . 47.0 t -128.54 126.09 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.781 0.832 . . . . 0.0 110.004 -174.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 35' ' ' SER . 54.7 tp -101.33 140.29 35.82 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.32 1.048 . . . . 0.0 110.844 177.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -156.29 115.61 3.51 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.01 1.324 . . . . 0.0 108.775 173.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 41.1 71.94 0.18 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.678 1.591 . . . . 0.0 113.881 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 81.9 tttt 58.72 27.47 15.96 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.155 0.982 . . . . 0.0 111.905 177.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -138.3 106.39 5.73 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.378 0.671 . . . . 0.0 109.455 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.423 HG12 ' HG3' ' A' ' 24' ' ' GLU . 41.4 t -99.71 112.75 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 174.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -101.53 132.18 47.31 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 170.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 22.9 m -113.51 128.0 56.29 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -108.39 154.51 21.75 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.875 1.27 . . . . 0.0 107.838 -172.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -105.12 160.2 15.25 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.698 0.799 . . . . 0.0 109.63 165.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.683 HG12 HD12 ' A' ' 90' ' ' LEU . 3.8 mp -146.62 100.68 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 102.578 -3.119 . . . . 0.0 102.578 -166.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.5 mp -113.63 133.7 22.16 Favored Pre-proline 0 N--CA 1.477 0.889 0 O-C-N 121.641 -0.662 . . . . 0.0 109.693 -168.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.09 -68.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.214 1.943 . . . . 0.0 110.256 160.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.9 t70 125.33 -66.1 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 C-N-CA 127.238 2.215 . . . . 0.0 107.743 163.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -171.04 25.72 0.1 OUTLIER Glycine 0 C--N 1.345 1.067 0 CA-C-N 115.515 -0.766 . . . . 0.0 113.203 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -135.69 -83.21 0.4 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 175.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -179.78 3.91 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.123 0.569 . . . . 0.0 111.925 -174.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.498 ' HB3' ' HB2' ' A' ' 83' ' ' ARG . 64.9 m-85 -106.77 134.94 49.14 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.41 0.684 . . . . 0.0 109.343 -169.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.2 mp -96.8 106.4 18.7 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 118.884 0.765 . . . . 0.0 109.348 -169.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.79 140.2 37.97 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.825 0.85 . . . . 0.0 110.13 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.491 ' HB ' ' HH ' ' A' ' 94' ' ' TYR . 22.7 t -114.99 124.51 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 176.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -93.56 97.29 10.41 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.402 HG21 ' ND2' ' A' ' 98' ' ' ASN . 76.6 p -87.53 -48.31 8.03 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.6 m -157.78 177.04 11.81 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.385 1.474 . . . . 0.0 108.134 166.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -85.45 -57.97 2.85 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.279 0.632 . . . . 0.0 110.436 -174.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.17 -31.2 61.81 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.821 0.701 . . . . 0.0 114.069 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.4 t -61.45 122.82 73.24 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 118.851 -0.595 . . . . 0.0 109.396 169.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -57.15 110.99 0.68 Allowed 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.5 2.133 . . . . 0.0 110.555 174.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.4 t -79.35 143.71 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.978 0.911 . . . . 0.0 109.115 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -114.89 130.75 56.96 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.498 ' HB2' ' HB3' ' A' ' 70' ' ' PHE . 32.0 ptt180 -94.81 134.07 37.83 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 171.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -113.74 149.44 34.82 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.257 1.023 . . . . 0.0 109.815 -174.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -92.1 -15.79 27.25 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.58 0.352 . . . . 0.0 110.354 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.9 p -142.53 151.12 41.3 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 124.371 1.068 . . . . 0.0 109.457 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 99.5 mt -62.87 -25.88 68.5 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.674 0.789 . . . . 0.0 111.497 172.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -59.85 -41.9 97.9 Favored Glycine 0 CA--C 1.537 1.456 0 N-CA-C 114.02 0.368 . . . . 0.0 114.02 174.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -63.27 -37.79 88.63 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.529 0.732 . . . . 0.0 110.979 176.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.683 HD12 HG12 ' A' ' 63' ' ' ILE . 6.6 tt -59.46 -57.33 13.46 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.814 1.246 . . . . 0.0 109.742 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 48.2 mm -59.79 -38.62 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.098 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.98 -44.88 54.23 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.568 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 42.0 tp -67.64 -50.67 56.79 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.084 0.554 . . . . 0.0 111.405 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.491 ' HH ' ' HB ' ' A' ' 73' ' ' VAL . 40.6 m-85 -75.35 -8.02 55.55 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -176.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.13 -24.12 64.43 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.431 0.634 . . . . 0.0 111.06 163.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -94.71 139.58 22.29 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.499 1.12 . . . . 0.0 108.87 174.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -48.94 127.0 16.06 Favored 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 123.137 2.558 . . . . 0.0 112.433 165.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.402 ' ND2' HG21 ' A' ' 75' ' ' THR . 26.2 p-10 -111.62 -45.1 3.4 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.194 -174.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 111.05 94.29 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 128.051 2.54 . . . . 0.0 106.341 -163.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 135.2 -38.99 1.74 Allowed Glycine 0 C--N 1.343 0.97 0 CA-C-N 116.052 -0.522 . . . . 0.0 113.1 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -69.41 136.93 52.29 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.859 0.464 . . . . 0.0 110.494 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.5 m -60.97 -28.31 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.585 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.409 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 25.4 p -163.06 -1.1 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 70.27 166.81 0.29 Allowed 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.947 0.899 . . . . 0.0 111.284 -167.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 37.3 mt -88.94 97.98 11.49 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.506 0.722 . . . . 0.0 109.804 -173.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.3 tp -82.86 -51.81 7.29 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.688 -175.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -165.71 146.46 5.77 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 123.726 0.81 . . . . 0.0 109.032 -172.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -56.89 -54.95 3.05 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.22 1.947 . . . . 0.0 111.885 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 30' ' ' ALA . 2.4 t . . . . . 0 N--CA 1.48 1.037 0 C-N-CA 125.717 1.607 . . . . 0.0 107.142 170.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.1 t . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 3.5 p-90 -90.55 12.9 17.31 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.528 0.731 . . . . 0.0 110.614 169.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 49.9 t80 -115.2 117.94 31.91 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -130.91 87.23 2.46 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.063 0.545 . . . . 0.0 109.865 -173.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -73.09 160.1 32.55 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 167.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.1 t70 63.61 26.11 14.54 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 122.064 0.935 . . . . 0.0 110.634 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.1 tt -131.87 123.57 27.78 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.597 1.559 . . . . 0.0 106.864 177.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.7 p -77.24 160.89 28.57 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.841 0.457 . . . . 0.0 110.281 -172.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -65.52 -34.43 78.25 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 117.952 0.342 . . . . 0.0 110.848 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.47 -47.59 81.47 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.796 0.838 . . . . 0.0 110.291 173.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.45 -32.72 73.78 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.615 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.412 ' HB3' HD13 ' A' ' 37' ' ' LEU . . . -65.25 -62.68 1.39 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.526 0.73 . . . . 0.0 111.184 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -62.66 -28.49 69.95 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.521 0.728 . . . . 0.0 112.465 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -68.27 -50.37 54.2 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 123.606 0.566 . . . . 0.0 109.485 175.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -58.52 -39.99 81.64 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.584 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.1 -48.26 74.31 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.926 0.89 . . . . 0.0 109.802 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.49 -31.98 73.3 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.121 0.968 . . . . 0.0 112.329 -175.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -81.65 -38.64 25.61 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.439 0.696 . . . . 0.0 110.592 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.26 -63.87 1.23 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -169.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.93 -41.34 1.57 Allowed Glycine 0 C--N 1.352 1.421 0 N-CA-C 112.12 -0.392 . . . . 0.0 112.12 -173.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.3 ttp85 58.02 17.58 4.52 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.902 1.281 . . . . 0.0 114.207 171.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -175.83 98.11 0.07 Allowed 'General case' 0 N--CA 1.479 0.978 0 O-C-N 121.552 -0.718 . . . . 0.0 109.626 -166.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.53 20.67 79.59 Favored Glycine 0 N--CA 1.478 1.493 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 11.2 m -90.05 119.64 30.57 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 124.487 1.115 . . . . 0.0 110.628 -172.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -126.16 159.12 33.8 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.033 0.444 . . . . 0.0 111.229 -173.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.412 HD13 ' HB3' ' A' ' 23' ' ' ALA . 3.6 pp -155.31 165.31 37.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.296 168.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 25.9 t -112.46 154.25 13.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 171.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.614 HH22 ' HG2' ' A' ' 42' ' ' GLU . 4.2 ptm180 -157.69 -177.82 6.86 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 123.205 0.602 . . . . 0.0 109.381 -176.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -90.77 125.57 35.74 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 172.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.2 m -57.43 147.65 25.68 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.382 0.673 . . . . 0.0 110.651 174.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.614 ' HG2' HH22 ' A' ' 39' ' ' ARG . 42.2 mt-10 -78.22 89.11 4.28 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.343 0.657 . . . . 0.0 111.967 -164.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.2 t 66.16 27.85 10.3 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.494 1.518 . . . . 0.0 111.57 173.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.2 t -71.89 -71.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.588 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -173.7 34.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.397 0.679 . . . . 0.0 110.786 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.21 35.78 56.68 Favored Glycine 0 N--CA 1.476 1.322 0 CA-C-N 116.618 -0.265 . . . . 0.0 112.96 -168.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 63' ' ' ILE . . . -90.87 164.2 14.13 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.66 0.784 . . . . 0.0 110.457 -173.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.512 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 97.2 m-85 -102.76 148.2 25.9 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.421 ' HB1' ' HG3' ' A' ' 39' ' ' ARG . . . -128.23 137.53 52.05 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.0 tp -112.06 104.0 12.22 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 47.4 m -104.26 114.08 28.07 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -174.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.68 141.44 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 -175.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 47.3 tp -126.96 144.45 51.01 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.946 0.898 . . . . 0.0 109.463 -176.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -154.26 109.58 3.14 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 46.19 71.59 0.28 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.544 1.138 . . . . 0.0 112.739 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 56.51 20.61 4.98 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.413 1.085 . . . . 0.0 113.74 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -124.86 108.9 12.39 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 120.921 0.391 . . . . 0.0 110.088 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.7 t -94.4 147.72 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 124.423 1.089 . . . . 0.0 110.046 -178.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.91 113.19 8.77 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.88 1.272 . . . . 0.0 107.599 174.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 66.5 p -107.93 138.38 44.28 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.466 ' HH ' ' HA ' ' A' ' 101' ' ' LEU . 41.9 m-85 -126.24 100.41 6.29 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -77.67 95.57 4.64 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.639 0.733 . . . . 0.0 109.48 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.518 HG23 HD13 ' A' ' 71' ' ' LEU . 32.5 mt -71.32 133.94 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.216 171.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -90.04 128.0 51.48 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 174.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -81.06 -81.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 123.1 2.533 . . . . 0.0 115.13 -157.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -149.8 160.85 43.23 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 118.262 0.483 . . . . 0.0 110.261 -163.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.58 -46.62 1.02 Allowed Glycine 0 N--CA 1.468 0.819 0 N-CA-C 107.417 -2.273 . . . . 0.0 107.417 -169.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -65.02 -147.07 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.649 0 CA-C-N 113.321 -1.439 . . . . 0.0 111.314 155.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -112.37 -24.36 9.81 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.512 0.725 . . . . 0.0 110.289 173.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -130.13 162.42 28.88 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.902 1.281 . . . . 0.0 110.985 -169.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.518 HD13 HG23 ' A' ' 63' ' ' ILE . 0.5 OUTLIER -102.95 132.02 49.49 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.426 1.09 . . . . 0.0 110.186 178.625 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.434 ' HA ' ' HG3' ' A' ' 83' ' ' ARG . . . -105.26 113.9 27.76 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.529 0.731 . . . . 0.0 112.802 -172.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.446 ' O ' HG12 ' A' ' 81' ' ' VAL . 23.0 t -85.32 138.73 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.69 0.796 . . . . 0.0 109.281 177.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -99.89 91.97 5.07 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.3 m -72.41 -65.39 0.79 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.079 0.551 . . . . 0.0 112.248 -166.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.2 t -168.82 178.23 4.69 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.668 0.387 . . . . 0.0 111.207 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -61.49 -39.01 89.4 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.718 1.207 . . . . 0.0 114.17 -168.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -139.68 40.86 1.37 Allowed Glycine 0 N--CA 1.472 1.081 0 CA-C-O 120.758 0.088 . . . . 0.0 113.044 -171.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.5 m -122.92 155.23 64.1 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 123.848 0.859 . . . . 0.0 109.285 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -65.61 128.65 20.54 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.556 2.171 . . . . 0.0 111.24 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 73' ' ' VAL . 45.6 t -90.02 126.57 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -120.29 139.2 53.07 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.12 0.568 . . . . 0.0 109.528 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.434 ' HG3' ' HA ' ' A' ' 72' ' ' ALA . 0.8 OUTLIER -101.99 157.67 16.7 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.348 1.059 . . . . 0.0 108.702 178.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.595 ' HE1' HD11 ' A' ' 93' ' ' LEU . 95.4 m-85 -130.99 160.67 33.89 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.815 0.846 . . . . 0.0 109.103 -173.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -99.35 -18.41 17.54 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.512 0.325 . . . . 0.0 110.489 174.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.8 p -146.7 154.0 40.91 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.764 0.826 . . . . 0.0 110.141 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' A' ' 90' ' ' LEU . 96.1 mt -64.15 -25.56 68.14 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.154 0.982 . . . . 0.0 111.805 173.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -56.89 -42.65 92.43 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 116.574 -0.284 . . . . 0.0 113.026 172.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -68.09 -34.08 75.74 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.668 0.787 . . . . 0.0 111.095 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.444 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 22.7 tp -56.24 -58.97 5.71 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.896 0.878 . . . . 0.0 110.262 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 44.9 mm -62.77 -37.92 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.747 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.2 -55.64 28.36 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 115.032 -0.986 . . . . 0.0 113.747 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.595 HD11 ' HE1' ' A' ' 84' ' ' PHE . 34.5 mt -75.77 -42.58 49.92 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -177.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -72.42 -7.41 49.62 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.6 -3.38 4.51 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 171.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 93' ' ' LEU . 13.4 pt20 -95.98 141.01 22.55 Favored Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 123.008 0.523 . . . . 0.0 109.685 174.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 96' ' ' GLN . 4.2 Cg_exo -78.84 173.27 13.81 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.829 2.352 . . . . 0.0 112.706 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 54.16 82.79 0.08 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.478 1.511 . . . . 0.0 111.885 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -159.35 9.43 0.12 Allowed 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.738 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.31 -13.62 56.99 Favored Glycine 0 N--CA 1.476 1.316 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -175.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.466 ' HA ' ' HH ' ' A' ' 61' ' ' TYR . 2.2 mm? -65.58 153.31 41.89 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.411 1.484 . . . . 0.0 111.849 175.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.8 m -82.65 76.3 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 164.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 104' ' ' ALA . 42.8 t 75.75 170.95 0.26 Allowed 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 113.879 -1.509 . . . . 0.0 110.6 -174.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.44 ' N ' ' SG ' ' A' ' 103' ' ' CYS . . . -72.47 166.48 22.52 Favored 'General case' 0 C--O 1.249 1.033 0 C-N-CA 122.984 0.514 . . . . 0.0 109.677 176.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 29.1 mt -73.68 92.58 1.99 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -85.15 -59.91 2.19 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.953 -170.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 35' ' ' SER . 50.3 tp -147.58 127.55 6.66 Favored Pre-proline 0 N--CA 1.469 0.524 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -175.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.471 ' HD2' HD13 ' A' ' 107' ' ' LEU . 10.6 Cg_endo -54.16 -72.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.156 1.904 . . . . 0.0 111.37 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 50.2 t . . . . . 0 C--O 1.252 1.187 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 174.977 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.5 t . . . . . 0 N--CA 1.475 0.796 0 CA-C-O 121.404 0.621 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.542 ' HB2' ' HA ' ' A' ' 37' ' ' LEU . 1.9 p-90 -80.75 -23.17 39.59 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 28.4 t80 -75.53 105.41 6.55 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.034 0.933 . . . . 0.0 110.422 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -127.36 108.24 10.67 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -54.68 150.4 9.61 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 123.335 0.654 . . . . 0.0 111.334 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.492 ' H ' ' HB3' ' A' ' 40' ' ' ASP . 37.7 t70 -9.71 76.31 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -149.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.444 ' O ' ' HB1' ' A' ' 22' ' ' ALA . 28.5 tp -62.14 -26.4 68.29 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.5 168.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.4 t 82.14 138.44 0.06 Allowed 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 125.587 1.555 . . . . 0.0 108.622 174.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -58.76 -45.39 89.86 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.111 0.564 . . . . 0.0 112.198 -168.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.42 -50.44 71.48 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.879 0.871 . . . . 0.0 111.516 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 18' ' ' LEU . . . -73.7 -19.03 60.93 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.704 -178.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.579 ' HB1' HD12 ' A' ' 37' ' ' LEU . . . -74.38 -53.33 9.83 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.147 0.979 . . . . 0.0 110.545 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.55 ' HA ' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -68.95 -21.91 64.16 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 123.682 0.614 . . . . 0.0 110.916 178.155 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -71.54 -51.2 24.77 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.091 0.556 . . . . 0.0 110.501 172.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.4 tp -57.98 -31.69 67.14 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.339 0.656 . . . . 0.0 111.578 174.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.55 HD13 ' HA ' ' A' ' 24' ' ' GLU . 85.6 mt -62.48 -59.95 4.24 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.75 -40.31 66.08 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.833 0.853 . . . . 0.0 112.937 -176.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -77.85 -55.45 5.31 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.578 0.751 . . . . 0.0 111.951 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.3 -60.9 2.05 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.064 0.545 . . . . 0.0 111.257 -172.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.69 82.18 0.31 Allowed Glycine 0 C--N 1.335 0.523 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -70.61 14.39 0.14 Allowed 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -166.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 175.16 138.56 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.172 0.989 . . . . 0.0 108.695 -171.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.92 -4.57 29.89 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 115.088 0.795 . . . . 0.0 115.088 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.5 m -86.92 161.88 18.02 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -166.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -151.23 153.19 34.42 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.878 0.871 . . . . 0.0 109.346 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.579 HD12 ' HB1' ' A' ' 23' ' ' ALA . 3.2 pp -149.82 155.17 39.63 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.446 0.699 . . . . 0.0 109.836 170.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 70.9 t -112.77 131.72 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -119.82 170.37 9.3 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.908 0.883 . . . . 0.0 109.594 175.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.492 ' HB3' ' H ' ' A' ' 17' ' ' ASP . 35.0 t70 -83.63 130.23 34.98 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 172.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.0 t -68.18 152.3 45.69 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.488 0.715 . . . . 0.0 111.118 -176.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -110.77 -36.52 5.68 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.4 t -54.45 -45.05 73.03 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.624 1.17 . . . . 0.0 111.061 173.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 65.1 t -130.12 115.92 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.52 0.728 . . . . 0.0 109.379 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.13 130.41 42.63 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.431 0.692 . . . . 0.0 110.877 174.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.46 -0.63 68.37 Favored Glycine 0 C--N 1.352 1.443 0 C-N-CA 122.894 0.283 . . . . 0.0 112.757 -177.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.0 176.75 4.95 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.897 0.879 . . . . 0.0 112.0 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.456 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 48.7 m-85 -126.0 168.67 13.62 Favored 'General case' 0 C--O 1.249 1.04 0 C-N-CA 124.888 1.275 . . . . 0.0 110.434 -176.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.56 148.47 42.6 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.059 1.344 . . . . 0.0 109.686 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.8 tp -123.73 114.64 20.2 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.112 0.965 . . . . 0.0 108.996 -176.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.488 ' HG ' HG22 ' A' ' 60' ' ' THR . 60.5 m -107.44 121.65 45.04 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.3 t -126.66 132.39 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -173.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 68.6 tp -123.84 118.15 26.46 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.93 0.892 . . . . 0.0 110.104 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -136.07 132.11 35.74 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 166.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 42.19 61.55 1.94 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 124.977 1.311 . . . . 0.0 113.562 -176.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm 62.92 2.34 0.99 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 125.194 1.398 . . . . 0.0 113.673 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -103.65 105.89 16.25 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -173.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.0 t -86.06 139.63 17.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.066 0.946 . . . . 0.0 109.413 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -135.16 115.52 13.48 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 173.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.488 HG22 ' HG ' ' A' ' 51' ' ' CYS . 51.5 m -109.66 130.79 55.48 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.539 ' HH ' HD13 ' A' ' 101' ' ' LEU . 61.5 m-85 -110.59 156.43 20.95 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.895 1.278 . . . . 0.0 108.26 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -100.91 156.52 17.34 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 163.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.644 HG13 HG11 ' A' ' 73' ' ' VAL . 2.9 mp -144.47 100.5 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 101.564 -3.495 . . . . 0.0 101.564 -167.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.21 154.76 37.44 Favored Pre-proline 0 C--N 1.318 -0.781 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -169.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.97 -73.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 121.485 1.457 . . . . 0.0 111.302 163.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 43.82 73.85 0.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.762 1.225 . . . . 0.0 111.925 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.24 -100.65 0.15 Allowed Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.026 -174.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 158.97 -25.09 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 126.167 1.787 . . . . 0.0 108.271 -170.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -152.07 -2.89 0.27 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.704 0.801 . . . . 0.0 112.121 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -119.59 160.83 21.71 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.733 0.813 . . . . 0.0 109.495 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -115.12 121.42 42.97 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.615 0.766 . . . . 0.0 109.377 173.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.14 117.9 33.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.56 0.744 . . . . 0.0 110.7 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.644 HG11 HG13 ' A' ' 63' ' ' ILE . 25.6 t -92.09 145.14 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.788 -177.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -101.13 90.12 4.03 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.68 173.22 10.09 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.762 178.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.4 t -65.54 108.32 1.98 Allowed 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -56.7 101.63 0.06 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.147 0.979 . . . . 0.0 110.293 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.32 -24.45 0.45 Allowed Glycine 0 CA--C 1.529 0.953 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -165.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.1 m -118.0 162.27 30.36 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 125.326 1.45 . . . . 0.0 107.654 168.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -63.01 132.12 35.5 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.247 1.965 . . . . 0.0 112.271 176.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 94.2 t -71.58 123.37 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.563 0.745 . . . . 0.0 109.746 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.502 ' HG2' HD12 ' A' ' 93' ' ' LEU . 10.6 tpt180 -111.97 121.75 45.87 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 123.17 0.294 . . . . 0.0 110.89 -175.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.67 155.79 16.62 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.938 0.895 . . . . 0.0 109.19 170.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -133.96 165.6 24.64 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.614 0.766 . . . . 0.0 110.374 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -89.36 -23.99 22.08 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.991 0.516 . . . . 0.0 111.049 168.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.1 t -147.95 155.39 41.5 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.774 0.43 . . . . 0.0 111.195 -175.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.473 ' O ' HG12 ' A' ' 91' ' ' ILE . 86.1 mt -60.14 -31.04 69.7 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.854 0.861 . . . . 0.0 112.132 175.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.94 -47.34 31.96 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 123.094 0.378 . . . . 0.0 114.021 176.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -69.69 -30.28 67.9 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.375 0.67 . . . . 0.0 111.318 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.2 tt -66.86 -36.67 82.85 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.699 0.8 . . . . 0.0 109.13 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 87' ' ' LEU . 47.2 mm -80.92 -40.14 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -169.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.97 -38.98 64.18 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.79 -0.641 . . . . 0.0 113.471 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.502 HD12 ' HG2' ' A' ' 82' ' ' ARG . 7.9 tt -73.42 -36.11 65.93 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.571 0.348 . . . . 0.0 110.189 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.483 ' CD2' HD22 ' A' ' 101' ' ' LEU . 2.0 m-85 -84.28 -9.39 58.53 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.871 0.468 . . . . 0.0 110.613 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.37 0.4 17.0 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.383 0.673 . . . . 0.0 111.287 165.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -92.63 125.69 54.79 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 169.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -66.24 172.64 8.53 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.776 2.317 . . . . 0.0 113.029 171.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.3 t30 55.4 39.62 31.22 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.661 1.185 . . . . 0.0 111.548 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -122.09 10.07 10.0 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.661 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 99.56 -14.01 60.88 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -174.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.539 HD13 ' HH ' ' A' ' 61' ' ' TYR . 4.1 mm? -72.56 150.73 42.89 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.19 1.396 . . . . 0.0 110.702 176.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.4 m -84.34 74.91 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-O 122.206 1.003 . . . . 0.0 109.558 172.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 39.6 t 72.59 27.83 2.27 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 113.438 -1.71 . . . . 0.0 111.25 172.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 77.85 165.5 0.23 Allowed 'General case' 0 C--N 1.354 0.781 0 C-N-CA 125.076 1.35 . . . . 0.0 112.937 172.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.8 mt -76.71 101.81 5.95 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.293 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 78.2 mt -104.78 -50.73 3.21 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 122.957 0.503 . . . . 0.0 112.091 -172.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 mp -113.05 130.16 23.82 Favored Pre-proline 0 N--CA 1.491 1.61 0 CA-C-O 118.776 -0.63 . . . . 0.0 109.766 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -83.48 9.4 4.12 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.79 2.326 . . . . 0.0 113.234 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.523 HG23 HD22 ' A' ' 37' ' ' LEU . 49.3 t . . . . . 0 C--O 1.252 1.214 0 C-N-CA 125.382 1.473 . . . . 0.0 109.396 -172.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.8 m . . . . . 0 CA--C 1.539 0.536 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -83.76 1.36 43.24 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -165.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -105.06 96.44 6.53 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -170.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -110.2 89.97 3.18 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.27 52.39 2.01 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.017 0.913 . . . . 0.0 110.558 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -146.77 -17.76 0.42 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.725 1.61 . . . . 0.0 109.748 -174.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 28.7 tp -112.36 100.34 8.71 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.457 0.703 . . . . 0.0 110.26 -164.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.2 p -47.07 157.25 0.18 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 125.161 1.384 . . . . 0.0 112.801 172.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.39 -37.1 86.34 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.255 0.622 . . . . 0.0 112.096 -172.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.29 -51.27 68.38 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.392 0.677 . . . . 0.0 111.014 177.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.77 -20.08 61.24 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.934 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.417 ' HB3' HD11 ' A' ' 37' ' ' LEU . . . -69.6 -55.58 9.7 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.296 0.638 . . . . 0.0 110.738 178.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.46 ' HB3' ' SG ' ' A' ' 51' ' ' CYS . 12.3 pt-20 -70.2 -26.54 63.92 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.259 0.623 . . . . 0.0 111.719 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -64.9 -51.98 59.0 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -61.9 -35.39 78.23 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.062 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.6 mt -68.47 -33.82 74.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.585 0.354 . . . . 0.0 110.382 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.18 -37.77 81.33 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.995 0.809 . . . . 0.0 111.652 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -83.46 -44.01 15.2 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.056 0.542 . . . . 0.0 112.22 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.39 -58.2 3.24 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.213 0.605 . . . . 0.0 112.018 -169.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -100.07 -35.76 4.4 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.751 -176.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 66.15 -7.72 0.38 Allowed 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 126.322 1.849 . . . . 0.0 114.452 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -171.18 127.79 0.7 Allowed 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 124.818 1.247 . . . . 0.0 107.647 -165.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.489 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . 65.05 11.61 52.05 Favored Glycine 0 N--CA 1.478 1.467 0 N-CA-C 114.107 0.403 . . . . 0.0 114.107 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.8 m -83.35 143.47 30.31 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.83 0.852 . . . . 0.0 110.278 -168.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -152.92 154.59 35.35 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.06 0.457 . . . . 0.0 110.52 176.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.417 HD11 ' HB3' ' A' ' 23' ' ' ALA . 4.6 pp -151.62 153.66 34.91 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.777 169.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.512 HG21 HD13 ' A' ' 50' ' ' LEU . 40.1 t -107.25 145.64 14.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.516 ' HG3' ' HB3' ' A' ' 49' ' ' ALA . 0.9 OUTLIER -138.94 -179.36 5.79 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 125.308 1.443 . . . . 0.0 108.312 -178.472 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -91.34 148.11 22.56 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 172.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.532 ' HB2' ' HB ' ' A' ' 44' ' ' VAL . 40.9 m -61.92 140.69 58.28 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.987 0.515 . . . . 0.0 110.412 173.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -35.35 -54.53 0.65 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 126.356 1.862 . . . . 0.0 114.168 -167.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.1 m -142.61 28.87 1.59 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.91 0.484 . . . . 0.0 110.045 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.532 ' HB ' ' HB2' ' A' ' 41' ' ' SER . 24.2 t -110.24 112.1 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.37 117.98 8.04 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.037 -177.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.89 -0.46 89.47 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 114.537 0.575 . . . . 0.0 114.537 172.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -92.92 155.24 17.71 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 117.161 0.481 . . . . 0.0 109.834 173.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.533 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 68.3 m-85 -110.67 158.24 18.83 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.647 0.736 . . . . 0.0 109.753 -175.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.516 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . . . -135.06 147.37 49.59 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 166.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.512 HD13 HG21 ' A' ' 38' ' ' VAL . 45.6 tp -125.77 139.24 53.68 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -177.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.46 ' SG ' ' HB3' ' A' ' 24' ' ' GLU . 44.6 t -124.84 128.55 48.87 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 175.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.626 HG13 ' SG ' ' A' ' 103' ' ' CYS . 12.8 t -137.0 140.41 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 123.538 0.735 . . . . 0.0 109.779 -176.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.7 tp -132.34 120.52 22.19 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.609 1.164 . . . . 0.0 110.148 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -147.77 146.14 29.07 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.473 0.709 . . . . 0.0 109.089 168.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 50.3 47.58 23.58 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.74 1.216 . . . . 0.0 111.837 -177.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt 54.75 27.68 9.14 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.641 1.177 . . . . 0.0 112.716 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -123.72 107.26 11.27 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.228 1.011 . . . . 0.0 108.888 -174.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.5 t -83.73 131.54 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.441 ' HD1' HG12 ' A' ' 102' ' ' VAL . 14.2 t-160 -135.84 111.08 9.0 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 176.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.2 p -104.87 127.22 52.61 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.961 0.904 . . . . 0.0 108.614 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -113.25 101.02 9.01 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.033 0.933 . . . . 0.0 108.846 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 84.4 mtm180 -70.9 155.63 40.57 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 168.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 91.7 mt -145.86 100.92 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 102.601 -3.111 . . . . 0.0 102.601 -152.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 mp -113.36 101.71 53.9 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 122.814 0.446 . . . . 0.0 110.617 -161.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.662 ' HB2' ' HA ' ' A' ' 68' ' ' GLU . 39.7 Cg_endo -66.3 103.62 0.67 Allowed 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.086 1.857 . . . . 0.0 110.02 167.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.16 -52.8 62.35 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.849 0.86 . . . . 0.0 110.446 -169.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -116.86 34.04 4.8 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.577 174.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.662 ' HA ' ' HB2' ' A' ' 65' ' ' PRO . 46.5 mt-10 50.29 4.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 -173.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -84.85 -49.21 8.6 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 119.602 1.092 . . . . 0.0 109.695 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 31.3 m-85 -127.57 142.07 51.47 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.715 0.806 . . . . 0.0 109.933 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -99.23 114.9 27.95 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.7 1.2 . . . . 0.0 108.736 -176.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.97 119.39 35.35 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.243 1.017 . . . . 0.0 111.277 -170.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.418 HG23 HG22 ' A' ' 63' ' ' ILE . 16.1 t -106.96 143.67 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.057 0.943 . . . . 0.0 108.956 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -113.49 91.89 3.8 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -172.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.6 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 30.7 p -108.26 28.36 8.38 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.897 0.879 . . . . 0.0 110.482 -177.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.4 m -68.66 94.52 0.59 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.975 0.91 . . . . 0.0 113.353 -167.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -118.41 2.02 11.82 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 124.229 1.012 . . . . 0.0 110.165 164.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.48 22.88 0.03 OUTLIER Glycine 0 N--CA 1.471 0.982 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.459 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.9 m -140.27 152.42 66.96 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.503 1.121 . . . . 0.0 108.969 -174.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -73.32 -175.19 1.88 Allowed 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.375 2.05 . . . . 0.0 111.903 172.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 62.9 t -76.63 123.92 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 176.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 39.8 tpt85 -100.7 116.07 31.74 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -175.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.436 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 32.2 mtp85 -95.33 145.07 25.37 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.292 1.037 . . . . 0.0 110.07 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.622 ' HE1' HD13 ' A' ' 93' ' ' LEU . 83.6 m-85 -126.93 152.87 46.55 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.905 0.882 . . . . 0.0 109.181 -178.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -85.7 -21.56 28.24 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 172.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.7 t -153.33 158.25 41.28 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 122.998 0.519 . . . . 0.0 110.725 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.98 -27.54 68.9 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.238 1.015 . . . . 0.0 109.979 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -52.83 -46.19 60.45 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-N 116.364 -0.38 . . . . 0.0 113.999 173.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -66.88 -30.7 70.93 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.442 0.697 . . . . 0.0 110.97 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.0 tt -62.53 -57.95 9.33 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.319 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.491 ' HA ' HD11 ' A' ' 105' ' ' LEU . 38.3 mm -54.41 -46.11 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.67 0.788 . . . . 0.0 111.206 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.05 -56.96 14.21 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 114.568 -1.196 . . . . 0.0 113.75 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.622 HD13 ' HE1' ' A' ' 84' ' ' PHE . 86.7 mt -74.0 -37.02 64.54 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.944 0.498 . . . . 0.0 111.675 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.409 ' HE2' HG11 ' A' ' 73' ' ' VAL . 5.9 m-30 -82.28 -5.51 58.6 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -169.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.13 -5.37 26.59 Favored 'General case' 0 CA--C 1.562 1.429 0 CA-C-O 120.805 0.336 . . . . 0.0 111.418 165.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -97.13 130.56 29.49 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 124.726 1.21 . . . . 0.0 109.095 173.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.47 -175.66 2.79 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.892 2.395 . . . . 0.0 113.311 173.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.6 t30 49.22 71.9 0.34 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 126.041 1.736 . . . . 0.0 112.277 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.552 ' HG3' HD21 ' A' ' 101' ' ' LEU . 12.7 pt20 -176.45 11.3 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.427 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.6 ' HA3' ' HB ' ' A' ' 75' ' ' THR . . . 122.94 -32.89 4.25 Favored Glycine 0 C--N 1.345 1.074 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -173.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.552 HD21 ' HG3' ' A' ' 99' ' ' GLN . 3.4 mm? -76.66 101.41 5.74 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.533 0.733 . . . . 0.0 109.287 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.451 HG22 ' SG ' ' A' ' 103' ' ' CYS . 4.7 m -69.74 -15.08 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.783 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.626 ' SG ' HG13 ' A' ' 52' ' ' VAL . 14.6 m -115.29 -47.38 2.85 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.582 1.153 . . . . 0.0 111.617 -174.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 69.94 139.34 0.04 OUTLIER 'General case' 0 C--N 1.357 0.906 0 O-C-N 125.27 1.606 . . . . 0.0 108.973 -158.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.491 HD11 ' HA ' ' A' ' 91' ' ' ILE . 46.0 mt -69.94 101.42 1.77 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -170.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.489 HD21 ' HA3' ' A' ' 34' ' ' GLY . 57.7 tp -108.68 -60.49 1.74 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.346 1.058 . . . . 0.0 111.056 -169.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 60.6 tp -120.48 101.41 46.35 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 123.165 0.586 . . . . 0.0 109.999 -169.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.38 122.0 5.89 Favored 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 122.884 2.389 . . . . 0.0 110.352 174.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 C--O 1.244 0.81 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.57 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.7 p . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . 4.9 p-90 -79.54 -21.35 45.28 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -175.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 89.0 t80 -81.66 125.79 31.0 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.486 171.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -117.67 129.76 55.94 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.43 ' O ' ' HB3' ' A' ' 40' ' ' ASP . 1.6 mpp_? -75.08 -37.93 61.44 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -174.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -130.93 90.1 2.84 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.988 0.899 . . . . 0.0 109.897 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.9 tp -135.59 139.77 44.11 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.841 1.256 . . . . 0.0 107.764 175.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.3 t -99.0 167.09 10.95 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.312 0.645 . . . . 0.0 110.342 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -64.74 -40.08 94.7 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.875 0.87 . . . . 0.0 113.184 -172.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.89 -48.34 77.04 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.067 0.547 . . . . 0.0 110.801 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.55 -30.81 70.54 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.674 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.486 ' HB3' HD13 ' A' ' 37' ' ' LEU . . . -65.98 -57.26 8.21 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.123 0.569 . . . . 0.0 110.922 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -58.01 -38.74 76.72 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.877 1.271 . . . . 0.0 112.041 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -70.17 -45.04 67.55 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.395 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.2 tp -58.16 -34.28 70.13 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.981 0.912 . . . . 0.0 111.441 175.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 23' ' ' ALA . 96.5 mt -66.11 -53.05 42.82 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.62 -39.14 87.12 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.265 1.026 . . . . 0.0 112.695 -172.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -73.37 -52.09 15.06 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.748 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.21 -56.18 3.79 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -166.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -101.98 -46.69 1.57 Allowed Glycine 0 N--CA 1.475 1.267 0 N-CA-C 113.404 0.121 . . . . 0.0 113.404 -172.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 49.05 21.49 0.49 Allowed 'General case' 0 CA--C 1.57 1.747 0 C-N-CA 126.196 1.798 . . . . 0.0 114.827 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -170.64 100.43 0.24 Allowed 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.27 -0.894 . . . . 0.0 109.361 -168.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.404 ' HA3' ' HB2' ' A' ' 106' ' ' LEU . . . 66.44 19.05 68.36 Favored Glycine 0 C--N 1.353 1.488 0 CA-C-O 121.465 0.48 . . . . 0.0 112.394 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 9.2 m -84.55 122.8 29.53 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 124.533 1.133 . . . . 0.0 110.859 -167.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 36.7 p90 -129.76 156.7 43.89 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.986 0.422 . . . . 0.0 110.725 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.486 HD13 ' HB3' ' A' ' 23' ' ' ALA . 4.3 pp -150.2 160.11 43.93 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 167.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 57.4 t -114.23 148.54 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 174.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -149.05 151.94 35.37 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.308 0.643 . . . . 0.0 109.476 -174.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.43 ' HB3' ' O ' ' A' ' 16' ' ' ARG . 25.3 t70 -91.11 118.33 30.34 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 174.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.3 m -92.69 97.33 10.72 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -173.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -55.29 -39.17 69.56 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.058 0.943 . . . . 0.0 112.325 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.6 m -58.31 -24.34 59.28 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.2 t -80.27 -87.0 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-O 119.476 -0.297 . . . . 0.0 110.913 -174.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -178.03 18.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 122.909 0.484 . . . . 0.0 111.595 -167.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.75 88.03 1.2 Allowed Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -159.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.3 163.75 39.71 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.717 0.807 . . . . 0.0 109.789 -170.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.594 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 21.2 m-85 -116.01 162.23 17.7 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.37 0.668 . . . . 0.0 109.69 168.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.55 149.38 43.81 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.169 0.988 . . . . 0.0 110.1 170.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.495 ' HB2' HD11 ' A' ' 63' ' ' ILE . 51.9 tp -117.2 111.29 19.24 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 55.4 m -101.17 121.52 41.98 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.4 t -125.19 143.52 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.48 HD11 HG22 ' A' ' 58' ' ' VAL . 51.0 tp -133.0 147.4 52.27 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.366 1.066 . . . . 0.0 109.214 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -162.33 115.88 1.77 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.9 tm0? 36.06 73.75 0.08 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 125.907 1.683 . . . . 0.0 112.612 -174.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 44.6 tptt 56.64 26.41 11.15 Favored 'General case' 0 CA--C 1.572 1.825 0 C-N-CA 124.391 1.076 . . . . 0.0 112.684 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -130.19 107.33 9.22 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 121.482 -0.761 . . . . 0.0 109.272 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.48 HG22 HD11 ' A' ' 53' ' ' LEU . 21.6 t -93.1 142.0 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.506 0.722 . . . . 0.0 109.995 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -137.14 112.77 9.43 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.639 1.576 . . . . 0.0 107.754 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.9 m -119.37 140.17 50.79 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.416 ' HH ' ' HA ' ' A' ' 101' ' ' LEU . 45.2 m-85 -133.98 113.8 12.55 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.719 0.807 . . . . 0.0 109.41 -173.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -64.79 156.89 29.16 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 171.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.594 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 79.7 mt -148.33 104.32 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 -158.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -96.01 102.44 10.65 Favored Pre-proline 0 N--CA 1.478 0.93 0 CA-C-N 118.885 0.766 . . . . 0.0 109.453 -168.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.438 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 93.1 Cg_endo -76.73 -56.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 123.043 2.495 . . . . 0.0 115.99 -163.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -125.9 141.02 52.17 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 118.146 0.43 . . . . 0.0 111.081 -162.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.05 -16.44 0.24 Allowed Glycine 0 CA--C 1.534 1.236 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.161 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -146.84 -70.5 0.24 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.776 1.231 . . . . 0.0 108.592 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -166.62 -41.31 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.989 -175.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -110.16 151.18 27.6 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.766 0.426 . . . . 0.0 111.222 -167.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.438 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 3.8 pp -99.73 111.58 23.9 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 171.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -101.1 123.48 45.33 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.133 0.573 . . . . 0.0 110.541 -173.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.774 HG22 HD12 ' A' ' 90' ' ' LEU . 57.5 t -93.91 138.12 21.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -95.54 88.45 5.06 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.407 ' HB ' HG22 ' A' ' 81' ' ' VAL . 1.6 m -73.44 -77.95 0.1 Allowed 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.416 -173.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.42 ' HB2' HG23 ' A' ' 79' ' ' VAL . 66.6 m -161.15 128.29 4.1 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.799 0.84 . . . . 0.0 110.437 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.4 mp0 -70.07 92.87 0.76 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 169.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.53 -36.13 0.69 Allowed Glycine 0 C--N 1.346 1.099 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -170.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.459 ' HB ' ' HB3' ' A' ' 99' ' ' GLN . 13.0 m -104.89 158.34 32.23 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 123.495 0.718 . . . . 0.0 109.171 177.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.36 111.05 1.18 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.256 1.971 . . . . 0.0 110.869 167.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.407 HG22 ' HB ' ' A' ' 75' ' ' THR . 95.7 t -93.6 132.25 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.944 0.898 . . . . 0.0 108.675 -177.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -112.13 136.13 51.91 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.948 0.499 . . . . 0.0 110.454 -173.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -89.92 140.97 29.1 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.303 1.041 . . . . 0.0 109.328 174.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -111.17 174.45 5.86 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.449 1.099 . . . . 0.0 110.207 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -120.08 -49.64 2.29 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -164.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.8 m -128.73 161.26 30.14 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 113.495 -1.684 . . . . 0.0 107.697 171.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.47 -26.13 67.7 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 118.647 0.658 . . . . 0.0 112.41 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -56.58 -34.93 64.93 Favored Glycine 0 N--CA 1.48 1.611 0 O-C-N 122.991 0.182 . . . . 0.0 113.47 169.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -67.45 -38.96 85.27 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.2 0.6 . . . . 0.0 110.677 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.774 HD12 HG22 ' A' ' 73' ' ' VAL . 37.6 tp -61.84 -64.71 0.85 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.855 0.862 . . . . 0.0 110.717 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.7 mm -59.68 -39.36 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.318 1.047 . . . . 0.0 111.063 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.18 -57.66 18.06 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.135 -0.939 . . . . 0.0 113.853 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.1 tt -67.63 -45.83 74.25 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.266 0.626 . . . . 0.0 110.101 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.478 ' HB3' ' HG ' ' A' ' 105' ' ' LEU . 5.7 m-30 -77.04 -12.15 59.9 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -170.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.42 -22.24 66.77 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.224 0.535 . . . . 0.0 110.835 169.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -94.45 139.25 22.31 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 174.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -46.3 117.75 2.13 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.105 2.537 . . . . 0.0 112.137 166.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -110.24 -58.37 2.08 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.518 -164.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.459 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . 9.4 mm-40 128.33 102.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 128.37 2.668 . . . . 0.0 107.595 -159.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 120.55 -39.91 2.31 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-O 120.117 -0.269 . . . . 0.0 113.432 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 94' ' ' TYR . 76.2 mt -68.9 150.28 47.93 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.8 p -64.49 -36.83 78.41 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.174 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 49.0 t -165.25 20.64 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.268 0.627 . . . . 0.0 111.146 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 72.14 167.97 0.31 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.611 1.165 . . . . 0.0 110.664 -169.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.478 ' HG ' ' HB3' ' A' ' 94' ' ' TYR . 23.4 mt -81.18 98.91 8.28 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.167 0.587 . . . . 0.0 109.611 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.404 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 89.8 mt -93.95 -46.5 7.14 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.459 0.704 . . . . 0.0 112.404 -172.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 35' ' ' SER . 68.5 tp -141.54 116.68 7.06 Favored Pre-proline 0 N--CA 1.486 1.373 0 C-N-CA 123.079 0.552 . . . . 0.0 111.055 -174.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.444 ' HB2' ' HB3' ' A' ' 13' ' ' TRP . 73.2 Cg_endo -77.94 136.38 14.83 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.372 2.048 . . . . 0.0 111.581 174.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--O 1.25 1.086 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.407 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 CA--C 1.553 1.095 0 CA-C-O 119.57 -0.252 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.502 ' HB3' ' HB3' ' A' ' 108' ' ' PRO . 6.1 p-90 -99.23 15.5 25.9 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.813 0.845 . . . . 0.0 112.005 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.436 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 61.7 t80 -113.76 116.09 28.83 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -131.23 99.16 4.77 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.207 0.603 . . . . 0.0 110.373 -177.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.478 ' HD3' ' N ' ' A' ' 17' ' ' ASP . 1.0 OUTLIER -72.73 150.59 42.74 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 167.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.478 ' N ' ' HD3' ' A' ' 16' ' ' ARG . 36.6 t70 79.19 3.54 2.33 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.891 1.276 . . . . 0.0 111.389 -175.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.2 tp -99.44 123.25 43.55 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.082 -1.011 . . . . 0.0 109.042 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.2 p -80.85 160.84 24.66 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.663 0.785 . . . . 0.0 109.917 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.45 ' HB3' ' NH2' ' A' ' 39' ' ' ARG . 5.5 ppt_? -64.63 -35.47 81.13 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 118.458 0.572 . . . . 0.0 112.252 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.87 -48.86 78.63 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.538 0.735 . . . . 0.0 110.75 175.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.21 -26.56 62.99 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.849 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.461 ' HB1' HD12 ' A' ' 37' ' ' LEU . . . -71.97 -54.55 9.62 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.72 0.808 . . . . 0.0 110.768 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.551 ' HG2' HG21 ' A' ' 58' ' ' VAL . 5.5 tm-20 -56.97 -39.72 75.14 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.951 1.3 . . . . 0.0 111.52 175.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.82 -46.72 80.78 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 123.976 0.798 . . . . 0.0 110.156 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -60.63 -43.87 97.02 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 124.088 0.868 . . . . 0.0 110.411 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.4 mt -65.26 -42.18 93.52 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.368 0.667 . . . . 0.0 110.186 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.47 -35.87 80.03 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.764 0.826 . . . . 0.0 111.604 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 46.5 ttt85 -77.69 -30.77 52.06 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.573 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.52 ' HB3' HG11 ' A' ' 109' ' ' VAL . . . -87.91 -61.43 1.72 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -172.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -125.31 -48.05 0.21 Allowed Glycine 0 N--CA 1.474 1.195 0 C-N-CA 122.951 0.31 . . . . 0.0 112.7 -169.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.461 ' HG3' HD23 ' A' ' 53' ' ' LEU . 40.2 ttp180 45.57 41.96 7.55 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.343 1.857 . . . . 0.0 114.541 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -174.16 88.52 0.06 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -174.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.512 ' HA2' ' SG ' ' A' ' 103' ' ' CYS . . . 83.75 12.75 76.91 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.785 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 m -83.75 118.93 24.23 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 124.634 1.173 . . . . 0.0 110.563 -169.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -125.98 158.92 34.05 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.084 0.468 . . . . 0.0 110.178 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.461 HD12 ' HB1' ' A' ' 23' ' ' ALA . 3.8 pp -153.7 164.94 37.44 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.731 166.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 97.7 t -119.27 148.64 22.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 170.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.45 ' NH2' ' HB3' ' A' ' 20' ' ' ARG . 43.7 ptt85 -153.6 -178.31 6.94 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -93.29 141.54 28.32 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 165.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.4 m -65.65 146.22 55.08 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 163.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -66.6 81.37 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -158.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.6 m 51.12 30.88 5.96 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.96 1.304 . . . . 0.0 112.654 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.1 m -72.46 -44.04 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.892 -168.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -174.01 9.32 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.441 0.697 . . . . 0.0 111.454 -169.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.77 19.19 60.16 Favored Glycine 0 N--CA 1.474 1.183 0 N-CA-C 112.141 -0.384 . . . . 0.0 112.141 -171.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.79 155.3 18.88 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.989 0.916 . . . . 0.0 111.681 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -106.55 158.85 16.62 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.023 0.929 . . . . 0.0 110.398 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.88 141.19 51.36 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.986 0.514 . . . . 0.0 110.136 169.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.599 HD23 HD23 ' A' ' 90' ' ' LEU . 51.9 tp -114.32 107.09 15.11 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.136 1.374 . . . . 0.0 107.495 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 42.5 t -104.04 114.37 28.57 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -175.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.7 t -120.61 133.14 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.025 0.93 . . . . 0.0 108.724 -175.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.461 HD23 ' HG3' ' A' ' 32' ' ' ARG . 12.3 tp -128.98 140.89 51.45 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.858 1.263 . . . . 0.0 109.283 -173.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -155.3 115.54 3.79 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 41.75 71.05 0.23 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.001 1.32 . . . . 0.0 113.892 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.9 mttt 59.31 23.4 11.83 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.407 1.083 . . . . 0.0 113.714 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -131.82 105.68 7.62 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.551 HG21 ' HG2' ' A' ' 24' ' ' GLU . 40.1 t -103.9 109.0 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.823 0.849 . . . . 0.0 109.053 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -103.02 123.33 46.41 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 171.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 36.8 m -120.01 141.9 49.29 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.046 0.939 . . . . 0.0 108.687 -172.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -124.39 100.44 6.68 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -172.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.5 mtp-105 -81.97 98.61 8.67 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.525 HG12 HG23 ' A' ' 73' ' ' VAL . 6.1 mt -75.45 110.51 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.362 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.0 mp -112.06 103.12 55.06 Favored Pre-proline 0 C--O 1.241 0.639 0 C-N-CA 124.887 1.275 . . . . 0.0 107.566 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.453 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 37.8 Cg_exo -58.05 -57.88 0.98 Allowed 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.259 1.972 . . . . 0.0 110.705 170.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.7 t70 56.01 36.09 26.74 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 122.788 1.28 . . . . 0.0 109.825 173.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.07 178.0 28.06 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.939 -165.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -108.9 -13.37 14.76 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 118.589 1.195 . . . . 0.0 111.029 -175.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -65.47 -85.0 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.451 0.701 . . . . 0.0 110.914 -174.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -131.04 155.68 46.46 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.675 0.75 . . . . 0.0 111.777 175.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.453 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -120.48 110.93 17.07 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.063 1.745 . . . . 0.0 107.578 169.346 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.12 132.0 43.33 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.147 0.579 . . . . 0.0 110.586 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.525 HG23 HG12 ' A' ' 63' ' ' ILE . 39.8 t -99.38 112.92 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -177.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -90.65 94.56 9.75 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.106 0.563 . . . . 0.0 109.923 -169.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.71 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 65.4 p -65.8 -27.88 68.6 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.612 0.765 . . . . 0.0 112.433 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.8 t -142.07 -169.97 3.05 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.006 0.922 . . . . 0.0 109.796 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -54.45 -55.3 30.28 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.473 1.109 . . . . 0.0 112.386 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.29 44.05 0.19 Allowed Glycine 0 CA--C 1.505 -0.536 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.855 176.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.0 m -69.32 166.3 31.01 Favored Pre-proline 0 CA--C 1.557 1.217 0 C-N-CA 123.347 0.659 . . . . 0.0 111.364 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.45 53.22 1.31 Allowed 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 122.89 2.393 . . . . 0.0 112.652 167.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.477 HG23 ' H ' ' A' ' 82' ' ' ARG . 4.3 p -55.85 176.44 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 C-N-CA 125.42 1.488 . . . . 0.0 111.989 162.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.477 ' H ' HG23 ' A' ' 81' ' ' VAL . 42.4 mmm-85 -108.93 140.49 42.34 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -169.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -95.18 126.44 40.5 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -112.18 166.01 11.65 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.447 0.467 . . . . 0.0 109.876 -175.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -132.27 -4.92 3.41 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.767 0.827 . . . . 0.0 109.006 169.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 88' ' ' GLY . 87.6 m -141.73 136.07 30.41 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.362 1.065 . . . . 0.0 109.645 -172.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 78.7 mt -66.35 -28.26 68.52 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.908 0.883 . . . . 0.0 111.125 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.423 ' H ' HG23 ' A' ' 86' ' ' THR . . . -57.65 -46.74 91.82 Favored Glycine 0 N--CA 1.475 1.234 0 N-CA-C 114.401 0.52 . . . . 0.0 114.401 174.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -65.56 -36.1 82.79 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.548 0.739 . . . . 0.0 111.01 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.599 HD23 HD23 ' A' ' 50' ' ' LEU . 6.5 tt -59.91 -63.68 1.21 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.937 1.295 . . . . 0.0 110.403 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 31.6 mm -60.67 -43.64 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.209 1.004 . . . . 0.0 110.94 -175.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.09 -48.69 66.44 Favored Glycine 0 C--N 1.343 0.955 0 O-C-N 124.219 0.95 . . . . 0.0 113.482 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.2 tt -67.04 -59.67 3.27 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.502 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . 20.2 m-85 -71.69 -5.9 37.19 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -166.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.67 -16.31 25.6 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.048 0.539 . . . . 0.0 111.867 165.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -90.76 146.46 34.08 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 173.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -91.72 -168.19 0.23 Allowed 'Trans proline' 0 C--N 1.363 1.338 0 C-N-CA 122.916 2.411 . . . . 0.0 111.939 172.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.4 t30 52.62 62.39 2.71 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.845 1.258 . . . . 0.0 111.868 176.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -174.31 5.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.985 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.71 ' HA3' ' HB ' ' A' ' 75' ' ' THR . . . 130.97 -31.49 3.17 Favored Glycine 0 N--CA 1.473 1.121 0 N-CA-C 112.221 -0.352 . . . . 0.0 112.221 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.502 ' HG ' ' HB3' ' A' ' 94' ' ' TYR . 3.9 mm? -83.17 97.34 8.77 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.5 m -46.63 -32.83 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 126.079 1.752 . . . . 0.0 114.533 -175.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.512 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 24.6 p -130.46 3.07 4.62 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.021 0.528 . . . . 0.0 111.731 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.423 ' HA ' ' HB3' ' A' ' 101' ' ' LEU . . . 66.6 -179.99 0.21 Allowed 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.344 1.028 . . . . 0.0 110.444 -171.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 60.9 mt -90.36 83.16 5.91 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 168.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.3 tp -110.3 -63.03 1.43 Allowed 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.161 -171.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.32 115.51 63.73 Favored Pre-proline 0 N--CA 1.485 1.305 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.502 ' HB3' ' HB3' ' A' ' 13' ' ' TRP . 4.9 Cg_exo -71.14 -90.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 121.805 1.67 . . . . 0.0 110.049 173.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.52 HG11 ' HB3' ' A' ' 30' ' ' ALA . 78.6 t . . . . . 0 C--O 1.254 1.342 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 172.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.7 t . . . . . 0 CA--C 1.556 1.195 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -70.68 -18.55 62.82 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.289 0.635 . . . . 0.0 110.033 172.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 76.2 t80 -85.54 130.42 34.58 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.129 0.572 . . . . 0.0 109.622 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -130.0 140.49 50.87 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -66.17 -53.53 36.35 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -169.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -155.67 72.34 0.79 Allowed 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 122.133 0.968 . . . . 0.0 111.44 175.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.677 HD22 HH21 ' A' ' 39' ' ' ARG . 8.7 tt -92.92 135.01 34.53 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 160.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.1 t -66.97 146.47 54.34 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.776 0.831 . . . . 0.0 110.043 -173.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.42 ' H ' ' NE ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -64.84 -42.24 95.08 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.671 0.389 . . . . 0.0 110.956 -176.422 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.15 -51.2 67.22 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.56 0.744 . . . . 0.0 111.306 172.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.22 -29.3 70.4 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.659 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.477 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -69.59 -45.82 67.77 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.535 1.134 . . . . 0.0 111.893 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 43.9 mt-10 -56.73 -44.46 81.68 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.669 0.787 . . . . 0.0 110.898 175.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.28 -40.02 86.1 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.412 177.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.5 -42.41 92.12 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.315 1.046 . . . . 0.0 109.65 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' A' ' 35' ' ' SER . 93.7 mt -65.52 -43.64 89.4 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.511 0.724 . . . . 0.0 110.461 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.95 -34.91 70.43 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 124.066 0.854 . . . . 0.0 112.283 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -87.83 -43.06 12.12 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.85 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.86 -61.79 1.86 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -167.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.419 ' HA3' ' HB3' ' A' ' 35' ' ' SER . . . -95.29 -33.0 6.72 Favored Glycine 0 C--N 1.352 1.465 0 CA-C-O 121.277 0.376 . . . . 0.0 112.368 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 68.07 0.61 2.47 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 126.904 2.081 . . . . 0.0 114.405 175.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.2 t70 175.53 125.71 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.29 0.636 . . . . 0.0 109.381 -175.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.57 6.06 70.01 Favored Glycine 0 N--CA 1.477 1.417 0 O-C-N 123.285 0.366 . . . . 0.0 112.714 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.606 ' HB2' HD21 ' A' ' 27' ' ' LEU . 3.1 p -80.69 136.9 36.27 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.022 0.929 . . . . 0.0 109.639 -172.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -137.13 158.51 44.28 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.817 0.447 . . . . 0.0 110.577 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.477 HD11 ' HB1' ' A' ' 23' ' ' ALA . 1.2 pp -155.23 165.98 34.97 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.19 0.996 . . . . 0.0 109.729 174.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 89.2 t -132.64 130.54 59.48 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 173.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.677 HH21 HD22 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -121.59 179.16 4.55 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 169.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -92.18 140.24 29.82 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 171.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.8 m -71.89 162.65 29.14 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.305 1.042 . . . . 0.0 111.613 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.84 -29.91 8.8 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.142 0.577 . . . . 0.0 110.704 -178.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.8 p -89.63 -58.21 2.6 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 123.739 0.816 . . . . 0.0 110.425 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.5 t -86.68 106.06 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -175.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.8 117.63 7.19 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.957 0.903 . . . . 0.0 111.773 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.42 -0.07 74.02 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-O 119.856 -0.413 . . . . 0.0 113.365 176.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.04 151.64 20.96 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 117.455 0.628 . . . . 0.0 111.689 -177.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -110.82 130.19 55.65 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.875 0.87 . . . . 0.0 111.333 -175.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.411 ' HB1' ' HG2' ' A' ' 39' ' ' ARG . . . -100.51 114.48 28.12 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.904 0.882 . . . . 0.0 110.251 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.5 tp -106.24 108.49 20.02 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 43.3 t -111.39 124.49 52.36 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.9 t -129.45 116.65 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.025 0.93 . . . . 0.0 109.675 -174.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.582 HD12 HG22 ' A' ' 58' ' ' VAL . 32.5 tp -86.34 142.83 28.2 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.058 0.943 . . . . 0.0 109.568 173.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -162.78 127.4 3.1 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.515 0.726 . . . . 0.0 109.719 167.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 47.35 62.78 2.25 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.5 1.52 . . . . 0.0 112.682 173.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.534 ' HB2' ' HZ1' ' A' ' 56' ' ' LYS . 0.1 OUTLIER 55.63 30.98 16.38 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.633 1.173 . . . . 0.0 111.949 179.676 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -141.52 105.93 4.84 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.265 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.582 HG22 HD12 ' A' ' 53' ' ' LEU . 2.7 t -92.98 122.8 44.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 172.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -114.98 140.29 49.15 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.9 p -111.76 136.58 50.83 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.842 0.857 . . . . 0.0 108.716 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -128.46 101.5 6.22 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -84.19 102.63 12.75 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.222 0.609 . . . . 0.0 109.825 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.43 ' H ' HD11 ' A' ' 63' ' ' ILE . 4.1 mp -71.39 129.86 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.935 168.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.61 139.82 23.36 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 123.709 0.804 . . . . 0.0 109.533 171.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 97.7 Cg_endo -83.11 111.51 1.9 Allowed 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.16 1.907 . . . . 0.0 111.129 169.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -69.43 -58.87 3.44 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.675 0.39 . . . . 0.0 110.185 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -96.74 33.04 5.98 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 119.543 -0.587 . . . . 0.0 112.548 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 69.49 -34.03 0.27 Allowed 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -89.11 -48.66 7.25 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.255 0.622 . . . . 0.0 111.094 -165.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -103.51 135.9 44.24 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 2.5 pp -106.68 151.1 25.54 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 172.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.522 ' HB1' ' HG2' ' A' ' 83' ' ' ARG . . . -138.93 134.23 32.92 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.163 -0.336 . . . . 0.0 111.481 -169.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.3 p -85.85 135.36 25.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 171.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -98.23 94.74 6.96 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.3 p -78.12 -63.84 1.3 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.407 0.683 . . . . 0.0 111.147 -170.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.516 ' HB3' HG23 ' A' ' 79' ' ' VAL . 41.3 t -177.37 140.15 0.27 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.916 0.886 . . . . 0.0 109.096 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -76.27 91.44 3.22 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 168.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.5 -27.15 0.42 Allowed Glycine 0 C--N 1.339 0.71 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -167.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.516 HG23 ' HB3' ' A' ' 76' ' ' SER . 34.7 m -127.4 156.58 74.8 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 124.482 1.113 . . . . 0.0 108.449 174.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.12 136.57 61.34 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.525 2.15 . . . . 0.0 112.986 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 95.9 t -94.68 134.52 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.103 0.961 . . . . 0.0 108.589 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.4 tpt85 -113.78 130.9 56.39 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.68 0.792 . . . . 0.0 109.998 -176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.522 ' HG2' ' HB1' ' A' ' 72' ' ' ALA . 48.1 mtm105 -101.81 156.08 17.73 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.046 0.939 . . . . 0.0 108.83 173.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -137.52 160.85 37.98 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.729 0.812 . . . . 0.0 109.059 -172.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -88.99 -24.1 22.47 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 173.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.464 HG22 ' H ' ' A' ' 88' ' ' GLY . 33.2 m -154.6 154.48 33.09 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 124.289 1.036 . . . . 0.0 109.974 -175.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.8 mt -58.85 -32.28 69.29 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.407 1.083 . . . . 0.0 112.272 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.464 ' H ' HG22 ' A' ' 86' ' ' THR . . . -54.15 -38.72 61.93 Favored Glycine 0 N--CA 1.476 1.319 0 O-C-N 123.613 0.571 . . . . 0.0 114.08 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -66.78 -38.24 86.14 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.298 0.639 . . . . 0.0 110.437 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.9 tt -61.27 -57.58 11.77 Favored 'General case' 0 C--O 1.209 -1.068 0 O-C-N 124.088 0.867 . . . . 0.0 110.306 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 30.9 mm -55.83 -45.28 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 C-N-CA 123.171 0.588 . . . . 0.0 112.099 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.8 -52.23 49.95 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.854 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 61.2 tp -69.09 -43.62 74.18 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.897 0.879 . . . . 0.0 111.526 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.451 ' HB3' HD13 ' A' ' 101' ' ' LEU . 41.8 m-85 -86.69 9.35 19.06 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.547 1.139 . . . . 0.0 112.841 -175.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.88 2.01 2.94 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 157.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -102.82 126.77 31.71 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 124.135 0.974 . . . . 0.0 111.013 174.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -71.7 -178.03 2.84 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.99 2.46 . . . . 0.0 112.802 171.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.5 t30 55.55 28.58 12.03 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 125.049 1.34 . . . . 0.0 111.93 -177.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -141.95 23.76 2.04 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.168 0.587 . . . . 0.0 111.323 -172.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 122.43 -39.15 2.36 Favored Glycine 0 C--N 1.347 1.163 0 C-N-CA 123.018 0.342 . . . . 0.0 112.355 174.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.451 HD13 ' HB3' ' A' ' 94' ' ' TYR . 19.5 mt -90.56 126.57 35.98 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 122.837 0.455 . . . . 0.0 110.899 -174.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.6 m -24.48 -47.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 C-N-CA 126.944 2.098 . . . . 0.0 115.186 176.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 46.2 t -160.91 29.76 0.15 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.537 0.735 . . . . 0.0 109.343 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 69.92 -177.17 0.21 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.624 1.17 . . . . 0.0 112.211 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.4 mt -85.94 101.33 12.79 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.841 177.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 75.6 mt -99.03 -58.95 1.82 Allowed 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -173.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.4 mp -119.05 103.48 47.76 Favored Pre-proline 0 N--CA 1.5 2.031 0 CA-C-N 118.879 0.763 . . . . 0.0 111.001 -174.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.14 115.22 4.27 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.883 2.389 . . . . 0.0 112.439 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 C--O 1.251 1.143 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -176.943 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 p . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.764 0.316 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.484 ' HB2' ' HA ' ' A' ' 37' ' ' LEU . 4.3 p-90 -79.93 -18.57 50.14 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 170.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.431 ' HE2' ' HD3' ' A' ' 16' ' ' ARG . 37.3 t80 -80.82 97.35 7.32 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 18' ' ' LEU . 96.4 m-70 -98.04 119.42 36.65 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.511 0.724 . . . . 0.0 110.143 -175.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.431 ' HD3' ' HE2' ' A' ' 14' ' ' TYR . 21.1 mmm180 -92.26 -9.46 42.05 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.915 1.286 . . . . 0.0 111.748 -178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -108.93 -9.42 15.13 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.55 0.74 . . . . 0.0 110.778 -174.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 15' ' ' HIS . 0.9 OUTLIER -113.27 131.07 56.06 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.317 1.047 . . . . 0.0 110.782 -166.686 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.5 p -88.92 -176.93 5.35 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.255 1.022 . . . . 0.0 111.128 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.64 ' HG3' HG23 ' A' ' 60' ' ' THR . 62.1 ttt180 -62.09 -50.38 72.15 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.997 0.919 . . . . 0.0 111.621 174.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.32 -43.99 92.62 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.125 0.57 . . . . 0.0 110.876 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.25 -30.12 70.97 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.86 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.4 -57.51 7.27 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.04 0.536 . . . . 0.0 109.882 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.421 ' HG2' HG13 ' A' ' 58' ' ' VAL . 36.5 mt-10 -53.45 -43.74 68.32 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.606 1.163 . . . . 0.0 111.674 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -67.29 -57.95 5.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.547 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.7 tt -61.86 -33.32 73.98 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.88 -174.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.483 HD22 ' HB2' ' A' ' 35' ' ' SER . 82.7 mt -67.68 -44.82 76.86 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.63 -27.58 69.04 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.71 0.804 . . . . 0.0 112.024 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -86.51 -48.97 7.92 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 122.997 0.519 . . . . 0.0 111.256 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.76 -59.2 2.87 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.598 0.759 . . . . 0.0 111.805 -170.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.525 ' HA3' ' HB3' ' A' ' 35' ' ' SER . . . -96.14 -46.35 2.63 Favored Glycine 0 C--N 1.346 1.084 0 O-C-N 123.044 0.215 . . . . 0.0 113.104 -175.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 50.48 26.04 2.2 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 125.842 1.657 . . . . 0.0 113.086 -175.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.0 t70 177.22 97.85 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -173.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.627 ' HA3' HD13 ' A' ' 106' ' ' LEU . . . 72.31 20.66 79.36 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-O 120.985 0.214 . . . . 0.0 113.332 174.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.525 ' HB3' ' HA3' ' A' ' 31' ' ' GLY . 5.7 p -81.59 124.08 29.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.961 0.904 . . . . 0.0 109.431 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -128.37 159.29 35.81 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.931 0.492 . . . . 0.0 110.016 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.484 ' HA ' ' HB2' ' A' ' 13' ' ' TRP . 4.1 pp -156.83 164.16 38.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.042 0.937 . . . . 0.0 109.842 169.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 47.3 t -122.81 154.34 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 173.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -155.77 -173.97 4.76 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.851 1.26 . . . . 0.0 108.803 -176.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -91.4 121.49 33.17 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 174.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.8 t -59.19 160.38 6.45 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 122.116 0.96 . . . . 0.0 113.271 -172.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.34 -29.64 4.11 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.209 1.804 . . . . 0.0 108.545 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.7 m -66.38 -38.71 88.16 Favored 'General case' 0 C--N 1.353 0.761 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.976 173.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.3 t -127.49 119.9 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.017 0.927 . . . . 0.0 108.76 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.45 134.07 51.73 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.435 0.694 . . . . 0.0 111.35 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.21 -1.82 88.06 Favored Glycine 0 C--N 1.348 1.214 0 O-C-N 123.176 0.298 . . . . 0.0 112.931 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -101.67 177.68 4.84 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.101 0.96 . . . . 0.0 111.615 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.592 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 44.7 m-85 -111.56 155.52 23.19 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.683 0.793 . . . . 0.0 109.328 175.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.66 142.94 50.63 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.821 0.848 . . . . 0.0 110.147 174.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.488 ' HB2' HD11 ' A' ' 63' ' ' ILE . 26.6 tp -117.09 113.48 22.36 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 42.2 t -103.99 118.85 37.66 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.8 t -125.28 137.09 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -176.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.462 HD12 HG22 ' A' ' 58' ' ' VAL . 27.0 tp -111.9 137.39 49.93 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.879 0.871 . . . . 0.0 110.216 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.53 ' HB2' ' HB2' ' A' ' 103' ' ' CYS . 88.8 t80 -142.0 103.42 4.31 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.395 1.078 . . . . 0.0 108.354 173.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 43.5 70.95 0.27 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.133 1.373 . . . . 0.0 113.212 172.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 79.9 tttt 55.68 38.23 29.87 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 124.891 1.276 . . . . 0.0 111.938 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -141.82 102.92 4.25 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 170.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.462 HG22 HD12 ' A' ' 53' ' ' LEU . 17.2 t -102.51 129.51 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -119.15 147.18 44.48 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.172 0.589 . . . . 0.0 109.578 170.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.64 HG23 ' HG3' ' A' ' 20' ' ' ARG . 17.7 p -117.37 132.82 56.51 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -123.54 107.03 11.1 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -171.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.485 ' H ' ' HD3' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -59.83 155.35 16.42 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 171.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.592 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 77.4 mt -146.86 111.74 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 102.742 -3.058 . . . . 0.0 102.742 -162.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.1 mp -91.54 113.68 59.39 Favored Pre-proline 0 N--CA 1.468 0.462 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -165.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.84 -34.17 82.92 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.409 2.739 . . . . 0.0 111.392 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.8 t70 58.55 93.91 0.03 OUTLIER 'General case' 0 C--N 1.364 1.224 0 C-N-CA 125.101 1.361 . . . . 0.0 111.578 166.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -54.95 80.22 0.01 OUTLIER Glycine 0 C--N 1.35 1.322 0 N-CA-C 115.668 1.027 . . . . 0.0 115.668 -174.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -153.07 -85.69 0.07 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 170.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -160.42 6.04 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 174.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -131.09 147.6 52.64 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.202 -0.937 . . . . 0.0 112.513 -174.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -120.73 129.8 53.78 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.947 1.299 . . . . 0.0 109.015 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.36 149.1 39.9 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.218 0.607 . . . . 0.0 110.271 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.7 t -89.23 130.11 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -108.13 130.81 55.09 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -171.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.9 t -137.47 -178.86 5.41 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.387 -170.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.2 t -69.8 6.22 1.25 Allowed 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -167.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 71.46 139.33 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.852 1.261 . . . . 0.0 111.127 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 113.73 -61.12 0.35 Allowed Glycine 0 C--N 1.342 0.863 0 N-CA-C 106.351 -2.7 . . . . 0.0 106.351 -175.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.467 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 4.3 m -63.63 116.47 26.48 Favored Pre-proline 0 CA--C 1.557 1.213 0 CA-C-N 113.891 -1.154 . . . . 0.0 109.327 156.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 4.7 Cg_exo -75.04 99.07 1.22 Allowed 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.362 2.708 . . . . 0.0 114.356 -168.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 75.4 t -35.8 120.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 123.936 0.895 . . . . 0.0 112.893 158.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 27.9 mmt85 -112.62 142.36 45.3 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 124.345 1.058 . . . . 0.0 108.869 176.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.8 ptt85 -97.81 142.59 29.38 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.544 0.738 . . . . 0.0 111.139 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.477 ' HE2' ' HE2' ' A' ' 94' ' ' TYR . 56.1 m-85 -133.97 163.26 29.93 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.679 1.192 . . . . 0.0 108.679 -176.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -140.15 62.89 1.49 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.095 0.474 . . . . 0.0 109.723 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.403 HG23 ' H ' ' A' ' 89' ' ' GLU . 7.6 t 149.76 133.75 0.0 OUTLIER 'General case' 0 C--N 1.362 1.151 0 C-N-CA 127.301 2.24 . . . . 0.0 106.969 -172.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.86 -29.46 68.31 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.698 0.799 . . . . 0.0 111.941 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -51.2 -46.57 51.23 Favored Glycine 0 C--N 1.353 1.477 0 O-C-N 123.872 0.732 . . . . 0.0 114.473 175.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.403 ' H ' HG23 ' A' ' 86' ' ' THR . 49.3 mm-40 -75.82 -29.85 58.81 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.637 0.375 . . . . 0.0 111.602 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.62 -63.29 1.1 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.438 0.695 . . . . 0.0 109.218 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.415 ' HA ' HD11 ' A' ' 105' ' ' LEU . 36.1 mm -60.28 -39.39 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.129 0.972 . . . . 0.0 111.177 178.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.84 -47.26 87.59 Favored Glycine 0 C--N 1.348 1.204 0 O-C-N 124.212 0.945 . . . . 0.0 113.753 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 34.8 tp -77.79 -43.36 30.89 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.58 0.352 . . . . 0.0 111.287 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.521 ' HB3' HD13 ' A' ' 101' ' ' LEU . 31.9 m-85 -80.74 -1.56 43.3 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -173.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.26 -8.87 56.52 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.174 0.511 . . . . 0.0 110.596 165.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.71 119.24 52.17 Favored Pre-proline 0 CA--C 1.56 1.346 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 175.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -72.69 -166.47 0.28 Allowed 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.128 2.552 . . . . 0.0 114.281 -171.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 56.98 44.56 22.69 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.921 1.288 . . . . 0.0 111.707 -175.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -131.95 8.46 4.44 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.114 -177.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 119.37 -19.6 9.86 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 112.214 -0.355 . . . . 0.0 112.214 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.521 HD13 ' HB3' ' A' ' 94' ' ' TYR . 64.8 mt -79.46 135.78 36.75 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.437 0.695 . . . . 0.0 111.869 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.2 m -59.74 -33.28 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.85 0.86 . . . . 0.0 110.617 171.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.53 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 53.9 t -144.55 151.02 38.48 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.401 1.08 . . . . 0.0 109.224 175.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.43 153.28 44.06 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.415 HD11 ' HA ' ' A' ' 91' ' ' ILE . 69.5 mt -69.59 95.72 0.87 Allowed 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 120.801 0.334 . . . . 0.0 110.176 -178.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.627 HD13 ' HA3' ' A' ' 34' ' ' GLY . 84.0 mt -100.67 -67.14 0.87 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.309 1.044 . . . . 0.0 110.938 -176.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.0 tt -106.37 113.75 62.93 Favored Pre-proline 0 N--CA 1.481 1.108 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -166.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.22 -37.05 76.97 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 123.496 2.797 . . . . 0.0 113.128 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.4 t . . . . . 0 C--O 1.257 1.464 0 C-N-CA 124.699 1.2 . . . . 0.0 110.252 -179.867 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.0 t . . . . . 0 C--O 1.239 0.53 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -74.9 -27.18 60.12 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.45 168.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -77.42 121.16 23.42 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.07 0.462 . . . . 0.0 109.803 -174.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.423 ' O ' ' HA ' ' A' ' 39' ' ' ARG . 91.4 m-70 -138.86 131.71 29.32 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 175.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.2 mtm180 -63.59 139.92 58.82 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 168.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -26.25 83.16 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 116.635 2.087 . . . . 0.0 116.635 -166.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 pp -66.17 -19.0 65.7 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.107 165.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.4 t 100.24 138.87 0.01 OUTLIER 'General case' 0 C--N 1.372 1.548 0 C-N-CA 127.489 2.315 . . . . 0.0 110.198 173.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -63.47 -45.02 92.69 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.655 0.782 . . . . 0.0 112.156 -176.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.17 -49.96 65.59 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.142 0.577 . . . . 0.0 110.67 173.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.83 -24.2 63.42 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.68 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.49 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -68.44 -58.47 4.29 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.814 0.845 . . . . 0.0 110.887 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.456 ' HG2' HG11 ' A' ' 58' ' ' VAL . 45.8 mt-10 -53.38 -38.25 63.18 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.02 0.928 . . . . 0.0 111.706 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -71.23 -44.9 64.44 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.078 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 33.4 tp -59.98 -43.42 95.15 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.061 0.944 . . . . 0.0 111.068 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 23' ' ' ALA . 94.6 mt -65.85 -49.88 66.59 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.523 0.729 . . . . 0.0 109.235 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.21 -34.24 73.38 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.066 0.946 . . . . 0.0 112.388 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -82.79 -50.49 8.61 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.244 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.48 -61.85 1.87 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.318 -171.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.82 -60.02 0.56 Allowed Glycine 0 C--N 1.352 1.467 0 CA-C-N 117.902 0.319 . . . . 0.0 113.548 -171.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 50.09 40.7 22.21 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.943 1.697 . . . . 0.0 113.817 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -170.31 83.83 0.11 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -171.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.81 22.9 78.29 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -177.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.2 m -87.0 119.82 27.61 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.017 0.927 . . . . 0.0 109.073 -171.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 19.2 p90 -131.89 158.56 41.04 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.011 0.434 . . . . 0.0 110.695 -175.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.49 HD12 ' HB2' ' A' ' 23' ' ' ALA . 4.1 pp -156.86 165.28 36.64 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.256 170.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.3 t -121.58 129.33 75.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 15' ' ' HIS . 3.7 ptm180 -125.57 163.36 22.9 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.252 1.021 . . . . 0.0 109.365 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -91.78 120.07 32.17 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.3 m -91.43 100.88 13.57 Favored 'General case' 0 C--O 1.247 0.953 0 C-N-CA 122.759 0.424 . . . . 0.0 110.565 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -62.64 94.92 0.07 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.47 0.652 . . . . 0.0 110.394 163.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.3 t -151.85 -55.88 0.14 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.9 m -125.66 149.2 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 165.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 8.79 -80.0 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 127.249 2.22 . . . . 0.0 115.334 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.18 79.88 0.21 Allowed Glycine 0 C--N 1.351 1.382 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.31 165.95 14.64 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 171.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -117.22 163.73 15.86 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.104 0.561 . . . . 0.0 111.031 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.62 146.75 46.4 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.052 0.941 . . . . 0.0 110.252 168.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.49 HD23 HD21 ' A' ' 90' ' ' LEU . 46.3 tp -116.7 114.91 24.69 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 176.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 61.0 m -101.05 116.26 32.43 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.4 t -119.17 124.07 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.472 HD13 ' H ' ' A' ' 54' ' ' TYR . 23.5 tp -119.54 145.16 46.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.021 0.928 . . . . 0.0 110.335 -177.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.472 ' H ' HD13 ' A' ' 53' ' ' LEU . 25.1 t80 -154.74 126.14 7.37 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 172.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 35.79 73.71 0.08 Allowed 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 78.6 tttt 52.26 35.85 18.02 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 125.086 1.355 . . . . 0.0 113.768 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -143.58 104.39 4.21 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 121.759 -0.588 . . . . 0.0 110.49 165.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.456 HG11 ' HG2' ' A' ' 24' ' ' GLU . 20.1 t -93.05 129.25 43.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 172.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -118.24 133.37 55.95 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 168.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.8 m -120.99 141.99 50.2 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -174.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.494 ' HH ' ' HA ' ' A' ' 101' ' ' LEU . 48.5 m-85 -128.67 99.7 5.45 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -170.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -76.95 103.57 6.96 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.471 HG23 ' HB2' ' A' ' 71' ' ' LEU . 4.0 mp -67.87 108.19 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.228 172.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.3 tp -110.1 108.95 59.04 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -174.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 14.5 Cg_exo -69.88 -57.39 0.12 Allowed 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.555 2.17 . . . . 0.0 112.439 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.8 t70 80.49 -70.39 0.09 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.965 1.306 . . . . 0.0 109.406 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.37 -38.35 80.66 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 168.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.503 ' HG2' ' HB2' ' A' ' 65' ' ' PRO . 48.7 mt-10 84.14 24.66 0.11 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.283 1.433 . . . . 0.0 113.304 164.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -103.82 -37.42 7.45 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 164.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -116.49 134.73 54.52 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.106 0.962 . . . . 0.0 109.256 170.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -105.71 111.92 24.79 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.965 0.906 . . . . 0.0 109.005 175.661 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . . . -99.01 132.42 44.33 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.92 0.488 . . . . 0.0 110.988 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.54 HG22 ' HG ' ' A' ' 90' ' ' LEU . 11.2 t -87.24 118.27 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.163 176.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -81.31 92.09 6.32 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.0 m -72.23 -42.85 65.24 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.794 -175.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.489 ' HB3' HG21 ' A' ' 79' ' ' VAL . 48.1 t 173.98 141.94 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.385 1.474 . . . . 0.0 109.019 169.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -74.63 86.82 2.14 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 168.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.95 -22.85 0.31 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -167.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.489 HG21 ' HB3' ' A' ' 76' ' ' SER . 32.6 m -128.31 157.84 73.25 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 124.033 0.933 . . . . 0.0 109.066 175.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.71 126.62 21.64 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.268 2.645 . . . . 0.0 113.312 172.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.467 HG11 ' O ' ' A' ' 73' ' ' VAL . 54.6 t -101.52 134.76 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.169 1.387 . . . . 0.0 108.521 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -111.5 137.77 48.89 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.336 0.654 . . . . 0.0 110.901 -172.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 48.4 ptt85 -96.5 150.44 20.62 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.805 0.842 . . . . 0.0 108.856 173.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -138.72 164.57 29.22 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.499 0.72 . . . . 0.0 109.442 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -111.63 -13.43 13.78 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.187 0.595 . . . . 0.0 110.142 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.577 HG23 ' H ' ' A' ' 88' ' ' GLY . 59.6 m -148.7 147.1 28.49 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.511 0.724 . . . . 0.0 109.214 -174.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.33 -28.68 69.87 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.179 0.592 . . . . 0.0 111.178 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.577 ' H ' HG23 ' A' ' 86' ' ' THR . . . -63.0 -36.34 93.33 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 122.987 0.327 . . . . 0.0 113.138 173.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.467 ' HG2' ' HB ' ' A' ' 86' ' ' THR . 33.1 mm-40 -62.07 -47.03 86.47 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.691 0.797 . . . . 0.0 110.22 175.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.54 ' HG ' HG22 ' A' ' 73' ' ' VAL . 4.8 tt -50.48 -61.55 2.12 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.25 1.42 . . . . 0.0 109.932 173.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 47.1 mm -60.99 -27.48 41.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.448 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.09 -60.58 8.77 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 123.634 0.584 . . . . 0.0 113.48 175.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.1 mt -74.46 -32.7 62.69 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.401 ' HB3' HD11 ' A' ' 101' ' ' LEU . 3.3 m-85 -82.19 -21.74 36.32 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.843 0.457 . . . . 0.0 112.176 -172.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.96 -17.28 63.11 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 168.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -132.45 69.3 79.94 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 124.651 1.18 . . . . 0.0 108.696 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.44 -81.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.233 1.955 . . . . 0.0 113.839 -168.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 90.08 -90.45 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.48 1.912 . . . . 0.0 106.821 -170.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -79.93 144.05 33.68 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 122.916 0.486 . . . . 0.0 111.912 170.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.82 -59.13 0.37 Allowed Glycine 0 C--N 1.35 1.315 0 C-N-CA 123.391 0.519 . . . . 0.0 113.176 166.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.494 ' HA ' ' HH ' ' A' ' 61' ' ' TYR . 24.7 mt -82.13 164.88 21.01 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -174.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.5 m -84.02 -24.37 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 CA-C-N 114.673 -1.148 . . . . 0.0 109.943 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 52.2 t -164.92 167.53 18.52 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 125.12 1.368 . . . . 0.0 108.745 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -77.36 170.68 16.12 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 120.93 0.395 . . . . 0.0 109.958 172.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.7 mt -81.53 97.46 7.83 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 175.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.9 mp -92.6 -57.93 2.52 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.017 0.927 . . . . 0.0 110.478 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 61.7 tp -131.09 107.06 14.96 Favored Pre-proline 0 N--CA 1.479 1.02 0 C-N-CA 123.379 0.671 . . . . 0.0 110.974 -165.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.99 124.12 10.3 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.368 2.045 . . . . 0.0 110.301 170.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 32.7 t . . . . . 0 CA--C 1.552 1.031 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -172.032 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.9 p . . . . . 0 N--CA 1.472 0.645 0 CA-C-O 121.315 0.579 . . . . 0.0 111.672 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 108' ' ' PRO . 1.9 p-90 -86.3 10.4 14.93 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.889 0.876 . . . . 0.0 112.761 -176.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.406 ' HA ' ' HB ' ' A' ' 38' ' ' VAL . 17.8 t80 -118.03 134.82 54.62 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -174.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.401 ' O ' ' HA ' ' A' ' 39' ' ' ARG . 71.2 m-70 -137.18 171.89 13.82 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.739 0.816 . . . . 0.0 110.276 178.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.4 171.99 16.64 Favored 'General case' 0 C--O 1.245 0.817 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 164.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 74.55 3.95 4.35 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.677 1.191 . . . . 0.0 110.209 -172.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.3 tp -105.98 120.52 41.97 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 125.956 1.702 . . . . 0.0 107.999 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.4 m -82.49 170.15 15.57 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.524 0.73 . . . . 0.0 110.41 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.497 HH11 ' HG2' ' A' ' 24' ' ' GLU . 4.7 tmm_? -58.97 -55.88 29.48 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.408 0.683 . . . . 0.0 110.764 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.81 -44.01 73.43 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.121 0.888 . . . . 0.0 111.084 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.02 -36.06 82.77 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.521 0.729 . . . . 0.0 112.185 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.523 ' HB3' HD13 ' A' ' 37' ' ' LEU . . . -65.22 -56.5 12.46 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.824 0.85 . . . . 0.0 111.608 -176.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.497 ' HG2' HH11 ' A' ' 20' ' ' ARG . 0.0 OUTLIER -69.12 -24.64 64.13 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.879 -179.171 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 31.8 mt-10 -64.86 -55.66 18.11 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 169.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.12 -23.49 47.5 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.494 0.717 . . . . 0.0 112.828 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.9 mt -71.86 -52.79 15.63 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 168.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.98 -21.48 50.83 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -168.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 30.5 mmt180 -74.42 -42.25 59.49 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 118.246 0.475 . . . . 0.0 110.677 176.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.53 -53.45 4.8 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.945 -174.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.27 -159.59 8.41 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.974 -163.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 175.49 138.89 0.05 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.274 1.029 . . . . 0.0 110.493 -171.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 62.6 m-20 96.67 87.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.207 1.403 . . . . 0.0 109.184 159.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.24 16.7 73.55 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.708 -173.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 m -82.49 123.43 29.16 Favored 'General case' 0 C--N 1.346 0.456 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.444 ' CE1' ' HB3' ' A' ' 105' ' ' LEU . 30.9 p90 -131.7 159.22 39.02 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.41 0.624 . . . . 0.0 111.345 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.523 HD13 ' HB3' ' A' ' 23' ' ' ALA . 3.3 pp -150.63 159.99 44.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.165 165.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.406 ' HB ' ' HA ' ' A' ' 14' ' ' TYR . 46.9 t -116.75 150.54 18.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 175.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.469 HH22 ' HG2' ' A' ' 42' ' ' GLU . 20.6 ptt85 -146.59 -179.61 6.89 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -81.64 126.47 31.8 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 167.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 93.7 p -73.12 163.54 27.99 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.752 0.421 . . . . 0.0 110.703 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.469 ' HG2' HH22 ' A' ' 39' ' ' ARG . 10.8 pt-20 -124.61 -16.27 6.31 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.445 0.698 . . . . 0.0 110.6 -177.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.0 m -68.46 -30.17 68.97 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.884 0.874 . . . . 0.0 111.057 172.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.469 HG11 ' HB3' ' A' ' 47' ' ' ALA . 1.8 p -145.99 117.5 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 124.192 0.997 . . . . 0.0 109.683 -175.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.03 132.63 49.73 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.447 1.099 . . . . 0.0 112.056 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.84 11.94 80.66 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.347 0.404 . . . . 0.0 113.708 177.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.469 ' HB3' HG11 ' A' ' 44' ' ' VAL . . . -118.59 178.06 4.6 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.739 0.816 . . . . 0.0 111.717 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.461 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 32.9 m-85 -114.7 166.78 11.38 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.592 0.757 . . . . 0.0 111.286 -176.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.42 145.61 41.17 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.012 0.925 . . . . 0.0 110.233 169.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.471 ' HB2' HD13 ' A' ' 63' ' ' ILE . 51.7 tp -121.5 114.3 21.04 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.99 1.316 . . . . 0.0 108.33 -176.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 36.2 t -108.68 122.12 46.45 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.276 1.03 . . . . 0.0 108.62 -174.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.2 t -129.54 115.61 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 123.452 0.701 . . . . 0.0 110.366 -171.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.2 tp -94.83 136.89 34.6 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.564 1.146 . . . . 0.0 110.132 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 60.2 t80 -163.02 122.5 2.19 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.313 1.045 . . . . 0.0 109.206 175.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 40.58 61.12 1.71 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.327 1.851 . . . . 0.0 113.6 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 62.41 30.08 17.27 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.57 1.148 . . . . 0.0 113.042 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -138.33 106.88 5.85 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.236 0.614 . . . . 0.0 109.548 177.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.3 t -101.66 114.64 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -105.79 126.3 52.01 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.0 m -113.02 136.02 53.15 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -127.99 110.35 12.44 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.874 0.87 . . . . 0.0 109.107 -171.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.436 ' H ' ' HD2' ' A' ' 62' ' ' ARG . 0.1 OUTLIER -59.55 157.0 12.27 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 169.446 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.471 HD13 ' HB2' ' A' ' 50' ' ' LEU . 90.7 mt -146.19 102.66 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 103.686 -2.709 . . . . 0.0 103.686 -162.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.7 mp -114.97 140.65 25.81 Favored Pre-proline 0 N--CA 1.475 0.804 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -166.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -58.58 -70.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 121.915 1.743 . . . . 0.0 109.274 164.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.0 t70 58.53 15.94 3.91 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.133 1.373 . . . . 0.0 112.639 167.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.38 137.38 3.77 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -34.08 -45.76 0.22 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 -165.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -113.21 -16.25 12.59 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -164.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.41 ' HB2' ' HB2' ' A' ' 83' ' ' ARG . 44.4 p90 -125.98 160.88 28.85 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.967 -0.458 . . . . 0.0 111.74 -167.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 pp -121.73 118.36 28.9 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.525 1.53 . . . . 0.0 107.144 166.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -111.95 148.48 33.65 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.735 0.779 . . . . 0.0 110.011 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.8 t -122.85 131.32 73.48 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -78.65 94.55 5.07 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.471 HG22 ' HA3' ' A' ' 100' ' ' GLY . 2.0 m -70.78 -63.06 1.17 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.059 -176.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.443 ' HB2' HG23 ' A' ' 79' ' ' VAL . 73.5 m -163.19 113.66 1.39 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.248 1.419 . . . . 0.0 107.62 170.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -68.62 97.41 0.79 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 170.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.16 -22.7 0.87 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -163.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.443 HG23 ' HB2' ' A' ' 76' ' ' SER . 22.5 m -129.84 153.21 80.87 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 125.375 1.47 . . . . 0.0 107.075 170.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -54.47 124.69 16.73 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.386 2.057 . . . . 0.0 112.8 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.6 t -86.09 140.32 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -102.11 136.21 42.35 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.031 0.533 . . . . 0.0 109.908 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.41 ' HB2' ' HB2' ' A' ' 70' ' ' PHE . 14.6 ptp180 -87.35 138.76 31.21 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 163.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -119.7 143.25 47.86 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.747 0.819 . . . . 0.0 109.277 176.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -84.66 -22.24 29.93 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.091 0.472 . . . . 0.0 110.43 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.663 ' HB ' ' HG2' ' A' ' 89' ' ' GLU . 51.0 m -141.79 149.01 39.83 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.74 0.816 . . . . 0.0 109.767 -177.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.24 -30.73 71.64 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.596 0.759 . . . . 0.0 109.525 176.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.567 ' H ' HG23 ' A' ' 86' ' ' THR . . . -53.92 -41.79 68.57 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-N 116.099 -0.501 . . . . 0.0 113.582 169.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.663 ' HG2' ' HB ' ' A' ' 86' ' ' THR . 31.0 mm-40 -71.45 -32.23 68.09 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.273 0.629 . . . . 0.0 110.7 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 46.5 tp -59.04 -59.25 5.77 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.318 0.647 . . . . 0.0 111.011 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 51.6 mm -62.25 -37.16 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.999 0.919 . . . . 0.0 111.004 -176.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.13 -51.73 53.91 Favored Glycine 0 CA--C 1.535 1.331 0 O-C-N 124.153 0.908 . . . . 0.0 113.292 174.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.0 mt -78.99 -23.17 44.6 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.091 0.556 . . . . 0.0 112.216 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -83.33 -18.31 39.39 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.03 -35.15 76.29 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.527 0.331 . . . . 0.0 110.539 170.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -127.0 76.42 76.0 Favored Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 124.371 1.068 . . . . 0.0 108.602 175.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -92.49 -66.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 123.363 2.708 . . . . 0.0 114.421 -169.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 59.66 55.84 3.85 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 124.845 1.258 . . . . 0.0 111.266 -173.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 160.45 97.87 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 126.734 2.014 . . . . 0.0 109.706 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.471 ' HA3' HG22 ' A' ' 75' ' ' THR . . . 104.33 -37.35 3.82 Favored Glycine 0 C--N 1.355 1.617 0 N-CA-C 113.758 0.263 . . . . 0.0 113.758 164.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -76.52 122.45 24.59 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.841 0.456 . . . . 0.0 110.829 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.2 m -52.73 -32.45 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 125.544 1.537 . . . . 0.0 114.19 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 36.4 t -153.54 3.31 0.28 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.108 0.563 . . . . 0.0 111.19 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 76.04 177.37 0.19 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.902 1.281 . . . . 0.0 110.669 -167.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.444 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 26.7 mt -93.05 103.39 15.7 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.51 -53.35 6.04 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.562 0.745 . . . . 0.0 111.03 -176.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.22 137.32 9.86 Favored Pre-proline 0 N--CA 1.483 1.222 0 C-N-CA 122.167 0.187 . . . . 0.0 111.199 -175.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.467 ' HB3' ' HB3' ' A' ' 13' ' ' TRP . 97.1 Cg_endo -78.79 137.08 13.9 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.333 2.022 . . . . 0.0 111.875 171.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 57.0 t . . . . . 0 CA--C 1.547 0.857 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.293 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.6 p . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -84.77 0.87 49.11 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.056 -1.027 . . . . 0.0 110.435 171.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -110.91 111.53 22.73 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -119.03 115.0 23.39 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 176.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -39.71 -49.31 2.26 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 125.565 1.546 . . . . 0.0 113.722 -172.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -156.96 70.55 0.64 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-O 122.312 1.053 . . . . 0.0 108.578 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.423 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 21.9 tp -64.77 -32.18 73.74 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 113.658 -1.61 . . . . 0.0 109.464 165.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.0 t 88.31 141.82 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 126.014 1.726 . . . . 0.0 107.944 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -60.83 -43.02 98.84 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.213 0.605 . . . . 0.0 112.079 -168.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.83 -48.01 73.09 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.507 0.723 . . . . 0.0 111.72 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 18' ' ' LEU . . . -72.44 -22.58 61.07 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.316 178.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.465 ' O ' ' HG ' ' A' ' 27' ' ' LEU . . . -67.67 -49.83 60.87 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.547 ' HG3' HG23 ' A' ' 58' ' ' VAL . 34.8 tt0 -54.53 -41.24 69.48 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 124.885 1.366 . . . . 0.0 111.296 175.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.0 -50.6 47.39 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.437 -177.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.84 -33.98 73.87 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.091 0.957 . . . . 0.0 111.881 176.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 23' ' ' ALA . 75.4 mt -64.73 -52.84 54.94 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.1 0.56 . . . . 0.0 109.683 175.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.29 -42.47 98.71 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.17 0.988 . . . . 0.0 111.947 -176.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -69.33 -41.33 76.82 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.888 -175.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.35 -62.82 1.39 Allowed 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.02 -38.46 2.89 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 113.886 0.314 . . . . 0.0 113.886 -166.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.84 12.76 0.12 Allowed 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 128.011 2.524 . . . . 0.0 116.28 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.525 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 4.5 m-20 -174.37 118.51 0.23 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -166.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.414 ' HA2' ' SG ' ' A' ' 103' ' ' CYS . . . 63.16 11.02 37.01 Favored Glycine 0 C--N 1.352 1.44 0 N-CA-C 113.906 0.322 . . . . 0.0 113.906 -177.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.9 m -83.69 123.68 30.07 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.142 0.977 . . . . 0.0 110.039 -168.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -135.73 156.38 48.92 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 120.767 0.318 . . . . 0.0 111.439 -176.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.438 HD11 ' HB3' ' A' ' 23' ' ' ALA . 4.4 pp -159.9 158.74 31.41 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 124.709 1.255 . . . . 0.0 109.673 169.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.419 HG23 HD12 ' A' ' 50' ' ' LEU . 21.9 t -114.05 150.65 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.414 HH22 ' HB2' ' A' ' 42' ' ' GLU . 1.7 ptm180 -148.0 177.13 9.61 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.264 1.025 . . . . 0.0 109.207 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -84.4 129.28 34.88 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.3 t -61.18 142.38 56.79 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.48 0.712 . . . . 0.0 112.108 -174.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.414 ' HB2' HH22 ' A' ' 39' ' ' ARG . 32.2 tt0 -107.03 0.24 23.48 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.984 178.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.2 t -104.97 -41.72 5.52 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.207 1.003 . . . . 0.0 110.069 -177.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.478 HG22 HD22 ' A' ' 64' ' ' LEU . 44.7 t -128.11 115.18 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.902 0.881 . . . . 0.0 109.528 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.22 124.63 24.6 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.929 0.891 . . . . 0.0 110.817 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.36 12.06 65.75 Favored Glycine 0 C--N 1.344 0.979 0 O-C-N 123.345 0.403 . . . . 0.0 112.746 -174.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.32 177.0 5.07 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.794 0.838 . . . . 0.0 111.168 172.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.426 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 70.4 m-85 -124.21 166.83 15.16 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.832 1.253 . . . . 0.0 110.254 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.9 147.79 48.31 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.358 1.063 . . . . 0.0 109.526 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.532 ' HB2' HD12 ' A' ' 63' ' ' ILE . 50.2 tp -123.99 123.92 41.45 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.062 1.345 . . . . 0.0 107.51 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 37.1 t -112.29 123.85 51.17 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.9 t -128.73 143.7 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.48 HD12 HG22 ' A' ' 58' ' ' VAL . 48.9 tp -130.3 144.71 51.54 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.113 0.965 . . . . 0.0 108.942 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 84.6 t80 -164.28 122.77 1.83 Allowed 'General case' 0 CA--C 1.537 0.479 0 O-C-N 124.318 1.011 . . . . 0.0 109.005 178.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 17.3 tm0? 41.74 70.07 0.3 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 125.404 1.482 . . . . 0.0 111.561 -177.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt 48.67 25.23 0.93 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 125.586 1.555 . . . . 0.0 114.288 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -131.32 117.36 18.82 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.355 0.662 . . . . 0.0 109.299 -178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.547 HG23 ' HG3' ' A' ' 24' ' ' GLU . 34.1 t -99.53 144.94 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.507 1.123 . . . . 0.0 109.623 -177.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -137.34 119.26 15.28 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 174.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 33.4 m -105.92 114.1 28.04 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -95.65 117.68 30.93 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -177.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 65.6 mtm-85 -62.25 158.37 17.32 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 170.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.532 HD12 ' HB2' ' A' ' 50' ' ' LEU . 76.2 mt -145.32 98.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 102.808 -3.034 . . . . 0.0 102.808 -175.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.478 HD22 HG22 ' A' ' 44' ' ' VAL . 10.6 mp -122.14 148.62 52.38 Favored Pre-proline 0 N--CA 1.477 0.923 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -172.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -44.29 -59.66 1.03 Allowed 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.53 2.153 . . . . 0.0 111.845 172.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.2 t70 47.33 71.5 0.32 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.857 1.263 . . . . 0.0 111.87 174.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.65 -75.95 0.24 Allowed Glycine 0 C--N 1.337 0.631 0 CA-C-O 119.459 -0.634 . . . . 0.0 111.626 -176.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 169.29 -40.44 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.051 1.34 . . . . 0.0 111.405 -175.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -131.35 -13.43 3.43 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -161.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -117.91 163.81 15.99 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.425 1.09 . . . . 0.0 110.443 -167.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.1 mp -104.54 109.34 21.19 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 171.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.43 126.05 42.45 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.192 0.997 . . . . 0.0 109.57 -175.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.5 t -96.09 133.27 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -178.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -94.52 89.32 5.77 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -175.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.473 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 21.2 p -71.04 -66.59 0.59 Allowed 'General case' 0 C--O 1.248 1.006 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.325 175.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.3 t 176.39 174.67 0.34 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.089 1.355 . . . . 0.0 109.945 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -68.01 160.7 28.22 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 123.786 0.834 . . . . 0.0 109.185 167.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.51 -72.54 2.16 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-N 118.451 0.569 . . . . 0.0 112.99 -170.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.1 m -65.6 145.94 99.01 Favored Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 123.662 0.785 . . . . 0.0 110.538 176.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.79 137.56 27.36 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.482 2.121 . . . . 0.0 113.483 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.4 t -69.58 118.12 13.42 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 167.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -98.62 117.38 32.93 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.508 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -100.69 149.99 23.21 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.714 0.806 . . . . 0.0 110.271 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -134.29 162.29 32.59 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.42 0.688 . . . . 0.0 112.399 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -74.08 -46.5 42.62 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.511 170.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 37.9 p -138.34 169.12 18.35 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.618 0.767 . . . . 0.0 110.999 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.462 ' O ' HG12 ' A' ' 91' ' ' ILE . 4.3 mm? -62.21 -34.42 76.44 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.584 0.754 . . . . 0.0 111.058 171.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -53.86 -43.89 70.92 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 122.975 0.172 . . . . 0.0 113.029 175.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -66.38 -36.15 82.13 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.252 0.621 . . . . 0.0 110.611 175.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.8 tt -64.7 -38.6 91.54 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.342 1.057 . . . . 0.0 110.828 -178.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 87' ' ' LEU . 50.3 mm -85.04 -35.54 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -168.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.3 -44.93 32.61 Favored Glycine 0 C--N 1.35 1.331 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.877 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.1 tp -76.11 -32.73 59.32 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.712 0.405 . . . . 0.0 111.239 -178.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.605 ' HB3' ' HG ' ' A' ' 105' ' ' LEU . 3.9 m-30 -78.12 -16.46 57.95 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.757 174.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.42 -2.16 10.33 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.136 0.574 . . . . 0.0 112.102 171.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -128.37 152.14 77.65 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 169.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -28.93 103.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 124.819 3.679 . . . . 0.0 114.967 165.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.458 ' HB3' HD22 ' A' ' 101' ' ' LEU . 8.3 t30 -106.28 -44.7 4.48 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.533 -177.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 107.93 115.78 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 128.184 2.594 . . . . 0.0 108.644 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.473 ' HA3' ' HB ' ' A' ' 75' ' ' THR . . . 110.04 -13.28 31.61 Favored Glycine 0 C--N 1.345 1.04 0 O-C-N 123.747 0.654 . . . . 0.0 112.266 -175.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.458 HD22 ' HB3' ' A' ' 98' ' ' ASN . 3.9 mm? -84.36 138.72 32.72 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.183 0.993 . . . . 0.0 111.699 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.1 p -60.68 -35.64 65.27 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 C-N-CA 124.425 1.09 . . . . 0.0 112.421 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.414 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 29.0 p -163.98 13.62 0.05 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.377 0.671 . . . . 0.0 111.455 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 74.15 176.96 0.24 Allowed 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 124.814 1.246 . . . . 0.0 109.771 -167.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.605 ' HG ' ' HB3' ' A' ' 94' ' ' TYR . 26.6 mt -92.88 113.87 26.27 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 56.1 tp -108.01 -63.32 1.33 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.513 0.725 . . . . 0.0 111.868 -173.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.442 HD21 HG23 ' A' ' 109' ' ' VAL . 5.0 tt -116.58 103.73 52.29 Favored Pre-proline 0 N--CA 1.479 0.999 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -170.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -73.74 119.24 5.8 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.56 2.173 . . . . 0.0 111.158 173.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.442 HG23 HD21 ' A' ' 107' ' ' LEU . 21.1 t . . . . . 0 CA--C 1.553 1.069 0 CA-C-O 118.038 -0.982 . . . . 0.0 108.371 -175.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 C--O 1.239 0.515 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -83.37 -29.1 28.47 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 172.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -74.67 122.75 23.69 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -138.41 93.36 2.73 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.371 0.669 . . . . 0.0 109.394 176.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -62.84 148.98 45.48 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 157.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.6 t70 81.41 -11.47 1.08 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.357 1.063 . . . . 0.0 111.736 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 tp -90.73 122.57 33.6 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.6 m -83.44 158.01 22.24 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.898 0.479 . . . . 0.0 109.851 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -62.58 -47.02 85.63 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -171.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.37 -45.32 80.58 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.416 0.686 . . . . 0.0 111.347 177.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.81 -34.39 76.66 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.86 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.543 ' HB2' HD11 ' A' ' 37' ' ' LEU . . . -66.23 -55.71 14.87 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.76 0.824 . . . . 0.0 111.422 -177.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.493 ' HG2' ' SG ' ' A' ' 51' ' ' CYS . 25.2 mt-10 -64.67 -28.77 69.83 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.521 1.128 . . . . 0.0 111.443 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -62.28 -50.99 69.51 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.462 0.705 . . . . 0.0 109.416 173.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.6 mt -66.77 -28.35 68.33 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.163 0.985 . . . . 0.0 112.077 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.493 HD23 ' HG ' ' A' ' 37' ' ' LEU . 75.0 mt -68.04 -45.01 75.15 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 118.058 0.39 . . . . 0.0 110.176 173.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.2 -26.78 63.09 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.653 0.781 . . . . 0.0 111.22 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -85.97 -60.54 1.98 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.369 0.668 . . . . 0.0 111.484 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.23 -54.92 5.49 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.626 0.771 . . . . 0.0 112.354 -166.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.582 ' HA3' ' HB3' ' A' ' 35' ' ' SER . . . -87.5 -34.1 10.78 Favored Glycine 0 N--CA 1.471 0.967 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 60.25 4.04 0.61 Allowed 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 126.445 1.898 . . . . 0.0 114.827 174.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.3 t70 164.52 133.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.09 1.356 . . . . 0.0 107.788 -171.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.61 -2.27 54.46 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 117.89 0.314 . . . . 0.0 113.579 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.582 ' HB3' ' HA3' ' A' ' 31' ' ' GLY . 1.9 p -82.54 130.37 35.1 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.406 1.082 . . . . 0.0 111.967 -169.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.409 ' CE1' ' HB3' ' A' ' 105' ' ' LEU . 46.2 p90 -127.33 151.93 48.12 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.031 0.532 . . . . 0.0 110.083 174.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' A' ' 23' ' ' ALA . 2.3 pp -144.9 160.89 40.59 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.718 0.807 . . . . 0.0 109.013 166.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.411 HG21 HD12 ' A' ' 87' ' ' LEU . 22.6 t -112.78 153.99 14.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.1 mtm180 -139.99 170.43 15.87 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.075 0.95 . . . . 0.0 109.661 -176.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -87.78 134.54 33.66 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.296 168.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.5 m -62.96 135.45 57.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.911 0.386 . . . . 0.0 111.143 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -102.27 14.88 30.77 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.207 1.003 . . . . 0.0 111.286 -172.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.0 t -147.33 -62.28 0.28 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.374 0.669 . . . . 0.0 109.898 -177.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.9 m -89.32 125.39 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -171.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 24.78 -133.88 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 127.585 2.354 . . . . 0.0 116.466 171.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.45 57.63 0.44 Allowed Glycine 0 C--N 1.358 1.772 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.42 174.15 6.0 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.63 0.772 . . . . 0.0 111.107 -173.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.557 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 81.0 m-85 -114.82 158.73 21.5 Favored 'General case' 0 C--O 1.25 1.083 0 C-N-CA 123.905 0.882 . . . . 0.0 109.827 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.24 141.21 52.23 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.535 1.134 . . . . 0.0 109.214 173.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.564 HD23 HD22 ' A' ' 90' ' ' LEU . 58.9 tp -123.32 115.75 22.19 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.493 ' SG ' ' HG2' ' A' ' 24' ' ' GLU . 45.9 t -114.19 119.08 35.85 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -176.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 5.1 t -127.77 140.56 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.218 0.607 . . . . 0.0 109.4 -170.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.8 tp -122.92 138.47 54.66 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.722 1.209 . . . . 0.0 109.035 -177.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -169.32 136.63 1.78 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.002 0.921 . . . . 0.0 109.622 172.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 47.35 42.49 14.02 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.819 1.248 . . . . 0.0 112.096 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 56.62 45.47 22.09 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.739 1.216 . . . . 0.0 112.641 -173.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -129.6 103.85 7.11 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 171.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 61.6 t -97.65 105.45 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 170.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -112.78 134.12 54.45 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 55.5 m -117.8 142.34 47.4 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.412 0.685 . . . . 0.0 109.453 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -124.74 154.85 40.24 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.54 1.136 . . . . 0.0 108.26 -177.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -102.39 160.98 14.07 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 166.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.641 HG12 HD12 ' A' ' 90' ' ' LEU . 3.7 mp -144.59 101.24 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 103.122 -2.918 . . . . 0.0 103.122 -163.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.1 mp -103.4 137.67 19.32 Favored Pre-proline 0 N--CA 1.481 1.119 0 CA-C-O 119.421 -0.323 . . . . 0.0 110.943 -163.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.63 -138.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 123.452 2.768 . . . . 0.0 111.081 175.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 68' ' ' GLU . 7.1 t70 169.47 -178.09 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 122.97 0.508 . . . . 0.0 110.323 -166.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -88.33 5.35 84.85 Favored Glycine 0 N--CA 1.491 2.342 0 CA-C-O 121.642 0.579 . . . . 0.0 112.337 167.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 66' ' ' ASP . 35.4 mt-10 -142.13 106.28 4.77 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 102.48 -3.156 . . . . 0.0 102.48 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -74.5 88.4 2.13 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 119.591 1.087 . . . . 0.0 111.287 -151.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.513 ' HB3' ' HB3' ' A' ' 83' ' ' ARG . 50.3 m-85 -116.24 138.27 51.44 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 124.398 1.079 . . . . 0.0 108.839 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 84' ' ' PHE . 8.7 mp -96.01 107.32 19.6 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 174.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -104.87 112.38 25.48 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.929 0.892 . . . . 0.0 110.013 -171.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.451 HG21 HG13 ' A' ' 63' ' ' ILE . 12.1 t -101.8 144.59 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.669 -175.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.2 86.9 2.51 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.45 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 4.3 p -80.86 -53.0 6.85 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.676 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.5 m -126.61 169.11 13.44 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.641 0.776 . . . . 0.0 110.536 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -88.11 -3.43 58.89 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.592 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -147.4 39.29 1.05 Allowed Glycine 0 C--N 1.35 1.306 0 CA-C-N 117.93 0.332 . . . . 0.0 113.086 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 m -120.34 151.18 53.17 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 123.73 0.812 . . . . 0.0 108.82 171.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.2 126.49 18.74 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 121.791 1.661 . . . . 0.0 110.557 170.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.6 t -68.95 127.45 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -177.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -98.48 117.97 34.11 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -171.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.513 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 88.3 mtm180 -99.0 126.73 44.77 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.036 0.934 . . . . 0.0 110.187 -173.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.518 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 71.1 m-85 -110.03 147.56 33.32 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.391 0.676 . . . . 0.0 111.781 -175.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -72.01 -38.59 69.58 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.263 0.625 . . . . 0.0 110.34 173.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.401 HG21 ' HG2' ' A' ' 89' ' ' GLU . 8.1 t -146.29 169.5 18.68 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.621 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.411 HD12 HG21 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -62.69 -29.65 70.81 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.937 174.182 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -55.22 -41.37 78.75 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 116.512 -0.313 . . . . 0.0 113.579 171.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.518 ' HB2' ' HB3' ' A' ' 84' ' ' PHE . 53.3 mm-40 -67.9 -39.67 83.59 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.494 0.717 . . . . 0.0 110.644 176.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.641 HD12 HG12 ' A' ' 63' ' ' ILE . 7.1 tt -57.7 -54.96 40.99 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.334 -178.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 40.9 mm -66.26 -34.15 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.297 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.03 -56.92 22.48 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.636 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.36 -40.09 74.24 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.134 0.574 . . . . 0.0 111.016 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.614 ' HA ' HE22 ' A' ' 99' ' ' GLN . 6.5 m-30 -78.21 -7.25 56.88 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -173.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.03 -13.72 58.62 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 122.472 0.309 . . . . 0.0 111.584 164.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -92.25 137.54 24.77 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 124.477 1.111 . . . . 0.0 109.771 173.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.87 175.17 11.72 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.925 2.416 . . . . 0.0 113.917 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.4 t30 58.88 73.06 0.5 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.253 1.421 . . . . 0.0 112.228 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.614 HE22 ' HA ' ' A' ' 94' ' ' TYR . 48.1 mt-30 -142.4 -13.06 0.8 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.337 1.055 . . . . 0.0 111.029 174.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.45 ' HA3' ' HB ' ' A' ' 75' ' ' THR . . . 122.27 -2.63 10.52 Favored Glycine 0 N--CA 1.48 1.629 0 C-N-CA 123.694 0.664 . . . . 0.0 112.005 -169.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 88.5 mt -74.66 168.29 20.11 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.787 1.235 . . . . 0.0 111.114 176.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.5 m -67.26 -47.92 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.412 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.872 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 49.0 t -173.73 40.05 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.348 1.059 . . . . 0.0 109.63 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 78.37 -177.8 0.1 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.088 1.355 . . . . 0.0 111.346 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.409 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 21.9 mt -105.53 99.56 9.16 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 175.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.01 -48.79 3.02 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.907 0.883 . . . . 0.0 111.326 -171.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 35' ' ' SER . 10.5 mp -112.43 124.12 32.66 Favored Pre-proline 0 N--CA 1.484 1.247 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.401 ' HB2' ' H ' ' A' ' 109' ' ' VAL . 14.3 Cg_exo -68.49 -87.14 0.0 OUTLIER 'Trans proline' 0 CA--C 1.556 1.59 0 C-N-CA 121.203 1.268 . . . . 0.0 110.088 167.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.401 ' H ' ' HB2' ' A' ' 108' ' ' PRO . 4.2 t . . . . . 0 C--O 1.25 1.128 0 C-N-CA 124.576 1.15 . . . . 0.0 108.137 177.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 CA--C 1.54 0.573 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 23.5 p-90 -93.27 -23.49 18.49 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 166.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 83.7 t80 -73.0 106.94 5.09 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 167.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -104.27 117.94 35.43 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -63.33 -46.3 87.27 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.946 0.899 . . . . 0.0 111.182 -170.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -114.47 81.7 1.59 Allowed 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.311 0.576 . . . . 0.0 109.585 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.7 tp -133.58 133.32 41.91 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.545 0.738 . . . . 0.0 110.376 176.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.6 m -99.17 170.28 8.8 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.673 0.789 . . . . 0.0 110.092 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.439 ' HG3' HG22 ' A' ' 60' ' ' THR . 38.8 ttt180 -62.1 -57.7 10.58 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -171.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.43 -42.96 78.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.149 0.58 . . . . 0.0 111.231 -178.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.33 -30.71 70.61 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.172 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.26 -50.2 49.21 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.521 0.729 . . . . 0.0 111.356 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.502 ' HA ' HD13 ' A' ' 27' ' ' LEU . 10.2 pt-20 -69.68 -22.2 63.45 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.985 178.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -68.33 -49.59 59.31 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 167.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 43.7 mt -59.58 -30.11 68.42 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.752 0.421 . . . . 0.0 111.627 174.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.502 HD13 ' HA ' ' A' ' 24' ' ' GLU . 48.1 mt -67.49 -47.07 71.09 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.49 0.316 . . . . 0.0 110.238 172.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.72 -42.71 97.89 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.4 0.68 . . . . 0.0 111.817 -173.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -87.0 -53.14 5.04 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.639 0.376 . . . . 0.0 110.643 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.29 -60.4 2.39 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 117.745 0.248 . . . . 0.0 111.127 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.84 126.41 34.5 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-O 121.293 0.385 . . . . 0.0 114.029 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 71.2 mtp85 -79.47 -41.49 27.4 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.449 1.1 . . . . 0.0 113.159 -177.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 170.14 132.95 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.773 1.229 . . . . 0.0 107.988 -169.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.565 ' HA2' ' SG ' ' A' ' 103' ' ' CYS . . . 68.33 24.05 74.93 Favored Glycine 0 N--CA 1.479 1.519 0 CA-C-N 118.259 0.481 . . . . 0.0 111.929 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 7.6 m -88.73 145.77 25.43 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 124.141 0.976 . . . . 0.0 110.472 -171.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -142.05 151.6 42.56 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.197 0.599 . . . . 0.0 109.919 -176.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.472 HD22 HG23 ' A' ' 109' ' ' VAL . 4.6 pp -140.79 154.18 46.14 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.38 169.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 71.5 t -121.61 146.96 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 170.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 48.6 ptt85 -160.74 -170.25 2.68 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.801 1.24 . . . . 0.0 108.324 -173.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.71 144.25 25.93 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.572 0.749 . . . . 0.0 109.203 169.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.415 ' HB3' ' HB2' ' A' ' 47' ' ' ALA . 35.6 t -70.41 160.84 31.6 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.972 0.909 . . . . 0.0 109.514 164.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -108.36 -14.57 14.65 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.8 m -81.11 -68.65 0.67 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.52 0.728 . . . . 0.0 109.975 -177.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.0 t -91.33 118.43 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.436 0.694 . . . . 0.0 109.444 -174.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 7.24 -82.17 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 127.791 2.436 . . . . 0.0 115.866 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.44 64.12 0.58 Allowed Glycine 0 C--N 1.346 1.12 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 174.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.415 ' HB2' ' HB3' ' A' ' 41' ' ' SER . . . -90.11 164.41 14.48 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.935 0.494 . . . . 0.0 110.234 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.509 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 20.9 m-85 -104.16 122.19 44.83 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.027 0.931 . . . . 0.0 109.127 -177.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -108.23 130.74 55.14 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.445 0.698 . . . . 0.0 109.533 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.7 tp -117.79 108.13 14.99 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.482 ' SG ' HG21 ' A' ' 60' ' ' THR . 56.3 m -106.52 123.59 48.32 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -176.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 35' ' ' SER . 58.4 t -130.09 128.16 64.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 124.022 0.929 . . . . 0.0 109.596 -172.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.438 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 56.7 tp -108.29 143.45 37.12 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.28 1.032 . . . . 0.0 109.615 175.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -163.52 112.37 1.25 Allowed 'General case' 0 CA--C 1.543 0.689 0 O-C-N 123.839 0.712 . . . . 0.0 109.25 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 50.76 57.71 6.34 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.954 1.301 . . . . 0.0 113.018 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.7 tttm 52.6 28.03 5.71 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.925 1.29 . . . . 0.0 112.662 -175.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -106.6 104.13 13.74 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 173.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.0 t -86.19 128.71 39.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 173.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -140.07 134.69 31.71 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.482 HG21 ' SG ' ' A' ' 51' ' ' CYS . 37.7 p -112.62 135.9 52.81 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 173.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -114.1 99.93 8.0 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -82.16 97.73 8.35 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.509 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 63.4 mt -71.53 120.67 20.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.778 163.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.4 mp -101.78 126.87 32.65 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 172.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 11.6 Cg_endo -56.11 -62.59 0.23 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.146 1.897 . . . . 0.0 111.042 177.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.4 t70 105.64 -82.16 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.856 1.663 . . . . 0.0 107.733 161.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -88.93 25.82 9.34 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-O 119.171 -0.794 . . . . 0.0 113.579 174.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 59.9 -3.72 0.11 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 175.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -101.81 -44.04 5.65 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.524 0.73 . . . . 0.0 110.941 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -111.54 158.81 18.76 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.639 1.176 . . . . 0.0 109.104 -174.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 4.4 pp -110.49 112.97 25.24 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 165.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.14 125.14 49.71 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.977 0.511 . . . . 0.0 110.943 -176.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.432 ' O ' HG22 ' A' ' 81' ' ' VAL . 22.9 t -85.73 130.91 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.316 -175.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -96.79 93.02 6.44 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.3 p -81.93 -66.33 0.9 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 174.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.494 ' HB2' HG23 ' A' ' 79' ' ' VAL . 50.4 m -162.66 134.4 5.24 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.333 1.053 . . . . 0.0 109.884 172.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -71.65 99.31 2.08 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 164.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.44 -28.91 1.49 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -164.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.494 HG23 ' HB2' ' A' ' 76' ' ' SER . 17.4 m -126.43 152.52 74.25 Favored Pre-proline 0 N--CA 1.485 1.305 0 C-N-CA 124.154 0.981 . . . . 0.0 109.552 177.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -50.72 113.44 1.07 Allowed 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 123.117 2.545 . . . . 0.0 114.013 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 73' ' ' VAL . 7.3 p -71.08 141.38 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 124.72 1.208 . . . . 0.0 110.565 177.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -109.95 119.45 39.36 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.701 0.8 . . . . 0.0 109.656 175.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -102.06 146.94 27.2 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.025 0.93 . . . . 0.0 109.355 172.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -133.74 163.24 29.9 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.939 0.896 . . . . 0.0 108.849 174.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -100.15 -21.14 15.66 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 172.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.515 HG23 ' H ' ' A' ' 88' ' ' GLY . 57.9 m -138.5 141.59 39.38 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -170.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.463 ' O ' HG12 ' A' ' 91' ' ' ILE . 96.1 mt -61.82 -31.27 71.5 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.279 0.632 . . . . 0.0 111.353 177.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.515 ' H ' HG23 ' A' ' 86' ' ' THR . . . -58.21 -34.19 72.86 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 113.749 0.26 . . . . 0.0 113.749 173.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.86 -40.37 75.81 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.463 0.705 . . . . 0.0 110.295 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.3 tp -56.92 -61.07 2.7 Favored 'General case' 0 C--N 1.356 0.891 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.158 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.487 ' HA ' HD12 ' A' ' 105' ' ' LEU . 29.8 mm -60.29 -40.17 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 124.301 1.04 . . . . 0.0 110.573 -177.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.64 -55.54 28.25 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 124.073 0.858 . . . . 0.0 113.853 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 50.9 tp -73.82 -34.71 64.69 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 122.801 0.44 . . . . 0.0 110.939 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.411 ' HA ' ' OD1' ' A' ' 98' ' ' ASN . 3.1 m-30 -86.61 0.87 53.6 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -172.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.99 8.86 6.19 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.346 0.658 . . . . 0.0 112.497 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -137.92 162.18 55.66 Favored Pre-proline 0 CA--C 1.55 0.942 0 C-N-CA 124.888 1.275 . . . . 0.0 108.261 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -49.44 118.53 3.74 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 123.161 2.574 . . . . 0.0 113.243 171.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.411 ' OD1' ' HA ' ' A' ' 94' ' ' TYR . 21.8 m120 -106.93 -78.44 0.58 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.75 0.82 . . . . 0.0 110.923 -174.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 148.34 101.46 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.387 1.475 . . . . 0.0 108.089 -156.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 105.55 -29.06 12.05 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-O 119.742 -0.477 . . . . 0.0 112.832 172.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 15.2 mt -71.09 145.34 49.91 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.736 0.414 . . . . 0.0 111.339 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.5 m -66.01 -27.45 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.566 0.746 . . . . 0.0 111.421 172.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.565 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 29.3 p -168.22 172.89 8.23 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.337 1.055 . . . . 0.0 109.829 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.87 151.54 38.97 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.569 171.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 91' ' ' ILE . 29.9 mt -77.7 103.96 7.95 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 92.6 mt -118.95 -60.96 1.7 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.921 0.488 . . . . 0.0 112.153 -172.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -95.43 140.87 22.55 Favored Pre-proline 0 N--CA 1.484 1.271 0 C-N-CA 122.732 0.413 . . . . 0.0 111.17 -169.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -73.94 -163.46 0.17 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.965 2.444 . . . . 0.0 112.444 172.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.472 HG23 HD22 ' A' ' 37' ' ' LEU . 72.3 t . . . . . 0 C--O 1.254 1.32 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -175.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 m . . . . . 0 C--O 1.24 0.6 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.409 ' CD1' ' HB3' ' A' ' 108' ' ' PRO . 33.5 p-90 -91.95 3.82 54.37 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.908 0.483 . . . . 0.0 110.894 176.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.471 ' HH ' ' HE1' ' A' ' 48' ' ' PHE . 73.5 t80 -110.56 127.66 55.31 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -123.11 144.2 49.48 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.0 mtp-105 -63.07 -64.49 0.9 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.681 0.792 . . . . 0.0 110.13 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -84.74 -101.66 0.05 Allowed 'General case' 0 C--O 1.246 0.901 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -177.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.3 tp 65.05 113.56 0.03 OUTLIER 'General case' 0 C--N 1.363 1.182 0 C-N-CA 125.336 1.454 . . . . 0.0 110.661 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.2 t -72.91 147.81 44.95 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 170.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -63.81 -38.04 89.63 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.133 0.973 . . . . 0.0 110.151 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.23 -45.38 87.81 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.726 173.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.81 -33.59 66.31 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.606 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.56 ' HB1' HD13 ' A' ' 37' ' ' LEU . . . -66.87 -51.93 49.56 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.739 0.816 . . . . 0.0 110.255 -177.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -54.26 -43.66 71.17 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.013 1.325 . . . . 0.0 111.323 174.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.39 -50.3 66.02 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.821 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.1 mt -61.85 -34.32 75.76 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.69 0.796 . . . . 0.0 112.295 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.7 mt -70.54 -59.09 3.04 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.92 -29.01 68.08 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.297 1.039 . . . . 0.0 112.977 -172.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -78.21 -44.94 24.33 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.413 0.685 . . . . 0.0 110.904 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.64 -59.24 2.82 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.438 0.637 . . . . 0.0 112.408 -170.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.06 -169.62 16.05 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 114.685 -1.143 . . . . 0.0 113.808 -165.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.404 ' HB3' ' H ' ' A' ' 33' ' ' ASP . 6.4 mpt_? -119.47 -157.57 0.7 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 125.143 1.377 . . . . 0.0 109.716 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.404 ' H ' ' HB3' ' A' ' 32' ' ' ARG . 8.1 p-10 -57.0 132.87 54.16 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.959 0.904 . . . . 0.0 112.099 -176.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.55 0.59 64.65 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.932 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 53' ' ' LEU . 56.8 m -71.64 116.58 12.17 Favored 'General case' 0 C--N 1.359 1.007 0 CA-C-N 117.764 0.782 . . . . 0.0 108.898 176.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 24.5 p90 -131.07 157.43 43.09 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.306 0.574 . . . . 0.0 111.639 -172.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.56 HD13 ' HB1' ' A' ' 23' ' ' ALA . 2.9 pp -150.93 164.11 37.12 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.69 169.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 86.2 t -125.94 149.26 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 171.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.499 ' HG3' ' HB3' ' A' ' 49' ' ' ALA . 0.5 OUTLIER -153.17 169.07 23.91 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.739 1.215 . . . . 0.0 108.726 -175.383 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 13.7 t70 -93.18 120.8 33.87 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 172.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.4 m -69.19 101.15 1.4 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.027 0.931 . . . . 0.0 111.282 -169.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.44 ' HG2' HH21 ' A' ' 39' ' ' ARG . 16.6 mm-40 -49.78 -31.67 12.16 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.411 1.484 . . . . 0.0 114.315 173.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.5 p -79.23 -17.4 54.88 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.944 0.498 . . . . 0.0 112.279 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.6 t -108.81 -64.76 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 122.996 0.519 . . . . 0.0 109.7 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 95.84 122.07 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.871 2.469 . . . . 0.0 109.547 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 63.46 58.18 12.31 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.746 1.279 . . . . 0.0 111.643 -173.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 40' ' ' ASP . . . -153.08 150.4 29.09 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.461 1.104 . . . . 0.0 108.149 -174.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.471 ' HE1' ' HH ' ' A' ' 14' ' ' TYR . 91.4 m-85 -113.53 125.1 53.82 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.388 0.994 . . . . 0.0 111.311 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . . . -104.4 127.27 52.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.52 0.728 . . . . 0.0 109.326 -177.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.4 tp -111.11 106.25 15.23 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 31.2 m -101.16 121.38 41.74 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -176.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.496 HG22 HD22 ' A' ' 101' ' ' LEU . 94.0 t -122.43 116.69 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.262 1.025 . . . . 0.0 109.37 -174.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.413 ' HB3' ' HB2' ' A' ' 35' ' ' SER . 36.9 tp -85.24 135.13 34.06 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.189 0.996 . . . . 0.0 111.273 -173.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.486 ' HB2' ' HG ' ' A' ' 103' ' ' CYS . 75.3 t80 -141.7 102.3 4.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.525 0.73 . . . . 0.0 109.103 167.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 57.5 54.21 6.71 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.231 1.012 . . . . 0.0 111.369 172.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? 75.27 -23.06 0.24 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 125.681 1.592 . . . . 0.0 112.441 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -88.8 101.35 13.94 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.902 0.858 . . . . 0.0 108.734 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 83.6 t -93.52 120.7 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.227 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -94.98 122.13 37.31 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 37.3 p -113.9 141.62 47.13 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -169.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -135.99 99.15 4.07 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -177.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -81.14 93.53 6.47 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.109 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.424 HG21 ' HB3' ' A' ' 71' ' ' LEU . 32.5 mt -79.9 136.63 23.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 124.494 1.117 . . . . 0.0 110.315 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.8 mp -121.2 141.22 32.56 Favored Pre-proline 0 N--CA 1.475 0.805 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -174.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.67 114.91 2.2 Favored 'Trans proline' 0 C--N 1.366 1.491 0 C-N-CA 122.038 1.826 . . . . 0.0 109.162 158.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -123.84 5.36 8.75 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 123.48 0.712 . . . . 0.0 110.44 -160.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.36 141.29 3.67 Favored Glycine 0 C--N 1.342 0.904 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -174.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 33.66 -76.75 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.016 2.228 . . . . 0.0 117.016 -166.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -163.02 22.37 0.09 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -163.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.404 ' HB3' ' HB2' ' A' ' 83' ' ' ARG . 72.1 m-85 -127.15 150.5 49.48 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.139 0.976 . . . . 0.0 109.717 -170.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.424 ' HB3' HG21 ' A' ' 63' ' ' ILE . 8.2 mp -99.11 150.05 22.42 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.28 1.032 . . . . 0.0 109.743 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -135.93 120.54 18.28 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.635 0.774 . . . . 0.0 109.836 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.8 t -84.93 128.04 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.27 1.028 . . . . 0.0 108.539 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -110.85 87.64 2.58 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -175.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.3 t -140.44 138.68 34.88 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.165 175.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.4 m 63.05 -2.12 0.44 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 165.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 60.71 -79.69 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 125.331 1.452 . . . . 0.0 112.429 -177.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.55 -28.48 62.52 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 -172.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.92 124.19 63.43 Favored Pre-proline 0 CA--C 1.561 1.392 0 CA-C-N 117.274 0.537 . . . . 0.0 110.632 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.414 ' HB2' HE22 ' A' ' 99' ' ' GLN . 81.3 Cg_exo -51.99 113.58 1.24 Allowed 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.653 2.235 . . . . 0.0 113.349 177.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 70.2 t -101.7 134.1 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.417 1.087 . . . . 0.0 108.751 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -105.29 151.6 23.94 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.453 ' O ' ' HD2' ' A' ' 83' ' ' ARG . 2.6 ppt_? -85.34 121.91 28.74 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 170.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -107.29 129.43 54.89 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.592 -0.693 . . . . 0.0 110.178 -176.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -84.64 -17.31 39.01 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.8 t -155.28 163.46 40.11 Favored 'General case' 0 C--O 1.248 0.99 0 C-N-CA 122.779 0.432 . . . . 0.0 110.372 172.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.403 ' O ' HG12 ' A' ' 91' ' ' ILE . 94.9 mt -60.22 -32.12 70.81 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.044 0.937 . . . . 0.0 111.677 177.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -55.86 -41.85 84.71 Favored Glycine 0 C--N 1.352 1.464 0 O-C-N 123.304 0.377 . . . . 0.0 112.762 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -65.85 -39.08 90.43 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.811 0.844 . . . . 0.0 111.033 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 47.7 tp -64.17 -41.72 97.02 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.191 0.996 . . . . 0.0 111.467 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 87' ' ' LEU . 49.8 mm -84.95 -28.18 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -168.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.42 -47.74 15.84 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.2 tt -61.28 -43.78 98.32 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.447 0.699 . . . . 0.0 110.325 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.499 ' HB3' HD13 ' A' ' 101' ' ' LEU . 3.0 m-85 -79.57 -9.76 59.68 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.509 0.724 . . . . 0.0 112.215 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.03 -0.72 19.85 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.734 0.413 . . . . 0.0 112.104 167.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -154.45 57.92 1.93 Allowed Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 124.465 1.106 . . . . 0.0 109.018 172.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.463 ' HG3' HD12 ' A' ' 101' ' ' LEU . 81.1 Cg_endo -75.35 -66.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.507 2.138 . . . . 0.0 113.706 -164.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.5 t30 57.77 39.24 27.29 Favored 'General case' 0 C--N 1.367 1.327 0 C-N-CA 124.325 1.05 . . . . 0.0 108.534 -170.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.414 HE22 ' HB2' ' A' ' 80' ' ' PRO . 20.9 mt-30 -177.75 86.38 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.243 1.017 . . . . 0.0 110.211 -162.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 103.93 -32.28 7.72 Favored Glycine 0 N--CA 1.474 1.187 0 C-N-CA 121.639 -0.315 . . . . 0.0 112.853 161.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.499 HD13 ' HB3' ' A' ' 94' ' ' TYR . 53.7 mt -87.64 123.96 33.04 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.675 0.39 . . . . 0.0 110.388 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.8 p -51.05 -32.83 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.457 0 C-N-CA 125.767 1.627 . . . . 0.0 113.514 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.486 ' HG ' ' HB2' ' A' ' 54' ' ' TYR . 26.2 p -153.64 16.07 0.51 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.979 0.512 . . . . 0.0 112.206 -175.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 67.26 -160.35 0.23 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.646 0.778 . . . . 0.0 110.891 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 56.9 mt -110.91 156.67 20.84 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 58.5 tp -164.94 -63.18 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.457 0.303 . . . . 0.0 111.051 -175.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 29.9 tp -111.52 102.56 53.56 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 122.792 0.437 . . . . 0.0 110.507 -167.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.409 ' HB3' ' CD1' ' A' ' 13' ' ' TRP . 12.3 Cg_exo -72.4 100.96 1.2 Allowed 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.587 2.192 . . . . 0.0 109.392 169.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 87.6 t . . . . . 0 C--O 1.245 0.852 0 CA-C-O 118.648 -0.691 . . . . 0.0 109.328 -171.433 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.6 m . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -115.26 12.53 16.48 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.108 0.563 . . . . 0.0 111.929 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -108.36 116.57 32.22 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -177.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -115.51 117.15 29.55 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -64.24 -58.51 6.36 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.385 0.674 . . . . 0.0 111.524 -175.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -111.11 86.48 2.33 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.394 1.092 . . . . 0.0 108.461 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.9 tp -133.14 133.74 43.26 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.457 -1.247 . . . . 0.0 107.926 177.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.4 m -80.04 155.0 27.79 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.502 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 77.3 ttt180 -65.85 -43.35 88.7 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 119.233 -0.413 . . . . 0.0 110.774 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.85 -48.08 67.32 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.449 0.7 . . . . 0.0 111.252 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.47 -25.13 63.93 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.087 177.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.419 ' HB1' HD13 ' A' ' 37' ' ' LEU . . . -74.81 -49.55 20.33 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.49 0.716 . . . . 0.0 111.664 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 1.1 mm-40 -62.72 -38.65 91.31 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.234 0.614 . . . . 0.0 110.01 177.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.3 -47.24 80.22 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 124.377 1.048 . . . . 0.0 109.995 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -54.7 -37.92 66.41 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.89 0.876 . . . . 0.0 110.869 176.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 53' ' ' LEU . 86.5 mt -79.77 -36.1 37.65 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.375 -0.203 . . . . 0.0 111.061 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.63 -41.75 83.4 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 122.706 0.403 . . . . 0.0 110.45 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -89.22 -60.29 1.99 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.119 0.968 . . . . 0.0 111.621 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.26 -50.47 14.32 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.176 0.19 . . . . 0.0 111.347 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.32 122.11 28.62 Favored Glycine 0 C--N 1.353 1.505 0 O-C-N 123.544 0.527 . . . . 0.0 113.72 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -71.0 -45.04 64.67 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.089 0.556 . . . . 0.0 111.075 -177.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 160.98 131.94 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 125.405 1.482 . . . . 0.0 108.172 -174.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.12 20.45 79.05 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 111.924 -0.471 . . . . 0.0 111.924 -176.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.489 ' HB3' ' HA ' ' A' ' 109' ' ' VAL . 13.7 m -83.48 144.94 29.22 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 124.377 1.071 . . . . 0.0 109.529 -178.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -141.75 150.49 41.84 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.96 0.409 . . . . 0.0 111.008 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.419 HD13 ' HB1' ' A' ' 23' ' ' ALA . 4.6 pp -138.26 148.86 45.16 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.913 0.885 . . . . 0.0 109.869 170.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.419 HG23 HD13 ' A' ' 50' ' ' LEU . 48.7 t -114.39 136.55 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -135.73 165.2 26.13 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 124.54 1.136 . . . . 0.0 109.412 -174.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -86.32 131.96 34.09 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 175.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 47' ' ' ALA . 40.4 m -91.46 162.56 14.51 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.292 1.037 . . . . 0.0 108.251 172.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -143.7 75.28 1.46 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.6 t -165.48 -68.69 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.664 -174.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 76.2 t -82.18 82.35 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 174.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 46.72 -122.67 1.28 Allowed 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 124.352 1.061 . . . . 0.0 111.183 -170.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -108.77 79.69 0.25 Allowed Glycine 0 C--N 1.356 1.67 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 172.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 41' ' ' SER . . . -92.38 174.51 7.25 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.542 0.737 . . . . 0.0 111.445 -172.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.519 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 87.2 m-85 -113.37 155.05 25.9 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.214 1.006 . . . . 0.0 109.72 173.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.52 146.98 48.63 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.619 1.168 . . . . 0.0 108.989 171.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 61' ' ' TYR . 40.8 tp -124.82 108.95 12.47 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.182 0.993 . . . . 0.0 109.239 -176.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.502 ' SG ' HG22 ' A' ' 60' ' ' THR . 52.9 m -93.92 126.1 38.93 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.1 t -132.71 121.28 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 CA-C-N 118.273 0.488 . . . . 0.0 109.852 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 40.2 tp -86.93 139.84 30.21 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.72 0.808 . . . . 0.0 109.248 171.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -163.56 121.49 1.89 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 170.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 41.88 67.26 0.59 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 126.012 1.725 . . . . 0.0 113.732 177.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.472 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 10.8 mmpt? 59.21 27.73 16.83 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.76 1.224 . . . . 0.0 112.897 178.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -139.36 107.14 5.64 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.781 0.832 . . . . 0.0 108.984 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.9 t -93.47 122.12 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 166.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -117.97 138.61 52.06 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.064 0.946 . . . . 0.0 108.907 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.502 HG22 ' SG ' ' A' ' 51' ' ' CYS . 21.4 p -106.56 139.51 40.9 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.471 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 23.9 m-85 -119.0 107.56 13.67 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -70.58 150.37 46.14 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 171.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 96.7 mt -147.27 105.77 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 102.605 -3.109 . . . . 0.0 102.605 -158.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.8 mp -107.19 98.03 20.89 Favored Pre-proline 0 N--CA 1.48 1.051 0 CA-C-O 118.634 -0.698 . . . . 0.0 111.484 -160.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 70' ' ' PHE . 37.3 Cg_endo -66.22 95.58 0.32 Allowed 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 122.5 2.133 . . . . 0.0 109.268 162.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -166.76 164.26 16.56 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 124.446 1.098 . . . . 0.0 108.683 -158.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.72 -67.05 3.05 Favored Glycine 0 C--N 1.349 1.272 0 C-N-CA 123.076 0.369 . . . . 0.0 113.047 171.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -142.22 23.99 1.98 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.105 1.362 . . . . 0.0 108.108 -178.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 t70 61.49 58.71 2.03 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.262 1.425 . . . . 0.0 109.972 -170.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 23.1 p90 -127.8 151.99 48.35 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.394 1.078 . . . . 0.0 108.105 169.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.15 109.44 22.19 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 176.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . . . -98.56 127.11 44.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.793 0.837 . . . . 0.0 110.42 -175.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.3 t -99.26 129.15 50.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -94.04 90.72 6.53 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -174.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.5 p -71.66 -34.36 69.66 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.237 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.9 m 75.94 167.12 0.27 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.878 1.671 . . . . 0.0 112.745 173.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 67.57 -162.64 0.22 Allowed 'General case' 0 C--N 1.358 0.972 0 C-N-CA 124.47 1.108 . . . . 0.0 111.693 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -49.5 -24.38 5.42 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 114.756 -1.111 . . . . 0.0 113.965 170.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.69 120.9 80.4 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.573 0.749 . . . . 0.0 109.654 174.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.36 142.52 72.92 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.94 2.427 . . . . 0.0 113.266 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 37.1 t -78.29 118.88 26.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 C-N-CA 124.297 1.039 . . . . 0.0 108.278 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -107.03 127.76 53.76 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.852 0.358 . . . . 0.0 110.494 -173.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.554 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 27.9 ptt180 -98.05 154.33 17.79 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.311 1.044 . . . . 0.0 109.997 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -130.29 154.85 47.19 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.369 0.668 . . . . 0.0 111.399 -175.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -72.67 -46.42 53.92 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.502 172.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.0 t -145.76 166.74 24.99 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.517 0.727 . . . . 0.0 110.975 -177.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.6 mt -60.0 -32.57 70.98 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.712 0.805 . . . . 0.0 111.43 175.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -52.45 -41.26 55.44 Favored Glycine 0 N--CA 1.48 1.6 0 O-C-N 123.027 0.205 . . . . 0.0 113.357 172.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -65.63 -41.06 93.09 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.739 0.815 . . . . 0.0 111.232 173.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.5 tt -68.11 -40.09 82.65 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.226 1.01 . . . . 0.0 110.873 -174.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 44.6 mm -86.05 -42.11 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -166.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.88 -35.21 72.31 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.763 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.1 tp -77.49 -40.98 41.08 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-N 116.907 0.353 . . . . 0.0 110.821 177.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.3 m-30 -80.98 4.37 19.81 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 118.099 0.409 . . . . 0.0 111.83 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.63 -4.02 3.76 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.842 0.857 . . . . 0.0 112.538 163.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -125.27 144.35 47.27 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 171.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -84.42 -154.13 0.05 OUTLIER 'Trans proline' 0 CA--C 1.555 1.531 0 C-N-CA 123.32 2.68 . . . . 0.0 112.387 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.5 t30 62.68 57.54 1.77 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.64 1.176 . . . . 0.0 110.032 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -170.41 31.22 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.808 178.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.66 -10.36 72.42 Favored Glycine 0 N--CA 1.477 1.424 0 O-C-N 120.886 -1.134 . . . . 0.0 112.433 173.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.13 130.93 43.41 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 168.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.426 HG13 ' HH ' ' A' ' 61' ' ' TYR . 13.2 p -60.09 -31.67 48.5 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 123.984 0.914 . . . . 0.0 111.142 177.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 28.4 p -160.11 165.44 31.73 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.529 1.132 . . . . 0.0 108.876 176.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.2 150.73 46.16 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 122.727 0.411 . . . . 0.0 110.169 174.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 75.7 mt -73.16 95.85 2.14 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.2 tp -119.67 -61.37 1.62 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.673 -169.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.462 HD13 ' HD2' ' A' ' 108' ' ' PRO . 45.1 tp -100.42 123.78 45.12 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 123.081 0.552 . . . . 0.0 109.797 -172.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.462 ' HD2' HD13 ' A' ' 107' ' ' LEU . 19.4 Cg_endo -59.03 -47.61 17.21 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.399 2.066 . . . . 0.0 111.242 172.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.489 ' HA ' ' HB3' ' A' ' 35' ' ' SER . 0.3 OUTLIER . . . . . 0 C--O 1.245 0.836 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.483 1.22 0 CA-C-O 120.292 0.091 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.533 ' HB3' ' HB3' ' A' ' 108' ' ' PRO 0.317 36.1 p-90 71.53 -54.56 0.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 128.569 2.748 . . . . 0.0 110.906 -177.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -76.35 123.83 26.57 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 173.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.406 ' CD2' ' HB2' ' A' ' 37' ' ' LEU . 93.3 m-70 -113.79 171.93 7.29 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.856 0.863 . . . . 0.0 110.797 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -81.95 -148.43 0.07 Allowed 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.601 169.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -65.04 106.04 1.18 Allowed 'General case' 0 CA--C 1.555 1.168 0 CA-C-O 121.786 0.803 . . . . 0.0 110.219 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.498 ' HB3' ' HB2' ' A' ' 39' ' ' ARG . 26.2 tp -136.1 138.45 42.08 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 57.4 p -96.15 172.39 8.01 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.399 0.68 . . . . 0.0 110.225 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -63.42 -51.75 64.43 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.448 0.699 . . . . 0.0 112.568 -176.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.47 -35.95 80.93 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.872 0.469 . . . . 0.0 111.265 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.84 -37.25 81.65 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.385 0.674 . . . . 0.0 111.1 174.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.33 -55.31 12.52 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.816 0.846 . . . . 0.0 111.703 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.467 ' HB3' HG13 ' A' ' 58' ' ' VAL . 13.3 pt-20 -66.13 -26.37 67.42 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.005 0.922 . . . . 0.0 112.375 -177.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -64.81 -51.18 63.54 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 172.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.9 tp -61.21 -40.16 92.91 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.974 178.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.419 HD21 ' HB2' ' A' ' 35' ' ' SER . 97.0 mt -64.58 -52.34 58.08 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.705 0.802 . . . . 0.0 110.505 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.43 -33.48 75.64 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.866 0.867 . . . . 0.0 112.566 -172.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -87.75 -57.79 2.81 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.783 -0.189 . . . . 0.0 111.383 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.73 -59.44 3.32 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.14 0.576 . . . . 0.0 112.325 -170.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -123.12 77.04 0.36 Allowed Glycine 0 C--N 1.342 0.885 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -71.47 102.57 2.7 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 118.996 -0.525 . . . . 0.0 110.015 -171.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.5 t70 97.7 116.2 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.638 1.575 . . . . 0.0 109.877 164.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.72 3.79 68.23 Favored Glycine 0 N--CA 1.476 1.313 0 CA-C-N 115.879 -0.6 . . . . 0.0 113.543 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.419 ' HB2' HD21 ' A' ' 27' ' ' LEU . 3.7 p -78.09 158.56 29.1 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.416 0.687 . . . . 0.0 111.56 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -145.9 158.95 43.84 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 172.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.406 ' HB2' ' CD2' ' A' ' 15' ' ' HIS . 4.1 pp -154.05 163.08 40.66 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.697 170.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.0 t -117.76 144.88 24.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 169.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.498 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 50.4 ptt85 -152.9 156.68 39.41 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.19 0.596 . . . . 0.0 110.051 -174.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -87.91 117.83 27.03 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 174.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.0 m -94.9 100.36 12.24 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 174.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -60.63 -39.45 88.28 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.196 0.598 . . . . 0.0 111.921 169.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.1 m -87.92 58.84 5.04 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.89 0.876 . . . . 0.0 112.183 -171.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.423 HG11 ' H ' ' A' ' 45' ' ' ALA . 2.1 p -155.49 -70.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.008 0.523 . . . . 0.0 110.17 172.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.423 ' H ' HG11 ' A' ' 44' ' ' VAL . . . -170.07 15.07 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.695 0.798 . . . . 0.0 110.539 -174.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.49 94.68 0.06 OUTLIER Glycine 0 C--N 1.344 1.026 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -161.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.562 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . . . -152.54 160.42 43.22 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -168.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.422 ' HD2' ' HB3' ' A' ' 65' ' ' PRO . 57.8 m-85 -109.58 137.12 47.87 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.932 0.493 . . . . 0.0 109.928 168.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -119.48 135.81 54.6 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.776 0.831 . . . . 0.0 109.816 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.509 HD22 HD23 ' A' ' 105' ' ' LEU . 66.8 tp -107.87 104.08 13.48 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 48.8 t -106.85 116.16 31.45 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -174.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.9 t -122.2 118.24 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.574 1.15 . . . . 0.0 109.151 -170.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 47.3 tp -91.75 131.91 36.78 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.768 0.827 . . . . 0.0 109.155 175.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -164.51 127.97 2.47 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.431 0.692 . . . . 0.0 110.32 172.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 47.69 53.23 11.55 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.351 1.46 . . . . 0.0 111.715 174.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 91.0 mttt 56.38 39.26 30.14 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.515 1.126 . . . . 0.0 112.05 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 59.2 m80 -136.77 105.8 5.96 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.334 1.054 . . . . 0.0 108.481 174.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.467 HG13 ' HB3' ' A' ' 24' ' ' GLU . 84.9 t -94.67 107.17 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 170.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -103.06 129.55 49.91 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 96.0 m -110.2 137.98 47.2 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.459 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 56.4 m-85 -120.64 101.47 7.77 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -86.13 96.47 9.9 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 119.082 0.855 . . . . 0.0 109.402 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.448 HD13 ' O ' ' A' ' 61' ' ' TYR . 4.9 mp -85.07 141.95 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 123.62 0.768 . . . . 0.0 110.805 171.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.9 mp -96.06 118.87 65.43 Favored Pre-proline 0 CA--C 1.557 1.219 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 172.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.562 ' HD3' ' HA ' ' A' ' 47' ' ' ALA . 92.3 Cg_endo -76.4 -51.98 0.09 OUTLIER 'Trans proline' 0 CA--C 1.556 1.589 0 C-N-CA 122.519 2.146 . . . . 0.0 116.361 -162.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -148.91 167.68 25.06 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 122.259 -0.276 . . . . 0.0 111.158 -158.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.15 -96.29 0.25 Allowed Glycine 0 C--N 1.35 1.323 0 C-N-CA 123.336 0.494 . . . . 0.0 111.898 178.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -126.05 30.31 5.68 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.983 0.913 . . . . 0.0 109.206 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -159.33 174.19 15.14 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.771 -162.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -120.26 158.19 27.55 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.52 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -93.42 111.49 23.17 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -170.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.749 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . . . -117.95 142.23 47.59 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.86 0.864 . . . . 0.0 110.748 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.6 t -89.24 142.57 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -108.84 90.99 3.46 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.8 p -87.58 -71.35 0.57 Allowed 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 172.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.2 t 179.92 140.72 0.13 Allowed 'General case' 0 C--N 1.351 0.658 0 C-N-CA 124.616 1.167 . . . . 0.0 108.955 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -70.83 128.2 35.23 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 140.52 -76.96 0.31 Allowed Glycine 0 C--N 1.346 1.135 0 N-CA-C 108.067 -2.013 . . . . 0.0 108.067 -166.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.3 m -64.41 140.08 97.88 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 123.838 0.855 . . . . 0.0 110.043 162.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -64.58 121.28 8.8 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.75 2.3 . . . . 0.0 112.056 -176.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 72.6 t -99.47 141.85 16.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.197 0.999 . . . . 0.0 108.463 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.8 mmt85 -117.31 143.7 45.65 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.553 0.741 . . . . 0.0 111.109 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.749 ' HG2' ' HB3' ' A' ' 72' ' ' ALA . 86.2 mtt-85 -94.89 148.41 22.34 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 166.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -127.39 161.9 27.58 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.163 0.585 . . . . 0.0 110.395 -174.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -95.3 -19.39 20.02 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.313 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.0 t -157.06 159.72 38.21 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 122.654 0.382 . . . . 0.0 111.592 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.4 mt -61.27 -34.44 75.18 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.186 0.994 . . . . 0.0 112.143 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.41 -38.77 91.63 Favored Glycine 0 C--N 1.349 1.254 0 O-C-N 123.206 0.317 . . . . 0.0 112.952 174.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -72.21 -37.16 69.3 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.649 0.78 . . . . 0.0 109.735 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.6 tt -54.28 -53.74 49.61 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.657 1.183 . . . . 0.0 110.428 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.9 mm -64.79 -36.3 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.414 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -53.89 -55.08 27.51 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 124.198 0.936 . . . . 0.0 113.298 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -76.47 -35.74 58.26 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 122.998 0.519 . . . . 0.0 111.843 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.49 ' CD2' HD21 ' A' ' 101' ' ' LEU . 7.4 m-85 -89.49 4.62 48.59 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -173.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.42 -6.82 48.72 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 122.719 0.408 . . . . 0.0 110.93 162.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -83.17 125.75 73.86 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.965 0.906 . . . . 0.0 110.337 174.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.94 179.78 6.18 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.387 2.058 . . . . 0.0 111.36 169.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 53.83 66.18 1.3 Allowed 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.877 0.871 . . . . 0.0 111.128 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -173.2 21.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.2 1.0 . . . . 0.0 110.383 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 107.52 -21.65 30.12 Favored Glycine 0 C--N 1.345 1.076 0 O-C-N 121.622 -0.674 . . . . 0.0 112.41 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.49 HD21 ' CD2' ' A' ' 94' ' ' TYR . 2.9 mm? -70.57 124.7 24.86 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.338 1.055 . . . . 0.0 110.582 177.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.9 p -52.96 -31.41 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.542 0 C-N-CA 124.21 1.004 . . . . 0.0 112.783 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 27.2 p -156.25 6.41 0.19 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.003 0.521 . . . . 0.0 112.309 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 68.0 -179.62 0.22 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.727 0.811 . . . . 0.0 110.594 -166.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.509 HD23 HD22 ' A' ' 50' ' ' LEU . 46.1 mt -90.0 91.53 8.61 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 79.1 mt -93.86 -69.31 0.76 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.928 0.891 . . . . 0.0 111.321 -174.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.7 mp -104.01 128.25 27.6 Favored Pre-proline 0 N--CA 1.48 1.048 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -173.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.533 ' HB3' ' HB3' ' A' ' 13' ' ' TRP . 35.5 Cg_exo -63.38 -124.25 0.0 OUTLIER 'Trans proline' 0 CA--C 1.571 2.334 0 C-N-CA 122.623 2.215 . . . . 0.0 111.576 169.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.7 t . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 176.914 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.8 t . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.489 ' HB3' ' O ' ' A' ' 108' ' ' PRO . 4.7 p-90 -94.77 -22.86 17.8 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.595 1.158 . . . . 0.0 109.341 166.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.494 ' HH ' ' HE1' ' A' ' 48' ' ' PHE . 84.6 t80 -71.68 109.05 5.33 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.862 173.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -128.27 120.29 26.84 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -59.06 -72.84 0.09 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.647 0.379 . . . . 0.0 110.937 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -85.48 59.05 5.39 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.72 0.808 . . . . 0.0 110.126 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 26.0 tp -88.2 -61.12 1.78 Allowed 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -176.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.2 m 93.81 145.94 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 127.125 2.17 . . . . 0.0 107.895 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.471 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 54.9 ttt180 -57.2 -46.83 82.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.112 0.565 . . . . 0.0 111.701 -177.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 25' ' ' GLU . . . -51.76 -47.92 63.93 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 124.173 0.92 . . . . 0.0 111.573 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.41 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -69.13 -38.04 78.63 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.459 177.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.425 ' HB1' HD12 ' A' ' 37' ' ' LEU . . . -61.4 -60.64 3.41 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.189 0.996 . . . . 0.0 112.114 -177.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 12.5 pt-20 -59.08 -29.58 67.44 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.246 1.019 . . . . 0.0 112.398 175.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.6 OUTLIER -67.1 -47.47 71.07 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.161 0.584 . . . . 0.0 109.522 178.119 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 22' ' ' ALA . 94.5 mt -59.59 -36.03 75.47 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.89 0.876 . . . . 0.0 111.341 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.3 mt -68.87 -54.55 15.0 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.24 -36.76 76.05 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.818 0.847 . . . . 0.0 112.748 -169.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -92.37 -59.47 2.08 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.35 -59.51 2.68 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -165.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.33 108.34 1.69 Allowed Glycine 0 C--N 1.349 1.304 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -175.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 50.8 ttt85 -57.75 -129.09 0.0 OUTLIER 'General case' 0 CA--C 1.581 2.173 0 C-N-CA 124.372 1.069 . . . . 0.0 113.236 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -74.68 148.83 40.24 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.282 -1.511 . . . . 0.0 111.442 -169.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.412 ' HA3' HD23 ' A' ' 106' ' ' LEU . . . 70.13 18.04 74.42 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.628 0.58 . . . . 0.0 114.207 -176.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.619 ' HB2' HG21 ' A' ' 109' ' ' VAL . 59.6 p -80.38 139.04 36.72 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -144.1 147.24 33.48 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.013 0.435 . . . . 0.0 110.255 177.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.425 HD12 ' HB1' ' A' ' 23' ' ' ALA . 1.6 pp -150.04 154.37 38.05 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.123 0.969 . . . . 0.0 108.701 168.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 79.6 t -114.73 131.02 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.492 ' HG3' ' HB3' ' A' ' 49' ' ' ALA . 5.9 ptm180 -116.79 168.64 10.04 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.214 1.005 . . . . 0.0 108.383 174.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -85.24 132.38 34.28 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 170.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 97.1 p -58.53 153.38 16.23 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 123.905 0.753 . . . . 0.0 111.596 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -71.73 79.58 0.85 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.711 0.804 . . . . 0.0 111.963 -172.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.3 m 53.55 28.31 7.63 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.954 1.301 . . . . 0.0 113.118 177.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.8 t -65.53 -73.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.499 0.72 . . . . 0.0 111.411 -172.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -172.41 34.7 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.238 0.615 . . . . 0.0 110.608 -177.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.39 35.49 33.14 Favored Glycine 0 N--CA 1.469 0.835 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.14 -174.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -97.08 169.77 9.58 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.568 0.747 . . . . 0.0 110.64 -177.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.494 ' HE1' ' HH ' ' A' ' 14' ' ' TYR . 95.6 m-85 -124.16 157.49 34.59 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.049 0.94 . . . . 0.0 109.849 178.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.492 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . . . -133.64 144.77 49.42 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.295 0.638 . . . . 0.0 109.512 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.2 tp -123.9 124.21 42.12 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.436 ' SG ' HG22 ' A' ' 60' ' ' THR . 39.0 m -115.03 121.14 42.19 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -178.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 35' ' ' SER . 60.4 t -128.48 125.42 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.791 0.837 . . . . 0.0 109.038 -175.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.468 ' HB3' ' OG ' ' A' ' 35' ' ' SER . 60.7 tp -96.21 138.73 33.38 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.343 0.657 . . . . 0.0 109.905 177.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -161.57 125.05 3.2 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.9 0.88 . . . . 0.0 108.961 175.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 50.26 52.57 14.49 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.08 1.352 . . . . 0.0 112.391 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 80.3 tttt 55.9 39.11 30.64 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.737 1.215 . . . . 0.0 112.119 -176.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -140.69 106.03 5.05 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.94 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 85.4 t -87.36 112.06 22.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 168.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -97.4 130.34 44.54 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 170.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.436 HG22 ' SG ' ' A' ' 51' ' ' CYS . 41.1 p -108.29 130.26 55.19 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -113.59 98.9 7.34 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.3 mtm105 -83.54 91.69 7.47 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.482 HD12 HD11 ' A' ' 90' ' ' LEU . 61.7 mt -77.56 122.39 32.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.701 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.9 mp -93.96 149.86 37.61 Favored Pre-proline 0 CA--C 1.547 0.832 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -178.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -79.42 -143.05 0.02 OUTLIER 'Trans proline' 0 CA--C 1.565 2.061 0 C-N-CA 122.942 2.428 . . . . 0.0 112.498 -170.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.568 ' HB3' ' H ' ' A' ' 70' ' ' PHE . 31.0 t70 -169.74 151.43 4.25 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.646 0.778 . . . . 0.0 109.841 -172.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -55.33 -35.28 60.47 Favored Glycine 0 C--N 1.349 1.266 0 O-C-N 124.035 0.835 . . . . 0.0 114.112 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -102.59 25.13 9.48 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.646 0.778 . . . . 0.0 111.416 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 58.91 57.67 3.51 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.508 1.523 . . . . 0.0 114.098 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.568 ' H ' ' HB3' ' A' ' 66' ' ' ASP . 96.4 m-85 -118.86 151.65 37.72 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 169.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 mp -98.2 108.28 20.94 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.97 118.15 33.9 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.607 0.763 . . . . 0.0 109.628 -175.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.518 HG13 ' HH ' ' A' ' 94' ' ' TYR . 12.9 t -99.72 140.96 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.918 0.887 . . . . 0.0 110.289 -176.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -108.09 89.73 3.08 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 176.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.3 m -90.82 125.51 35.74 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -171.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.2 m 59.01 -89.98 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.067 1.347 . . . . 0.0 112.061 177.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 176.75 -26.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.592 1.157 . . . . 0.0 111.057 -177.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -132.03 40.61 1.6 Allowed Glycine 0 N--CA 1.47 0.966 0 CA-C-N 116.694 -0.23 . . . . 0.0 112.861 -170.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.6 p -143.7 135.47 12.95 Favored Pre-proline 0 CA--C 1.555 1.168 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -40.14 135.06 1.76 Allowed 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 124.182 3.255 . . . . 0.0 115.091 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 73' ' ' VAL . 88.0 t -64.04 131.16 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.733 1.213 . . . . 0.0 109.473 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -105.32 116.48 32.02 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -174.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -93.34 146.12 23.97 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 172.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -125.56 146.57 49.62 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.695 0.798 . . . . 0.0 110.091 175.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -75.11 -40.04 60.18 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.764 0.425 . . . . 0.0 110.481 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.0 p -141.05 173.92 11.01 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.831 0.852 . . . . 0.0 109.854 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.4 HD21 HG12 ' A' ' 38' ' ' VAL . 1.4 tm? -68.37 -34.8 76.71 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.041 0.936 . . . . 0.0 109.455 175.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -60.66 -38.5 95.18 Favored Glycine 0 C--N 1.357 1.698 0 O-C-N 123.241 0.338 . . . . 0.0 113.341 175.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -64.93 -45.17 86.95 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.592 0.757 . . . . 0.0 111.096 174.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.482 HD11 HD12 ' A' ' 63' ' ' ILE . 8.2 tt -52.7 -50.34 63.53 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.426 1.09 . . . . 0.0 111.059 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.7 mm -70.3 -33.51 54.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.215 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.8 -57.31 20.09 Favored Glycine 0 CA--C 1.532 1.117 0 O-C-N 123.589 0.556 . . . . 0.0 114.163 178.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.1 mp -70.43 -31.17 68.25 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.098 0.559 . . . . 0.0 111.402 -178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.518 ' HH ' HG13 ' A' ' 73' ' ' VAL . 8.0 m-30 -78.94 -18.87 53.05 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 178.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.544 ' HA ' ' HB2' ' A' ' 105' ' ' LEU . . . -61.01 -20.74 62.85 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.443 0.697 . . . . 0.0 112.707 174.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -110.9 166.32 10.98 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 123.643 0.777 . . . . 0.0 109.403 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -49.89 105.7 0.1 Allowed 'Trans proline' 0 C--N 1.386 2.518 0 C-N-CA 123.063 2.508 . . . . 0.0 112.327 168.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -90.97 -51.64 5.24 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.943 0.897 . . . . 0.0 111.521 -174.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 109.55 101.03 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 128.477 2.711 . . . . 0.0 108.673 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.15 -17.72 11.52 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.849 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 49.1 mt -77.31 143.95 38.43 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.821 0.448 . . . . 0.0 111.012 176.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.2 m -75.29 71.85 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 CA-C-O 121.826 0.822 . . . . 0.0 109.309 165.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 2.6 p 78.81 179.6 0.12 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.65 1.98 . . . . 0.0 110.761 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.06 -178.09 6.72 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.431 0.692 . . . . 0.0 110.895 -177.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.544 ' HB2' ' HA ' ' A' ' 95' ' ' ALA . 29.0 mt -93.03 106.34 18.32 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 174.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.412 HD23 ' HA3' ' A' ' 34' ' ' GLY . 4.2 mm? -97.13 -56.89 2.41 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.379 0.672 . . . . 0.0 110.863 -176.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.5 pp -133.25 147.33 64.63 Favored Pre-proline 0 N--CA 1.486 1.333 0 C-N-CA 122.636 0.374 . . . . 0.0 111.407 -169.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.489 ' O ' ' HB3' ' A' ' 13' ' ' TRP . 65.0 Cg_endo -77.81 -11.99 16.56 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 123.155 2.57 . . . . 0.0 115.154 -171.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.619 HG21 ' HB2' ' A' ' 35' ' ' SER . 22.3 t . . . . . 0 N--CA 1.503 2.223 0 C-N-CA 124.994 1.318 . . . . 0.0 109.5 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.2 m . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.438 ' HB3' ' HB3' ' A' ' 108' ' ' PRO . 1.6 p-90 -80.37 3.47 21.11 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.459 0.704 . . . . 0.0 112.009 -172.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -110.82 102.33 10.86 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -172.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -118.22 119.1 33.68 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -67.56 -81.59 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.622 0.769 . . . . 0.0 111.477 -164.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -83.77 42.69 0.86 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 118.382 0.537 . . . . 0.0 111.761 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.435 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 35.8 tp -68.16 -48.0 66.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.839 0.456 . . . . 0.0 109.851 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.8 m 79.98 152.78 0.12 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.647 1.179 . . . . 0.0 110.684 170.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -56.58 -62.61 1.61 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.631 1.172 . . . . 0.0 112.546 -168.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.76 -50.66 67.89 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.598 0.759 . . . . 0.0 112.256 -178.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 18' ' ' LEU . . . -65.46 -32.12 73.56 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.219 -178.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.75 -53.54 26.45 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.646 0.378 . . . . 0.0 111.629 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.26 -32.84 74.71 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 123.784 0.678 . . . . 0.0 111.619 -178.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -69.26 -43.65 73.51 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.228 0.33 . . . . 0.0 110.712 176.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.5 -27.0 66.64 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.515 0.726 . . . . 0.0 111.933 174.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.8 mt -66.96 -60.26 2.79 Favored 'General case' 0 C--N 1.348 0.52 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 170.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.79 -32.29 63.37 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.377 1.071 . . . . 0.0 112.951 -176.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.05 -58.0 3.49 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.74 0.816 . . . . 0.0 109.687 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.9 -55.18 5.16 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.295 -168.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -99.86 -58.28 0.89 Allowed Glycine 0 N--CA 1.47 0.96 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 -176.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.528 ' HA ' HD23 ' A' ' 53' ' ' LEU . 53.9 ttp180 51.9 104.86 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.083 2.153 . . . . 0.0 113.345 -170.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.8 t70 88.99 120.92 0.03 OUTLIER 'General case' 0 C--N 1.36 1.047 0 C-N-CA 124.778 1.231 . . . . 0.0 109.241 163.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.482 ' HA2' ' SG ' ' A' ' 103' ' ' CYS . . . 77.29 -0.43 68.39 Favored Glycine 0 C--N 1.352 1.43 0 CA-C-N 116.388 -0.369 . . . . 0.0 113.335 -168.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.0 m -82.91 141.22 32.35 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.903 0.881 . . . . 0.0 109.526 -175.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.438 ' HB2' HG22 ' A' ' 52' ' ' VAL . 20.6 p90 -144.76 158.21 43.87 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 175.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 pp -160.31 161.3 33.24 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.267 0.627 . . . . 0.0 109.944 168.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.471 HG21 HD13 ' A' ' 91' ' ' ILE . 40.2 t -110.91 145.55 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.406 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 17.6 mtm180 -132.33 165.52 24.02 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.829 0.851 . . . . 0.0 108.892 -176.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -89.18 119.2 29.46 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 158.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 56.4 m -58.97 147.64 33.57 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.456 0.473 . . . . 0.0 109.906 -175.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -77.05 77.23 3.59 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.279 1.032 . . . . 0.0 110.943 -162.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.5 t 50.13 54.61 10.79 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 125.497 1.519 . . . . 0.0 111.646 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 m -96.27 -55.5 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.904 -178.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -168.98 16.98 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.517 0.727 . . . . 0.0 111.305 -176.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.63 34.51 35.03 Favored Glycine 0 N--CA 1.474 1.168 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 -173.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -94.14 167.59 11.47 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.794 0.837 . . . . 0.0 112.194 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.526 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 79.0 m-85 -105.6 140.93 37.92 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.811 1.245 . . . . 0.0 109.309 171.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 39' ' ' ARG . . . -117.42 126.19 52.22 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.946 0.498 . . . . 0.0 109.899 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.3 tp -108.81 104.08 13.28 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -177.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 53.5 t -102.55 120.21 40.15 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -176.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.438 HG22 ' HB2' ' A' ' 36' ' ' PHE . 56.3 t -128.05 121.42 56.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.373 1.069 . . . . 0.0 108.579 -175.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.528 HD23 ' HA ' ' A' ' 32' ' ' ARG . 43.1 tp -100.38 131.66 46.18 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.805 0.842 . . . . 0.0 109.013 174.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -167.0 145.53 5.08 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.167 0.917 . . . . 0.0 109.305 -177.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 47.82 41.45 14.33 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 125.852 1.661 . . . . 0.0 112.898 177.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.2 tttp 56.01 37.34 28.74 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.754 1.221 . . . . 0.0 111.684 -176.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -142.4 115.92 9.09 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.472 -174.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.2 t -83.82 139.03 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 173.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -139.21 123.85 18.45 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.8 m -114.16 129.97 56.61 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.485 ' HD2' ' HA ' ' A' ' 75' ' ' THR . 9.3 m-85 -115.22 100.58 8.24 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 -176.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -78.23 100.02 6.49 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.526 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 3.2 mp -70.02 118.65 14.8 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.764 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 165.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -120.88 131.17 24.55 Favored Pre-proline 0 C--O 1.241 0.611 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.52 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.593 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 7.1 Cg_exo -73.17 -74.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 122.241 1.961 . . . . 0.0 110.607 171.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.7 t70 71.36 124.94 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.733 1.213 . . . . 0.0 108.379 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 49.62 -143.99 9.69 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.593 -153.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -117.62 -154.2 0.55 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.268 0.627 . . . . 0.0 110.308 169.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.0 t70 88.02 -74.9 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 126.158 1.783 . . . . 0.0 110.491 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -129.65 158.91 38.02 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 121.408 0.623 . . . . 0.0 112.04 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.593 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 3.0 pp -110.49 123.31 49.67 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.416 1.086 . . . . 0.0 108.722 165.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.82 123.79 48.67 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.253 0.621 . . . . 0.0 111.008 -177.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 7.3 p -85.53 147.13 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -110.96 91.68 3.75 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.724 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 41.1 p -77.1 -58.88 3.03 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.13 -177.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.9 m -138.09 153.69 49.28 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.358 0.663 . . . . 0.0 110.343 -177.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -77.71 138.02 38.82 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.042 0.537 . . . . 0.0 110.043 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.57 32.49 67.59 Favored Glycine 0 CA--C 1.523 0.537 0 O-C-N 123.749 0.656 . . . . 0.0 114.029 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.7 m -133.78 144.43 51.81 Favored Pre-proline 0 N--CA 1.481 1.079 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.22 103.15 1.56 Allowed 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.273 1.982 . . . . 0.0 109.312 168.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.476 HG11 ' H ' ' A' ' 82' ' ' ARG . 4.7 t -79.75 174.14 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.26 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.476 ' H ' HG11 ' A' ' 81' ' ' VAL . 5.5 tpp180 -95.81 133.31 40.1 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -175.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -91.77 138.87 31.2 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -124.21 149.54 46.27 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.494 0.718 . . . . 0.0 109.468 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -96.17 -16.1 21.69 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.5 m -144.33 140.2 28.99 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.936 0.895 . . . . 0.0 109.081 -178.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -63.59 -31.83 73.11 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.433 1.093 . . . . 0.0 110.051 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -54.87 -42.03 78.14 Favored Glycine 0 CA--C 1.541 1.707 0 CA-C-N 116.409 -0.36 . . . . 0.0 113.923 172.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.39 -37.13 84.59 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.56 0.744 . . . . 0.0 110.791 176.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.424 HD12 ' HB ' ' A' ' 73' ' ' VAL . 9.3 tt -61.7 -55.0 35.12 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.265 1.026 . . . . 0.0 111.299 -176.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.471 HD13 HG21 ' A' ' 38' ' ' VAL . 49.8 mt -66.46 -37.53 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 123.44 0.463 . . . . 0.0 110.727 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.92 -52.39 46.85 Favored Glycine 0 C--N 1.342 0.913 0 O-C-N 123.769 0.668 . . . . 0.0 112.838 176.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 51.8 tp -72.15 -43.5 64.55 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.082 0.553 . . . . 0.0 111.412 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.474 ' HE2' HG11 ' A' ' 73' ' ' VAL . 18.6 m-85 -82.75 0.52 43.24 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -174.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.43 -25.41 64.32 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-O 121.472 0.653 . . . . 0.0 109.696 158.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -95.84 128.72 36.51 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.994 1.317 . . . . 0.0 107.565 171.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -80.55 -155.47 0.06 OUTLIER 'Trans proline' 0 CA--C 1.557 1.655 0 C-N-CA 122.837 2.358 . . . . 0.0 112.643 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 67.51 48.51 1.1 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.438 1.095 . . . . 0.0 111.842 171.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -163.32 10.69 0.06 Allowed 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.42 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.724 ' HA3' ' HB ' ' A' ' 75' ' ' THR . . . 127.28 -12.35 6.73 Favored Glycine 0 C--N 1.355 1.61 0 O-C-N 122.041 -0.412 . . . . 0.0 113.102 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.4 118.26 21.88 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.992 0.917 . . . . 0.0 111.422 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.7 p -55.55 -32.27 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.484 1.114 . . . . 0.0 111.24 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.482 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 53.8 t -138.31 145.18 40.89 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.003 0.921 . . . . 0.0 109.821 177.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.38 141.07 54.23 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 169.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 62.3 mt -76.17 92.86 3.29 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -174.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.422 ' HG ' ' HG ' ' A' ' 107' ' ' LEU . 47.4 tp -101.19 -58.14 1.95 Allowed 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.304 -171.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.422 ' HG ' ' HG ' ' A' ' 106' ' ' LEU . 58.6 mt -142.25 123.9 8.8 Favored Pre-proline 0 N--CA 1.485 1.302 0 C-N-CA 123.598 0.759 . . . . 0.0 109.336 -170.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.438 ' HB3' ' HB3' ' A' ' 13' ' ' TRP . 27.1 Cg_endo -61.06 -74.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 122.602 2.201 . . . . 0.0 112.906 -176.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 55.8 t . . . . . 0 CA--C 1.551 1.005 0 C-N-CA 124.242 1.017 . . . . 0.0 108.668 -177.577 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.1 m . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -99.29 -18.82 17.38 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 161.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -75.53 104.51 6.12 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 166.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -113.59 96.27 5.78 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -54.45 -39.82 67.8 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 124.38 1.05 . . . . 0.0 113.178 -164.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -125.11 85.72 2.45 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.3 tp -115.82 -45.22 2.89 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.437 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.5 t 79.9 155.29 0.14 Allowed 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 124.746 1.218 . . . . 0.0 110.229 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -57.56 -50.66 72.37 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -172.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.07 -53.99 50.35 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.587 0.755 . . . . 0.0 111.948 -176.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.53 -30.93 68.88 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.24 0.616 . . . . 0.0 111.836 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.522 ' HB2' HD13 ' A' ' 37' ' ' LEU . . . -65.57 -58.96 4.51 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.685 0.794 . . . . 0.0 111.496 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.525 ' HG3' HG21 ' A' ' 58' ' ' VAL . 34.6 tt0 -56.97 -42.59 80.44 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.264 1.425 . . . . 0.0 111.976 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -67.8 -39.88 83.95 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.137 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 33.4 tp -63.16 -38.71 92.27 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.935 0.894 . . . . 0.0 111.667 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.498 HD23 ' HG ' ' A' ' 37' ' ' LEU . 95.6 mt -68.0 -29.36 68.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.256 0.622 . . . . 0.0 111.097 177.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.23 -54.39 5.78 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.81 0.844 . . . . 0.0 111.085 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -66.8 -46.01 76.57 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.419 0.688 . . . . 0.0 111.226 -174.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.65 -60.59 1.9 Allowed 'General case' 0 C--N 1.349 0.551 0 C-N-CA 123.003 0.521 . . . . 0.0 110.803 -172.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.35 -36.97 19.16 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-O 119.799 -0.445 . . . . 0.0 113.704 -172.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? 74.79 -25.25 0.2 Allowed 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 125.273 1.429 . . . . 0.0 113.477 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.4 t70 174.93 141.69 0.05 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.661 0.784 . . . . 0.0 109.369 -165.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.56 9.82 65.72 Favored Glycine 0 C--N 1.358 1.787 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 12.4 m -84.71 146.73 27.27 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.295 1.038 . . . . 0.0 111.007 -168.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -150.83 151.88 32.92 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 174.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.522 HD13 ' HB2' ' A' ' 23' ' ' ALA . 2.9 pp -152.6 158.85 43.04 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 169.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.593 HG23 HD13 ' A' ' 87' ' ' LEU . 36.8 t -112.11 154.74 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.1 ptt85 -156.21 175.09 14.45 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.907 0.883 . . . . 0.0 109.039 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.17 145.2 24.87 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.5 m -56.17 148.63 17.68 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.658 0.783 . . . . 0.0 113.041 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -88.72 3.61 50.25 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.248 1.019 . . . . 0.0 112.048 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.0 m -134.48 -63.6 0.71 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.148 0.579 . . . . 0.0 111.101 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.45 HG23 ' HB3' ' A' ' 47' ' ' ALA . 14.7 m -85.86 117.79 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 121.726 0.774 . . . . 0.0 110.672 -178.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.32 128.7 37.37 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.616 -1.174 . . . . 0.0 112.551 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.89 7.42 81.02 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 114.691 0.636 . . . . 0.0 114.691 177.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HB3' HG23 ' A' ' 44' ' ' VAL . . . -100.81 173.78 6.35 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.149 0.58 . . . . 0.0 109.901 174.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -117.03 160.8 20.4 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-O 121.388 0.613 . . . . 0.0 112.027 -178.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.61 144.85 42.15 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.23 168.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.464 HD11 HG22 ' A' ' 38' ' ' VAL . 51.0 tp -125.05 110.59 14.35 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.695 1.198 . . . . 0.0 108.483 -174.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 35.5 t -104.23 123.02 46.59 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -175.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.2 t -130.48 121.8 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.636 0.774 . . . . 0.0 109.714 -172.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.1 tp -111.22 115.64 29.7 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.297 1.039 . . . . 0.0 109.685 175.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -145.79 144.77 30.49 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 166.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 53.45 36.56 23.47 Favored 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 124.536 1.134 . . . . 0.0 112.277 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 65.7 mttm 58.68 36.47 24.98 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.403 1.081 . . . . 0.0 112.412 -173.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -126.04 104.91 8.53 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.525 HG21 ' HG3' ' A' ' 24' ' ' GLU . 17.5 t -100.69 107.91 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.739 0.816 . . . . 0.0 108.877 174.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -112.14 140.63 46.67 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 171.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 89.2 m -106.63 135.75 47.62 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -117.1 100.04 7.46 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -63.48 155.28 29.74 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 168.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 92.3 mt -144.95 101.92 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 102.59 -3.115 . . . . 0.0 102.59 -158.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.1 mp -105.11 111.59 65.15 Favored Pre-proline 0 N--CA 1.472 0.649 0 O-C-N 123.351 0.407 . . . . 0.0 109.94 -161.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.433 ' HG3' ' HG ' ' A' ' 71' ' ' LEU . 1.4 Cg_endo -81.76 108.55 1.89 Allowed 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.606 2.204 . . . . 0.0 109.422 162.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -82.15 137.24 35.01 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 174.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -46.73 77.57 0.0 OUTLIER Glycine 0 CA--C 1.538 1.49 0 N-CA-C 117.172 1.629 . . . . 0.0 117.172 -172.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -151.84 -83.29 0.09 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.366 1.866 . . . . 0.0 106.77 170.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -167.33 4.28 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 178.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 83.5 m-85 -115.81 140.29 49.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.237 -0.914 . . . . 0.0 110.899 -170.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.433 ' HG ' ' HG3' ' A' ' 65' ' ' PRO . 5.3 mp -111.07 112.3 24.02 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.964 0.905 . . . . 0.0 109.536 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.63 143.03 28.72 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.95 0.5 . . . . 0.0 112.17 -174.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.48 ' O ' HG12 ' A' ' 81' ' ' VAL . 39.1 t -109.38 137.46 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.212 1.005 . . . . 0.0 108.434 169.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -112.28 130.0 56.09 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -170.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.414 ' OG1' ' HA3' ' A' ' 100' ' ' GLY . 3.6 t -158.76 -41.8 0.06 Allowed 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.232 -175.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 65.9 m 58.68 -109.03 0.44 Allowed 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 117.777 -1.106 . . . . 0.0 111.808 -174.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 72.18 -42.14 0.52 Allowed 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.155 1.382 . . . . 0.0 113.427 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 148.01 -21.18 1.42 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 -166.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.489 HG11 ' HA ' ' A' ' 99' ' ' GLN . 14.0 m -84.44 134.25 43.06 Favored Pre-proline 0 CA--C 1.557 1.215 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 173.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.69 146.46 97.19 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.605 2.203 . . . . 0.0 112.015 175.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 73' ' ' VAL . 42.0 t -68.23 130.49 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -105.92 118.91 37.82 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -172.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -102.32 121.19 41.8 Favored 'General case' 0 C--N 1.344 0.355 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.448 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 54.5 p90 -109.0 153.62 23.34 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.472 0.709 . . . . 0.0 110.199 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -104.46 -9.6 18.28 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.778 0.831 . . . . 0.0 110.061 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.7 t -149.04 144.22 26.57 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.29 0.636 . . . . 0.0 109.403 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.593 HD13 HG23 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -60.73 -31.02 70.35 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.481 1.112 . . . . 0.0 111.232 -173.589 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -55.23 -34.42 58.93 Favored Glycine 0 CA--C 1.539 1.566 0 N-CA-C 113.984 0.354 . . . . 0.0 113.984 174.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 84' ' ' PHE . 46.9 mt-10 -68.28 -40.53 81.79 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.34 0.656 . . . . 0.0 110.982 175.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 51.0 tp -53.12 -55.54 23.27 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.336 0.589 . . . . 0.0 110.628 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.6 mm -66.97 -36.21 76.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.79 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.12 -52.34 53.06 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.754 0.659 . . . . 0.0 113.55 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.5 mt -65.74 -56.86 9.81 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.992 0.917 . . . . 0.0 111.102 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.593 ' HB3' HD11 ' A' ' 101' ' ' LEU . 83.8 m-85 -79.59 -4.25 50.68 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -170.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.32 -27.7 67.55 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.21 0.529 . . . . 0.0 110.513 164.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -84.17 131.52 50.67 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.146 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.458 ' HB3' ' HB3' ' A' ' 104' ' ' ALA . 81.7 Cg_endo -80.49 -172.97 1.67 Allowed 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.673 2.249 . . . . 0.0 113.598 -175.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 56.6 61.02 2.82 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.407 1.483 . . . . 0.0 111.33 -178.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.489 ' HA ' HG11 ' A' ' 79' ' ' VAL . 46.2 mt-30 -143.76 12.39 1.67 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.356 1.062 . . . . 0.0 111.441 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.414 ' HA3' ' OG1' ' A' ' 75' ' ' THR . . . 110.58 -5.79 29.69 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 112.16 -0.376 . . . . 0.0 112.16 178.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.593 HD11 ' HB3' ' A' ' 94' ' ' TYR . 94.4 mt -78.85 146.86 33.42 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.277 1.031 . . . . 0.0 111.234 -178.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.4 m -63.3 -26.72 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.391 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.83 171.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 31.9 p -162.61 171.85 16.29 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.514 1.126 . . . . 0.0 110.281 171.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' A' ' 97' ' ' PRO . . . -66.68 145.35 55.65 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 169.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 73.9 mt -64.38 103.39 0.64 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -177.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 62.5 tp -111.31 -60.25 1.86 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.589 0.756 . . . . 0.0 111.576 -166.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 35' ' ' SER . 5.8 tt -114.46 97.42 46.3 Favored Pre-proline 0 N--CA 1.474 0.741 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -169.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -81.44 130.34 6.98 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 122.232 1.955 . . . . 0.0 111.214 175.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.7 t . . . . . 0 C--O 1.251 1.174 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.186 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 t . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.485 ' HB2' ' HB2' ' A' ' 108' ' ' PRO . 77.2 t90 92.45 -43.9 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.938 1.295 . . . . 0.0 110.928 163.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 87.9 t80 -109.71 110.78 21.92 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -174.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -126.48 106.18 9.27 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -176.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.52 ' HA ' ' HB3' ' A' ' 40' ' ' ASP . 39.8 ttm180 -74.94 152.0 38.83 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.402 176.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.526 ' HA ' ' HG2' ' A' ' 42' ' ' GLU 0.291 11.3 p-10 36.82 51.8 0.97 Allowed 'General case' 0 C--N 1.37 1.494 0 C-N-CA 125.356 1.462 . . . . 0.0 114.527 -172.325 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.7 tp -114.73 124.54 52.05 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 169.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.7 m -69.06 156.4 38.71 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.945 0.498 . . . . 0.0 110.235 -178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.3 ttp85 -54.04 -52.14 61.8 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.775 0.43 . . . . 0.0 111.061 172.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.03 -45.26 71.52 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.33 1.052 . . . . 0.0 111.867 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.06 -29.85 64.56 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.578 0.751 . . . . 0.0 112.089 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.577 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -76.84 -47.53 21.13 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.571 0.748 . . . . 0.0 111.419 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.513 ' HG3' HG22 ' A' ' 58' ' ' VAL . 32.8 tt0 -51.79 -39.82 59.33 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.252 1.421 . . . . 0.0 111.187 169.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -63.96 -47.72 79.3 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.3 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.7 tp -57.86 -45.14 86.75 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.677 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.599 HD22 HD22 ' A' ' 37' ' ' LEU . 94.2 mt -63.45 -50.45 69.7 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.016 0.927 . . . . 0.0 110.623 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.16 -34.5 73.66 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.756 0.823 . . . . 0.0 111.681 -175.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -83.88 -32.71 25.04 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.493 0.717 . . . . 0.0 111.384 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.82 -65.8 0.98 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -174.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.91 -47.22 0.84 Allowed Glycine 0 C--N 1.356 1.666 0 CA-C-N 117.995 0.362 . . . . 0.0 113.422 -172.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 55.9 24.9 8.01 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 125.573 1.549 . . . . 0.0 114.924 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -174.4 100.15 0.1 Allowed 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.264 -0.897 . . . . 0.0 109.582 -174.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.03 15.83 80.89 Favored Glycine 0 N--CA 1.474 1.199 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.908 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.1 m -85.53 116.29 23.74 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.916 0.887 . . . . 0.0 109.684 -170.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 44.7 p90 -126.74 159.45 33.69 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.814 0.34 . . . . 0.0 111.672 -175.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.599 HD22 HD22 ' A' ' 27' ' ' LEU . 1.6 pt? -163.13 163.73 25.6 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.008 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 25.6 t -126.71 122.69 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 175.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.435 HH21 HD23 ' A' ' 37' ' ' LEU . 9.3 ptp85 -116.87 157.66 25.27 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -177.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.52 ' HB3' ' HA ' ' A' ' 16' ' ' ARG . 33.6 t70 -93.82 122.96 36.83 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 170.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.4 m -57.16 151.98 14.46 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.706 0.629 . . . . 0.0 111.403 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.526 ' HG2' ' HA ' ' A' ' 17' ' ' ASP . 32.5 mt-10 -81.93 -22.14 36.89 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -163.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.3 t -167.6 103.33 0.5 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 172.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.1 p -158.84 169.88 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 C-N-CA 123.9 0.88 . . . . 0.0 109.564 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.99 23.21 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 175.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.58 91.2 1.49 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -175.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.16 134.68 15.32 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.488 1.115 . . . . 0.0 109.5 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -110.62 143.39 41.12 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.002 0.921 . . . . 0.0 109.197 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.1 125.2 52.06 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.606 0.362 . . . . 0.0 110.86 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.3 tp -105.51 131.62 52.69 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.714 ' SG ' HG23 ' A' ' 60' ' ' THR . 73.6 m -123.86 141.24 52.21 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 118.527 0.603 . . . . 0.0 110.126 171.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.6 t -125.47 114.72 40.88 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 170.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.638 HD11 HG21 ' A' ' 58' ' ' VAL . 13.8 tp -99.56 137.83 37.49 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.34 1.056 . . . . 0.0 108.921 176.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -149.44 102.87 3.23 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.003 1.321 . . . . 0.0 108.178 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 48.93 68.95 0.63 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.758 0.823 . . . . 0.0 112.808 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt 62.28 12.99 5.58 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -110.47 102.34 10.96 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.638 HG21 HD11 ' A' ' 53' ' ' LEU . 3.4 t -107.87 120.82 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -114.75 140.53 48.82 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 172.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.714 HG23 ' SG ' ' A' ' 51' ' ' CYS . 62.7 p -112.71 136.45 52.29 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.574 1.15 . . . . 0.0 109.072 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.29 96.91 4.43 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 178.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -80.94 100.7 9.05 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.481 HG21 HD13 ' A' ' 71' ' ' LEU . 15.6 mt -72.06 128.78 35.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.231 -1.35 . . . . 0.0 109.651 173.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.5 135.77 19.64 Favored Pre-proline 0 C--O 1.24 0.567 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 170.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 36.6 Cg_exo -62.1 -62.28 0.13 Allowed 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 122.786 2.324 . . . . 0.0 114.133 177.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.5 t70 87.91 -69.27 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.598 1.559 . . . . 0.0 109.2 175.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -85.5 16.71 38.54 Favored Glycine 0 C--N 1.357 1.698 0 CA-C-O 119.71 -0.495 . . . . 0.0 113.517 169.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 66.09 -30.76 0.14 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 174.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -76.5 -45.11 32.34 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.437 1.017 . . . . 0.0 111.131 -170.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 25.3 p90 -108.39 145.3 34.76 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 124.915 1.286 . . . . 0.0 108.504 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 2.6 pt? -99.23 118.96 37.09 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 164.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.62 117.6 33.44 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.528 0.731 . . . . 0.0 110.713 -175.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.817 HG21 HD11 ' A' ' 90' ' ' LEU . 14.6 t -89.58 116.28 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.094 0.958 . . . . 0.0 110.342 177.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -90.39 92.11 8.76 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.427 HG21 ' HE2' ' A' ' 94' ' ' TYR . 0.2 OUTLIER -54.07 -58.61 6.69 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.419 177.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.0 m -155.3 131.19 10.01 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.454 1.502 . . . . 0.0 107.336 163.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -66.16 95.46 0.29 Allowed 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 165.51 -58.21 0.25 Allowed Glycine 0 C--N 1.343 0.93 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -172.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.38 140.83 82.54 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 124.051 0.94 . . . . 0.0 109.41 169.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -49.9 87.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.386 2.511 0 C-N-CA 123.599 2.866 . . . . 0.0 114.134 173.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 73' ' ' VAL . 7.4 p -36.72 143.78 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 126.262 1.825 . . . . 0.0 115.252 169.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -107.18 132.86 52.58 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 124.2 1.0 . . . . 0.0 109.505 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -99.12 146.87 25.66 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.078 0.951 . . . . 0.0 109.001 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -136.23 164.78 27.28 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.911 0.884 . . . . 0.0 109.038 -174.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -126.44 -13.31 6.06 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.847 0.459 . . . . 0.0 110.333 176.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.544 ' HB ' ' HG3' ' A' ' 89' ' ' GLU . 20.8 m -140.15 140.7 36.01 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.631 0.772 . . . . 0.0 109.376 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 75.0 mt -58.36 -32.82 68.91 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.616 0.766 . . . . 0.0 111.551 172.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.493 ' H ' HG21 ' A' ' 86' ' ' THR . . . -60.39 -33.16 79.83 Favored Glycine 0 CA--C 1.532 1.154 0 O-C-N 123.493 0.496 . . . . 0.0 113.582 174.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.544 ' HG3' ' HB ' ' A' ' 86' ' ' THR . 47.6 mt-10 -71.83 -40.85 68.78 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.933 0.493 . . . . 0.0 110.168 176.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.817 HD11 HG21 ' A' ' 73' ' ' VAL . 42.2 tp -52.7 -51.59 59.67 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.553 0.741 . . . . 0.0 110.344 174.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 49.7 mm -62.79 -39.28 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.432 177.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.15 -57.32 20.39 Favored Glycine 0 CA--C 1.529 0.911 0 O-C-N 123.621 0.576 . . . . 0.0 113.44 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.7 mp -70.74 -52.01 23.58 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.562 0.745 . . . . 0.0 112.006 -177.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.521 ' HB3' HD13 ' A' ' 101' ' ' LEU . 30.2 m-85 -68.66 -17.26 64.06 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -173.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.44 -19.93 51.22 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 171.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -77.99 124.13 86.13 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 123.396 0.678 . . . . 0.0 109.996 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -70.95 168.29 23.54 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.67 2.246 . . . . 0.0 111.724 173.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 53.8 58.11 5.41 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.85 0.86 . . . . 0.0 110.532 -174.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -142.52 -15.91 0.73 Allowed 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.701 -177.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 141.54 -18.06 2.64 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -175.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.521 HD13 ' HB3' ' A' ' 94' ' ' TYR . 17.7 mt -99.93 105.98 17.75 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.23 0.612 . . . . 0.0 110.105 175.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.6 m -44.96 -25.98 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 125.221 1.408 . . . . 0.0 114.538 174.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 36.7 t -124.27 -11.3 7.47 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.141 0.576 . . . . 0.0 112.444 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 64.11 178.57 0.17 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.122 0.969 . . . . 0.0 111.399 -167.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.1 mt -77.62 92.12 4.06 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.7 176.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.0 tt -81.78 -65.38 1.02 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.856 0.462 . . . . 0.0 109.906 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -146.22 130.05 8.48 Favored Pre-proline 0 N--CA 1.491 1.575 0 C-N-CA 122.295 0.238 . . . . 0.0 110.919 -174.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.485 ' HB2' ' HB2' ' A' ' 13' ' ' TRP . 80.8 Cg_endo -74.38 145.13 33.61 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.689 2.259 . . . . 0.0 111.779 177.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 57.2 t . . . . . 0 C--O 1.256 1.422 0 C-N-CA 123.799 0.84 . . . . 0.0 109.533 179.543 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.5 mtp . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 123.14 144.81 6.71 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -136.41 97.91 3.69 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.314 1.046 . . . . 0.0 108.523 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -135.92 99.4 4.15 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.32 0.648 . . . . 0.0 110.226 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.3 t60 -154.83 96.07 1.83 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -73.54 165.21 25.5 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.329 0.585 . . . . 0.0 111.991 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -83.14 -169.57 2.6 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.292 174.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 37.7 m80 63.91 32.74 13.02 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.04 0.936 . . . . 0.0 109.754 -174.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.5 t -82.58 68.05 8.87 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 122.027 0.918 . . . . 0.0 109.748 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -139.59 139.27 36.75 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.686 -1.143 . . . . 0.0 107.995 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.602 ' SD ' ' HB2' ' A' ' 108' ' ' PRO . 44.1 ttm -72.14 -48.19 45.41 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 172.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.6 m 62.08 108.61 0.02 OUTLIER 'General case' 0 C--N 1.359 0.984 0 O-C-N 124.87 1.356 . . . . 0.0 109.569 -168.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 4.3 p-90 -85.41 -1.13 56.7 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.966 -0.459 . . . . 0.0 110.761 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -107.33 113.57 27.04 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -173.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.512 ' HE2' HD22 ' A' ' 37' ' ' LEU . 1.9 p80 -138.97 109.95 6.78 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.518 1.127 . . . . 0.0 108.76 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -86.73 26.82 1.06 Allowed 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 124.17 0.988 . . . . 0.0 110.634 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -160.39 25.31 0.16 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.295 0.638 . . . . 0.0 111.098 -162.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 20.0 tp -108.99 -49.09 3.18 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.675 -0.64 . . . . 0.0 111.63 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.4 t 80.08 153.23 0.12 Allowed 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 124.856 1.262 . . . . 0.0 109.869 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.469 ' HB2' ' NH1' ' A' ' 39' ' ' ARG . 74.5 ttt180 -64.21 -38.87 92.6 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 118.019 0.372 . . . . 0.0 111.512 -168.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.57 -54.82 23.56 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 123.652 0.595 . . . . 0.0 110.752 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.77 -22.55 43.02 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.9 -57.08 4.13 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 123.206 0.602 . . . . 0.0 111.542 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.423 ' HG3' HG12 ' A' ' 58' ' ' VAL . 36.7 tt0 -57.76 -37.08 73.03 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.076 1.351 . . . . 0.0 111.26 173.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -71.05 -38.18 72.53 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.365 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -55.13 -43.76 74.43 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.285 0.634 . . . . 0.0 110.083 173.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.547 HD21 ' HB3' ' A' ' 35' ' ' SER . 82.8 mt -71.92 -42.31 66.84 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 123.485 0.49 . . . . 0.0 110.413 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.36 -37.32 71.65 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.543 0.737 . . . . 0.0 112.21 -174.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.7 mtp180 -82.16 -50.56 8.89 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.024 0.53 . . . . 0.0 111.325 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.414 ' HB2' HG13 ' A' ' 109' ' ' VAL . . . -66.41 -46.8 75.35 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.559 0.344 . . . . 0.0 110.314 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.38 125.84 0.0 OUTLIER Glycine 0 CA--C 1.538 1.515 0 N-CA-C 118.854 2.302 . . . . 0.0 118.854 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 177.66 103.22 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 165.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -62.44 149.92 41.36 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -154.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.409 ' HA2' ' SG ' ' A' ' 103' ' ' CYS . . . 89.56 17.45 54.77 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -161.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.547 ' HB3' HD21 ' A' ' 27' ' ' LEU . 17.2 m -71.81 130.59 41.44 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 124.434 1.094 . . . . 0.0 108.895 -177.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -141.74 155.14 45.65 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.118 0.485 . . . . 0.0 111.034 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.512 HD22 ' HE2' ' A' ' 15' ' ' HIS . 0.8 OUTLIER -158.58 153.47 25.0 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.612 166.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.6 t -105.28 117.41 50.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.523 ' HG3' ' HB3' ' A' ' 49' ' ' ALA . 2.1 ptm180 -113.58 168.49 9.72 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 122.168 0.985 . . . . 0.0 110.816 -178.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -54.44 127.91 29.57 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 113.122 -1.854 . . . . 0.0 110.838 165.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.0 m -74.48 143.99 44.38 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 162.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -78.48 83.58 4.67 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.3 m 67.29 -75.51 0.06 Allowed 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 126.201 1.8 . . . . 0.0 111.785 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.469 HG21 ' H ' ' A' ' 45' ' ' ALA 0.317 35.1 m 39.21 -84.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 126.996 2.118 . . . . 0.0 113.743 -167.335 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.469 ' H ' HG21 ' A' ' 44' ' ' VAL . . . -156.6 29.48 0.33 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.147 0.979 . . . . 0.0 109.309 -175.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.48 49.64 7.98 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.532 -175.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.53 176.51 5.01 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.455 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 59.0 m-85 -114.67 157.19 23.45 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.437 1.495 . . . . 0.0 107.447 174.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.523 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . . . -128.87 147.05 50.79 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.391 0.676 . . . . 0.0 110.098 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.4 tp -125.84 113.3 17.06 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.27 1.028 . . . . 0.0 108.577 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 52.6 t -100.58 123.23 44.51 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 35' ' ' SER . 47.0 t -128.54 126.09 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.781 0.832 . . . . 0.0 110.004 -174.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 35' ' ' SER . 54.7 tp -101.33 140.29 35.82 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.32 1.048 . . . . 0.0 110.844 177.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -156.29 115.61 3.51 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.01 1.324 . . . . 0.0 108.775 173.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 41.1 71.94 0.18 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.678 1.591 . . . . 0.0 113.881 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 81.9 tttt 58.72 27.47 15.96 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.155 0.982 . . . . 0.0 111.905 177.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -138.3 106.39 5.73 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.378 0.671 . . . . 0.0 109.455 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.423 HG12 ' HG3' ' A' ' 24' ' ' GLU . 41.4 t -99.71 112.75 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 174.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -101.53 132.18 47.31 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 170.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 22.9 m -113.51 128.0 56.29 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -108.39 154.51 21.75 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.875 1.27 . . . . 0.0 107.838 -172.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -105.12 160.2 15.25 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.698 0.799 . . . . 0.0 109.63 165.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.683 HG12 HD12 ' A' ' 90' ' ' LEU . 3.8 mp -146.62 100.68 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 102.578 -3.119 . . . . 0.0 102.578 -166.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.5 mp -113.63 133.7 22.16 Favored Pre-proline 0 N--CA 1.477 0.889 0 O-C-N 121.641 -0.662 . . . . 0.0 109.693 -168.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.09 -68.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.214 1.943 . . . . 0.0 110.256 160.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.9 t70 125.33 -66.1 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 C-N-CA 127.238 2.215 . . . . 0.0 107.743 163.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -171.04 25.72 0.1 OUTLIER Glycine 0 C--N 1.345 1.067 0 CA-C-N 115.515 -0.766 . . . . 0.0 113.203 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -135.69 -83.21 0.4 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 175.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -179.78 3.91 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.123 0.569 . . . . 0.0 111.925 -174.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.498 ' HB3' ' HB2' ' A' ' 83' ' ' ARG . 64.9 m-85 -106.77 134.94 49.14 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.41 0.684 . . . . 0.0 109.343 -169.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.2 mp -96.8 106.4 18.7 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 118.884 0.765 . . . . 0.0 109.348 -169.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.79 140.2 37.97 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.825 0.85 . . . . 0.0 110.13 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.491 ' HB ' ' HH ' ' A' ' 94' ' ' TYR . 22.7 t -114.99 124.51 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 176.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -93.56 97.29 10.41 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.402 HG21 ' ND2' ' A' ' 98' ' ' ASN . 76.6 p -87.53 -48.31 8.03 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.6 m -157.78 177.04 11.81 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.385 1.474 . . . . 0.0 108.134 166.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -85.45 -57.97 2.85 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.279 0.632 . . . . 0.0 110.436 -174.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.17 -31.2 61.81 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.821 0.701 . . . . 0.0 114.069 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.4 t -61.45 122.82 73.24 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 118.851 -0.595 . . . . 0.0 109.396 169.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -57.15 110.99 0.68 Allowed 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.5 2.133 . . . . 0.0 110.555 174.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.4 t -79.35 143.71 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.978 0.911 . . . . 0.0 109.115 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -114.89 130.75 56.96 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.498 ' HB2' ' HB3' ' A' ' 70' ' ' PHE . 32.0 ptt180 -94.81 134.07 37.83 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 171.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -113.74 149.44 34.82 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.257 1.023 . . . . 0.0 109.815 -174.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -92.1 -15.79 27.25 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.58 0.352 . . . . 0.0 110.354 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.9 p -142.53 151.12 41.3 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 124.371 1.068 . . . . 0.0 109.457 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 99.5 mt -62.87 -25.88 68.5 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.674 0.789 . . . . 0.0 111.497 172.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -59.85 -41.9 97.9 Favored Glycine 0 CA--C 1.537 1.456 0 N-CA-C 114.02 0.368 . . . . 0.0 114.02 174.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -63.27 -37.79 88.63 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.529 0.732 . . . . 0.0 110.979 176.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.683 HD12 HG12 ' A' ' 63' ' ' ILE . 6.6 tt -59.46 -57.33 13.46 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.814 1.246 . . . . 0.0 109.742 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 48.2 mm -59.79 -38.62 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.098 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.98 -44.88 54.23 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.568 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 42.0 tp -67.64 -50.67 56.79 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.084 0.554 . . . . 0.0 111.405 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.491 ' HH ' ' HB ' ' A' ' 73' ' ' VAL . 40.6 m-85 -75.35 -8.02 55.55 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -176.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.13 -24.12 64.43 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.431 0.634 . . . . 0.0 111.06 163.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -94.71 139.58 22.29 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.499 1.12 . . . . 0.0 108.87 174.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -48.94 127.0 16.06 Favored 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 123.137 2.558 . . . . 0.0 112.433 165.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.402 ' ND2' HG21 ' A' ' 75' ' ' THR . 26.2 p-10 -111.62 -45.1 3.4 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.194 -174.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 111.05 94.29 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 128.051 2.54 . . . . 0.0 106.341 -163.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 135.2 -38.99 1.74 Allowed Glycine 0 C--N 1.343 0.97 0 CA-C-N 116.052 -0.522 . . . . 0.0 113.1 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -69.41 136.93 52.29 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.859 0.464 . . . . 0.0 110.494 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.5 m -60.97 -28.31 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.585 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.409 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 25.4 p -163.06 -1.1 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 70.27 166.81 0.29 Allowed 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.947 0.899 . . . . 0.0 111.284 -167.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 37.3 mt -88.94 97.98 11.49 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.506 0.722 . . . . 0.0 109.804 -173.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.3 tp -82.86 -51.81 7.29 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.688 -175.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -165.71 146.46 5.77 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 123.726 0.81 . . . . 0.0 109.032 -172.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.602 ' HB2' ' SD ' ' A' ' 11' ' ' MET . 42.4 Cg_exo -56.89 -54.95 3.05 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.22 1.947 . . . . 0.0 111.885 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 30' ' ' ALA . 2.4 t . . . . . 0 N--CA 1.48 1.037 0 C-N-CA 125.717 1.607 . . . . 0.0 107.142 170.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptp . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.61 -44.31 0.42 Allowed Glycine 0 C--N 1.338 0.662 0 N-CA-C 111.746 -0.542 . . . . 0.0 111.746 -177.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 63.65 -163.43 0.27 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.26 1.024 . . . . 0.0 110.749 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -142.11 112.49 7.1 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.846 0.355 . . . . 0.0 110.308 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -83.35 -172.54 4.2 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.416 0.686 . . . . 0.0 109.834 169.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 70.36 90.31 0.1 Allowed 'General case' 0 C--N 1.358 0.964 0 C-N-CA 124.261 1.025 . . . . 0.0 110.137 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -66.08 -50.87 62.58 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.336 1.054 . . . . 0.0 109.295 175.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -172.76 -79.57 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.9 p 175.9 128.8 0.04 OUTLIER 'General case' 0 C--O 1.241 0.649 0 C-N-CA 125.412 1.485 . . . . 0.0 107.842 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -91.34 58.95 3.77 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.218 1.009 . . . . 0.0 109.502 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -165.95 52.23 0.09 Allowed 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 114.4 -1.273 . . . . 0.0 109.105 -175.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.1 t -62.28 152.43 33.67 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.663 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 3.5 p-90 -90.55 12.9 17.31 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.528 0.731 . . . . 0.0 110.614 169.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 49.9 t80 -115.2 117.94 31.91 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -130.91 87.23 2.46 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.063 0.545 . . . . 0.0 109.865 -173.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -73.09 160.1 32.55 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 167.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.1 t70 63.61 26.11 14.54 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 122.064 0.935 . . . . 0.0 110.634 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.1 tt -131.87 123.57 27.78 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.597 1.559 . . . . 0.0 106.864 177.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.7 p -77.24 160.89 28.57 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.841 0.457 . . . . 0.0 110.281 -172.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -65.52 -34.43 78.25 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 117.952 0.342 . . . . 0.0 110.848 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.47 -47.59 81.47 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.796 0.838 . . . . 0.0 110.291 173.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.45 -32.72 73.78 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.615 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.412 ' HB3' HD13 ' A' ' 37' ' ' LEU . . . -65.25 -62.68 1.39 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.526 0.73 . . . . 0.0 111.184 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -62.66 -28.49 69.95 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.521 0.728 . . . . 0.0 112.465 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -68.27 -50.37 54.2 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 123.606 0.566 . . . . 0.0 109.485 175.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -58.52 -39.99 81.64 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.584 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.1 -48.26 74.31 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.926 0.89 . . . . 0.0 109.802 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.49 -31.98 73.3 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.121 0.968 . . . . 0.0 112.329 -175.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -81.65 -38.64 25.61 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.439 0.696 . . . . 0.0 110.592 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.26 -63.87 1.23 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -169.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.93 -41.34 1.57 Allowed Glycine 0 C--N 1.352 1.421 0 N-CA-C 112.12 -0.392 . . . . 0.0 112.12 -173.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.3 ttp85 58.02 17.58 4.52 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.902 1.281 . . . . 0.0 114.207 171.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -175.83 98.11 0.07 Allowed 'General case' 0 N--CA 1.479 0.978 0 O-C-N 121.552 -0.718 . . . . 0.0 109.626 -166.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.53 20.67 79.59 Favored Glycine 0 N--CA 1.478 1.493 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 11.2 m -90.05 119.64 30.57 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 124.487 1.115 . . . . 0.0 110.628 -172.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -126.16 159.12 33.8 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.033 0.444 . . . . 0.0 111.229 -173.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.412 HD13 ' HB3' ' A' ' 23' ' ' ALA . 3.6 pp -155.31 165.31 37.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.296 168.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 25.9 t -112.46 154.25 13.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 171.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.614 HH22 ' HG2' ' A' ' 42' ' ' GLU . 4.2 ptm180 -157.69 -177.82 6.86 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 123.205 0.602 . . . . 0.0 109.381 -176.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -90.77 125.57 35.74 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 172.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.2 m -57.43 147.65 25.68 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.382 0.673 . . . . 0.0 110.651 174.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.614 ' HG2' HH22 ' A' ' 39' ' ' ARG . 42.2 mt-10 -78.22 89.11 4.28 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.343 0.657 . . . . 0.0 111.967 -164.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.2 t 66.16 27.85 10.3 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.494 1.518 . . . . 0.0 111.57 173.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.2 t -71.89 -71.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.588 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -173.7 34.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.397 0.679 . . . . 0.0 110.786 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.21 35.78 56.68 Favored Glycine 0 N--CA 1.476 1.322 0 CA-C-N 116.618 -0.265 . . . . 0.0 112.96 -168.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 63' ' ' ILE . . . -90.87 164.2 14.13 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.66 0.784 . . . . 0.0 110.457 -173.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.512 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 97.2 m-85 -102.76 148.2 25.9 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.421 ' HB1' ' HG3' ' A' ' 39' ' ' ARG . . . -128.23 137.53 52.05 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.0 tp -112.06 104.0 12.22 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 47.4 m -104.26 114.08 28.07 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -174.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.68 141.44 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 -175.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 47.3 tp -126.96 144.45 51.01 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.946 0.898 . . . . 0.0 109.463 -176.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -154.26 109.58 3.14 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 46.19 71.59 0.28 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.544 1.138 . . . . 0.0 112.739 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 56.51 20.61 4.98 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.413 1.085 . . . . 0.0 113.74 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -124.86 108.9 12.39 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 120.921 0.391 . . . . 0.0 110.088 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.7 t -94.4 147.72 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 124.423 1.089 . . . . 0.0 110.046 -178.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.91 113.19 8.77 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.88 1.272 . . . . 0.0 107.599 174.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 66.5 p -107.93 138.38 44.28 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.466 ' HH ' ' HA ' ' A' ' 101' ' ' LEU . 41.9 m-85 -126.24 100.41 6.29 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -77.67 95.57 4.64 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.639 0.733 . . . . 0.0 109.48 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.518 HG23 HD13 ' A' ' 71' ' ' LEU . 32.5 mt -71.32 133.94 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.216 171.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -90.04 128.0 51.48 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 174.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -81.06 -81.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 123.1 2.533 . . . . 0.0 115.13 -157.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -149.8 160.85 43.23 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 118.262 0.483 . . . . 0.0 110.261 -163.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.58 -46.62 1.02 Allowed Glycine 0 N--CA 1.468 0.819 0 N-CA-C 107.417 -2.273 . . . . 0.0 107.417 -169.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -65.02 -147.07 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.649 0 CA-C-N 113.321 -1.439 . . . . 0.0 111.314 155.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -112.37 -24.36 9.81 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.512 0.725 . . . . 0.0 110.289 173.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -130.13 162.42 28.88 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.902 1.281 . . . . 0.0 110.985 -169.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.518 HD13 HG23 ' A' ' 63' ' ' ILE . 0.5 OUTLIER -102.95 132.02 49.49 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.426 1.09 . . . . 0.0 110.186 178.625 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.434 ' HA ' ' HG3' ' A' ' 83' ' ' ARG . . . -105.26 113.9 27.76 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.529 0.731 . . . . 0.0 112.802 -172.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.446 ' O ' HG12 ' A' ' 81' ' ' VAL . 23.0 t -85.32 138.73 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.69 0.796 . . . . 0.0 109.281 177.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -99.89 91.97 5.07 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.3 m -72.41 -65.39 0.79 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.079 0.551 . . . . 0.0 112.248 -166.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.2 t -168.82 178.23 4.69 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.668 0.387 . . . . 0.0 111.207 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -61.49 -39.01 89.4 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.718 1.207 . . . . 0.0 114.17 -168.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -139.68 40.86 1.37 Allowed Glycine 0 N--CA 1.472 1.081 0 CA-C-O 120.758 0.088 . . . . 0.0 113.044 -171.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.5 m -122.92 155.23 64.1 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 123.848 0.859 . . . . 0.0 109.285 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -65.61 128.65 20.54 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.556 2.171 . . . . 0.0 111.24 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 73' ' ' VAL . 45.6 t -90.02 126.57 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -120.29 139.2 53.07 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.12 0.568 . . . . 0.0 109.528 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.434 ' HG3' ' HA ' ' A' ' 72' ' ' ALA . 0.8 OUTLIER -101.99 157.67 16.7 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.348 1.059 . . . . 0.0 108.702 178.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.595 ' HE1' HD11 ' A' ' 93' ' ' LEU . 95.4 m-85 -130.99 160.67 33.89 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.815 0.846 . . . . 0.0 109.103 -173.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -99.35 -18.41 17.54 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.512 0.325 . . . . 0.0 110.489 174.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.8 p -146.7 154.0 40.91 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.764 0.826 . . . . 0.0 110.141 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' A' ' 90' ' ' LEU . 96.1 mt -64.15 -25.56 68.14 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.154 0.982 . . . . 0.0 111.805 173.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -56.89 -42.65 92.43 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 116.574 -0.284 . . . . 0.0 113.026 172.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -68.09 -34.08 75.74 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.668 0.787 . . . . 0.0 111.095 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.444 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 22.7 tp -56.24 -58.97 5.71 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.896 0.878 . . . . 0.0 110.262 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 44.9 mm -62.77 -37.92 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.747 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.2 -55.64 28.36 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 115.032 -0.986 . . . . 0.0 113.747 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.595 HD11 ' HE1' ' A' ' 84' ' ' PHE . 34.5 mt -75.77 -42.58 49.92 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -177.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -72.42 -7.41 49.62 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.6 -3.38 4.51 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 171.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 93' ' ' LEU . 13.4 pt20 -95.98 141.01 22.55 Favored Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 123.008 0.523 . . . . 0.0 109.685 174.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 96' ' ' GLN . 4.2 Cg_exo -78.84 173.27 13.81 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.829 2.352 . . . . 0.0 112.706 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 54.16 82.79 0.08 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.478 1.511 . . . . 0.0 111.885 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -159.35 9.43 0.12 Allowed 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.738 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.31 -13.62 56.99 Favored Glycine 0 N--CA 1.476 1.316 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -175.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.466 ' HA ' ' HH ' ' A' ' 61' ' ' TYR . 2.2 mm? -65.58 153.31 41.89 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.411 1.484 . . . . 0.0 111.849 175.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.8 m -82.65 76.3 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 164.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 104' ' ' ALA . 42.8 t 75.75 170.95 0.26 Allowed 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 113.879 -1.509 . . . . 0.0 110.6 -174.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.44 ' N ' ' SG ' ' A' ' 103' ' ' CYS . . . -72.47 166.48 22.52 Favored 'General case' 0 C--O 1.249 1.033 0 C-N-CA 122.984 0.514 . . . . 0.0 109.677 176.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 29.1 mt -73.68 92.58 1.99 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -85.15 -59.91 2.19 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.953 -170.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 35' ' ' SER . 50.3 tp -147.58 127.55 6.66 Favored Pre-proline 0 N--CA 1.469 0.524 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -175.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.471 ' HD2' HD13 ' A' ' 107' ' ' LEU . 10.6 Cg_endo -54.16 -72.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.156 1.904 . . . . 0.0 111.37 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 50.2 t . . . . . 0 C--O 1.252 1.187 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 174.977 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptp . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 120.806 0.336 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.31 103.92 0.23 Allowed Glycine 0 C--N 1.344 1.0 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -133.13 -12.82 2.81 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.834 0.853 . . . . 0.0 110.516 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -81.9 85.31 6.7 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 122.975 0.51 . . . . 0.0 110.242 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -154.16 144.78 22.39 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.322 1.049 . . . . 0.0 108.281 175.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -49.5 115.47 1.36 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.42 1.088 . . . . 0.0 112.274 -172.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -99.23 114.59 27.48 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-O 121.014 0.435 . . . . 0.0 110.127 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -74.53 147.77 41.52 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.563 170.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.2 p -58.39 156.51 10.1 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.831 0.852 . . . . 0.0 110.872 175.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 63.3 t-80 -49.76 135.03 19.85 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.259 1.024 . . . . 0.0 111.88 -174.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 88.5 mtp -63.0 175.84 0.81 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.612 0.765 . . . . 0.0 111.901 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.5 t 71.33 141.37 0.05 Allowed 'General case' 0 C--N 1.355 0.838 0 C-N-CA 124.532 1.133 . . . . 0.0 109.848 -172.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.542 ' HB2' ' HA ' ' A' ' 37' ' ' LEU . 1.9 p-90 -80.75 -23.17 39.59 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 28.4 t80 -75.53 105.41 6.55 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.034 0.933 . . . . 0.0 110.422 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -127.36 108.24 10.67 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -54.68 150.4 9.61 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 123.335 0.654 . . . . 0.0 111.334 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.492 ' H ' ' HB3' ' A' ' 40' ' ' ASP . 37.7 t70 -9.71 76.31 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -149.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.444 ' O ' ' HB1' ' A' ' 22' ' ' ALA . 28.5 tp -62.14 -26.4 68.29 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.5 168.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.4 t 82.14 138.44 0.06 Allowed 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 125.587 1.555 . . . . 0.0 108.622 174.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -58.76 -45.39 89.86 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.111 0.564 . . . . 0.0 112.198 -168.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.42 -50.44 71.48 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.879 0.871 . . . . 0.0 111.516 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 18' ' ' LEU . . . -73.7 -19.03 60.93 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.704 -178.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.579 ' HB1' HD12 ' A' ' 37' ' ' LEU . . . -74.38 -53.33 9.83 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.147 0.979 . . . . 0.0 110.545 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.55 ' HA ' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -68.95 -21.91 64.16 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 123.682 0.614 . . . . 0.0 110.916 178.155 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -71.54 -51.2 24.77 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.091 0.556 . . . . 0.0 110.501 172.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.4 tp -57.98 -31.69 67.14 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.339 0.656 . . . . 0.0 111.578 174.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.55 HD13 ' HA ' ' A' ' 24' ' ' GLU . 85.6 mt -62.48 -59.95 4.24 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.75 -40.31 66.08 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.833 0.853 . . . . 0.0 112.937 -176.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -77.85 -55.45 5.31 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.578 0.751 . . . . 0.0 111.951 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.3 -60.9 2.05 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.064 0.545 . . . . 0.0 111.257 -172.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.69 82.18 0.31 Allowed Glycine 0 C--N 1.335 0.523 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -70.61 14.39 0.14 Allowed 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -166.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 175.16 138.56 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.172 0.989 . . . . 0.0 108.695 -171.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.92 -4.57 29.89 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 115.088 0.795 . . . . 0.0 115.088 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.5 m -86.92 161.88 18.02 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -166.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -151.23 153.19 34.42 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.878 0.871 . . . . 0.0 109.346 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.579 HD12 ' HB1' ' A' ' 23' ' ' ALA . 3.2 pp -149.82 155.17 39.63 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.446 0.699 . . . . 0.0 109.836 170.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 70.9 t -112.77 131.72 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -119.82 170.37 9.3 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.908 0.883 . . . . 0.0 109.594 175.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.492 ' HB3' ' H ' ' A' ' 17' ' ' ASP . 35.0 t70 -83.63 130.23 34.98 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 172.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.0 t -68.18 152.3 45.69 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.488 0.715 . . . . 0.0 111.118 -176.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -110.77 -36.52 5.68 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.4 t -54.45 -45.05 73.03 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.624 1.17 . . . . 0.0 111.061 173.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 65.1 t -130.12 115.92 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.52 0.728 . . . . 0.0 109.379 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.13 130.41 42.63 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.431 0.692 . . . . 0.0 110.877 174.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.46 -0.63 68.37 Favored Glycine 0 C--N 1.352 1.443 0 C-N-CA 122.894 0.283 . . . . 0.0 112.757 -177.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.0 176.75 4.95 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.897 0.879 . . . . 0.0 112.0 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.456 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 48.7 m-85 -126.0 168.67 13.62 Favored 'General case' 0 C--O 1.249 1.04 0 C-N-CA 124.888 1.275 . . . . 0.0 110.434 -176.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.56 148.47 42.6 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.059 1.344 . . . . 0.0 109.686 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.8 tp -123.73 114.64 20.2 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.112 0.965 . . . . 0.0 108.996 -176.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.488 ' HG ' HG22 ' A' ' 60' ' ' THR . 60.5 m -107.44 121.65 45.04 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.3 t -126.66 132.39 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -173.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 68.6 tp -123.84 118.15 26.46 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.93 0.892 . . . . 0.0 110.104 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -136.07 132.11 35.74 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 166.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 42.19 61.55 1.94 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 124.977 1.311 . . . . 0.0 113.562 -176.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm 62.92 2.34 0.99 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 125.194 1.398 . . . . 0.0 113.673 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -103.65 105.89 16.25 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -173.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.0 t -86.06 139.63 17.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.066 0.946 . . . . 0.0 109.413 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -135.16 115.52 13.48 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 173.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.488 HG22 ' HG ' ' A' ' 51' ' ' CYS . 51.5 m -109.66 130.79 55.48 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.539 ' HH ' HD13 ' A' ' 101' ' ' LEU . 61.5 m-85 -110.59 156.43 20.95 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.895 1.278 . . . . 0.0 108.26 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -100.91 156.52 17.34 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 163.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.644 HG13 HG11 ' A' ' 73' ' ' VAL . 2.9 mp -144.47 100.5 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 101.564 -3.495 . . . . 0.0 101.564 -167.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.21 154.76 37.44 Favored Pre-proline 0 C--N 1.318 -0.781 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -169.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.97 -73.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 121.485 1.457 . . . . 0.0 111.302 163.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 43.82 73.85 0.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.762 1.225 . . . . 0.0 111.925 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.24 -100.65 0.15 Allowed Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.026 -174.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 158.97 -25.09 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 126.167 1.787 . . . . 0.0 108.271 -170.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -152.07 -2.89 0.27 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.704 0.801 . . . . 0.0 112.121 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -119.59 160.83 21.71 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.733 0.813 . . . . 0.0 109.495 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -115.12 121.42 42.97 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.615 0.766 . . . . 0.0 109.377 173.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.14 117.9 33.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.56 0.744 . . . . 0.0 110.7 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.644 HG11 HG13 ' A' ' 63' ' ' ILE . 25.6 t -92.09 145.14 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.788 -177.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -101.13 90.12 4.03 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.68 173.22 10.09 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.762 178.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.4 t -65.54 108.32 1.98 Allowed 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -56.7 101.63 0.06 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.147 0.979 . . . . 0.0 110.293 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.32 -24.45 0.45 Allowed Glycine 0 CA--C 1.529 0.953 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -165.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.1 m -118.0 162.27 30.36 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 125.326 1.45 . . . . 0.0 107.654 168.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -63.01 132.12 35.5 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.247 1.965 . . . . 0.0 112.271 176.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 94.2 t -71.58 123.37 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.563 0.745 . . . . 0.0 109.746 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.502 ' HG2' HD12 ' A' ' 93' ' ' LEU . 10.6 tpt180 -111.97 121.75 45.87 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 123.17 0.294 . . . . 0.0 110.89 -175.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.67 155.79 16.62 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.938 0.895 . . . . 0.0 109.19 170.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -133.96 165.6 24.64 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.614 0.766 . . . . 0.0 110.374 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -89.36 -23.99 22.08 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.991 0.516 . . . . 0.0 111.049 168.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.1 t -147.95 155.39 41.5 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.774 0.43 . . . . 0.0 111.195 -175.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.473 ' O ' HG12 ' A' ' 91' ' ' ILE . 86.1 mt -60.14 -31.04 69.7 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.854 0.861 . . . . 0.0 112.132 175.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.94 -47.34 31.96 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 123.094 0.378 . . . . 0.0 114.021 176.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -69.69 -30.28 67.9 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.375 0.67 . . . . 0.0 111.318 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.2 tt -66.86 -36.67 82.85 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.699 0.8 . . . . 0.0 109.13 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 87' ' ' LEU . 47.2 mm -80.92 -40.14 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -169.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.97 -38.98 64.18 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.79 -0.641 . . . . 0.0 113.471 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.502 HD12 ' HG2' ' A' ' 82' ' ' ARG . 7.9 tt -73.42 -36.11 65.93 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.571 0.348 . . . . 0.0 110.189 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.483 ' CD2' HD22 ' A' ' 101' ' ' LEU . 2.0 m-85 -84.28 -9.39 58.53 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.871 0.468 . . . . 0.0 110.613 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.37 0.4 17.0 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.383 0.673 . . . . 0.0 111.287 165.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -92.63 125.69 54.79 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 169.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -66.24 172.64 8.53 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.776 2.317 . . . . 0.0 113.029 171.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.3 t30 55.4 39.62 31.22 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.661 1.185 . . . . 0.0 111.548 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -122.09 10.07 10.0 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.661 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 99.56 -14.01 60.88 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -174.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.539 HD13 ' HH ' ' A' ' 61' ' ' TYR . 4.1 mm? -72.56 150.73 42.89 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.19 1.396 . . . . 0.0 110.702 176.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.4 m -84.34 74.91 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-O 122.206 1.003 . . . . 0.0 109.558 172.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 39.6 t 72.59 27.83 2.27 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 113.438 -1.71 . . . . 0.0 111.25 172.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 77.85 165.5 0.23 Allowed 'General case' 0 C--N 1.354 0.781 0 C-N-CA 125.076 1.35 . . . . 0.0 112.937 172.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.8 mt -76.71 101.81 5.95 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.293 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 78.2 mt -104.78 -50.73 3.21 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 122.957 0.503 . . . . 0.0 112.091 -172.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 mp -113.05 130.16 23.82 Favored Pre-proline 0 N--CA 1.491 1.61 0 CA-C-O 118.776 -0.63 . . . . 0.0 109.766 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -83.48 9.4 4.12 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.79 2.326 . . . . 0.0 113.234 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.523 HG23 HD22 ' A' ' 37' ' ' LEU . 49.3 t . . . . . 0 C--O 1.252 1.214 0 C-N-CA 125.382 1.473 . . . . 0.0 109.396 -172.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.785 0.326 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -142.39 132.9 5.36 Favored Glycine 0 C--N 1.341 0.831 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 175.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -72.39 120.98 18.76 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.881 0.472 . . . . 0.0 110.418 -173.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -98.53 149.96 22.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.927 0.891 . . . . 0.0 109.796 174.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -70.29 158.68 35.46 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.029 0.532 . . . . 0.0 110.101 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -66.29 152.93 43.91 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.863 0.465 . . . . 0.0 110.916 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -71.42 152.19 43.34 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 170.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -65.73 165.54 12.5 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.643 0.377 . . . . 0.0 110.933 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.4 m -62.01 120.39 10.73 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 122.662 0.385 . . . . 0.0 110.729 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -65.02 102.65 0.64 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 173.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 95.9 mmm -69.21 82.47 0.35 Allowed 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.813 0.816 . . . . 0.0 112.183 -168.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.8 m -155.6 103.02 2.26 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -83.76 1.36 43.24 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -165.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -105.06 96.44 6.53 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -170.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -110.2 89.97 3.18 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.27 52.39 2.01 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.017 0.913 . . . . 0.0 110.558 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -146.77 -17.76 0.42 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.725 1.61 . . . . 0.0 109.748 -174.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 28.7 tp -112.36 100.34 8.71 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.457 0.703 . . . . 0.0 110.26 -164.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.2 p -47.07 157.25 0.18 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 125.161 1.384 . . . . 0.0 112.801 172.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.39 -37.1 86.34 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.255 0.622 . . . . 0.0 112.096 -172.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.29 -51.27 68.38 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.392 0.677 . . . . 0.0 111.014 177.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.77 -20.08 61.24 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.934 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.417 ' HB3' HD11 ' A' ' 37' ' ' LEU . . . -69.6 -55.58 9.7 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.296 0.638 . . . . 0.0 110.738 178.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.46 ' HB3' ' SG ' ' A' ' 51' ' ' CYS . 12.3 pt-20 -70.2 -26.54 63.92 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.259 0.623 . . . . 0.0 111.719 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -64.9 -51.98 59.0 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -61.9 -35.39 78.23 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.062 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.6 mt -68.47 -33.82 74.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.585 0.354 . . . . 0.0 110.382 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.18 -37.77 81.33 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.995 0.809 . . . . 0.0 111.652 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -83.46 -44.01 15.2 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.056 0.542 . . . . 0.0 112.22 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.39 -58.2 3.24 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.213 0.605 . . . . 0.0 112.018 -169.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -100.07 -35.76 4.4 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.751 -176.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 66.15 -7.72 0.38 Allowed 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 126.322 1.849 . . . . 0.0 114.452 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -171.18 127.79 0.7 Allowed 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 124.818 1.247 . . . . 0.0 107.647 -165.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.489 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . 65.05 11.61 52.05 Favored Glycine 0 N--CA 1.478 1.467 0 N-CA-C 114.107 0.403 . . . . 0.0 114.107 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.8 m -83.35 143.47 30.31 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.83 0.852 . . . . 0.0 110.278 -168.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -152.92 154.59 35.35 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.06 0.457 . . . . 0.0 110.52 176.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.417 HD11 ' HB3' ' A' ' 23' ' ' ALA . 4.6 pp -151.62 153.66 34.91 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.777 169.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.512 HG21 HD13 ' A' ' 50' ' ' LEU . 40.1 t -107.25 145.64 14.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.516 ' HG3' ' HB3' ' A' ' 49' ' ' ALA . 0.9 OUTLIER -138.94 -179.36 5.79 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 125.308 1.443 . . . . 0.0 108.312 -178.472 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -91.34 148.11 22.56 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 172.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.532 ' HB2' ' HB ' ' A' ' 44' ' ' VAL . 40.9 m -61.92 140.69 58.28 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.987 0.515 . . . . 0.0 110.412 173.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -35.35 -54.53 0.65 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 126.356 1.862 . . . . 0.0 114.168 -167.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.1 m -142.61 28.87 1.59 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.91 0.484 . . . . 0.0 110.045 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.532 ' HB ' ' HB2' ' A' ' 41' ' ' SER . 24.2 t -110.24 112.1 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.37 117.98 8.04 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.037 -177.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.89 -0.46 89.47 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 114.537 0.575 . . . . 0.0 114.537 172.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -92.92 155.24 17.71 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 117.161 0.481 . . . . 0.0 109.834 173.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.533 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 68.3 m-85 -110.67 158.24 18.83 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.647 0.736 . . . . 0.0 109.753 -175.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.516 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . . . -135.06 147.37 49.59 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 166.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.512 HD13 HG21 ' A' ' 38' ' ' VAL . 45.6 tp -125.77 139.24 53.68 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -177.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.46 ' SG ' ' HB3' ' A' ' 24' ' ' GLU . 44.6 t -124.84 128.55 48.87 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 175.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.626 HG13 ' SG ' ' A' ' 103' ' ' CYS . 12.8 t -137.0 140.41 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 123.538 0.735 . . . . 0.0 109.779 -176.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.7 tp -132.34 120.52 22.19 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.609 1.164 . . . . 0.0 110.148 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -147.77 146.14 29.07 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.473 0.709 . . . . 0.0 109.089 168.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 50.3 47.58 23.58 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.74 1.216 . . . . 0.0 111.837 -177.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt 54.75 27.68 9.14 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.641 1.177 . . . . 0.0 112.716 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -123.72 107.26 11.27 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.228 1.011 . . . . 0.0 108.888 -174.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.5 t -83.73 131.54 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.441 ' HD1' HG12 ' A' ' 102' ' ' VAL . 14.2 t-160 -135.84 111.08 9.0 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 176.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.2 p -104.87 127.22 52.61 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.961 0.904 . . . . 0.0 108.614 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -113.25 101.02 9.01 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.033 0.933 . . . . 0.0 108.846 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 84.4 mtm180 -70.9 155.63 40.57 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 168.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 91.7 mt -145.86 100.92 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 102.601 -3.111 . . . . 0.0 102.601 -152.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 mp -113.36 101.71 53.9 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 122.814 0.446 . . . . 0.0 110.617 -161.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.662 ' HB2' ' HA ' ' A' ' 68' ' ' GLU . 39.7 Cg_endo -66.3 103.62 0.67 Allowed 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.086 1.857 . . . . 0.0 110.02 167.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.16 -52.8 62.35 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.849 0.86 . . . . 0.0 110.446 -169.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -116.86 34.04 4.8 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.577 174.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.662 ' HA ' ' HB2' ' A' ' 65' ' ' PRO . 46.5 mt-10 50.29 4.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 -173.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -84.85 -49.21 8.6 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 119.602 1.092 . . . . 0.0 109.695 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 31.3 m-85 -127.57 142.07 51.47 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.715 0.806 . . . . 0.0 109.933 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -99.23 114.9 27.95 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.7 1.2 . . . . 0.0 108.736 -176.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.97 119.39 35.35 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.243 1.017 . . . . 0.0 111.277 -170.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.418 HG23 HG22 ' A' ' 63' ' ' ILE . 16.1 t -106.96 143.67 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.057 0.943 . . . . 0.0 108.956 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -113.49 91.89 3.8 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -172.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.6 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 30.7 p -108.26 28.36 8.38 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.897 0.879 . . . . 0.0 110.482 -177.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.4 m -68.66 94.52 0.59 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.975 0.91 . . . . 0.0 113.353 -167.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -118.41 2.02 11.82 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 124.229 1.012 . . . . 0.0 110.165 164.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.48 22.88 0.03 OUTLIER Glycine 0 N--CA 1.471 0.982 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.459 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.9 m -140.27 152.42 66.96 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.503 1.121 . . . . 0.0 108.969 -174.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -73.32 -175.19 1.88 Allowed 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.375 2.05 . . . . 0.0 111.903 172.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 62.9 t -76.63 123.92 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 176.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 39.8 tpt85 -100.7 116.07 31.74 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -175.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.436 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 32.2 mtp85 -95.33 145.07 25.37 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.292 1.037 . . . . 0.0 110.07 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.622 ' HE1' HD13 ' A' ' 93' ' ' LEU . 83.6 m-85 -126.93 152.87 46.55 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.905 0.882 . . . . 0.0 109.181 -178.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -85.7 -21.56 28.24 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 172.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.7 t -153.33 158.25 41.28 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 122.998 0.519 . . . . 0.0 110.725 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.98 -27.54 68.9 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.238 1.015 . . . . 0.0 109.979 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -52.83 -46.19 60.45 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-N 116.364 -0.38 . . . . 0.0 113.999 173.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -66.88 -30.7 70.93 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.442 0.697 . . . . 0.0 110.97 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.0 tt -62.53 -57.95 9.33 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.319 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.491 ' HA ' HD11 ' A' ' 105' ' ' LEU . 38.3 mm -54.41 -46.11 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.67 0.788 . . . . 0.0 111.206 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.05 -56.96 14.21 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 114.568 -1.196 . . . . 0.0 113.75 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.622 HD13 ' HE1' ' A' ' 84' ' ' PHE . 86.7 mt -74.0 -37.02 64.54 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.944 0.498 . . . . 0.0 111.675 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.409 ' HE2' HG11 ' A' ' 73' ' ' VAL . 5.9 m-30 -82.28 -5.51 58.6 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -169.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.13 -5.37 26.59 Favored 'General case' 0 CA--C 1.562 1.429 0 CA-C-O 120.805 0.336 . . . . 0.0 111.418 165.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -97.13 130.56 29.49 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 124.726 1.21 . . . . 0.0 109.095 173.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.47 -175.66 2.79 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.892 2.395 . . . . 0.0 113.311 173.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.6 t30 49.22 71.9 0.34 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 126.041 1.736 . . . . 0.0 112.277 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.552 ' HG3' HD21 ' A' ' 101' ' ' LEU . 12.7 pt20 -176.45 11.3 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.427 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.6 ' HA3' ' HB ' ' A' ' 75' ' ' THR . . . 122.94 -32.89 4.25 Favored Glycine 0 C--N 1.345 1.074 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -173.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.552 HD21 ' HG3' ' A' ' 99' ' ' GLN . 3.4 mm? -76.66 101.41 5.74 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.533 0.733 . . . . 0.0 109.287 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.451 HG22 ' SG ' ' A' ' 103' ' ' CYS . 4.7 m -69.74 -15.08 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.783 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.626 ' SG ' HG13 ' A' ' 52' ' ' VAL . 14.6 m -115.29 -47.38 2.85 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.582 1.153 . . . . 0.0 111.617 -174.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 69.94 139.34 0.04 OUTLIER 'General case' 0 C--N 1.357 0.906 0 O-C-N 125.27 1.606 . . . . 0.0 108.973 -158.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.491 HD11 ' HA ' ' A' ' 91' ' ' ILE . 46.0 mt -69.94 101.42 1.77 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -170.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.489 HD21 ' HA3' ' A' ' 34' ' ' GLY . 57.7 tp -108.68 -60.49 1.74 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.346 1.058 . . . . 0.0 111.056 -169.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 60.6 tp -120.48 101.41 46.35 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 123.165 0.586 . . . . 0.0 109.999 -169.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.38 122.0 5.89 Favored 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 122.884 2.389 . . . . 0.0 110.352 174.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 C--O 1.244 0.81 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.57 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.464 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.001 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.62 158.72 35.8 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.888 -177.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -170.74 161.49 7.39 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.372 1.069 . . . . 0.0 109.523 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -143.62 127.32 17.12 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -176.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -103.57 156.65 17.62 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -166.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -141.13 130.8 24.1 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.697 1.199 . . . . 0.0 108.813 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -145.31 99.04 3.25 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -62.69 99.78 0.17 Allowed 'General case' 0 N--CA 1.48 1.068 0 O-C-N 123.709 0.631 . . . . 0.0 110.714 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.8 p -155.92 107.76 2.56 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.795 0.838 . . . . 0.0 109.077 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -111.92 159.81 18.03 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 123.653 0.781 . . . . 0.0 109.161 178.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 75.2 mtp -73.33 145.48 45.95 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.683 0.793 . . . . 0.0 109.973 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.7 p -65.8 149.14 50.64 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.281 0.632 . . . . 0.0 110.438 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . 4.9 p-90 -79.54 -21.35 45.28 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -175.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 89.0 t80 -81.66 125.79 31.0 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.486 171.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -117.67 129.76 55.94 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.43 ' O ' ' HB3' ' A' ' 40' ' ' ASP . 1.6 mpp_? -75.08 -37.93 61.44 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -174.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -130.93 90.1 2.84 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.988 0.899 . . . . 0.0 109.897 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.9 tp -135.59 139.77 44.11 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.841 1.256 . . . . 0.0 107.764 175.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.3 t -99.0 167.09 10.95 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.312 0.645 . . . . 0.0 110.342 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -64.74 -40.08 94.7 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.875 0.87 . . . . 0.0 113.184 -172.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.89 -48.34 77.04 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.067 0.547 . . . . 0.0 110.801 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.55 -30.81 70.54 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.674 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.486 ' HB3' HD13 ' A' ' 37' ' ' LEU . . . -65.98 -57.26 8.21 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.123 0.569 . . . . 0.0 110.922 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -58.01 -38.74 76.72 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.877 1.271 . . . . 0.0 112.041 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -70.17 -45.04 67.55 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.395 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.2 tp -58.16 -34.28 70.13 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.981 0.912 . . . . 0.0 111.441 175.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 23' ' ' ALA . 96.5 mt -66.11 -53.05 42.82 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.62 -39.14 87.12 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.265 1.026 . . . . 0.0 112.695 -172.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -73.37 -52.09 15.06 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.748 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.21 -56.18 3.79 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -166.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -101.98 -46.69 1.57 Allowed Glycine 0 N--CA 1.475 1.267 0 N-CA-C 113.404 0.121 . . . . 0.0 113.404 -172.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 49.05 21.49 0.49 Allowed 'General case' 0 CA--C 1.57 1.747 0 C-N-CA 126.196 1.798 . . . . 0.0 114.827 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -170.64 100.43 0.24 Allowed 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.27 -0.894 . . . . 0.0 109.361 -168.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.404 ' HA3' ' HB2' ' A' ' 106' ' ' LEU . . . 66.44 19.05 68.36 Favored Glycine 0 C--N 1.353 1.488 0 CA-C-O 121.465 0.48 . . . . 0.0 112.394 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 9.2 m -84.55 122.8 29.53 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 124.533 1.133 . . . . 0.0 110.859 -167.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 36.7 p90 -129.76 156.7 43.89 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.986 0.422 . . . . 0.0 110.725 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.486 HD13 ' HB3' ' A' ' 23' ' ' ALA . 4.3 pp -150.2 160.11 43.93 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 167.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 57.4 t -114.23 148.54 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 174.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -149.05 151.94 35.37 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.308 0.643 . . . . 0.0 109.476 -174.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.43 ' HB3' ' O ' ' A' ' 16' ' ' ARG . 25.3 t70 -91.11 118.33 30.34 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 174.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.3 m -92.69 97.33 10.72 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -173.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -55.29 -39.17 69.56 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.058 0.943 . . . . 0.0 112.325 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.6 m -58.31 -24.34 59.28 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.2 t -80.27 -87.0 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-O 119.476 -0.297 . . . . 0.0 110.913 -174.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -178.03 18.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 122.909 0.484 . . . . 0.0 111.595 -167.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.75 88.03 1.2 Allowed Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -159.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.3 163.75 39.71 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.717 0.807 . . . . 0.0 109.789 -170.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.594 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 21.2 m-85 -116.01 162.23 17.7 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.37 0.668 . . . . 0.0 109.69 168.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.55 149.38 43.81 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.169 0.988 . . . . 0.0 110.1 170.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.495 ' HB2' HD11 ' A' ' 63' ' ' ILE . 51.9 tp -117.2 111.29 19.24 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 55.4 m -101.17 121.52 41.98 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.4 t -125.19 143.52 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.48 HD11 HG22 ' A' ' 58' ' ' VAL . 51.0 tp -133.0 147.4 52.27 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.366 1.066 . . . . 0.0 109.214 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -162.33 115.88 1.77 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.9 tm0? 36.06 73.75 0.08 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 125.907 1.683 . . . . 0.0 112.612 -174.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 44.6 tptt 56.64 26.41 11.15 Favored 'General case' 0 CA--C 1.572 1.825 0 C-N-CA 124.391 1.076 . . . . 0.0 112.684 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -130.19 107.33 9.22 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 121.482 -0.761 . . . . 0.0 109.272 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.48 HG22 HD11 ' A' ' 53' ' ' LEU . 21.6 t -93.1 142.0 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.506 0.722 . . . . 0.0 109.995 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -137.14 112.77 9.43 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.639 1.576 . . . . 0.0 107.754 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.9 m -119.37 140.17 50.79 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.416 ' HH ' ' HA ' ' A' ' 101' ' ' LEU . 45.2 m-85 -133.98 113.8 12.55 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.719 0.807 . . . . 0.0 109.41 -173.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -64.79 156.89 29.16 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 171.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.594 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 79.7 mt -148.33 104.32 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 -158.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -96.01 102.44 10.65 Favored Pre-proline 0 N--CA 1.478 0.93 0 CA-C-N 118.885 0.766 . . . . 0.0 109.453 -168.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.438 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 93.1 Cg_endo -76.73 -56.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 123.043 2.495 . . . . 0.0 115.99 -163.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -125.9 141.02 52.17 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 118.146 0.43 . . . . 0.0 111.081 -162.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.05 -16.44 0.24 Allowed Glycine 0 CA--C 1.534 1.236 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.161 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -146.84 -70.5 0.24 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.776 1.231 . . . . 0.0 108.592 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -166.62 -41.31 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.989 -175.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -110.16 151.18 27.6 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.766 0.426 . . . . 0.0 111.222 -167.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.438 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 3.8 pp -99.73 111.58 23.9 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 171.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -101.1 123.48 45.33 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.133 0.573 . . . . 0.0 110.541 -173.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.774 HG22 HD12 ' A' ' 90' ' ' LEU . 57.5 t -93.91 138.12 21.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -95.54 88.45 5.06 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.407 ' HB ' HG22 ' A' ' 81' ' ' VAL . 1.6 m -73.44 -77.95 0.1 Allowed 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.416 -173.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.42 ' HB2' HG23 ' A' ' 79' ' ' VAL . 66.6 m -161.15 128.29 4.1 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.799 0.84 . . . . 0.0 110.437 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.4 mp0 -70.07 92.87 0.76 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 169.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.53 -36.13 0.69 Allowed Glycine 0 C--N 1.346 1.099 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -170.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.459 ' HB ' ' HB3' ' A' ' 99' ' ' GLN . 13.0 m -104.89 158.34 32.23 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 123.495 0.718 . . . . 0.0 109.171 177.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.36 111.05 1.18 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.256 1.971 . . . . 0.0 110.869 167.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.407 HG22 ' HB ' ' A' ' 75' ' ' THR . 95.7 t -93.6 132.25 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.944 0.898 . . . . 0.0 108.675 -177.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -112.13 136.13 51.91 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.948 0.499 . . . . 0.0 110.454 -173.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -89.92 140.97 29.1 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.303 1.041 . . . . 0.0 109.328 174.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -111.17 174.45 5.86 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.449 1.099 . . . . 0.0 110.207 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -120.08 -49.64 2.29 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -164.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.8 m -128.73 161.26 30.14 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 113.495 -1.684 . . . . 0.0 107.697 171.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.47 -26.13 67.7 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 118.647 0.658 . . . . 0.0 112.41 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -56.58 -34.93 64.93 Favored Glycine 0 N--CA 1.48 1.611 0 O-C-N 122.991 0.182 . . . . 0.0 113.47 169.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -67.45 -38.96 85.27 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.2 0.6 . . . . 0.0 110.677 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.774 HD12 HG22 ' A' ' 73' ' ' VAL . 37.6 tp -61.84 -64.71 0.85 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.855 0.862 . . . . 0.0 110.717 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.7 mm -59.68 -39.36 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.318 1.047 . . . . 0.0 111.063 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.18 -57.66 18.06 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.135 -0.939 . . . . 0.0 113.853 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.1 tt -67.63 -45.83 74.25 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.266 0.626 . . . . 0.0 110.101 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.478 ' HB3' ' HG ' ' A' ' 105' ' ' LEU . 5.7 m-30 -77.04 -12.15 59.9 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -170.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.42 -22.24 66.77 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.224 0.535 . . . . 0.0 110.835 169.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -94.45 139.25 22.31 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 174.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -46.3 117.75 2.13 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.105 2.537 . . . . 0.0 112.137 166.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -110.24 -58.37 2.08 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.518 -164.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.459 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . 9.4 mm-40 128.33 102.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 128.37 2.668 . . . . 0.0 107.595 -159.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 120.55 -39.91 2.31 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-O 120.117 -0.269 . . . . 0.0 113.432 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 94' ' ' TYR . 76.2 mt -68.9 150.28 47.93 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.8 p -64.49 -36.83 78.41 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.174 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 49.0 t -165.25 20.64 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.268 0.627 . . . . 0.0 111.146 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 72.14 167.97 0.31 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.611 1.165 . . . . 0.0 110.664 -169.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.478 ' HG ' ' HB3' ' A' ' 94' ' ' TYR . 23.4 mt -81.18 98.91 8.28 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.167 0.587 . . . . 0.0 109.611 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.404 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 89.8 mt -93.95 -46.5 7.14 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.459 0.704 . . . . 0.0 112.404 -172.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 35' ' ' SER . 68.5 tp -141.54 116.68 7.06 Favored Pre-proline 0 N--CA 1.486 1.373 0 C-N-CA 123.079 0.552 . . . . 0.0 111.055 -174.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.444 ' HB2' ' HB3' ' A' ' 13' ' ' TRP . 73.2 Cg_endo -77.94 136.38 14.83 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.372 2.048 . . . . 0.0 111.581 174.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--O 1.25 1.086 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.407 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.9 mtt . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 132.21 119.56 2.07 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 112.387 -0.285 . . . . 0.0 112.387 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -141.46 112.04 7.05 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -94.42 97.79 10.43 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.083 0.468 . . . . 0.0 110.374 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -98.65 126.3 44.2 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.695 1.198 . . . . 0.0 108.486 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -96.84 147.6 23.78 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.099 0.56 . . . . 0.0 110.778 -178.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 -160.37 125.58 3.9 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.467 1.107 . . . . 0.0 109.318 174.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -142.07 157.8 44.49 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.25 1.02 . . . . 0.0 110.369 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.4 m -122.53 101.68 7.62 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.026 0.931 . . . . 0.0 108.593 171.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -108.83 90.45 3.3 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.262 1.025 . . . . 0.0 108.882 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -83.47 62.68 6.91 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 175.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.8 t 55.67 -107.52 0.39 Allowed 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 124.177 0.991 . . . . 0.0 110.56 -171.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.502 ' HB3' ' HB3' ' A' ' 108' ' ' PRO . 6.1 p-90 -99.23 15.5 25.9 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.813 0.845 . . . . 0.0 112.005 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.436 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 61.7 t80 -113.76 116.09 28.83 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -131.23 99.16 4.77 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.207 0.603 . . . . 0.0 110.373 -177.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.478 ' HD3' ' N ' ' A' ' 17' ' ' ASP . 1.0 OUTLIER -72.73 150.59 42.74 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 167.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.478 ' N ' ' HD3' ' A' ' 16' ' ' ARG . 36.6 t70 79.19 3.54 2.33 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.891 1.276 . . . . 0.0 111.389 -175.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.2 tp -99.44 123.25 43.55 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.082 -1.011 . . . . 0.0 109.042 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.2 p -80.85 160.84 24.66 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.663 0.785 . . . . 0.0 109.917 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.45 ' HB3' ' NH2' ' A' ' 39' ' ' ARG . 5.5 ppt_? -64.63 -35.47 81.13 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 118.458 0.572 . . . . 0.0 112.252 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.87 -48.86 78.63 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.538 0.735 . . . . 0.0 110.75 175.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.21 -26.56 62.99 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.849 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.461 ' HB1' HD12 ' A' ' 37' ' ' LEU . . . -71.97 -54.55 9.62 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.72 0.808 . . . . 0.0 110.768 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.551 ' HG2' HG21 ' A' ' 58' ' ' VAL . 5.5 tm-20 -56.97 -39.72 75.14 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.951 1.3 . . . . 0.0 111.52 175.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.82 -46.72 80.78 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 123.976 0.798 . . . . 0.0 110.156 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -60.63 -43.87 97.02 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 124.088 0.868 . . . . 0.0 110.411 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.4 mt -65.26 -42.18 93.52 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.368 0.667 . . . . 0.0 110.186 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.47 -35.87 80.03 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.764 0.826 . . . . 0.0 111.604 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 46.5 ttt85 -77.69 -30.77 52.06 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.573 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.52 ' HB3' HG11 ' A' ' 109' ' ' VAL . . . -87.91 -61.43 1.72 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -172.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -125.31 -48.05 0.21 Allowed Glycine 0 N--CA 1.474 1.195 0 C-N-CA 122.951 0.31 . . . . 0.0 112.7 -169.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.461 ' HG3' HD23 ' A' ' 53' ' ' LEU . 40.2 ttp180 45.57 41.96 7.55 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.343 1.857 . . . . 0.0 114.541 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -174.16 88.52 0.06 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -174.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.512 ' HA2' ' SG ' ' A' ' 103' ' ' CYS . . . 83.75 12.75 76.91 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.785 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 m -83.75 118.93 24.23 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 124.634 1.173 . . . . 0.0 110.563 -169.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -125.98 158.92 34.05 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.084 0.468 . . . . 0.0 110.178 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.461 HD12 ' HB1' ' A' ' 23' ' ' ALA . 3.8 pp -153.7 164.94 37.44 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.731 166.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 97.7 t -119.27 148.64 22.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 170.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.45 ' NH2' ' HB3' ' A' ' 20' ' ' ARG . 43.7 ptt85 -153.6 -178.31 6.94 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -93.29 141.54 28.32 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 165.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.4 m -65.65 146.22 55.08 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 163.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -66.6 81.37 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -158.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.6 m 51.12 30.88 5.96 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.96 1.304 . . . . 0.0 112.654 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.1 m -72.46 -44.04 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.892 -168.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -174.01 9.32 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.441 0.697 . . . . 0.0 111.454 -169.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.77 19.19 60.16 Favored Glycine 0 N--CA 1.474 1.183 0 N-CA-C 112.141 -0.384 . . . . 0.0 112.141 -171.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.79 155.3 18.88 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.989 0.916 . . . . 0.0 111.681 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -106.55 158.85 16.62 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.023 0.929 . . . . 0.0 110.398 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.88 141.19 51.36 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.986 0.514 . . . . 0.0 110.136 169.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.599 HD23 HD23 ' A' ' 90' ' ' LEU . 51.9 tp -114.32 107.09 15.11 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.136 1.374 . . . . 0.0 107.495 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 42.5 t -104.04 114.37 28.57 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -175.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.7 t -120.61 133.14 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.025 0.93 . . . . 0.0 108.724 -175.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.461 HD23 ' HG3' ' A' ' 32' ' ' ARG . 12.3 tp -128.98 140.89 51.45 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.858 1.263 . . . . 0.0 109.283 -173.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -155.3 115.54 3.79 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 41.75 71.05 0.23 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.001 1.32 . . . . 0.0 113.892 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.9 mttt 59.31 23.4 11.83 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.407 1.083 . . . . 0.0 113.714 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -131.82 105.68 7.62 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.551 HG21 ' HG2' ' A' ' 24' ' ' GLU . 40.1 t -103.9 109.0 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.823 0.849 . . . . 0.0 109.053 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -103.02 123.33 46.41 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 171.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 36.8 m -120.01 141.9 49.29 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.046 0.939 . . . . 0.0 108.687 -172.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -124.39 100.44 6.68 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -172.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.5 mtp-105 -81.97 98.61 8.67 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.525 HG12 HG23 ' A' ' 73' ' ' VAL . 6.1 mt -75.45 110.51 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.362 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.0 mp -112.06 103.12 55.06 Favored Pre-proline 0 C--O 1.241 0.639 0 C-N-CA 124.887 1.275 . . . . 0.0 107.566 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.453 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 37.8 Cg_exo -58.05 -57.88 0.98 Allowed 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.259 1.972 . . . . 0.0 110.705 170.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.7 t70 56.01 36.09 26.74 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 122.788 1.28 . . . . 0.0 109.825 173.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.07 178.0 28.06 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.939 -165.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -108.9 -13.37 14.76 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 118.589 1.195 . . . . 0.0 111.029 -175.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -65.47 -85.0 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.451 0.701 . . . . 0.0 110.914 -174.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -131.04 155.68 46.46 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.675 0.75 . . . . 0.0 111.777 175.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.453 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -120.48 110.93 17.07 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.063 1.745 . . . . 0.0 107.578 169.346 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.12 132.0 43.33 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.147 0.579 . . . . 0.0 110.586 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.525 HG23 HG12 ' A' ' 63' ' ' ILE . 39.8 t -99.38 112.92 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -177.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -90.65 94.56 9.75 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.106 0.563 . . . . 0.0 109.923 -169.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.71 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 65.4 p -65.8 -27.88 68.6 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.612 0.765 . . . . 0.0 112.433 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.8 t -142.07 -169.97 3.05 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.006 0.922 . . . . 0.0 109.796 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -54.45 -55.3 30.28 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.473 1.109 . . . . 0.0 112.386 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.29 44.05 0.19 Allowed Glycine 0 CA--C 1.505 -0.536 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.855 176.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.0 m -69.32 166.3 31.01 Favored Pre-proline 0 CA--C 1.557 1.217 0 C-N-CA 123.347 0.659 . . . . 0.0 111.364 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.45 53.22 1.31 Allowed 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 122.89 2.393 . . . . 0.0 112.652 167.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.477 HG23 ' H ' ' A' ' 82' ' ' ARG . 4.3 p -55.85 176.44 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 C-N-CA 125.42 1.488 . . . . 0.0 111.989 162.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.477 ' H ' HG23 ' A' ' 81' ' ' VAL . 42.4 mmm-85 -108.93 140.49 42.34 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -169.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -95.18 126.44 40.5 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -112.18 166.01 11.65 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.447 0.467 . . . . 0.0 109.876 -175.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -132.27 -4.92 3.41 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.767 0.827 . . . . 0.0 109.006 169.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 88' ' ' GLY . 87.6 m -141.73 136.07 30.41 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.362 1.065 . . . . 0.0 109.645 -172.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 78.7 mt -66.35 -28.26 68.52 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.908 0.883 . . . . 0.0 111.125 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.423 ' H ' HG23 ' A' ' 86' ' ' THR . . . -57.65 -46.74 91.82 Favored Glycine 0 N--CA 1.475 1.234 0 N-CA-C 114.401 0.52 . . . . 0.0 114.401 174.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -65.56 -36.1 82.79 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.548 0.739 . . . . 0.0 111.01 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.599 HD23 HD23 ' A' ' 50' ' ' LEU . 6.5 tt -59.91 -63.68 1.21 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.937 1.295 . . . . 0.0 110.403 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 31.6 mm -60.67 -43.64 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.209 1.004 . . . . 0.0 110.94 -175.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.09 -48.69 66.44 Favored Glycine 0 C--N 1.343 0.955 0 O-C-N 124.219 0.95 . . . . 0.0 113.482 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.2 tt -67.04 -59.67 3.27 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.502 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . 20.2 m-85 -71.69 -5.9 37.19 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -166.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.67 -16.31 25.6 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.048 0.539 . . . . 0.0 111.867 165.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -90.76 146.46 34.08 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 173.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -91.72 -168.19 0.23 Allowed 'Trans proline' 0 C--N 1.363 1.338 0 C-N-CA 122.916 2.411 . . . . 0.0 111.939 172.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.4 t30 52.62 62.39 2.71 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.845 1.258 . . . . 0.0 111.868 176.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -174.31 5.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.985 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.71 ' HA3' ' HB ' ' A' ' 75' ' ' THR . . . 130.97 -31.49 3.17 Favored Glycine 0 N--CA 1.473 1.121 0 N-CA-C 112.221 -0.352 . . . . 0.0 112.221 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.502 ' HG ' ' HB3' ' A' ' 94' ' ' TYR . 3.9 mm? -83.17 97.34 8.77 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.5 m -46.63 -32.83 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 126.079 1.752 . . . . 0.0 114.533 -175.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.512 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 24.6 p -130.46 3.07 4.62 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.021 0.528 . . . . 0.0 111.731 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.423 ' HA ' ' HB3' ' A' ' 101' ' ' LEU . . . 66.6 -179.99 0.21 Allowed 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.344 1.028 . . . . 0.0 110.444 -171.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 60.9 mt -90.36 83.16 5.91 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 168.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.3 tp -110.3 -63.03 1.43 Allowed 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.161 -171.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.32 115.51 63.73 Favored Pre-proline 0 N--CA 1.485 1.305 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.502 ' HB3' ' HB3' ' A' ' 13' ' ' TRP . 4.9 Cg_exo -71.14 -90.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 121.805 1.67 . . . . 0.0 110.049 173.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.52 HG11 ' HB3' ' A' ' 30' ' ' ALA . 78.6 t . . . . . 0 C--O 1.254 1.342 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 172.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 tpp . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.95 -42.14 3.13 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 115.313 0.885 . . . . 0.0 115.313 166.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -54.33 98.84 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.168 0.987 . . . . 0.0 113.267 -170.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -136.39 -67.16 0.52 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 170.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.1 t60 51.41 55.34 9.57 Favored 'General case' 0 C--N 1.363 1.177 0 C-N-CA 125.082 1.353 . . . . 0.0 111.0 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -150.04 129.91 13.36 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.139 0.976 . . . . 0.0 109.553 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -132.72 146.14 51.61 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.186 0.994 . . . . 0.0 108.813 172.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -62.87 87.31 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.946 0.899 . . . . 0.0 111.562 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.7 p -78.61 98.86 6.32 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.865 176.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -82.61 70.14 9.52 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 122.062 0.934 . . . . 0.0 110.84 -175.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 10.1 tpt -92.65 128.45 38.51 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.716 176.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.7 t -172.78 -141.53 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 124.129 0.971 . . . . 0.0 108.681 -176.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -70.68 -18.55 62.82 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.289 0.635 . . . . 0.0 110.033 172.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 76.2 t80 -85.54 130.42 34.58 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.129 0.572 . . . . 0.0 109.622 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -130.0 140.49 50.87 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -66.17 -53.53 36.35 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -169.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -155.67 72.34 0.79 Allowed 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 122.133 0.968 . . . . 0.0 111.44 175.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.677 HD22 HH21 ' A' ' 39' ' ' ARG . 8.7 tt -92.92 135.01 34.53 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 160.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.1 t -66.97 146.47 54.34 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.776 0.831 . . . . 0.0 110.043 -173.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.42 ' H ' ' NE ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -64.84 -42.24 95.08 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.671 0.389 . . . . 0.0 110.956 -176.422 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.15 -51.2 67.22 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.56 0.744 . . . . 0.0 111.306 172.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.22 -29.3 70.4 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.659 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.477 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -69.59 -45.82 67.77 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.535 1.134 . . . . 0.0 111.893 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 43.9 mt-10 -56.73 -44.46 81.68 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.669 0.787 . . . . 0.0 110.898 175.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.28 -40.02 86.1 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.412 177.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.5 -42.41 92.12 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.315 1.046 . . . . 0.0 109.65 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' A' ' 35' ' ' SER . 93.7 mt -65.52 -43.64 89.4 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.511 0.724 . . . . 0.0 110.461 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.95 -34.91 70.43 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 124.066 0.854 . . . . 0.0 112.283 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -87.83 -43.06 12.12 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.85 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.86 -61.79 1.86 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -167.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.419 ' HA3' ' HB3' ' A' ' 35' ' ' SER . . . -95.29 -33.0 6.72 Favored Glycine 0 C--N 1.352 1.465 0 CA-C-O 121.277 0.376 . . . . 0.0 112.368 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 68.07 0.61 2.47 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 126.904 2.081 . . . . 0.0 114.405 175.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.2 t70 175.53 125.71 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.29 0.636 . . . . 0.0 109.381 -175.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.57 6.06 70.01 Favored Glycine 0 N--CA 1.477 1.417 0 O-C-N 123.285 0.366 . . . . 0.0 112.714 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.606 ' HB2' HD21 ' A' ' 27' ' ' LEU . 3.1 p -80.69 136.9 36.27 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.022 0.929 . . . . 0.0 109.639 -172.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -137.13 158.51 44.28 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.817 0.447 . . . . 0.0 110.577 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.477 HD11 ' HB1' ' A' ' 23' ' ' ALA . 1.2 pp -155.23 165.98 34.97 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.19 0.996 . . . . 0.0 109.729 174.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 89.2 t -132.64 130.54 59.48 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 173.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.677 HH21 HD22 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -121.59 179.16 4.55 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 169.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -92.18 140.24 29.82 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 171.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.8 m -71.89 162.65 29.14 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.305 1.042 . . . . 0.0 111.613 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.84 -29.91 8.8 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.142 0.577 . . . . 0.0 110.704 -178.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.8 p -89.63 -58.21 2.6 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 123.739 0.816 . . . . 0.0 110.425 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.5 t -86.68 106.06 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -175.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.8 117.63 7.19 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.957 0.903 . . . . 0.0 111.773 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.42 -0.07 74.02 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-O 119.856 -0.413 . . . . 0.0 113.365 176.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.04 151.64 20.96 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 117.455 0.628 . . . . 0.0 111.689 -177.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -110.82 130.19 55.65 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.875 0.87 . . . . 0.0 111.333 -175.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.411 ' HB1' ' HG2' ' A' ' 39' ' ' ARG . . . -100.51 114.48 28.12 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.904 0.882 . . . . 0.0 110.251 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.5 tp -106.24 108.49 20.02 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 43.3 t -111.39 124.49 52.36 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.9 t -129.45 116.65 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.025 0.93 . . . . 0.0 109.675 -174.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.582 HD12 HG22 ' A' ' 58' ' ' VAL . 32.5 tp -86.34 142.83 28.2 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.058 0.943 . . . . 0.0 109.568 173.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -162.78 127.4 3.1 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.515 0.726 . . . . 0.0 109.719 167.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 47.35 62.78 2.25 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.5 1.52 . . . . 0.0 112.682 173.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.534 ' HB2' ' HZ1' ' A' ' 56' ' ' LYS . 0.1 OUTLIER 55.63 30.98 16.38 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.633 1.173 . . . . 0.0 111.949 179.676 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -141.52 105.93 4.84 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.265 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.582 HG22 HD12 ' A' ' 53' ' ' LEU . 2.7 t -92.98 122.8 44.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 172.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -114.98 140.29 49.15 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.9 p -111.76 136.58 50.83 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.842 0.857 . . . . 0.0 108.716 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -128.46 101.5 6.22 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -84.19 102.63 12.75 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.222 0.609 . . . . 0.0 109.825 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.43 ' H ' HD11 ' A' ' 63' ' ' ILE . 4.1 mp -71.39 129.86 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.935 168.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.61 139.82 23.36 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 123.709 0.804 . . . . 0.0 109.533 171.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 97.7 Cg_endo -83.11 111.51 1.9 Allowed 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.16 1.907 . . . . 0.0 111.129 169.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -69.43 -58.87 3.44 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.675 0.39 . . . . 0.0 110.185 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -96.74 33.04 5.98 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 119.543 -0.587 . . . . 0.0 112.548 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 69.49 -34.03 0.27 Allowed 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -89.11 -48.66 7.25 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.255 0.622 . . . . 0.0 111.094 -165.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -103.51 135.9 44.24 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 2.5 pp -106.68 151.1 25.54 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 172.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.522 ' HB1' ' HG2' ' A' ' 83' ' ' ARG . . . -138.93 134.23 32.92 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.163 -0.336 . . . . 0.0 111.481 -169.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.3 p -85.85 135.36 25.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 171.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -98.23 94.74 6.96 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.3 p -78.12 -63.84 1.3 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.407 0.683 . . . . 0.0 111.147 -170.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.516 ' HB3' HG23 ' A' ' 79' ' ' VAL . 41.3 t -177.37 140.15 0.27 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.916 0.886 . . . . 0.0 109.096 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -76.27 91.44 3.22 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 168.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.5 -27.15 0.42 Allowed Glycine 0 C--N 1.339 0.71 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -167.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.516 HG23 ' HB3' ' A' ' 76' ' ' SER . 34.7 m -127.4 156.58 74.8 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 124.482 1.113 . . . . 0.0 108.449 174.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.12 136.57 61.34 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.525 2.15 . . . . 0.0 112.986 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 95.9 t -94.68 134.52 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.103 0.961 . . . . 0.0 108.589 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.4 tpt85 -113.78 130.9 56.39 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.68 0.792 . . . . 0.0 109.998 -176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.522 ' HG2' ' HB1' ' A' ' 72' ' ' ALA . 48.1 mtm105 -101.81 156.08 17.73 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.046 0.939 . . . . 0.0 108.83 173.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -137.52 160.85 37.98 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.729 0.812 . . . . 0.0 109.059 -172.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -88.99 -24.1 22.47 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 173.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.464 HG22 ' H ' ' A' ' 88' ' ' GLY . 33.2 m -154.6 154.48 33.09 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 124.289 1.036 . . . . 0.0 109.974 -175.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.8 mt -58.85 -32.28 69.29 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.407 1.083 . . . . 0.0 112.272 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.464 ' H ' HG22 ' A' ' 86' ' ' THR . . . -54.15 -38.72 61.93 Favored Glycine 0 N--CA 1.476 1.319 0 O-C-N 123.613 0.571 . . . . 0.0 114.08 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -66.78 -38.24 86.14 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.298 0.639 . . . . 0.0 110.437 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.9 tt -61.27 -57.58 11.77 Favored 'General case' 0 C--O 1.209 -1.068 0 O-C-N 124.088 0.867 . . . . 0.0 110.306 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 30.9 mm -55.83 -45.28 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 C-N-CA 123.171 0.588 . . . . 0.0 112.099 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.8 -52.23 49.95 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.854 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 61.2 tp -69.09 -43.62 74.18 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.897 0.879 . . . . 0.0 111.526 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.451 ' HB3' HD13 ' A' ' 101' ' ' LEU . 41.8 m-85 -86.69 9.35 19.06 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.547 1.139 . . . . 0.0 112.841 -175.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.88 2.01 2.94 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 157.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -102.82 126.77 31.71 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 124.135 0.974 . . . . 0.0 111.013 174.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -71.7 -178.03 2.84 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.99 2.46 . . . . 0.0 112.802 171.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.5 t30 55.55 28.58 12.03 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 125.049 1.34 . . . . 0.0 111.93 -177.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -141.95 23.76 2.04 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.168 0.587 . . . . 0.0 111.323 -172.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 122.43 -39.15 2.36 Favored Glycine 0 C--N 1.347 1.163 0 C-N-CA 123.018 0.342 . . . . 0.0 112.355 174.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.451 HD13 ' HB3' ' A' ' 94' ' ' TYR . 19.5 mt -90.56 126.57 35.98 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 122.837 0.455 . . . . 0.0 110.899 -174.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.6 m -24.48 -47.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 C-N-CA 126.944 2.098 . . . . 0.0 115.186 176.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 46.2 t -160.91 29.76 0.15 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.537 0.735 . . . . 0.0 109.343 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 69.92 -177.17 0.21 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.624 1.17 . . . . 0.0 112.211 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.4 mt -85.94 101.33 12.79 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.841 177.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 75.6 mt -99.03 -58.95 1.82 Allowed 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -173.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.4 mp -119.05 103.48 47.76 Favored Pre-proline 0 N--CA 1.5 2.031 0 CA-C-N 118.879 0.763 . . . . 0.0 111.001 -174.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.14 115.22 4.27 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.883 2.389 . . . . 0.0 112.439 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 C--O 1.251 1.143 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -176.943 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.4 ttm . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.08 61.94 0.93 Allowed Glycine 0 C--N 1.349 1.25 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 -70.48 85.88 0.62 Allowed 'General case' 0 CA--C 1.553 1.087 0 CA-C-O 121.411 0.624 . . . . 0.0 111.002 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -169.59 100.61 0.33 Allowed 'General case' 0 C--N 1.349 0.56 0 C-N-CA 124.131 0.972 . . . . 0.0 109.102 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -125.57 13.63 8.12 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.677 0.791 . . . . 0.0 110.784 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -96.65 104.91 16.94 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 173.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -139.99 74.46 1.47 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 172.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.7 t60 -99.94 113.08 25.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.804 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.4 p -110.88 156.17 21.55 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.89 0.876 . . . . 0.0 109.502 174.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -171.71 -40.78 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.554 0.742 . . . . 0.0 109.222 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.4 mpt? 60.89 -175.86 0.12 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.096 1.358 . . . . 0.0 112.031 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 p -168.8 160.67 10.58 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.815 0.446 . . . . 0.0 111.709 -173.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.484 ' HB2' ' HA ' ' A' ' 37' ' ' LEU . 4.3 p-90 -79.93 -18.57 50.14 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 170.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.431 ' HE2' ' HD3' ' A' ' 16' ' ' ARG . 37.3 t80 -80.82 97.35 7.32 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 18' ' ' LEU . 96.4 m-70 -98.04 119.42 36.65 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.511 0.724 . . . . 0.0 110.143 -175.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.431 ' HD3' ' HE2' ' A' ' 14' ' ' TYR . 21.1 mmm180 -92.26 -9.46 42.05 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.915 1.286 . . . . 0.0 111.748 -178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -108.93 -9.42 15.13 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.55 0.74 . . . . 0.0 110.778 -174.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 15' ' ' HIS . 0.9 OUTLIER -113.27 131.07 56.06 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.317 1.047 . . . . 0.0 110.782 -166.686 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.5 p -88.92 -176.93 5.35 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.255 1.022 . . . . 0.0 111.128 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.64 ' HG3' HG23 ' A' ' 60' ' ' THR . 62.1 ttt180 -62.09 -50.38 72.15 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.997 0.919 . . . . 0.0 111.621 174.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.32 -43.99 92.62 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.125 0.57 . . . . 0.0 110.876 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.25 -30.12 70.97 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.86 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.4 -57.51 7.27 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.04 0.536 . . . . 0.0 109.882 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.421 ' HG2' HG13 ' A' ' 58' ' ' VAL . 36.5 mt-10 -53.45 -43.74 68.32 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.606 1.163 . . . . 0.0 111.674 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -67.29 -57.95 5.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.547 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.7 tt -61.86 -33.32 73.98 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.88 -174.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.483 HD22 ' HB2' ' A' ' 35' ' ' SER . 82.7 mt -67.68 -44.82 76.86 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.63 -27.58 69.04 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.71 0.804 . . . . 0.0 112.024 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -86.51 -48.97 7.92 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 122.997 0.519 . . . . 0.0 111.256 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.76 -59.2 2.87 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.598 0.759 . . . . 0.0 111.805 -170.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.525 ' HA3' ' HB3' ' A' ' 35' ' ' SER . . . -96.14 -46.35 2.63 Favored Glycine 0 C--N 1.346 1.084 0 O-C-N 123.044 0.215 . . . . 0.0 113.104 -175.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 50.48 26.04 2.2 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 125.842 1.657 . . . . 0.0 113.086 -175.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.0 t70 177.22 97.85 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -173.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.627 ' HA3' HD13 ' A' ' 106' ' ' LEU . . . 72.31 20.66 79.36 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-O 120.985 0.214 . . . . 0.0 113.332 174.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.525 ' HB3' ' HA3' ' A' ' 31' ' ' GLY . 5.7 p -81.59 124.08 29.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.961 0.904 . . . . 0.0 109.431 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -128.37 159.29 35.81 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.931 0.492 . . . . 0.0 110.016 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.484 ' HA ' ' HB2' ' A' ' 13' ' ' TRP . 4.1 pp -156.83 164.16 38.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.042 0.937 . . . . 0.0 109.842 169.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 47.3 t -122.81 154.34 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 173.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -155.77 -173.97 4.76 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.851 1.26 . . . . 0.0 108.803 -176.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -91.4 121.49 33.17 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 174.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.8 t -59.19 160.38 6.45 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 122.116 0.96 . . . . 0.0 113.271 -172.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.34 -29.64 4.11 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.209 1.804 . . . . 0.0 108.545 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.7 m -66.38 -38.71 88.16 Favored 'General case' 0 C--N 1.353 0.761 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.976 173.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.3 t -127.49 119.9 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.017 0.927 . . . . 0.0 108.76 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.45 134.07 51.73 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.435 0.694 . . . . 0.0 111.35 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.21 -1.82 88.06 Favored Glycine 0 C--N 1.348 1.214 0 O-C-N 123.176 0.298 . . . . 0.0 112.931 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -101.67 177.68 4.84 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.101 0.96 . . . . 0.0 111.615 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.592 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 44.7 m-85 -111.56 155.52 23.19 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.683 0.793 . . . . 0.0 109.328 175.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.66 142.94 50.63 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.821 0.848 . . . . 0.0 110.147 174.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.488 ' HB2' HD11 ' A' ' 63' ' ' ILE . 26.6 tp -117.09 113.48 22.36 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 42.2 t -103.99 118.85 37.66 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.8 t -125.28 137.09 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -176.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.462 HD12 HG22 ' A' ' 58' ' ' VAL . 27.0 tp -111.9 137.39 49.93 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.879 0.871 . . . . 0.0 110.216 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.53 ' HB2' ' HB2' ' A' ' 103' ' ' CYS . 88.8 t80 -142.0 103.42 4.31 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.395 1.078 . . . . 0.0 108.354 173.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 43.5 70.95 0.27 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.133 1.373 . . . . 0.0 113.212 172.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 79.9 tttt 55.68 38.23 29.87 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 124.891 1.276 . . . . 0.0 111.938 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -141.82 102.92 4.25 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 170.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.462 HG22 HD12 ' A' ' 53' ' ' LEU . 17.2 t -102.51 129.51 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -119.15 147.18 44.48 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.172 0.589 . . . . 0.0 109.578 170.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.64 HG23 ' HG3' ' A' ' 20' ' ' ARG . 17.7 p -117.37 132.82 56.51 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -123.54 107.03 11.1 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -171.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.485 ' H ' ' HD3' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -59.83 155.35 16.42 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 171.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.592 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 77.4 mt -146.86 111.74 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 102.742 -3.058 . . . . 0.0 102.742 -162.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.1 mp -91.54 113.68 59.39 Favored Pre-proline 0 N--CA 1.468 0.462 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -165.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.84 -34.17 82.92 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.409 2.739 . . . . 0.0 111.392 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.8 t70 58.55 93.91 0.03 OUTLIER 'General case' 0 C--N 1.364 1.224 0 C-N-CA 125.101 1.361 . . . . 0.0 111.578 166.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -54.95 80.22 0.01 OUTLIER Glycine 0 C--N 1.35 1.322 0 N-CA-C 115.668 1.027 . . . . 0.0 115.668 -174.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -153.07 -85.69 0.07 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 170.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -160.42 6.04 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 174.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -131.09 147.6 52.64 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.202 -0.937 . . . . 0.0 112.513 -174.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -120.73 129.8 53.78 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.947 1.299 . . . . 0.0 109.015 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.36 149.1 39.9 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.218 0.607 . . . . 0.0 110.271 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.7 t -89.23 130.11 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -108.13 130.81 55.09 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -171.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.9 t -137.47 -178.86 5.41 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.387 -170.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.2 t -69.8 6.22 1.25 Allowed 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -167.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 71.46 139.33 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.852 1.261 . . . . 0.0 111.127 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 113.73 -61.12 0.35 Allowed Glycine 0 C--N 1.342 0.863 0 N-CA-C 106.351 -2.7 . . . . 0.0 106.351 -175.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.467 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 4.3 m -63.63 116.47 26.48 Favored Pre-proline 0 CA--C 1.557 1.213 0 CA-C-N 113.891 -1.154 . . . . 0.0 109.327 156.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 4.7 Cg_exo -75.04 99.07 1.22 Allowed 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.362 2.708 . . . . 0.0 114.356 -168.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 75.4 t -35.8 120.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 123.936 0.895 . . . . 0.0 112.893 158.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 27.9 mmt85 -112.62 142.36 45.3 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 124.345 1.058 . . . . 0.0 108.869 176.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.8 ptt85 -97.81 142.59 29.38 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.544 0.738 . . . . 0.0 111.139 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.477 ' HE2' ' HE2' ' A' ' 94' ' ' TYR . 56.1 m-85 -133.97 163.26 29.93 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.679 1.192 . . . . 0.0 108.679 -176.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -140.15 62.89 1.49 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.095 0.474 . . . . 0.0 109.723 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.403 HG23 ' H ' ' A' ' 89' ' ' GLU . 7.6 t 149.76 133.75 0.0 OUTLIER 'General case' 0 C--N 1.362 1.151 0 C-N-CA 127.301 2.24 . . . . 0.0 106.969 -172.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.86 -29.46 68.31 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.698 0.799 . . . . 0.0 111.941 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -51.2 -46.57 51.23 Favored Glycine 0 C--N 1.353 1.477 0 O-C-N 123.872 0.732 . . . . 0.0 114.473 175.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.403 ' H ' HG23 ' A' ' 86' ' ' THR . 49.3 mm-40 -75.82 -29.85 58.81 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.637 0.375 . . . . 0.0 111.602 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.62 -63.29 1.1 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.438 0.695 . . . . 0.0 109.218 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.415 ' HA ' HD11 ' A' ' 105' ' ' LEU . 36.1 mm -60.28 -39.39 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.129 0.972 . . . . 0.0 111.177 178.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.84 -47.26 87.59 Favored Glycine 0 C--N 1.348 1.204 0 O-C-N 124.212 0.945 . . . . 0.0 113.753 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 34.8 tp -77.79 -43.36 30.89 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.58 0.352 . . . . 0.0 111.287 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.521 ' HB3' HD13 ' A' ' 101' ' ' LEU . 31.9 m-85 -80.74 -1.56 43.3 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -173.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.26 -8.87 56.52 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.174 0.511 . . . . 0.0 110.596 165.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.71 119.24 52.17 Favored Pre-proline 0 CA--C 1.56 1.346 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 175.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -72.69 -166.47 0.28 Allowed 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.128 2.552 . . . . 0.0 114.281 -171.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 56.98 44.56 22.69 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.921 1.288 . . . . 0.0 111.707 -175.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -131.95 8.46 4.44 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.114 -177.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 119.37 -19.6 9.86 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 112.214 -0.355 . . . . 0.0 112.214 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.521 HD13 ' HB3' ' A' ' 94' ' ' TYR . 64.8 mt -79.46 135.78 36.75 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.437 0.695 . . . . 0.0 111.869 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.2 m -59.74 -33.28 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.85 0.86 . . . . 0.0 110.617 171.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.53 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 53.9 t -144.55 151.02 38.48 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.401 1.08 . . . . 0.0 109.224 175.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.43 153.28 44.06 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.415 HD11 ' HA ' ' A' ' 91' ' ' ILE . 69.5 mt -69.59 95.72 0.87 Allowed 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 120.801 0.334 . . . . 0.0 110.176 -178.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.627 HD13 ' HA3' ' A' ' 34' ' ' GLY . 84.0 mt -100.67 -67.14 0.87 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.309 1.044 . . . . 0.0 110.938 -176.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.0 tt -106.37 113.75 62.93 Favored Pre-proline 0 N--CA 1.481 1.108 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -166.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.22 -37.05 76.97 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 123.496 2.797 . . . . 0.0 113.128 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.4 t . . . . . 0 C--O 1.257 1.464 0 C-N-CA 124.699 1.2 . . . . 0.0 110.252 -179.867 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -117.78 76.9 0.29 Allowed Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.4 m170 -110.23 149.36 30.25 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.758 0.823 . . . . 0.0 110.527 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.7 p-80 -157.93 -73.47 0.09 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.828 0.851 . . . . 0.0 109.528 172.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 47.0 t60 39.89 78.8 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 125.637 1.575 . . . . 0.0 113.906 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -137.52 146.31 44.0 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.345 0.658 . . . . 0.0 109.803 176.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -105.48 62.79 0.68 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 172.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -92.13 143.72 26.16 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.567 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.3 t 69.49 121.19 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.961 1.304 . . . . 0.0 111.863 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 59.2 m80 -137.16 101.98 4.7 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.963 0.905 . . . . 0.0 108.715 174.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.2 ttt -74.4 95.02 2.64 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.0 t -169.59 163.18 10.15 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.936 0.894 . . . . 0.0 109.523 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -74.9 -27.18 60.12 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.45 168.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -77.42 121.16 23.42 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.07 0.462 . . . . 0.0 109.803 -174.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.423 ' O ' ' HA ' ' A' ' 39' ' ' ARG . 91.4 m-70 -138.86 131.71 29.32 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 175.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.2 mtm180 -63.59 139.92 58.82 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 168.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -26.25 83.16 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 116.635 2.087 . . . . 0.0 116.635 -166.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 pp -66.17 -19.0 65.7 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.107 165.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.4 t 100.24 138.87 0.01 OUTLIER 'General case' 0 C--N 1.372 1.548 0 C-N-CA 127.489 2.315 . . . . 0.0 110.198 173.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -63.47 -45.02 92.69 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.655 0.782 . . . . 0.0 112.156 -176.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.17 -49.96 65.59 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.142 0.577 . . . . 0.0 110.67 173.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.83 -24.2 63.42 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.68 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.49 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -68.44 -58.47 4.29 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.814 0.845 . . . . 0.0 110.887 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.456 ' HG2' HG11 ' A' ' 58' ' ' VAL . 45.8 mt-10 -53.38 -38.25 63.18 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.02 0.928 . . . . 0.0 111.706 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -71.23 -44.9 64.44 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.078 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 33.4 tp -59.98 -43.42 95.15 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.061 0.944 . . . . 0.0 111.068 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 23' ' ' ALA . 94.6 mt -65.85 -49.88 66.59 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.523 0.729 . . . . 0.0 109.235 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.21 -34.24 73.38 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.066 0.946 . . . . 0.0 112.388 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -82.79 -50.49 8.61 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.244 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.48 -61.85 1.87 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.318 -171.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.82 -60.02 0.56 Allowed Glycine 0 C--N 1.352 1.467 0 CA-C-N 117.902 0.319 . . . . 0.0 113.548 -171.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 50.09 40.7 22.21 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.943 1.697 . . . . 0.0 113.817 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -170.31 83.83 0.11 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -171.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.81 22.9 78.29 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -177.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.2 m -87.0 119.82 27.61 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.017 0.927 . . . . 0.0 109.073 -171.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 19.2 p90 -131.89 158.56 41.04 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.011 0.434 . . . . 0.0 110.695 -175.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.49 HD12 ' HB2' ' A' ' 23' ' ' ALA . 4.1 pp -156.86 165.28 36.64 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.256 170.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.3 t -121.58 129.33 75.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 15' ' ' HIS . 3.7 ptm180 -125.57 163.36 22.9 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.252 1.021 . . . . 0.0 109.365 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -91.78 120.07 32.17 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.3 m -91.43 100.88 13.57 Favored 'General case' 0 C--O 1.247 0.953 0 C-N-CA 122.759 0.424 . . . . 0.0 110.565 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -62.64 94.92 0.07 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.47 0.652 . . . . 0.0 110.394 163.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.3 t -151.85 -55.88 0.14 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.9 m -125.66 149.2 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 165.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 8.79 -80.0 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 127.249 2.22 . . . . 0.0 115.334 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.18 79.88 0.21 Allowed Glycine 0 C--N 1.351 1.382 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.31 165.95 14.64 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 171.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -117.22 163.73 15.86 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.104 0.561 . . . . 0.0 111.031 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.62 146.75 46.4 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.052 0.941 . . . . 0.0 110.252 168.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.49 HD23 HD21 ' A' ' 90' ' ' LEU . 46.3 tp -116.7 114.91 24.69 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 176.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 61.0 m -101.05 116.26 32.43 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.4 t -119.17 124.07 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.472 HD13 ' H ' ' A' ' 54' ' ' TYR . 23.5 tp -119.54 145.16 46.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.021 0.928 . . . . 0.0 110.335 -177.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.472 ' H ' HD13 ' A' ' 53' ' ' LEU . 25.1 t80 -154.74 126.14 7.37 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 172.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 35.79 73.71 0.08 Allowed 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 78.6 tttt 52.26 35.85 18.02 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 125.086 1.355 . . . . 0.0 113.768 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -143.58 104.39 4.21 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 121.759 -0.588 . . . . 0.0 110.49 165.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.456 HG11 ' HG2' ' A' ' 24' ' ' GLU . 20.1 t -93.05 129.25 43.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 172.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -118.24 133.37 55.95 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 168.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.8 m -120.99 141.99 50.2 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -174.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.494 ' HH ' ' HA ' ' A' ' 101' ' ' LEU . 48.5 m-85 -128.67 99.7 5.45 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -170.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -76.95 103.57 6.96 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.471 HG23 ' HB2' ' A' ' 71' ' ' LEU . 4.0 mp -67.87 108.19 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.228 172.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.3 tp -110.1 108.95 59.04 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -174.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 14.5 Cg_exo -69.88 -57.39 0.12 Allowed 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.555 2.17 . . . . 0.0 112.439 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.8 t70 80.49 -70.39 0.09 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.965 1.306 . . . . 0.0 109.406 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.37 -38.35 80.66 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 168.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.503 ' HG2' ' HB2' ' A' ' 65' ' ' PRO . 48.7 mt-10 84.14 24.66 0.11 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.283 1.433 . . . . 0.0 113.304 164.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -103.82 -37.42 7.45 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 164.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -116.49 134.73 54.52 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.106 0.962 . . . . 0.0 109.256 170.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -105.71 111.92 24.79 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.965 0.906 . . . . 0.0 109.005 175.661 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . . . -99.01 132.42 44.33 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.92 0.488 . . . . 0.0 110.988 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.54 HG22 ' HG ' ' A' ' 90' ' ' LEU . 11.2 t -87.24 118.27 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.163 176.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -81.31 92.09 6.32 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.0 m -72.23 -42.85 65.24 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.794 -175.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.489 ' HB3' HG21 ' A' ' 79' ' ' VAL . 48.1 t 173.98 141.94 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.385 1.474 . . . . 0.0 109.019 169.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -74.63 86.82 2.14 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 168.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.95 -22.85 0.31 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -167.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.489 HG21 ' HB3' ' A' ' 76' ' ' SER . 32.6 m -128.31 157.84 73.25 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 124.033 0.933 . . . . 0.0 109.066 175.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.71 126.62 21.64 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.268 2.645 . . . . 0.0 113.312 172.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.467 HG11 ' O ' ' A' ' 73' ' ' VAL . 54.6 t -101.52 134.76 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.169 1.387 . . . . 0.0 108.521 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -111.5 137.77 48.89 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.336 0.654 . . . . 0.0 110.901 -172.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 48.4 ptt85 -96.5 150.44 20.62 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.805 0.842 . . . . 0.0 108.856 173.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -138.72 164.57 29.22 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.499 0.72 . . . . 0.0 109.442 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -111.63 -13.43 13.78 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.187 0.595 . . . . 0.0 110.142 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.577 HG23 ' H ' ' A' ' 88' ' ' GLY . 59.6 m -148.7 147.1 28.49 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.511 0.724 . . . . 0.0 109.214 -174.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.33 -28.68 69.87 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.179 0.592 . . . . 0.0 111.178 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.577 ' H ' HG23 ' A' ' 86' ' ' THR . . . -63.0 -36.34 93.33 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 122.987 0.327 . . . . 0.0 113.138 173.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.467 ' HG2' ' HB ' ' A' ' 86' ' ' THR . 33.1 mm-40 -62.07 -47.03 86.47 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.691 0.797 . . . . 0.0 110.22 175.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.54 ' HG ' HG22 ' A' ' 73' ' ' VAL . 4.8 tt -50.48 -61.55 2.12 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.25 1.42 . . . . 0.0 109.932 173.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 47.1 mm -60.99 -27.48 41.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.448 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.09 -60.58 8.77 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 123.634 0.584 . . . . 0.0 113.48 175.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.1 mt -74.46 -32.7 62.69 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.401 ' HB3' HD11 ' A' ' 101' ' ' LEU . 3.3 m-85 -82.19 -21.74 36.32 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.843 0.457 . . . . 0.0 112.176 -172.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.96 -17.28 63.11 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 168.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -132.45 69.3 79.94 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 124.651 1.18 . . . . 0.0 108.696 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.44 -81.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.233 1.955 . . . . 0.0 113.839 -168.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 90.08 -90.45 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.48 1.912 . . . . 0.0 106.821 -170.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -79.93 144.05 33.68 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 122.916 0.486 . . . . 0.0 111.912 170.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.82 -59.13 0.37 Allowed Glycine 0 C--N 1.35 1.315 0 C-N-CA 123.391 0.519 . . . . 0.0 113.176 166.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.494 ' HA ' ' HH ' ' A' ' 61' ' ' TYR . 24.7 mt -82.13 164.88 21.01 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -174.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.5 m -84.02 -24.37 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 CA-C-N 114.673 -1.148 . . . . 0.0 109.943 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 52.2 t -164.92 167.53 18.52 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 125.12 1.368 . . . . 0.0 108.745 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -77.36 170.68 16.12 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 120.93 0.395 . . . . 0.0 109.958 172.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.7 mt -81.53 97.46 7.83 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 175.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.9 mp -92.6 -57.93 2.52 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.017 0.927 . . . . 0.0 110.478 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 61.7 tp -131.09 107.06 14.96 Favored Pre-proline 0 N--CA 1.479 1.02 0 C-N-CA 123.379 0.671 . . . . 0.0 110.974 -165.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.99 124.12 10.3 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.368 2.045 . . . . 0.0 110.301 170.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 32.7 t . . . . . 0 CA--C 1.552 1.031 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -172.032 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.501 0.191 . . . . 0.0 110.65 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.09 70.74 1.12 Allowed Glycine 0 C--N 1.349 1.252 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.899 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -149.87 119.19 6.84 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.005 0.522 . . . . 0.0 109.77 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -158.7 113.6 2.54 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.098 0.559 . . . . 0.0 110.581 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -127.2 171.04 11.78 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.501 1.12 . . . . 0.0 108.907 166.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -164.1 102.1 0.87 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.309 0.643 . . . . 0.0 109.66 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -131.0 53.34 1.99 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.875 0.87 . . . . 0.0 108.729 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -86.22 -66.8 0.86 Allowed 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.862 -172.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 p -150.77 88.23 1.47 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.382 0.673 . . . . 0.0 110.762 -173.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 42.4 m170 -132.2 103.53 6.29 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.993 0.917 . . . . 0.0 109.971 177.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 56.9 ttp -120.65 -9.21 9.4 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.076 0.95 . . . . 0.0 109.461 170.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.9 p -72.47 166.3 22.88 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 123.474 0.709 . . . . 0.0 111.672 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 108' ' ' PRO . 1.9 p-90 -86.3 10.4 14.93 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.889 0.876 . . . . 0.0 112.761 -176.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.406 ' HA ' ' HB ' ' A' ' 38' ' ' VAL . 17.8 t80 -118.03 134.82 54.62 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -174.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.401 ' O ' ' HA ' ' A' ' 39' ' ' ARG . 71.2 m-70 -137.18 171.89 13.82 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.739 0.816 . . . . 0.0 110.276 178.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.4 171.99 16.64 Favored 'General case' 0 C--O 1.245 0.817 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 164.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 74.55 3.95 4.35 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.677 1.191 . . . . 0.0 110.209 -172.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.3 tp -105.98 120.52 41.97 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 125.956 1.702 . . . . 0.0 107.999 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.4 m -82.49 170.15 15.57 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.524 0.73 . . . . 0.0 110.41 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.497 HH11 ' HG2' ' A' ' 24' ' ' GLU . 4.7 tmm_? -58.97 -55.88 29.48 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.408 0.683 . . . . 0.0 110.764 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.81 -44.01 73.43 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.121 0.888 . . . . 0.0 111.084 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.02 -36.06 82.77 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.521 0.729 . . . . 0.0 112.185 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.523 ' HB3' HD13 ' A' ' 37' ' ' LEU . . . -65.22 -56.5 12.46 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.824 0.85 . . . . 0.0 111.608 -176.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.497 ' HG2' HH11 ' A' ' 20' ' ' ARG . 0.0 OUTLIER -69.12 -24.64 64.13 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.879 -179.171 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 31.8 mt-10 -64.86 -55.66 18.11 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 169.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.12 -23.49 47.5 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.494 0.717 . . . . 0.0 112.828 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.9 mt -71.86 -52.79 15.63 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 168.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.98 -21.48 50.83 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -168.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 30.5 mmt180 -74.42 -42.25 59.49 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 118.246 0.475 . . . . 0.0 110.677 176.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.53 -53.45 4.8 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.945 -174.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.27 -159.59 8.41 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.974 -163.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 175.49 138.89 0.05 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.274 1.029 . . . . 0.0 110.493 -171.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 62.6 m-20 96.67 87.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.207 1.403 . . . . 0.0 109.184 159.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.24 16.7 73.55 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.708 -173.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 m -82.49 123.43 29.16 Favored 'General case' 0 C--N 1.346 0.456 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.444 ' CE1' ' HB3' ' A' ' 105' ' ' LEU . 30.9 p90 -131.7 159.22 39.02 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.41 0.624 . . . . 0.0 111.345 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.523 HD13 ' HB3' ' A' ' 23' ' ' ALA . 3.3 pp -150.63 159.99 44.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.165 165.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.406 ' HB ' ' HA ' ' A' ' 14' ' ' TYR . 46.9 t -116.75 150.54 18.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 175.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.469 HH22 ' HG2' ' A' ' 42' ' ' GLU . 20.6 ptt85 -146.59 -179.61 6.89 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -81.64 126.47 31.8 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 167.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 93.7 p -73.12 163.54 27.99 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.752 0.421 . . . . 0.0 110.703 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.469 ' HG2' HH22 ' A' ' 39' ' ' ARG . 10.8 pt-20 -124.61 -16.27 6.31 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.445 0.698 . . . . 0.0 110.6 -177.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.0 m -68.46 -30.17 68.97 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.884 0.874 . . . . 0.0 111.057 172.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.469 HG11 ' HB3' ' A' ' 47' ' ' ALA . 1.8 p -145.99 117.5 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 124.192 0.997 . . . . 0.0 109.683 -175.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.03 132.63 49.73 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.447 1.099 . . . . 0.0 112.056 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.84 11.94 80.66 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.347 0.404 . . . . 0.0 113.708 177.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.469 ' HB3' HG11 ' A' ' 44' ' ' VAL . . . -118.59 178.06 4.6 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.739 0.816 . . . . 0.0 111.717 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.461 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 32.9 m-85 -114.7 166.78 11.38 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.592 0.757 . . . . 0.0 111.286 -176.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.42 145.61 41.17 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.012 0.925 . . . . 0.0 110.233 169.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.471 ' HB2' HD13 ' A' ' 63' ' ' ILE . 51.7 tp -121.5 114.3 21.04 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.99 1.316 . . . . 0.0 108.33 -176.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 36.2 t -108.68 122.12 46.45 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.276 1.03 . . . . 0.0 108.62 -174.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.2 t -129.54 115.61 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 123.452 0.701 . . . . 0.0 110.366 -171.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.2 tp -94.83 136.89 34.6 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.564 1.146 . . . . 0.0 110.132 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 60.2 t80 -163.02 122.5 2.19 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.313 1.045 . . . . 0.0 109.206 175.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 40.58 61.12 1.71 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.327 1.851 . . . . 0.0 113.6 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 62.41 30.08 17.27 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.57 1.148 . . . . 0.0 113.042 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -138.33 106.88 5.85 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.236 0.614 . . . . 0.0 109.548 177.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.3 t -101.66 114.64 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -105.79 126.3 52.01 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.0 m -113.02 136.02 53.15 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -127.99 110.35 12.44 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.874 0.87 . . . . 0.0 109.107 -171.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.436 ' H ' ' HD2' ' A' ' 62' ' ' ARG . 0.1 OUTLIER -59.55 157.0 12.27 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 169.446 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.471 HD13 ' HB2' ' A' ' 50' ' ' LEU . 90.7 mt -146.19 102.66 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 103.686 -2.709 . . . . 0.0 103.686 -162.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.7 mp -114.97 140.65 25.81 Favored Pre-proline 0 N--CA 1.475 0.804 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -166.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -58.58 -70.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 121.915 1.743 . . . . 0.0 109.274 164.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.0 t70 58.53 15.94 3.91 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.133 1.373 . . . . 0.0 112.639 167.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.38 137.38 3.77 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -34.08 -45.76 0.22 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 -165.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -113.21 -16.25 12.59 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -164.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.41 ' HB2' ' HB2' ' A' ' 83' ' ' ARG . 44.4 p90 -125.98 160.88 28.85 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.967 -0.458 . . . . 0.0 111.74 -167.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 pp -121.73 118.36 28.9 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.525 1.53 . . . . 0.0 107.144 166.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -111.95 148.48 33.65 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.735 0.779 . . . . 0.0 110.011 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.8 t -122.85 131.32 73.48 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -78.65 94.55 5.07 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.471 HG22 ' HA3' ' A' ' 100' ' ' GLY . 2.0 m -70.78 -63.06 1.17 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.059 -176.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.443 ' HB2' HG23 ' A' ' 79' ' ' VAL . 73.5 m -163.19 113.66 1.39 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.248 1.419 . . . . 0.0 107.62 170.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -68.62 97.41 0.79 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 170.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.16 -22.7 0.87 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -163.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.443 HG23 ' HB2' ' A' ' 76' ' ' SER . 22.5 m -129.84 153.21 80.87 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 125.375 1.47 . . . . 0.0 107.075 170.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -54.47 124.69 16.73 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.386 2.057 . . . . 0.0 112.8 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.6 t -86.09 140.32 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -102.11 136.21 42.35 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.031 0.533 . . . . 0.0 109.908 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.41 ' HB2' ' HB2' ' A' ' 70' ' ' PHE . 14.6 ptp180 -87.35 138.76 31.21 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 163.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -119.7 143.25 47.86 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.747 0.819 . . . . 0.0 109.277 176.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -84.66 -22.24 29.93 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.091 0.472 . . . . 0.0 110.43 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.663 ' HB ' ' HG2' ' A' ' 89' ' ' GLU . 51.0 m -141.79 149.01 39.83 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.74 0.816 . . . . 0.0 109.767 -177.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.24 -30.73 71.64 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.596 0.759 . . . . 0.0 109.525 176.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.567 ' H ' HG23 ' A' ' 86' ' ' THR . . . -53.92 -41.79 68.57 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-N 116.099 -0.501 . . . . 0.0 113.582 169.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.663 ' HG2' ' HB ' ' A' ' 86' ' ' THR . 31.0 mm-40 -71.45 -32.23 68.09 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.273 0.629 . . . . 0.0 110.7 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 46.5 tp -59.04 -59.25 5.77 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.318 0.647 . . . . 0.0 111.011 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 51.6 mm -62.25 -37.16 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.999 0.919 . . . . 0.0 111.004 -176.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.13 -51.73 53.91 Favored Glycine 0 CA--C 1.535 1.331 0 O-C-N 124.153 0.908 . . . . 0.0 113.292 174.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.0 mt -78.99 -23.17 44.6 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.091 0.556 . . . . 0.0 112.216 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -83.33 -18.31 39.39 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.03 -35.15 76.29 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.527 0.331 . . . . 0.0 110.539 170.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -127.0 76.42 76.0 Favored Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 124.371 1.068 . . . . 0.0 108.602 175.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -92.49 -66.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 123.363 2.708 . . . . 0.0 114.421 -169.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 59.66 55.84 3.85 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 124.845 1.258 . . . . 0.0 111.266 -173.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 160.45 97.87 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 126.734 2.014 . . . . 0.0 109.706 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.471 ' HA3' HG22 ' A' ' 75' ' ' THR . . . 104.33 -37.35 3.82 Favored Glycine 0 C--N 1.355 1.617 0 N-CA-C 113.758 0.263 . . . . 0.0 113.758 164.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -76.52 122.45 24.59 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.841 0.456 . . . . 0.0 110.829 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.2 m -52.73 -32.45 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 125.544 1.537 . . . . 0.0 114.19 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 36.4 t -153.54 3.31 0.28 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.108 0.563 . . . . 0.0 111.19 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 76.04 177.37 0.19 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.902 1.281 . . . . 0.0 110.669 -167.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.444 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 26.7 mt -93.05 103.39 15.7 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.51 -53.35 6.04 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.562 0.745 . . . . 0.0 111.03 -176.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.22 137.32 9.86 Favored Pre-proline 0 N--CA 1.483 1.222 0 C-N-CA 122.167 0.187 . . . . 0.0 111.199 -175.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.467 ' HB3' ' HB3' ' A' ' 13' ' ' TRP . 97.1 Cg_endo -78.79 137.08 13.9 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.333 2.022 . . . . 0.0 111.875 171.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 57.0 t . . . . . 0 CA--C 1.547 0.857 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.293 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 87.25 129.79 2.9 Favored Glycine 0 C--N 1.349 1.259 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -173.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -74.22 -25.43 59.66 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.82 0.448 . . . . 0.0 110.443 177.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 43.1 t60 63.81 15.83 9.35 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 125.299 1.44 . . . . 0.0 112.182 172.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -107.31 27.18 9.33 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -66.52 112.21 3.99 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 124.155 0.982 . . . . 0.0 110.504 -174.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -136.29 64.4 1.56 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.136 0.974 . . . . 0.0 108.445 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -141.81 119.06 11.42 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.762 0.825 . . . . 0.0 110.239 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 75.6 p -134.53 -14.84 2.18 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.342 1.057 . . . . 0.0 111.164 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.3 m170 65.6 107.68 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.487 1.515 . . . . 0.0 111.721 -176.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 43.2 ttm -95.54 21.65 8.0 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.793 0.806 . . . . 0.0 110.631 -177.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.6 p -75.14 -165.88 0.44 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 163.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -84.77 0.87 49.11 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.056 -1.027 . . . . 0.0 110.435 171.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -110.91 111.53 22.73 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -119.03 115.0 23.39 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 176.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -39.71 -49.31 2.26 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 125.565 1.546 . . . . 0.0 113.722 -172.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -156.96 70.55 0.64 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-O 122.312 1.053 . . . . 0.0 108.578 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.423 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 21.9 tp -64.77 -32.18 73.74 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 113.658 -1.61 . . . . 0.0 109.464 165.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.0 t 88.31 141.82 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 126.014 1.726 . . . . 0.0 107.944 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -60.83 -43.02 98.84 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.213 0.605 . . . . 0.0 112.079 -168.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.83 -48.01 73.09 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.507 0.723 . . . . 0.0 111.72 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 18' ' ' LEU . . . -72.44 -22.58 61.07 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.316 178.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.465 ' O ' ' HG ' ' A' ' 27' ' ' LEU . . . -67.67 -49.83 60.87 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.547 ' HG3' HG23 ' A' ' 58' ' ' VAL . 34.8 tt0 -54.53 -41.24 69.48 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 124.885 1.366 . . . . 0.0 111.296 175.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.0 -50.6 47.39 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.437 -177.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.84 -33.98 73.87 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.091 0.957 . . . . 0.0 111.881 176.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 23' ' ' ALA . 75.4 mt -64.73 -52.84 54.94 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.1 0.56 . . . . 0.0 109.683 175.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.29 -42.47 98.71 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.17 0.988 . . . . 0.0 111.947 -176.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -69.33 -41.33 76.82 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.888 -175.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.35 -62.82 1.39 Allowed 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.02 -38.46 2.89 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 113.886 0.314 . . . . 0.0 113.886 -166.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.84 12.76 0.12 Allowed 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 128.011 2.524 . . . . 0.0 116.28 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.525 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 4.5 m-20 -174.37 118.51 0.23 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -166.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.414 ' HA2' ' SG ' ' A' ' 103' ' ' CYS . . . 63.16 11.02 37.01 Favored Glycine 0 C--N 1.352 1.44 0 N-CA-C 113.906 0.322 . . . . 0.0 113.906 -177.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.9 m -83.69 123.68 30.07 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.142 0.977 . . . . 0.0 110.039 -168.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -135.73 156.38 48.92 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 120.767 0.318 . . . . 0.0 111.439 -176.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.438 HD11 ' HB3' ' A' ' 23' ' ' ALA . 4.4 pp -159.9 158.74 31.41 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 124.709 1.255 . . . . 0.0 109.673 169.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.419 HG23 HD12 ' A' ' 50' ' ' LEU . 21.9 t -114.05 150.65 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.414 HH22 ' HB2' ' A' ' 42' ' ' GLU . 1.7 ptm180 -148.0 177.13 9.61 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.264 1.025 . . . . 0.0 109.207 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -84.4 129.28 34.88 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.3 t -61.18 142.38 56.79 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.48 0.712 . . . . 0.0 112.108 -174.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.414 ' HB2' HH22 ' A' ' 39' ' ' ARG . 32.2 tt0 -107.03 0.24 23.48 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.984 178.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.2 t -104.97 -41.72 5.52 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.207 1.003 . . . . 0.0 110.069 -177.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.478 HG22 HD22 ' A' ' 64' ' ' LEU . 44.7 t -128.11 115.18 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.902 0.881 . . . . 0.0 109.528 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.22 124.63 24.6 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.929 0.891 . . . . 0.0 110.817 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.36 12.06 65.75 Favored Glycine 0 C--N 1.344 0.979 0 O-C-N 123.345 0.403 . . . . 0.0 112.746 -174.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.32 177.0 5.07 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.794 0.838 . . . . 0.0 111.168 172.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.426 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 70.4 m-85 -124.21 166.83 15.16 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.832 1.253 . . . . 0.0 110.254 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.9 147.79 48.31 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.358 1.063 . . . . 0.0 109.526 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.532 ' HB2' HD12 ' A' ' 63' ' ' ILE . 50.2 tp -123.99 123.92 41.45 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.062 1.345 . . . . 0.0 107.51 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 37.1 t -112.29 123.85 51.17 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.9 t -128.73 143.7 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.48 HD12 HG22 ' A' ' 58' ' ' VAL . 48.9 tp -130.3 144.71 51.54 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.113 0.965 . . . . 0.0 108.942 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 84.6 t80 -164.28 122.77 1.83 Allowed 'General case' 0 CA--C 1.537 0.479 0 O-C-N 124.318 1.011 . . . . 0.0 109.005 178.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 17.3 tm0? 41.74 70.07 0.3 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 125.404 1.482 . . . . 0.0 111.561 -177.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt 48.67 25.23 0.93 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 125.586 1.555 . . . . 0.0 114.288 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -131.32 117.36 18.82 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.355 0.662 . . . . 0.0 109.299 -178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.547 HG23 ' HG3' ' A' ' 24' ' ' GLU . 34.1 t -99.53 144.94 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.507 1.123 . . . . 0.0 109.623 -177.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -137.34 119.26 15.28 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 174.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 33.4 m -105.92 114.1 28.04 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -95.65 117.68 30.93 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -177.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 65.6 mtm-85 -62.25 158.37 17.32 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 170.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.532 HD12 ' HB2' ' A' ' 50' ' ' LEU . 76.2 mt -145.32 98.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 102.808 -3.034 . . . . 0.0 102.808 -175.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.478 HD22 HG22 ' A' ' 44' ' ' VAL . 10.6 mp -122.14 148.62 52.38 Favored Pre-proline 0 N--CA 1.477 0.923 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -172.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -44.29 -59.66 1.03 Allowed 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.53 2.153 . . . . 0.0 111.845 172.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.2 t70 47.33 71.5 0.32 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.857 1.263 . . . . 0.0 111.87 174.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.65 -75.95 0.24 Allowed Glycine 0 C--N 1.337 0.631 0 CA-C-O 119.459 -0.634 . . . . 0.0 111.626 -176.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 169.29 -40.44 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.051 1.34 . . . . 0.0 111.405 -175.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -131.35 -13.43 3.43 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -161.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -117.91 163.81 15.99 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.425 1.09 . . . . 0.0 110.443 -167.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.1 mp -104.54 109.34 21.19 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 171.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.43 126.05 42.45 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.192 0.997 . . . . 0.0 109.57 -175.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.5 t -96.09 133.27 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -178.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -94.52 89.32 5.77 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -175.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.473 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 21.2 p -71.04 -66.59 0.59 Allowed 'General case' 0 C--O 1.248 1.006 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.325 175.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.3 t 176.39 174.67 0.34 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.089 1.355 . . . . 0.0 109.945 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -68.01 160.7 28.22 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 123.786 0.834 . . . . 0.0 109.185 167.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.51 -72.54 2.16 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-N 118.451 0.569 . . . . 0.0 112.99 -170.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.1 m -65.6 145.94 99.01 Favored Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 123.662 0.785 . . . . 0.0 110.538 176.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.79 137.56 27.36 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.482 2.121 . . . . 0.0 113.483 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.4 t -69.58 118.12 13.42 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 167.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -98.62 117.38 32.93 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.508 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -100.69 149.99 23.21 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.714 0.806 . . . . 0.0 110.271 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -134.29 162.29 32.59 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.42 0.688 . . . . 0.0 112.399 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -74.08 -46.5 42.62 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.511 170.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 37.9 p -138.34 169.12 18.35 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.618 0.767 . . . . 0.0 110.999 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.462 ' O ' HG12 ' A' ' 91' ' ' ILE . 4.3 mm? -62.21 -34.42 76.44 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.584 0.754 . . . . 0.0 111.058 171.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -53.86 -43.89 70.92 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 122.975 0.172 . . . . 0.0 113.029 175.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -66.38 -36.15 82.13 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.252 0.621 . . . . 0.0 110.611 175.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.8 tt -64.7 -38.6 91.54 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.342 1.057 . . . . 0.0 110.828 -178.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 87' ' ' LEU . 50.3 mm -85.04 -35.54 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -168.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.3 -44.93 32.61 Favored Glycine 0 C--N 1.35 1.331 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.877 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.1 tp -76.11 -32.73 59.32 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.712 0.405 . . . . 0.0 111.239 -178.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.605 ' HB3' ' HG ' ' A' ' 105' ' ' LEU . 3.9 m-30 -78.12 -16.46 57.95 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.757 174.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.42 -2.16 10.33 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.136 0.574 . . . . 0.0 112.102 171.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -128.37 152.14 77.65 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 169.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -28.93 103.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 124.819 3.679 . . . . 0.0 114.967 165.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.458 ' HB3' HD22 ' A' ' 101' ' ' LEU . 8.3 t30 -106.28 -44.7 4.48 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.533 -177.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 107.93 115.78 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 128.184 2.594 . . . . 0.0 108.644 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.473 ' HA3' ' HB ' ' A' ' 75' ' ' THR . . . 110.04 -13.28 31.61 Favored Glycine 0 C--N 1.345 1.04 0 O-C-N 123.747 0.654 . . . . 0.0 112.266 -175.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.458 HD22 ' HB3' ' A' ' 98' ' ' ASN . 3.9 mm? -84.36 138.72 32.72 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.183 0.993 . . . . 0.0 111.699 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.1 p -60.68 -35.64 65.27 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 C-N-CA 124.425 1.09 . . . . 0.0 112.421 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.414 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 29.0 p -163.98 13.62 0.05 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.377 0.671 . . . . 0.0 111.455 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 74.15 176.96 0.24 Allowed 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 124.814 1.246 . . . . 0.0 109.771 -167.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.605 ' HG ' ' HB3' ' A' ' 94' ' ' TYR . 26.6 mt -92.88 113.87 26.27 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 56.1 tp -108.01 -63.32 1.33 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.513 0.725 . . . . 0.0 111.868 -173.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.442 HD21 HG23 ' A' ' 109' ' ' VAL . 5.0 tt -116.58 103.73 52.29 Favored Pre-proline 0 N--CA 1.479 0.999 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -170.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -73.74 119.24 5.8 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.56 2.173 . . . . 0.0 111.158 173.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.442 HG23 HD21 ' A' ' 107' ' ' LEU . 21.1 t . . . . . 0 CA--C 1.553 1.069 0 CA-C-O 118.038 -0.982 . . . . 0.0 108.371 -175.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -169.08 62.91 0.19 Allowed Glycine 0 C--N 1.344 1.025 0 N-CA-C 111.953 -0.459 . . . . 0.0 111.953 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -88.3 94.81 9.96 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 172.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 -70.83 117.7 12.67 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.779 0.832 . . . . 0.0 110.205 -176.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -136.98 46.05 2.21 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.71 0.804 . . . . 0.0 109.556 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -75.98 75.04 2.88 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 172.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -151.19 34.36 0.58 Allowed 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 122.594 1.188 . . . . 0.0 108.694 -172.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -80.62 84.41 6.2 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.359 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.1 m -139.93 88.41 2.23 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.482 0.713 . . . . 0.0 109.577 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -171.42 152.46 3.28 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.884 1.273 . . . . 0.0 108.445 175.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.408 ' SD ' ' N ' ' A' ' 11' ' ' MET . 1.5 mpt? -70.8 83.18 0.64 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.871 0.843 . . . . 0.0 110.32 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.1 t -95.36 99.56 11.46 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.581 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -83.37 -29.1 28.47 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 172.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -74.67 122.75 23.69 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -138.41 93.36 2.73 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.371 0.669 . . . . 0.0 109.394 176.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -62.84 148.98 45.48 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 157.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.6 t70 81.41 -11.47 1.08 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.357 1.063 . . . . 0.0 111.736 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 tp -90.73 122.57 33.6 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.6 m -83.44 158.01 22.24 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.898 0.479 . . . . 0.0 109.851 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -62.58 -47.02 85.63 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -171.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.37 -45.32 80.58 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.416 0.686 . . . . 0.0 111.347 177.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.81 -34.39 76.66 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.86 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.543 ' HB2' HD11 ' A' ' 37' ' ' LEU . . . -66.23 -55.71 14.87 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.76 0.824 . . . . 0.0 111.422 -177.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.493 ' HG2' ' SG ' ' A' ' 51' ' ' CYS . 25.2 mt-10 -64.67 -28.77 69.83 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.521 1.128 . . . . 0.0 111.443 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -62.28 -50.99 69.51 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.462 0.705 . . . . 0.0 109.416 173.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.6 mt -66.77 -28.35 68.33 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.163 0.985 . . . . 0.0 112.077 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.493 HD23 ' HG ' ' A' ' 37' ' ' LEU . 75.0 mt -68.04 -45.01 75.15 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 118.058 0.39 . . . . 0.0 110.176 173.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.2 -26.78 63.09 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.653 0.781 . . . . 0.0 111.22 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -85.97 -60.54 1.98 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.369 0.668 . . . . 0.0 111.484 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.23 -54.92 5.49 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.626 0.771 . . . . 0.0 112.354 -166.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.582 ' HA3' ' HB3' ' A' ' 35' ' ' SER . . . -87.5 -34.1 10.78 Favored Glycine 0 N--CA 1.471 0.967 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 60.25 4.04 0.61 Allowed 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 126.445 1.898 . . . . 0.0 114.827 174.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.3 t70 164.52 133.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.09 1.356 . . . . 0.0 107.788 -171.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.61 -2.27 54.46 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 117.89 0.314 . . . . 0.0 113.579 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.582 ' HB3' ' HA3' ' A' ' 31' ' ' GLY . 1.9 p -82.54 130.37 35.1 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.406 1.082 . . . . 0.0 111.967 -169.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.409 ' CE1' ' HB3' ' A' ' 105' ' ' LEU . 46.2 p90 -127.33 151.93 48.12 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.031 0.532 . . . . 0.0 110.083 174.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' A' ' 23' ' ' ALA . 2.3 pp -144.9 160.89 40.59 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.718 0.807 . . . . 0.0 109.013 166.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.411 HG21 HD12 ' A' ' 87' ' ' LEU . 22.6 t -112.78 153.99 14.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.1 mtm180 -139.99 170.43 15.87 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.075 0.95 . . . . 0.0 109.661 -176.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -87.78 134.54 33.66 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.296 168.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.5 m -62.96 135.45 57.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.911 0.386 . . . . 0.0 111.143 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -102.27 14.88 30.77 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.207 1.003 . . . . 0.0 111.286 -172.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.0 t -147.33 -62.28 0.28 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.374 0.669 . . . . 0.0 109.898 -177.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.9 m -89.32 125.39 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -171.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 24.78 -133.88 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 127.585 2.354 . . . . 0.0 116.466 171.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.45 57.63 0.44 Allowed Glycine 0 C--N 1.358 1.772 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.42 174.15 6.0 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.63 0.772 . . . . 0.0 111.107 -173.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.557 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 81.0 m-85 -114.82 158.73 21.5 Favored 'General case' 0 C--O 1.25 1.083 0 C-N-CA 123.905 0.882 . . . . 0.0 109.827 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.24 141.21 52.23 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.535 1.134 . . . . 0.0 109.214 173.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.564 HD23 HD22 ' A' ' 90' ' ' LEU . 58.9 tp -123.32 115.75 22.19 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.493 ' SG ' ' HG2' ' A' ' 24' ' ' GLU . 45.9 t -114.19 119.08 35.85 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -176.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 5.1 t -127.77 140.56 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.218 0.607 . . . . 0.0 109.4 -170.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.8 tp -122.92 138.47 54.66 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.722 1.209 . . . . 0.0 109.035 -177.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -169.32 136.63 1.78 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.002 0.921 . . . . 0.0 109.622 172.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 47.35 42.49 14.02 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.819 1.248 . . . . 0.0 112.096 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 56.62 45.47 22.09 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.739 1.216 . . . . 0.0 112.641 -173.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -129.6 103.85 7.11 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 171.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 61.6 t -97.65 105.45 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 170.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -112.78 134.12 54.45 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 55.5 m -117.8 142.34 47.4 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.412 0.685 . . . . 0.0 109.453 -175.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -124.74 154.85 40.24 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.54 1.136 . . . . 0.0 108.26 -177.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -102.39 160.98 14.07 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 166.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.641 HG12 HD12 ' A' ' 90' ' ' LEU . 3.7 mp -144.59 101.24 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 103.122 -2.918 . . . . 0.0 103.122 -163.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.1 mp -103.4 137.67 19.32 Favored Pre-proline 0 N--CA 1.481 1.119 0 CA-C-O 119.421 -0.323 . . . . 0.0 110.943 -163.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.63 -138.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 123.452 2.768 . . . . 0.0 111.081 175.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 68' ' ' GLU . 7.1 t70 169.47 -178.09 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 122.97 0.508 . . . . 0.0 110.323 -166.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -88.33 5.35 84.85 Favored Glycine 0 N--CA 1.491 2.342 0 CA-C-O 121.642 0.579 . . . . 0.0 112.337 167.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 66' ' ' ASP . 35.4 mt-10 -142.13 106.28 4.77 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 102.48 -3.156 . . . . 0.0 102.48 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -74.5 88.4 2.13 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 119.591 1.087 . . . . 0.0 111.287 -151.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.513 ' HB3' ' HB3' ' A' ' 83' ' ' ARG . 50.3 m-85 -116.24 138.27 51.44 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 124.398 1.079 . . . . 0.0 108.839 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 84' ' ' PHE . 8.7 mp -96.01 107.32 19.6 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 174.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -104.87 112.38 25.48 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.929 0.892 . . . . 0.0 110.013 -171.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.451 HG21 HG13 ' A' ' 63' ' ' ILE . 12.1 t -101.8 144.59 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.669 -175.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.2 86.9 2.51 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.45 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 4.3 p -80.86 -53.0 6.85 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.676 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.5 m -126.61 169.11 13.44 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.641 0.776 . . . . 0.0 110.536 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -88.11 -3.43 58.89 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.592 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -147.4 39.29 1.05 Allowed Glycine 0 C--N 1.35 1.306 0 CA-C-N 117.93 0.332 . . . . 0.0 113.086 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 m -120.34 151.18 53.17 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 123.73 0.812 . . . . 0.0 108.82 171.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.2 126.49 18.74 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 121.791 1.661 . . . . 0.0 110.557 170.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.6 t -68.95 127.45 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -177.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -98.48 117.97 34.11 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -171.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.513 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 88.3 mtm180 -99.0 126.73 44.77 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.036 0.934 . . . . 0.0 110.187 -173.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.518 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 71.1 m-85 -110.03 147.56 33.32 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.391 0.676 . . . . 0.0 111.781 -175.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -72.01 -38.59 69.58 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.263 0.625 . . . . 0.0 110.34 173.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.401 HG21 ' HG2' ' A' ' 89' ' ' GLU . 8.1 t -146.29 169.5 18.68 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.621 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.411 HD12 HG21 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -62.69 -29.65 70.81 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.937 174.182 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -55.22 -41.37 78.75 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 116.512 -0.313 . . . . 0.0 113.579 171.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.518 ' HB2' ' HB3' ' A' ' 84' ' ' PHE . 53.3 mm-40 -67.9 -39.67 83.59 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.494 0.717 . . . . 0.0 110.644 176.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.641 HD12 HG12 ' A' ' 63' ' ' ILE . 7.1 tt -57.7 -54.96 40.99 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.334 -178.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 40.9 mm -66.26 -34.15 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.297 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.03 -56.92 22.48 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.636 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.36 -40.09 74.24 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.134 0.574 . . . . 0.0 111.016 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.614 ' HA ' HE22 ' A' ' 99' ' ' GLN . 6.5 m-30 -78.21 -7.25 56.88 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -173.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.03 -13.72 58.62 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 122.472 0.309 . . . . 0.0 111.584 164.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -92.25 137.54 24.77 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 124.477 1.111 . . . . 0.0 109.771 173.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.87 175.17 11.72 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.925 2.416 . . . . 0.0 113.917 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.4 t30 58.88 73.06 0.5 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.253 1.421 . . . . 0.0 112.228 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.614 HE22 ' HA ' ' A' ' 94' ' ' TYR . 48.1 mt-30 -142.4 -13.06 0.8 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.337 1.055 . . . . 0.0 111.029 174.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.45 ' HA3' ' HB ' ' A' ' 75' ' ' THR . . . 122.27 -2.63 10.52 Favored Glycine 0 N--CA 1.48 1.629 0 C-N-CA 123.694 0.664 . . . . 0.0 112.005 -169.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 88.5 mt -74.66 168.29 20.11 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.787 1.235 . . . . 0.0 111.114 176.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.5 m -67.26 -47.92 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.412 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.872 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 49.0 t -173.73 40.05 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.348 1.059 . . . . 0.0 109.63 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 78.37 -177.8 0.1 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.088 1.355 . . . . 0.0 111.346 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.409 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 21.9 mt -105.53 99.56 9.16 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 175.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.01 -48.79 3.02 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.907 0.883 . . . . 0.0 111.326 -171.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 35' ' ' SER . 10.5 mp -112.43 124.12 32.66 Favored Pre-proline 0 N--CA 1.484 1.247 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.401 ' HB2' ' H ' ' A' ' 109' ' ' VAL . 14.3 Cg_exo -68.49 -87.14 0.0 OUTLIER 'Trans proline' 0 CA--C 1.556 1.59 0 C-N-CA 121.203 1.268 . . . . 0.0 110.088 167.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.401 ' H ' ' HB2' ' A' ' 108' ' ' PRO . 4.2 t . . . . . 0 C--O 1.25 1.128 0 C-N-CA 124.576 1.15 . . . . 0.0 108.137 177.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.467 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -140.52 142.47 12.41 Favored Glycine 0 C--N 1.343 0.917 0 N-CA-C 112.705 -0.158 . . . . 0.0 112.705 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -85.52 -157.63 0.33 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.377 1.071 . . . . 0.0 109.14 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -74.93 127.06 32.33 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 165.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -156.36 133.31 10.44 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.348 0.659 . . . . 0.0 109.848 -177.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -147.11 174.41 11.6 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.611 1.164 . . . . 0.0 108.911 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -156.58 86.69 1.0 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -83.94 94.8 8.34 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.143 0.577 . . . . 0.0 109.697 174.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.8 p -126.69 89.78 3.05 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.349 1.06 . . . . 0.0 109.383 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.97 140.07 48.96 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.05 176.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.6 ttt -78.28 -29.12 47.75 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.114 0.483 . . . . 0.0 110.318 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.3 m -155.82 173.45 16.74 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.388 1.075 . . . . 0.0 109.993 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 23.5 p-90 -93.27 -23.49 18.49 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 166.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 83.7 t80 -73.0 106.94 5.09 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 167.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -104.27 117.94 35.43 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -63.33 -46.3 87.27 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.946 0.899 . . . . 0.0 111.182 -170.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -114.47 81.7 1.59 Allowed 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.311 0.576 . . . . 0.0 109.585 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.7 tp -133.58 133.32 41.91 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.545 0.738 . . . . 0.0 110.376 176.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.6 m -99.17 170.28 8.8 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.673 0.789 . . . . 0.0 110.092 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.439 ' HG3' HG22 ' A' ' 60' ' ' THR . 38.8 ttt180 -62.1 -57.7 10.58 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -171.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.43 -42.96 78.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.149 0.58 . . . . 0.0 111.231 -178.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.33 -30.71 70.61 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.172 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.26 -50.2 49.21 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.521 0.729 . . . . 0.0 111.356 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.502 ' HA ' HD13 ' A' ' 27' ' ' LEU . 10.2 pt-20 -69.68 -22.2 63.45 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.985 178.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -68.33 -49.59 59.31 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 167.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 43.7 mt -59.58 -30.11 68.42 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.752 0.421 . . . . 0.0 111.627 174.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.502 HD13 ' HA ' ' A' ' 24' ' ' GLU . 48.1 mt -67.49 -47.07 71.09 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.49 0.316 . . . . 0.0 110.238 172.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.72 -42.71 97.89 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.4 0.68 . . . . 0.0 111.817 -173.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -87.0 -53.14 5.04 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.639 0.376 . . . . 0.0 110.643 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.29 -60.4 2.39 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 117.745 0.248 . . . . 0.0 111.127 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.84 126.41 34.5 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-O 121.293 0.385 . . . . 0.0 114.029 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 71.2 mtp85 -79.47 -41.49 27.4 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.449 1.1 . . . . 0.0 113.159 -177.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 170.14 132.95 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.773 1.229 . . . . 0.0 107.988 -169.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.565 ' HA2' ' SG ' ' A' ' 103' ' ' CYS . . . 68.33 24.05 74.93 Favored Glycine 0 N--CA 1.479 1.519 0 CA-C-N 118.259 0.481 . . . . 0.0 111.929 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 7.6 m -88.73 145.77 25.43 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 124.141 0.976 . . . . 0.0 110.472 -171.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -142.05 151.6 42.56 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.197 0.599 . . . . 0.0 109.919 -176.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.472 HD22 HG23 ' A' ' 109' ' ' VAL . 4.6 pp -140.79 154.18 46.14 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.38 169.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 71.5 t -121.61 146.96 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 170.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 48.6 ptt85 -160.74 -170.25 2.68 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.801 1.24 . . . . 0.0 108.324 -173.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.71 144.25 25.93 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.572 0.749 . . . . 0.0 109.203 169.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.415 ' HB3' ' HB2' ' A' ' 47' ' ' ALA . 35.6 t -70.41 160.84 31.6 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.972 0.909 . . . . 0.0 109.514 164.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -108.36 -14.57 14.65 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.8 m -81.11 -68.65 0.67 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.52 0.728 . . . . 0.0 109.975 -177.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.0 t -91.33 118.43 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.436 0.694 . . . . 0.0 109.444 -174.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 7.24 -82.17 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 127.791 2.436 . . . . 0.0 115.866 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.44 64.12 0.58 Allowed Glycine 0 C--N 1.346 1.12 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 174.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.415 ' HB2' ' HB3' ' A' ' 41' ' ' SER . . . -90.11 164.41 14.48 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.935 0.494 . . . . 0.0 110.234 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.509 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 20.9 m-85 -104.16 122.19 44.83 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.027 0.931 . . . . 0.0 109.127 -177.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -108.23 130.74 55.14 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.445 0.698 . . . . 0.0 109.533 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.7 tp -117.79 108.13 14.99 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.482 ' SG ' HG21 ' A' ' 60' ' ' THR . 56.3 m -106.52 123.59 48.32 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -176.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 35' ' ' SER . 58.4 t -130.09 128.16 64.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 124.022 0.929 . . . . 0.0 109.596 -172.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.438 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 56.7 tp -108.29 143.45 37.12 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.28 1.032 . . . . 0.0 109.615 175.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -163.52 112.37 1.25 Allowed 'General case' 0 CA--C 1.543 0.689 0 O-C-N 123.839 0.712 . . . . 0.0 109.25 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 50.76 57.71 6.34 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.954 1.301 . . . . 0.0 113.018 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.7 tttm 52.6 28.03 5.71 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.925 1.29 . . . . 0.0 112.662 -175.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -106.6 104.13 13.74 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 173.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.0 t -86.19 128.71 39.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 173.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -140.07 134.69 31.71 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.482 HG21 ' SG ' ' A' ' 51' ' ' CYS . 37.7 p -112.62 135.9 52.81 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 173.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -114.1 99.93 8.0 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -82.16 97.73 8.35 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.509 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 63.4 mt -71.53 120.67 20.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.778 163.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.4 mp -101.78 126.87 32.65 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 172.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 11.6 Cg_endo -56.11 -62.59 0.23 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.146 1.897 . . . . 0.0 111.042 177.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.4 t70 105.64 -82.16 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.856 1.663 . . . . 0.0 107.733 161.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -88.93 25.82 9.34 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-O 119.171 -0.794 . . . . 0.0 113.579 174.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 59.9 -3.72 0.11 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 175.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -101.81 -44.04 5.65 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.524 0.73 . . . . 0.0 110.941 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -111.54 158.81 18.76 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.639 1.176 . . . . 0.0 109.104 -174.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 4.4 pp -110.49 112.97 25.24 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 165.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.14 125.14 49.71 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.977 0.511 . . . . 0.0 110.943 -176.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.432 ' O ' HG22 ' A' ' 81' ' ' VAL . 22.9 t -85.73 130.91 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.316 -175.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -96.79 93.02 6.44 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.3 p -81.93 -66.33 0.9 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 174.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.494 ' HB2' HG23 ' A' ' 79' ' ' VAL . 50.4 m -162.66 134.4 5.24 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.333 1.053 . . . . 0.0 109.884 172.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -71.65 99.31 2.08 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 164.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.44 -28.91 1.49 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -164.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.494 HG23 ' HB2' ' A' ' 76' ' ' SER . 17.4 m -126.43 152.52 74.25 Favored Pre-proline 0 N--CA 1.485 1.305 0 C-N-CA 124.154 0.981 . . . . 0.0 109.552 177.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -50.72 113.44 1.07 Allowed 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 123.117 2.545 . . . . 0.0 114.013 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 73' ' ' VAL . 7.3 p -71.08 141.38 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 124.72 1.208 . . . . 0.0 110.565 177.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -109.95 119.45 39.36 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.701 0.8 . . . . 0.0 109.656 175.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -102.06 146.94 27.2 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.025 0.93 . . . . 0.0 109.355 172.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -133.74 163.24 29.9 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.939 0.896 . . . . 0.0 108.849 174.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -100.15 -21.14 15.66 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 172.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.515 HG23 ' H ' ' A' ' 88' ' ' GLY . 57.9 m -138.5 141.59 39.38 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -170.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.463 ' O ' HG12 ' A' ' 91' ' ' ILE . 96.1 mt -61.82 -31.27 71.5 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.279 0.632 . . . . 0.0 111.353 177.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.515 ' H ' HG23 ' A' ' 86' ' ' THR . . . -58.21 -34.19 72.86 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 113.749 0.26 . . . . 0.0 113.749 173.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.86 -40.37 75.81 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.463 0.705 . . . . 0.0 110.295 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.3 tp -56.92 -61.07 2.7 Favored 'General case' 0 C--N 1.356 0.891 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.158 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.487 ' HA ' HD12 ' A' ' 105' ' ' LEU . 29.8 mm -60.29 -40.17 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 124.301 1.04 . . . . 0.0 110.573 -177.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.64 -55.54 28.25 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 124.073 0.858 . . . . 0.0 113.853 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 50.9 tp -73.82 -34.71 64.69 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 122.801 0.44 . . . . 0.0 110.939 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.411 ' HA ' ' OD1' ' A' ' 98' ' ' ASN . 3.1 m-30 -86.61 0.87 53.6 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -172.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.99 8.86 6.19 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.346 0.658 . . . . 0.0 112.497 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -137.92 162.18 55.66 Favored Pre-proline 0 CA--C 1.55 0.942 0 C-N-CA 124.888 1.275 . . . . 0.0 108.261 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -49.44 118.53 3.74 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 123.161 2.574 . . . . 0.0 113.243 171.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.411 ' OD1' ' HA ' ' A' ' 94' ' ' TYR . 21.8 m120 -106.93 -78.44 0.58 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.75 0.82 . . . . 0.0 110.923 -174.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 148.34 101.46 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.387 1.475 . . . . 0.0 108.089 -156.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 105.55 -29.06 12.05 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-O 119.742 -0.477 . . . . 0.0 112.832 172.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 15.2 mt -71.09 145.34 49.91 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.736 0.414 . . . . 0.0 111.339 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.5 m -66.01 -27.45 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.566 0.746 . . . . 0.0 111.421 172.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.565 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 29.3 p -168.22 172.89 8.23 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.337 1.055 . . . . 0.0 109.829 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.87 151.54 38.97 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.569 171.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 91' ' ' ILE . 29.9 mt -77.7 103.96 7.95 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 92.6 mt -118.95 -60.96 1.7 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.921 0.488 . . . . 0.0 112.153 -172.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -95.43 140.87 22.55 Favored Pre-proline 0 N--CA 1.484 1.271 0 C-N-CA 122.732 0.413 . . . . 0.0 111.17 -169.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -73.94 -163.46 0.17 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.965 2.444 . . . . 0.0 112.444 172.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.472 HG23 HD22 ' A' ' 37' ' ' LEU . 72.3 t . . . . . 0 C--O 1.254 1.32 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -175.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtt . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.79 37.28 0.08 OUTLIER Glycine 0 C--N 1.344 0.996 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -77.67 -5.32 50.05 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 123.484 0.714 . . . . 0.0 110.868 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -111.06 73.83 0.84 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 167.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -76.45 102.87 6.17 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -110.26 123.89 50.61 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.099 0.96 . . . . 0.0 109.32 172.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -79.41 23.81 0.38 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.684 0.794 . . . . 0.0 112.317 -176.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -123.51 49.87 1.66 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.301 1.041 . . . . 0.0 108.366 171.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.7 m -68.75 -2.25 8.9 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.538 1.135 . . . . 0.0 113.951 -173.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.8 m80 64.48 33.5 10.97 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.03 0.932 . . . . 0.0 110.329 -177.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.504 ' HE2' ' HG3' ' A' ' 16' ' ' ARG . 23.2 ptm -80.43 71.17 7.24 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.459 -177.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 m -75.8 -61.37 1.95 Allowed 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.211 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.409 ' CD1' ' HB3' ' A' ' 108' ' ' PRO . 33.5 p-90 -91.95 3.82 54.37 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.908 0.483 . . . . 0.0 110.894 176.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.471 ' HH ' ' HE1' ' A' ' 48' ' ' PHE . 73.5 t80 -110.56 127.66 55.31 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -123.11 144.2 49.48 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.504 ' HG3' ' HE2' ' A' ' 11' ' ' MET . 24.0 mtp-105 -63.07 -64.49 0.9 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.681 0.792 . . . . 0.0 110.13 176.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -84.74 -101.66 0.05 Allowed 'General case' 0 C--O 1.246 0.901 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -177.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.3 tp 65.05 113.56 0.03 OUTLIER 'General case' 0 C--N 1.363 1.182 0 C-N-CA 125.336 1.454 . . . . 0.0 110.661 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.2 t -72.91 147.81 44.95 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 170.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -63.81 -38.04 89.63 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.133 0.973 . . . . 0.0 110.151 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.23 -45.38 87.81 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.726 173.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.81 -33.59 66.31 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.606 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.56 ' HB1' HD13 ' A' ' 37' ' ' LEU . . . -66.87 -51.93 49.56 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.739 0.816 . . . . 0.0 110.255 -177.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -54.26 -43.66 71.17 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.013 1.325 . . . . 0.0 111.323 174.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.39 -50.3 66.02 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.821 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.1 mt -61.85 -34.32 75.76 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.69 0.796 . . . . 0.0 112.295 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.7 mt -70.54 -59.09 3.04 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.92 -29.01 68.08 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.297 1.039 . . . . 0.0 112.977 -172.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -78.21 -44.94 24.33 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.413 0.685 . . . . 0.0 110.904 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.64 -59.24 2.82 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.438 0.637 . . . . 0.0 112.408 -170.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.06 -169.62 16.05 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 114.685 -1.143 . . . . 0.0 113.808 -165.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.404 ' HB3' ' H ' ' A' ' 33' ' ' ASP . 6.4 mpt_? -119.47 -157.57 0.7 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 125.143 1.377 . . . . 0.0 109.716 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.404 ' H ' ' HB3' ' A' ' 32' ' ' ARG . 8.1 p-10 -57.0 132.87 54.16 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.959 0.904 . . . . 0.0 112.099 -176.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.55 0.59 64.65 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.932 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 53' ' ' LEU . 56.8 m -71.64 116.58 12.17 Favored 'General case' 0 C--N 1.359 1.007 0 CA-C-N 117.764 0.782 . . . . 0.0 108.898 176.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 24.5 p90 -131.07 157.43 43.09 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.306 0.574 . . . . 0.0 111.639 -172.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.56 HD13 ' HB1' ' A' ' 23' ' ' ALA . 2.9 pp -150.93 164.11 37.12 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.69 169.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 86.2 t -125.94 149.26 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 171.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.499 ' HG3' ' HB3' ' A' ' 49' ' ' ALA . 0.5 OUTLIER -153.17 169.07 23.91 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.739 1.215 . . . . 0.0 108.726 -175.383 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 13.7 t70 -93.18 120.8 33.87 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 172.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.4 m -69.19 101.15 1.4 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.027 0.931 . . . . 0.0 111.282 -169.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.44 ' HG2' HH21 ' A' ' 39' ' ' ARG . 16.6 mm-40 -49.78 -31.67 12.16 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.411 1.484 . . . . 0.0 114.315 173.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.5 p -79.23 -17.4 54.88 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.944 0.498 . . . . 0.0 112.279 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.6 t -108.81 -64.76 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 122.996 0.519 . . . . 0.0 109.7 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 95.84 122.07 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.871 2.469 . . . . 0.0 109.547 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 63.46 58.18 12.31 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.746 1.279 . . . . 0.0 111.643 -173.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 40' ' ' ASP . . . -153.08 150.4 29.09 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.461 1.104 . . . . 0.0 108.149 -174.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.471 ' HE1' ' HH ' ' A' ' 14' ' ' TYR . 91.4 m-85 -113.53 125.1 53.82 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.388 0.994 . . . . 0.0 111.311 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . . . -104.4 127.27 52.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.52 0.728 . . . . 0.0 109.326 -177.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.4 tp -111.11 106.25 15.23 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 31.2 m -101.16 121.38 41.74 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -176.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.496 HG22 HD22 ' A' ' 101' ' ' LEU . 94.0 t -122.43 116.69 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.262 1.025 . . . . 0.0 109.37 -174.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.413 ' HB3' ' HB2' ' A' ' 35' ' ' SER . 36.9 tp -85.24 135.13 34.06 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.189 0.996 . . . . 0.0 111.273 -173.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.486 ' HB2' ' HG ' ' A' ' 103' ' ' CYS . 75.3 t80 -141.7 102.3 4.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.525 0.73 . . . . 0.0 109.103 167.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 57.5 54.21 6.71 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.231 1.012 . . . . 0.0 111.369 172.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? 75.27 -23.06 0.24 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 125.681 1.592 . . . . 0.0 112.441 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -88.8 101.35 13.94 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.902 0.858 . . . . 0.0 108.734 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 83.6 t -93.52 120.7 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.227 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -94.98 122.13 37.31 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 37.3 p -113.9 141.62 47.13 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -169.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -135.99 99.15 4.07 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -177.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -81.14 93.53 6.47 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.109 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.424 HG21 ' HB3' ' A' ' 71' ' ' LEU . 32.5 mt -79.9 136.63 23.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 124.494 1.117 . . . . 0.0 110.315 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.8 mp -121.2 141.22 32.56 Favored Pre-proline 0 N--CA 1.475 0.805 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -174.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.67 114.91 2.2 Favored 'Trans proline' 0 C--N 1.366 1.491 0 C-N-CA 122.038 1.826 . . . . 0.0 109.162 158.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -123.84 5.36 8.75 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 123.48 0.712 . . . . 0.0 110.44 -160.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.36 141.29 3.67 Favored Glycine 0 C--N 1.342 0.904 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -174.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 33.66 -76.75 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.016 2.228 . . . . 0.0 117.016 -166.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -163.02 22.37 0.09 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -163.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.404 ' HB3' ' HB2' ' A' ' 83' ' ' ARG . 72.1 m-85 -127.15 150.5 49.48 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.139 0.976 . . . . 0.0 109.717 -170.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.424 ' HB3' HG21 ' A' ' 63' ' ' ILE . 8.2 mp -99.11 150.05 22.42 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.28 1.032 . . . . 0.0 109.743 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -135.93 120.54 18.28 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.635 0.774 . . . . 0.0 109.836 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.8 t -84.93 128.04 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.27 1.028 . . . . 0.0 108.539 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -110.85 87.64 2.58 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -175.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.3 t -140.44 138.68 34.88 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.165 175.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.4 m 63.05 -2.12 0.44 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 165.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 60.71 -79.69 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 125.331 1.452 . . . . 0.0 112.429 -177.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.55 -28.48 62.52 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 -172.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.92 124.19 63.43 Favored Pre-proline 0 CA--C 1.561 1.392 0 CA-C-N 117.274 0.537 . . . . 0.0 110.632 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.414 ' HB2' HE22 ' A' ' 99' ' ' GLN . 81.3 Cg_exo -51.99 113.58 1.24 Allowed 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.653 2.235 . . . . 0.0 113.349 177.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 70.2 t -101.7 134.1 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.417 1.087 . . . . 0.0 108.751 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -105.29 151.6 23.94 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.453 ' O ' ' HD2' ' A' ' 83' ' ' ARG . 2.6 ppt_? -85.34 121.91 28.74 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 170.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -107.29 129.43 54.89 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.592 -0.693 . . . . 0.0 110.178 -176.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -84.64 -17.31 39.01 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.8 t -155.28 163.46 40.11 Favored 'General case' 0 C--O 1.248 0.99 0 C-N-CA 122.779 0.432 . . . . 0.0 110.372 172.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.403 ' O ' HG12 ' A' ' 91' ' ' ILE . 94.9 mt -60.22 -32.12 70.81 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.044 0.937 . . . . 0.0 111.677 177.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -55.86 -41.85 84.71 Favored Glycine 0 C--N 1.352 1.464 0 O-C-N 123.304 0.377 . . . . 0.0 112.762 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -65.85 -39.08 90.43 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.811 0.844 . . . . 0.0 111.033 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 47.7 tp -64.17 -41.72 97.02 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.191 0.996 . . . . 0.0 111.467 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 87' ' ' LEU . 49.8 mm -84.95 -28.18 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -168.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.42 -47.74 15.84 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.2 tt -61.28 -43.78 98.32 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.447 0.699 . . . . 0.0 110.325 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.499 ' HB3' HD13 ' A' ' 101' ' ' LEU . 3.0 m-85 -79.57 -9.76 59.68 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.509 0.724 . . . . 0.0 112.215 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.03 -0.72 19.85 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.734 0.413 . . . . 0.0 112.104 167.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -154.45 57.92 1.93 Allowed Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 124.465 1.106 . . . . 0.0 109.018 172.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.463 ' HG3' HD12 ' A' ' 101' ' ' LEU . 81.1 Cg_endo -75.35 -66.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.507 2.138 . . . . 0.0 113.706 -164.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.5 t30 57.77 39.24 27.29 Favored 'General case' 0 C--N 1.367 1.327 0 C-N-CA 124.325 1.05 . . . . 0.0 108.534 -170.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.414 HE22 ' HB2' ' A' ' 80' ' ' PRO . 20.9 mt-30 -177.75 86.38 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.243 1.017 . . . . 0.0 110.211 -162.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 103.93 -32.28 7.72 Favored Glycine 0 N--CA 1.474 1.187 0 C-N-CA 121.639 -0.315 . . . . 0.0 112.853 161.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.499 HD13 ' HB3' ' A' ' 94' ' ' TYR . 53.7 mt -87.64 123.96 33.04 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.675 0.39 . . . . 0.0 110.388 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.8 p -51.05 -32.83 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.457 0 C-N-CA 125.767 1.627 . . . . 0.0 113.514 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.486 ' HG ' ' HB2' ' A' ' 54' ' ' TYR . 26.2 p -153.64 16.07 0.51 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.979 0.512 . . . . 0.0 112.206 -175.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 67.26 -160.35 0.23 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.646 0.778 . . . . 0.0 110.891 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 56.9 mt -110.91 156.67 20.84 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 58.5 tp -164.94 -63.18 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.457 0.303 . . . . 0.0 111.051 -175.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 29.9 tp -111.52 102.56 53.56 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 122.792 0.437 . . . . 0.0 110.507 -167.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.409 ' HB3' ' CD1' ' A' ' 13' ' ' TRP . 12.3 Cg_exo -72.4 100.96 1.2 Allowed 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.587 2.192 . . . . 0.0 109.392 169.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 87.6 t . . . . . 0 C--O 1.245 0.852 0 CA-C-O 118.648 -0.691 . . . . 0.0 109.328 -171.433 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptp . . . . . 0 N--CA 1.481 1.096 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 167.55 -148.31 12.82 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.6 p-80 -160.01 92.11 0.99 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.974 0.91 . . . . 0.0 109.802 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -90.59 113.99 26.13 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.409 0.684 . . . . 0.0 109.909 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -106.87 134.08 50.57 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.884 0.873 . . . . 0.0 110.251 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -153.6 88.49 1.28 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.632 0.773 . . . . 0.0 109.568 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -143.25 153.65 43.01 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.287 1.035 . . . . 0.0 109.796 173.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -132.08 158.94 40.29 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.425 1.09 . . . . 0.0 109.133 172.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.0 t -64.36 155.71 31.5 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.353 0.661 . . . . 0.0 110.92 176.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -135.9 97.64 3.69 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.915 0.886 . . . . 0.0 110.293 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 67.7 mtm -128.41 123.97 35.11 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 172.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.6 m -61.29 -78.15 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.858 0.863 . . . . 0.0 111.765 -169.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -115.26 12.53 16.48 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.108 0.563 . . . . 0.0 111.929 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -108.36 116.57 32.22 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -177.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -115.51 117.15 29.55 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -64.24 -58.51 6.36 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.385 0.674 . . . . 0.0 111.524 -175.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -111.11 86.48 2.33 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.394 1.092 . . . . 0.0 108.461 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.9 tp -133.14 133.74 43.26 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.457 -1.247 . . . . 0.0 107.926 177.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.4 m -80.04 155.0 27.79 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.502 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 77.3 ttt180 -65.85 -43.35 88.7 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 119.233 -0.413 . . . . 0.0 110.774 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.85 -48.08 67.32 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.449 0.7 . . . . 0.0 111.252 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.47 -25.13 63.93 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.087 177.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.419 ' HB1' HD13 ' A' ' 37' ' ' LEU . . . -74.81 -49.55 20.33 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.49 0.716 . . . . 0.0 111.664 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 1.1 mm-40 -62.72 -38.65 91.31 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.234 0.614 . . . . 0.0 110.01 177.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.3 -47.24 80.22 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 124.377 1.048 . . . . 0.0 109.995 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -54.7 -37.92 66.41 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.89 0.876 . . . . 0.0 110.869 176.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 53' ' ' LEU . 86.5 mt -79.77 -36.1 37.65 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.375 -0.203 . . . . 0.0 111.061 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.63 -41.75 83.4 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 122.706 0.403 . . . . 0.0 110.45 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -89.22 -60.29 1.99 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.119 0.968 . . . . 0.0 111.621 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.26 -50.47 14.32 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.176 0.19 . . . . 0.0 111.347 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.32 122.11 28.62 Favored Glycine 0 C--N 1.353 1.505 0 O-C-N 123.544 0.527 . . . . 0.0 113.72 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -71.0 -45.04 64.67 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.089 0.556 . . . . 0.0 111.075 -177.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 160.98 131.94 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 125.405 1.482 . . . . 0.0 108.172 -174.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.12 20.45 79.05 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 111.924 -0.471 . . . . 0.0 111.924 -176.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.489 ' HB3' ' HA ' ' A' ' 109' ' ' VAL . 13.7 m -83.48 144.94 29.22 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 124.377 1.071 . . . . 0.0 109.529 -178.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -141.75 150.49 41.84 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.96 0.409 . . . . 0.0 111.008 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.419 HD13 ' HB1' ' A' ' 23' ' ' ALA . 4.6 pp -138.26 148.86 45.16 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.913 0.885 . . . . 0.0 109.869 170.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.419 HG23 HD13 ' A' ' 50' ' ' LEU . 48.7 t -114.39 136.55 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -135.73 165.2 26.13 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 124.54 1.136 . . . . 0.0 109.412 -174.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -86.32 131.96 34.09 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 175.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 47' ' ' ALA . 40.4 m -91.46 162.56 14.51 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.292 1.037 . . . . 0.0 108.251 172.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -143.7 75.28 1.46 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.6 t -165.48 -68.69 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.664 -174.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 76.2 t -82.18 82.35 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 174.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 46.72 -122.67 1.28 Allowed 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 124.352 1.061 . . . . 0.0 111.183 -170.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -108.77 79.69 0.25 Allowed Glycine 0 C--N 1.356 1.67 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 172.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 41' ' ' SER . . . -92.38 174.51 7.25 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.542 0.737 . . . . 0.0 111.445 -172.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.519 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 87.2 m-85 -113.37 155.05 25.9 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.214 1.006 . . . . 0.0 109.72 173.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.52 146.98 48.63 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.619 1.168 . . . . 0.0 108.989 171.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 61' ' ' TYR . 40.8 tp -124.82 108.95 12.47 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.182 0.993 . . . . 0.0 109.239 -176.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.502 ' SG ' HG22 ' A' ' 60' ' ' THR . 52.9 m -93.92 126.1 38.93 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.1 t -132.71 121.28 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 CA-C-N 118.273 0.488 . . . . 0.0 109.852 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 40.2 tp -86.93 139.84 30.21 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.72 0.808 . . . . 0.0 109.248 171.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -163.56 121.49 1.89 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 170.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 41.88 67.26 0.59 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 126.012 1.725 . . . . 0.0 113.732 177.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.472 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 10.8 mmpt? 59.21 27.73 16.83 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.76 1.224 . . . . 0.0 112.897 178.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -139.36 107.14 5.64 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.781 0.832 . . . . 0.0 108.984 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.9 t -93.47 122.12 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 166.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -117.97 138.61 52.06 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.064 0.946 . . . . 0.0 108.907 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.502 HG22 ' SG ' ' A' ' 51' ' ' CYS . 21.4 p -106.56 139.51 40.9 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.471 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 23.9 m-85 -119.0 107.56 13.67 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -70.58 150.37 46.14 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 171.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 96.7 mt -147.27 105.77 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 102.605 -3.109 . . . . 0.0 102.605 -158.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.8 mp -107.19 98.03 20.89 Favored Pre-proline 0 N--CA 1.48 1.051 0 CA-C-O 118.634 -0.698 . . . . 0.0 111.484 -160.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 70' ' ' PHE . 37.3 Cg_endo -66.22 95.58 0.32 Allowed 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 122.5 2.133 . . . . 0.0 109.268 162.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -166.76 164.26 16.56 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 124.446 1.098 . . . . 0.0 108.683 -158.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.72 -67.05 3.05 Favored Glycine 0 C--N 1.349 1.272 0 C-N-CA 123.076 0.369 . . . . 0.0 113.047 171.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -142.22 23.99 1.98 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.105 1.362 . . . . 0.0 108.108 -178.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 t70 61.49 58.71 2.03 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.262 1.425 . . . . 0.0 109.972 -170.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 23.1 p90 -127.8 151.99 48.35 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.394 1.078 . . . . 0.0 108.105 169.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.15 109.44 22.19 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 176.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . . . -98.56 127.11 44.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.793 0.837 . . . . 0.0 110.42 -175.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.3 t -99.26 129.15 50.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -94.04 90.72 6.53 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -174.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.5 p -71.66 -34.36 69.66 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.237 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.9 m 75.94 167.12 0.27 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.878 1.671 . . . . 0.0 112.745 173.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 67.57 -162.64 0.22 Allowed 'General case' 0 C--N 1.358 0.972 0 C-N-CA 124.47 1.108 . . . . 0.0 111.693 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -49.5 -24.38 5.42 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 114.756 -1.111 . . . . 0.0 113.965 170.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.69 120.9 80.4 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.573 0.749 . . . . 0.0 109.654 174.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.36 142.52 72.92 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.94 2.427 . . . . 0.0 113.266 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 37.1 t -78.29 118.88 26.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 C-N-CA 124.297 1.039 . . . . 0.0 108.278 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -107.03 127.76 53.76 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.852 0.358 . . . . 0.0 110.494 -173.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.554 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 27.9 ptt180 -98.05 154.33 17.79 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.311 1.044 . . . . 0.0 109.997 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -130.29 154.85 47.19 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.369 0.668 . . . . 0.0 111.399 -175.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -72.67 -46.42 53.92 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.502 172.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.0 t -145.76 166.74 24.99 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.517 0.727 . . . . 0.0 110.975 -177.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.6 mt -60.0 -32.57 70.98 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.712 0.805 . . . . 0.0 111.43 175.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -52.45 -41.26 55.44 Favored Glycine 0 N--CA 1.48 1.6 0 O-C-N 123.027 0.205 . . . . 0.0 113.357 172.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -65.63 -41.06 93.09 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.739 0.815 . . . . 0.0 111.232 173.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.5 tt -68.11 -40.09 82.65 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.226 1.01 . . . . 0.0 110.873 -174.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 44.6 mm -86.05 -42.11 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -166.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.88 -35.21 72.31 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.763 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.1 tp -77.49 -40.98 41.08 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-N 116.907 0.353 . . . . 0.0 110.821 177.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.3 m-30 -80.98 4.37 19.81 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 118.099 0.409 . . . . 0.0 111.83 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.63 -4.02 3.76 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.842 0.857 . . . . 0.0 112.538 163.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -125.27 144.35 47.27 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 171.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -84.42 -154.13 0.05 OUTLIER 'Trans proline' 0 CA--C 1.555 1.531 0 C-N-CA 123.32 2.68 . . . . 0.0 112.387 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.5 t30 62.68 57.54 1.77 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.64 1.176 . . . . 0.0 110.032 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -170.41 31.22 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.808 178.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.66 -10.36 72.42 Favored Glycine 0 N--CA 1.477 1.424 0 O-C-N 120.886 -1.134 . . . . 0.0 112.433 173.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.13 130.93 43.41 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 168.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.426 HG13 ' HH ' ' A' ' 61' ' ' TYR . 13.2 p -60.09 -31.67 48.5 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 123.984 0.914 . . . . 0.0 111.142 177.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 28.4 p -160.11 165.44 31.73 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.529 1.132 . . . . 0.0 108.876 176.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.2 150.73 46.16 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 122.727 0.411 . . . . 0.0 110.169 174.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 75.7 mt -73.16 95.85 2.14 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.2 tp -119.67 -61.37 1.62 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.673 -169.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.462 HD13 ' HD2' ' A' ' 108' ' ' PRO . 45.1 tp -100.42 123.78 45.12 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 123.081 0.552 . . . . 0.0 109.797 -172.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.462 ' HD2' HD13 ' A' ' 107' ' ' LEU . 19.4 Cg_endo -59.03 -47.61 17.21 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.399 2.066 . . . . 0.0 111.242 172.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.489 ' HA ' ' HB3' ' A' ' 35' ' ' SER . 0.3 OUTLIER . . . . . 0 C--O 1.245 0.836 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ttt . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.21 117.99 0.14 Allowed Glycine 0 C--N 1.35 1.336 0 O-C-N 123.573 0.546 . . . . 0.0 112.477 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -137.81 153.14 49.68 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 117.496 0.648 . . . . 0.0 109.836 177.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -109.68 -76.71 0.6 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 61.93 91.69 0.06 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.898 1.279 . . . . 0.0 112.6 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -108.52 -76.55 0.61 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.693 0.797 . . . . 0.0 108.949 174.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 52.91 -119.69 1.56 Allowed 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 124.716 1.206 . . . . 0.0 109.912 -172.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 48.84 -165.79 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.523 1.129 . . . . 0.0 113.031 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.1 t 70.45 156.03 0.15 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.503 1.121 . . . . 0.0 112.802 169.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -157.3 -52.29 0.07 Allowed 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -178.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.429 ' SD ' HD12 ' A' ' 26' ' ' LEU . 65.7 mtt 53.99 34.36 19.55 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.938 1.295 . . . . 0.0 113.447 169.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t -84.44 55.75 3.52 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.697 1.199 . . . . 0.0 110.97 -176.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.533 ' HB3' ' HB3' ' A' ' 108' ' ' PRO 0.317 36.1 p-90 71.53 -54.56 0.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 128.569 2.748 . . . . 0.0 110.906 -177.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -76.35 123.83 26.57 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 173.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.406 ' CD2' ' HB2' ' A' ' 37' ' ' LEU . 93.3 m-70 -113.79 171.93 7.29 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.856 0.863 . . . . 0.0 110.797 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -81.95 -148.43 0.07 Allowed 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.601 169.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -65.04 106.04 1.18 Allowed 'General case' 0 CA--C 1.555 1.168 0 CA-C-O 121.786 0.803 . . . . 0.0 110.219 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.498 ' HB3' ' HB2' ' A' ' 39' ' ' ARG . 26.2 tp -136.1 138.45 42.08 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 57.4 p -96.15 172.39 8.01 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.399 0.68 . . . . 0.0 110.225 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -63.42 -51.75 64.43 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.448 0.699 . . . . 0.0 112.568 -176.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.47 -35.95 80.93 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.872 0.469 . . . . 0.0 111.265 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.84 -37.25 81.65 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.385 0.674 . . . . 0.0 111.1 174.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.33 -55.31 12.52 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.816 0.846 . . . . 0.0 111.703 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.467 ' HB3' HG13 ' A' ' 58' ' ' VAL . 13.3 pt-20 -66.13 -26.37 67.42 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.005 0.922 . . . . 0.0 112.375 -177.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -64.81 -51.18 63.54 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 172.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.429 HD12 ' SD ' ' A' ' 11' ' ' MET . 25.9 tp -61.21 -40.16 92.91 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.974 178.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.419 HD21 ' HB2' ' A' ' 35' ' ' SER . 97.0 mt -64.58 -52.34 58.08 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.705 0.802 . . . . 0.0 110.505 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.43 -33.48 75.64 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.866 0.867 . . . . 0.0 112.566 -172.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -87.75 -57.79 2.81 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.783 -0.189 . . . . 0.0 111.383 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.73 -59.44 3.32 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.14 0.576 . . . . 0.0 112.325 -170.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -123.12 77.04 0.36 Allowed Glycine 0 C--N 1.342 0.885 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -71.47 102.57 2.7 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 118.996 -0.525 . . . . 0.0 110.015 -171.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.5 t70 97.7 116.2 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.638 1.575 . . . . 0.0 109.877 164.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.72 3.79 68.23 Favored Glycine 0 N--CA 1.476 1.313 0 CA-C-N 115.879 -0.6 . . . . 0.0 113.543 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.419 ' HB2' HD21 ' A' ' 27' ' ' LEU . 3.7 p -78.09 158.56 29.1 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.416 0.687 . . . . 0.0 111.56 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -145.9 158.95 43.84 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 172.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.406 ' HB2' ' CD2' ' A' ' 15' ' ' HIS . 4.1 pp -154.05 163.08 40.66 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.697 170.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.0 t -117.76 144.88 24.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 169.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.498 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 50.4 ptt85 -152.9 156.68 39.41 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.19 0.596 . . . . 0.0 110.051 -174.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -87.91 117.83 27.03 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 174.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.0 m -94.9 100.36 12.24 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 174.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -60.63 -39.45 88.28 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.196 0.598 . . . . 0.0 111.921 169.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.1 m -87.92 58.84 5.04 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.89 0.876 . . . . 0.0 112.183 -171.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.423 HG11 ' H ' ' A' ' 45' ' ' ALA . 2.1 p -155.49 -70.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.008 0.523 . . . . 0.0 110.17 172.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.423 ' H ' HG11 ' A' ' 44' ' ' VAL . . . -170.07 15.07 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.695 0.798 . . . . 0.0 110.539 -174.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.49 94.68 0.06 OUTLIER Glycine 0 C--N 1.344 1.026 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -161.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.562 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . . . -152.54 160.42 43.22 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -168.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.422 ' HD2' ' HB3' ' A' ' 65' ' ' PRO . 57.8 m-85 -109.58 137.12 47.87 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.932 0.493 . . . . 0.0 109.928 168.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -119.48 135.81 54.6 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.776 0.831 . . . . 0.0 109.816 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.509 HD22 HD23 ' A' ' 105' ' ' LEU . 66.8 tp -107.87 104.08 13.48 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 48.8 t -106.85 116.16 31.45 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -174.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.9 t -122.2 118.24 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.574 1.15 . . . . 0.0 109.151 -170.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 47.3 tp -91.75 131.91 36.78 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.768 0.827 . . . . 0.0 109.155 175.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -164.51 127.97 2.47 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.431 0.692 . . . . 0.0 110.32 172.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 47.69 53.23 11.55 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.351 1.46 . . . . 0.0 111.715 174.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 91.0 mttt 56.38 39.26 30.14 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.515 1.126 . . . . 0.0 112.05 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 59.2 m80 -136.77 105.8 5.96 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.334 1.054 . . . . 0.0 108.481 174.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.467 HG13 ' HB3' ' A' ' 24' ' ' GLU . 84.9 t -94.67 107.17 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 170.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -103.06 129.55 49.91 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 96.0 m -110.2 137.98 47.2 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.459 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 56.4 m-85 -120.64 101.47 7.77 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -86.13 96.47 9.9 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 119.082 0.855 . . . . 0.0 109.402 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.448 HD13 ' O ' ' A' ' 61' ' ' TYR . 4.9 mp -85.07 141.95 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 123.62 0.768 . . . . 0.0 110.805 171.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.9 mp -96.06 118.87 65.43 Favored Pre-proline 0 CA--C 1.557 1.219 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 172.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.562 ' HD3' ' HA ' ' A' ' 47' ' ' ALA . 92.3 Cg_endo -76.4 -51.98 0.09 OUTLIER 'Trans proline' 0 CA--C 1.556 1.589 0 C-N-CA 122.519 2.146 . . . . 0.0 116.361 -162.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -148.91 167.68 25.06 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 122.259 -0.276 . . . . 0.0 111.158 -158.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.15 -96.29 0.25 Allowed Glycine 0 C--N 1.35 1.323 0 C-N-CA 123.336 0.494 . . . . 0.0 111.898 178.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -126.05 30.31 5.68 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.983 0.913 . . . . 0.0 109.206 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -159.33 174.19 15.14 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.771 -162.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -120.26 158.19 27.55 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.52 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -93.42 111.49 23.17 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -170.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.749 ' HB3' ' HG2' ' A' ' 83' ' ' ARG . . . -117.95 142.23 47.59 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.86 0.864 . . . . 0.0 110.748 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.6 t -89.24 142.57 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -108.84 90.99 3.46 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.8 p -87.58 -71.35 0.57 Allowed 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 172.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.2 t 179.92 140.72 0.13 Allowed 'General case' 0 C--N 1.351 0.658 0 C-N-CA 124.616 1.167 . . . . 0.0 108.955 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -70.83 128.2 35.23 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 140.52 -76.96 0.31 Allowed Glycine 0 C--N 1.346 1.135 0 N-CA-C 108.067 -2.013 . . . . 0.0 108.067 -166.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.3 m -64.41 140.08 97.88 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 123.838 0.855 . . . . 0.0 110.043 162.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -64.58 121.28 8.8 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.75 2.3 . . . . 0.0 112.056 -176.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 72.6 t -99.47 141.85 16.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.197 0.999 . . . . 0.0 108.463 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.8 mmt85 -117.31 143.7 45.65 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.553 0.741 . . . . 0.0 111.109 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.749 ' HG2' ' HB3' ' A' ' 72' ' ' ALA . 86.2 mtt-85 -94.89 148.41 22.34 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 166.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -127.39 161.9 27.58 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.163 0.585 . . . . 0.0 110.395 -174.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -95.3 -19.39 20.02 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.313 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.0 t -157.06 159.72 38.21 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 122.654 0.382 . . . . 0.0 111.592 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.4 mt -61.27 -34.44 75.18 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.186 0.994 . . . . 0.0 112.143 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.41 -38.77 91.63 Favored Glycine 0 C--N 1.349 1.254 0 O-C-N 123.206 0.317 . . . . 0.0 112.952 174.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -72.21 -37.16 69.3 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.649 0.78 . . . . 0.0 109.735 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.6 tt -54.28 -53.74 49.61 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.657 1.183 . . . . 0.0 110.428 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.9 mm -64.79 -36.3 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.414 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -53.89 -55.08 27.51 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 124.198 0.936 . . . . 0.0 113.298 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -76.47 -35.74 58.26 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 122.998 0.519 . . . . 0.0 111.843 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.49 ' CD2' HD21 ' A' ' 101' ' ' LEU . 7.4 m-85 -89.49 4.62 48.59 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -173.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.42 -6.82 48.72 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 122.719 0.408 . . . . 0.0 110.93 162.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -83.17 125.75 73.86 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.965 0.906 . . . . 0.0 110.337 174.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.94 179.78 6.18 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.387 2.058 . . . . 0.0 111.36 169.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 53.83 66.18 1.3 Allowed 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.877 0.871 . . . . 0.0 111.128 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -173.2 21.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.2 1.0 . . . . 0.0 110.383 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 107.52 -21.65 30.12 Favored Glycine 0 C--N 1.345 1.076 0 O-C-N 121.622 -0.674 . . . . 0.0 112.41 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.49 HD21 ' CD2' ' A' ' 94' ' ' TYR . 2.9 mm? -70.57 124.7 24.86 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.338 1.055 . . . . 0.0 110.582 177.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.9 p -52.96 -31.41 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.542 0 C-N-CA 124.21 1.004 . . . . 0.0 112.783 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 27.2 p -156.25 6.41 0.19 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.003 0.521 . . . . 0.0 112.309 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 68.0 -179.62 0.22 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.727 0.811 . . . . 0.0 110.594 -166.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.509 HD23 HD22 ' A' ' 50' ' ' LEU . 46.1 mt -90.0 91.53 8.61 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 79.1 mt -93.86 -69.31 0.76 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.928 0.891 . . . . 0.0 111.321 -174.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.7 mp -104.01 128.25 27.6 Favored Pre-proline 0 N--CA 1.48 1.048 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -173.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.533 ' HB3' ' HB3' ' A' ' 13' ' ' TRP . 35.5 Cg_exo -63.38 -124.25 0.0 OUTLIER 'Trans proline' 0 CA--C 1.571 2.334 0 C-N-CA 122.623 2.215 . . . . 0.0 111.576 169.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.7 t . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 176.914 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -177.07 50.53 0.1 Allowed Glycine 0 C--N 1.349 1.264 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -68.01 100.96 1.04 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.381 0.672 . . . . 0.0 110.641 178.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -133.42 101.2 5.07 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.623 0.769 . . . . 0.0 108.967 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -73.45 111.33 8.48 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-O 121.192 0.52 . . . . 0.0 110.02 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -144.62 165.46 27.95 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.164 0.986 . . . . 0.0 109.406 177.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 66.77 7.88 5.56 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 123.969 0.908 . . . . 0.0 112.375 172.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -125.77 95.56 4.47 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.674 0.79 . . . . 0.0 109.086 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.6 m -146.05 -66.16 0.3 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.586 0.755 . . . . 0.0 109.267 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 54.75 56.35 6.82 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.337 1.055 . . . . 0.0 110.155 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 28.1 ttt -73.77 83.14 1.62 Allowed 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.937 -171.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.8 t 178.16 176.55 0.46 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.347 1.459 . . . . 0.0 109.142 178.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.489 ' HB3' ' O ' ' A' ' 108' ' ' PRO . 4.7 p-90 -94.77 -22.86 17.8 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.595 1.158 . . . . 0.0 109.341 166.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.494 ' HH ' ' HE1' ' A' ' 48' ' ' PHE . 84.6 t80 -71.68 109.05 5.33 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.862 173.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -128.27 120.29 26.84 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -59.06 -72.84 0.09 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.647 0.379 . . . . 0.0 110.937 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -85.48 59.05 5.39 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.72 0.808 . . . . 0.0 110.126 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 26.0 tp -88.2 -61.12 1.78 Allowed 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -176.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.2 m 93.81 145.94 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 127.125 2.17 . . . . 0.0 107.895 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.471 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 54.9 ttt180 -57.2 -46.83 82.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.112 0.565 . . . . 0.0 111.701 -177.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 25' ' ' GLU . . . -51.76 -47.92 63.93 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 124.173 0.92 . . . . 0.0 111.573 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.41 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -69.13 -38.04 78.63 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.459 177.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.425 ' HB1' HD12 ' A' ' 37' ' ' LEU . . . -61.4 -60.64 3.41 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.189 0.996 . . . . 0.0 112.114 -177.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 12.5 pt-20 -59.08 -29.58 67.44 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.246 1.019 . . . . 0.0 112.398 175.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.6 OUTLIER -67.1 -47.47 71.07 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.161 0.584 . . . . 0.0 109.522 178.119 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 22' ' ' ALA . 94.5 mt -59.59 -36.03 75.47 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.89 0.876 . . . . 0.0 111.341 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.3 mt -68.87 -54.55 15.0 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.24 -36.76 76.05 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.818 0.847 . . . . 0.0 112.748 -169.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -92.37 -59.47 2.08 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.35 -59.51 2.68 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -165.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.33 108.34 1.69 Allowed Glycine 0 C--N 1.349 1.304 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -175.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 50.8 ttt85 -57.75 -129.09 0.0 OUTLIER 'General case' 0 CA--C 1.581 2.173 0 C-N-CA 124.372 1.069 . . . . 0.0 113.236 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -74.68 148.83 40.24 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.282 -1.511 . . . . 0.0 111.442 -169.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.412 ' HA3' HD23 ' A' ' 106' ' ' LEU . . . 70.13 18.04 74.42 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.628 0.58 . . . . 0.0 114.207 -176.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.619 ' HB2' HG21 ' A' ' 109' ' ' VAL . 59.6 p -80.38 139.04 36.72 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -144.1 147.24 33.48 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.013 0.435 . . . . 0.0 110.255 177.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.425 HD12 ' HB1' ' A' ' 23' ' ' ALA . 1.6 pp -150.04 154.37 38.05 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.123 0.969 . . . . 0.0 108.701 168.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 79.6 t -114.73 131.02 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.492 ' HG3' ' HB3' ' A' ' 49' ' ' ALA . 5.9 ptm180 -116.79 168.64 10.04 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.214 1.005 . . . . 0.0 108.383 174.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -85.24 132.38 34.28 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 170.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 97.1 p -58.53 153.38 16.23 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 123.905 0.753 . . . . 0.0 111.596 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -71.73 79.58 0.85 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.711 0.804 . . . . 0.0 111.963 -172.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.3 m 53.55 28.31 7.63 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.954 1.301 . . . . 0.0 113.118 177.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.8 t -65.53 -73.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.499 0.72 . . . . 0.0 111.411 -172.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -172.41 34.7 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.238 0.615 . . . . 0.0 110.608 -177.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.39 35.49 33.14 Favored Glycine 0 N--CA 1.469 0.835 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.14 -174.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -97.08 169.77 9.58 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.568 0.747 . . . . 0.0 110.64 -177.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.494 ' HE1' ' HH ' ' A' ' 14' ' ' TYR . 95.6 m-85 -124.16 157.49 34.59 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.049 0.94 . . . . 0.0 109.849 178.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.492 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . . . -133.64 144.77 49.42 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.295 0.638 . . . . 0.0 109.512 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.2 tp -123.9 124.21 42.12 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.436 ' SG ' HG22 ' A' ' 60' ' ' THR . 39.0 m -115.03 121.14 42.19 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -178.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 35' ' ' SER . 60.4 t -128.48 125.42 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.791 0.837 . . . . 0.0 109.038 -175.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.468 ' HB3' ' OG ' ' A' ' 35' ' ' SER . 60.7 tp -96.21 138.73 33.38 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.343 0.657 . . . . 0.0 109.905 177.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -161.57 125.05 3.2 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.9 0.88 . . . . 0.0 108.961 175.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 50.26 52.57 14.49 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.08 1.352 . . . . 0.0 112.391 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 80.3 tttt 55.9 39.11 30.64 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.737 1.215 . . . . 0.0 112.119 -176.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -140.69 106.03 5.05 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.94 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 85.4 t -87.36 112.06 22.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 168.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -97.4 130.34 44.54 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 170.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.436 HG22 ' SG ' ' A' ' 51' ' ' CYS . 41.1 p -108.29 130.26 55.19 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -113.59 98.9 7.34 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.3 mtm105 -83.54 91.69 7.47 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.482 HD12 HD11 ' A' ' 90' ' ' LEU . 61.7 mt -77.56 122.39 32.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.701 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.9 mp -93.96 149.86 37.61 Favored Pre-proline 0 CA--C 1.547 0.832 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -178.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -79.42 -143.05 0.02 OUTLIER 'Trans proline' 0 CA--C 1.565 2.061 0 C-N-CA 122.942 2.428 . . . . 0.0 112.498 -170.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.568 ' HB3' ' H ' ' A' ' 70' ' ' PHE . 31.0 t70 -169.74 151.43 4.25 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.646 0.778 . . . . 0.0 109.841 -172.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -55.33 -35.28 60.47 Favored Glycine 0 C--N 1.349 1.266 0 O-C-N 124.035 0.835 . . . . 0.0 114.112 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -102.59 25.13 9.48 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.646 0.778 . . . . 0.0 111.416 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 58.91 57.67 3.51 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.508 1.523 . . . . 0.0 114.098 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.568 ' H ' ' HB3' ' A' ' 66' ' ' ASP . 96.4 m-85 -118.86 151.65 37.72 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 169.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 mp -98.2 108.28 20.94 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.97 118.15 33.9 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.607 0.763 . . . . 0.0 109.628 -175.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.518 HG13 ' HH ' ' A' ' 94' ' ' TYR . 12.9 t -99.72 140.96 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.918 0.887 . . . . 0.0 110.289 -176.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -108.09 89.73 3.08 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 176.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.3 m -90.82 125.51 35.74 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -171.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.2 m 59.01 -89.98 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.067 1.347 . . . . 0.0 112.061 177.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 176.75 -26.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.592 1.157 . . . . 0.0 111.057 -177.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -132.03 40.61 1.6 Allowed Glycine 0 N--CA 1.47 0.966 0 CA-C-N 116.694 -0.23 . . . . 0.0 112.861 -170.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.6 p -143.7 135.47 12.95 Favored Pre-proline 0 CA--C 1.555 1.168 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -40.14 135.06 1.76 Allowed 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 124.182 3.255 . . . . 0.0 115.091 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 73' ' ' VAL . 88.0 t -64.04 131.16 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.733 1.213 . . . . 0.0 109.473 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -105.32 116.48 32.02 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -174.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -93.34 146.12 23.97 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 172.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -125.56 146.57 49.62 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.695 0.798 . . . . 0.0 110.091 175.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -75.11 -40.04 60.18 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.764 0.425 . . . . 0.0 110.481 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.0 p -141.05 173.92 11.01 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.831 0.852 . . . . 0.0 109.854 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.4 HD21 HG12 ' A' ' 38' ' ' VAL . 1.4 tm? -68.37 -34.8 76.71 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.041 0.936 . . . . 0.0 109.455 175.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -60.66 -38.5 95.18 Favored Glycine 0 C--N 1.357 1.698 0 O-C-N 123.241 0.338 . . . . 0.0 113.341 175.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -64.93 -45.17 86.95 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.592 0.757 . . . . 0.0 111.096 174.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.482 HD11 HD12 ' A' ' 63' ' ' ILE . 8.2 tt -52.7 -50.34 63.53 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.426 1.09 . . . . 0.0 111.059 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.7 mm -70.3 -33.51 54.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.215 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.8 -57.31 20.09 Favored Glycine 0 CA--C 1.532 1.117 0 O-C-N 123.589 0.556 . . . . 0.0 114.163 178.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.1 mp -70.43 -31.17 68.25 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.098 0.559 . . . . 0.0 111.402 -178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.518 ' HH ' HG13 ' A' ' 73' ' ' VAL . 8.0 m-30 -78.94 -18.87 53.05 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 178.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.544 ' HA ' ' HB2' ' A' ' 105' ' ' LEU . . . -61.01 -20.74 62.85 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.443 0.697 . . . . 0.0 112.707 174.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -110.9 166.32 10.98 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 123.643 0.777 . . . . 0.0 109.403 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -49.89 105.7 0.1 Allowed 'Trans proline' 0 C--N 1.386 2.518 0 C-N-CA 123.063 2.508 . . . . 0.0 112.327 168.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -90.97 -51.64 5.24 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.943 0.897 . . . . 0.0 111.521 -174.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 109.55 101.03 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 128.477 2.711 . . . . 0.0 108.673 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.15 -17.72 11.52 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.849 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 49.1 mt -77.31 143.95 38.43 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.821 0.448 . . . . 0.0 111.012 176.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.2 m -75.29 71.85 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 CA-C-O 121.826 0.822 . . . . 0.0 109.309 165.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 2.6 p 78.81 179.6 0.12 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.65 1.98 . . . . 0.0 110.761 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.06 -178.09 6.72 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.431 0.692 . . . . 0.0 110.895 -177.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.544 ' HB2' ' HA ' ' A' ' 95' ' ' ALA . 29.0 mt -93.03 106.34 18.32 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 174.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.412 HD23 ' HA3' ' A' ' 34' ' ' GLY . 4.2 mm? -97.13 -56.89 2.41 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.379 0.672 . . . . 0.0 110.863 -176.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.5 pp -133.25 147.33 64.63 Favored Pre-proline 0 N--CA 1.486 1.333 0 C-N-CA 122.636 0.374 . . . . 0.0 111.407 -169.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.489 ' O ' ' HB3' ' A' ' 13' ' ' TRP . 65.0 Cg_endo -77.81 -11.99 16.56 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 123.155 2.57 . . . . 0.0 115.154 -171.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.619 HG21 ' HB2' ' A' ' 35' ' ' SER . 22.3 t . . . . . 0 N--CA 1.503 2.223 0 C-N-CA 124.994 1.318 . . . . 0.0 109.5 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.452 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 166.01 -25.86 0.16 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -77.17 123.41 26.38 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.647 0.779 . . . . 0.0 110.148 178.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -163.74 150.69 12.09 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.111 0.964 . . . . 0.0 109.199 173.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -85.22 175.52 8.9 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.684 0.754 . . . . 0.0 111.183 175.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -156.56 146.73 21.25 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.425 176.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -98.72 79.23 2.41 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -152.84 102.86 2.71 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.0 m -70.77 151.86 44.39 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.562 0.745 . . . . 0.0 111.285 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -125.59 137.19 53.89 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.643 0.777 . . . . 0.0 109.657 177.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -158.48 -45.3 0.06 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.138 0.975 . . . . 0.0 108.934 175.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.2 m 38.44 86.22 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.789 1.636 . . . . 0.0 112.781 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.438 ' HB3' ' HB3' ' A' ' 108' ' ' PRO . 1.6 p-90 -80.37 3.47 21.11 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.459 0.704 . . . . 0.0 112.009 -172.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -110.82 102.33 10.86 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -172.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -118.22 119.1 33.68 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -67.56 -81.59 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.622 0.769 . . . . 0.0 111.477 -164.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -83.77 42.69 0.86 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 118.382 0.537 . . . . 0.0 111.761 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.435 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 35.8 tp -68.16 -48.0 66.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.839 0.456 . . . . 0.0 109.851 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.8 m 79.98 152.78 0.12 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.647 1.179 . . . . 0.0 110.684 170.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -56.58 -62.61 1.61 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.631 1.172 . . . . 0.0 112.546 -168.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.76 -50.66 67.89 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.598 0.759 . . . . 0.0 112.256 -178.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 18' ' ' LEU . . . -65.46 -32.12 73.56 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.219 -178.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.75 -53.54 26.45 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.646 0.378 . . . . 0.0 111.629 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.26 -32.84 74.71 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 123.784 0.678 . . . . 0.0 111.619 -178.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -69.26 -43.65 73.51 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.228 0.33 . . . . 0.0 110.712 176.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.5 -27.0 66.64 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.515 0.726 . . . . 0.0 111.933 174.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.8 mt -66.96 -60.26 2.79 Favored 'General case' 0 C--N 1.348 0.52 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 170.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.79 -32.29 63.37 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.377 1.071 . . . . 0.0 112.951 -176.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.05 -58.0 3.49 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.74 0.816 . . . . 0.0 109.687 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.9 -55.18 5.16 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.295 -168.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -99.86 -58.28 0.89 Allowed Glycine 0 N--CA 1.47 0.96 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 -176.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.528 ' HA ' HD23 ' A' ' 53' ' ' LEU . 53.9 ttp180 51.9 104.86 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.083 2.153 . . . . 0.0 113.345 -170.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.8 t70 88.99 120.92 0.03 OUTLIER 'General case' 0 C--N 1.36 1.047 0 C-N-CA 124.778 1.231 . . . . 0.0 109.241 163.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.482 ' HA2' ' SG ' ' A' ' 103' ' ' CYS . . . 77.29 -0.43 68.39 Favored Glycine 0 C--N 1.352 1.43 0 CA-C-N 116.388 -0.369 . . . . 0.0 113.335 -168.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.0 m -82.91 141.22 32.35 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.903 0.881 . . . . 0.0 109.526 -175.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.438 ' HB2' HG22 ' A' ' 52' ' ' VAL . 20.6 p90 -144.76 158.21 43.87 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 175.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 pp -160.31 161.3 33.24 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.267 0.627 . . . . 0.0 109.944 168.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.471 HG21 HD13 ' A' ' 91' ' ' ILE . 40.2 t -110.91 145.55 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.406 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 17.6 mtm180 -132.33 165.52 24.02 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.829 0.851 . . . . 0.0 108.892 -176.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -89.18 119.2 29.46 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 158.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 56.4 m -58.97 147.64 33.57 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.456 0.473 . . . . 0.0 109.906 -175.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -77.05 77.23 3.59 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.279 1.032 . . . . 0.0 110.943 -162.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.5 t 50.13 54.61 10.79 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 125.497 1.519 . . . . 0.0 111.646 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 m -96.27 -55.5 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.904 -178.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -168.98 16.98 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.517 0.727 . . . . 0.0 111.305 -176.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.63 34.51 35.03 Favored Glycine 0 N--CA 1.474 1.168 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 -173.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -94.14 167.59 11.47 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.794 0.837 . . . . 0.0 112.194 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.526 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 79.0 m-85 -105.6 140.93 37.92 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.811 1.245 . . . . 0.0 109.309 171.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 39' ' ' ARG . . . -117.42 126.19 52.22 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.946 0.498 . . . . 0.0 109.899 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.3 tp -108.81 104.08 13.28 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -177.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 53.5 t -102.55 120.21 40.15 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -176.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.438 HG22 ' HB2' ' A' ' 36' ' ' PHE . 56.3 t -128.05 121.42 56.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.373 1.069 . . . . 0.0 108.579 -175.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.528 HD23 ' HA ' ' A' ' 32' ' ' ARG . 43.1 tp -100.38 131.66 46.18 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.805 0.842 . . . . 0.0 109.013 174.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -167.0 145.53 5.08 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.167 0.917 . . . . 0.0 109.305 -177.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 47.82 41.45 14.33 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 125.852 1.661 . . . . 0.0 112.898 177.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.2 tttp 56.01 37.34 28.74 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.754 1.221 . . . . 0.0 111.684 -176.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -142.4 115.92 9.09 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.472 -174.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.2 t -83.82 139.03 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 173.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -139.21 123.85 18.45 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.8 m -114.16 129.97 56.61 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.485 ' HD2' ' HA ' ' A' ' 75' ' ' THR . 9.3 m-85 -115.22 100.58 8.24 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 -176.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -78.23 100.02 6.49 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.526 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 3.2 mp -70.02 118.65 14.8 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.764 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 165.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -120.88 131.17 24.55 Favored Pre-proline 0 C--O 1.241 0.611 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.52 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.593 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 7.1 Cg_exo -73.17 -74.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 122.241 1.961 . . . . 0.0 110.607 171.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.7 t70 71.36 124.94 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.733 1.213 . . . . 0.0 108.379 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 49.62 -143.99 9.69 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.593 -153.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -117.62 -154.2 0.55 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.268 0.627 . . . . 0.0 110.308 169.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.0 t70 88.02 -74.9 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 126.158 1.783 . . . . 0.0 110.491 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -129.65 158.91 38.02 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 121.408 0.623 . . . . 0.0 112.04 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.593 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 3.0 pp -110.49 123.31 49.67 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.416 1.086 . . . . 0.0 108.722 165.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.82 123.79 48.67 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.253 0.621 . . . . 0.0 111.008 -177.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 7.3 p -85.53 147.13 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -110.96 91.68 3.75 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.724 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 41.1 p -77.1 -58.88 3.03 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.13 -177.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.9 m -138.09 153.69 49.28 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.358 0.663 . . . . 0.0 110.343 -177.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -77.71 138.02 38.82 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.042 0.537 . . . . 0.0 110.043 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.57 32.49 67.59 Favored Glycine 0 CA--C 1.523 0.537 0 O-C-N 123.749 0.656 . . . . 0.0 114.029 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.7 m -133.78 144.43 51.81 Favored Pre-proline 0 N--CA 1.481 1.079 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.22 103.15 1.56 Allowed 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.273 1.982 . . . . 0.0 109.312 168.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.476 HG11 ' H ' ' A' ' 82' ' ' ARG . 4.7 t -79.75 174.14 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.26 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.476 ' H ' HG11 ' A' ' 81' ' ' VAL . 5.5 tpp180 -95.81 133.31 40.1 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -175.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -91.77 138.87 31.2 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -124.21 149.54 46.27 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.494 0.718 . . . . 0.0 109.468 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -96.17 -16.1 21.69 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.5 m -144.33 140.2 28.99 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.936 0.895 . . . . 0.0 109.081 -178.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -63.59 -31.83 73.11 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.433 1.093 . . . . 0.0 110.051 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -54.87 -42.03 78.14 Favored Glycine 0 CA--C 1.541 1.707 0 CA-C-N 116.409 -0.36 . . . . 0.0 113.923 172.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.39 -37.13 84.59 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.56 0.744 . . . . 0.0 110.791 176.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.424 HD12 ' HB ' ' A' ' 73' ' ' VAL . 9.3 tt -61.7 -55.0 35.12 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.265 1.026 . . . . 0.0 111.299 -176.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.471 HD13 HG21 ' A' ' 38' ' ' VAL . 49.8 mt -66.46 -37.53 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 123.44 0.463 . . . . 0.0 110.727 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.92 -52.39 46.85 Favored Glycine 0 C--N 1.342 0.913 0 O-C-N 123.769 0.668 . . . . 0.0 112.838 176.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 51.8 tp -72.15 -43.5 64.55 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.082 0.553 . . . . 0.0 111.412 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.474 ' HE2' HG11 ' A' ' 73' ' ' VAL . 18.6 m-85 -82.75 0.52 43.24 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -174.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.43 -25.41 64.32 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-O 121.472 0.653 . . . . 0.0 109.696 158.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -95.84 128.72 36.51 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.994 1.317 . . . . 0.0 107.565 171.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -80.55 -155.47 0.06 OUTLIER 'Trans proline' 0 CA--C 1.557 1.655 0 C-N-CA 122.837 2.358 . . . . 0.0 112.643 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 67.51 48.51 1.1 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.438 1.095 . . . . 0.0 111.842 171.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -163.32 10.69 0.06 Allowed 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.42 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.724 ' HA3' ' HB ' ' A' ' 75' ' ' THR . . . 127.28 -12.35 6.73 Favored Glycine 0 C--N 1.355 1.61 0 O-C-N 122.041 -0.412 . . . . 0.0 113.102 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.4 118.26 21.88 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.992 0.917 . . . . 0.0 111.422 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.7 p -55.55 -32.27 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.484 1.114 . . . . 0.0 111.24 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.482 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 53.8 t -138.31 145.18 40.89 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.003 0.921 . . . . 0.0 109.821 177.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.38 141.07 54.23 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 169.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 62.3 mt -76.17 92.86 3.29 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -174.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.422 ' HG ' ' HG ' ' A' ' 107' ' ' LEU . 47.4 tp -101.19 -58.14 1.95 Allowed 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.304 -171.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.422 ' HG ' ' HG ' ' A' ' 106' ' ' LEU . 58.6 mt -142.25 123.9 8.8 Favored Pre-proline 0 N--CA 1.485 1.302 0 C-N-CA 123.598 0.759 . . . . 0.0 109.336 -170.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.438 ' HB3' ' HB3' ' A' ' 13' ' ' TRP . 27.1 Cg_endo -61.06 -74.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 122.602 2.201 . . . . 0.0 112.906 -176.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 55.8 t . . . . . 0 CA--C 1.551 1.005 0 C-N-CA 124.242 1.017 . . . . 0.0 108.668 -177.577 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 ttp . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.21 10.27 85.65 Favored Glycine 0 C--N 1.347 1.184 0 O-C-N 123.509 0.505 . . . . 0.0 113.946 171.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -83.61 103.23 12.77 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -137.5 89.71 2.44 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -103.09 87.92 3.02 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 169.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -79.52 127.71 32.47 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 172.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -76.04 128.46 35.06 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.65 0.38 . . . . 0.0 110.134 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -70.99 161.87 30.39 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.362 0.665 . . . . 0.0 110.904 175.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.6 m -62.81 162.73 10.49 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.537 1.135 . . . . 0.0 113.374 -170.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -62.62 -30.41 71.34 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 168.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.464 ' SD ' ' N ' ' A' ' 12' ' ' SER . 1.6 tmt? 61.81 -88.78 0.03 OUTLIER 'General case' 0 C--N 1.355 0.847 0 C-N-CA 125.596 1.558 . . . . 0.0 110.573 170.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.464 ' N ' ' SD ' ' A' ' 11' ' ' MET . 67.1 m -168.86 124.39 0.91 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.165 1.386 . . . . 0.0 108.699 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -99.29 -18.82 17.38 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 161.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -75.53 104.51 6.12 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 166.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -113.59 96.27 5.78 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -54.45 -39.82 67.8 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 124.38 1.05 . . . . 0.0 113.178 -164.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -125.11 85.72 2.45 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.3 tp -115.82 -45.22 2.89 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.437 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.5 t 79.9 155.29 0.14 Allowed 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 124.746 1.218 . . . . 0.0 110.229 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -57.56 -50.66 72.37 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -172.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.07 -53.99 50.35 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.587 0.755 . . . . 0.0 111.948 -176.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.53 -30.93 68.88 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.24 0.616 . . . . 0.0 111.836 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.522 ' HB2' HD13 ' A' ' 37' ' ' LEU . . . -65.57 -58.96 4.51 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.685 0.794 . . . . 0.0 111.496 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.525 ' HG3' HG21 ' A' ' 58' ' ' VAL . 34.6 tt0 -56.97 -42.59 80.44 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.264 1.425 . . . . 0.0 111.976 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -67.8 -39.88 83.95 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.137 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 33.4 tp -63.16 -38.71 92.27 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.935 0.894 . . . . 0.0 111.667 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.498 HD23 ' HG ' ' A' ' 37' ' ' LEU . 95.6 mt -68.0 -29.36 68.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.256 0.622 . . . . 0.0 111.097 177.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.23 -54.39 5.78 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.81 0.844 . . . . 0.0 111.085 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -66.8 -46.01 76.57 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.419 0.688 . . . . 0.0 111.226 -174.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.65 -60.59 1.9 Allowed 'General case' 0 C--N 1.349 0.551 0 C-N-CA 123.003 0.521 . . . . 0.0 110.803 -172.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.35 -36.97 19.16 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-O 119.799 -0.445 . . . . 0.0 113.704 -172.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? 74.79 -25.25 0.2 Allowed 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 125.273 1.429 . . . . 0.0 113.477 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.4 t70 174.93 141.69 0.05 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.661 0.784 . . . . 0.0 109.369 -165.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.56 9.82 65.72 Favored Glycine 0 C--N 1.358 1.787 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 12.4 m -84.71 146.73 27.27 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.295 1.038 . . . . 0.0 111.007 -168.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -150.83 151.88 32.92 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 174.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.522 HD13 ' HB2' ' A' ' 23' ' ' ALA . 2.9 pp -152.6 158.85 43.04 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 169.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.593 HG23 HD13 ' A' ' 87' ' ' LEU . 36.8 t -112.11 154.74 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.1 ptt85 -156.21 175.09 14.45 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.907 0.883 . . . . 0.0 109.039 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.17 145.2 24.87 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.5 m -56.17 148.63 17.68 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.658 0.783 . . . . 0.0 113.041 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -88.72 3.61 50.25 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.248 1.019 . . . . 0.0 112.048 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.0 m -134.48 -63.6 0.71 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.148 0.579 . . . . 0.0 111.101 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.45 HG23 ' HB3' ' A' ' 47' ' ' ALA . 14.7 m -85.86 117.79 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 121.726 0.774 . . . . 0.0 110.672 -178.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.32 128.7 37.37 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.616 -1.174 . . . . 0.0 112.551 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.89 7.42 81.02 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 114.691 0.636 . . . . 0.0 114.691 177.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HB3' HG23 ' A' ' 44' ' ' VAL . . . -100.81 173.78 6.35 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.149 0.58 . . . . 0.0 109.901 174.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -117.03 160.8 20.4 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-O 121.388 0.613 . . . . 0.0 112.027 -178.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.61 144.85 42.15 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.23 168.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.464 HD11 HG22 ' A' ' 38' ' ' VAL . 51.0 tp -125.05 110.59 14.35 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.695 1.198 . . . . 0.0 108.483 -174.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 35.5 t -104.23 123.02 46.59 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -175.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.2 t -130.48 121.8 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.636 0.774 . . . . 0.0 109.714 -172.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.1 tp -111.22 115.64 29.7 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.297 1.039 . . . . 0.0 109.685 175.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -145.79 144.77 30.49 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 166.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 53.45 36.56 23.47 Favored 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 124.536 1.134 . . . . 0.0 112.277 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 65.7 mttm 58.68 36.47 24.98 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.403 1.081 . . . . 0.0 112.412 -173.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -126.04 104.91 8.53 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.525 HG21 ' HG3' ' A' ' 24' ' ' GLU . 17.5 t -100.69 107.91 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.739 0.816 . . . . 0.0 108.877 174.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -112.14 140.63 46.67 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 171.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 89.2 m -106.63 135.75 47.62 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -117.1 100.04 7.46 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -63.48 155.28 29.74 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 168.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 92.3 mt -144.95 101.92 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 102.59 -3.115 . . . . 0.0 102.59 -158.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.1 mp -105.11 111.59 65.15 Favored Pre-proline 0 N--CA 1.472 0.649 0 O-C-N 123.351 0.407 . . . . 0.0 109.94 -161.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.433 ' HG3' ' HG ' ' A' ' 71' ' ' LEU . 1.4 Cg_endo -81.76 108.55 1.89 Allowed 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.606 2.204 . . . . 0.0 109.422 162.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -82.15 137.24 35.01 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 174.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -46.73 77.57 0.0 OUTLIER Glycine 0 CA--C 1.538 1.49 0 N-CA-C 117.172 1.629 . . . . 0.0 117.172 -172.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -151.84 -83.29 0.09 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.366 1.866 . . . . 0.0 106.77 170.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -167.33 4.28 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 178.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 83.5 m-85 -115.81 140.29 49.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.237 -0.914 . . . . 0.0 110.899 -170.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.433 ' HG ' ' HG3' ' A' ' 65' ' ' PRO . 5.3 mp -111.07 112.3 24.02 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.964 0.905 . . . . 0.0 109.536 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.63 143.03 28.72 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.95 0.5 . . . . 0.0 112.17 -174.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.48 ' O ' HG12 ' A' ' 81' ' ' VAL . 39.1 t -109.38 137.46 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.212 1.005 . . . . 0.0 108.434 169.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -112.28 130.0 56.09 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -170.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.414 ' OG1' ' HA3' ' A' ' 100' ' ' GLY . 3.6 t -158.76 -41.8 0.06 Allowed 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.232 -175.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 65.9 m 58.68 -109.03 0.44 Allowed 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 117.777 -1.106 . . . . 0.0 111.808 -174.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 72.18 -42.14 0.52 Allowed 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.155 1.382 . . . . 0.0 113.427 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 148.01 -21.18 1.42 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 -166.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.489 HG11 ' HA ' ' A' ' 99' ' ' GLN . 14.0 m -84.44 134.25 43.06 Favored Pre-proline 0 CA--C 1.557 1.215 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 173.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.69 146.46 97.19 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.605 2.203 . . . . 0.0 112.015 175.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 73' ' ' VAL . 42.0 t -68.23 130.49 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -105.92 118.91 37.82 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -172.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -102.32 121.19 41.8 Favored 'General case' 0 C--N 1.344 0.355 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.448 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 54.5 p90 -109.0 153.62 23.34 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.472 0.709 . . . . 0.0 110.199 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -104.46 -9.6 18.28 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.778 0.831 . . . . 0.0 110.061 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.7 t -149.04 144.22 26.57 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.29 0.636 . . . . 0.0 109.403 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.593 HD13 HG23 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -60.73 -31.02 70.35 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.481 1.112 . . . . 0.0 111.232 -173.589 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -55.23 -34.42 58.93 Favored Glycine 0 CA--C 1.539 1.566 0 N-CA-C 113.984 0.354 . . . . 0.0 113.984 174.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 84' ' ' PHE . 46.9 mt-10 -68.28 -40.53 81.79 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.34 0.656 . . . . 0.0 110.982 175.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 51.0 tp -53.12 -55.54 23.27 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.336 0.589 . . . . 0.0 110.628 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.6 mm -66.97 -36.21 76.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.79 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.12 -52.34 53.06 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.754 0.659 . . . . 0.0 113.55 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.5 mt -65.74 -56.86 9.81 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.992 0.917 . . . . 0.0 111.102 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.593 ' HB3' HD11 ' A' ' 101' ' ' LEU . 83.8 m-85 -79.59 -4.25 50.68 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -170.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.32 -27.7 67.55 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.21 0.529 . . . . 0.0 110.513 164.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -84.17 131.52 50.67 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.146 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.458 ' HB3' ' HB3' ' A' ' 104' ' ' ALA . 81.7 Cg_endo -80.49 -172.97 1.67 Allowed 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.673 2.249 . . . . 0.0 113.598 -175.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 56.6 61.02 2.82 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.407 1.483 . . . . 0.0 111.33 -178.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.489 ' HA ' HG11 ' A' ' 79' ' ' VAL . 46.2 mt-30 -143.76 12.39 1.67 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.356 1.062 . . . . 0.0 111.441 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.414 ' HA3' ' OG1' ' A' ' 75' ' ' THR . . . 110.58 -5.79 29.69 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 112.16 -0.376 . . . . 0.0 112.16 178.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.593 HD11 ' HB3' ' A' ' 94' ' ' TYR . 94.4 mt -78.85 146.86 33.42 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.277 1.031 . . . . 0.0 111.234 -178.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.4 m -63.3 -26.72 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.391 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.83 171.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 31.9 p -162.61 171.85 16.29 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.514 1.126 . . . . 0.0 110.281 171.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' A' ' 97' ' ' PRO . . . -66.68 145.35 55.65 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 169.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 73.9 mt -64.38 103.39 0.64 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -177.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 62.5 tp -111.31 -60.25 1.86 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.589 0.756 . . . . 0.0 111.576 -166.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 35' ' ' SER . 5.8 tt -114.46 97.42 46.3 Favored Pre-proline 0 N--CA 1.474 0.741 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -169.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -81.44 130.34 6.98 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 122.232 1.955 . . . . 0.0 111.214 175.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.7 t . . . . . 0 C--O 1.251 1.174 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.186 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.439 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 66.3 43.96 91.71 Favored Glycine 0 C--N 1.345 1.029 0 O-C-N 123.722 0.639 . . . . 0.0 112.12 -173.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -62.65 141.32 58.57 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.07 0.948 . . . . 0.0 110.735 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -74.14 100.64 3.7 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.05 0.54 . . . . 0.0 110.427 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -133.47 94.04 3.25 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 124.219 1.008 . . . . 0.0 108.645 173.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -65.94 92.04 0.16 Allowed 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.315 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -87.16 55.49 3.58 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 122.146 0.974 . . . . 0.0 109.615 -177.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -139.99 163.75 31.85 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.334 -174.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.0 m 71.48 116.08 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.727 1.211 . . . . 0.0 110.611 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -71.89 171.62 11.4 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 123.068 0.547 . . . . 0.0 109.717 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 46.5 ttp 68.81 8.06 6.54 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.812 0.845 . . . . 0.0 111.188 177.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 t -72.14 -54.36 9.95 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.702 0.801 . . . . 0.0 110.199 -175.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.485 ' HB2' ' HB2' ' A' ' 108' ' ' PRO . 77.2 t90 92.45 -43.9 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.938 1.295 . . . . 0.0 110.928 163.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 87.9 t80 -109.71 110.78 21.92 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -174.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -126.48 106.18 9.27 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -176.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.52 ' HA ' ' HB3' ' A' ' 40' ' ' ASP . 39.8 ttm180 -74.94 152.0 38.83 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.402 176.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.526 ' HA ' ' HG2' ' A' ' 42' ' ' GLU 0.291 11.3 p-10 36.82 51.8 0.97 Allowed 'General case' 0 C--N 1.37 1.494 0 C-N-CA 125.356 1.462 . . . . 0.0 114.527 -172.325 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.7 tp -114.73 124.54 52.05 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 169.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.7 m -69.06 156.4 38.71 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.945 0.498 . . . . 0.0 110.235 -178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.3 ttp85 -54.04 -52.14 61.8 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.775 0.43 . . . . 0.0 111.061 172.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.03 -45.26 71.52 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.33 1.052 . . . . 0.0 111.867 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.06 -29.85 64.56 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.578 0.751 . . . . 0.0 112.089 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.577 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -76.84 -47.53 21.13 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.571 0.748 . . . . 0.0 111.419 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.513 ' HG3' HG22 ' A' ' 58' ' ' VAL . 32.8 tt0 -51.79 -39.82 59.33 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.252 1.421 . . . . 0.0 111.187 169.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -63.96 -47.72 79.3 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.3 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.7 tp -57.86 -45.14 86.75 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.677 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.599 HD22 HD22 ' A' ' 37' ' ' LEU . 94.2 mt -63.45 -50.45 69.7 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.016 0.927 . . . . 0.0 110.623 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.16 -34.5 73.66 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.756 0.823 . . . . 0.0 111.681 -175.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -83.88 -32.71 25.04 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.493 0.717 . . . . 0.0 111.384 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.82 -65.8 0.98 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -174.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.91 -47.22 0.84 Allowed Glycine 0 C--N 1.356 1.666 0 CA-C-N 117.995 0.362 . . . . 0.0 113.422 -172.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 55.9 24.9 8.01 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 125.573 1.549 . . . . 0.0 114.924 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -174.4 100.15 0.1 Allowed 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.264 -0.897 . . . . 0.0 109.582 -174.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.03 15.83 80.89 Favored Glycine 0 N--CA 1.474 1.199 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.908 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.1 m -85.53 116.29 23.74 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.916 0.887 . . . . 0.0 109.684 -170.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 44.7 p90 -126.74 159.45 33.69 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.814 0.34 . . . . 0.0 111.672 -175.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.599 HD22 HD22 ' A' ' 27' ' ' LEU . 1.6 pt? -163.13 163.73 25.6 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.008 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 25.6 t -126.71 122.69 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 175.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.435 HH21 HD23 ' A' ' 37' ' ' LEU . 9.3 ptp85 -116.87 157.66 25.27 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -177.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.52 ' HB3' ' HA ' ' A' ' 16' ' ' ARG . 33.6 t70 -93.82 122.96 36.83 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 170.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.4 m -57.16 151.98 14.46 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.706 0.629 . . . . 0.0 111.403 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.526 ' HG2' ' HA ' ' A' ' 17' ' ' ASP . 32.5 mt-10 -81.93 -22.14 36.89 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -163.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.3 t -167.6 103.33 0.5 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 172.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.1 p -158.84 169.88 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 C-N-CA 123.9 0.88 . . . . 0.0 109.564 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.99 23.21 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 175.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.58 91.2 1.49 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -175.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.16 134.68 15.32 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.488 1.115 . . . . 0.0 109.5 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -110.62 143.39 41.12 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.002 0.921 . . . . 0.0 109.197 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.1 125.2 52.06 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.606 0.362 . . . . 0.0 110.86 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.3 tp -105.51 131.62 52.69 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.714 ' SG ' HG23 ' A' ' 60' ' ' THR . 73.6 m -123.86 141.24 52.21 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 118.527 0.603 . . . . 0.0 110.126 171.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.6 t -125.47 114.72 40.88 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 170.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.638 HD11 HG21 ' A' ' 58' ' ' VAL . 13.8 tp -99.56 137.83 37.49 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.34 1.056 . . . . 0.0 108.921 176.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -149.44 102.87 3.23 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.003 1.321 . . . . 0.0 108.178 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 48.93 68.95 0.63 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.758 0.823 . . . . 0.0 112.808 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt 62.28 12.99 5.58 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -110.47 102.34 10.96 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.638 HG21 HD11 ' A' ' 53' ' ' LEU . 3.4 t -107.87 120.82 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -114.75 140.53 48.82 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 172.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.714 HG23 ' SG ' ' A' ' 51' ' ' CYS . 62.7 p -112.71 136.45 52.29 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.574 1.15 . . . . 0.0 109.072 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.29 96.91 4.43 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 178.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -80.94 100.7 9.05 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.481 HG21 HD13 ' A' ' 71' ' ' LEU . 15.6 mt -72.06 128.78 35.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.231 -1.35 . . . . 0.0 109.651 173.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.5 135.77 19.64 Favored Pre-proline 0 C--O 1.24 0.567 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 170.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 36.6 Cg_exo -62.1 -62.28 0.13 Allowed 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 122.786 2.324 . . . . 0.0 114.133 177.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.5 t70 87.91 -69.27 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.598 1.559 . . . . 0.0 109.2 175.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -85.5 16.71 38.54 Favored Glycine 0 C--N 1.357 1.698 0 CA-C-O 119.71 -0.495 . . . . 0.0 113.517 169.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 66.09 -30.76 0.14 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 174.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -76.5 -45.11 32.34 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.437 1.017 . . . . 0.0 111.131 -170.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 25.3 p90 -108.39 145.3 34.76 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 124.915 1.286 . . . . 0.0 108.504 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 2.6 pt? -99.23 118.96 37.09 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 164.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.62 117.6 33.44 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.528 0.731 . . . . 0.0 110.713 -175.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.817 HG21 HD11 ' A' ' 90' ' ' LEU . 14.6 t -89.58 116.28 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.094 0.958 . . . . 0.0 110.342 177.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -90.39 92.11 8.76 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.427 HG21 ' HE2' ' A' ' 94' ' ' TYR . 0.2 OUTLIER -54.07 -58.61 6.69 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.419 177.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.0 m -155.3 131.19 10.01 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.454 1.502 . . . . 0.0 107.336 163.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -66.16 95.46 0.29 Allowed 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 165.51 -58.21 0.25 Allowed Glycine 0 C--N 1.343 0.93 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -172.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.38 140.83 82.54 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 124.051 0.94 . . . . 0.0 109.41 169.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -49.9 87.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.386 2.511 0 C-N-CA 123.599 2.866 . . . . 0.0 114.134 173.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 73' ' ' VAL . 7.4 p -36.72 143.78 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 126.262 1.825 . . . . 0.0 115.252 169.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -107.18 132.86 52.58 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 124.2 1.0 . . . . 0.0 109.505 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -99.12 146.87 25.66 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.078 0.951 . . . . 0.0 109.001 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -136.23 164.78 27.28 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.911 0.884 . . . . 0.0 109.038 -174.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -126.44 -13.31 6.06 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.847 0.459 . . . . 0.0 110.333 176.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.544 ' HB ' ' HG3' ' A' ' 89' ' ' GLU . 20.8 m -140.15 140.7 36.01 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.631 0.772 . . . . 0.0 109.376 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 75.0 mt -58.36 -32.82 68.91 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.616 0.766 . . . . 0.0 111.551 172.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.493 ' H ' HG21 ' A' ' 86' ' ' THR . . . -60.39 -33.16 79.83 Favored Glycine 0 CA--C 1.532 1.154 0 O-C-N 123.493 0.496 . . . . 0.0 113.582 174.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.544 ' HG3' ' HB ' ' A' ' 86' ' ' THR . 47.6 mt-10 -71.83 -40.85 68.78 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.933 0.493 . . . . 0.0 110.168 176.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.817 HD11 HG21 ' A' ' 73' ' ' VAL . 42.2 tp -52.7 -51.59 59.67 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.553 0.741 . . . . 0.0 110.344 174.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 49.7 mm -62.79 -39.28 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.432 177.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.15 -57.32 20.39 Favored Glycine 0 CA--C 1.529 0.911 0 O-C-N 123.621 0.576 . . . . 0.0 113.44 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.7 mp -70.74 -52.01 23.58 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.562 0.745 . . . . 0.0 112.006 -177.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.521 ' HB3' HD13 ' A' ' 101' ' ' LEU . 30.2 m-85 -68.66 -17.26 64.06 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -173.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.44 -19.93 51.22 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 171.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -77.99 124.13 86.13 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 123.396 0.678 . . . . 0.0 109.996 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -70.95 168.29 23.54 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.67 2.246 . . . . 0.0 111.724 173.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 53.8 58.11 5.41 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.85 0.86 . . . . 0.0 110.532 -174.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -142.52 -15.91 0.73 Allowed 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.701 -177.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 141.54 -18.06 2.64 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -175.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.521 HD13 ' HB3' ' A' ' 94' ' ' TYR . 17.7 mt -99.93 105.98 17.75 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.23 0.612 . . . . 0.0 110.105 175.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.6 m -44.96 -25.98 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 125.221 1.408 . . . . 0.0 114.538 174.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 36.7 t -124.27 -11.3 7.47 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.141 0.576 . . . . 0.0 112.444 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 64.11 178.57 0.17 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.122 0.969 . . . . 0.0 111.399 -167.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.1 mt -77.62 92.12 4.06 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.7 176.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.0 tt -81.78 -65.38 1.02 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.856 0.462 . . . . 0.0 109.906 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -146.22 130.05 8.48 Favored Pre-proline 0 N--CA 1.491 1.575 0 C-N-CA 122.295 0.238 . . . . 0.0 110.919 -174.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.485 ' HB2' ' HB2' ' A' ' 13' ' ' TRP . 80.8 Cg_endo -74.38 145.13 33.61 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.689 2.259 . . . . 0.0 111.779 177.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 57.2 t . . . . . 0 C--O 1.256 1.422 0 C-N-CA 123.799 0.84 . . . . 0.0 109.533 179.543 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.411 ' HB2' ' HA ' ' A' ' 37' ' ' LEU . 4.3 p-90 -85.41 -1.13 56.7 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.966 -0.459 . . . . 0.0 110.761 -177.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -107.33 113.57 27.04 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -173.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.431 ' NE2' ' HB2' ' A' ' 37' ' ' LEU . 1.9 p80 -138.97 109.95 6.78 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.518 1.127 . . . . 0.0 108.76 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -86.73 26.82 1.06 Allowed 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 124.17 0.988 . . . . 0.0 110.634 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -160.39 25.31 0.16 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.295 0.638 . . . . 0.0 111.098 -162.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 20.0 tp -108.99 -49.09 3.18 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.675 -0.64 . . . . 0.0 111.63 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.4 t 80.08 153.23 0.12 Allowed 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 124.856 1.262 . . . . 0.0 109.869 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HB2' ' NH1' ' A' ' 39' ' ' ARG . 74.5 ttt180 -64.21 -38.87 92.6 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 118.019 0.372 . . . . 0.0 111.512 -168.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.57 -54.82 23.56 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 123.652 0.595 . . . . 0.0 110.752 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.77 -22.55 43.02 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.9 -57.08 4.13 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 123.206 0.602 . . . . 0.0 111.542 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.429 ' HG3' HG11 ' A' ' 58' ' ' VAL . 36.7 tt0 -57.76 -37.08 73.03 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.076 1.351 . . . . 0.0 111.26 173.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -71.05 -38.18 72.53 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.365 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -55.13 -43.76 74.43 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.285 0.634 . . . . 0.0 110.083 173.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.569 HD22 ' HB3' ' A' ' 35' ' ' SER . 82.8 mt -71.92 -42.31 66.84 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 123.485 0.49 . . . . 0.0 110.413 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.36 -37.32 71.65 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.543 0.737 . . . . 0.0 112.21 -174.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.7 mtp180 -82.16 -50.56 8.89 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.024 0.53 . . . . 0.0 111.325 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.476 ' HB1' HG11 ' A' ' 109' ' ' VAL . . . -66.41 -46.8 75.35 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.559 0.344 . . . . 0.0 110.314 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.38 125.84 0.0 OUTLIER Glycine 0 CA--C 1.538 1.515 0 N-CA-C 118.854 2.302 . . . . 0.0 118.854 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 177.66 103.22 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 165.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -62.44 149.92 41.36 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -154.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.41 ' HA2' ' SG ' ' A' ' 103' ' ' CYS . . . 89.56 17.45 54.77 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -161.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.569 ' HB3' HD22 ' A' ' 27' ' ' LEU . 17.2 m -71.81 130.59 41.44 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 124.434 1.094 . . . . 0.0 108.895 -177.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 108' ' ' PRO . 50.9 p90 -141.74 155.14 45.65 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.118 0.485 . . . . 0.0 111.034 177.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.465 ' HG ' HD21 ' A' ' 27' ' ' LEU . 0.8 OUTLIER -158.58 153.47 25.0 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.612 166.876 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.6 t -105.28 117.41 50.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.543 ' HG3' ' HB3' ' A' ' 49' ' ' ALA . 2.1 ptm180 -113.58 168.49 9.72 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 122.168 0.985 . . . . 0.0 110.816 -178.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -54.44 127.91 29.57 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 113.122 -1.854 . . . . 0.0 110.838 165.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.0 m -74.48 143.99 44.38 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 162.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -78.48 83.58 4.67 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.3 m 67.29 -75.51 0.06 Allowed 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 126.201 1.8 . . . . 0.0 111.785 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.607 HG23 ' H ' ' A' ' 45' ' ' ALA 0.317 35.1 m 39.21 -84.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 126.996 2.118 . . . . 0.0 113.743 -167.335 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.607 ' H ' HG23 ' A' ' 44' ' ' VAL . . . -156.6 29.48 0.33 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.147 0.979 . . . . 0.0 109.309 -175.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.48 49.64 7.98 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.532 -175.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.53 176.51 5.01 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.44 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 59.0 m-85 -114.67 157.19 23.45 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.437 1.495 . . . . 0.0 107.447 174.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.543 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . . . -128.87 147.05 50.79 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.391 0.676 . . . . 0.0 110.098 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.4 tp -125.84 113.3 17.06 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.27 1.028 . . . . 0.0 108.577 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 52.6 t -100.58 123.23 44.51 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.0 t -128.54 126.09 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.781 0.832 . . . . 0.0 110.004 -174.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 35' ' ' SER . 54.7 tp -101.33 140.29 35.82 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.32 1.048 . . . . 0.0 110.844 177.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -156.29 115.61 3.51 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.01 1.324 . . . . 0.0 108.775 173.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 41.1 71.94 0.18 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.678 1.591 . . . . 0.0 113.881 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 81.9 tttt 58.72 27.47 15.96 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.155 0.982 . . . . 0.0 111.905 177.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -138.3 106.39 5.73 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.378 0.671 . . . . 0.0 109.455 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.429 HG11 ' HG3' ' A' ' 24' ' ' GLU . 41.4 t -99.71 112.75 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 174.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -101.53 132.18 47.31 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 170.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 22.9 m -113.51 128.0 56.29 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -108.39 154.51 21.75 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.875 1.27 . . . . 0.0 107.838 -172.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -105.12 160.2 15.25 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.698 0.799 . . . . 0.0 109.63 165.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.733 HG12 HD11 ' A' ' 90' ' ' LEU . 3.8 mp -146.62 100.68 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 102.578 -3.119 . . . . 0.0 102.578 -166.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.5 mp -113.63 133.7 22.16 Favored Pre-proline 0 N--CA 1.477 0.889 0 O-C-N 121.641 -0.662 . . . . 0.0 109.693 -168.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.09 -68.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.214 1.943 . . . . 0.0 110.256 160.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.9 t70 125.33 -66.1 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 C-N-CA 127.238 2.215 . . . . 0.0 107.743 163.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -171.04 25.72 0.1 OUTLIER Glycine 0 C--N 1.345 1.067 0 CA-C-N 115.515 -0.766 . . . . 0.0 113.203 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -135.69 -83.21 0.4 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 175.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -179.78 3.91 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.123 0.569 . . . . 0.0 111.925 -174.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.512 ' HB3' ' HB2' ' A' ' 83' ' ' ARG . 64.9 m-85 -106.77 134.94 49.14 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.41 0.684 . . . . 0.0 109.343 -169.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.2 mp -96.8 106.4 18.7 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 118.884 0.765 . . . . 0.0 109.348 -169.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.79 140.2 37.97 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.825 0.85 . . . . 0.0 110.13 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.504 HG22 HG13 ' A' ' 63' ' ' ILE . 22.7 t -114.99 124.51 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 176.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -93.56 97.29 10.41 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.404 HG21 ' ND2' ' A' ' 98' ' ' ASN . 76.6 p -87.53 -48.31 8.03 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.6 m -157.78 177.04 11.81 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.385 1.474 . . . . 0.0 108.134 166.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -85.45 -57.97 2.85 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.279 0.632 . . . . 0.0 110.436 -174.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.17 -31.2 61.81 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.821 0.701 . . . . 0.0 114.069 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.4 t -61.45 122.82 73.24 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 118.851 -0.595 . . . . 0.0 109.396 169.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -57.15 110.99 0.68 Allowed 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.5 2.133 . . . . 0.0 110.555 174.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.4 t -79.35 143.71 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.978 0.911 . . . . 0.0 109.115 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -114.89 130.75 56.96 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.512 ' HB2' ' HB3' ' A' ' 70' ' ' PHE . 32.0 ptt180 -94.81 134.07 37.83 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 171.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -113.74 149.44 34.82 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.257 1.023 . . . . 0.0 109.815 -174.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -92.1 -15.79 27.25 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.58 0.352 . . . . 0.0 110.354 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.9 p -142.53 151.12 41.3 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 124.371 1.068 . . . . 0.0 109.457 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 99.5 mt -62.87 -25.88 68.5 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.674 0.789 . . . . 0.0 111.497 172.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -59.85 -41.9 97.9 Favored Glycine 0 CA--C 1.537 1.456 0 N-CA-C 114.02 0.368 . . . . 0.0 114.02 174.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -63.27 -37.79 88.63 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.529 0.732 . . . . 0.0 110.979 176.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.733 HD11 HG12 ' A' ' 63' ' ' ILE . 6.6 tt -59.46 -57.33 13.46 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.814 1.246 . . . . 0.0 109.742 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.412 ' HA ' HD12 ' A' ' 105' ' ' LEU . 48.2 mm -59.79 -38.62 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.098 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.98 -44.88 54.23 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.568 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 42.0 tp -67.64 -50.67 56.79 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.084 0.554 . . . . 0.0 111.405 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -75.35 -8.02 55.55 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.13 -24.12 64.43 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.431 0.634 . . . . 0.0 111.06 163.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -94.71 139.58 22.29 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.499 1.12 . . . . 0.0 108.87 174.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -48.94 127.0 16.06 Favored 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 123.137 2.558 . . . . 0.0 112.433 165.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.404 ' ND2' HG21 ' A' ' 75' ' ' THR . 26.2 p-10 -111.62 -45.1 3.4 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.194 -174.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 111.05 94.29 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 128.051 2.54 . . . . 0.0 106.341 -163.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 135.2 -38.99 1.74 Allowed Glycine 0 C--N 1.343 0.97 0 CA-C-N 116.052 -0.522 . . . . 0.0 113.1 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.444 ' HB3' ' H ' ' A' ' 104' ' ' ALA . 2.6 mm? -69.41 136.93 52.29 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.859 0.464 . . . . 0.0 110.494 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.5 m -60.97 -28.31 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.585 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.41 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 25.4 p -163.06 -1.1 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.444 ' H ' ' HB3' ' A' ' 101' ' ' LEU . . . 70.27 166.81 0.29 Allowed 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.947 0.899 . . . . 0.0 111.284 -167.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 91' ' ' ILE . 37.3 mt -88.94 97.98 11.49 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.506 0.722 . . . . 0.0 109.804 -173.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.3 tp -82.86 -51.81 7.29 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.688 -175.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -165.71 146.46 5.77 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 123.726 0.81 . . . . 0.0 109.032 -172.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 42.4 Cg_exo -56.89 -54.95 3.05 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.22 1.947 . . . . 0.0 111.885 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.476 HG11 ' HB1' ' A' ' 30' ' ' ALA . 2.4 t . . . . . 0 N--CA 1.48 1.037 0 C-N-CA 125.717 1.607 . . . . 0.0 107.142 170.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.1 t . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 3.5 p-90 -90.55 12.9 17.31 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.528 0.731 . . . . 0.0 110.614 169.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 49.9 t80 -115.2 117.94 31.91 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -130.91 87.23 2.46 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.063 0.545 . . . . 0.0 109.865 -173.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -73.09 160.1 32.55 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 167.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.1 t70 63.61 26.11 14.54 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 122.064 0.935 . . . . 0.0 110.634 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.1 tt -131.87 123.57 27.78 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.597 1.559 . . . . 0.0 106.864 177.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.7 p -77.24 160.89 28.57 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.841 0.457 . . . . 0.0 110.281 -172.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -65.52 -34.43 78.25 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 117.952 0.342 . . . . 0.0 110.848 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.47 -47.59 81.47 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.796 0.838 . . . . 0.0 110.291 173.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.45 -32.72 73.78 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.615 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.25 -62.68 1.39 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.526 0.73 . . . . 0.0 111.184 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -62.66 -28.49 69.95 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.521 0.728 . . . . 0.0 112.465 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -68.27 -50.37 54.2 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 123.606 0.566 . . . . 0.0 109.485 175.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -58.52 -39.99 81.64 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.584 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.1 -48.26 74.31 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.926 0.89 . . . . 0.0 109.802 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.49 -31.98 73.3 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.121 0.968 . . . . 0.0 112.329 -175.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -81.65 -38.64 25.61 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.439 0.696 . . . . 0.0 110.592 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.26 -63.87 1.23 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -169.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.93 -41.34 1.57 Allowed Glycine 0 C--N 1.352 1.421 0 N-CA-C 112.12 -0.392 . . . . 0.0 112.12 -173.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.3 ttp85 58.02 17.58 4.52 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.902 1.281 . . . . 0.0 114.207 171.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -175.83 98.11 0.07 Allowed 'General case' 0 N--CA 1.479 0.978 0 O-C-N 121.552 -0.718 . . . . 0.0 109.626 -166.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.53 20.67 79.59 Favored Glycine 0 N--CA 1.478 1.493 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 11.2 m -90.05 119.64 30.57 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 124.487 1.115 . . . . 0.0 110.628 -172.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -126.16 159.12 33.8 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.033 0.444 . . . . 0.0 111.229 -173.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.6 pp -155.31 165.31 37.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.296 168.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 25.9 t -112.46 154.25 13.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 171.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.645 HH22 ' HG2' ' A' ' 42' ' ' GLU . 4.2 ptm180 -157.69 -177.82 6.86 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 123.205 0.602 . . . . 0.0 109.381 -176.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -90.77 125.57 35.74 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 172.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.2 m -57.43 147.65 25.68 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.382 0.673 . . . . 0.0 110.651 174.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.645 ' HG2' HH22 ' A' ' 39' ' ' ARG . 42.2 mt-10 -78.22 89.11 4.28 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.343 0.657 . . . . 0.0 111.967 -164.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.2 t 66.16 27.85 10.3 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.494 1.518 . . . . 0.0 111.57 173.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.2 t -71.89 -71.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.588 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -173.7 34.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.397 0.679 . . . . 0.0 110.786 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.21 35.78 56.68 Favored Glycine 0 N--CA 1.476 1.322 0 CA-C-N 116.618 -0.265 . . . . 0.0 112.96 -168.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 63' ' ' ILE . . . -90.87 164.2 14.13 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.66 0.784 . . . . 0.0 110.457 -173.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.519 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 97.2 m-85 -102.76 148.2 25.9 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.445 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . . . -128.23 137.53 52.05 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.0 tp -112.06 104.0 12.22 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 47.4 m -104.26 114.08 28.07 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -174.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.68 141.44 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 -175.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.416 HD13 HG22 ' A' ' 58' ' ' VAL . 47.3 tp -126.96 144.45 51.01 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.946 0.898 . . . . 0.0 109.463 -176.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.402 ' HB3' ' HB ' ' A' ' 102' ' ' VAL . 66.0 t80 -154.26 109.58 3.14 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 46.19 71.59 0.28 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.544 1.138 . . . . 0.0 112.739 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 56.51 20.61 4.98 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.413 1.085 . . . . 0.0 113.74 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -124.86 108.9 12.39 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 120.921 0.391 . . . . 0.0 110.088 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.416 HG22 HD13 ' A' ' 53' ' ' LEU . 31.7 t -94.4 147.72 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 124.423 1.089 . . . . 0.0 110.046 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.91 113.19 8.77 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.88 1.272 . . . . 0.0 107.599 174.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 66.5 p -107.93 138.38 44.28 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -126.24 100.41 6.29 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -77.67 95.57 4.64 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.639 0.733 . . . . 0.0 109.48 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.521 HG21 HD12 ' A' ' 71' ' ' LEU . 32.5 mt -71.32 133.94 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.216 171.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -90.04 128.0 51.48 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 174.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -81.06 -81.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 123.1 2.533 . . . . 0.0 115.13 -157.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -149.8 160.85 43.23 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 118.262 0.483 . . . . 0.0 110.261 -163.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.58 -46.62 1.02 Allowed Glycine 0 N--CA 1.468 0.819 0 N-CA-C 107.417 -2.273 . . . . 0.0 107.417 -169.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -65.02 -147.07 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.649 0 CA-C-N 113.321 -1.439 . . . . 0.0 111.314 155.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -112.37 -24.36 9.81 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.512 0.725 . . . . 0.0 110.289 173.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -130.13 162.42 28.88 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.902 1.281 . . . . 0.0 110.985 -169.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.521 HD12 HG21 ' A' ' 63' ' ' ILE . 0.5 OUTLIER -102.95 132.02 49.49 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.426 1.09 . . . . 0.0 110.186 178.625 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -105.26 113.9 27.76 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.529 0.731 . . . . 0.0 112.802 -172.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 81' ' ' VAL . 23.0 t -85.32 138.73 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.69 0.796 . . . . 0.0 109.281 177.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -99.89 91.97 5.07 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.3 m -72.41 -65.39 0.79 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.079 0.551 . . . . 0.0 112.248 -166.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.2 t -168.82 178.23 4.69 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.668 0.387 . . . . 0.0 111.207 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -61.49 -39.01 89.4 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.718 1.207 . . . . 0.0 114.17 -168.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -139.68 40.86 1.37 Allowed Glycine 0 N--CA 1.472 1.081 0 CA-C-O 120.758 0.088 . . . . 0.0 113.044 -171.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.5 m -122.92 155.23 64.1 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 123.848 0.859 . . . . 0.0 109.285 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -65.61 128.65 20.54 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.556 2.171 . . . . 0.0 111.24 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 73' ' ' VAL . 45.6 t -90.02 126.57 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -120.29 139.2 53.07 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.12 0.568 . . . . 0.0 109.528 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -101.99 157.67 16.7 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.348 1.059 . . . . 0.0 108.702 178.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.637 ' HE1' HD12 ' A' ' 93' ' ' LEU . 95.4 m-85 -130.99 160.67 33.89 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.815 0.846 . . . . 0.0 109.103 -173.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -99.35 -18.41 17.54 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.512 0.325 . . . . 0.0 110.489 174.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.8 p -146.7 154.0 40.91 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.764 0.826 . . . . 0.0 110.141 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.448 ' O ' ' HB3' ' A' ' 90' ' ' LEU . 96.1 mt -64.15 -25.56 68.14 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.154 0.982 . . . . 0.0 111.805 173.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -56.89 -42.65 92.43 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 116.574 -0.284 . . . . 0.0 113.026 172.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -68.09 -34.08 75.74 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.668 0.787 . . . . 0.0 111.095 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 22.7 tp -56.24 -58.97 5.71 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.896 0.878 . . . . 0.0 110.262 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 44.9 mm -62.77 -37.92 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.747 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.2 -55.64 28.36 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 115.032 -0.986 . . . . 0.0 113.747 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.637 HD12 ' HE1' ' A' ' 84' ' ' PHE . 34.5 mt -75.77 -42.58 49.92 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -177.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -72.42 -7.41 49.62 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.6 -3.38 4.51 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 171.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 93' ' ' LEU . 13.4 pt20 -95.98 141.01 22.55 Favored Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 123.008 0.523 . . . . 0.0 109.685 174.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 96' ' ' GLN . 4.2 Cg_exo -78.84 173.27 13.81 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.829 2.352 . . . . 0.0 112.706 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 54.16 82.79 0.08 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.478 1.511 . . . . 0.0 111.885 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -159.35 9.43 0.12 Allowed 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.738 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.31 -13.62 56.99 Favored Glycine 0 N--CA 1.476 1.316 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -175.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.418 ' HB3' ' O ' ' A' ' 103' ' ' CYS . 2.2 mm? -65.58 153.31 41.89 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.411 1.484 . . . . 0.0 111.849 175.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 54' ' ' TYR . 19.8 m -82.65 76.3 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 164.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 104' ' ' ALA . 42.8 t 75.75 170.95 0.26 Allowed 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 113.879 -1.509 . . . . 0.0 110.6 -174.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.44 ' N ' ' SG ' ' A' ' 103' ' ' CYS . . . -72.47 166.48 22.52 Favored 'General case' 0 C--O 1.249 1.033 0 C-N-CA 122.984 0.514 . . . . 0.0 109.677 176.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 29.1 mt -73.68 92.58 1.99 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -85.15 -59.91 2.19 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.953 -170.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.496 HD12 ' HD2' ' A' ' 108' ' ' PRO . 50.3 tp -147.58 127.55 6.66 Favored Pre-proline 0 N--CA 1.469 0.524 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -175.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.496 ' HD2' HD12 ' A' ' 107' ' ' LEU . 10.6 Cg_endo -54.16 -72.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.156 1.904 . . . . 0.0 111.37 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 50.2 t . . . . . 0 C--O 1.252 1.187 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 174.977 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.5 t . . . . . 0 N--CA 1.475 0.796 0 CA-C-O 121.404 0.621 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.586 ' HB2' ' HA ' ' A' ' 37' ' ' LEU . 1.9 p-90 -80.75 -23.17 39.59 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 28.4 t80 -75.53 105.41 6.55 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.034 0.933 . . . . 0.0 110.422 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -127.36 108.24 10.67 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -54.68 150.4 9.61 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 123.335 0.654 . . . . 0.0 111.334 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.599 ' H ' ' HB3' ' A' ' 40' ' ' ASP . 37.7 t70 -9.71 76.31 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -149.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.431 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 28.5 tp -62.14 -26.4 68.29 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.5 168.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.4 t 82.14 138.44 0.06 Allowed 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 125.587 1.555 . . . . 0.0 108.622 174.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -58.76 -45.39 89.86 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.111 0.564 . . . . 0.0 112.198 -168.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.42 -50.44 71.48 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.879 0.871 . . . . 0.0 111.516 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -73.7 -19.03 60.93 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.704 -178.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.605 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -74.38 -53.33 9.83 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.147 0.979 . . . . 0.0 110.545 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.567 ' HA ' HD12 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -68.95 -21.91 64.16 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 123.682 0.614 . . . . 0.0 110.916 178.155 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -71.54 -51.2 24.77 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.091 0.556 . . . . 0.0 110.501 172.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.4 tp -57.98 -31.69 67.14 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.339 0.656 . . . . 0.0 111.578 174.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.567 HD12 ' HA ' ' A' ' 24' ' ' GLU . 85.6 mt -62.48 -59.95 4.24 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.75 -40.31 66.08 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.833 0.853 . . . . 0.0 112.937 -176.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -77.85 -55.45 5.31 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.578 0.751 . . . . 0.0 111.951 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.3 -60.9 2.05 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.064 0.545 . . . . 0.0 111.257 -172.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.69 82.18 0.31 Allowed Glycine 0 C--N 1.335 0.523 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -70.61 14.39 0.14 Allowed 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -166.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 175.16 138.56 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.172 0.989 . . . . 0.0 108.695 -171.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.92 -4.57 29.89 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 115.088 0.795 . . . . 0.0 115.088 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.5 m -86.92 161.88 18.02 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -166.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -151.23 153.19 34.42 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.878 0.871 . . . . 0.0 109.346 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.605 HD11 ' HB1' ' A' ' 23' ' ' ALA . 3.2 pp -149.82 155.17 39.63 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.446 0.699 . . . . 0.0 109.836 170.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 70.9 t -112.77 131.72 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -119.82 170.37 9.3 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.908 0.883 . . . . 0.0 109.594 175.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.599 ' HB3' ' H ' ' A' ' 17' ' ' ASP . 35.0 t70 -83.63 130.23 34.98 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 172.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.0 t -68.18 152.3 45.69 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.488 0.715 . . . . 0.0 111.118 -176.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -110.77 -36.52 5.68 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.4 t -54.45 -45.05 73.03 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.624 1.17 . . . . 0.0 111.061 173.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 65.1 t -130.12 115.92 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.52 0.728 . . . . 0.0 109.379 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.13 130.41 42.63 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.431 0.692 . . . . 0.0 110.877 174.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.46 -0.63 68.37 Favored Glycine 0 C--N 1.352 1.443 0 C-N-CA 122.894 0.283 . . . . 0.0 112.757 -177.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.0 176.75 4.95 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.897 0.879 . . . . 0.0 112.0 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.437 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 48.7 m-85 -126.0 168.67 13.62 Favored 'General case' 0 C--O 1.249 1.04 0 C-N-CA 124.888 1.275 . . . . 0.0 110.434 -176.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.56 148.47 42.6 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.059 1.344 . . . . 0.0 109.686 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.8 tp -123.73 114.64 20.2 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.112 0.965 . . . . 0.0 108.996 -176.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 60.5 m -107.44 121.65 45.04 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.3 t -126.66 132.39 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -173.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 68.6 tp -123.84 118.15 26.46 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.93 0.892 . . . . 0.0 110.104 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -136.07 132.11 35.74 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 166.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 42.19 61.55 1.94 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 124.977 1.311 . . . . 0.0 113.562 -176.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm 62.92 2.34 0.99 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 125.194 1.398 . . . . 0.0 113.673 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -103.65 105.89 16.25 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -173.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.0 t -86.06 139.63 17.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.066 0.946 . . . . 0.0 109.413 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -135.16 115.52 13.48 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 173.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 51.5 m -109.66 130.79 55.48 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -110.59 156.43 20.95 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.895 1.278 . . . . 0.0 108.26 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -100.91 156.52 17.34 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 163.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.659 HG13 HG13 ' A' ' 73' ' ' VAL . 2.9 mp -144.47 100.5 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 101.564 -3.495 . . . . 0.0 101.564 -167.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.21 154.76 37.44 Favored Pre-proline 0 C--N 1.318 -0.781 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -169.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.97 -73.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 121.485 1.457 . . . . 0.0 111.302 163.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 43.82 73.85 0.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.762 1.225 . . . . 0.0 111.925 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.24 -100.65 0.15 Allowed Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.026 -174.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 158.97 -25.09 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 126.167 1.787 . . . . 0.0 108.271 -170.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -152.07 -2.89 0.27 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.704 0.801 . . . . 0.0 112.121 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -119.59 160.83 21.71 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.733 0.813 . . . . 0.0 109.495 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.408 ' H ' HD23 ' A' ' 71' ' ' LEU . 1.5 pt? -115.12 121.42 42.97 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.615 0.766 . . . . 0.0 109.377 173.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.14 117.9 33.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.56 0.744 . . . . 0.0 110.7 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.659 HG13 HG13 ' A' ' 63' ' ' ILE . 25.6 t -92.09 145.14 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.788 -177.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -101.13 90.12 4.03 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.68 173.22 10.09 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.762 178.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.4 t -65.54 108.32 1.98 Allowed 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -56.7 101.63 0.06 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.147 0.979 . . . . 0.0 110.293 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.32 -24.45 0.45 Allowed Glycine 0 CA--C 1.529 0.953 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -165.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.1 m -118.0 162.27 30.36 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 125.326 1.45 . . . . 0.0 107.654 168.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -63.01 132.12 35.5 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.247 1.965 . . . . 0.0 112.271 176.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 94.2 t -71.58 123.37 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.563 0.745 . . . . 0.0 109.746 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.509 ' HG2' HD13 ' A' ' 93' ' ' LEU . 10.6 tpt180 -111.97 121.75 45.87 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 123.17 0.294 . . . . 0.0 110.89 -175.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.67 155.79 16.62 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.938 0.895 . . . . 0.0 109.19 170.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -133.96 165.6 24.64 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.614 0.766 . . . . 0.0 110.374 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -89.36 -23.99 22.08 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.991 0.516 . . . . 0.0 111.049 168.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.1 t -147.95 155.39 41.5 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.774 0.43 . . . . 0.0 111.195 -175.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.489 ' O ' HG12 ' A' ' 91' ' ' ILE . 86.1 mt -60.14 -31.04 69.7 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.854 0.861 . . . . 0.0 112.132 175.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.94 -47.34 31.96 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 123.094 0.378 . . . . 0.0 114.021 176.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -69.69 -30.28 67.9 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.375 0.67 . . . . 0.0 111.318 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.2 tt -66.86 -36.67 82.85 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.699 0.8 . . . . 0.0 109.13 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 87' ' ' LEU . 47.2 mm -80.92 -40.14 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -169.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.97 -38.98 64.18 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.79 -0.641 . . . . 0.0 113.471 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.509 HD13 ' HG2' ' A' ' 82' ' ' ARG . 7.9 tt -73.42 -36.11 65.93 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.571 0.348 . . . . 0.0 110.189 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.494 ' CD2' HD21 ' A' ' 101' ' ' LEU . 2.0 m-85 -84.28 -9.39 58.53 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.871 0.468 . . . . 0.0 110.613 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.37 0.4 17.0 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.383 0.673 . . . . 0.0 111.287 165.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -92.63 125.69 54.79 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 169.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -66.24 172.64 8.53 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.776 2.317 . . . . 0.0 113.029 171.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.3 t30 55.4 39.62 31.22 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.661 1.185 . . . . 0.0 111.548 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -122.09 10.07 10.0 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.661 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 99.56 -14.01 60.88 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -174.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.494 HD21 ' CD2' ' A' ' 94' ' ' TYR . 4.1 mm? -72.56 150.73 42.89 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.19 1.396 . . . . 0.0 110.702 176.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.4 m -84.34 74.91 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-O 122.206 1.003 . . . . 0.0 109.558 172.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 39.6 t 72.59 27.83 2.27 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 113.438 -1.71 . . . . 0.0 111.25 172.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 77.85 165.5 0.23 Allowed 'General case' 0 C--N 1.354 0.781 0 C-N-CA 125.076 1.35 . . . . 0.0 112.937 172.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.8 mt -76.71 101.81 5.95 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.293 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 78.2 mt -104.78 -50.73 3.21 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 122.957 0.503 . . . . 0.0 112.091 -172.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 mp -113.05 130.16 23.82 Favored Pre-proline 0 N--CA 1.491 1.61 0 CA-C-O 118.776 -0.63 . . . . 0.0 109.766 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -83.48 9.4 4.12 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.79 2.326 . . . . 0.0 113.234 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.542 HG21 HD23 ' A' ' 37' ' ' LEU . 49.3 t . . . . . 0 C--O 1.252 1.214 0 C-N-CA 125.382 1.473 . . . . 0.0 109.396 -172.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.8 m . . . . . 0 CA--C 1.539 0.536 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -83.76 1.36 43.24 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -165.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -105.06 96.44 6.53 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -170.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -110.2 89.97 3.18 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.27 52.39 2.01 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.017 0.913 . . . . 0.0 110.558 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -146.77 -17.76 0.42 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.725 1.61 . . . . 0.0 109.748 -174.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 28.7 tp -112.36 100.34 8.71 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.457 0.703 . . . . 0.0 110.26 -164.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.2 p -47.07 157.25 0.18 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 125.161 1.384 . . . . 0.0 112.801 172.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.39 -37.1 86.34 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.255 0.622 . . . . 0.0 112.096 -172.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.29 -51.27 68.38 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.392 0.677 . . . . 0.0 111.014 177.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.77 -20.08 61.24 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.934 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.6 -55.58 9.7 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.296 0.638 . . . . 0.0 110.738 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.459 ' HB3' ' SG ' ' A' ' 51' ' ' CYS . 12.3 pt-20 -70.2 -26.54 63.92 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.259 0.623 . . . . 0.0 111.719 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -64.9 -51.98 59.0 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -61.9 -35.39 78.23 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.062 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.6 mt -68.47 -33.82 74.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.585 0.354 . . . . 0.0 110.382 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.18 -37.77 81.33 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.995 0.809 . . . . 0.0 111.652 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -83.46 -44.01 15.2 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.056 0.542 . . . . 0.0 112.22 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.39 -58.2 3.24 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.213 0.605 . . . . 0.0 112.018 -169.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -100.07 -35.76 4.4 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.751 -176.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 66.15 -7.72 0.38 Allowed 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 126.322 1.849 . . . . 0.0 114.452 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -171.18 127.79 0.7 Allowed 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 124.818 1.247 . . . . 0.0 107.647 -165.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.479 ' HA3' HD23 ' A' ' 106' ' ' LEU . . . 65.05 11.61 52.05 Favored Glycine 0 N--CA 1.478 1.467 0 N-CA-C 114.107 0.403 . . . . 0.0 114.107 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.8 m -83.35 143.47 30.31 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.83 0.852 . . . . 0.0 110.278 -168.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -152.92 154.59 35.35 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.06 0.457 . . . . 0.0 110.52 176.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -151.62 153.66 34.91 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.777 169.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.557 HG22 HD13 ' A' ' 50' ' ' LEU . 40.1 t -107.25 145.64 14.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.543 ' HG3' ' HB3' ' A' ' 49' ' ' ALA . 0.9 OUTLIER -138.94 -179.36 5.79 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 125.308 1.443 . . . . 0.0 108.312 -178.472 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -91.34 148.11 22.56 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 172.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.555 ' HB2' ' HB ' ' A' ' 44' ' ' VAL . 40.9 m -61.92 140.69 58.28 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.987 0.515 . . . . 0.0 110.412 173.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -35.35 -54.53 0.65 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 126.356 1.862 . . . . 0.0 114.168 -167.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.1 m -142.61 28.87 1.59 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.91 0.484 . . . . 0.0 110.045 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.555 ' HB ' ' HB2' ' A' ' 41' ' ' SER . 24.2 t -110.24 112.1 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.37 117.98 8.04 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.037 -177.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.89 -0.46 89.47 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 114.537 0.575 . . . . 0.0 114.537 172.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -92.92 155.24 17.71 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 117.161 0.481 . . . . 0.0 109.834 173.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.54 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 68.3 m-85 -110.67 158.24 18.83 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.647 0.736 . . . . 0.0 109.753 -175.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.543 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . . . -135.06 147.37 49.59 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 166.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.557 HD13 HG22 ' A' ' 38' ' ' VAL . 45.6 tp -125.77 139.24 53.68 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -177.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.459 ' SG ' ' HB3' ' A' ' 24' ' ' GLU . 44.6 t -124.84 128.55 48.87 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 175.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.661 HG12 ' SG ' ' A' ' 103' ' ' CYS . 12.8 t -137.0 140.41 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 123.538 0.735 . . . . 0.0 109.779 -176.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.7 tp -132.34 120.52 22.19 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.609 1.164 . . . . 0.0 110.148 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -147.77 146.14 29.07 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.473 0.709 . . . . 0.0 109.089 168.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 50.3 47.58 23.58 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.74 1.216 . . . . 0.0 111.837 -177.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt 54.75 27.68 9.14 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.641 1.177 . . . . 0.0 112.716 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -123.72 107.26 11.27 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.228 1.011 . . . . 0.0 108.888 -174.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.5 t -83.73 131.54 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -135.84 111.08 9.0 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 176.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.2 p -104.87 127.22 52.61 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.961 0.904 . . . . 0.0 108.614 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -113.25 101.02 9.01 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.033 0.933 . . . . 0.0 108.846 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 84.4 mtm180 -70.9 155.63 40.57 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 168.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 91.7 mt -145.86 100.92 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 102.601 -3.111 . . . . 0.0 102.601 -152.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 mp -113.36 101.71 53.9 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 122.814 0.446 . . . . 0.0 110.617 -161.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.716 ' HB2' ' HA ' ' A' ' 68' ' ' GLU . 39.7 Cg_endo -66.3 103.62 0.67 Allowed 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.086 1.857 . . . . 0.0 110.02 167.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.16 -52.8 62.35 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.849 0.86 . . . . 0.0 110.446 -169.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -116.86 34.04 4.8 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.577 174.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.716 ' HA ' ' HB2' ' A' ' 65' ' ' PRO . 46.5 mt-10 50.29 4.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 -173.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -84.85 -49.21 8.6 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 119.602 1.092 . . . . 0.0 109.695 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 31.3 m-85 -127.57 142.07 51.47 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.715 0.806 . . . . 0.0 109.933 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.23 114.9 27.95 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.7 1.2 . . . . 0.0 108.736 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.97 119.39 35.35 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.243 1.017 . . . . 0.0 111.277 -170.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.441 HG22 HG23 ' A' ' 63' ' ' ILE . 16.1 t -106.96 143.67 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.057 0.943 . . . . 0.0 108.956 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -113.49 91.89 3.8 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -172.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.62 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 30.7 p -108.26 28.36 8.38 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.897 0.879 . . . . 0.0 110.482 -177.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.4 m -68.66 94.52 0.59 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.975 0.91 . . . . 0.0 113.353 -167.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -118.41 2.02 11.82 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 124.229 1.012 . . . . 0.0 110.165 164.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.48 22.88 0.03 OUTLIER Glycine 0 N--CA 1.471 0.982 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.459 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.9 m -140.27 152.42 66.96 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.503 1.121 . . . . 0.0 108.969 -174.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -73.32 -175.19 1.88 Allowed 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.375 2.05 . . . . 0.0 111.903 172.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 62.9 t -76.63 123.92 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 176.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 39.8 tpt85 -100.7 116.07 31.74 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -175.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.447 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 32.2 mtp85 -95.33 145.07 25.37 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.292 1.037 . . . . 0.0 110.07 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.648 ' HE1' HD12 ' A' ' 93' ' ' LEU . 83.6 m-85 -126.93 152.87 46.55 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.905 0.882 . . . . 0.0 109.181 -178.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -85.7 -21.56 28.24 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 172.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.7 t -153.33 158.25 41.28 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 122.998 0.519 . . . . 0.0 110.725 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.98 -27.54 68.9 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.238 1.015 . . . . 0.0 109.979 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -52.83 -46.19 60.45 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-N 116.364 -0.38 . . . . 0.0 113.999 173.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -66.88 -30.7 70.93 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.442 0.697 . . . . 0.0 110.97 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.0 tt -62.53 -57.95 9.33 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.319 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.494 ' HA ' HD12 ' A' ' 105' ' ' LEU . 38.3 mm -54.41 -46.11 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.67 0.788 . . . . 0.0 111.206 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.05 -56.96 14.21 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 114.568 -1.196 . . . . 0.0 113.75 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.648 HD12 ' HE1' ' A' ' 84' ' ' PHE . 86.7 mt -74.0 -37.02 64.54 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.944 0.498 . . . . 0.0 111.675 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.425 ' HE2' HG11 ' A' ' 73' ' ' VAL . 5.9 m-30 -82.28 -5.51 58.6 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -169.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.13 -5.37 26.59 Favored 'General case' 0 CA--C 1.562 1.429 0 CA-C-O 120.805 0.336 . . . . 0.0 111.418 165.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -97.13 130.56 29.49 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 124.726 1.21 . . . . 0.0 109.095 173.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.47 -175.66 2.79 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.892 2.395 . . . . 0.0 113.311 173.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.6 t30 49.22 71.9 0.34 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 126.041 1.736 . . . . 0.0 112.277 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.568 ' HG3' HD23 ' A' ' 101' ' ' LEU . 12.7 pt20 -176.45 11.3 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.427 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.62 ' HA3' ' HB ' ' A' ' 75' ' ' THR . . . 122.94 -32.89 4.25 Favored Glycine 0 C--N 1.345 1.074 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -173.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.568 HD23 ' HG3' ' A' ' 99' ' ' GLN . 3.4 mm? -76.66 101.41 5.74 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.533 0.733 . . . . 0.0 109.287 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.462 HG23 ' SG ' ' A' ' 103' ' ' CYS . 4.7 m -69.74 -15.08 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.783 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.661 ' SG ' HG12 ' A' ' 52' ' ' VAL . 14.6 m -115.29 -47.38 2.85 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.582 1.153 . . . . 0.0 111.617 -174.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 69.94 139.34 0.04 OUTLIER 'General case' 0 C--N 1.357 0.906 0 O-C-N 125.27 1.606 . . . . 0.0 108.973 -158.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 91' ' ' ILE . 46.0 mt -69.94 101.42 1.77 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -170.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.479 HD23 ' HA3' ' A' ' 34' ' ' GLY . 57.7 tp -108.68 -60.49 1.74 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.346 1.058 . . . . 0.0 111.056 -169.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 60.6 tp -120.48 101.41 46.35 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 123.165 0.586 . . . . 0.0 109.999 -169.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.38 122.0 5.89 Favored 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 122.884 2.389 . . . . 0.0 110.352 174.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 C--O 1.244 0.81 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.57 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.7 p . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.449 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . 4.9 p-90 -79.54 -21.35 45.28 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -175.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.456 ' HH ' ' HE1' ' A' ' 48' ' ' PHE . 89.0 t80 -81.66 125.79 31.0 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.486 171.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -117.67 129.76 55.94 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.438 ' O ' ' HB3' ' A' ' 40' ' ' ASP . 1.6 mpp_? -75.08 -37.93 61.44 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -174.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -130.93 90.1 2.84 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.988 0.899 . . . . 0.0 109.897 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.9 tp -135.59 139.77 44.11 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.841 1.256 . . . . 0.0 107.764 175.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.3 t -99.0 167.09 10.95 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.312 0.645 . . . . 0.0 110.342 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -64.74 -40.08 94.7 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.875 0.87 . . . . 0.0 113.184 -172.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.89 -48.34 77.04 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.067 0.547 . . . . 0.0 110.801 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.55 -30.81 70.54 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.674 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.478 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -65.98 -57.26 8.21 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.123 0.569 . . . . 0.0 110.922 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -58.01 -38.74 76.72 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.877 1.271 . . . . 0.0 112.041 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -70.17 -45.04 67.55 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.395 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.2 tp -58.16 -34.28 70.13 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.981 0.912 . . . . 0.0 111.441 175.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 23' ' ' ALA . 96.5 mt -66.11 -53.05 42.82 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.62 -39.14 87.12 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.265 1.026 . . . . 0.0 112.695 -172.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -73.37 -52.09 15.06 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.748 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.21 -56.18 3.79 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -166.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -101.98 -46.69 1.57 Allowed Glycine 0 N--CA 1.475 1.267 0 N-CA-C 113.404 0.121 . . . . 0.0 113.404 -172.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 49.05 21.49 0.49 Allowed 'General case' 0 CA--C 1.57 1.747 0 C-N-CA 126.196 1.798 . . . . 0.0 114.827 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -170.64 100.43 0.24 Allowed 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.27 -0.894 . . . . 0.0 109.361 -168.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.407 ' HA3' ' HB2' ' A' ' 106' ' ' LEU . . . 66.44 19.05 68.36 Favored Glycine 0 C--N 1.353 1.488 0 CA-C-O 121.465 0.48 . . . . 0.0 112.394 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 9.2 m -84.55 122.8 29.53 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 124.533 1.133 . . . . 0.0 110.859 -167.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 36.7 p90 -129.76 156.7 43.89 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.986 0.422 . . . . 0.0 110.725 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.478 HD11 ' HB1' ' A' ' 23' ' ' ALA . 4.3 pp -150.2 160.11 43.93 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 167.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 57.4 t -114.23 148.54 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 174.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -149.05 151.94 35.37 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.308 0.643 . . . . 0.0 109.476 -174.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' A' ' 16' ' ' ARG . 25.3 t70 -91.11 118.33 30.34 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 174.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.3 m -92.69 97.33 10.72 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -173.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -55.29 -39.17 69.56 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.058 0.943 . . . . 0.0 112.325 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.6 m -58.31 -24.34 59.28 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.2 t -80.27 -87.0 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-O 119.476 -0.297 . . . . 0.0 110.913 -174.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -178.03 18.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 122.909 0.484 . . . . 0.0 111.595 -167.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.75 88.03 1.2 Allowed Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -159.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.3 163.75 39.71 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.717 0.807 . . . . 0.0 109.789 -170.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.596 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 21.2 m-85 -116.01 162.23 17.7 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.37 0.668 . . . . 0.0 109.69 168.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.55 149.38 43.81 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.169 0.988 . . . . 0.0 110.1 170.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.511 ' HB2' HD11 ' A' ' 63' ' ' ILE . 51.9 tp -117.2 111.29 19.24 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 55.4 m -101.17 121.52 41.98 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.4 t -125.19 143.52 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.532 HD13 HG22 ' A' ' 58' ' ' VAL . 51.0 tp -133.0 147.4 52.27 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.366 1.066 . . . . 0.0 109.214 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -162.33 115.88 1.77 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.9 tm0? 36.06 73.75 0.08 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 125.907 1.683 . . . . 0.0 112.612 -174.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 44.6 tptt 56.64 26.41 11.15 Favored 'General case' 0 CA--C 1.572 1.825 0 C-N-CA 124.391 1.076 . . . . 0.0 112.684 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -130.19 107.33 9.22 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 121.482 -0.761 . . . . 0.0 109.272 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.532 HG22 HD13 ' A' ' 53' ' ' LEU . 21.6 t -93.1 142.0 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.506 0.722 . . . . 0.0 109.995 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -137.14 112.77 9.43 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.639 1.576 . . . . 0.0 107.754 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.9 m -119.37 140.17 50.79 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -133.98 113.8 12.55 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.719 0.807 . . . . 0.0 109.41 -173.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -64.79 156.89 29.16 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 171.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.596 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 79.7 mt -148.33 104.32 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 -158.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -96.01 102.44 10.65 Favored Pre-proline 0 N--CA 1.478 0.93 0 CA-C-N 118.885 0.766 . . . . 0.0 109.453 -168.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.457 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 93.1 Cg_endo -76.73 -56.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 123.043 2.495 . . . . 0.0 115.99 -163.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -125.9 141.02 52.17 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 118.146 0.43 . . . . 0.0 111.081 -162.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.05 -16.44 0.24 Allowed Glycine 0 CA--C 1.534 1.236 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.161 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -146.84 -70.5 0.24 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.776 1.231 . . . . 0.0 108.592 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -166.62 -41.31 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.989 -175.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -110.16 151.18 27.6 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.766 0.426 . . . . 0.0 111.222 -167.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.457 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 3.8 pp -99.73 111.58 23.9 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 171.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -101.1 123.48 45.33 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.133 0.573 . . . . 0.0 110.541 -173.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.801 HG21 HD13 ' A' ' 90' ' ' LEU . 57.5 t -93.91 138.12 21.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -95.54 88.45 5.06 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.6 m -73.44 -77.95 0.1 Allowed 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.416 -173.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.433 ' HB2' HG22 ' A' ' 79' ' ' VAL . 66.6 m -161.15 128.29 4.1 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.799 0.84 . . . . 0.0 110.437 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.4 mp0 -70.07 92.87 0.76 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 169.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.53 -36.13 0.69 Allowed Glycine 0 C--N 1.346 1.099 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -170.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 99' ' ' GLN . 13.0 m -104.89 158.34 32.23 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 123.495 0.718 . . . . 0.0 109.171 177.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.36 111.05 1.18 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.256 1.971 . . . . 0.0 110.869 167.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 95.7 t -93.6 132.25 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.944 0.898 . . . . 0.0 108.675 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -112.13 136.13 51.91 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.948 0.499 . . . . 0.0 110.454 -173.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -89.92 140.97 29.1 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.303 1.041 . . . . 0.0 109.328 174.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -111.17 174.45 5.86 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.449 1.099 . . . . 0.0 110.207 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -120.08 -49.64 2.29 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -164.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.8 m -128.73 161.26 30.14 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 113.495 -1.684 . . . . 0.0 107.697 171.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.47 -26.13 67.7 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 118.647 0.658 . . . . 0.0 112.41 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -56.58 -34.93 64.93 Favored Glycine 0 N--CA 1.48 1.611 0 O-C-N 122.991 0.182 . . . . 0.0 113.47 169.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -67.45 -38.96 85.27 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.2 0.6 . . . . 0.0 110.677 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.801 HD13 HG21 ' A' ' 73' ' ' VAL . 37.6 tp -61.84 -64.71 0.85 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.855 0.862 . . . . 0.0 110.717 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.7 mm -59.68 -39.36 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.318 1.047 . . . . 0.0 111.063 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.18 -57.66 18.06 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.135 -0.939 . . . . 0.0 113.853 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.1 tt -67.63 -45.83 74.25 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.266 0.626 . . . . 0.0 110.101 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.469 ' HB3' ' HG ' ' A' ' 105' ' ' LEU . 5.7 m-30 -77.04 -12.15 59.9 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -170.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.42 -22.24 66.77 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.224 0.535 . . . . 0.0 110.835 169.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -94.45 139.25 22.31 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 174.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -46.3 117.75 2.13 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.105 2.537 . . . . 0.0 112.137 166.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -110.24 -58.37 2.08 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.518 -164.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.445 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . 9.4 mm-40 128.33 102.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 128.37 2.668 . . . . 0.0 107.595 -159.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 120.55 -39.91 2.31 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-O 120.117 -0.269 . . . . 0.0 113.432 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.438 HD11 ' HB3' ' A' ' 94' ' ' TYR . 76.2 mt -68.9 150.28 47.93 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.8 p -64.49 -36.83 78.41 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.174 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.4 ' SG ' HD11 ' A' ' 106' ' ' LEU . 49.0 t -165.25 20.64 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.268 0.627 . . . . 0.0 111.146 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 72.14 167.97 0.31 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.611 1.165 . . . . 0.0 110.664 -169.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.469 ' HG ' ' HB3' ' A' ' 94' ' ' TYR . 23.4 mt -81.18 98.91 8.28 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.167 0.587 . . . . 0.0 109.611 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.407 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 89.8 mt -93.95 -46.5 7.14 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.459 0.704 . . . . 0.0 112.404 -172.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 35' ' ' SER . 68.5 tp -141.54 116.68 7.06 Favored Pre-proline 0 N--CA 1.486 1.373 0 C-N-CA 123.079 0.552 . . . . 0.0 111.055 -174.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.449 ' HB2' ' HB3' ' A' ' 13' ' ' TRP . 73.2 Cg_endo -77.94 136.38 14.83 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.372 2.048 . . . . 0.0 111.581 174.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--O 1.25 1.086 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.407 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 CA--C 1.553 1.095 0 CA-C-O 119.57 -0.252 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.509 ' HB3' ' HB3' ' A' ' 108' ' ' PRO . 6.1 p-90 -99.23 15.5 25.9 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.813 0.845 . . . . 0.0 112.005 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 61.7 t80 -113.76 116.09 28.83 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -131.23 99.16 4.77 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.207 0.603 . . . . 0.0 110.373 -177.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.478 ' HD3' ' N ' ' A' ' 17' ' ' ASP . 1.0 OUTLIER -72.73 150.59 42.74 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 167.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.478 ' N ' ' HD3' ' A' ' 16' ' ' ARG . 36.6 t70 79.19 3.54 2.33 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.891 1.276 . . . . 0.0 111.389 -175.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.2 tp -99.44 123.25 43.55 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.082 -1.011 . . . . 0.0 109.042 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.2 p -80.85 160.84 24.66 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.663 0.785 . . . . 0.0 109.917 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.445 ' HB3' ' NH2' ' A' ' 39' ' ' ARG . 5.5 ppt_? -64.63 -35.47 81.13 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 118.458 0.572 . . . . 0.0 112.252 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.87 -48.86 78.63 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.538 0.735 . . . . 0.0 110.75 175.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.21 -26.56 62.99 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.849 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.462 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -71.97 -54.55 9.62 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.72 0.808 . . . . 0.0 110.768 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.578 ' HG2' HG21 ' A' ' 58' ' ' VAL . 5.5 tm-20 -56.97 -39.72 75.14 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.951 1.3 . . . . 0.0 111.52 175.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.82 -46.72 80.78 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 123.976 0.798 . . . . 0.0 110.156 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -60.63 -43.87 97.02 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 124.088 0.868 . . . . 0.0 110.411 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.4 mt -65.26 -42.18 93.52 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.368 0.667 . . . . 0.0 110.186 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.47 -35.87 80.03 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.764 0.826 . . . . 0.0 111.604 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 46.5 ttt85 -77.69 -30.77 52.06 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.573 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.53 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -87.91 -61.43 1.72 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -172.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -125.31 -48.05 0.21 Allowed Glycine 0 N--CA 1.474 1.195 0 C-N-CA 122.951 0.31 . . . . 0.0 112.7 -169.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.476 ' HG3' HD21 ' A' ' 53' ' ' LEU . 40.2 ttp180 45.57 41.96 7.55 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.343 1.857 . . . . 0.0 114.541 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -174.16 88.52 0.06 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -174.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.516 ' HA2' ' SG ' ' A' ' 103' ' ' CYS . . . 83.75 12.75 76.91 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.785 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 m -83.75 118.93 24.23 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 124.634 1.173 . . . . 0.0 110.563 -169.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -125.98 158.92 34.05 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.084 0.468 . . . . 0.0 110.178 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.462 HD11 ' HB1' ' A' ' 23' ' ' ALA . 3.8 pp -153.7 164.94 37.44 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.731 166.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.42 HG22 HD13 ' A' ' 50' ' ' LEU . 97.7 t -119.27 148.64 22.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 170.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.445 ' NH2' ' HB3' ' A' ' 20' ' ' ARG . 43.7 ptt85 -153.6 -178.31 6.94 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -93.29 141.54 28.32 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 165.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.4 m -65.65 146.22 55.08 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 163.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -66.6 81.37 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -158.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.6 m 51.12 30.88 5.96 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.96 1.304 . . . . 0.0 112.654 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.1 m -72.46 -44.04 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.892 -168.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -174.01 9.32 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.441 0.697 . . . . 0.0 111.454 -169.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.77 19.19 60.16 Favored Glycine 0 N--CA 1.474 1.183 0 N-CA-C 112.141 -0.384 . . . . 0.0 112.141 -171.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.79 155.3 18.88 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.989 0.916 . . . . 0.0 111.681 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -106.55 158.85 16.62 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.023 0.929 . . . . 0.0 110.398 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.88 141.19 51.36 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.986 0.514 . . . . 0.0 110.136 169.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.598 HD22 HD21 ' A' ' 90' ' ' LEU . 51.9 tp -114.32 107.09 15.11 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.136 1.374 . . . . 0.0 107.495 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 42.5 t -104.04 114.37 28.57 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -175.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.7 t -120.61 133.14 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.025 0.93 . . . . 0.0 108.724 -175.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.476 HD21 ' HG3' ' A' ' 32' ' ' ARG . 12.3 tp -128.98 140.89 51.45 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.858 1.263 . . . . 0.0 109.283 -173.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -155.3 115.54 3.79 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 41.75 71.05 0.23 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.001 1.32 . . . . 0.0 113.892 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.9 mttt 59.31 23.4 11.83 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.407 1.083 . . . . 0.0 113.714 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -131.82 105.68 7.62 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.578 HG21 ' HG2' ' A' ' 24' ' ' GLU . 40.1 t -103.9 109.0 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.823 0.849 . . . . 0.0 109.053 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -103.02 123.33 46.41 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 171.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 36.8 m -120.01 141.9 49.29 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.046 0.939 . . . . 0.0 108.687 -172.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -124.39 100.44 6.68 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -172.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.5 mtp-105 -81.97 98.61 8.67 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.52 HG12 HG22 ' A' ' 73' ' ' VAL . 6.1 mt -75.45 110.51 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.362 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.0 mp -112.06 103.12 55.06 Favored Pre-proline 0 C--O 1.241 0.639 0 C-N-CA 124.887 1.275 . . . . 0.0 107.566 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -58.05 -57.88 0.98 Allowed 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.259 1.972 . . . . 0.0 110.705 170.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.7 t70 56.01 36.09 26.74 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 122.788 1.28 . . . . 0.0 109.825 173.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.07 178.0 28.06 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.939 -165.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -108.9 -13.37 14.76 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 118.589 1.195 . . . . 0.0 111.029 -175.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -65.47 -85.0 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.451 0.701 . . . . 0.0 110.914 -174.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -131.04 155.68 46.46 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.675 0.75 . . . . 0.0 111.777 175.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.48 110.93 17.07 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.063 1.745 . . . . 0.0 107.578 169.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.12 132.0 43.33 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.147 0.579 . . . . 0.0 110.586 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.52 HG22 HG12 ' A' ' 63' ' ' ILE . 39.8 t -99.38 112.92 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -177.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -90.65 94.56 9.75 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.106 0.563 . . . . 0.0 109.923 -169.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.684 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 65.4 p -65.8 -27.88 68.6 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.612 0.765 . . . . 0.0 112.433 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.8 t -142.07 -169.97 3.05 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.006 0.922 . . . . 0.0 109.796 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -54.45 -55.3 30.28 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.473 1.109 . . . . 0.0 112.386 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.29 44.05 0.19 Allowed Glycine 0 CA--C 1.505 -0.536 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.855 176.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.0 m -69.32 166.3 31.01 Favored Pre-proline 0 CA--C 1.557 1.217 0 C-N-CA 123.347 0.659 . . . . 0.0 111.364 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.45 53.22 1.31 Allowed 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 122.89 2.393 . . . . 0.0 112.652 167.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.509 HG22 ' H ' ' A' ' 82' ' ' ARG . 4.3 p -55.85 176.44 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 C-N-CA 125.42 1.488 . . . . 0.0 111.989 162.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.509 ' H ' HG22 ' A' ' 81' ' ' VAL . 42.4 mmm-85 -108.93 140.49 42.34 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -169.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -95.18 126.44 40.5 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -112.18 166.01 11.65 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.447 0.467 . . . . 0.0 109.876 -175.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -132.27 -4.92 3.41 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.767 0.827 . . . . 0.0 109.006 169.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.529 HG22 ' H ' ' A' ' 88' ' ' GLY . 87.6 m -141.73 136.07 30.41 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.362 1.065 . . . . 0.0 109.645 -172.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 78.7 mt -66.35 -28.26 68.52 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.908 0.883 . . . . 0.0 111.125 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.529 ' H ' HG22 ' A' ' 86' ' ' THR . . . -57.65 -46.74 91.82 Favored Glycine 0 N--CA 1.475 1.234 0 N-CA-C 114.401 0.52 . . . . 0.0 114.401 174.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -65.56 -36.1 82.79 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.548 0.739 . . . . 0.0 111.01 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.598 HD21 HD22 ' A' ' 50' ' ' LEU . 6.5 tt -59.91 -63.68 1.21 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.937 1.295 . . . . 0.0 110.403 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 31.6 mm -60.67 -43.64 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.209 1.004 . . . . 0.0 110.94 -175.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.09 -48.69 66.44 Favored Glycine 0 C--N 1.343 0.955 0 O-C-N 124.219 0.95 . . . . 0.0 113.482 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.2 tt -67.04 -59.67 3.27 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.481 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . 20.2 m-85 -71.69 -5.9 37.19 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -166.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.67 -16.31 25.6 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.048 0.539 . . . . 0.0 111.867 165.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -90.76 146.46 34.08 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 173.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -91.72 -168.19 0.23 Allowed 'Trans proline' 0 C--N 1.363 1.338 0 C-N-CA 122.916 2.411 . . . . 0.0 111.939 172.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.4 t30 52.62 62.39 2.71 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.845 1.258 . . . . 0.0 111.868 176.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -174.31 5.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.985 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.684 ' HA3' ' HB ' ' A' ' 75' ' ' THR . . . 130.97 -31.49 3.17 Favored Glycine 0 N--CA 1.473 1.121 0 N-CA-C 112.221 -0.352 . . . . 0.0 112.221 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' A' ' 94' ' ' TYR . 3.9 mm? -83.17 97.34 8.77 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.5 m -46.63 -32.83 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 126.079 1.752 . . . . 0.0 114.533 -175.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.516 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 24.6 p -130.46 3.07 4.62 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.021 0.528 . . . . 0.0 111.731 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.404 ' HA ' ' HB3' ' A' ' 101' ' ' LEU . . . 66.6 -179.99 0.21 Allowed 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.344 1.028 . . . . 0.0 110.444 -171.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 60.9 mt -90.36 83.16 5.91 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 168.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.3 tp -110.3 -63.03 1.43 Allowed 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.161 -171.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.32 115.51 63.73 Favored Pre-proline 0 N--CA 1.485 1.305 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.509 ' HB3' ' HB3' ' A' ' 13' ' ' TRP . 4.9 Cg_exo -71.14 -90.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 121.805 1.67 . . . . 0.0 110.049 173.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.53 HG13 ' HB1' ' A' ' 30' ' ' ALA . 78.6 t . . . . . 0 C--O 1.254 1.342 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 172.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.7 t . . . . . 0 CA--C 1.556 1.195 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -70.68 -18.55 62.82 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.289 0.635 . . . . 0.0 110.033 172.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 76.2 t80 -85.54 130.42 34.58 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.129 0.572 . . . . 0.0 109.622 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -130.0 140.49 50.87 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -66.17 -53.53 36.35 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -169.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -155.67 72.34 0.79 Allowed 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 122.133 0.968 . . . . 0.0 111.44 175.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.71 HD22 HH21 ' A' ' 39' ' ' ARG . 8.7 tt -92.92 135.01 34.53 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 160.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.404 ' O ' HD23 ' A' ' 18' ' ' LEU . 48.1 t -66.97 146.47 54.34 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.776 0.831 . . . . 0.0 110.043 -173.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.47 ' NE ' ' H ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -64.84 -42.24 95.08 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.671 0.389 . . . . 0.0 110.956 -176.422 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.15 -51.2 67.22 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.56 0.744 . . . . 0.0 111.306 172.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.22 -29.3 70.4 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.659 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.433 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -69.59 -45.82 67.77 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.535 1.134 . . . . 0.0 111.893 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 43.9 mt-10 -56.73 -44.46 81.68 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.669 0.787 . . . . 0.0 110.898 175.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.28 -40.02 86.1 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.412 177.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.5 -42.41 92.12 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.315 1.046 . . . . 0.0 109.65 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.59 HD22 ' HB2' ' A' ' 35' ' ' SER . 93.7 mt -65.52 -43.64 89.4 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.511 0.724 . . . . 0.0 110.461 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.95 -34.91 70.43 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 124.066 0.854 . . . . 0.0 112.283 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -87.83 -43.06 12.12 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.85 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.86 -61.79 1.86 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -167.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.425 ' HA3' ' HB3' ' A' ' 35' ' ' SER . . . -95.29 -33.0 6.72 Favored Glycine 0 C--N 1.352 1.465 0 CA-C-O 121.277 0.376 . . . . 0.0 112.368 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 68.07 0.61 2.47 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 126.904 2.081 . . . . 0.0 114.405 175.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.2 t70 175.53 125.71 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.29 0.636 . . . . 0.0 109.381 -175.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.57 6.06 70.01 Favored Glycine 0 N--CA 1.477 1.417 0 O-C-N 123.285 0.366 . . . . 0.0 112.714 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.59 ' HB2' HD22 ' A' ' 27' ' ' LEU . 3.1 p -80.69 136.9 36.27 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.022 0.929 . . . . 0.0 109.639 -172.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.415 ' HB2' HG22 ' A' ' 52' ' ' VAL . 29.4 p90 -137.13 158.51 44.28 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.817 0.447 . . . . 0.0 110.577 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.447 HD11 ' HB3' ' A' ' 51' ' ' CYS . 1.2 pp -155.23 165.98 34.97 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.19 0.996 . . . . 0.0 109.729 174.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 89.2 t -132.64 130.54 59.48 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 173.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.71 HH21 HD22 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -121.59 179.16 4.55 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 169.859 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -92.18 140.24 29.82 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 171.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.8 m -71.89 162.65 29.14 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.305 1.042 . . . . 0.0 111.613 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.84 -29.91 8.8 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.142 0.577 . . . . 0.0 110.704 -178.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.8 p -89.63 -58.21 2.6 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 123.739 0.816 . . . . 0.0 110.425 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.5 t -86.68 106.06 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -175.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.8 117.63 7.19 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.957 0.903 . . . . 0.0 111.773 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.42 -0.07 74.02 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-O 119.856 -0.413 . . . . 0.0 113.365 176.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.04 151.64 20.96 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 117.455 0.628 . . . . 0.0 111.689 -177.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -110.82 130.19 55.65 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.875 0.87 . . . . 0.0 111.333 -175.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.419 ' HB3' ' HG2' ' A' ' 39' ' ' ARG . . . -100.51 114.48 28.12 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.904 0.882 . . . . 0.0 110.251 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.5 tp -106.24 108.49 20.02 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.447 ' HB3' HD11 ' A' ' 37' ' ' LEU . 43.3 t -111.39 124.49 52.36 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -177.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 36' ' ' PHE . 17.9 t -129.45 116.65 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.025 0.93 . . . . 0.0 109.675 -174.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.671 HD13 HG22 ' A' ' 58' ' ' VAL . 32.5 tp -86.34 142.83 28.2 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.058 0.943 . . . . 0.0 109.568 173.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -162.78 127.4 3.1 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.515 0.726 . . . . 0.0 109.719 167.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 47.35 62.78 2.25 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.5 1.52 . . . . 0.0 112.682 173.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.63 30.98 16.38 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.633 1.173 . . . . 0.0 111.949 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -141.52 105.93 4.84 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.265 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.671 HG22 HD13 ' A' ' 53' ' ' LEU . 2.7 t -92.98 122.8 44.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 172.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -114.98 140.29 49.15 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.9 p -111.76 136.58 50.83 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.842 0.857 . . . . 0.0 108.716 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -128.46 101.5 6.22 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -84.19 102.63 12.75 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.222 0.609 . . . . 0.0 109.825 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.1 mp -71.39 129.86 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.935 168.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.61 139.82 23.36 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 123.709 0.804 . . . . 0.0 109.533 171.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -83.11 111.51 1.9 Allowed 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.16 1.907 . . . . 0.0 111.129 169.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -69.43 -58.87 3.44 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.675 0.39 . . . . 0.0 110.185 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -96.74 33.04 5.98 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 119.543 -0.587 . . . . 0.0 112.548 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 69.49 -34.03 0.27 Allowed 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -89.11 -48.66 7.25 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.255 0.622 . . . . 0.0 111.094 -165.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -103.51 135.9 44.24 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp -106.68 151.1 25.54 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.557 ' HB2' ' HG2' ' A' ' 83' ' ' ARG . . . -138.93 134.23 32.92 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.163 -0.336 . . . . 0.0 111.481 -169.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.3 p -85.85 135.36 25.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 171.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -98.23 94.74 6.96 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.3 p -78.12 -63.84 1.3 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.407 0.683 . . . . 0.0 111.147 -170.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.538 ' HB3' HG22 ' A' ' 79' ' ' VAL . 41.3 t -177.37 140.15 0.27 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.916 0.886 . . . . 0.0 109.096 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -76.27 91.44 3.22 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 168.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.5 -27.15 0.42 Allowed Glycine 0 C--N 1.339 0.71 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -167.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 76' ' ' SER . 34.7 m -127.4 156.58 74.8 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 124.482 1.113 . . . . 0.0 108.449 174.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.12 136.57 61.34 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.525 2.15 . . . . 0.0 112.986 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 95.9 t -94.68 134.52 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.103 0.961 . . . . 0.0 108.589 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.4 tpt85 -113.78 130.9 56.39 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.68 0.792 . . . . 0.0 109.998 -176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.557 ' HG2' ' HB2' ' A' ' 72' ' ' ALA . 48.1 mtm105 -101.81 156.08 17.73 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.046 0.939 . . . . 0.0 108.83 173.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -137.52 160.85 37.98 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.729 0.812 . . . . 0.0 109.059 -172.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -88.99 -24.1 22.47 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 173.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 88' ' ' GLY . 33.2 m -154.6 154.48 33.09 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 124.289 1.036 . . . . 0.0 109.974 -175.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.8 mt -58.85 -32.28 69.29 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.407 1.083 . . . . 0.0 112.272 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.521 ' H ' HG22 ' A' ' 86' ' ' THR . . . -54.15 -38.72 61.93 Favored Glycine 0 N--CA 1.476 1.319 0 O-C-N 123.613 0.571 . . . . 0.0 114.08 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -66.78 -38.24 86.14 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.298 0.639 . . . . 0.0 110.437 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.9 tt -61.27 -57.58 11.77 Favored 'General case' 0 C--O 1.209 -1.068 0 O-C-N 124.088 0.867 . . . . 0.0 110.306 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 30.9 mm -55.83 -45.28 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 C-N-CA 123.171 0.588 . . . . 0.0 112.099 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.8 -52.23 49.95 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.854 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 61.2 tp -69.09 -43.62 74.18 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.897 0.879 . . . . 0.0 111.526 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.432 ' HB3' HD11 ' A' ' 101' ' ' LEU . 41.8 m-85 -86.69 9.35 19.06 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.547 1.139 . . . . 0.0 112.841 -175.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.88 2.01 2.94 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 157.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -102.82 126.77 31.71 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 124.135 0.974 . . . . 0.0 111.013 174.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -71.7 -178.03 2.84 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.99 2.46 . . . . 0.0 112.802 171.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.5 t30 55.55 28.58 12.03 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 125.049 1.34 . . . . 0.0 111.93 -177.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -141.95 23.76 2.04 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.168 0.587 . . . . 0.0 111.323 -172.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 122.43 -39.15 2.36 Favored Glycine 0 C--N 1.347 1.163 0 C-N-CA 123.018 0.342 . . . . 0.0 112.355 174.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.432 HD11 ' HB3' ' A' ' 94' ' ' TYR . 19.5 mt -90.56 126.57 35.98 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 122.837 0.455 . . . . 0.0 110.899 -174.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.6 m -24.48 -47.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 C-N-CA 126.944 2.098 . . . . 0.0 115.186 176.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.403 ' SG ' HD11 ' A' ' 106' ' ' LEU . 46.2 t -160.91 29.76 0.15 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.537 0.735 . . . . 0.0 109.343 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 69.92 -177.17 0.21 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.624 1.17 . . . . 0.0 112.211 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.4 mt -85.94 101.33 12.79 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.841 177.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.403 HD11 ' SG ' ' A' ' 103' ' ' CYS . 75.6 mt -99.03 -58.95 1.82 Allowed 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -173.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.4 mp -119.05 103.48 47.76 Favored Pre-proline 0 N--CA 1.5 2.031 0 CA-C-N 118.879 0.763 . . . . 0.0 111.001 -174.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.14 115.22 4.27 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.883 2.389 . . . . 0.0 112.439 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 C--O 1.251 1.143 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -176.943 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 p . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.764 0.316 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.512 ' HB2' ' HA ' ' A' ' 37' ' ' LEU . 4.3 p-90 -79.93 -18.57 50.14 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 170.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.445 ' HE2' ' HD3' ' A' ' 16' ' ' ARG . 37.3 t80 -80.82 97.35 7.32 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 18' ' ' LEU . 96.4 m-70 -98.04 119.42 36.65 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.511 0.724 . . . . 0.0 110.143 -175.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.445 ' HD3' ' HE2' ' A' ' 14' ' ' TYR . 21.1 mmm180 -92.26 -9.46 42.05 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.915 1.286 . . . . 0.0 111.748 -178.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -108.93 -9.42 15.13 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.55 0.74 . . . . 0.0 110.778 -174.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 15' ' ' HIS . 0.9 OUTLIER -113.27 131.07 56.06 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.317 1.047 . . . . 0.0 110.782 -166.686 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.5 p -88.92 -176.93 5.35 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.255 1.022 . . . . 0.0 111.128 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.649 ' HG3' HG21 ' A' ' 60' ' ' THR . 62.1 ttt180 -62.09 -50.38 72.15 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.997 0.919 . . . . 0.0 111.621 174.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.32 -43.99 92.62 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.125 0.57 . . . . 0.0 110.876 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.25 -30.12 70.97 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.86 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.4 -57.51 7.27 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.04 0.536 . . . . 0.0 109.882 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.42 ' HG2' HG11 ' A' ' 58' ' ' VAL . 36.5 mt-10 -53.45 -43.74 68.32 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.606 1.163 . . . . 0.0 111.674 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -67.29 -57.95 5.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.547 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.7 tt -61.86 -33.32 73.98 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.88 -174.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.488 HD22 ' HB2' ' A' ' 35' ' ' SER . 82.7 mt -67.68 -44.82 76.86 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.63 -27.58 69.04 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.71 0.804 . . . . 0.0 112.024 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -86.51 -48.97 7.92 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 122.997 0.519 . . . . 0.0 111.256 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.76 -59.2 2.87 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.598 0.759 . . . . 0.0 111.805 -170.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.53 ' HA3' ' HB3' ' A' ' 35' ' ' SER . . . -96.14 -46.35 2.63 Favored Glycine 0 C--N 1.346 1.084 0 O-C-N 123.044 0.215 . . . . 0.0 113.104 -175.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 50.48 26.04 2.2 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 125.842 1.657 . . . . 0.0 113.086 -175.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.0 t70 177.22 97.85 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -173.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.642 ' HA3' HD12 ' A' ' 106' ' ' LEU . . . 72.31 20.66 79.36 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-O 120.985 0.214 . . . . 0.0 113.332 174.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.53 ' HB3' ' HA3' ' A' ' 31' ' ' GLY . 5.7 p -81.59 124.08 29.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.961 0.904 . . . . 0.0 109.431 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -128.37 159.29 35.81 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.931 0.492 . . . . 0.0 110.016 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.512 ' HA ' ' HB2' ' A' ' 13' ' ' TRP . 4.1 pp -156.83 164.16 38.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.042 0.937 . . . . 0.0 109.842 169.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 47.3 t -122.81 154.34 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 173.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -155.77 -173.97 4.76 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.851 1.26 . . . . 0.0 108.803 -176.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -91.4 121.49 33.17 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 174.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.8 t -59.19 160.38 6.45 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 122.116 0.96 . . . . 0.0 113.271 -172.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.34 -29.64 4.11 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.209 1.804 . . . . 0.0 108.545 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.7 m -66.38 -38.71 88.16 Favored 'General case' 0 C--N 1.353 0.761 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.976 173.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.3 t -127.49 119.9 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.017 0.927 . . . . 0.0 108.76 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.45 134.07 51.73 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.435 0.694 . . . . 0.0 111.35 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.21 -1.82 88.06 Favored Glycine 0 C--N 1.348 1.214 0 O-C-N 123.176 0.298 . . . . 0.0 112.931 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -101.67 177.68 4.84 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.101 0.96 . . . . 0.0 111.615 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.601 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 44.7 m-85 -111.56 155.52 23.19 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.683 0.793 . . . . 0.0 109.328 175.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.66 142.94 50.63 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.821 0.848 . . . . 0.0 110.147 174.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.507 ' HB2' HD11 ' A' ' 63' ' ' ILE . 26.6 tp -117.09 113.48 22.36 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 42.2 t -103.99 118.85 37.66 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.8 t -125.28 137.09 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -176.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.531 HD13 HG22 ' A' ' 58' ' ' VAL . 27.0 tp -111.9 137.39 49.93 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.879 0.871 . . . . 0.0 110.216 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.547 ' HB2' ' HB2' ' A' ' 103' ' ' CYS . 88.8 t80 -142.0 103.42 4.31 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.395 1.078 . . . . 0.0 108.354 173.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 43.5 70.95 0.27 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.133 1.373 . . . . 0.0 113.212 172.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 79.9 tttt 55.68 38.23 29.87 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 124.891 1.276 . . . . 0.0 111.938 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -141.82 102.92 4.25 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 170.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.531 HG22 HD13 ' A' ' 53' ' ' LEU . 17.2 t -102.51 129.51 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -119.15 147.18 44.48 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.172 0.589 . . . . 0.0 109.578 170.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.649 HG21 ' HG3' ' A' ' 20' ' ' ARG . 17.7 p -117.37 132.82 56.51 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -123.54 107.03 11.1 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -171.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.574 ' HD3' ' H ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -59.83 155.35 16.42 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 171.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 77.4 mt -146.86 111.74 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 102.742 -3.058 . . . . 0.0 102.742 -162.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.1 mp -91.54 113.68 59.39 Favored Pre-proline 0 N--CA 1.468 0.462 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -165.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.84 -34.17 82.92 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.409 2.739 . . . . 0.0 111.392 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.8 t70 58.55 93.91 0.03 OUTLIER 'General case' 0 C--N 1.364 1.224 0 C-N-CA 125.101 1.361 . . . . 0.0 111.578 166.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -54.95 80.22 0.01 OUTLIER Glycine 0 C--N 1.35 1.322 0 N-CA-C 115.668 1.027 . . . . 0.0 115.668 -174.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -153.07 -85.69 0.07 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 170.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -160.42 6.04 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 174.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -131.09 147.6 52.64 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.202 -0.937 . . . . 0.0 112.513 -174.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.508 HD23 ' H ' ' A' ' 71' ' ' LEU . 2.5 pt? -120.73 129.8 53.78 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.947 1.299 . . . . 0.0 109.015 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.36 149.1 39.9 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.218 0.607 . . . . 0.0 110.271 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.7 t -89.23 130.11 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -108.13 130.81 55.09 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -171.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.9 t -137.47 -178.86 5.41 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.387 -170.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.2 t -69.8 6.22 1.25 Allowed 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -167.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 71.46 139.33 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.852 1.261 . . . . 0.0 111.127 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 113.73 -61.12 0.35 Allowed Glycine 0 C--N 1.342 0.863 0 N-CA-C 106.351 -2.7 . . . . 0.0 106.351 -175.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.476 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 4.3 m -63.63 116.47 26.48 Favored Pre-proline 0 CA--C 1.557 1.213 0 CA-C-N 113.891 -1.154 . . . . 0.0 109.327 156.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 4.7 Cg_exo -75.04 99.07 1.22 Allowed 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.362 2.708 . . . . 0.0 114.356 -168.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 75.4 t -35.8 120.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 123.936 0.895 . . . . 0.0 112.893 158.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 27.9 mmt85 -112.62 142.36 45.3 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 124.345 1.058 . . . . 0.0 108.869 176.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.8 ptt85 -97.81 142.59 29.38 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.544 0.738 . . . . 0.0 111.139 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.481 ' HE2' ' HE2' ' A' ' 94' ' ' TYR . 56.1 m-85 -133.97 163.26 29.93 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.679 1.192 . . . . 0.0 108.679 -176.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -140.15 62.89 1.49 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.095 0.474 . . . . 0.0 109.723 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.457 HG23 ' H ' ' A' ' 89' ' ' GLU . 7.6 t 149.76 133.75 0.0 OUTLIER 'General case' 0 C--N 1.362 1.151 0 C-N-CA 127.301 2.24 . . . . 0.0 106.969 -172.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.86 -29.46 68.31 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.698 0.799 . . . . 0.0 111.941 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -51.2 -46.57 51.23 Favored Glycine 0 C--N 1.353 1.477 0 O-C-N 123.872 0.732 . . . . 0.0 114.473 175.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.457 ' H ' HG23 ' A' ' 86' ' ' THR . 49.3 mm-40 -75.82 -29.85 58.81 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.637 0.375 . . . . 0.0 111.602 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.62 -63.29 1.1 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.438 0.695 . . . . 0.0 109.218 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.426 ' HA ' HD12 ' A' ' 105' ' ' LEU . 36.1 mm -60.28 -39.39 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.129 0.972 . . . . 0.0 111.177 178.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.84 -47.26 87.59 Favored Glycine 0 C--N 1.348 1.204 0 O-C-N 124.212 0.945 . . . . 0.0 113.753 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 34.8 tp -77.79 -43.36 30.89 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.58 0.352 . . . . 0.0 111.287 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.527 ' HB3' HD11 ' A' ' 101' ' ' LEU . 31.9 m-85 -80.74 -1.56 43.3 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -173.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.26 -8.87 56.52 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.174 0.511 . . . . 0.0 110.596 165.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.71 119.24 52.17 Favored Pre-proline 0 CA--C 1.56 1.346 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 175.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -72.69 -166.47 0.28 Allowed 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.128 2.552 . . . . 0.0 114.281 -171.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 56.98 44.56 22.69 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.921 1.288 . . . . 0.0 111.707 -175.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -131.95 8.46 4.44 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.114 -177.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 119.37 -19.6 9.86 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 112.214 -0.355 . . . . 0.0 112.214 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.527 HD11 ' HB3' ' A' ' 94' ' ' TYR . 64.8 mt -79.46 135.78 36.75 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.437 0.695 . . . . 0.0 111.869 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.2 m -59.74 -33.28 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.85 0.86 . . . . 0.0 110.617 171.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 53.9 t -144.55 151.02 38.48 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.401 1.08 . . . . 0.0 109.224 175.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.43 153.28 44.06 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 91' ' ' ILE . 69.5 mt -69.59 95.72 0.87 Allowed 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 120.801 0.334 . . . . 0.0 110.176 -178.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.642 HD12 ' HA3' ' A' ' 34' ' ' GLY . 84.0 mt -100.67 -67.14 0.87 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.309 1.044 . . . . 0.0 110.938 -176.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.431 HD22 HG22 ' A' ' 109' ' ' VAL . 2.0 tt -106.37 113.75 62.93 Favored Pre-proline 0 N--CA 1.481 1.108 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -166.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.22 -37.05 76.97 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 123.496 2.797 . . . . 0.0 113.128 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.431 HG22 HD22 ' A' ' 107' ' ' LEU . 29.4 t . . . . . 0 C--O 1.257 1.464 0 C-N-CA 124.699 1.2 . . . . 0.0 110.252 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.0 t . . . . . 0 C--O 1.239 0.53 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -74.9 -27.18 60.12 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.45 168.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -77.42 121.16 23.42 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.07 0.462 . . . . 0.0 109.803 -174.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.423 ' O ' ' HA ' ' A' ' 39' ' ' ARG . 91.4 m-70 -138.86 131.71 29.32 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 175.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.2 mtm180 -63.59 139.92 58.82 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 168.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.404 ' H ' ' HB3' ' A' ' 40' ' ' ASP . 27.2 t70 -26.25 83.16 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 116.635 2.087 . . . . 0.0 116.635 -166.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 pp -66.17 -19.0 65.7 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.107 165.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.4 t 100.24 138.87 0.01 OUTLIER 'General case' 0 C--N 1.372 1.548 0 C-N-CA 127.489 2.315 . . . . 0.0 110.198 173.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -63.47 -45.02 92.69 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.655 0.782 . . . . 0.0 112.156 -176.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.17 -49.96 65.59 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.142 0.577 . . . . 0.0 110.67 173.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.83 -24.2 63.42 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.68 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.467 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -68.44 -58.47 4.29 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.814 0.845 . . . . 0.0 110.887 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.462 ' HG2' HG11 ' A' ' 58' ' ' VAL . 45.8 mt-10 -53.38 -38.25 63.18 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.02 0.928 . . . . 0.0 111.706 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -71.23 -44.9 64.44 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.078 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 33.4 tp -59.98 -43.42 95.15 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.061 0.944 . . . . 0.0 111.068 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 23' ' ' ALA . 94.6 mt -65.85 -49.88 66.59 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.523 0.729 . . . . 0.0 109.235 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.21 -34.24 73.38 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.066 0.946 . . . . 0.0 112.388 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -82.79 -50.49 8.61 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.244 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.48 -61.85 1.87 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.318 -171.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.82 -60.02 0.56 Allowed Glycine 0 C--N 1.352 1.467 0 CA-C-N 117.902 0.319 . . . . 0.0 113.548 -171.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 50.09 40.7 22.21 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.943 1.697 . . . . 0.0 113.817 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -170.31 83.83 0.11 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -171.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.81 22.9 78.29 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -177.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.2 m -87.0 119.82 27.61 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.017 0.927 . . . . 0.0 109.073 -171.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.498 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 19.2 p90 -131.89 158.56 41.04 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.011 0.434 . . . . 0.0 110.695 -175.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.467 HD11 ' HB1' ' A' ' 23' ' ' ALA . 4.1 pp -156.86 165.28 36.64 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.256 170.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.3 t -121.58 129.33 75.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 15' ' ' HIS . 3.7 ptm180 -125.57 163.36 22.9 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.252 1.021 . . . . 0.0 109.365 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.404 ' HB3' ' H ' ' A' ' 17' ' ' ASP . 23.1 t70 -91.78 120.07 32.17 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.3 m -91.43 100.88 13.57 Favored 'General case' 0 C--O 1.247 0.953 0 C-N-CA 122.759 0.424 . . . . 0.0 110.565 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -62.64 94.92 0.07 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.47 0.652 . . . . 0.0 110.394 163.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.3 t -151.85 -55.88 0.14 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.9 m -125.66 149.2 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 165.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 8.79 -80.0 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 127.249 2.22 . . . . 0.0 115.334 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.18 79.88 0.21 Allowed Glycine 0 C--N 1.351 1.382 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.31 165.95 14.64 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 171.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -117.22 163.73 15.86 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.104 0.561 . . . . 0.0 111.031 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.62 146.75 46.4 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.052 0.941 . . . . 0.0 110.252 168.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.51 HD22 HD21 ' A' ' 90' ' ' LEU . 46.3 tp -116.7 114.91 24.69 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 176.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 61.0 m -101.05 116.26 32.43 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.4 t -119.17 124.07 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.418 ' HB2' HG22 ' A' ' 58' ' ' VAL . 23.5 tp -119.54 145.16 46.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.021 0.928 . . . . 0.0 110.335 -177.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.416 ' H ' HD12 ' A' ' 53' ' ' LEU . 25.1 t80 -154.74 126.14 7.37 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 172.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 35.79 73.71 0.08 Allowed 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 78.6 tttt 52.26 35.85 18.02 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 125.086 1.355 . . . . 0.0 113.768 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -143.58 104.39 4.21 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 121.759 -0.588 . . . . 0.0 110.49 165.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.462 HG11 ' HG2' ' A' ' 24' ' ' GLU . 20.1 t -93.05 129.25 43.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 172.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -118.24 133.37 55.95 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 168.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.8 m -120.99 141.99 50.2 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -174.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -128.67 99.7 5.45 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -170.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -76.95 103.57 6.96 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.514 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.0 mp -67.87 108.19 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.228 172.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.3 tp -110.1 108.95 59.04 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -174.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.514 ' HB2' ' HG2' ' A' ' 68' ' ' GLU . 14.5 Cg_exo -69.88 -57.39 0.12 Allowed 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.555 2.17 . . . . 0.0 112.439 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.8 t70 80.49 -70.39 0.09 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.965 1.306 . . . . 0.0 109.406 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.37 -38.35 80.66 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 168.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.514 ' HG2' ' HB2' ' A' ' 65' ' ' PRO . 48.7 mt-10 84.14 24.66 0.11 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.283 1.433 . . . . 0.0 113.304 164.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -103.82 -37.42 7.45 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 164.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -116.49 134.73 54.52 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.106 0.962 . . . . 0.0 109.256 170.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -105.71 111.92 24.79 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.965 0.906 . . . . 0.0 109.005 175.661 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . . . -99.01 132.42 44.33 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.92 0.488 . . . . 0.0 110.988 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.514 HG21 ' HG ' ' A' ' 90' ' ' LEU . 11.2 t -87.24 118.27 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.163 176.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -81.31 92.09 6.32 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.0 m -72.23 -42.85 65.24 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.794 -175.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.503 ' HB3' HG22 ' A' ' 79' ' ' VAL . 48.1 t 173.98 141.94 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.385 1.474 . . . . 0.0 109.019 169.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -74.63 86.82 2.14 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 168.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.95 -22.85 0.31 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -167.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.503 HG22 ' HB3' ' A' ' 76' ' ' SER . 32.6 m -128.31 157.84 73.25 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 124.033 0.933 . . . . 0.0 109.066 175.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.71 126.62 21.64 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.268 2.645 . . . . 0.0 113.312 172.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 73' ' ' VAL . 54.6 t -101.52 134.76 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.169 1.387 . . . . 0.0 108.521 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -111.5 137.77 48.89 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.336 0.654 . . . . 0.0 110.901 -172.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 48.4 ptt85 -96.5 150.44 20.62 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.805 0.842 . . . . 0.0 108.856 173.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -138.72 164.57 29.22 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.499 0.72 . . . . 0.0 109.442 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -111.63 -13.43 13.78 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.187 0.595 . . . . 0.0 110.142 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.648 HG22 ' H ' ' A' ' 88' ' ' GLY . 59.6 m -148.7 147.1 28.49 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.511 0.724 . . . . 0.0 109.214 -174.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.33 -28.68 69.87 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.179 0.592 . . . . 0.0 111.178 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.648 ' H ' HG22 ' A' ' 86' ' ' THR . . . -63.0 -36.34 93.33 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 122.987 0.327 . . . . 0.0 113.138 173.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.47 ' HG2' ' HB ' ' A' ' 86' ' ' THR . 33.1 mm-40 -62.07 -47.03 86.47 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.691 0.797 . . . . 0.0 110.22 175.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.514 ' HG ' HG21 ' A' ' 73' ' ' VAL . 4.8 tt -50.48 -61.55 2.12 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.25 1.42 . . . . 0.0 109.932 173.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 47.1 mm -60.99 -27.48 41.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.448 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.09 -60.58 8.77 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 123.634 0.584 . . . . 0.0 113.48 175.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.1 mt -74.46 -32.7 62.69 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -82.19 -21.74 36.32 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.843 0.457 . . . . 0.0 112.176 -172.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.96 -17.28 63.11 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 168.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -132.45 69.3 79.94 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 124.651 1.18 . . . . 0.0 108.696 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.44 -81.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.233 1.955 . . . . 0.0 113.839 -168.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 90.08 -90.45 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.48 1.912 . . . . 0.0 106.821 -170.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -79.93 144.05 33.68 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 122.916 0.486 . . . . 0.0 111.912 170.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.82 -59.13 0.37 Allowed Glycine 0 C--N 1.35 1.315 0 C-N-CA 123.391 0.519 . . . . 0.0 113.176 166.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 24.7 mt -82.13 164.88 21.01 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.5 m -84.02 -24.37 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 CA-C-N 114.673 -1.148 . . . . 0.0 109.943 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 52.2 t -164.92 167.53 18.52 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 125.12 1.368 . . . . 0.0 108.745 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -77.36 170.68 16.12 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 120.93 0.395 . . . . 0.0 109.958 172.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.7 mt -81.53 97.46 7.83 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 175.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.9 mp -92.6 -57.93 2.52 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.017 0.927 . . . . 0.0 110.478 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 61.7 tp -131.09 107.06 14.96 Favored Pre-proline 0 N--CA 1.479 1.02 0 C-N-CA 123.379 0.671 . . . . 0.0 110.974 -165.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.99 124.12 10.3 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.368 2.045 . . . . 0.0 110.301 170.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 32.7 t . . . . . 0 CA--C 1.552 1.031 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -172.032 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.9 p . . . . . 0 N--CA 1.472 0.645 0 CA-C-O 121.315 0.579 . . . . 0.0 111.672 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.522 ' HB3' ' HB3' ' A' ' 108' ' ' PRO . 1.9 p-90 -86.3 10.4 14.93 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.889 0.876 . . . . 0.0 112.761 -176.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.421 ' HA ' ' HB ' ' A' ' 38' ' ' VAL . 17.8 t80 -118.03 134.82 54.62 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -174.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -137.18 171.89 13.82 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.739 0.816 . . . . 0.0 110.276 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.4 171.99 16.64 Favored 'General case' 0 C--O 1.245 0.817 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 164.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 74.55 3.95 4.35 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.677 1.191 . . . . 0.0 110.209 -172.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.3 tp -105.98 120.52 41.97 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 125.956 1.702 . . . . 0.0 107.999 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.4 m -82.49 170.15 15.57 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.524 0.73 . . . . 0.0 110.41 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.513 HH11 ' HG2' ' A' ' 24' ' ' GLU . 4.7 tmm_? -58.97 -55.88 29.48 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.408 0.683 . . . . 0.0 110.764 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.81 -44.01 73.43 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.121 0.888 . . . . 0.0 111.084 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.02 -36.06 82.77 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.521 0.729 . . . . 0.0 112.185 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.548 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -65.22 -56.5 12.46 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.824 0.85 . . . . 0.0 111.608 -176.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.513 ' HG2' HH11 ' A' ' 20' ' ' ARG . 0.0 OUTLIER -69.12 -24.64 64.13 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.879 -179.171 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 31.8 mt-10 -64.86 -55.66 18.11 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 169.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.12 -23.49 47.5 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.494 0.717 . . . . 0.0 112.828 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.9 mt -71.86 -52.79 15.63 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 168.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.98 -21.48 50.83 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -168.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 30.5 mmt180 -74.42 -42.25 59.49 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 118.246 0.475 . . . . 0.0 110.677 176.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.53 -53.45 4.8 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.945 -174.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.27 -159.59 8.41 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.974 -163.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 175.49 138.89 0.05 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.274 1.029 . . . . 0.0 110.493 -171.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.554 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 62.6 m-20 96.67 87.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.207 1.403 . . . . 0.0 109.184 159.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.24 16.7 73.55 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.708 -173.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 m -82.49 123.43 29.16 Favored 'General case' 0 C--N 1.346 0.456 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.448 ' CE1' ' HB3' ' A' ' 105' ' ' LEU . 30.9 p90 -131.7 159.22 39.02 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.41 0.624 . . . . 0.0 111.345 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.548 HD11 ' HB1' ' A' ' 23' ' ' ALA . 3.3 pp -150.63 159.99 44.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.165 165.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.421 ' HB ' ' HA ' ' A' ' 14' ' ' TYR . 46.9 t -116.75 150.54 18.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 175.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.501 HH22 ' HG2' ' A' ' 42' ' ' GLU . 20.6 ptt85 -146.59 -179.61 6.89 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -81.64 126.47 31.8 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 167.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 93.7 p -73.12 163.54 27.99 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.752 0.421 . . . . 0.0 110.703 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.501 ' HG2' HH22 ' A' ' 39' ' ' ARG . 10.8 pt-20 -124.61 -16.27 6.31 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.445 0.698 . . . . 0.0 110.6 -177.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.0 m -68.46 -30.17 68.97 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.884 0.874 . . . . 0.0 111.057 172.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.492 HG13 ' HB3' ' A' ' 47' ' ' ALA . 1.8 p -145.99 117.5 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 124.192 0.997 . . . . 0.0 109.683 -175.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.03 132.63 49.73 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.447 1.099 . . . . 0.0 112.056 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.84 11.94 80.66 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.347 0.404 . . . . 0.0 113.708 177.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.492 ' HB3' HG13 ' A' ' 44' ' ' VAL . . . -118.59 178.06 4.6 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.739 0.816 . . . . 0.0 111.717 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.474 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 32.9 m-85 -114.7 166.78 11.38 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.592 0.757 . . . . 0.0 111.286 -176.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.42 145.61 41.17 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.012 0.925 . . . . 0.0 110.233 169.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.491 ' HB2' HD11 ' A' ' 63' ' ' ILE . 51.7 tp -121.5 114.3 21.04 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.99 1.316 . . . . 0.0 108.33 -176.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 36.2 t -108.68 122.12 46.45 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.276 1.03 . . . . 0.0 108.62 -174.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.2 t -129.54 115.61 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 123.452 0.701 . . . . 0.0 110.366 -171.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.432 HD13 HG22 ' A' ' 58' ' ' VAL . 17.2 tp -94.83 136.89 34.6 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.564 1.146 . . . . 0.0 110.132 177.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 60.2 t80 -163.02 122.5 2.19 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.313 1.045 . . . . 0.0 109.206 175.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 40.58 61.12 1.71 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.327 1.851 . . . . 0.0 113.6 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 62.41 30.08 17.27 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.57 1.148 . . . . 0.0 113.042 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -138.33 106.88 5.85 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.236 0.614 . . . . 0.0 109.548 177.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.432 HG22 HD13 ' A' ' 53' ' ' LEU . 18.3 t -101.66 114.64 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -105.79 126.3 52.01 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.0 m -113.02 136.02 53.15 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -127.99 110.35 12.44 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.874 0.87 . . . . 0.0 109.107 -171.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.508 ' HD2' ' H ' ' A' ' 62' ' ' ARG . 0.1 OUTLIER -59.55 157.0 12.27 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 169.446 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.491 HD11 ' HB2' ' A' ' 50' ' ' LEU . 90.7 mt -146.19 102.66 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 103.686 -2.709 . . . . 0.0 103.686 -162.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.7 mp -114.97 140.65 25.81 Favored Pre-proline 0 N--CA 1.475 0.804 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -166.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 33.6 Cg_exo -58.58 -70.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 121.915 1.743 . . . . 0.0 109.274 164.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.0 t70 58.53 15.94 3.91 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.133 1.373 . . . . 0.0 112.639 167.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.38 137.38 3.77 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -34.08 -45.76 0.22 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 -165.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -113.21 -16.25 12.59 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -164.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.414 ' HB2' ' HB2' ' A' ' 83' ' ' ARG . 44.4 p90 -125.98 160.88 28.85 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.967 -0.458 . . . . 0.0 111.74 -167.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 3.9 pp -121.73 118.36 28.9 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.525 1.53 . . . . 0.0 107.144 166.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -111.95 148.48 33.65 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.735 0.779 . . . . 0.0 110.011 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.8 t -122.85 131.32 73.48 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -78.65 94.55 5.07 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.471 HG22 ' HA3' ' A' ' 100' ' ' GLY . 2.0 m -70.78 -63.06 1.17 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.059 -176.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.459 ' HB2' HG22 ' A' ' 79' ' ' VAL . 73.5 m -163.19 113.66 1.39 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.248 1.419 . . . . 0.0 107.62 170.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -68.62 97.41 0.79 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 170.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.16 -22.7 0.87 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -163.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.459 HG22 ' HB2' ' A' ' 76' ' ' SER . 22.5 m -129.84 153.21 80.87 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 125.375 1.47 . . . . 0.0 107.075 170.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -54.47 124.69 16.73 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.386 2.057 . . . . 0.0 112.8 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.6 t -86.09 140.32 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -102.11 136.21 42.35 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.031 0.533 . . . . 0.0 109.908 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.414 ' HB2' ' HB2' ' A' ' 70' ' ' PHE . 14.6 ptp180 -87.35 138.76 31.21 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 163.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -119.7 143.25 47.86 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.747 0.819 . . . . 0.0 109.277 176.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -84.66 -22.24 29.93 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.091 0.472 . . . . 0.0 110.43 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.677 ' HB ' ' HG2' ' A' ' 89' ' ' GLU . 51.0 m -141.79 149.01 39.83 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.74 0.816 . . . . 0.0 109.767 -177.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.24 -30.73 71.64 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.596 0.759 . . . . 0.0 109.525 176.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.66 ' H ' HG22 ' A' ' 86' ' ' THR . . . -53.92 -41.79 68.57 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-N 116.099 -0.501 . . . . 0.0 113.582 169.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.677 ' HG2' ' HB ' ' A' ' 86' ' ' THR . 31.0 mm-40 -71.45 -32.23 68.09 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.273 0.629 . . . . 0.0 110.7 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 46.5 tp -59.04 -59.25 5.77 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.318 0.647 . . . . 0.0 111.011 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 51.6 mm -62.25 -37.16 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.999 0.919 . . . . 0.0 111.004 -176.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.13 -51.73 53.91 Favored Glycine 0 CA--C 1.535 1.331 0 O-C-N 124.153 0.908 . . . . 0.0 113.292 174.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.0 mt -78.99 -23.17 44.6 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.091 0.556 . . . . 0.0 112.216 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -83.33 -18.31 39.39 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.03 -35.15 76.29 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.527 0.331 . . . . 0.0 110.539 170.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -127.0 76.42 76.0 Favored Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 124.371 1.068 . . . . 0.0 108.602 175.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -92.49 -66.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 123.363 2.708 . . . . 0.0 114.421 -169.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 59.66 55.84 3.85 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 124.845 1.258 . . . . 0.0 111.266 -173.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 160.45 97.87 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 126.734 2.014 . . . . 0.0 109.706 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.471 ' HA3' HG22 ' A' ' 75' ' ' THR . . . 104.33 -37.35 3.82 Favored Glycine 0 C--N 1.355 1.617 0 N-CA-C 113.758 0.263 . . . . 0.0 113.758 164.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -76.52 122.45 24.59 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.841 0.456 . . . . 0.0 110.829 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.2 m -52.73 -32.45 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 125.544 1.537 . . . . 0.0 114.19 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 36.4 t -153.54 3.31 0.28 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.108 0.563 . . . . 0.0 111.19 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 76.04 177.37 0.19 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.902 1.281 . . . . 0.0 110.669 -167.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.448 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 26.7 mt -93.05 103.39 15.7 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.51 -53.35 6.04 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.562 0.745 . . . . 0.0 111.03 -176.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.22 137.32 9.86 Favored Pre-proline 0 N--CA 1.483 1.222 0 C-N-CA 122.167 0.187 . . . . 0.0 111.199 -175.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.522 ' HB3' ' HB3' ' A' ' 13' ' ' TRP . 97.1 Cg_endo -78.79 137.08 13.9 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.333 2.022 . . . . 0.0 111.875 171.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 57.0 t . . . . . 0 CA--C 1.547 0.857 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.293 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.6 p . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -84.77 0.87 49.11 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.056 -1.027 . . . . 0.0 110.435 171.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -110.91 111.53 22.73 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -119.03 115.0 23.39 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 176.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -39.71 -49.31 2.26 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 125.565 1.546 . . . . 0.0 113.722 -172.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -156.96 70.55 0.64 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-O 122.312 1.053 . . . . 0.0 108.578 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 21.9 tp -64.77 -32.18 73.74 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 113.658 -1.61 . . . . 0.0 109.464 165.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.0 t 88.31 141.82 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 126.014 1.726 . . . . 0.0 107.944 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -60.83 -43.02 98.84 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.213 0.605 . . . . 0.0 112.079 -168.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.83 -48.01 73.09 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.507 0.723 . . . . 0.0 111.72 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -72.44 -22.58 61.07 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.316 178.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.476 ' O ' ' HG ' ' A' ' 27' ' ' LEU . . . -67.67 -49.83 60.87 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.594 ' HG3' HG21 ' A' ' 58' ' ' VAL . 34.8 tt0 -54.53 -41.24 69.48 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 124.885 1.366 . . . . 0.0 111.296 175.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.0 -50.6 47.39 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.437 -177.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.84 -33.98 73.87 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.091 0.957 . . . . 0.0 111.881 176.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 23' ' ' ALA . 75.4 mt -64.73 -52.84 54.94 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.1 0.56 . . . . 0.0 109.683 175.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.29 -42.47 98.71 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.17 0.988 . . . . 0.0 111.947 -176.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -69.33 -41.33 76.82 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.888 -175.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.35 -62.82 1.39 Allowed 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.02 -38.46 2.89 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 113.886 0.314 . . . . 0.0 113.886 -166.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.84 12.76 0.12 Allowed 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 128.011 2.524 . . . . 0.0 116.28 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 4.5 m-20 -174.37 118.51 0.23 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -166.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.429 ' HA2' ' SG ' ' A' ' 103' ' ' CYS . . . 63.16 11.02 37.01 Favored Glycine 0 C--N 1.352 1.44 0 N-CA-C 113.906 0.322 . . . . 0.0 113.906 -177.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.9 m -83.69 123.68 30.07 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.142 0.977 . . . . 0.0 110.039 -168.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -135.73 156.38 48.92 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 120.767 0.318 . . . . 0.0 111.439 -176.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.432 HD11 ' HB1' ' A' ' 23' ' ' ALA . 4.4 pp -159.9 158.74 31.41 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 124.709 1.255 . . . . 0.0 109.673 169.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.44 HG22 HD13 ' A' ' 50' ' ' LEU . 21.9 t -114.05 150.65 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.451 HH22 ' HB2' ' A' ' 42' ' ' GLU . 1.7 ptm180 -148.0 177.13 9.61 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.264 1.025 . . . . 0.0 109.207 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -84.4 129.28 34.88 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.3 t -61.18 142.38 56.79 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.48 0.712 . . . . 0.0 112.108 -174.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.451 ' HB2' HH22 ' A' ' 39' ' ' ARG . 32.2 tt0 -107.03 0.24 23.48 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.984 178.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.2 t -104.97 -41.72 5.52 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.207 1.003 . . . . 0.0 110.069 -177.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.5 HG21 HD21 ' A' ' 64' ' ' LEU . 44.7 t -128.11 115.18 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.902 0.881 . . . . 0.0 109.528 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.22 124.63 24.6 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.929 0.891 . . . . 0.0 110.817 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.36 12.06 65.75 Favored Glycine 0 C--N 1.344 0.979 0 O-C-N 123.345 0.403 . . . . 0.0 112.746 -174.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.32 177.0 5.07 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.794 0.838 . . . . 0.0 111.168 172.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.422 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 70.4 m-85 -124.21 166.83 15.16 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.832 1.253 . . . . 0.0 110.254 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.9 147.79 48.31 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.358 1.063 . . . . 0.0 109.526 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.561 ' HB2' HD11 ' A' ' 63' ' ' ILE . 50.2 tp -123.99 123.92 41.45 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.062 1.345 . . . . 0.0 107.51 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 37.1 t -112.29 123.85 51.17 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.9 t -128.73 143.7 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.545 HD13 HG22 ' A' ' 58' ' ' VAL . 48.9 tp -130.3 144.71 51.54 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.113 0.965 . . . . 0.0 108.942 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 84.6 t80 -164.28 122.77 1.83 Allowed 'General case' 0 CA--C 1.537 0.479 0 O-C-N 124.318 1.011 . . . . 0.0 109.005 178.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 17.3 tm0? 41.74 70.07 0.3 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 125.404 1.482 . . . . 0.0 111.561 -177.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt 48.67 25.23 0.93 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 125.586 1.555 . . . . 0.0 114.288 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -131.32 117.36 18.82 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.355 0.662 . . . . 0.0 109.299 -178.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.594 HG21 ' HG3' ' A' ' 24' ' ' GLU . 34.1 t -99.53 144.94 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.507 1.123 . . . . 0.0 109.623 -177.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -137.34 119.26 15.28 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 174.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 33.4 m -105.92 114.1 28.04 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -95.65 117.68 30.93 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -177.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 65.6 mtm-85 -62.25 158.37 17.32 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 170.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.561 HD11 ' HB2' ' A' ' 50' ' ' LEU . 76.2 mt -145.32 98.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 102.808 -3.034 . . . . 0.0 102.808 -175.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.5 HD21 HG21 ' A' ' 44' ' ' VAL . 10.6 mp -122.14 148.62 52.38 Favored Pre-proline 0 N--CA 1.477 0.923 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -172.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 70' ' ' PHE . 87.8 Cg_exo -44.29 -59.66 1.03 Allowed 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.53 2.153 . . . . 0.0 111.845 172.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.2 t70 47.33 71.5 0.32 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.857 1.263 . . . . 0.0 111.87 174.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.65 -75.95 0.24 Allowed Glycine 0 C--N 1.337 0.631 0 CA-C-O 119.459 -0.634 . . . . 0.0 111.626 -176.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 169.29 -40.44 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.051 1.34 . . . . 0.0 111.405 -175.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -131.35 -13.43 3.43 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -161.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 97.8 m-85 -117.91 163.81 15.99 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.425 1.09 . . . . 0.0 110.443 -167.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.1 mp -104.54 109.34 21.19 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 171.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.43 126.05 42.45 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.192 0.997 . . . . 0.0 109.57 -175.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.5 t -96.09 133.27 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -178.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -94.52 89.32 5.77 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -175.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.469 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 21.2 p -71.04 -66.59 0.59 Allowed 'General case' 0 C--O 1.248 1.006 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.325 175.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.3 t 176.39 174.67 0.34 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.089 1.355 . . . . 0.0 109.945 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -68.01 160.7 28.22 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 123.786 0.834 . . . . 0.0 109.185 167.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.51 -72.54 2.16 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-N 118.451 0.569 . . . . 0.0 112.99 -170.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.1 m -65.6 145.94 99.01 Favored Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 123.662 0.785 . . . . 0.0 110.538 176.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.79 137.56 27.36 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.482 2.121 . . . . 0.0 113.483 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.4 t -69.58 118.12 13.42 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 167.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -98.62 117.38 32.93 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.508 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -100.69 149.99 23.21 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.714 0.806 . . . . 0.0 110.271 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -134.29 162.29 32.59 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.42 0.688 . . . . 0.0 112.399 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -74.08 -46.5 42.62 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.511 170.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 37.9 p -138.34 169.12 18.35 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.618 0.767 . . . . 0.0 110.999 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.482 ' O ' HG12 ' A' ' 91' ' ' ILE . 4.3 mm? -62.21 -34.42 76.44 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.584 0.754 . . . . 0.0 111.058 171.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -53.86 -43.89 70.92 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 122.975 0.172 . . . . 0.0 113.029 175.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -66.38 -36.15 82.13 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.252 0.621 . . . . 0.0 110.611 175.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.424 HD13 HD13 ' A' ' 87' ' ' LEU . 7.8 tt -64.7 -38.6 91.54 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.342 1.057 . . . . 0.0 110.828 -178.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 87' ' ' LEU . 50.3 mm -85.04 -35.54 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -168.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.3 -44.93 32.61 Favored Glycine 0 C--N 1.35 1.331 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.877 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.1 tp -76.11 -32.73 59.32 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.712 0.405 . . . . 0.0 111.239 -178.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.616 ' HB3' ' HG ' ' A' ' 105' ' ' LEU . 3.9 m-30 -78.12 -16.46 57.95 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.757 174.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.42 -2.16 10.33 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.136 0.574 . . . . 0.0 112.102 171.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -128.37 152.14 77.65 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 169.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -28.93 103.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 124.819 3.679 . . . . 0.0 114.967 165.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.512 ' HB3' HD23 ' A' ' 101' ' ' LEU . 8.3 t30 -106.28 -44.7 4.48 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.533 -177.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 107.93 115.78 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 128.184 2.594 . . . . 0.0 108.644 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.469 ' HA3' ' HB ' ' A' ' 75' ' ' THR . . . 110.04 -13.28 31.61 Favored Glycine 0 C--N 1.345 1.04 0 O-C-N 123.747 0.654 . . . . 0.0 112.266 -175.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.512 HD23 ' HB3' ' A' ' 98' ' ' ASN . 3.9 mm? -84.36 138.72 32.72 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.183 0.993 . . . . 0.0 111.699 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.1 p -60.68 -35.64 65.27 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 C-N-CA 124.425 1.09 . . . . 0.0 112.421 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.429 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 29.0 p -163.98 13.62 0.05 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.377 0.671 . . . . 0.0 111.455 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.443 ' H ' ' HB3' ' A' ' 101' ' ' LEU . . . 74.15 176.96 0.24 Allowed 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 124.814 1.246 . . . . 0.0 109.771 -167.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.616 ' HG ' ' HB3' ' A' ' 94' ' ' TYR . 26.6 mt -92.88 113.87 26.27 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.412 ' HB3' ' HA3' ' A' ' 34' ' ' GLY . 56.1 tp -108.01 -63.32 1.33 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.513 0.725 . . . . 0.0 111.868 -173.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.459 HD22 HG22 ' A' ' 109' ' ' VAL . 5.0 tt -116.58 103.73 52.29 Favored Pre-proline 0 N--CA 1.479 0.999 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -170.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -73.74 119.24 5.8 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.56 2.173 . . . . 0.0 111.158 173.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.459 HG22 HD22 ' A' ' 107' ' ' LEU . 21.1 t . . . . . 0 CA--C 1.553 1.069 0 CA-C-O 118.038 -0.982 . . . . 0.0 108.371 -175.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 C--O 1.239 0.515 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -83.37 -29.1 28.47 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 172.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -74.67 122.75 23.69 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -138.41 93.36 2.73 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.371 0.669 . . . . 0.0 109.394 176.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -62.84 148.98 45.48 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 157.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.6 t70 81.41 -11.47 1.08 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.357 1.063 . . . . 0.0 111.736 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 tp -90.73 122.57 33.6 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.6 m -83.44 158.01 22.24 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.898 0.479 . . . . 0.0 109.851 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -62.58 -47.02 85.63 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -171.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.37 -45.32 80.58 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.416 0.686 . . . . 0.0 111.347 177.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.81 -34.39 76.66 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.86 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.594 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -66.23 -55.71 14.87 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.76 0.824 . . . . 0.0 111.422 -177.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.501 ' HG2' ' SG ' ' A' ' 51' ' ' CYS . 25.2 mt-10 -64.67 -28.77 69.83 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.521 1.128 . . . . 0.0 111.443 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -62.28 -50.99 69.51 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.462 0.705 . . . . 0.0 109.416 173.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.6 mt -66.77 -28.35 68.33 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.163 0.985 . . . . 0.0 112.077 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.503 HD21 ' HG ' ' A' ' 37' ' ' LEU . 75.0 mt -68.04 -45.01 75.15 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 118.058 0.39 . . . . 0.0 110.176 173.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.2 -26.78 63.09 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.653 0.781 . . . . 0.0 111.22 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -85.97 -60.54 1.98 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.369 0.668 . . . . 0.0 111.484 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.23 -54.92 5.49 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.626 0.771 . . . . 0.0 112.354 -166.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.595 ' HA3' ' HB3' ' A' ' 35' ' ' SER . . . -87.5 -34.1 10.78 Favored Glycine 0 N--CA 1.471 0.967 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 60.25 4.04 0.61 Allowed 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 126.445 1.898 . . . . 0.0 114.827 174.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.3 t70 164.52 133.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.09 1.356 . . . . 0.0 107.788 -171.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.61 -2.27 54.46 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 117.89 0.314 . . . . 0.0 113.579 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.595 ' HB3' ' HA3' ' A' ' 31' ' ' GLY . 1.9 p -82.54 130.37 35.1 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.406 1.082 . . . . 0.0 111.967 -169.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.411 ' CE1' ' HB3' ' A' ' 105' ' ' LEU . 46.2 p90 -127.33 151.93 48.12 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.031 0.532 . . . . 0.0 110.083 174.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.594 HD11 ' HB1' ' A' ' 23' ' ' ALA . 2.3 pp -144.9 160.89 40.59 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.718 0.807 . . . . 0.0 109.013 166.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.447 HG21 HD11 ' A' ' 87' ' ' LEU . 22.6 t -112.78 153.99 14.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.416 HH22 HG21 ' A' ' 60' ' ' THR . 30.1 mtm180 -139.99 170.43 15.87 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.075 0.95 . . . . 0.0 109.661 -176.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -87.78 134.54 33.66 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.296 168.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.5 m -62.96 135.45 57.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.911 0.386 . . . . 0.0 111.143 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -102.27 14.88 30.77 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.207 1.003 . . . . 0.0 111.286 -172.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.0 t -147.33 -62.28 0.28 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.374 0.669 . . . . 0.0 109.898 -177.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.9 m -89.32 125.39 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -171.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 24.78 -133.88 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 127.585 2.354 . . . . 0.0 116.466 171.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.45 57.63 0.44 Allowed Glycine 0 C--N 1.358 1.772 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.42 174.15 6.0 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.63 0.772 . . . . 0.0 111.107 -173.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.55 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 81.0 m-85 -114.82 158.73 21.5 Favored 'General case' 0 C--O 1.25 1.083 0 C-N-CA 123.905 0.882 . . . . 0.0 109.827 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.24 141.21 52.23 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.535 1.134 . . . . 0.0 109.214 173.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.573 HD22 HD21 ' A' ' 90' ' ' LEU . 58.9 tp -123.32 115.75 22.19 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.501 ' SG ' ' HG2' ' A' ' 24' ' ' GLU . 45.9 t -114.19 119.08 35.85 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -176.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 5.1 t -127.77 140.56 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.218 0.607 . . . . 0.0 109.4 -170.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.8 tp -122.92 138.47 54.66 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.722 1.209 . . . . 0.0 109.035 -177.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -169.32 136.63 1.78 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.002 0.921 . . . . 0.0 109.622 172.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 47.35 42.49 14.02 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.819 1.248 . . . . 0.0 112.096 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 56.62 45.47 22.09 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.739 1.216 . . . . 0.0 112.641 -173.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -129.6 103.85 7.11 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 171.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 61.6 t -97.65 105.45 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 170.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -112.78 134.12 54.45 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.416 HG21 HH22 ' A' ' 39' ' ' ARG . 55.5 m -117.8 142.34 47.4 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.412 0.685 . . . . 0.0 109.453 -175.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -124.74 154.85 40.24 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.54 1.136 . . . . 0.0 108.26 -177.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -102.39 160.98 14.07 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 166.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.658 HG12 HD11 ' A' ' 90' ' ' LEU . 3.7 mp -144.59 101.24 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 103.122 -2.918 . . . . 0.0 103.122 -163.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.1 mp -103.4 137.67 19.32 Favored Pre-proline 0 N--CA 1.481 1.119 0 CA-C-O 119.421 -0.323 . . . . 0.0 110.943 -163.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.63 -138.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 123.452 2.768 . . . . 0.0 111.081 175.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 68' ' ' GLU . 7.1 t70 169.47 -178.09 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 122.97 0.508 . . . . 0.0 110.323 -166.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -88.33 5.35 84.85 Favored Glycine 0 N--CA 1.491 2.342 0 CA-C-O 121.642 0.579 . . . . 0.0 112.337 167.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 66' ' ' ASP . 35.4 mt-10 -142.13 106.28 4.77 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 102.48 -3.156 . . . . 0.0 102.48 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -74.5 88.4 2.13 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 119.591 1.087 . . . . 0.0 111.287 -151.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.488 ' HB3' ' HB3' ' A' ' 83' ' ' ARG . 50.3 m-85 -116.24 138.27 51.44 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 124.398 1.079 . . . . 0.0 108.839 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 84' ' ' PHE . 8.7 mp -96.01 107.32 19.6 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 174.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -104.87 112.38 25.48 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.929 0.892 . . . . 0.0 110.013 -171.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.48 HG22 HG13 ' A' ' 63' ' ' ILE . 12.1 t -101.8 144.59 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.669 -175.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.2 86.9 2.51 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.452 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 4.3 p -80.86 -53.0 6.85 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.676 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.5 m -126.61 169.11 13.44 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.641 0.776 . . . . 0.0 110.536 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -88.11 -3.43 58.89 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.592 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -147.4 39.29 1.05 Allowed Glycine 0 C--N 1.35 1.306 0 CA-C-N 117.93 0.332 . . . . 0.0 113.086 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 m -120.34 151.18 53.17 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 123.73 0.812 . . . . 0.0 108.82 171.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.2 126.49 18.74 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 121.791 1.661 . . . . 0.0 110.557 170.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.6 t -68.95 127.45 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -177.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -98.48 117.97 34.11 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -171.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.488 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 88.3 mtm180 -99.0 126.73 44.77 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.036 0.934 . . . . 0.0 110.187 -173.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.519 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 71.1 m-85 -110.03 147.56 33.32 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.391 0.676 . . . . 0.0 111.781 -175.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -72.01 -38.59 69.58 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.263 0.625 . . . . 0.0 110.34 173.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.4 HG22 ' HG2' ' A' ' 89' ' ' GLU . 8.1 t -146.29 169.5 18.68 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.621 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.447 HD11 HG21 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -62.69 -29.65 70.81 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.937 174.182 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -55.22 -41.37 78.75 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 116.512 -0.313 . . . . 0.0 113.579 171.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 84' ' ' PHE . 53.3 mm-40 -67.9 -39.67 83.59 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.494 0.717 . . . . 0.0 110.644 176.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.658 HD11 HG12 ' A' ' 63' ' ' ILE . 7.1 tt -57.7 -54.96 40.99 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.334 -178.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 40.9 mm -66.26 -34.15 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.297 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.03 -56.92 22.48 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.636 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.36 -40.09 74.24 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.134 0.574 . . . . 0.0 111.016 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.666 ' HA ' HE22 ' A' ' 99' ' ' GLN . 6.5 m-30 -78.21 -7.25 56.88 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -173.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.03 -13.72 58.62 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 122.472 0.309 . . . . 0.0 111.584 164.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -92.25 137.54 24.77 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 124.477 1.111 . . . . 0.0 109.771 173.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.87 175.17 11.72 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.925 2.416 . . . . 0.0 113.917 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.4 t30 58.88 73.06 0.5 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.253 1.421 . . . . 0.0 112.228 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.666 HE22 ' HA ' ' A' ' 94' ' ' TYR . 48.1 mt-30 -142.4 -13.06 0.8 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.337 1.055 . . . . 0.0 111.029 174.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.452 ' HA3' ' HB ' ' A' ' 75' ' ' THR . . . 122.27 -2.63 10.52 Favored Glycine 0 N--CA 1.48 1.629 0 C-N-CA 123.694 0.664 . . . . 0.0 112.005 -169.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 88.5 mt -74.66 168.29 20.11 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.787 1.235 . . . . 0.0 111.114 176.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.5 m -67.26 -47.92 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.412 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.872 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 49.0 t -173.73 40.05 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.348 1.059 . . . . 0.0 109.63 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 78.37 -177.8 0.1 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.088 1.355 . . . . 0.0 111.346 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.411 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 21.9 mt -105.53 99.56 9.16 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 175.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 106' ' ' LEU . 0.8 OUTLIER -112.01 -48.79 3.02 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.907 0.883 . . . . 0.0 111.326 -171.754 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 35' ' ' SER . 10.5 mp -112.43 124.12 32.66 Favored Pre-proline 0 N--CA 1.484 1.247 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.49 -87.14 0.0 OUTLIER 'Trans proline' 0 CA--C 1.556 1.59 0 C-N-CA 121.203 1.268 . . . . 0.0 110.088 167.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 t . . . . . 0 C--O 1.25 1.128 0 C-N-CA 124.576 1.15 . . . . 0.0 108.137 177.782 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 CA--C 1.54 0.573 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 23.5 p-90 -93.27 -23.49 18.49 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 166.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 83.7 t80 -73.0 106.94 5.09 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 167.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -104.27 117.94 35.43 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -63.33 -46.3 87.27 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.946 0.899 . . . . 0.0 111.182 -170.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -114.47 81.7 1.59 Allowed 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.311 0.576 . . . . 0.0 109.585 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.7 tp -133.58 133.32 41.91 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.545 0.738 . . . . 0.0 110.376 176.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.6 m -99.17 170.28 8.8 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.673 0.789 . . . . 0.0 110.092 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.442 ' HG3' HG21 ' A' ' 60' ' ' THR . 38.8 ttt180 -62.1 -57.7 10.58 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -171.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.43 -42.96 78.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.149 0.58 . . . . 0.0 111.231 -178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.33 -30.71 70.61 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.172 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.26 -50.2 49.21 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.521 0.729 . . . . 0.0 111.356 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.489 ' HA ' HD12 ' A' ' 27' ' ' LEU . 10.2 pt-20 -69.68 -22.2 63.45 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.985 178.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -68.33 -49.59 59.31 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 167.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.405 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 43.7 mt -59.58 -30.11 68.42 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.752 0.421 . . . . 0.0 111.627 174.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 24' ' ' GLU . 48.1 mt -67.49 -47.07 71.09 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.49 0.316 . . . . 0.0 110.238 172.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.72 -42.71 97.89 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.4 0.68 . . . . 0.0 111.817 -173.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -87.0 -53.14 5.04 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.639 0.376 . . . . 0.0 110.643 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -78.29 -60.4 2.39 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 117.745 0.248 . . . . 0.0 111.127 -175.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.84 126.41 34.5 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-O 121.293 0.385 . . . . 0.0 114.029 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 71.2 mtp85 -79.47 -41.49 27.4 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.449 1.1 . . . . 0.0 113.159 -177.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 170.14 132.95 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.773 1.229 . . . . 0.0 107.988 -169.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.576 ' HA2' ' SG ' ' A' ' 103' ' ' CYS . . . 68.33 24.05 74.93 Favored Glycine 0 N--CA 1.479 1.519 0 CA-C-N 118.259 0.481 . . . . 0.0 111.929 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 7.6 m -88.73 145.77 25.43 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 124.141 0.976 . . . . 0.0 110.472 -171.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -142.05 151.6 42.56 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.197 0.599 . . . . 0.0 109.919 -176.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.492 HD23 HG21 ' A' ' 109' ' ' VAL . 4.6 pp -140.79 154.18 46.14 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.38 169.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 71.5 t -121.61 146.96 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 170.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 48.6 ptt85 -160.74 -170.25 2.68 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.801 1.24 . . . . 0.0 108.324 -173.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.71 144.25 25.93 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.572 0.749 . . . . 0.0 109.203 169.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.43 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . 35.6 t -70.41 160.84 31.6 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.972 0.909 . . . . 0.0 109.514 164.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -108.36 -14.57 14.65 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.8 m -81.11 -68.65 0.67 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.52 0.728 . . . . 0.0 109.975 -177.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.0 t -91.33 118.43 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.436 0.694 . . . . 0.0 109.444 -174.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 7.24 -82.17 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 127.791 2.436 . . . . 0.0 115.866 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.44 64.12 0.58 Allowed Glycine 0 C--N 1.346 1.12 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 174.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 41' ' ' SER . . . -90.11 164.41 14.48 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.935 0.494 . . . . 0.0 110.234 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.518 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 20.9 m-85 -104.16 122.19 44.83 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.027 0.931 . . . . 0.0 109.127 -177.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -108.23 130.74 55.14 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.445 0.698 . . . . 0.0 109.533 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.7 tp -117.79 108.13 14.99 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.495 ' SG ' HG22 ' A' ' 60' ' ' THR . 56.3 m -106.52 123.59 48.32 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -176.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 35' ' ' SER . 58.4 t -130.09 128.16 64.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 124.022 0.929 . . . . 0.0 109.596 -172.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 56.7 tp -108.29 143.45 37.12 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.28 1.032 . . . . 0.0 109.615 175.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -163.52 112.37 1.25 Allowed 'General case' 0 CA--C 1.543 0.689 0 O-C-N 123.839 0.712 . . . . 0.0 109.25 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 50.76 57.71 6.34 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.954 1.301 . . . . 0.0 113.018 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.7 tttm 52.6 28.03 5.71 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.925 1.29 . . . . 0.0 112.662 -175.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -106.6 104.13 13.74 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 173.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.0 t -86.19 128.71 39.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 173.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -140.07 134.69 31.71 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.495 HG22 ' SG ' ' A' ' 51' ' ' CYS . 37.7 p -112.62 135.9 52.81 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 173.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -114.1 99.93 8.0 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -82.16 97.73 8.35 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.518 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 63.4 mt -71.53 120.67 20.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.778 163.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.4 mp -101.78 126.87 32.65 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 172.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 11.6 Cg_endo -56.11 -62.59 0.23 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.146 1.897 . . . . 0.0 111.042 177.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.4 t70 105.64 -82.16 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.856 1.663 . . . . 0.0 107.733 161.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -88.93 25.82 9.34 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-O 119.171 -0.794 . . . . 0.0 113.579 174.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 59.9 -3.72 0.11 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 175.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -101.81 -44.04 5.65 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.524 0.73 . . . . 0.0 110.941 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -111.54 158.81 18.76 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.639 1.176 . . . . 0.0 109.104 -174.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 4.4 pp -110.49 112.97 25.24 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 165.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.14 125.14 49.71 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.977 0.511 . . . . 0.0 110.943 -176.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 81' ' ' VAL . 22.9 t -85.73 130.91 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.316 -175.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -96.79 93.02 6.44 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.3 p -81.93 -66.33 0.9 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 174.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.541 ' HB2' HG22 ' A' ' 79' ' ' VAL . 50.4 m -162.66 134.4 5.24 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.333 1.053 . . . . 0.0 109.884 172.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -71.65 99.31 2.08 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 164.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.44 -28.91 1.49 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -164.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.541 HG22 ' HB2' ' A' ' 76' ' ' SER . 17.4 m -126.43 152.52 74.25 Favored Pre-proline 0 N--CA 1.485 1.305 0 C-N-CA 124.154 0.981 . . . . 0.0 109.552 177.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -50.72 113.44 1.07 Allowed 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 123.117 2.545 . . . . 0.0 114.013 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 73' ' ' VAL . 7.3 p -71.08 141.38 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 124.72 1.208 . . . . 0.0 110.565 177.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -109.95 119.45 39.36 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.701 0.8 . . . . 0.0 109.656 175.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -102.06 146.94 27.2 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.025 0.93 . . . . 0.0 109.355 172.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -133.74 163.24 29.9 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.939 0.896 . . . . 0.0 108.849 174.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -100.15 -21.14 15.66 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 172.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.598 HG22 ' H ' ' A' ' 88' ' ' GLY . 57.9 m -138.5 141.59 39.38 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -170.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.478 ' O ' HG12 ' A' ' 91' ' ' ILE . 96.1 mt -61.82 -31.27 71.5 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.279 0.632 . . . . 0.0 111.353 177.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.598 ' H ' HG22 ' A' ' 86' ' ' THR . . . -58.21 -34.19 72.86 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 113.749 0.26 . . . . 0.0 113.749 173.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.86 -40.37 75.81 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.463 0.705 . . . . 0.0 110.295 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.3 tp -56.92 -61.07 2.7 Favored 'General case' 0 C--N 1.356 0.891 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.158 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.498 ' HA ' HD12 ' A' ' 105' ' ' LEU . 29.8 mm -60.29 -40.17 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 124.301 1.04 . . . . 0.0 110.573 -177.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.64 -55.54 28.25 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 124.073 0.858 . . . . 0.0 113.853 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 50.9 tp -73.82 -34.71 64.69 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 122.801 0.44 . . . . 0.0 110.939 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.417 ' HA ' ' OD1' ' A' ' 98' ' ' ASN . 3.1 m-30 -86.61 0.87 53.6 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -172.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.99 8.86 6.19 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.346 0.658 . . . . 0.0 112.497 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -137.92 162.18 55.66 Favored Pre-proline 0 CA--C 1.55 0.942 0 C-N-CA 124.888 1.275 . . . . 0.0 108.261 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -49.44 118.53 3.74 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 123.161 2.574 . . . . 0.0 113.243 171.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.417 ' OD1' ' HA ' ' A' ' 94' ' ' TYR . 21.8 m120 -106.93 -78.44 0.58 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.75 0.82 . . . . 0.0 110.923 -174.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 148.34 101.46 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.387 1.475 . . . . 0.0 108.089 -156.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 105.55 -29.06 12.05 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-O 119.742 -0.477 . . . . 0.0 112.832 172.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 15.2 mt -71.09 145.34 49.91 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.736 0.414 . . . . 0.0 111.339 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.5 m -66.01 -27.45 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.566 0.746 . . . . 0.0 111.421 172.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.576 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 29.3 p -168.22 172.89 8.23 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.337 1.055 . . . . 0.0 109.829 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.87 151.54 38.97 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.569 171.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 91' ' ' ILE . 29.9 mt -77.7 103.96 7.95 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 92.6 mt -118.95 -60.96 1.7 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.921 0.488 . . . . 0.0 112.153 -172.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -95.43 140.87 22.55 Favored Pre-proline 0 N--CA 1.484 1.271 0 C-N-CA 122.732 0.413 . . . . 0.0 111.17 -169.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -73.94 -163.46 0.17 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.965 2.444 . . . . 0.0 112.444 172.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.492 HG21 HD23 ' A' ' 37' ' ' LEU . 72.3 t . . . . . 0 C--O 1.254 1.32 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -175.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 m . . . . . 0 C--O 1.24 0.6 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.43 ' CD1' ' HB3' ' A' ' 108' ' ' PRO . 33.5 p-90 -91.95 3.82 54.37 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.908 0.483 . . . . 0.0 110.894 176.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.437 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 73.5 t80 -110.56 127.66 55.31 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -123.11 144.2 49.48 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.0 mtp-105 -63.07 -64.49 0.9 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.681 0.792 . . . . 0.0 110.13 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -84.74 -101.66 0.05 Allowed 'General case' 0 C--O 1.246 0.901 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -177.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.3 tp 65.05 113.56 0.03 OUTLIER 'General case' 0 C--N 1.363 1.182 0 C-N-CA 125.336 1.454 . . . . 0.0 110.661 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.2 t -72.91 147.81 44.95 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 170.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -63.81 -38.04 89.63 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.133 0.973 . . . . 0.0 110.151 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.23 -45.38 87.81 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.726 173.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.81 -33.59 66.31 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.606 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.576 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -66.87 -51.93 49.56 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.739 0.816 . . . . 0.0 110.255 -177.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -54.26 -43.66 71.17 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.013 1.325 . . . . 0.0 111.323 174.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.39 -50.3 66.02 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.821 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.1 mt -61.85 -34.32 75.76 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.69 0.796 . . . . 0.0 112.295 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.7 mt -70.54 -59.09 3.04 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.92 -29.01 68.08 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.297 1.039 . . . . 0.0 112.977 -172.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -78.21 -44.94 24.33 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.413 0.685 . . . . 0.0 110.904 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.64 -59.24 2.82 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.438 0.637 . . . . 0.0 112.408 -170.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.06 -169.62 16.05 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 114.685 -1.143 . . . . 0.0 113.808 -165.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.452 ' HB3' ' H ' ' A' ' 33' ' ' ASP . 6.4 mpt_? -119.47 -157.57 0.7 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 125.143 1.377 . . . . 0.0 109.716 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.452 ' H ' ' HB3' ' A' ' 32' ' ' ARG . 8.1 p-10 -57.0 132.87 54.16 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.959 0.904 . . . . 0.0 112.099 -176.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.55 0.59 64.65 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.932 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.43 ' HB2' ' HB3' ' A' ' 53' ' ' LEU . 56.8 m -71.64 116.58 12.17 Favored 'General case' 0 C--N 1.359 1.007 0 CA-C-N 117.764 0.782 . . . . 0.0 108.898 176.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 24.5 p90 -131.07 157.43 43.09 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.306 0.574 . . . . 0.0 111.639 -172.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.576 HD11 ' HB1' ' A' ' 23' ' ' ALA . 2.9 pp -150.93 164.11 37.12 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.69 169.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 49' ' ' ALA . 86.2 t -125.94 149.26 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 171.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.517 ' HG3' ' HB3' ' A' ' 49' ' ' ALA . 0.5 OUTLIER -153.17 169.07 23.91 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.739 1.215 . . . . 0.0 108.726 -175.383 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 13.7 t70 -93.18 120.8 33.87 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 172.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.4 m -69.19 101.15 1.4 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.027 0.931 . . . . 0.0 111.282 -169.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.454 ' HG2' HH21 ' A' ' 39' ' ' ARG . 16.6 mm-40 -49.78 -31.67 12.16 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.411 1.484 . . . . 0.0 114.315 173.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.5 p -79.23 -17.4 54.88 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.944 0.498 . . . . 0.0 112.279 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.6 t -108.81 -64.76 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 122.996 0.519 . . . . 0.0 109.7 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 95.84 122.07 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.871 2.469 . . . . 0.0 109.547 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 63.46 58.18 12.31 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.746 1.279 . . . . 0.0 111.643 -173.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 40' ' ' ASP . . . -153.08 150.4 29.09 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.461 1.104 . . . . 0.0 108.149 -174.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -113.53 125.1 53.82 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.388 0.994 . . . . 0.0 111.311 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.517 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . . . -104.4 127.27 52.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.52 0.728 . . . . 0.0 109.326 -177.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.4 tp -111.11 106.25 15.23 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 31.2 m -101.16 121.38 41.74 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -176.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.506 HG21 HD22 ' A' ' 101' ' ' LEU . 94.0 t -122.43 116.69 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.262 1.025 . . . . 0.0 109.37 -174.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 35' ' ' SER . 36.9 tp -85.24 135.13 34.06 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.189 0.996 . . . . 0.0 111.273 -173.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -141.7 102.3 4.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.525 0.73 . . . . 0.0 109.103 167.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 57.5 54.21 6.71 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.231 1.012 . . . . 0.0 111.369 172.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.419 ' H ' HD11 ' A' ' 53' ' ' LEU . 14.7 tmtt? 75.27 -23.06 0.24 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 125.681 1.592 . . . . 0.0 112.441 -177.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -88.8 101.35 13.94 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.902 0.858 . . . . 0.0 108.734 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 83.6 t -93.52 120.7 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.227 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -94.98 122.13 37.31 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 37.3 p -113.9 141.62 47.13 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -169.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -135.99 99.15 4.07 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -177.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -81.14 93.53 6.47 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.109 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.437 HG22 ' HB3' ' A' ' 71' ' ' LEU . 32.5 mt -79.9 136.63 23.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 124.494 1.117 . . . . 0.0 110.315 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.8 mp -121.2 141.22 32.56 Favored Pre-proline 0 N--CA 1.475 0.805 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -174.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 70' ' ' PHE . 52.5 Cg_exo -58.67 114.91 2.2 Favored 'Trans proline' 0 C--N 1.366 1.491 0 C-N-CA 122.038 1.826 . . . . 0.0 109.162 158.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -123.84 5.36 8.75 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 123.48 0.712 . . . . 0.0 110.44 -160.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.36 141.29 3.67 Favored Glycine 0 C--N 1.342 0.904 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -174.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 33.66 -76.75 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.016 2.228 . . . . 0.0 117.016 -166.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -163.02 22.37 0.09 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -163.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 72.1 m-85 -127.15 150.5 49.48 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.139 0.976 . . . . 0.0 109.717 -170.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.437 ' HB3' HG22 ' A' ' 63' ' ' ILE . 8.2 mp -99.11 150.05 22.42 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.28 1.032 . . . . 0.0 109.743 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -135.93 120.54 18.28 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.635 0.774 . . . . 0.0 109.836 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.8 t -84.93 128.04 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.27 1.028 . . . . 0.0 108.539 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -110.85 87.64 2.58 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -175.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.3 t -140.44 138.68 34.88 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.165 175.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.4 m 63.05 -2.12 0.44 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 165.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 60.71 -79.69 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 125.331 1.452 . . . . 0.0 112.429 -177.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.55 -28.48 62.52 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 -172.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.92 124.19 63.43 Favored Pre-proline 0 CA--C 1.561 1.392 0 CA-C-N 117.274 0.537 . . . . 0.0 110.632 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.413 ' HB2' HE22 ' A' ' 99' ' ' GLN . 81.3 Cg_exo -51.99 113.58 1.24 Allowed 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.653 2.235 . . . . 0.0 113.349 177.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 70.2 t -101.7 134.1 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.417 1.087 . . . . 0.0 108.751 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -105.29 151.6 23.94 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.471 ' O ' ' HD2' ' A' ' 83' ' ' ARG . 2.6 ppt_? -85.34 121.91 28.74 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 170.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -107.29 129.43 54.89 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.592 -0.693 . . . . 0.0 110.178 -176.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -84.64 -17.31 39.01 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.8 t -155.28 163.46 40.11 Favored 'General case' 0 C--O 1.248 0.99 0 C-N-CA 122.779 0.432 . . . . 0.0 110.372 172.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.424 ' O ' HG12 ' A' ' 91' ' ' ILE . 94.9 mt -60.22 -32.12 70.81 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.044 0.937 . . . . 0.0 111.677 177.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -55.86 -41.85 84.71 Favored Glycine 0 C--N 1.352 1.464 0 O-C-N 123.304 0.377 . . . . 0.0 112.762 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -65.85 -39.08 90.43 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.811 0.844 . . . . 0.0 111.033 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 47.7 tp -64.17 -41.72 97.02 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.191 0.996 . . . . 0.0 111.467 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 87' ' ' LEU . 49.8 mm -84.95 -28.18 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -168.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.42 -47.74 15.84 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.2 tt -61.28 -43.78 98.32 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.447 0.699 . . . . 0.0 110.325 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.492 ' HB3' HD11 ' A' ' 101' ' ' LEU . 3.0 m-85 -79.57 -9.76 59.68 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.509 0.724 . . . . 0.0 112.215 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.03 -0.72 19.85 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.734 0.413 . . . . 0.0 112.104 167.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -154.45 57.92 1.93 Allowed Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 124.465 1.106 . . . . 0.0 109.018 172.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.466 ' HG3' HD12 ' A' ' 101' ' ' LEU . 81.1 Cg_endo -75.35 -66.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.507 2.138 . . . . 0.0 113.706 -164.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.5 t30 57.77 39.24 27.29 Favored 'General case' 0 C--N 1.367 1.327 0 C-N-CA 124.325 1.05 . . . . 0.0 108.534 -170.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.413 HE22 ' HB2' ' A' ' 80' ' ' PRO . 20.9 mt-30 -177.75 86.38 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.243 1.017 . . . . 0.0 110.211 -162.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 103.93 -32.28 7.72 Favored Glycine 0 N--CA 1.474 1.187 0 C-N-CA 121.639 -0.315 . . . . 0.0 112.853 161.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.506 HD22 HG21 ' A' ' 52' ' ' VAL . 53.7 mt -87.64 123.96 33.04 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.675 0.39 . . . . 0.0 110.388 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.8 p -51.05 -32.83 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.457 0 C-N-CA 125.767 1.627 . . . . 0.0 113.514 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 26.2 p -153.64 16.07 0.51 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.979 0.512 . . . . 0.0 112.206 -175.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 67.26 -160.35 0.23 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.646 0.778 . . . . 0.0 110.891 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 56.9 mt -110.91 156.67 20.84 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 58.5 tp -164.94 -63.18 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.457 0.303 . . . . 0.0 111.051 -175.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 29.9 tp -111.52 102.56 53.56 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 122.792 0.437 . . . . 0.0 110.507 -167.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.43 ' HB3' ' CD1' ' A' ' 13' ' ' TRP . 12.3 Cg_exo -72.4 100.96 1.2 Allowed 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.587 2.192 . . . . 0.0 109.392 169.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 87.6 t . . . . . 0 C--O 1.245 0.852 0 CA-C-O 118.648 -0.691 . . . . 0.0 109.328 -171.433 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.6 m . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -115.26 12.53 16.48 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.108 0.563 . . . . 0.0 111.929 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.415 ' HE2' ' HG2' ' A' ' 16' ' ' ARG . 53.8 t80 -108.36 116.57 32.22 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -177.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -115.51 117.15 29.55 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.415 ' HG2' ' HE2' ' A' ' 14' ' ' TYR . 80.9 mtt180 -64.24 -58.51 6.36 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.385 0.674 . . . . 0.0 111.524 -175.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -111.11 86.48 2.33 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.394 1.092 . . . . 0.0 108.461 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.9 tp -133.14 133.74 43.26 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.457 -1.247 . . . . 0.0 107.926 177.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.4 m -80.04 155.0 27.79 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.505 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 77.3 ttt180 -65.85 -43.35 88.7 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 119.233 -0.413 . . . . 0.0 110.774 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.85 -48.08 67.32 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.449 0.7 . . . . 0.0 111.252 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.47 -25.13 63.93 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.087 177.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.81 -49.55 20.33 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.49 0.716 . . . . 0.0 111.664 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 1.1 mm-40 -62.72 -38.65 91.31 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.234 0.614 . . . . 0.0 110.01 177.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.3 -47.24 80.22 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 124.377 1.048 . . . . 0.0 109.995 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -54.7 -37.92 66.41 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.89 0.876 . . . . 0.0 110.869 176.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 53' ' ' LEU . 86.5 mt -79.77 -36.1 37.65 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.375 -0.203 . . . . 0.0 111.061 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.63 -41.75 83.4 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 122.706 0.403 . . . . 0.0 110.45 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -89.22 -60.29 1.99 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.119 0.968 . . . . 0.0 111.621 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.26 -50.47 14.32 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.176 0.19 . . . . 0.0 111.347 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.32 122.11 28.62 Favored Glycine 0 C--N 1.353 1.505 0 O-C-N 123.544 0.527 . . . . 0.0 113.72 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -71.0 -45.04 64.67 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.089 0.556 . . . . 0.0 111.075 -177.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 160.98 131.94 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 125.405 1.482 . . . . 0.0 108.172 -174.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.12 20.45 79.05 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 111.924 -0.471 . . . . 0.0 111.924 -176.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 109' ' ' VAL . 13.7 m -83.48 144.94 29.22 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 124.377 1.071 . . . . 0.0 109.529 -178.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -141.75 150.49 41.84 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.96 0.409 . . . . 0.0 111.008 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -138.26 148.86 45.16 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.913 0.885 . . . . 0.0 109.869 170.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.468 HG22 HD13 ' A' ' 50' ' ' LEU . 48.7 t -114.39 136.55 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -135.73 165.2 26.13 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 124.54 1.136 . . . . 0.0 109.412 -174.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -86.32 131.96 34.09 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 175.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.444 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . 40.4 m -91.46 162.56 14.51 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.292 1.037 . . . . 0.0 108.251 172.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -143.7 75.28 1.46 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.6 t -165.48 -68.69 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.664 -174.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 76.2 t -82.18 82.35 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 174.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 46.72 -122.67 1.28 Allowed 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 124.352 1.061 . . . . 0.0 111.183 -170.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -108.77 79.69 0.25 Allowed Glycine 0 C--N 1.356 1.67 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 172.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 41' ' ' SER . . . -92.38 174.51 7.25 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.542 0.737 . . . . 0.0 111.445 -172.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.522 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 87.2 m-85 -113.37 155.05 25.9 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.214 1.006 . . . . 0.0 109.72 173.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.52 146.98 48.63 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.619 1.168 . . . . 0.0 108.989 171.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 61' ' ' TYR . 40.8 tp -124.82 108.95 12.47 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.182 0.993 . . . . 0.0 109.239 -176.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.505 ' SG ' HG22 ' A' ' 60' ' ' THR . 52.9 m -93.92 126.1 38.93 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.1 t -132.71 121.28 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 CA-C-N 118.273 0.488 . . . . 0.0 109.852 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 40.2 tp -86.93 139.84 30.21 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.72 0.808 . . . . 0.0 109.248 171.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -163.56 121.49 1.89 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 170.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 41.88 67.26 0.59 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 126.012 1.725 . . . . 0.0 113.732 177.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.465 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 10.8 mmpt? 59.21 27.73 16.83 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.76 1.224 . . . . 0.0 112.897 178.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -139.36 107.14 5.64 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.781 0.832 . . . . 0.0 108.984 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.9 t -93.47 122.12 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 166.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -117.97 138.61 52.06 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.064 0.946 . . . . 0.0 108.907 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.505 HG22 ' SG ' ' A' ' 51' ' ' CYS . 21.4 p -106.56 139.51 40.9 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.477 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 23.9 m-85 -119.0 107.56 13.67 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -70.58 150.37 46.14 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 171.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 96.7 mt -147.27 105.77 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 102.605 -3.109 . . . . 0.0 102.605 -158.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.8 mp -107.19 98.03 20.89 Favored Pre-proline 0 N--CA 1.48 1.051 0 CA-C-O 118.634 -0.698 . . . . 0.0 111.484 -160.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 70' ' ' PHE . 37.3 Cg_endo -66.22 95.58 0.32 Allowed 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 122.5 2.133 . . . . 0.0 109.268 162.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -166.76 164.26 16.56 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 124.446 1.098 . . . . 0.0 108.683 -158.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.72 -67.05 3.05 Favored Glycine 0 C--N 1.349 1.272 0 C-N-CA 123.076 0.369 . . . . 0.0 113.047 171.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -142.22 23.99 1.98 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.105 1.362 . . . . 0.0 108.108 -178.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 t70 61.49 58.71 2.03 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.262 1.425 . . . . 0.0 109.972 -170.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.439 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 23.1 p90 -127.8 151.99 48.35 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.394 1.078 . . . . 0.0 108.105 169.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.15 109.44 22.19 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 176.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . . . -98.56 127.11 44.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.793 0.837 . . . . 0.0 110.42 -175.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.3 t -99.26 129.15 50.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -94.04 90.72 6.53 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -174.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.5 p -71.66 -34.36 69.66 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.237 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.9 m 75.94 167.12 0.27 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.878 1.671 . . . . 0.0 112.745 173.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 67.57 -162.64 0.22 Allowed 'General case' 0 C--N 1.358 0.972 0 C-N-CA 124.47 1.108 . . . . 0.0 111.693 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -49.5 -24.38 5.42 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 114.756 -1.111 . . . . 0.0 113.965 170.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.69 120.9 80.4 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.573 0.749 . . . . 0.0 109.654 174.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.36 142.52 72.92 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.94 2.427 . . . . 0.0 113.266 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 37.1 t -78.29 118.88 26.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 C-N-CA 124.297 1.039 . . . . 0.0 108.278 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -107.03 127.76 53.76 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.852 0.358 . . . . 0.0 110.494 -173.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.545 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 27.9 ptt180 -98.05 154.33 17.79 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.311 1.044 . . . . 0.0 109.997 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -130.29 154.85 47.19 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.369 0.668 . . . . 0.0 111.399 -175.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -72.67 -46.42 53.92 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.502 172.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.0 t -145.76 166.74 24.99 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.517 0.727 . . . . 0.0 110.975 -177.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.6 mt -60.0 -32.57 70.98 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.712 0.805 . . . . 0.0 111.43 175.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -52.45 -41.26 55.44 Favored Glycine 0 N--CA 1.48 1.6 0 O-C-N 123.027 0.205 . . . . 0.0 113.357 172.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -65.63 -41.06 93.09 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.739 0.815 . . . . 0.0 111.232 173.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.5 tt -68.11 -40.09 82.65 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.226 1.01 . . . . 0.0 110.873 -174.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 44.6 mm -86.05 -42.11 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -166.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.88 -35.21 72.31 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.763 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.411 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 27.1 tp -77.49 -40.98 41.08 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-N 116.907 0.353 . . . . 0.0 110.821 177.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.3 m-30 -80.98 4.37 19.81 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 118.099 0.409 . . . . 0.0 111.83 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.63 -4.02 3.76 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.842 0.857 . . . . 0.0 112.538 163.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 93' ' ' LEU . 10.9 pt20 -125.27 144.35 47.27 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 171.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -84.42 -154.13 0.05 OUTLIER 'Trans proline' 0 CA--C 1.555 1.531 0 C-N-CA 123.32 2.68 . . . . 0.0 112.387 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.5 t30 62.68 57.54 1.77 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.64 1.176 . . . . 0.0 110.032 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -170.41 31.22 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.808 178.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.66 -10.36 72.42 Favored Glycine 0 N--CA 1.477 1.424 0 O-C-N 120.886 -1.134 . . . . 0.0 112.433 173.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.13 130.93 43.41 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 168.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.2 p -60.09 -31.67 48.5 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 123.984 0.914 . . . . 0.0 111.142 177.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 28.4 p -160.11 165.44 31.73 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.529 1.132 . . . . 0.0 108.876 176.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.2 150.73 46.16 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 122.727 0.411 . . . . 0.0 110.169 174.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 75.7 mt -73.16 95.85 2.14 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.2 tp -119.67 -61.37 1.62 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.673 -169.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.459 HD12 ' HD2' ' A' ' 108' ' ' PRO . 45.1 tp -100.42 123.78 45.12 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 123.081 0.552 . . . . 0.0 109.797 -172.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.459 ' HD2' HD12 ' A' ' 107' ' ' LEU . 19.4 Cg_endo -59.03 -47.61 17.21 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.399 2.066 . . . . 0.0 111.242 172.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.475 ' HA ' ' HB3' ' A' ' 35' ' ' SER . 0.3 OUTLIER . . . . . 0 C--O 1.245 0.836 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.483 1.22 0 CA-C-O 120.292 0.091 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.524 ' HB3' ' HB3' ' A' ' 108' ' ' PRO 0.317 36.1 p-90 71.53 -54.56 0.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 128.569 2.748 . . . . 0.0 110.906 -177.89 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -76.35 123.83 26.57 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 173.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.407 ' CD2' ' HB2' ' A' ' 37' ' ' LEU . 93.3 m-70 -113.79 171.93 7.29 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.856 0.863 . . . . 0.0 110.797 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -81.95 -148.43 0.07 Allowed 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.601 169.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -65.04 106.04 1.18 Allowed 'General case' 0 CA--C 1.555 1.168 0 CA-C-O 121.786 0.803 . . . . 0.0 110.219 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 39' ' ' ARG . 26.2 tp -136.1 138.45 42.08 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 57.4 p -96.15 172.39 8.01 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.399 0.68 . . . . 0.0 110.225 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -63.42 -51.75 64.43 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.448 0.699 . . . . 0.0 112.568 -176.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.47 -35.95 80.93 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.872 0.469 . . . . 0.0 111.265 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.84 -37.25 81.65 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.385 0.674 . . . . 0.0 111.1 174.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.33 -55.31 12.52 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.816 0.846 . . . . 0.0 111.703 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.493 ' HB3' HG11 ' A' ' 58' ' ' VAL . 13.3 pt-20 -66.13 -26.37 67.42 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.005 0.922 . . . . 0.0 112.375 -177.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -64.81 -51.18 63.54 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 172.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.9 tp -61.21 -40.16 92.91 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.974 178.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.0 mt -64.58 -52.34 58.08 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.705 0.802 . . . . 0.0 110.505 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.43 -33.48 75.64 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.866 0.867 . . . . 0.0 112.566 -172.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -87.75 -57.79 2.81 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.783 -0.189 . . . . 0.0 111.383 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.73 -59.44 3.32 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.14 0.576 . . . . 0.0 112.325 -170.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -123.12 77.04 0.36 Allowed Glycine 0 C--N 1.342 0.885 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -71.47 102.57 2.7 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 118.996 -0.525 . . . . 0.0 110.015 -171.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.5 t70 97.7 116.2 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.638 1.575 . . . . 0.0 109.877 164.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.72 3.79 68.23 Favored Glycine 0 N--CA 1.476 1.313 0 CA-C-N 115.879 -0.6 . . . . 0.0 113.543 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.7 p -78.09 158.56 29.1 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.416 0.687 . . . . 0.0 111.56 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -145.9 158.95 43.84 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 172.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.411 ' O ' HD12 ' A' ' 50' ' ' LEU . 4.1 pp -154.05 163.08 40.66 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.697 170.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.0 t -117.76 144.88 24.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 169.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.516 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 50.4 ptt85 -152.9 156.68 39.41 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.19 0.596 . . . . 0.0 110.051 -174.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -87.91 117.83 27.03 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 174.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.0 m -94.9 100.36 12.24 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 174.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -60.63 -39.45 88.28 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.196 0.598 . . . . 0.0 111.921 169.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.1 m -87.92 58.84 5.04 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.89 0.876 . . . . 0.0 112.183 -171.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.469 HG13 ' H ' ' A' ' 45' ' ' ALA . 2.1 p -155.49 -70.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.008 0.523 . . . . 0.0 110.17 172.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.469 ' H ' HG13 ' A' ' 44' ' ' VAL . . . -170.07 15.07 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.695 0.798 . . . . 0.0 110.539 -174.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.49 94.68 0.06 OUTLIER Glycine 0 C--N 1.344 1.026 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -161.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.583 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . . . -152.54 160.42 43.22 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -168.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.431 ' HD2' ' HB3' ' A' ' 65' ' ' PRO . 57.8 m-85 -109.58 137.12 47.87 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.932 0.493 . . . . 0.0 109.928 168.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -119.48 135.81 54.6 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.776 0.831 . . . . 0.0 109.816 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.535 HD21 HD21 ' A' ' 105' ' ' LEU . 66.8 tp -107.87 104.08 13.48 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 48.8 t -106.85 116.16 31.45 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -174.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.9 t -122.2 118.24 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.574 1.15 . . . . 0.0 109.151 -170.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 47.3 tp -91.75 131.91 36.78 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.768 0.827 . . . . 0.0 109.155 175.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.402 ' HD2' HG22 ' A' ' 102' ' ' VAL . 83.9 t80 -164.51 127.97 2.47 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.431 0.692 . . . . 0.0 110.32 172.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 47.69 53.23 11.55 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.351 1.46 . . . . 0.0 111.715 174.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 91.0 mttt 56.38 39.26 30.14 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.515 1.126 . . . . 0.0 112.05 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 59.2 m80 -136.77 105.8 5.96 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.334 1.054 . . . . 0.0 108.481 174.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.493 HG11 ' HB3' ' A' ' 24' ' ' GLU . 84.9 t -94.67 107.17 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 170.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -103.06 129.55 49.91 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 96.0 m -110.2 137.98 47.2 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.462 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 56.4 m-85 -120.64 101.47 7.77 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -86.13 96.47 9.9 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 119.082 0.855 . . . . 0.0 109.402 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.454 HD12 ' O ' ' A' ' 61' ' ' TYR . 4.9 mp -85.07 141.95 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 123.62 0.768 . . . . 0.0 110.805 171.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.9 mp -96.06 118.87 65.43 Favored Pre-proline 0 CA--C 1.557 1.219 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 172.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.598 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 92.3 Cg_endo -76.4 -51.98 0.09 OUTLIER 'Trans proline' 0 CA--C 1.556 1.589 0 C-N-CA 122.519 2.146 . . . . 0.0 116.361 -162.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -148.91 167.68 25.06 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 122.259 -0.276 . . . . 0.0 111.158 -158.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.15 -96.29 0.25 Allowed Glycine 0 C--N 1.35 1.323 0 C-N-CA 123.336 0.494 . . . . 0.0 111.898 178.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -126.05 30.31 5.68 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.983 0.913 . . . . 0.0 109.206 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -159.33 174.19 15.14 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.771 -162.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -120.26 158.19 27.55 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.598 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -93.42 111.49 23.17 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -170.636 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.781 ' HB2' ' HG2' ' A' ' 83' ' ' ARG . . . -117.95 142.23 47.59 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.86 0.864 . . . . 0.0 110.748 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.6 t -89.24 142.57 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -108.84 90.99 3.46 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.8 p -87.58 -71.35 0.57 Allowed 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 172.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.2 t 179.92 140.72 0.13 Allowed 'General case' 0 C--N 1.351 0.658 0 C-N-CA 124.616 1.167 . . . . 0.0 108.955 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -70.83 128.2 35.23 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 140.52 -76.96 0.31 Allowed Glycine 0 C--N 1.346 1.135 0 N-CA-C 108.067 -2.013 . . . . 0.0 108.067 -166.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.3 m -64.41 140.08 97.88 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 123.838 0.855 . . . . 0.0 110.043 162.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -64.58 121.28 8.8 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.75 2.3 . . . . 0.0 112.056 -176.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 72.6 t -99.47 141.85 16.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.197 0.999 . . . . 0.0 108.463 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.8 mmt85 -117.31 143.7 45.65 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.553 0.741 . . . . 0.0 111.109 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.781 ' HG2' ' HB2' ' A' ' 72' ' ' ALA . 86.2 mtt-85 -94.89 148.41 22.34 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 166.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -127.39 161.9 27.58 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.163 0.585 . . . . 0.0 110.395 -174.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -95.3 -19.39 20.02 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.313 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.401 HG23 ' H ' ' A' ' 89' ' ' GLU . 15.0 t -157.06 159.72 38.21 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 122.654 0.382 . . . . 0.0 111.592 -176.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.4 mt -61.27 -34.44 75.18 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.186 0.994 . . . . 0.0 112.143 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.41 -38.77 91.63 Favored Glycine 0 C--N 1.349 1.254 0 O-C-N 123.206 0.317 . . . . 0.0 112.952 174.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.401 ' H ' HG23 ' A' ' 86' ' ' THR . 26.2 tt0 -72.21 -37.16 69.3 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.649 0.78 . . . . 0.0 109.735 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.6 tt -54.28 -53.74 49.61 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.657 1.183 . . . . 0.0 110.428 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.9 mm -64.79 -36.3 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.414 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -53.89 -55.08 27.51 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 124.198 0.936 . . . . 0.0 113.298 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -76.47 -35.74 58.26 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 122.998 0.519 . . . . 0.0 111.843 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.531 ' CD2' HD21 ' A' ' 101' ' ' LEU . 7.4 m-85 -89.49 4.62 48.59 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -173.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.42 -6.82 48.72 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 122.719 0.408 . . . . 0.0 110.93 162.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -83.17 125.75 73.86 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.965 0.906 . . . . 0.0 110.337 174.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.94 179.78 6.18 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.387 2.058 . . . . 0.0 111.36 169.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 53.83 66.18 1.3 Allowed 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.877 0.871 . . . . 0.0 111.128 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -173.2 21.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.2 1.0 . . . . 0.0 110.383 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 107.52 -21.65 30.12 Favored Glycine 0 C--N 1.345 1.076 0 O-C-N 121.622 -0.674 . . . . 0.0 112.41 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.531 HD21 ' CD2' ' A' ' 94' ' ' TYR . 2.9 mm? -70.57 124.7 24.86 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.338 1.055 . . . . 0.0 110.582 177.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.402 HG22 ' HD2' ' A' ' 54' ' ' TYR . 13.9 p -52.96 -31.41 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.542 0 C-N-CA 124.21 1.004 . . . . 0.0 112.783 -178.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 27.2 p -156.25 6.41 0.19 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.003 0.521 . . . . 0.0 112.309 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 68.0 -179.62 0.22 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.727 0.811 . . . . 0.0 110.594 -166.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.535 HD21 HD21 ' A' ' 50' ' ' LEU . 46.1 mt -90.0 91.53 8.61 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 79.1 mt -93.86 -69.31 0.76 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.928 0.891 . . . . 0.0 111.321 -174.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.7 mp -104.01 128.25 27.6 Favored Pre-proline 0 N--CA 1.48 1.048 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -173.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.524 ' HB3' ' HB3' ' A' ' 13' ' ' TRP . 35.5 Cg_exo -63.38 -124.25 0.0 OUTLIER 'Trans proline' 0 CA--C 1.571 2.334 0 C-N-CA 122.623 2.215 . . . . 0.0 111.576 169.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.7 t . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 176.914 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.8 t . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.5 ' HB3' ' O ' ' A' ' 108' ' ' PRO . 4.7 p-90 -94.77 -22.86 17.8 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.595 1.158 . . . . 0.0 109.341 166.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 84.6 t80 -71.68 109.05 5.33 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.862 173.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -128.27 120.29 26.84 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -59.06 -72.84 0.09 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.647 0.379 . . . . 0.0 110.937 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -85.48 59.05 5.39 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.72 0.808 . . . . 0.0 110.126 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 26.0 tp -88.2 -61.12 1.78 Allowed 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -176.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.2 m 93.81 145.94 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 127.125 2.17 . . . . 0.0 107.895 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.473 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 54.9 ttt180 -57.2 -46.83 82.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.112 0.565 . . . . 0.0 111.701 -177.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.523 ' O ' ' HB2' ' A' ' 25' ' ' GLU . . . -51.76 -47.92 63.93 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 124.173 0.92 . . . . 0.0 111.573 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.419 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -69.13 -38.04 78.63 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.459 177.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.447 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -61.4 -60.64 3.41 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.189 0.996 . . . . 0.0 112.114 -177.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 12.5 pt-20 -59.08 -29.58 67.44 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.246 1.019 . . . . 0.0 112.398 175.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.6 OUTLIER -67.1 -47.47 71.07 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.161 0.584 . . . . 0.0 109.522 178.119 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 22' ' ' ALA . 94.5 mt -59.59 -36.03 75.47 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.89 0.876 . . . . 0.0 111.341 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.3 mt -68.87 -54.55 15.0 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.24 -36.76 76.05 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.818 0.847 . . . . 0.0 112.748 -169.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -92.37 -59.47 2.08 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -73.35 -59.51 2.68 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -165.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.33 108.34 1.69 Allowed Glycine 0 C--N 1.349 1.304 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -175.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 50.8 ttt85 -57.75 -129.09 0.0 OUTLIER 'General case' 0 CA--C 1.581 2.173 0 C-N-CA 124.372 1.069 . . . . 0.0 113.236 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -74.68 148.83 40.24 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.282 -1.511 . . . . 0.0 111.442 -169.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.415 ' HA3' HD23 ' A' ' 106' ' ' LEU . . . 70.13 18.04 74.42 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.628 0.58 . . . . 0.0 114.207 -176.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.634 ' HB2' HG22 ' A' ' 109' ' ' VAL . 59.6 p -80.38 139.04 36.72 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -144.1 147.24 33.48 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.013 0.435 . . . . 0.0 110.255 177.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.447 HD11 ' HB1' ' A' ' 23' ' ' ALA . 1.6 pp -150.04 154.37 38.05 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.123 0.969 . . . . 0.0 108.701 168.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 79.6 t -114.73 131.02 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.496 ' HG3' ' HB3' ' A' ' 49' ' ' ALA . 5.9 ptm180 -116.79 168.64 10.04 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.214 1.005 . . . . 0.0 108.383 174.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -85.24 132.38 34.28 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 170.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 97.1 p -58.53 153.38 16.23 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 123.905 0.753 . . . . 0.0 111.596 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -71.73 79.58 0.85 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.711 0.804 . . . . 0.0 111.963 -172.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.3 m 53.55 28.31 7.63 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.954 1.301 . . . . 0.0 113.118 177.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.8 t -65.53 -73.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.499 0.72 . . . . 0.0 111.411 -172.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -172.41 34.7 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.238 0.615 . . . . 0.0 110.608 -177.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.39 35.49 33.14 Favored Glycine 0 N--CA 1.469 0.835 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.14 -174.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -97.08 169.77 9.58 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.568 0.747 . . . . 0.0 110.64 -177.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -124.16 157.49 34.59 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.049 0.94 . . . . 0.0 109.849 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.496 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . . . -133.64 144.77 49.42 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.295 0.638 . . . . 0.0 109.512 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.2 tp -123.9 124.21 42.12 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.447 ' SG ' HG22 ' A' ' 60' ' ' THR . 39.0 m -115.03 121.14 42.19 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -178.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 35' ' ' SER . 60.4 t -128.48 125.42 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.791 0.837 . . . . 0.0 109.038 -175.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.477 ' HB3' ' OG ' ' A' ' 35' ' ' SER . 60.7 tp -96.21 138.73 33.38 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.343 0.657 . . . . 0.0 109.905 177.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -161.57 125.05 3.2 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.9 0.88 . . . . 0.0 108.961 175.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 50.26 52.57 14.49 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.08 1.352 . . . . 0.0 112.391 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 80.3 tttt 55.9 39.11 30.64 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.737 1.215 . . . . 0.0 112.119 -176.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -140.69 106.03 5.05 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.94 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 85.4 t -87.36 112.06 22.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 168.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -97.4 130.34 44.54 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 170.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.447 HG22 ' SG ' ' A' ' 51' ' ' CYS . 41.1 p -108.29 130.26 55.19 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -113.59 98.9 7.34 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.3 mtm105 -83.54 91.69 7.47 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.506 HD13 HD11 ' A' ' 90' ' ' LEU . 61.7 mt -77.56 122.39 32.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.701 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.9 mp -93.96 149.86 37.61 Favored Pre-proline 0 CA--C 1.547 0.832 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -178.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -79.42 -143.05 0.02 OUTLIER 'Trans proline' 0 CA--C 1.565 2.061 0 C-N-CA 122.942 2.428 . . . . 0.0 112.498 -170.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.647 ' HB3' ' H ' ' A' ' 70' ' ' PHE . 31.0 t70 -169.74 151.43 4.25 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.646 0.778 . . . . 0.0 109.841 -172.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -55.33 -35.28 60.47 Favored Glycine 0 C--N 1.349 1.266 0 O-C-N 124.035 0.835 . . . . 0.0 114.112 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -102.59 25.13 9.48 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.646 0.778 . . . . 0.0 111.416 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 58.91 57.67 3.51 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.508 1.523 . . . . 0.0 114.098 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.647 ' H ' ' HB3' ' A' ' 66' ' ' ASP . 96.4 m-85 -118.86 151.65 37.72 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 169.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 mp -98.2 108.28 20.94 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.97 118.15 33.9 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.607 0.763 . . . . 0.0 109.628 -175.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 81' ' ' VAL . 12.9 t -99.72 140.96 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.918 0.887 . . . . 0.0 110.289 -176.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -108.09 89.73 3.08 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 176.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.3 m -90.82 125.51 35.74 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -171.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.2 m 59.01 -89.98 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.067 1.347 . . . . 0.0 112.061 177.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 176.75 -26.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.592 1.157 . . . . 0.0 111.057 -177.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -132.03 40.61 1.6 Allowed Glycine 0 N--CA 1.47 0.966 0 CA-C-N 116.694 -0.23 . . . . 0.0 112.861 -170.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.6 p -143.7 135.47 12.95 Favored Pre-proline 0 CA--C 1.555 1.168 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -40.14 135.06 1.76 Allowed 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 124.182 3.255 . . . . 0.0 115.091 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 73' ' ' VAL . 88.0 t -64.04 131.16 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.733 1.213 . . . . 0.0 109.473 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -105.32 116.48 32.02 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -174.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -93.34 146.12 23.97 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 172.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -125.56 146.57 49.62 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.695 0.798 . . . . 0.0 110.091 175.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -75.11 -40.04 60.18 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.764 0.425 . . . . 0.0 110.481 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.0 p -141.05 173.92 11.01 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.831 0.852 . . . . 0.0 109.854 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -68.37 -34.8 76.71 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.041 0.936 . . . . 0.0 109.455 175.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -60.66 -38.5 95.18 Favored Glycine 0 C--N 1.357 1.698 0 O-C-N 123.241 0.338 . . . . 0.0 113.341 175.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -64.93 -45.17 86.95 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.592 0.757 . . . . 0.0 111.096 174.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.506 HD11 HD13 ' A' ' 63' ' ' ILE . 8.2 tt -52.7 -50.34 63.53 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.426 1.09 . . . . 0.0 111.059 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.7 mm -70.3 -33.51 54.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.215 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.8 -57.31 20.09 Favored Glycine 0 CA--C 1.532 1.117 0 O-C-N 123.589 0.556 . . . . 0.0 114.163 178.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.1 mp -70.43 -31.17 68.25 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.098 0.559 . . . . 0.0 111.402 -178.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 -78.94 -18.87 53.05 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' A' ' 105' ' ' LEU . . . -61.01 -20.74 62.85 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.443 0.697 . . . . 0.0 112.707 174.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -110.9 166.32 10.98 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 123.643 0.777 . . . . 0.0 109.403 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -49.89 105.7 0.1 Allowed 'Trans proline' 0 C--N 1.386 2.518 0 C-N-CA 123.063 2.508 . . . . 0.0 112.327 168.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -90.97 -51.64 5.24 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.943 0.897 . . . . 0.0 111.521 -174.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 109.55 101.03 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 128.477 2.711 . . . . 0.0 108.673 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.15 -17.72 11.52 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.849 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 49.1 mt -77.31 143.95 38.43 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.821 0.448 . . . . 0.0 111.012 176.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.2 m -75.29 71.85 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 CA-C-O 121.826 0.822 . . . . 0.0 109.309 165.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 2.6 p 78.81 179.6 0.12 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.65 1.98 . . . . 0.0 110.761 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.06 -178.09 6.72 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.431 0.692 . . . . 0.0 110.895 -177.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 95' ' ' ALA . 29.0 mt -93.03 106.34 18.32 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 174.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.415 HD23 ' HA3' ' A' ' 34' ' ' GLY . 4.2 mm? -97.13 -56.89 2.41 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.379 0.672 . . . . 0.0 110.863 -176.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.5 pp -133.25 147.33 64.63 Favored Pre-proline 0 N--CA 1.486 1.333 0 C-N-CA 122.636 0.374 . . . . 0.0 111.407 -169.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.5 ' O ' ' HB3' ' A' ' 13' ' ' TRP . 65.0 Cg_endo -77.81 -11.99 16.56 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 123.155 2.57 . . . . 0.0 115.154 -171.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.634 HG22 ' HB2' ' A' ' 35' ' ' SER . 22.3 t . . . . . 0 N--CA 1.503 2.223 0 C-N-CA 124.994 1.318 . . . . 0.0 109.5 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.2 m . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 108' ' ' PRO . 1.6 p-90 -80.37 3.47 21.11 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.459 0.704 . . . . 0.0 112.009 -172.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -110.82 102.33 10.86 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -172.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -118.22 119.1 33.68 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -67.56 -81.59 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.622 0.769 . . . . 0.0 111.477 -164.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -83.77 42.69 0.86 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 118.382 0.537 . . . . 0.0 111.761 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.441 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 35.8 tp -68.16 -48.0 66.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.839 0.456 . . . . 0.0 109.851 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.8 m 79.98 152.78 0.12 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.647 1.179 . . . . 0.0 110.684 170.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -56.58 -62.61 1.61 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.631 1.172 . . . . 0.0 112.546 -168.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.76 -50.66 67.89 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.598 0.759 . . . . 0.0 112.256 -178.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -65.46 -32.12 73.56 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.219 -178.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.75 -53.54 26.45 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.646 0.378 . . . . 0.0 111.629 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.26 -32.84 74.71 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 123.784 0.678 . . . . 0.0 111.619 -178.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -69.26 -43.65 73.51 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.228 0.33 . . . . 0.0 110.712 176.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.5 -27.0 66.64 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.515 0.726 . . . . 0.0 111.933 174.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.8 mt -66.96 -60.26 2.79 Favored 'General case' 0 C--N 1.348 0.52 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 170.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.79 -32.29 63.37 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.377 1.071 . . . . 0.0 112.951 -176.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.05 -58.0 3.49 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.74 0.816 . . . . 0.0 109.687 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.9 -55.18 5.16 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.295 -168.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -99.86 -58.28 0.89 Allowed Glycine 0 N--CA 1.47 0.96 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 -176.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.577 ' HA ' HD23 ' A' ' 53' ' ' LEU . 53.9 ttp180 51.9 104.86 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.083 2.153 . . . . 0.0 113.345 -170.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.8 t70 88.99 120.92 0.03 OUTLIER 'General case' 0 C--N 1.36 1.047 0 C-N-CA 124.778 1.231 . . . . 0.0 109.241 163.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.497 ' HA2' ' SG ' ' A' ' 103' ' ' CYS . . . 77.29 -0.43 68.39 Favored Glycine 0 C--N 1.352 1.43 0 CA-C-N 116.388 -0.369 . . . . 0.0 113.335 -168.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.0 m -82.91 141.22 32.35 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.903 0.881 . . . . 0.0 109.526 -175.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.455 ' HB2' HG22 ' A' ' 52' ' ' VAL . 20.6 p90 -144.76 158.21 43.87 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 175.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 pp -160.31 161.3 33.24 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.267 0.627 . . . . 0.0 109.944 168.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.472 HG21 HD11 ' A' ' 91' ' ' ILE . 40.2 t -110.91 145.55 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.412 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 17.6 mtm180 -132.33 165.52 24.02 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.829 0.851 . . . . 0.0 108.892 -176.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -89.18 119.2 29.46 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 158.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 56.4 m -58.97 147.64 33.57 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.456 0.473 . . . . 0.0 109.906 -175.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.431 ' CD ' ' H ' ' A' ' 42' ' ' GLU . 1.4 pm0 -77.05 77.23 3.59 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.279 1.032 . . . . 0.0 110.943 -162.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.5 t 50.13 54.61 10.79 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 125.497 1.519 . . . . 0.0 111.646 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 m -96.27 -55.5 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.904 -178.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -168.98 16.98 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.517 0.727 . . . . 0.0 111.305 -176.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.63 34.51 35.03 Favored Glycine 0 N--CA 1.474 1.168 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 -173.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -94.14 167.59 11.47 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.794 0.837 . . . . 0.0 112.194 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.537 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 79.0 m-85 -105.6 140.93 37.92 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.811 1.245 . . . . 0.0 109.309 171.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' A' ' 39' ' ' ARG . . . -117.42 126.19 52.22 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.946 0.498 . . . . 0.0 109.899 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.3 tp -108.81 104.08 13.28 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -177.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 53.5 t -102.55 120.21 40.15 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -176.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.455 HG22 ' HB2' ' A' ' 36' ' ' PHE . 56.3 t -128.05 121.42 56.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.373 1.069 . . . . 0.0 108.579 -175.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.577 HD23 ' HA ' ' A' ' 32' ' ' ARG . 43.1 tp -100.38 131.66 46.18 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.805 0.842 . . . . 0.0 109.013 174.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -167.0 145.53 5.08 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.167 0.917 . . . . 0.0 109.305 -177.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 47.82 41.45 14.33 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 125.852 1.661 . . . . 0.0 112.898 177.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.2 tttp 56.01 37.34 28.74 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.754 1.221 . . . . 0.0 111.684 -176.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -142.4 115.92 9.09 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.472 -174.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.4 HG22 HD13 ' A' ' 53' ' ' LEU . 45.2 t -83.82 139.03 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 173.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -139.21 123.85 18.45 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.8 m -114.16 129.97 56.61 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.502 ' HD2' ' HA ' ' A' ' 75' ' ' THR . 9.3 m-85 -115.22 100.58 8.24 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 -176.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -78.23 100.02 6.49 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 3.2 mp -70.02 118.65 14.8 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.764 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 165.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.478 ' H ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -120.88 131.17 24.55 Favored Pre-proline 0 C--O 1.241 0.611 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.52 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 7.1 Cg_exo -73.17 -74.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 122.241 1.961 . . . . 0.0 110.607 171.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.7 t70 71.36 124.94 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.733 1.213 . . . . 0.0 108.379 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 49.62 -143.99 9.69 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.593 -153.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -117.62 -154.2 0.55 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.268 0.627 . . . . 0.0 110.308 169.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.0 t70 88.02 -74.9 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 126.158 1.783 . . . . 0.0 110.491 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -129.65 158.91 38.02 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 121.408 0.623 . . . . 0.0 112.04 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 3.0 pp -110.49 123.31 49.67 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.416 1.086 . . . . 0.0 108.722 165.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.82 123.79 48.67 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.253 0.621 . . . . 0.0 111.008 -177.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 7.3 p -85.53 147.13 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -110.96 91.68 3.75 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.711 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 41.1 p -77.1 -58.88 3.03 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.13 -177.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.9 m -138.09 153.69 49.28 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.358 0.663 . . . . 0.0 110.343 -177.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -77.71 138.02 38.82 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.042 0.537 . . . . 0.0 110.043 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.57 32.49 67.59 Favored Glycine 0 CA--C 1.523 0.537 0 O-C-N 123.749 0.656 . . . . 0.0 114.029 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.7 m -133.78 144.43 51.81 Favored Pre-proline 0 N--CA 1.481 1.079 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.22 103.15 1.56 Allowed 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.273 1.982 . . . . 0.0 109.312 168.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.482 HG12 ' H ' ' A' ' 82' ' ' ARG . 4.7 t -79.75 174.14 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.26 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.482 ' H ' HG12 ' A' ' 81' ' ' VAL . 5.5 tpp180 -95.81 133.31 40.1 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -175.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -91.77 138.87 31.2 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -124.21 149.54 46.27 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.494 0.718 . . . . 0.0 109.468 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -96.17 -16.1 21.69 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 88' ' ' GLY . 25.5 m -144.33 140.2 28.99 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.936 0.895 . . . . 0.0 109.081 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -63.59 -31.83 73.11 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.433 1.093 . . . . 0.0 110.051 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.483 ' H ' HG22 ' A' ' 86' ' ' THR . . . -54.87 -42.03 78.14 Favored Glycine 0 CA--C 1.541 1.707 0 CA-C-N 116.409 -0.36 . . . . 0.0 113.923 172.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.39 -37.13 84.59 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.56 0.744 . . . . 0.0 110.791 176.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.406 HD11 ' HB ' ' A' ' 73' ' ' VAL . 9.3 tt -61.7 -55.0 35.12 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.265 1.026 . . . . 0.0 111.299 -176.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.472 HD11 HG21 ' A' ' 38' ' ' VAL . 49.8 mt -66.46 -37.53 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 123.44 0.463 . . . . 0.0 110.727 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.92 -52.39 46.85 Favored Glycine 0 C--N 1.342 0.913 0 O-C-N 123.769 0.668 . . . . 0.0 112.838 176.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 51.8 tp -72.15 -43.5 64.55 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.082 0.553 . . . . 0.0 111.412 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.484 ' HE2' HG11 ' A' ' 73' ' ' VAL . 18.6 m-85 -82.75 0.52 43.24 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -174.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.43 -25.41 64.32 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-O 121.472 0.653 . . . . 0.0 109.696 158.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -95.84 128.72 36.51 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.994 1.317 . . . . 0.0 107.565 171.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -80.55 -155.47 0.06 OUTLIER 'Trans proline' 0 CA--C 1.557 1.655 0 C-N-CA 122.837 2.358 . . . . 0.0 112.643 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 67.51 48.51 1.1 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.438 1.095 . . . . 0.0 111.842 171.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -163.32 10.69 0.06 Allowed 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.42 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.711 ' HA3' ' HB ' ' A' ' 75' ' ' THR . . . 127.28 -12.35 6.73 Favored Glycine 0 C--N 1.355 1.61 0 O-C-N 122.041 -0.412 . . . . 0.0 113.102 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.4 118.26 21.88 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.992 0.917 . . . . 0.0 111.422 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.7 p -55.55 -32.27 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.484 1.114 . . . . 0.0 111.24 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.497 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 53.8 t -138.31 145.18 40.89 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.003 0.921 . . . . 0.0 109.821 177.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.38 141.07 54.23 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 169.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 62.3 mt -76.17 92.86 3.29 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -174.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.433 ' HG ' ' HG ' ' A' ' 107' ' ' LEU . 47.4 tp -101.19 -58.14 1.95 Allowed 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.304 -171.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.433 ' HG ' ' HG ' ' A' ' 106' ' ' LEU . 58.6 mt -142.25 123.9 8.8 Favored Pre-proline 0 N--CA 1.485 1.302 0 C-N-CA 123.598 0.759 . . . . 0.0 109.336 -170.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.467 ' HB3' ' HB3' ' A' ' 13' ' ' TRP . 27.1 Cg_endo -61.06 -74.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 122.602 2.201 . . . . 0.0 112.906 -176.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 55.8 t . . . . . 0 CA--C 1.551 1.005 0 C-N-CA 124.242 1.017 . . . . 0.0 108.668 -177.577 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.1 m . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -99.29 -18.82 17.38 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 161.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -75.53 104.51 6.12 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 166.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -113.59 96.27 5.78 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -54.45 -39.82 67.8 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 124.38 1.05 . . . . 0.0 113.178 -164.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -125.11 85.72 2.45 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.3 tp -115.82 -45.22 2.89 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.437 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.5 t 79.9 155.29 0.14 Allowed 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 124.746 1.218 . . . . 0.0 110.229 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -57.56 -50.66 72.37 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -172.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.07 -53.99 50.35 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.587 0.755 . . . . 0.0 111.948 -176.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.53 -30.93 68.88 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.24 0.616 . . . . 0.0 111.836 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.524 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -65.57 -58.96 4.51 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.685 0.794 . . . . 0.0 111.496 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.571 ' HG3' HG21 ' A' ' 58' ' ' VAL . 34.6 tt0 -56.97 -42.59 80.44 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.264 1.425 . . . . 0.0 111.976 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -67.8 -39.88 83.95 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.137 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.402 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 33.4 tp -63.16 -38.71 92.27 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.935 0.894 . . . . 0.0 111.667 175.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.495 HD21 ' HG ' ' A' ' 37' ' ' LEU . 95.6 mt -68.0 -29.36 68.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.256 0.622 . . . . 0.0 111.097 177.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.23 -54.39 5.78 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.81 0.844 . . . . 0.0 111.085 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.402 ' HG2' ' HA ' ' A' ' 26' ' ' LEU . 11.1 ptp180 -66.8 -46.01 76.57 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.419 0.688 . . . . 0.0 111.226 -174.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.4 ' N ' ' HG3' ' A' ' 29' ' ' ARG . . . -89.65 -60.59 1.9 Allowed 'General case' 0 C--N 1.349 0.551 0 C-N-CA 123.003 0.521 . . . . 0.0 110.803 -172.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.35 -36.97 19.16 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-O 119.799 -0.445 . . . . 0.0 113.704 -172.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? 74.79 -25.25 0.2 Allowed 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 125.273 1.429 . . . . 0.0 113.477 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.4 t70 174.93 141.69 0.05 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.661 0.784 . . . . 0.0 109.369 -165.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.56 9.82 65.72 Favored Glycine 0 C--N 1.358 1.787 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 12.4 m -84.71 146.73 27.27 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.295 1.038 . . . . 0.0 111.007 -168.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -150.83 151.88 32.92 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 174.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.524 HD11 ' HB1' ' A' ' 23' ' ' ALA . 2.9 pp -152.6 158.85 43.04 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 169.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.607 HG21 HD11 ' A' ' 87' ' ' LEU . 36.8 t -112.11 154.74 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.1 ptt85 -156.21 175.09 14.45 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.907 0.883 . . . . 0.0 109.039 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.17 145.2 24.87 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.5 m -56.17 148.63 17.68 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.658 0.783 . . . . 0.0 113.041 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -88.72 3.61 50.25 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.248 1.019 . . . . 0.0 112.048 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.0 m -134.48 -63.6 0.71 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.148 0.579 . . . . 0.0 111.101 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 47' ' ' ALA . 14.7 m -85.86 117.79 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 121.726 0.774 . . . . 0.0 110.672 -178.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.32 128.7 37.37 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.616 -1.174 . . . . 0.0 112.551 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.89 7.42 81.02 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 114.691 0.636 . . . . 0.0 114.691 177.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.478 ' HB3' HG23 ' A' ' 44' ' ' VAL . . . -100.81 173.78 6.35 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.149 0.58 . . . . 0.0 109.901 174.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -117.03 160.8 20.4 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-O 121.388 0.613 . . . . 0.0 112.027 -178.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.61 144.85 42.15 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.23 168.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.489 HD13 HG22 ' A' ' 38' ' ' VAL . 51.0 tp -125.05 110.59 14.35 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.695 1.198 . . . . 0.0 108.483 -174.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 35.5 t -104.23 123.02 46.59 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -175.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.2 t -130.48 121.8 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.636 0.774 . . . . 0.0 109.714 -172.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.424 HD13 HG22 ' A' ' 58' ' ' VAL . 16.1 tp -111.22 115.64 29.7 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.297 1.039 . . . . 0.0 109.685 175.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -145.79 144.77 30.49 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 166.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 53.45 36.56 23.47 Favored 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 124.536 1.134 . . . . 0.0 112.277 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 65.7 mttm 58.68 36.47 24.98 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.403 1.081 . . . . 0.0 112.412 -173.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -126.04 104.91 8.53 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.571 HG21 ' HG3' ' A' ' 24' ' ' GLU . 17.5 t -100.69 107.91 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.739 0.816 . . . . 0.0 108.877 174.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -112.14 140.63 46.67 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 171.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 89.2 m -106.63 135.75 47.62 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -117.1 100.04 7.46 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -63.48 155.28 29.74 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 168.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 92.3 mt -144.95 101.92 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 102.59 -3.115 . . . . 0.0 102.59 -158.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.1 mp -105.11 111.59 65.15 Favored Pre-proline 0 N--CA 1.472 0.649 0 O-C-N 123.351 0.407 . . . . 0.0 109.94 -161.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 70' ' ' PHE . 1.4 Cg_endo -81.76 108.55 1.89 Allowed 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.606 2.204 . . . . 0.0 109.422 162.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -82.15 137.24 35.01 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 174.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -46.73 77.57 0.0 OUTLIER Glycine 0 CA--C 1.538 1.49 0 N-CA-C 117.172 1.629 . . . . 0.0 117.172 -172.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -151.84 -83.29 0.09 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.366 1.866 . . . . 0.0 106.77 170.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -167.33 4.28 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 178.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 83.5 m-85 -115.81 140.29 49.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.237 -0.914 . . . . 0.0 110.899 -170.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.408 ' HG ' ' HG3' ' A' ' 65' ' ' PRO . 5.3 mp -111.07 112.3 24.02 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.964 0.905 . . . . 0.0 109.536 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.63 143.03 28.72 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.95 0.5 . . . . 0.0 112.17 -174.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 81' ' ' VAL . 39.1 t -109.38 137.46 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.212 1.005 . . . . 0.0 108.434 169.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -112.28 130.0 56.09 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -170.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.422 ' OG1' ' HA3' ' A' ' 100' ' ' GLY . 3.6 t -158.76 -41.8 0.06 Allowed 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.232 -175.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 65.9 m 58.68 -109.03 0.44 Allowed 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 117.777 -1.106 . . . . 0.0 111.808 -174.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 72.18 -42.14 0.52 Allowed 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.155 1.382 . . . . 0.0 113.427 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 148.01 -21.18 1.42 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 -166.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.515 HG11 ' HA ' ' A' ' 99' ' ' GLN . 14.0 m -84.44 134.25 43.06 Favored Pre-proline 0 CA--C 1.557 1.215 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 173.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.69 146.46 97.19 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.605 2.203 . . . . 0.0 112.015 175.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 73' ' ' VAL . 42.0 t -68.23 130.49 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -105.92 118.91 37.82 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -172.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -102.32 121.19 41.8 Favored 'General case' 0 C--N 1.344 0.355 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 54.5 p90 -109.0 153.62 23.34 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.472 0.709 . . . . 0.0 110.199 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -104.46 -9.6 18.28 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.778 0.831 . . . . 0.0 110.061 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.7 t -149.04 144.22 26.57 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.29 0.636 . . . . 0.0 109.403 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.607 HD11 HG21 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -60.73 -31.02 70.35 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.481 1.112 . . . . 0.0 111.232 -173.589 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -55.23 -34.42 58.93 Favored Glycine 0 CA--C 1.539 1.566 0 N-CA-C 113.984 0.354 . . . . 0.0 113.984 174.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 84' ' ' PHE . 46.9 mt-10 -68.28 -40.53 81.79 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.34 0.656 . . . . 0.0 110.982 175.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 51.0 tp -53.12 -55.54 23.27 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.336 0.589 . . . . 0.0 110.628 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.6 mm -66.97 -36.21 76.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.79 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.12 -52.34 53.06 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.754 0.659 . . . . 0.0 113.55 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.5 mt -65.74 -56.86 9.81 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.992 0.917 . . . . 0.0 111.102 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.616 ' HB3' HD11 ' A' ' 101' ' ' LEU . 83.8 m-85 -79.59 -4.25 50.68 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -170.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.32 -27.7 67.55 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.21 0.529 . . . . 0.0 110.513 164.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -84.17 131.52 50.67 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.146 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.446 ' HB3' ' HB2' ' A' ' 104' ' ' ALA . 81.7 Cg_endo -80.49 -172.97 1.67 Allowed 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.673 2.249 . . . . 0.0 113.598 -175.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 56.6 61.02 2.82 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.407 1.483 . . . . 0.0 111.33 -178.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.515 ' HA ' HG11 ' A' ' 79' ' ' VAL . 46.2 mt-30 -143.76 12.39 1.67 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.356 1.062 . . . . 0.0 111.441 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.422 ' HA3' ' OG1' ' A' ' 75' ' ' THR . . . 110.58 -5.79 29.69 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 112.16 -0.376 . . . . 0.0 112.16 178.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.616 HD11 ' HB3' ' A' ' 94' ' ' TYR . 94.4 mt -78.85 146.86 33.42 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.277 1.031 . . . . 0.0 111.234 -178.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.4 m -63.3 -26.72 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.391 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.83 171.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 31.9 p -162.61 171.85 16.29 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.514 1.126 . . . . 0.0 110.281 171.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.446 ' HB2' ' HB3' ' A' ' 97' ' ' PRO . . . -66.68 145.35 55.65 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 169.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 73.9 mt -64.38 103.39 0.64 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -177.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 62.5 tp -111.31 -60.25 1.86 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.589 0.756 . . . . 0.0 111.576 -166.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 35' ' ' SER . 5.8 tt -114.46 97.42 46.3 Favored Pre-proline 0 N--CA 1.474 0.741 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -169.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -81.44 130.34 6.98 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 122.232 1.955 . . . . 0.0 111.214 175.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.7 t . . . . . 0 C--O 1.251 1.174 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.186 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 t . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 108' ' ' PRO . 77.2 t90 92.45 -43.9 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.938 1.295 . . . . 0.0 110.928 163.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.555 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 87.9 t80 -109.71 110.78 21.92 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -174.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -126.48 106.18 9.27 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -176.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.543 ' HA ' ' HB3' ' A' ' 40' ' ' ASP . 39.8 ttm180 -74.94 152.0 38.83 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.402 176.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.547 ' HA ' ' HG2' ' A' ' 42' ' ' GLU 0.291 11.3 p-10 36.82 51.8 0.97 Allowed 'General case' 0 C--N 1.37 1.494 0 C-N-CA 125.356 1.462 . . . . 0.0 114.527 -172.325 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.7 tp -114.73 124.54 52.05 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 169.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.7 m -69.06 156.4 38.71 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.945 0.498 . . . . 0.0 110.235 -178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.3 ttp85 -54.04 -52.14 61.8 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.775 0.43 . . . . 0.0 111.061 172.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.03 -45.26 71.52 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.33 1.052 . . . . 0.0 111.867 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.06 -29.85 64.56 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.578 0.751 . . . . 0.0 112.089 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.601 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -76.84 -47.53 21.13 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.571 0.748 . . . . 0.0 111.419 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.558 ' HG3' HG21 ' A' ' 58' ' ' VAL . 32.8 tt0 -51.79 -39.82 59.33 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.252 1.421 . . . . 0.0 111.187 169.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -63.96 -47.72 79.3 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.3 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.7 tp -57.86 -45.14 86.75 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.677 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.615 HD21 HD22 ' A' ' 37' ' ' LEU . 94.2 mt -63.45 -50.45 69.7 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.016 0.927 . . . . 0.0 110.623 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.16 -34.5 73.66 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.756 0.823 . . . . 0.0 111.681 -175.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -83.88 -32.71 25.04 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.493 0.717 . . . . 0.0 111.384 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.82 -65.8 0.98 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -174.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.91 -47.22 0.84 Allowed Glycine 0 C--N 1.356 1.666 0 CA-C-N 117.995 0.362 . . . . 0.0 113.422 -172.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 55.9 24.9 8.01 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 125.573 1.549 . . . . 0.0 114.924 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -174.4 100.15 0.1 Allowed 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.264 -0.897 . . . . 0.0 109.582 -174.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.03 15.83 80.89 Favored Glycine 0 N--CA 1.474 1.199 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.908 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.1 m -85.53 116.29 23.74 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.916 0.887 . . . . 0.0 109.684 -170.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -126.74 159.45 33.69 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.814 0.34 . . . . 0.0 111.672 -175.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.615 HD22 HD21 ' A' ' 27' ' ' LEU . 1.6 pt? -163.13 163.73 25.6 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.008 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 25.6 t -126.71 122.69 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 175.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.436 HH21 HD21 ' A' ' 37' ' ' LEU . 9.3 ptp85 -116.87 157.66 25.27 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -177.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.543 ' HB3' ' HA ' ' A' ' 16' ' ' ARG . 33.6 t70 -93.82 122.96 36.83 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 170.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.4 m -57.16 151.98 14.46 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.706 0.629 . . . . 0.0 111.403 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.547 ' HG2' ' HA ' ' A' ' 17' ' ' ASP . 32.5 mt-10 -81.93 -22.14 36.89 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -163.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.3 t -167.6 103.33 0.5 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 172.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.465 HG11 ' HB3' ' A' ' 47' ' ' ALA . 8.1 p -158.84 169.88 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 C-N-CA 123.9 0.88 . . . . 0.0 109.564 -178.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.99 23.21 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 175.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.446 ' H ' HG13 ' A' ' 44' ' ' VAL . . . 92.58 91.2 1.49 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -175.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.465 ' HB3' HG11 ' A' ' 44' ' ' VAL . . . -152.16 134.68 15.32 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.488 1.115 . . . . 0.0 109.5 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -110.62 143.39 41.12 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.002 0.921 . . . . 0.0 109.197 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.1 125.2 52.06 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.606 0.362 . . . . 0.0 110.86 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 37' ' ' LEU . 40.3 tp -105.51 131.62 52.69 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.724 ' SG ' HG22 ' A' ' 60' ' ' THR . 73.6 m -123.86 141.24 52.21 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 118.527 0.603 . . . . 0.0 110.126 171.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.6 t -125.47 114.72 40.88 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 170.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.709 HD13 HG22 ' A' ' 58' ' ' VAL . 13.8 tp -99.56 137.83 37.49 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.34 1.056 . . . . 0.0 108.921 176.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -149.44 102.87 3.23 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.003 1.321 . . . . 0.0 108.178 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 48.93 68.95 0.63 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.758 0.823 . . . . 0.0 112.808 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt 62.28 12.99 5.58 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -110.47 102.34 10.96 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.709 HG22 HD13 ' A' ' 53' ' ' LEU . 3.4 t -107.87 120.82 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -114.75 140.53 48.82 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 172.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.724 HG22 ' SG ' ' A' ' 51' ' ' CYS . 62.7 p -112.71 136.45 52.29 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.574 1.15 . . . . 0.0 109.072 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.29 96.91 4.43 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 178.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -80.94 100.7 9.05 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.471 HG21 HD12 ' A' ' 71' ' ' LEU . 15.6 mt -72.06 128.78 35.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.231 -1.35 . . . . 0.0 109.651 173.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.406 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -137.5 135.77 19.64 Favored Pre-proline 0 C--O 1.24 0.567 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 170.918 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 36.6 Cg_exo -62.1 -62.28 0.13 Allowed 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 122.786 2.324 . . . . 0.0 114.133 177.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.5 t70 87.91 -69.27 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.598 1.559 . . . . 0.0 109.2 175.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -85.5 16.71 38.54 Favored Glycine 0 C--N 1.357 1.698 0 CA-C-O 119.71 -0.495 . . . . 0.0 113.517 169.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 66.09 -30.76 0.14 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 174.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -76.5 -45.11 32.34 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.437 1.017 . . . . 0.0 111.131 -170.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 25.3 p90 -108.39 145.3 34.76 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 124.915 1.286 . . . . 0.0 108.504 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.496 HD23 ' H ' ' A' ' 71' ' ' LEU . 2.6 pt? -99.23 118.96 37.09 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 164.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.62 117.6 33.44 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.528 0.731 . . . . 0.0 110.713 -175.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.858 HG21 HD13 ' A' ' 90' ' ' LEU . 14.6 t -89.58 116.28 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.094 0.958 . . . . 0.0 110.342 177.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -90.39 92.11 8.76 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.422 HG23 ' HE2' ' A' ' 94' ' ' TYR . 0.2 OUTLIER -54.07 -58.61 6.69 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.419 177.961 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.0 m -155.3 131.19 10.01 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.454 1.502 . . . . 0.0 107.336 163.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -66.16 95.46 0.29 Allowed 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 165.51 -58.21 0.25 Allowed Glycine 0 C--N 1.343 0.93 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -172.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.38 140.83 82.54 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 124.051 0.94 . . . . 0.0 109.41 169.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -49.9 87.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.386 2.511 0 C-N-CA 123.599 2.866 . . . . 0.0 114.134 173.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 73' ' ' VAL . 7.4 p -36.72 143.78 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 126.262 1.825 . . . . 0.0 115.252 169.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -107.18 132.86 52.58 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 124.2 1.0 . . . . 0.0 109.505 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -99.12 146.87 25.66 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.078 0.951 . . . . 0.0 109.001 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -136.23 164.78 27.28 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.911 0.884 . . . . 0.0 109.038 -174.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -126.44 -13.31 6.06 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.847 0.459 . . . . 0.0 110.333 176.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 88' ' ' GLY . 20.8 m -140.15 140.7 36.01 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.631 0.772 . . . . 0.0 109.376 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 75.0 mt -58.36 -32.82 68.91 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.616 0.766 . . . . 0.0 111.551 172.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.582 ' H ' HG22 ' A' ' 86' ' ' THR . . . -60.39 -33.16 79.83 Favored Glycine 0 CA--C 1.532 1.154 0 O-C-N 123.493 0.496 . . . . 0.0 113.582 174.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.528 ' HG3' ' HB ' ' A' ' 86' ' ' THR . 47.6 mt-10 -71.83 -40.85 68.78 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.933 0.493 . . . . 0.0 110.168 176.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.858 HD13 HG21 ' A' ' 73' ' ' VAL . 42.2 tp -52.7 -51.59 59.67 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.553 0.741 . . . . 0.0 110.344 174.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.407 HD11 ' CZ2' ' A' ' 13' ' ' TRP . 49.7 mm -62.79 -39.28 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.432 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.15 -57.32 20.39 Favored Glycine 0 CA--C 1.529 0.911 0 O-C-N 123.621 0.576 . . . . 0.0 113.44 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.7 mp -70.74 -52.01 23.58 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.562 0.745 . . . . 0.0 112.006 -177.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.51 ' HB3' HD11 ' A' ' 101' ' ' LEU . 30.2 m-85 -68.66 -17.26 64.06 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -173.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.44 -19.93 51.22 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 171.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -77.99 124.13 86.13 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 123.396 0.678 . . . . 0.0 109.996 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -70.95 168.29 23.54 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.67 2.246 . . . . 0.0 111.724 173.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 53.8 58.11 5.41 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.85 0.86 . . . . 0.0 110.532 -174.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -142.52 -15.91 0.73 Allowed 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.701 -177.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 141.54 -18.06 2.64 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -175.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.51 HD11 ' HB3' ' A' ' 94' ' ' TYR . 17.7 mt -99.93 105.98 17.75 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.23 0.612 . . . . 0.0 110.105 175.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.6 m -44.96 -25.98 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 125.221 1.408 . . . . 0.0 114.538 174.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 36.7 t -124.27 -11.3 7.47 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.141 0.576 . . . . 0.0 112.444 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 64.11 178.57 0.17 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.122 0.969 . . . . 0.0 111.399 -167.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.1 mt -77.62 92.12 4.06 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.7 176.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.0 tt -81.78 -65.38 1.02 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.856 0.462 . . . . 0.0 109.906 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -146.22 130.05 8.48 Favored Pre-proline 0 N--CA 1.491 1.575 0 C-N-CA 122.295 0.238 . . . . 0.0 110.919 -174.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.487 ' HB2' ' HB2' ' A' ' 13' ' ' TRP . 80.8 Cg_endo -74.38 145.13 33.61 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.689 2.259 . . . . 0.0 111.779 177.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 57.2 t . . . . . 0 C--O 1.256 1.422 0 C-N-CA 123.799 0.84 . . . . 0.0 109.533 179.543 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.5 mtp . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 123.14 144.81 6.71 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -136.41 97.91 3.69 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.314 1.046 . . . . 0.0 108.523 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -135.92 99.4 4.15 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.32 0.648 . . . . 0.0 110.226 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.3 t60 -154.83 96.07 1.83 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -73.54 165.21 25.5 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.329 0.585 . . . . 0.0 111.991 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -83.14 -169.57 2.6 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.292 174.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 37.7 m80 63.91 32.74 13.02 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.04 0.936 . . . . 0.0 109.754 -174.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.5 t -82.58 68.05 8.87 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 122.027 0.918 . . . . 0.0 109.748 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -139.59 139.27 36.75 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.686 -1.143 . . . . 0.0 107.995 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.618 ' SD ' ' HB2' ' A' ' 108' ' ' PRO . 44.1 ttm -72.14 -48.19 45.41 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 172.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.6 m 62.08 108.61 0.02 OUTLIER 'General case' 0 C--N 1.359 0.984 0 O-C-N 124.87 1.356 . . . . 0.0 109.569 -168.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.411 ' HB2' ' HA ' ' A' ' 37' ' ' LEU . 4.3 p-90 -85.41 -1.13 56.7 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.966 -0.459 . . . . 0.0 110.761 -177.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -107.33 113.57 27.04 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -173.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.431 ' NE2' ' HB2' ' A' ' 37' ' ' LEU . 1.9 p80 -138.97 109.95 6.78 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.518 1.127 . . . . 0.0 108.76 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -86.73 26.82 1.06 Allowed 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 124.17 0.988 . . . . 0.0 110.634 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -160.39 25.31 0.16 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.295 0.638 . . . . 0.0 111.098 -162.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 20.0 tp -108.99 -49.09 3.18 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.675 -0.64 . . . . 0.0 111.63 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.4 t 80.08 153.23 0.12 Allowed 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 124.856 1.262 . . . . 0.0 109.869 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HB2' ' NH1' ' A' ' 39' ' ' ARG . 74.5 ttt180 -64.21 -38.87 92.6 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 118.019 0.372 . . . . 0.0 111.512 -168.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.57 -54.82 23.56 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 123.652 0.595 . . . . 0.0 110.752 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.77 -22.55 43.02 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.9 -57.08 4.13 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 123.206 0.602 . . . . 0.0 111.542 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.429 ' HG3' HG11 ' A' ' 58' ' ' VAL . 36.7 tt0 -57.76 -37.08 73.03 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.076 1.351 . . . . 0.0 111.26 173.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -71.05 -38.18 72.53 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.365 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -55.13 -43.76 74.43 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.285 0.634 . . . . 0.0 110.083 173.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.569 HD22 ' HB3' ' A' ' 35' ' ' SER . 82.8 mt -71.92 -42.31 66.84 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 123.485 0.49 . . . . 0.0 110.413 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.36 -37.32 71.65 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.543 0.737 . . . . 0.0 112.21 -174.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.7 mtp180 -82.16 -50.56 8.89 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.024 0.53 . . . . 0.0 111.325 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.476 ' HB1' HG11 ' A' ' 109' ' ' VAL . . . -66.41 -46.8 75.35 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.559 0.344 . . . . 0.0 110.314 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.38 125.84 0.0 OUTLIER Glycine 0 CA--C 1.538 1.515 0 N-CA-C 118.854 2.302 . . . . 0.0 118.854 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 177.66 103.22 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 165.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -62.44 149.92 41.36 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -154.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.41 ' HA2' ' SG ' ' A' ' 103' ' ' CYS . . . 89.56 17.45 54.77 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -161.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.569 ' HB3' HD22 ' A' ' 27' ' ' LEU . 17.2 m -71.81 130.59 41.44 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 124.434 1.094 . . . . 0.0 108.895 -177.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 108' ' ' PRO . 50.9 p90 -141.74 155.14 45.65 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.118 0.485 . . . . 0.0 111.034 177.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.465 ' HG ' HD21 ' A' ' 27' ' ' LEU . 0.8 OUTLIER -158.58 153.47 25.0 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.612 166.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.6 t -105.28 117.41 50.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.543 ' HG3' ' HB3' ' A' ' 49' ' ' ALA . 2.1 ptm180 -113.58 168.49 9.72 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 122.168 0.985 . . . . 0.0 110.816 -178.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -54.44 127.91 29.57 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 113.122 -1.854 . . . . 0.0 110.838 165.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.0 m -74.48 143.99 44.38 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 162.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -78.48 83.58 4.67 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.3 m 67.29 -75.51 0.06 Allowed 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 126.201 1.8 . . . . 0.0 111.785 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.607 HG23 ' H ' ' A' ' 45' ' ' ALA 0.317 35.1 m 39.21 -84.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 126.996 2.118 . . . . 0.0 113.743 -167.335 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.607 ' H ' HG23 ' A' ' 44' ' ' VAL . . . -156.6 29.48 0.33 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.147 0.979 . . . . 0.0 109.309 -175.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.48 49.64 7.98 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.532 -175.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.53 176.51 5.01 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.44 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 59.0 m-85 -114.67 157.19 23.45 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.437 1.495 . . . . 0.0 107.447 174.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.543 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . . . -128.87 147.05 50.79 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.391 0.676 . . . . 0.0 110.098 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.4 tp -125.84 113.3 17.06 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.27 1.028 . . . . 0.0 108.577 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 52.6 t -100.58 123.23 44.51 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.0 t -128.54 126.09 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.781 0.832 . . . . 0.0 110.004 -174.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 35' ' ' SER . 54.7 tp -101.33 140.29 35.82 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.32 1.048 . . . . 0.0 110.844 177.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -156.29 115.61 3.51 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.01 1.324 . . . . 0.0 108.775 173.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 41.1 71.94 0.18 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.678 1.591 . . . . 0.0 113.881 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 81.9 tttt 58.72 27.47 15.96 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.155 0.982 . . . . 0.0 111.905 177.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -138.3 106.39 5.73 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.378 0.671 . . . . 0.0 109.455 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.429 HG11 ' HG3' ' A' ' 24' ' ' GLU . 41.4 t -99.71 112.75 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 174.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -101.53 132.18 47.31 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 170.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 22.9 m -113.51 128.0 56.29 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -108.39 154.51 21.75 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.875 1.27 . . . . 0.0 107.838 -172.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -105.12 160.2 15.25 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.698 0.799 . . . . 0.0 109.63 165.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.733 HG12 HD11 ' A' ' 90' ' ' LEU . 3.8 mp -146.62 100.68 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 102.578 -3.119 . . . . 0.0 102.578 -166.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.5 mp -113.63 133.7 22.16 Favored Pre-proline 0 N--CA 1.477 0.889 0 O-C-N 121.641 -0.662 . . . . 0.0 109.693 -168.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.09 -68.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.214 1.943 . . . . 0.0 110.256 160.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.9 t70 125.33 -66.1 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 C-N-CA 127.238 2.215 . . . . 0.0 107.743 163.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -171.04 25.72 0.1 OUTLIER Glycine 0 C--N 1.345 1.067 0 CA-C-N 115.515 -0.766 . . . . 0.0 113.203 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -135.69 -83.21 0.4 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 175.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -179.78 3.91 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.123 0.569 . . . . 0.0 111.925 -174.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.512 ' HB3' ' HB2' ' A' ' 83' ' ' ARG . 64.9 m-85 -106.77 134.94 49.14 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.41 0.684 . . . . 0.0 109.343 -169.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.2 mp -96.8 106.4 18.7 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 118.884 0.765 . . . . 0.0 109.348 -169.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.79 140.2 37.97 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.825 0.85 . . . . 0.0 110.13 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.504 HG22 HG13 ' A' ' 63' ' ' ILE . 22.7 t -114.99 124.51 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 176.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -93.56 97.29 10.41 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.404 HG21 ' ND2' ' A' ' 98' ' ' ASN . 76.6 p -87.53 -48.31 8.03 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.6 m -157.78 177.04 11.81 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.385 1.474 . . . . 0.0 108.134 166.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -85.45 -57.97 2.85 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.279 0.632 . . . . 0.0 110.436 -174.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.17 -31.2 61.81 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.821 0.701 . . . . 0.0 114.069 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.4 t -61.45 122.82 73.24 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 118.851 -0.595 . . . . 0.0 109.396 169.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -57.15 110.99 0.68 Allowed 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.5 2.133 . . . . 0.0 110.555 174.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.4 t -79.35 143.71 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.978 0.911 . . . . 0.0 109.115 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -114.89 130.75 56.96 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.512 ' HB2' ' HB3' ' A' ' 70' ' ' PHE . 32.0 ptt180 -94.81 134.07 37.83 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 171.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -113.74 149.44 34.82 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.257 1.023 . . . . 0.0 109.815 -174.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -92.1 -15.79 27.25 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.58 0.352 . . . . 0.0 110.354 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.9 p -142.53 151.12 41.3 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 124.371 1.068 . . . . 0.0 109.457 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 99.5 mt -62.87 -25.88 68.5 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.674 0.789 . . . . 0.0 111.497 172.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -59.85 -41.9 97.9 Favored Glycine 0 CA--C 1.537 1.456 0 N-CA-C 114.02 0.368 . . . . 0.0 114.02 174.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -63.27 -37.79 88.63 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.529 0.732 . . . . 0.0 110.979 176.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.733 HD11 HG12 ' A' ' 63' ' ' ILE . 6.6 tt -59.46 -57.33 13.46 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.814 1.246 . . . . 0.0 109.742 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.412 ' HA ' HD12 ' A' ' 105' ' ' LEU . 48.2 mm -59.79 -38.62 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.098 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.98 -44.88 54.23 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.568 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 42.0 tp -67.64 -50.67 56.79 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.084 0.554 . . . . 0.0 111.405 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -75.35 -8.02 55.55 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.13 -24.12 64.43 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.431 0.634 . . . . 0.0 111.06 163.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -94.71 139.58 22.29 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.499 1.12 . . . . 0.0 108.87 174.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -48.94 127.0 16.06 Favored 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 123.137 2.558 . . . . 0.0 112.433 165.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.404 ' ND2' HG21 ' A' ' 75' ' ' THR . 26.2 p-10 -111.62 -45.1 3.4 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.194 -174.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 111.05 94.29 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 128.051 2.54 . . . . 0.0 106.341 -163.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 135.2 -38.99 1.74 Allowed Glycine 0 C--N 1.343 0.97 0 CA-C-N 116.052 -0.522 . . . . 0.0 113.1 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.444 ' HB3' ' H ' ' A' ' 104' ' ' ALA . 2.6 mm? -69.41 136.93 52.29 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.859 0.464 . . . . 0.0 110.494 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.5 m -60.97 -28.31 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.585 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.41 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 25.4 p -163.06 -1.1 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.444 ' H ' ' HB3' ' A' ' 101' ' ' LEU . . . 70.27 166.81 0.29 Allowed 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.947 0.899 . . . . 0.0 111.284 -167.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 91' ' ' ILE . 37.3 mt -88.94 97.98 11.49 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.506 0.722 . . . . 0.0 109.804 -173.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.3 tp -82.86 -51.81 7.29 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.688 -175.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -165.71 146.46 5.77 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 123.726 0.81 . . . . 0.0 109.032 -172.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.618 ' HB2' ' SD ' ' A' ' 11' ' ' MET . 42.4 Cg_exo -56.89 -54.95 3.05 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.22 1.947 . . . . 0.0 111.885 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.476 HG11 ' HB1' ' A' ' 30' ' ' ALA . 2.4 t . . . . . 0 N--CA 1.48 1.037 0 C-N-CA 125.717 1.607 . . . . 0.0 107.142 170.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptp . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.61 -44.31 0.42 Allowed Glycine 0 C--N 1.338 0.662 0 N-CA-C 111.746 -0.542 . . . . 0.0 111.746 -177.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 63.65 -163.43 0.27 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.26 1.024 . . . . 0.0 110.749 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -142.11 112.49 7.1 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.846 0.355 . . . . 0.0 110.308 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -83.35 -172.54 4.2 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.416 0.686 . . . . 0.0 109.834 169.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 70.36 90.31 0.1 Allowed 'General case' 0 C--N 1.358 0.964 0 C-N-CA 124.261 1.025 . . . . 0.0 110.137 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -66.08 -50.87 62.58 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.336 1.054 . . . . 0.0 109.295 175.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -172.76 -79.57 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.9 p 175.9 128.8 0.04 OUTLIER 'General case' 0 C--O 1.241 0.649 0 C-N-CA 125.412 1.485 . . . . 0.0 107.842 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -91.34 58.95 3.77 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.218 1.009 . . . . 0.0 109.502 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -165.95 52.23 0.09 Allowed 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 114.4 -1.273 . . . . 0.0 109.105 -175.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.1 t -62.28 152.43 33.67 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.663 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 3.5 p-90 -90.55 12.9 17.31 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.528 0.731 . . . . 0.0 110.614 169.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 49.9 t80 -115.2 117.94 31.91 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -130.91 87.23 2.46 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.063 0.545 . . . . 0.0 109.865 -173.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -73.09 160.1 32.55 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 167.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.1 t70 63.61 26.11 14.54 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 122.064 0.935 . . . . 0.0 110.634 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.1 tt -131.87 123.57 27.78 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.597 1.559 . . . . 0.0 106.864 177.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.7 p -77.24 160.89 28.57 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.841 0.457 . . . . 0.0 110.281 -172.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -65.52 -34.43 78.25 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 117.952 0.342 . . . . 0.0 110.848 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.47 -47.59 81.47 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.796 0.838 . . . . 0.0 110.291 173.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.45 -32.72 73.78 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.615 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.25 -62.68 1.39 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.526 0.73 . . . . 0.0 111.184 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -62.66 -28.49 69.95 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.521 0.728 . . . . 0.0 112.465 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -68.27 -50.37 54.2 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 123.606 0.566 . . . . 0.0 109.485 175.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -58.52 -39.99 81.64 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.584 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.1 -48.26 74.31 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.926 0.89 . . . . 0.0 109.802 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.49 -31.98 73.3 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.121 0.968 . . . . 0.0 112.329 -175.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -81.65 -38.64 25.61 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.439 0.696 . . . . 0.0 110.592 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.26 -63.87 1.23 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -169.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.93 -41.34 1.57 Allowed Glycine 0 C--N 1.352 1.421 0 N-CA-C 112.12 -0.392 . . . . 0.0 112.12 -173.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.3 ttp85 58.02 17.58 4.52 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.902 1.281 . . . . 0.0 114.207 171.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -175.83 98.11 0.07 Allowed 'General case' 0 N--CA 1.479 0.978 0 O-C-N 121.552 -0.718 . . . . 0.0 109.626 -166.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.53 20.67 79.59 Favored Glycine 0 N--CA 1.478 1.493 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 11.2 m -90.05 119.64 30.57 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 124.487 1.115 . . . . 0.0 110.628 -172.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -126.16 159.12 33.8 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.033 0.444 . . . . 0.0 111.229 -173.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.6 pp -155.31 165.31 37.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.296 168.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 25.9 t -112.46 154.25 13.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 171.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.645 HH22 ' HG2' ' A' ' 42' ' ' GLU . 4.2 ptm180 -157.69 -177.82 6.86 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 123.205 0.602 . . . . 0.0 109.381 -176.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -90.77 125.57 35.74 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 172.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.2 m -57.43 147.65 25.68 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.382 0.673 . . . . 0.0 110.651 174.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.645 ' HG2' HH22 ' A' ' 39' ' ' ARG . 42.2 mt-10 -78.22 89.11 4.28 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.343 0.657 . . . . 0.0 111.967 -164.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.2 t 66.16 27.85 10.3 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.494 1.518 . . . . 0.0 111.57 173.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.2 t -71.89 -71.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.588 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -173.7 34.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.397 0.679 . . . . 0.0 110.786 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.21 35.78 56.68 Favored Glycine 0 N--CA 1.476 1.322 0 CA-C-N 116.618 -0.265 . . . . 0.0 112.96 -168.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 63' ' ' ILE . . . -90.87 164.2 14.13 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.66 0.784 . . . . 0.0 110.457 -173.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.519 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 97.2 m-85 -102.76 148.2 25.9 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.445 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . . . -128.23 137.53 52.05 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.0 tp -112.06 104.0 12.22 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 47.4 m -104.26 114.08 28.07 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -174.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.68 141.44 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 -175.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.416 HD13 HG22 ' A' ' 58' ' ' VAL . 47.3 tp -126.96 144.45 51.01 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.946 0.898 . . . . 0.0 109.463 -176.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.402 ' HB3' ' HB ' ' A' ' 102' ' ' VAL . 66.0 t80 -154.26 109.58 3.14 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 46.19 71.59 0.28 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.544 1.138 . . . . 0.0 112.739 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 56.51 20.61 4.98 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.413 1.085 . . . . 0.0 113.74 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -124.86 108.9 12.39 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 120.921 0.391 . . . . 0.0 110.088 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.416 HG22 HD13 ' A' ' 53' ' ' LEU . 31.7 t -94.4 147.72 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 124.423 1.089 . . . . 0.0 110.046 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.91 113.19 8.77 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.88 1.272 . . . . 0.0 107.599 174.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 66.5 p -107.93 138.38 44.28 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -126.24 100.41 6.29 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -77.67 95.57 4.64 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.639 0.733 . . . . 0.0 109.48 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.521 HG21 HD12 ' A' ' 71' ' ' LEU . 32.5 mt -71.32 133.94 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.216 171.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -90.04 128.0 51.48 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 174.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -81.06 -81.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 123.1 2.533 . . . . 0.0 115.13 -157.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -149.8 160.85 43.23 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 118.262 0.483 . . . . 0.0 110.261 -163.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.58 -46.62 1.02 Allowed Glycine 0 N--CA 1.468 0.819 0 N-CA-C 107.417 -2.273 . . . . 0.0 107.417 -169.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -65.02 -147.07 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.649 0 CA-C-N 113.321 -1.439 . . . . 0.0 111.314 155.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -112.37 -24.36 9.81 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.512 0.725 . . . . 0.0 110.289 173.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -130.13 162.42 28.88 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.902 1.281 . . . . 0.0 110.985 -169.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.521 HD12 HG21 ' A' ' 63' ' ' ILE . 0.5 OUTLIER -102.95 132.02 49.49 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.426 1.09 . . . . 0.0 110.186 178.625 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -105.26 113.9 27.76 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.529 0.731 . . . . 0.0 112.802 -172.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 81' ' ' VAL . 23.0 t -85.32 138.73 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.69 0.796 . . . . 0.0 109.281 177.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -99.89 91.97 5.07 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.3 m -72.41 -65.39 0.79 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.079 0.551 . . . . 0.0 112.248 -166.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.2 t -168.82 178.23 4.69 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.668 0.387 . . . . 0.0 111.207 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -61.49 -39.01 89.4 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.718 1.207 . . . . 0.0 114.17 -168.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -139.68 40.86 1.37 Allowed Glycine 0 N--CA 1.472 1.081 0 CA-C-O 120.758 0.088 . . . . 0.0 113.044 -171.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.5 m -122.92 155.23 64.1 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 123.848 0.859 . . . . 0.0 109.285 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -65.61 128.65 20.54 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.556 2.171 . . . . 0.0 111.24 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 73' ' ' VAL . 45.6 t -90.02 126.57 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -120.29 139.2 53.07 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.12 0.568 . . . . 0.0 109.528 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -101.99 157.67 16.7 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.348 1.059 . . . . 0.0 108.702 178.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.637 ' HE1' HD12 ' A' ' 93' ' ' LEU . 95.4 m-85 -130.99 160.67 33.89 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.815 0.846 . . . . 0.0 109.103 -173.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -99.35 -18.41 17.54 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.512 0.325 . . . . 0.0 110.489 174.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.8 p -146.7 154.0 40.91 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.764 0.826 . . . . 0.0 110.141 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.448 ' O ' ' HB3' ' A' ' 90' ' ' LEU . 96.1 mt -64.15 -25.56 68.14 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.154 0.982 . . . . 0.0 111.805 173.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -56.89 -42.65 92.43 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 116.574 -0.284 . . . . 0.0 113.026 172.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -68.09 -34.08 75.74 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.668 0.787 . . . . 0.0 111.095 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 22.7 tp -56.24 -58.97 5.71 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.896 0.878 . . . . 0.0 110.262 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 44.9 mm -62.77 -37.92 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.747 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.2 -55.64 28.36 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 115.032 -0.986 . . . . 0.0 113.747 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.637 HD12 ' HE1' ' A' ' 84' ' ' PHE . 34.5 mt -75.77 -42.58 49.92 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -177.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -72.42 -7.41 49.62 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.6 -3.38 4.51 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 171.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 93' ' ' LEU . 13.4 pt20 -95.98 141.01 22.55 Favored Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 123.008 0.523 . . . . 0.0 109.685 174.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 96' ' ' GLN . 4.2 Cg_exo -78.84 173.27 13.81 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.829 2.352 . . . . 0.0 112.706 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 54.16 82.79 0.08 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.478 1.511 . . . . 0.0 111.885 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -159.35 9.43 0.12 Allowed 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.738 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.31 -13.62 56.99 Favored Glycine 0 N--CA 1.476 1.316 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -175.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.418 ' HB3' ' O ' ' A' ' 103' ' ' CYS . 2.2 mm? -65.58 153.31 41.89 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.411 1.484 . . . . 0.0 111.849 175.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 54' ' ' TYR . 19.8 m -82.65 76.3 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 164.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 104' ' ' ALA . 42.8 t 75.75 170.95 0.26 Allowed 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 113.879 -1.509 . . . . 0.0 110.6 -174.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.44 ' N ' ' SG ' ' A' ' 103' ' ' CYS . . . -72.47 166.48 22.52 Favored 'General case' 0 C--O 1.249 1.033 0 C-N-CA 122.984 0.514 . . . . 0.0 109.677 176.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 29.1 mt -73.68 92.58 1.99 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -85.15 -59.91 2.19 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.953 -170.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.496 HD12 ' HD2' ' A' ' 108' ' ' PRO . 50.3 tp -147.58 127.55 6.66 Favored Pre-proline 0 N--CA 1.469 0.524 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -175.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.496 ' HD2' HD12 ' A' ' 107' ' ' LEU . 10.6 Cg_endo -54.16 -72.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.156 1.904 . . . . 0.0 111.37 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 50.2 t . . . . . 0 C--O 1.252 1.187 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 174.977 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptp . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 120.806 0.336 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.31 103.92 0.23 Allowed Glycine 0 C--N 1.344 1.0 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -133.13 -12.82 2.81 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.834 0.853 . . . . 0.0 110.516 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -81.9 85.31 6.7 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 122.975 0.51 . . . . 0.0 110.242 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -154.16 144.78 22.39 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.322 1.049 . . . . 0.0 108.281 175.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -49.5 115.47 1.36 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.42 1.088 . . . . 0.0 112.274 -172.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -99.23 114.59 27.48 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-O 121.014 0.435 . . . . 0.0 110.127 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -74.53 147.77 41.52 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.563 170.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.2 p -58.39 156.51 10.1 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.831 0.852 . . . . 0.0 110.872 175.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 63.3 t-80 -49.76 135.03 19.85 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.259 1.024 . . . . 0.0 111.88 -174.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 88.5 mtp -63.0 175.84 0.81 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.612 0.765 . . . . 0.0 111.901 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.5 t 71.33 141.37 0.05 Allowed 'General case' 0 C--N 1.355 0.838 0 C-N-CA 124.532 1.133 . . . . 0.0 109.848 -172.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.586 ' HB2' ' HA ' ' A' ' 37' ' ' LEU . 1.9 p-90 -80.75 -23.17 39.59 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 28.4 t80 -75.53 105.41 6.55 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.034 0.933 . . . . 0.0 110.422 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -127.36 108.24 10.67 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -54.68 150.4 9.61 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 123.335 0.654 . . . . 0.0 111.334 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.599 ' H ' ' HB3' ' A' ' 40' ' ' ASP . 37.7 t70 -9.71 76.31 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -149.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.431 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 28.5 tp -62.14 -26.4 68.29 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.5 168.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.4 t 82.14 138.44 0.06 Allowed 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 125.587 1.555 . . . . 0.0 108.622 174.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -58.76 -45.39 89.86 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.111 0.564 . . . . 0.0 112.198 -168.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.42 -50.44 71.48 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.879 0.871 . . . . 0.0 111.516 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -73.7 -19.03 60.93 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.704 -178.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.605 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -74.38 -53.33 9.83 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.147 0.979 . . . . 0.0 110.545 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.567 ' HA ' HD12 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -68.95 -21.91 64.16 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 123.682 0.614 . . . . 0.0 110.916 178.155 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -71.54 -51.2 24.77 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.091 0.556 . . . . 0.0 110.501 172.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.4 tp -57.98 -31.69 67.14 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.339 0.656 . . . . 0.0 111.578 174.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.567 HD12 ' HA ' ' A' ' 24' ' ' GLU . 85.6 mt -62.48 -59.95 4.24 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.75 -40.31 66.08 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.833 0.853 . . . . 0.0 112.937 -176.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -77.85 -55.45 5.31 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.578 0.751 . . . . 0.0 111.951 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.3 -60.9 2.05 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.064 0.545 . . . . 0.0 111.257 -172.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.69 82.18 0.31 Allowed Glycine 0 C--N 1.335 0.523 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -70.61 14.39 0.14 Allowed 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -166.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 175.16 138.56 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.172 0.989 . . . . 0.0 108.695 -171.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.92 -4.57 29.89 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 115.088 0.795 . . . . 0.0 115.088 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.5 m -86.92 161.88 18.02 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -166.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -151.23 153.19 34.42 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.878 0.871 . . . . 0.0 109.346 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.605 HD11 ' HB1' ' A' ' 23' ' ' ALA . 3.2 pp -149.82 155.17 39.63 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.446 0.699 . . . . 0.0 109.836 170.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 70.9 t -112.77 131.72 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -119.82 170.37 9.3 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.908 0.883 . . . . 0.0 109.594 175.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.599 ' HB3' ' H ' ' A' ' 17' ' ' ASP . 35.0 t70 -83.63 130.23 34.98 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 172.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.0 t -68.18 152.3 45.69 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.488 0.715 . . . . 0.0 111.118 -176.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -110.77 -36.52 5.68 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.4 t -54.45 -45.05 73.03 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.624 1.17 . . . . 0.0 111.061 173.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 65.1 t -130.12 115.92 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.52 0.728 . . . . 0.0 109.379 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.13 130.41 42.63 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.431 0.692 . . . . 0.0 110.877 174.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.46 -0.63 68.37 Favored Glycine 0 C--N 1.352 1.443 0 C-N-CA 122.894 0.283 . . . . 0.0 112.757 -177.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.0 176.75 4.95 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.897 0.879 . . . . 0.0 112.0 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.437 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 48.7 m-85 -126.0 168.67 13.62 Favored 'General case' 0 C--O 1.249 1.04 0 C-N-CA 124.888 1.275 . . . . 0.0 110.434 -176.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.56 148.47 42.6 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.059 1.344 . . . . 0.0 109.686 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.8 tp -123.73 114.64 20.2 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.112 0.965 . . . . 0.0 108.996 -176.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 60.5 m -107.44 121.65 45.04 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.3 t -126.66 132.39 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -173.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 68.6 tp -123.84 118.15 26.46 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.93 0.892 . . . . 0.0 110.104 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -136.07 132.11 35.74 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 166.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 42.19 61.55 1.94 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 124.977 1.311 . . . . 0.0 113.562 -176.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm 62.92 2.34 0.99 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 125.194 1.398 . . . . 0.0 113.673 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -103.65 105.89 16.25 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -173.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.0 t -86.06 139.63 17.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.066 0.946 . . . . 0.0 109.413 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -135.16 115.52 13.48 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 173.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 51.5 m -109.66 130.79 55.48 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -110.59 156.43 20.95 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.895 1.278 . . . . 0.0 108.26 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -100.91 156.52 17.34 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 163.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.659 HG13 HG13 ' A' ' 73' ' ' VAL . 2.9 mp -144.47 100.5 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 101.564 -3.495 . . . . 0.0 101.564 -167.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.21 154.76 37.44 Favored Pre-proline 0 C--N 1.318 -0.781 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -169.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.97 -73.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 121.485 1.457 . . . . 0.0 111.302 163.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 43.82 73.85 0.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.762 1.225 . . . . 0.0 111.925 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.24 -100.65 0.15 Allowed Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.026 -174.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 158.97 -25.09 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 126.167 1.787 . . . . 0.0 108.271 -170.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -152.07 -2.89 0.27 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.704 0.801 . . . . 0.0 112.121 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -119.59 160.83 21.71 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.733 0.813 . . . . 0.0 109.495 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.408 ' H ' HD23 ' A' ' 71' ' ' LEU . 1.5 pt? -115.12 121.42 42.97 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.615 0.766 . . . . 0.0 109.377 173.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.14 117.9 33.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.56 0.744 . . . . 0.0 110.7 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.659 HG13 HG13 ' A' ' 63' ' ' ILE . 25.6 t -92.09 145.14 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.788 -177.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -101.13 90.12 4.03 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.68 173.22 10.09 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.762 178.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.4 t -65.54 108.32 1.98 Allowed 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -56.7 101.63 0.06 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.147 0.979 . . . . 0.0 110.293 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.32 -24.45 0.45 Allowed Glycine 0 CA--C 1.529 0.953 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -165.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.1 m -118.0 162.27 30.36 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 125.326 1.45 . . . . 0.0 107.654 168.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -63.01 132.12 35.5 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.247 1.965 . . . . 0.0 112.271 176.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 94.2 t -71.58 123.37 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.563 0.745 . . . . 0.0 109.746 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.509 ' HG2' HD13 ' A' ' 93' ' ' LEU . 10.6 tpt180 -111.97 121.75 45.87 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 123.17 0.294 . . . . 0.0 110.89 -175.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.67 155.79 16.62 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.938 0.895 . . . . 0.0 109.19 170.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -133.96 165.6 24.64 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.614 0.766 . . . . 0.0 110.374 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -89.36 -23.99 22.08 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.991 0.516 . . . . 0.0 111.049 168.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.1 t -147.95 155.39 41.5 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.774 0.43 . . . . 0.0 111.195 -175.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.489 ' O ' HG12 ' A' ' 91' ' ' ILE . 86.1 mt -60.14 -31.04 69.7 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.854 0.861 . . . . 0.0 112.132 175.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.94 -47.34 31.96 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 123.094 0.378 . . . . 0.0 114.021 176.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -69.69 -30.28 67.9 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.375 0.67 . . . . 0.0 111.318 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.2 tt -66.86 -36.67 82.85 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.699 0.8 . . . . 0.0 109.13 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 87' ' ' LEU . 47.2 mm -80.92 -40.14 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -169.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.97 -38.98 64.18 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.79 -0.641 . . . . 0.0 113.471 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.509 HD13 ' HG2' ' A' ' 82' ' ' ARG . 7.9 tt -73.42 -36.11 65.93 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.571 0.348 . . . . 0.0 110.189 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.494 ' CD2' HD21 ' A' ' 101' ' ' LEU . 2.0 m-85 -84.28 -9.39 58.53 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.871 0.468 . . . . 0.0 110.613 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.37 0.4 17.0 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.383 0.673 . . . . 0.0 111.287 165.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -92.63 125.69 54.79 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 169.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -66.24 172.64 8.53 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.776 2.317 . . . . 0.0 113.029 171.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.3 t30 55.4 39.62 31.22 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.661 1.185 . . . . 0.0 111.548 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -122.09 10.07 10.0 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.661 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 99.56 -14.01 60.88 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -174.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.494 HD21 ' CD2' ' A' ' 94' ' ' TYR . 4.1 mm? -72.56 150.73 42.89 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.19 1.396 . . . . 0.0 110.702 176.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.4 m -84.34 74.91 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-O 122.206 1.003 . . . . 0.0 109.558 172.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 39.6 t 72.59 27.83 2.27 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 113.438 -1.71 . . . . 0.0 111.25 172.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 77.85 165.5 0.23 Allowed 'General case' 0 C--N 1.354 0.781 0 C-N-CA 125.076 1.35 . . . . 0.0 112.937 172.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.8 mt -76.71 101.81 5.95 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.293 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 78.2 mt -104.78 -50.73 3.21 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 122.957 0.503 . . . . 0.0 112.091 -172.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 mp -113.05 130.16 23.82 Favored Pre-proline 0 N--CA 1.491 1.61 0 CA-C-O 118.776 -0.63 . . . . 0.0 109.766 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -83.48 9.4 4.12 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.79 2.326 . . . . 0.0 113.234 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.542 HG21 HD23 ' A' ' 37' ' ' LEU . 49.3 t . . . . . 0 C--O 1.252 1.214 0 C-N-CA 125.382 1.473 . . . . 0.0 109.396 -172.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.785 0.326 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -142.39 132.9 5.36 Favored Glycine 0 C--N 1.341 0.831 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 175.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -72.39 120.98 18.76 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.881 0.472 . . . . 0.0 110.418 -173.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -98.53 149.96 22.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.927 0.891 . . . . 0.0 109.796 174.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -70.29 158.68 35.46 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.029 0.532 . . . . 0.0 110.101 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -66.29 152.93 43.91 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.863 0.465 . . . . 0.0 110.916 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -71.42 152.19 43.34 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 170.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -65.73 165.54 12.5 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.643 0.377 . . . . 0.0 110.933 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.4 m -62.01 120.39 10.73 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 122.662 0.385 . . . . 0.0 110.729 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -65.02 102.65 0.64 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 173.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 95.9 mmm -69.21 82.47 0.35 Allowed 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.813 0.816 . . . . 0.0 112.183 -168.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.8 m -155.6 103.02 2.26 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -83.76 1.36 43.24 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -165.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -105.06 96.44 6.53 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -170.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -110.2 89.97 3.18 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.27 52.39 2.01 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.017 0.913 . . . . 0.0 110.558 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -146.77 -17.76 0.42 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.725 1.61 . . . . 0.0 109.748 -174.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 28.7 tp -112.36 100.34 8.71 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.457 0.703 . . . . 0.0 110.26 -164.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.2 p -47.07 157.25 0.18 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 125.161 1.384 . . . . 0.0 112.801 172.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.39 -37.1 86.34 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.255 0.622 . . . . 0.0 112.096 -172.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.29 -51.27 68.38 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.392 0.677 . . . . 0.0 111.014 177.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.77 -20.08 61.24 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.934 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.6 -55.58 9.7 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.296 0.638 . . . . 0.0 110.738 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.459 ' HB3' ' SG ' ' A' ' 51' ' ' CYS . 12.3 pt-20 -70.2 -26.54 63.92 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.259 0.623 . . . . 0.0 111.719 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -64.9 -51.98 59.0 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -61.9 -35.39 78.23 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.062 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.6 mt -68.47 -33.82 74.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.585 0.354 . . . . 0.0 110.382 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.18 -37.77 81.33 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.995 0.809 . . . . 0.0 111.652 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -83.46 -44.01 15.2 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.056 0.542 . . . . 0.0 112.22 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.39 -58.2 3.24 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.213 0.605 . . . . 0.0 112.018 -169.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -100.07 -35.76 4.4 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.751 -176.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 66.15 -7.72 0.38 Allowed 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 126.322 1.849 . . . . 0.0 114.452 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -171.18 127.79 0.7 Allowed 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 124.818 1.247 . . . . 0.0 107.647 -165.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.479 ' HA3' HD23 ' A' ' 106' ' ' LEU . . . 65.05 11.61 52.05 Favored Glycine 0 N--CA 1.478 1.467 0 N-CA-C 114.107 0.403 . . . . 0.0 114.107 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.8 m -83.35 143.47 30.31 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.83 0.852 . . . . 0.0 110.278 -168.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -152.92 154.59 35.35 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.06 0.457 . . . . 0.0 110.52 176.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -151.62 153.66 34.91 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.777 169.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.557 HG22 HD13 ' A' ' 50' ' ' LEU . 40.1 t -107.25 145.64 14.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.543 ' HG3' ' HB3' ' A' ' 49' ' ' ALA . 0.9 OUTLIER -138.94 -179.36 5.79 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 125.308 1.443 . . . . 0.0 108.312 -178.472 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -91.34 148.11 22.56 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 172.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.555 ' HB2' ' HB ' ' A' ' 44' ' ' VAL . 40.9 m -61.92 140.69 58.28 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.987 0.515 . . . . 0.0 110.412 173.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -35.35 -54.53 0.65 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 126.356 1.862 . . . . 0.0 114.168 -167.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.1 m -142.61 28.87 1.59 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.91 0.484 . . . . 0.0 110.045 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.555 ' HB ' ' HB2' ' A' ' 41' ' ' SER . 24.2 t -110.24 112.1 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.37 117.98 8.04 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.037 -177.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.89 -0.46 89.47 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 114.537 0.575 . . . . 0.0 114.537 172.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -92.92 155.24 17.71 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 117.161 0.481 . . . . 0.0 109.834 173.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.54 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 68.3 m-85 -110.67 158.24 18.83 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.647 0.736 . . . . 0.0 109.753 -175.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.543 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . . . -135.06 147.37 49.59 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 166.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.557 HD13 HG22 ' A' ' 38' ' ' VAL . 45.6 tp -125.77 139.24 53.68 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -177.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.459 ' SG ' ' HB3' ' A' ' 24' ' ' GLU . 44.6 t -124.84 128.55 48.87 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 175.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.661 HG12 ' SG ' ' A' ' 103' ' ' CYS . 12.8 t -137.0 140.41 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 123.538 0.735 . . . . 0.0 109.779 -176.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.7 tp -132.34 120.52 22.19 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.609 1.164 . . . . 0.0 110.148 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -147.77 146.14 29.07 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.473 0.709 . . . . 0.0 109.089 168.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 50.3 47.58 23.58 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.74 1.216 . . . . 0.0 111.837 -177.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt 54.75 27.68 9.14 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.641 1.177 . . . . 0.0 112.716 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -123.72 107.26 11.27 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.228 1.011 . . . . 0.0 108.888 -174.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.5 t -83.73 131.54 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -135.84 111.08 9.0 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 176.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.2 p -104.87 127.22 52.61 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.961 0.904 . . . . 0.0 108.614 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -113.25 101.02 9.01 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.033 0.933 . . . . 0.0 108.846 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 84.4 mtm180 -70.9 155.63 40.57 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 168.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 91.7 mt -145.86 100.92 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 102.601 -3.111 . . . . 0.0 102.601 -152.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 mp -113.36 101.71 53.9 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 122.814 0.446 . . . . 0.0 110.617 -161.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.716 ' HB2' ' HA ' ' A' ' 68' ' ' GLU . 39.7 Cg_endo -66.3 103.62 0.67 Allowed 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.086 1.857 . . . . 0.0 110.02 167.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.16 -52.8 62.35 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.849 0.86 . . . . 0.0 110.446 -169.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -116.86 34.04 4.8 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.577 174.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.716 ' HA ' ' HB2' ' A' ' 65' ' ' PRO . 46.5 mt-10 50.29 4.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 -173.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -84.85 -49.21 8.6 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 119.602 1.092 . . . . 0.0 109.695 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 31.3 m-85 -127.57 142.07 51.47 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.715 0.806 . . . . 0.0 109.933 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.23 114.9 27.95 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.7 1.2 . . . . 0.0 108.736 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.97 119.39 35.35 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.243 1.017 . . . . 0.0 111.277 -170.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.441 HG22 HG23 ' A' ' 63' ' ' ILE . 16.1 t -106.96 143.67 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.057 0.943 . . . . 0.0 108.956 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -113.49 91.89 3.8 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -172.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.62 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 30.7 p -108.26 28.36 8.38 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.897 0.879 . . . . 0.0 110.482 -177.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.4 m -68.66 94.52 0.59 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.975 0.91 . . . . 0.0 113.353 -167.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -118.41 2.02 11.82 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 124.229 1.012 . . . . 0.0 110.165 164.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.48 22.88 0.03 OUTLIER Glycine 0 N--CA 1.471 0.982 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.459 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.9 m -140.27 152.42 66.96 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.503 1.121 . . . . 0.0 108.969 -174.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -73.32 -175.19 1.88 Allowed 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.375 2.05 . . . . 0.0 111.903 172.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 62.9 t -76.63 123.92 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 176.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 39.8 tpt85 -100.7 116.07 31.74 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -175.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.447 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 32.2 mtp85 -95.33 145.07 25.37 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.292 1.037 . . . . 0.0 110.07 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.648 ' HE1' HD12 ' A' ' 93' ' ' LEU . 83.6 m-85 -126.93 152.87 46.55 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.905 0.882 . . . . 0.0 109.181 -178.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -85.7 -21.56 28.24 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 172.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.7 t -153.33 158.25 41.28 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 122.998 0.519 . . . . 0.0 110.725 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.98 -27.54 68.9 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.238 1.015 . . . . 0.0 109.979 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -52.83 -46.19 60.45 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-N 116.364 -0.38 . . . . 0.0 113.999 173.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -66.88 -30.7 70.93 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.442 0.697 . . . . 0.0 110.97 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.0 tt -62.53 -57.95 9.33 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.319 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.494 ' HA ' HD12 ' A' ' 105' ' ' LEU . 38.3 mm -54.41 -46.11 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.67 0.788 . . . . 0.0 111.206 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.05 -56.96 14.21 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 114.568 -1.196 . . . . 0.0 113.75 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.648 HD12 ' HE1' ' A' ' 84' ' ' PHE . 86.7 mt -74.0 -37.02 64.54 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.944 0.498 . . . . 0.0 111.675 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.425 ' HE2' HG11 ' A' ' 73' ' ' VAL . 5.9 m-30 -82.28 -5.51 58.6 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -169.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.13 -5.37 26.59 Favored 'General case' 0 CA--C 1.562 1.429 0 CA-C-O 120.805 0.336 . . . . 0.0 111.418 165.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -97.13 130.56 29.49 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 124.726 1.21 . . . . 0.0 109.095 173.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.47 -175.66 2.79 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.892 2.395 . . . . 0.0 113.311 173.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.6 t30 49.22 71.9 0.34 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 126.041 1.736 . . . . 0.0 112.277 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.568 ' HG3' HD23 ' A' ' 101' ' ' LEU . 12.7 pt20 -176.45 11.3 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.427 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.62 ' HA3' ' HB ' ' A' ' 75' ' ' THR . . . 122.94 -32.89 4.25 Favored Glycine 0 C--N 1.345 1.074 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -173.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.568 HD23 ' HG3' ' A' ' 99' ' ' GLN . 3.4 mm? -76.66 101.41 5.74 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.533 0.733 . . . . 0.0 109.287 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.462 HG23 ' SG ' ' A' ' 103' ' ' CYS . 4.7 m -69.74 -15.08 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.783 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.661 ' SG ' HG12 ' A' ' 52' ' ' VAL . 14.6 m -115.29 -47.38 2.85 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.582 1.153 . . . . 0.0 111.617 -174.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 69.94 139.34 0.04 OUTLIER 'General case' 0 C--N 1.357 0.906 0 O-C-N 125.27 1.606 . . . . 0.0 108.973 -158.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 91' ' ' ILE . 46.0 mt -69.94 101.42 1.77 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -170.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.479 HD23 ' HA3' ' A' ' 34' ' ' GLY . 57.7 tp -108.68 -60.49 1.74 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.346 1.058 . . . . 0.0 111.056 -169.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 60.6 tp -120.48 101.41 46.35 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 123.165 0.586 . . . . 0.0 109.999 -169.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.38 122.0 5.89 Favored 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 122.884 2.389 . . . . 0.0 110.352 174.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 C--O 1.244 0.81 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.57 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.001 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.62 158.72 35.8 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.888 -177.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -170.74 161.49 7.39 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.372 1.069 . . . . 0.0 109.523 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -143.62 127.32 17.12 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -176.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -103.57 156.65 17.62 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -166.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -141.13 130.8 24.1 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.697 1.199 . . . . 0.0 108.813 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -145.31 99.04 3.25 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -62.69 99.78 0.17 Allowed 'General case' 0 N--CA 1.48 1.068 0 O-C-N 123.709 0.631 . . . . 0.0 110.714 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.8 p -155.92 107.76 2.56 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.795 0.838 . . . . 0.0 109.077 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -111.92 159.81 18.03 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 123.653 0.781 . . . . 0.0 109.161 178.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 75.2 mtp -73.33 145.48 45.95 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.683 0.793 . . . . 0.0 109.973 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.7 p -65.8 149.14 50.64 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.281 0.632 . . . . 0.0 110.438 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.449 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . 4.9 p-90 -79.54 -21.35 45.28 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -175.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.456 ' HH ' ' HE1' ' A' ' 48' ' ' PHE . 89.0 t80 -81.66 125.79 31.0 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.486 171.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -117.67 129.76 55.94 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.438 ' O ' ' HB3' ' A' ' 40' ' ' ASP . 1.6 mpp_? -75.08 -37.93 61.44 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -174.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -130.93 90.1 2.84 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.988 0.899 . . . . 0.0 109.897 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.9 tp -135.59 139.77 44.11 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.841 1.256 . . . . 0.0 107.764 175.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.3 t -99.0 167.09 10.95 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.312 0.645 . . . . 0.0 110.342 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -64.74 -40.08 94.7 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.875 0.87 . . . . 0.0 113.184 -172.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.89 -48.34 77.04 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.067 0.547 . . . . 0.0 110.801 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.55 -30.81 70.54 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.674 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.478 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -65.98 -57.26 8.21 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.123 0.569 . . . . 0.0 110.922 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -58.01 -38.74 76.72 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.877 1.271 . . . . 0.0 112.041 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -70.17 -45.04 67.55 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.395 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.2 tp -58.16 -34.28 70.13 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.981 0.912 . . . . 0.0 111.441 175.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 23' ' ' ALA . 96.5 mt -66.11 -53.05 42.82 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.62 -39.14 87.12 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.265 1.026 . . . . 0.0 112.695 -172.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -73.37 -52.09 15.06 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.748 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.21 -56.18 3.79 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -166.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -101.98 -46.69 1.57 Allowed Glycine 0 N--CA 1.475 1.267 0 N-CA-C 113.404 0.121 . . . . 0.0 113.404 -172.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 49.05 21.49 0.49 Allowed 'General case' 0 CA--C 1.57 1.747 0 C-N-CA 126.196 1.798 . . . . 0.0 114.827 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -170.64 100.43 0.24 Allowed 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.27 -0.894 . . . . 0.0 109.361 -168.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.407 ' HA3' ' HB2' ' A' ' 106' ' ' LEU . . . 66.44 19.05 68.36 Favored Glycine 0 C--N 1.353 1.488 0 CA-C-O 121.465 0.48 . . . . 0.0 112.394 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 9.2 m -84.55 122.8 29.53 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 124.533 1.133 . . . . 0.0 110.859 -167.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 36.7 p90 -129.76 156.7 43.89 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.986 0.422 . . . . 0.0 110.725 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.478 HD11 ' HB1' ' A' ' 23' ' ' ALA . 4.3 pp -150.2 160.11 43.93 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 167.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 57.4 t -114.23 148.54 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 174.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -149.05 151.94 35.37 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.308 0.643 . . . . 0.0 109.476 -174.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' A' ' 16' ' ' ARG . 25.3 t70 -91.11 118.33 30.34 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 174.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.3 m -92.69 97.33 10.72 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -173.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -55.29 -39.17 69.56 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.058 0.943 . . . . 0.0 112.325 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.6 m -58.31 -24.34 59.28 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.2 t -80.27 -87.0 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-O 119.476 -0.297 . . . . 0.0 110.913 -174.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -178.03 18.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 122.909 0.484 . . . . 0.0 111.595 -167.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.75 88.03 1.2 Allowed Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -159.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.3 163.75 39.71 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.717 0.807 . . . . 0.0 109.789 -170.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.596 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 21.2 m-85 -116.01 162.23 17.7 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.37 0.668 . . . . 0.0 109.69 168.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.55 149.38 43.81 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.169 0.988 . . . . 0.0 110.1 170.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.511 ' HB2' HD11 ' A' ' 63' ' ' ILE . 51.9 tp -117.2 111.29 19.24 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 55.4 m -101.17 121.52 41.98 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.4 t -125.19 143.52 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.532 HD13 HG22 ' A' ' 58' ' ' VAL . 51.0 tp -133.0 147.4 52.27 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.366 1.066 . . . . 0.0 109.214 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -162.33 115.88 1.77 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.9 tm0? 36.06 73.75 0.08 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 125.907 1.683 . . . . 0.0 112.612 -174.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 44.6 tptt 56.64 26.41 11.15 Favored 'General case' 0 CA--C 1.572 1.825 0 C-N-CA 124.391 1.076 . . . . 0.0 112.684 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -130.19 107.33 9.22 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 121.482 -0.761 . . . . 0.0 109.272 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.532 HG22 HD13 ' A' ' 53' ' ' LEU . 21.6 t -93.1 142.0 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.506 0.722 . . . . 0.0 109.995 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -137.14 112.77 9.43 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.639 1.576 . . . . 0.0 107.754 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.9 m -119.37 140.17 50.79 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -133.98 113.8 12.55 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.719 0.807 . . . . 0.0 109.41 -173.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -64.79 156.89 29.16 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 171.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.596 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 79.7 mt -148.33 104.32 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 -158.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -96.01 102.44 10.65 Favored Pre-proline 0 N--CA 1.478 0.93 0 CA-C-N 118.885 0.766 . . . . 0.0 109.453 -168.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.457 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 93.1 Cg_endo -76.73 -56.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 123.043 2.495 . . . . 0.0 115.99 -163.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -125.9 141.02 52.17 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 118.146 0.43 . . . . 0.0 111.081 -162.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.05 -16.44 0.24 Allowed Glycine 0 CA--C 1.534 1.236 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.161 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -146.84 -70.5 0.24 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.776 1.231 . . . . 0.0 108.592 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -166.62 -41.31 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.989 -175.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -110.16 151.18 27.6 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.766 0.426 . . . . 0.0 111.222 -167.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.457 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 3.8 pp -99.73 111.58 23.9 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 171.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -101.1 123.48 45.33 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.133 0.573 . . . . 0.0 110.541 -173.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.801 HG21 HD13 ' A' ' 90' ' ' LEU . 57.5 t -93.91 138.12 21.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -95.54 88.45 5.06 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.6 m -73.44 -77.95 0.1 Allowed 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.416 -173.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.433 ' HB2' HG22 ' A' ' 79' ' ' VAL . 66.6 m -161.15 128.29 4.1 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.799 0.84 . . . . 0.0 110.437 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.4 mp0 -70.07 92.87 0.76 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 169.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.53 -36.13 0.69 Allowed Glycine 0 C--N 1.346 1.099 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -170.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 99' ' ' GLN . 13.0 m -104.89 158.34 32.23 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 123.495 0.718 . . . . 0.0 109.171 177.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.36 111.05 1.18 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.256 1.971 . . . . 0.0 110.869 167.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 95.7 t -93.6 132.25 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.944 0.898 . . . . 0.0 108.675 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -112.13 136.13 51.91 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.948 0.499 . . . . 0.0 110.454 -173.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -89.92 140.97 29.1 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.303 1.041 . . . . 0.0 109.328 174.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -111.17 174.45 5.86 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.449 1.099 . . . . 0.0 110.207 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -120.08 -49.64 2.29 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -164.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.8 m -128.73 161.26 30.14 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 113.495 -1.684 . . . . 0.0 107.697 171.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.47 -26.13 67.7 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 118.647 0.658 . . . . 0.0 112.41 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -56.58 -34.93 64.93 Favored Glycine 0 N--CA 1.48 1.611 0 O-C-N 122.991 0.182 . . . . 0.0 113.47 169.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -67.45 -38.96 85.27 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.2 0.6 . . . . 0.0 110.677 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.801 HD13 HG21 ' A' ' 73' ' ' VAL . 37.6 tp -61.84 -64.71 0.85 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.855 0.862 . . . . 0.0 110.717 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.7 mm -59.68 -39.36 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.318 1.047 . . . . 0.0 111.063 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.18 -57.66 18.06 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.135 -0.939 . . . . 0.0 113.853 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.1 tt -67.63 -45.83 74.25 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.266 0.626 . . . . 0.0 110.101 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.469 ' HB3' ' HG ' ' A' ' 105' ' ' LEU . 5.7 m-30 -77.04 -12.15 59.9 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -170.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.42 -22.24 66.77 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.224 0.535 . . . . 0.0 110.835 169.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -94.45 139.25 22.31 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 174.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -46.3 117.75 2.13 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.105 2.537 . . . . 0.0 112.137 166.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -110.24 -58.37 2.08 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.518 -164.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.445 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . 9.4 mm-40 128.33 102.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 128.37 2.668 . . . . 0.0 107.595 -159.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 120.55 -39.91 2.31 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-O 120.117 -0.269 . . . . 0.0 113.432 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.438 HD11 ' HB3' ' A' ' 94' ' ' TYR . 76.2 mt -68.9 150.28 47.93 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.8 p -64.49 -36.83 78.41 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.174 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.4 ' SG ' HD11 ' A' ' 106' ' ' LEU . 49.0 t -165.25 20.64 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.268 0.627 . . . . 0.0 111.146 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 72.14 167.97 0.31 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.611 1.165 . . . . 0.0 110.664 -169.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.469 ' HG ' ' HB3' ' A' ' 94' ' ' TYR . 23.4 mt -81.18 98.91 8.28 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.167 0.587 . . . . 0.0 109.611 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.407 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 89.8 mt -93.95 -46.5 7.14 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.459 0.704 . . . . 0.0 112.404 -172.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 35' ' ' SER . 68.5 tp -141.54 116.68 7.06 Favored Pre-proline 0 N--CA 1.486 1.373 0 C-N-CA 123.079 0.552 . . . . 0.0 111.055 -174.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.449 ' HB2' ' HB3' ' A' ' 13' ' ' TRP . 73.2 Cg_endo -77.94 136.38 14.83 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.372 2.048 . . . . 0.0 111.581 174.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--O 1.25 1.086 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.407 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.9 mtt . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 132.21 119.56 2.07 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 112.387 -0.285 . . . . 0.0 112.387 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -141.46 112.04 7.05 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -94.42 97.79 10.43 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.083 0.468 . . . . 0.0 110.374 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -98.65 126.3 44.2 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.695 1.198 . . . . 0.0 108.486 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -96.84 147.6 23.78 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.099 0.56 . . . . 0.0 110.778 -178.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 -160.37 125.58 3.9 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.467 1.107 . . . . 0.0 109.318 174.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -142.07 157.8 44.49 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.25 1.02 . . . . 0.0 110.369 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.4 m -122.53 101.68 7.62 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.026 0.931 . . . . 0.0 108.593 171.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -108.83 90.45 3.3 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.262 1.025 . . . . 0.0 108.882 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -83.47 62.68 6.91 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 175.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.8 t 55.67 -107.52 0.39 Allowed 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 124.177 0.991 . . . . 0.0 110.56 -171.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.509 ' HB3' ' HB3' ' A' ' 108' ' ' PRO . 6.1 p-90 -99.23 15.5 25.9 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.813 0.845 . . . . 0.0 112.005 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 61.7 t80 -113.76 116.09 28.83 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -131.23 99.16 4.77 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.207 0.603 . . . . 0.0 110.373 -177.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.478 ' HD3' ' N ' ' A' ' 17' ' ' ASP . 1.0 OUTLIER -72.73 150.59 42.74 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 167.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.478 ' N ' ' HD3' ' A' ' 16' ' ' ARG . 36.6 t70 79.19 3.54 2.33 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.891 1.276 . . . . 0.0 111.389 -175.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.2 tp -99.44 123.25 43.55 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.082 -1.011 . . . . 0.0 109.042 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.2 p -80.85 160.84 24.66 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.663 0.785 . . . . 0.0 109.917 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.445 ' HB3' ' NH2' ' A' ' 39' ' ' ARG . 5.5 ppt_? -64.63 -35.47 81.13 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 118.458 0.572 . . . . 0.0 112.252 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.87 -48.86 78.63 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.538 0.735 . . . . 0.0 110.75 175.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.21 -26.56 62.99 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.849 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.462 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -71.97 -54.55 9.62 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.72 0.808 . . . . 0.0 110.768 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.578 ' HG2' HG21 ' A' ' 58' ' ' VAL . 5.5 tm-20 -56.97 -39.72 75.14 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.951 1.3 . . . . 0.0 111.52 175.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.82 -46.72 80.78 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 123.976 0.798 . . . . 0.0 110.156 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -60.63 -43.87 97.02 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 124.088 0.868 . . . . 0.0 110.411 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.4 mt -65.26 -42.18 93.52 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.368 0.667 . . . . 0.0 110.186 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.47 -35.87 80.03 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.764 0.826 . . . . 0.0 111.604 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 46.5 ttt85 -77.69 -30.77 52.06 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.573 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.53 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -87.91 -61.43 1.72 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -172.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -125.31 -48.05 0.21 Allowed Glycine 0 N--CA 1.474 1.195 0 C-N-CA 122.951 0.31 . . . . 0.0 112.7 -169.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.476 ' HG3' HD21 ' A' ' 53' ' ' LEU . 40.2 ttp180 45.57 41.96 7.55 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.343 1.857 . . . . 0.0 114.541 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -174.16 88.52 0.06 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -174.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.516 ' HA2' ' SG ' ' A' ' 103' ' ' CYS . . . 83.75 12.75 76.91 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.785 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 m -83.75 118.93 24.23 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 124.634 1.173 . . . . 0.0 110.563 -169.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -125.98 158.92 34.05 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.084 0.468 . . . . 0.0 110.178 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.462 HD11 ' HB1' ' A' ' 23' ' ' ALA . 3.8 pp -153.7 164.94 37.44 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.731 166.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.42 HG22 HD13 ' A' ' 50' ' ' LEU . 97.7 t -119.27 148.64 22.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 170.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.445 ' NH2' ' HB3' ' A' ' 20' ' ' ARG . 43.7 ptt85 -153.6 -178.31 6.94 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -93.29 141.54 28.32 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 165.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.4 m -65.65 146.22 55.08 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 163.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -66.6 81.37 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -158.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.6 m 51.12 30.88 5.96 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.96 1.304 . . . . 0.0 112.654 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.1 m -72.46 -44.04 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.892 -168.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -174.01 9.32 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.441 0.697 . . . . 0.0 111.454 -169.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.77 19.19 60.16 Favored Glycine 0 N--CA 1.474 1.183 0 N-CA-C 112.141 -0.384 . . . . 0.0 112.141 -171.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.79 155.3 18.88 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.989 0.916 . . . . 0.0 111.681 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -106.55 158.85 16.62 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.023 0.929 . . . . 0.0 110.398 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.88 141.19 51.36 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.986 0.514 . . . . 0.0 110.136 169.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.598 HD22 HD21 ' A' ' 90' ' ' LEU . 51.9 tp -114.32 107.09 15.11 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.136 1.374 . . . . 0.0 107.495 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 42.5 t -104.04 114.37 28.57 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -175.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.7 t -120.61 133.14 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.025 0.93 . . . . 0.0 108.724 -175.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.476 HD21 ' HG3' ' A' ' 32' ' ' ARG . 12.3 tp -128.98 140.89 51.45 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.858 1.263 . . . . 0.0 109.283 -173.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -155.3 115.54 3.79 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 41.75 71.05 0.23 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.001 1.32 . . . . 0.0 113.892 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.9 mttt 59.31 23.4 11.83 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.407 1.083 . . . . 0.0 113.714 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -131.82 105.68 7.62 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.578 HG21 ' HG2' ' A' ' 24' ' ' GLU . 40.1 t -103.9 109.0 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.823 0.849 . . . . 0.0 109.053 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -103.02 123.33 46.41 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 171.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 36.8 m -120.01 141.9 49.29 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.046 0.939 . . . . 0.0 108.687 -172.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -124.39 100.44 6.68 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -172.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.5 mtp-105 -81.97 98.61 8.67 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.52 HG12 HG22 ' A' ' 73' ' ' VAL . 6.1 mt -75.45 110.51 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.362 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.0 mp -112.06 103.12 55.06 Favored Pre-proline 0 C--O 1.241 0.639 0 C-N-CA 124.887 1.275 . . . . 0.0 107.566 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -58.05 -57.88 0.98 Allowed 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.259 1.972 . . . . 0.0 110.705 170.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.7 t70 56.01 36.09 26.74 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 122.788 1.28 . . . . 0.0 109.825 173.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.07 178.0 28.06 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.939 -165.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -108.9 -13.37 14.76 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 118.589 1.195 . . . . 0.0 111.029 -175.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -65.47 -85.0 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.451 0.701 . . . . 0.0 110.914 -174.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -131.04 155.68 46.46 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.675 0.75 . . . . 0.0 111.777 175.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.48 110.93 17.07 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.063 1.745 . . . . 0.0 107.578 169.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.12 132.0 43.33 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.147 0.579 . . . . 0.0 110.586 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.52 HG22 HG12 ' A' ' 63' ' ' ILE . 39.8 t -99.38 112.92 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -177.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -90.65 94.56 9.75 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.106 0.563 . . . . 0.0 109.923 -169.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.684 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 65.4 p -65.8 -27.88 68.6 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.612 0.765 . . . . 0.0 112.433 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.8 t -142.07 -169.97 3.05 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.006 0.922 . . . . 0.0 109.796 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -54.45 -55.3 30.28 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.473 1.109 . . . . 0.0 112.386 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.29 44.05 0.19 Allowed Glycine 0 CA--C 1.505 -0.536 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.855 176.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.0 m -69.32 166.3 31.01 Favored Pre-proline 0 CA--C 1.557 1.217 0 C-N-CA 123.347 0.659 . . . . 0.0 111.364 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.45 53.22 1.31 Allowed 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 122.89 2.393 . . . . 0.0 112.652 167.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.509 HG22 ' H ' ' A' ' 82' ' ' ARG . 4.3 p -55.85 176.44 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 C-N-CA 125.42 1.488 . . . . 0.0 111.989 162.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.509 ' H ' HG22 ' A' ' 81' ' ' VAL . 42.4 mmm-85 -108.93 140.49 42.34 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -169.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -95.18 126.44 40.5 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -112.18 166.01 11.65 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.447 0.467 . . . . 0.0 109.876 -175.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -132.27 -4.92 3.41 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.767 0.827 . . . . 0.0 109.006 169.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.529 HG22 ' H ' ' A' ' 88' ' ' GLY . 87.6 m -141.73 136.07 30.41 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.362 1.065 . . . . 0.0 109.645 -172.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 78.7 mt -66.35 -28.26 68.52 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.908 0.883 . . . . 0.0 111.125 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.529 ' H ' HG22 ' A' ' 86' ' ' THR . . . -57.65 -46.74 91.82 Favored Glycine 0 N--CA 1.475 1.234 0 N-CA-C 114.401 0.52 . . . . 0.0 114.401 174.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -65.56 -36.1 82.79 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.548 0.739 . . . . 0.0 111.01 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.598 HD21 HD22 ' A' ' 50' ' ' LEU . 6.5 tt -59.91 -63.68 1.21 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.937 1.295 . . . . 0.0 110.403 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 31.6 mm -60.67 -43.64 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.209 1.004 . . . . 0.0 110.94 -175.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.09 -48.69 66.44 Favored Glycine 0 C--N 1.343 0.955 0 O-C-N 124.219 0.95 . . . . 0.0 113.482 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.2 tt -67.04 -59.67 3.27 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.481 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . 20.2 m-85 -71.69 -5.9 37.19 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -166.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.67 -16.31 25.6 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.048 0.539 . . . . 0.0 111.867 165.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -90.76 146.46 34.08 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 173.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -91.72 -168.19 0.23 Allowed 'Trans proline' 0 C--N 1.363 1.338 0 C-N-CA 122.916 2.411 . . . . 0.0 111.939 172.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.4 t30 52.62 62.39 2.71 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.845 1.258 . . . . 0.0 111.868 176.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -174.31 5.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.985 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.684 ' HA3' ' HB ' ' A' ' 75' ' ' THR . . . 130.97 -31.49 3.17 Favored Glycine 0 N--CA 1.473 1.121 0 N-CA-C 112.221 -0.352 . . . . 0.0 112.221 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' A' ' 94' ' ' TYR . 3.9 mm? -83.17 97.34 8.77 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.5 m -46.63 -32.83 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 126.079 1.752 . . . . 0.0 114.533 -175.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.516 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 24.6 p -130.46 3.07 4.62 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.021 0.528 . . . . 0.0 111.731 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.404 ' HA ' ' HB3' ' A' ' 101' ' ' LEU . . . 66.6 -179.99 0.21 Allowed 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.344 1.028 . . . . 0.0 110.444 -171.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 60.9 mt -90.36 83.16 5.91 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 168.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.3 tp -110.3 -63.03 1.43 Allowed 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.161 -171.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.32 115.51 63.73 Favored Pre-proline 0 N--CA 1.485 1.305 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.509 ' HB3' ' HB3' ' A' ' 13' ' ' TRP . 4.9 Cg_exo -71.14 -90.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 121.805 1.67 . . . . 0.0 110.049 173.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.53 HG13 ' HB1' ' A' ' 30' ' ' ALA . 78.6 t . . . . . 0 C--O 1.254 1.342 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 172.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 tpp . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.95 -42.14 3.13 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 115.313 0.885 . . . . 0.0 115.313 166.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -54.33 98.84 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.168 0.987 . . . . 0.0 113.267 -170.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -136.39 -67.16 0.52 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 170.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.1 t60 51.41 55.34 9.57 Favored 'General case' 0 C--N 1.363 1.177 0 C-N-CA 125.082 1.353 . . . . 0.0 111.0 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -150.04 129.91 13.36 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.139 0.976 . . . . 0.0 109.553 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -132.72 146.14 51.61 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.186 0.994 . . . . 0.0 108.813 172.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -62.87 87.31 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.946 0.899 . . . . 0.0 111.562 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.7 p -78.61 98.86 6.32 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.865 176.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -82.61 70.14 9.52 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 122.062 0.934 . . . . 0.0 110.84 -175.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 10.1 tpt -92.65 128.45 38.51 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.716 176.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.7 t -172.78 -141.53 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 124.129 0.971 . . . . 0.0 108.681 -176.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -70.68 -18.55 62.82 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.289 0.635 . . . . 0.0 110.033 172.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 76.2 t80 -85.54 130.42 34.58 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.129 0.572 . . . . 0.0 109.622 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -130.0 140.49 50.87 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -66.17 -53.53 36.35 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -169.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -155.67 72.34 0.79 Allowed 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 122.133 0.968 . . . . 0.0 111.44 175.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.71 HD22 HH21 ' A' ' 39' ' ' ARG . 8.7 tt -92.92 135.01 34.53 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 160.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.404 ' O ' HD23 ' A' ' 18' ' ' LEU . 48.1 t -66.97 146.47 54.34 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.776 0.831 . . . . 0.0 110.043 -173.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.47 ' NE ' ' H ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -64.84 -42.24 95.08 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.671 0.389 . . . . 0.0 110.956 -176.422 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.15 -51.2 67.22 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.56 0.744 . . . . 0.0 111.306 172.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.22 -29.3 70.4 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.659 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.433 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -69.59 -45.82 67.77 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.535 1.134 . . . . 0.0 111.893 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 43.9 mt-10 -56.73 -44.46 81.68 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.669 0.787 . . . . 0.0 110.898 175.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.28 -40.02 86.1 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.412 177.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.5 -42.41 92.12 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.315 1.046 . . . . 0.0 109.65 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.59 HD22 ' HB2' ' A' ' 35' ' ' SER . 93.7 mt -65.52 -43.64 89.4 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.511 0.724 . . . . 0.0 110.461 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.95 -34.91 70.43 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 124.066 0.854 . . . . 0.0 112.283 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -87.83 -43.06 12.12 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.85 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.86 -61.79 1.86 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -167.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.425 ' HA3' ' HB3' ' A' ' 35' ' ' SER . . . -95.29 -33.0 6.72 Favored Glycine 0 C--N 1.352 1.465 0 CA-C-O 121.277 0.376 . . . . 0.0 112.368 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 68.07 0.61 2.47 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 126.904 2.081 . . . . 0.0 114.405 175.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.2 t70 175.53 125.71 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.29 0.636 . . . . 0.0 109.381 -175.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.57 6.06 70.01 Favored Glycine 0 N--CA 1.477 1.417 0 O-C-N 123.285 0.366 . . . . 0.0 112.714 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.59 ' HB2' HD22 ' A' ' 27' ' ' LEU . 3.1 p -80.69 136.9 36.27 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.022 0.929 . . . . 0.0 109.639 -172.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.415 ' HB2' HG22 ' A' ' 52' ' ' VAL . 29.4 p90 -137.13 158.51 44.28 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.817 0.447 . . . . 0.0 110.577 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.447 HD11 ' HB3' ' A' ' 51' ' ' CYS . 1.2 pp -155.23 165.98 34.97 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.19 0.996 . . . . 0.0 109.729 174.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 89.2 t -132.64 130.54 59.48 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 173.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.71 HH21 HD22 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -121.59 179.16 4.55 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 169.859 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -92.18 140.24 29.82 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 171.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.8 m -71.89 162.65 29.14 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.305 1.042 . . . . 0.0 111.613 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.84 -29.91 8.8 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.142 0.577 . . . . 0.0 110.704 -178.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.8 p -89.63 -58.21 2.6 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 123.739 0.816 . . . . 0.0 110.425 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.5 t -86.68 106.06 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -175.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.8 117.63 7.19 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.957 0.903 . . . . 0.0 111.773 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.42 -0.07 74.02 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-O 119.856 -0.413 . . . . 0.0 113.365 176.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.04 151.64 20.96 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 117.455 0.628 . . . . 0.0 111.689 -177.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -110.82 130.19 55.65 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.875 0.87 . . . . 0.0 111.333 -175.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.419 ' HB3' ' HG2' ' A' ' 39' ' ' ARG . . . -100.51 114.48 28.12 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.904 0.882 . . . . 0.0 110.251 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.5 tp -106.24 108.49 20.02 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.447 ' HB3' HD11 ' A' ' 37' ' ' LEU . 43.3 t -111.39 124.49 52.36 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -177.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 36' ' ' PHE . 17.9 t -129.45 116.65 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.025 0.93 . . . . 0.0 109.675 -174.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.671 HD13 HG22 ' A' ' 58' ' ' VAL . 32.5 tp -86.34 142.83 28.2 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.058 0.943 . . . . 0.0 109.568 173.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -162.78 127.4 3.1 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.515 0.726 . . . . 0.0 109.719 167.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 47.35 62.78 2.25 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.5 1.52 . . . . 0.0 112.682 173.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.63 30.98 16.38 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.633 1.173 . . . . 0.0 111.949 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -141.52 105.93 4.84 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.265 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.671 HG22 HD13 ' A' ' 53' ' ' LEU . 2.7 t -92.98 122.8 44.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 172.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -114.98 140.29 49.15 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.9 p -111.76 136.58 50.83 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.842 0.857 . . . . 0.0 108.716 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -128.46 101.5 6.22 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -84.19 102.63 12.75 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.222 0.609 . . . . 0.0 109.825 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.1 mp -71.39 129.86 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.935 168.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.61 139.82 23.36 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 123.709 0.804 . . . . 0.0 109.533 171.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -83.11 111.51 1.9 Allowed 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.16 1.907 . . . . 0.0 111.129 169.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -69.43 -58.87 3.44 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.675 0.39 . . . . 0.0 110.185 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -96.74 33.04 5.98 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 119.543 -0.587 . . . . 0.0 112.548 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 69.49 -34.03 0.27 Allowed 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -89.11 -48.66 7.25 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.255 0.622 . . . . 0.0 111.094 -165.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -103.51 135.9 44.24 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp -106.68 151.1 25.54 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.557 ' HB2' ' HG2' ' A' ' 83' ' ' ARG . . . -138.93 134.23 32.92 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.163 -0.336 . . . . 0.0 111.481 -169.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.3 p -85.85 135.36 25.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 171.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -98.23 94.74 6.96 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.3 p -78.12 -63.84 1.3 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.407 0.683 . . . . 0.0 111.147 -170.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.538 ' HB3' HG22 ' A' ' 79' ' ' VAL . 41.3 t -177.37 140.15 0.27 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.916 0.886 . . . . 0.0 109.096 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -76.27 91.44 3.22 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 168.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.5 -27.15 0.42 Allowed Glycine 0 C--N 1.339 0.71 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -167.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 76' ' ' SER . 34.7 m -127.4 156.58 74.8 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 124.482 1.113 . . . . 0.0 108.449 174.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.12 136.57 61.34 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.525 2.15 . . . . 0.0 112.986 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 95.9 t -94.68 134.52 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.103 0.961 . . . . 0.0 108.589 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.4 tpt85 -113.78 130.9 56.39 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.68 0.792 . . . . 0.0 109.998 -176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.557 ' HG2' ' HB2' ' A' ' 72' ' ' ALA . 48.1 mtm105 -101.81 156.08 17.73 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.046 0.939 . . . . 0.0 108.83 173.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -137.52 160.85 37.98 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.729 0.812 . . . . 0.0 109.059 -172.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -88.99 -24.1 22.47 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 173.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 88' ' ' GLY . 33.2 m -154.6 154.48 33.09 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 124.289 1.036 . . . . 0.0 109.974 -175.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.8 mt -58.85 -32.28 69.29 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.407 1.083 . . . . 0.0 112.272 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.521 ' H ' HG22 ' A' ' 86' ' ' THR . . . -54.15 -38.72 61.93 Favored Glycine 0 N--CA 1.476 1.319 0 O-C-N 123.613 0.571 . . . . 0.0 114.08 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -66.78 -38.24 86.14 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.298 0.639 . . . . 0.0 110.437 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.9 tt -61.27 -57.58 11.77 Favored 'General case' 0 C--O 1.209 -1.068 0 O-C-N 124.088 0.867 . . . . 0.0 110.306 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 30.9 mm -55.83 -45.28 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 C-N-CA 123.171 0.588 . . . . 0.0 112.099 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.8 -52.23 49.95 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.854 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 61.2 tp -69.09 -43.62 74.18 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.897 0.879 . . . . 0.0 111.526 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.432 ' HB3' HD11 ' A' ' 101' ' ' LEU . 41.8 m-85 -86.69 9.35 19.06 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.547 1.139 . . . . 0.0 112.841 -175.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.88 2.01 2.94 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 157.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -102.82 126.77 31.71 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 124.135 0.974 . . . . 0.0 111.013 174.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -71.7 -178.03 2.84 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.99 2.46 . . . . 0.0 112.802 171.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.5 t30 55.55 28.58 12.03 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 125.049 1.34 . . . . 0.0 111.93 -177.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -141.95 23.76 2.04 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.168 0.587 . . . . 0.0 111.323 -172.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 122.43 -39.15 2.36 Favored Glycine 0 C--N 1.347 1.163 0 C-N-CA 123.018 0.342 . . . . 0.0 112.355 174.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.432 HD11 ' HB3' ' A' ' 94' ' ' TYR . 19.5 mt -90.56 126.57 35.98 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 122.837 0.455 . . . . 0.0 110.899 -174.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.6 m -24.48 -47.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 C-N-CA 126.944 2.098 . . . . 0.0 115.186 176.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.403 ' SG ' HD11 ' A' ' 106' ' ' LEU . 46.2 t -160.91 29.76 0.15 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.537 0.735 . . . . 0.0 109.343 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 69.92 -177.17 0.21 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.624 1.17 . . . . 0.0 112.211 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.4 mt -85.94 101.33 12.79 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.841 177.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.403 HD11 ' SG ' ' A' ' 103' ' ' CYS . 75.6 mt -99.03 -58.95 1.82 Allowed 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -173.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.4 mp -119.05 103.48 47.76 Favored Pre-proline 0 N--CA 1.5 2.031 0 CA-C-N 118.879 0.763 . . . . 0.0 111.001 -174.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.14 115.22 4.27 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.883 2.389 . . . . 0.0 112.439 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 C--O 1.251 1.143 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -176.943 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.4 ttm . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.08 61.94 0.93 Allowed Glycine 0 C--N 1.349 1.25 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 -70.48 85.88 0.62 Allowed 'General case' 0 CA--C 1.553 1.087 0 CA-C-O 121.411 0.624 . . . . 0.0 111.002 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -169.59 100.61 0.33 Allowed 'General case' 0 C--N 1.349 0.56 0 C-N-CA 124.131 0.972 . . . . 0.0 109.102 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -125.57 13.63 8.12 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.677 0.791 . . . . 0.0 110.784 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -96.65 104.91 16.94 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 173.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -139.99 74.46 1.47 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 172.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.7 t60 -99.94 113.08 25.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.804 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.4 p -110.88 156.17 21.55 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.89 0.876 . . . . 0.0 109.502 174.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -171.71 -40.78 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.554 0.742 . . . . 0.0 109.222 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.4 mpt? 60.89 -175.86 0.12 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.096 1.358 . . . . 0.0 112.031 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 p -168.8 160.67 10.58 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.815 0.446 . . . . 0.0 111.709 -173.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.512 ' HB2' ' HA ' ' A' ' 37' ' ' LEU . 4.3 p-90 -79.93 -18.57 50.14 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 170.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.445 ' HE2' ' HD3' ' A' ' 16' ' ' ARG . 37.3 t80 -80.82 97.35 7.32 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 18' ' ' LEU . 96.4 m-70 -98.04 119.42 36.65 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.511 0.724 . . . . 0.0 110.143 -175.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.445 ' HD3' ' HE2' ' A' ' 14' ' ' TYR . 21.1 mmm180 -92.26 -9.46 42.05 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.915 1.286 . . . . 0.0 111.748 -178.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -108.93 -9.42 15.13 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.55 0.74 . . . . 0.0 110.778 -174.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 15' ' ' HIS . 0.9 OUTLIER -113.27 131.07 56.06 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.317 1.047 . . . . 0.0 110.782 -166.686 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.5 p -88.92 -176.93 5.35 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.255 1.022 . . . . 0.0 111.128 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.649 ' HG3' HG21 ' A' ' 60' ' ' THR . 62.1 ttt180 -62.09 -50.38 72.15 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.997 0.919 . . . . 0.0 111.621 174.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.32 -43.99 92.62 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.125 0.57 . . . . 0.0 110.876 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.25 -30.12 70.97 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.86 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.4 -57.51 7.27 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.04 0.536 . . . . 0.0 109.882 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.42 ' HG2' HG11 ' A' ' 58' ' ' VAL . 36.5 mt-10 -53.45 -43.74 68.32 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.606 1.163 . . . . 0.0 111.674 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -67.29 -57.95 5.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.547 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.7 tt -61.86 -33.32 73.98 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.88 -174.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.488 HD22 ' HB2' ' A' ' 35' ' ' SER . 82.7 mt -67.68 -44.82 76.86 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.63 -27.58 69.04 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.71 0.804 . . . . 0.0 112.024 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -86.51 -48.97 7.92 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 122.997 0.519 . . . . 0.0 111.256 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.76 -59.2 2.87 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.598 0.759 . . . . 0.0 111.805 -170.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.53 ' HA3' ' HB3' ' A' ' 35' ' ' SER . . . -96.14 -46.35 2.63 Favored Glycine 0 C--N 1.346 1.084 0 O-C-N 123.044 0.215 . . . . 0.0 113.104 -175.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 50.48 26.04 2.2 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 125.842 1.657 . . . . 0.0 113.086 -175.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.0 t70 177.22 97.85 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -173.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.642 ' HA3' HD12 ' A' ' 106' ' ' LEU . . . 72.31 20.66 79.36 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-O 120.985 0.214 . . . . 0.0 113.332 174.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.53 ' HB3' ' HA3' ' A' ' 31' ' ' GLY . 5.7 p -81.59 124.08 29.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.961 0.904 . . . . 0.0 109.431 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -128.37 159.29 35.81 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.931 0.492 . . . . 0.0 110.016 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.512 ' HA ' ' HB2' ' A' ' 13' ' ' TRP . 4.1 pp -156.83 164.16 38.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.042 0.937 . . . . 0.0 109.842 169.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 47.3 t -122.81 154.34 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 173.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -155.77 -173.97 4.76 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.851 1.26 . . . . 0.0 108.803 -176.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -91.4 121.49 33.17 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 174.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.8 t -59.19 160.38 6.45 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 122.116 0.96 . . . . 0.0 113.271 -172.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.34 -29.64 4.11 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.209 1.804 . . . . 0.0 108.545 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.7 m -66.38 -38.71 88.16 Favored 'General case' 0 C--N 1.353 0.761 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.976 173.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.3 t -127.49 119.9 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.017 0.927 . . . . 0.0 108.76 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.45 134.07 51.73 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.435 0.694 . . . . 0.0 111.35 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.21 -1.82 88.06 Favored Glycine 0 C--N 1.348 1.214 0 O-C-N 123.176 0.298 . . . . 0.0 112.931 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -101.67 177.68 4.84 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.101 0.96 . . . . 0.0 111.615 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.601 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 44.7 m-85 -111.56 155.52 23.19 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.683 0.793 . . . . 0.0 109.328 175.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.66 142.94 50.63 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.821 0.848 . . . . 0.0 110.147 174.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.507 ' HB2' HD11 ' A' ' 63' ' ' ILE . 26.6 tp -117.09 113.48 22.36 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 42.2 t -103.99 118.85 37.66 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.8 t -125.28 137.09 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -176.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.531 HD13 HG22 ' A' ' 58' ' ' VAL . 27.0 tp -111.9 137.39 49.93 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.879 0.871 . . . . 0.0 110.216 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.547 ' HB2' ' HB2' ' A' ' 103' ' ' CYS . 88.8 t80 -142.0 103.42 4.31 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.395 1.078 . . . . 0.0 108.354 173.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 43.5 70.95 0.27 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.133 1.373 . . . . 0.0 113.212 172.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 79.9 tttt 55.68 38.23 29.87 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 124.891 1.276 . . . . 0.0 111.938 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -141.82 102.92 4.25 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 170.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.531 HG22 HD13 ' A' ' 53' ' ' LEU . 17.2 t -102.51 129.51 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -119.15 147.18 44.48 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.172 0.589 . . . . 0.0 109.578 170.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.649 HG21 ' HG3' ' A' ' 20' ' ' ARG . 17.7 p -117.37 132.82 56.51 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -123.54 107.03 11.1 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -171.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.574 ' HD3' ' H ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -59.83 155.35 16.42 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 171.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 77.4 mt -146.86 111.74 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 102.742 -3.058 . . . . 0.0 102.742 -162.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.1 mp -91.54 113.68 59.39 Favored Pre-proline 0 N--CA 1.468 0.462 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -165.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.84 -34.17 82.92 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.409 2.739 . . . . 0.0 111.392 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.8 t70 58.55 93.91 0.03 OUTLIER 'General case' 0 C--N 1.364 1.224 0 C-N-CA 125.101 1.361 . . . . 0.0 111.578 166.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -54.95 80.22 0.01 OUTLIER Glycine 0 C--N 1.35 1.322 0 N-CA-C 115.668 1.027 . . . . 0.0 115.668 -174.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -153.07 -85.69 0.07 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 170.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -160.42 6.04 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 174.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -131.09 147.6 52.64 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.202 -0.937 . . . . 0.0 112.513 -174.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.508 HD23 ' H ' ' A' ' 71' ' ' LEU . 2.5 pt? -120.73 129.8 53.78 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.947 1.299 . . . . 0.0 109.015 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.36 149.1 39.9 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.218 0.607 . . . . 0.0 110.271 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.7 t -89.23 130.11 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -108.13 130.81 55.09 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -171.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.9 t -137.47 -178.86 5.41 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.387 -170.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.2 t -69.8 6.22 1.25 Allowed 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -167.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 71.46 139.33 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.852 1.261 . . . . 0.0 111.127 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 113.73 -61.12 0.35 Allowed Glycine 0 C--N 1.342 0.863 0 N-CA-C 106.351 -2.7 . . . . 0.0 106.351 -175.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.476 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 4.3 m -63.63 116.47 26.48 Favored Pre-proline 0 CA--C 1.557 1.213 0 CA-C-N 113.891 -1.154 . . . . 0.0 109.327 156.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 4.7 Cg_exo -75.04 99.07 1.22 Allowed 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.362 2.708 . . . . 0.0 114.356 -168.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 75.4 t -35.8 120.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 123.936 0.895 . . . . 0.0 112.893 158.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 27.9 mmt85 -112.62 142.36 45.3 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 124.345 1.058 . . . . 0.0 108.869 176.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.8 ptt85 -97.81 142.59 29.38 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.544 0.738 . . . . 0.0 111.139 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.481 ' HE2' ' HE2' ' A' ' 94' ' ' TYR . 56.1 m-85 -133.97 163.26 29.93 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.679 1.192 . . . . 0.0 108.679 -176.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -140.15 62.89 1.49 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.095 0.474 . . . . 0.0 109.723 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.457 HG23 ' H ' ' A' ' 89' ' ' GLU . 7.6 t 149.76 133.75 0.0 OUTLIER 'General case' 0 C--N 1.362 1.151 0 C-N-CA 127.301 2.24 . . . . 0.0 106.969 -172.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.86 -29.46 68.31 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.698 0.799 . . . . 0.0 111.941 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -51.2 -46.57 51.23 Favored Glycine 0 C--N 1.353 1.477 0 O-C-N 123.872 0.732 . . . . 0.0 114.473 175.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.457 ' H ' HG23 ' A' ' 86' ' ' THR . 49.3 mm-40 -75.82 -29.85 58.81 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.637 0.375 . . . . 0.0 111.602 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.62 -63.29 1.1 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.438 0.695 . . . . 0.0 109.218 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.426 ' HA ' HD12 ' A' ' 105' ' ' LEU . 36.1 mm -60.28 -39.39 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.129 0.972 . . . . 0.0 111.177 178.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.84 -47.26 87.59 Favored Glycine 0 C--N 1.348 1.204 0 O-C-N 124.212 0.945 . . . . 0.0 113.753 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 34.8 tp -77.79 -43.36 30.89 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.58 0.352 . . . . 0.0 111.287 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.527 ' HB3' HD11 ' A' ' 101' ' ' LEU . 31.9 m-85 -80.74 -1.56 43.3 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -173.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.26 -8.87 56.52 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.174 0.511 . . . . 0.0 110.596 165.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.71 119.24 52.17 Favored Pre-proline 0 CA--C 1.56 1.346 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 175.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -72.69 -166.47 0.28 Allowed 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.128 2.552 . . . . 0.0 114.281 -171.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 56.98 44.56 22.69 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.921 1.288 . . . . 0.0 111.707 -175.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -131.95 8.46 4.44 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.114 -177.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 119.37 -19.6 9.86 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 112.214 -0.355 . . . . 0.0 112.214 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.527 HD11 ' HB3' ' A' ' 94' ' ' TYR . 64.8 mt -79.46 135.78 36.75 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.437 0.695 . . . . 0.0 111.869 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.2 m -59.74 -33.28 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.85 0.86 . . . . 0.0 110.617 171.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 53.9 t -144.55 151.02 38.48 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.401 1.08 . . . . 0.0 109.224 175.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.43 153.28 44.06 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 91' ' ' ILE . 69.5 mt -69.59 95.72 0.87 Allowed 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 120.801 0.334 . . . . 0.0 110.176 -178.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.642 HD12 ' HA3' ' A' ' 34' ' ' GLY . 84.0 mt -100.67 -67.14 0.87 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.309 1.044 . . . . 0.0 110.938 -176.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.431 HD22 HG22 ' A' ' 109' ' ' VAL . 2.0 tt -106.37 113.75 62.93 Favored Pre-proline 0 N--CA 1.481 1.108 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -166.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.22 -37.05 76.97 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 123.496 2.797 . . . . 0.0 113.128 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.431 HG22 HD22 ' A' ' 107' ' ' LEU . 29.4 t . . . . . 0 C--O 1.257 1.464 0 C-N-CA 124.699 1.2 . . . . 0.0 110.252 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -117.78 76.9 0.29 Allowed Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.4 m170 -110.23 149.36 30.25 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.758 0.823 . . . . 0.0 110.527 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.7 p-80 -157.93 -73.47 0.09 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.828 0.851 . . . . 0.0 109.528 172.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 47.0 t60 39.89 78.8 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 125.637 1.575 . . . . 0.0 113.906 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -137.52 146.31 44.0 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.345 0.658 . . . . 0.0 109.803 176.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -105.48 62.79 0.68 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 172.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -92.13 143.72 26.16 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.567 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.3 t 69.49 121.19 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.961 1.304 . . . . 0.0 111.863 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 59.2 m80 -137.16 101.98 4.7 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.963 0.905 . . . . 0.0 108.715 174.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.2 ttt -74.4 95.02 2.64 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.0 t -169.59 163.18 10.15 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.936 0.894 . . . . 0.0 109.523 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -74.9 -27.18 60.12 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.45 168.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -77.42 121.16 23.42 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.07 0.462 . . . . 0.0 109.803 -174.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.423 ' O ' ' HA ' ' A' ' 39' ' ' ARG . 91.4 m-70 -138.86 131.71 29.32 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 175.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.2 mtm180 -63.59 139.92 58.82 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 168.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.404 ' H ' ' HB3' ' A' ' 40' ' ' ASP . 27.2 t70 -26.25 83.16 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 116.635 2.087 . . . . 0.0 116.635 -166.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 pp -66.17 -19.0 65.7 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.107 165.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.4 t 100.24 138.87 0.01 OUTLIER 'General case' 0 C--N 1.372 1.548 0 C-N-CA 127.489 2.315 . . . . 0.0 110.198 173.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -63.47 -45.02 92.69 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.655 0.782 . . . . 0.0 112.156 -176.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.17 -49.96 65.59 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.142 0.577 . . . . 0.0 110.67 173.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.83 -24.2 63.42 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.68 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.467 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -68.44 -58.47 4.29 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.814 0.845 . . . . 0.0 110.887 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.462 ' HG2' HG11 ' A' ' 58' ' ' VAL . 45.8 mt-10 -53.38 -38.25 63.18 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.02 0.928 . . . . 0.0 111.706 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -71.23 -44.9 64.44 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.078 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 33.4 tp -59.98 -43.42 95.15 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.061 0.944 . . . . 0.0 111.068 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 23' ' ' ALA . 94.6 mt -65.85 -49.88 66.59 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.523 0.729 . . . . 0.0 109.235 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.21 -34.24 73.38 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.066 0.946 . . . . 0.0 112.388 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -82.79 -50.49 8.61 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.244 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.48 -61.85 1.87 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.318 -171.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.82 -60.02 0.56 Allowed Glycine 0 C--N 1.352 1.467 0 CA-C-N 117.902 0.319 . . . . 0.0 113.548 -171.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 50.09 40.7 22.21 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.943 1.697 . . . . 0.0 113.817 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -170.31 83.83 0.11 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -171.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.81 22.9 78.29 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -177.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.2 m -87.0 119.82 27.61 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.017 0.927 . . . . 0.0 109.073 -171.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.498 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 19.2 p90 -131.89 158.56 41.04 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.011 0.434 . . . . 0.0 110.695 -175.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.467 HD11 ' HB1' ' A' ' 23' ' ' ALA . 4.1 pp -156.86 165.28 36.64 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.256 170.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.3 t -121.58 129.33 75.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 15' ' ' HIS . 3.7 ptm180 -125.57 163.36 22.9 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.252 1.021 . . . . 0.0 109.365 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.404 ' HB3' ' H ' ' A' ' 17' ' ' ASP . 23.1 t70 -91.78 120.07 32.17 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.3 m -91.43 100.88 13.57 Favored 'General case' 0 C--O 1.247 0.953 0 C-N-CA 122.759 0.424 . . . . 0.0 110.565 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -62.64 94.92 0.07 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.47 0.652 . . . . 0.0 110.394 163.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.3 t -151.85 -55.88 0.14 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.9 m -125.66 149.2 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 165.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 8.79 -80.0 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 127.249 2.22 . . . . 0.0 115.334 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.18 79.88 0.21 Allowed Glycine 0 C--N 1.351 1.382 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.31 165.95 14.64 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 171.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -117.22 163.73 15.86 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.104 0.561 . . . . 0.0 111.031 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.62 146.75 46.4 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.052 0.941 . . . . 0.0 110.252 168.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.51 HD22 HD21 ' A' ' 90' ' ' LEU . 46.3 tp -116.7 114.91 24.69 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 176.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 61.0 m -101.05 116.26 32.43 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.4 t -119.17 124.07 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.418 ' HB2' HG22 ' A' ' 58' ' ' VAL . 23.5 tp -119.54 145.16 46.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.021 0.928 . . . . 0.0 110.335 -177.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.416 ' H ' HD12 ' A' ' 53' ' ' LEU . 25.1 t80 -154.74 126.14 7.37 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 172.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 35.79 73.71 0.08 Allowed 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 78.6 tttt 52.26 35.85 18.02 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 125.086 1.355 . . . . 0.0 113.768 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -143.58 104.39 4.21 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 121.759 -0.588 . . . . 0.0 110.49 165.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.462 HG11 ' HG2' ' A' ' 24' ' ' GLU . 20.1 t -93.05 129.25 43.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 172.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -118.24 133.37 55.95 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 168.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.8 m -120.99 141.99 50.2 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -174.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -128.67 99.7 5.45 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -170.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -76.95 103.57 6.96 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.514 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.0 mp -67.87 108.19 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.228 172.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.3 tp -110.1 108.95 59.04 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -174.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.514 ' HB2' ' HG2' ' A' ' 68' ' ' GLU . 14.5 Cg_exo -69.88 -57.39 0.12 Allowed 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.555 2.17 . . . . 0.0 112.439 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.8 t70 80.49 -70.39 0.09 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.965 1.306 . . . . 0.0 109.406 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.37 -38.35 80.66 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 168.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.514 ' HG2' ' HB2' ' A' ' 65' ' ' PRO . 48.7 mt-10 84.14 24.66 0.11 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.283 1.433 . . . . 0.0 113.304 164.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -103.82 -37.42 7.45 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 164.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -116.49 134.73 54.52 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.106 0.962 . . . . 0.0 109.256 170.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -105.71 111.92 24.79 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.965 0.906 . . . . 0.0 109.005 175.661 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . . . -99.01 132.42 44.33 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.92 0.488 . . . . 0.0 110.988 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.514 HG21 ' HG ' ' A' ' 90' ' ' LEU . 11.2 t -87.24 118.27 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.163 176.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -81.31 92.09 6.32 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.0 m -72.23 -42.85 65.24 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.794 -175.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.503 ' HB3' HG22 ' A' ' 79' ' ' VAL . 48.1 t 173.98 141.94 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.385 1.474 . . . . 0.0 109.019 169.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -74.63 86.82 2.14 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 168.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.95 -22.85 0.31 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -167.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.503 HG22 ' HB3' ' A' ' 76' ' ' SER . 32.6 m -128.31 157.84 73.25 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 124.033 0.933 . . . . 0.0 109.066 175.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.71 126.62 21.64 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.268 2.645 . . . . 0.0 113.312 172.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 73' ' ' VAL . 54.6 t -101.52 134.76 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.169 1.387 . . . . 0.0 108.521 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -111.5 137.77 48.89 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.336 0.654 . . . . 0.0 110.901 -172.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 48.4 ptt85 -96.5 150.44 20.62 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.805 0.842 . . . . 0.0 108.856 173.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -138.72 164.57 29.22 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.499 0.72 . . . . 0.0 109.442 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -111.63 -13.43 13.78 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.187 0.595 . . . . 0.0 110.142 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.648 HG22 ' H ' ' A' ' 88' ' ' GLY . 59.6 m -148.7 147.1 28.49 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.511 0.724 . . . . 0.0 109.214 -174.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.33 -28.68 69.87 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.179 0.592 . . . . 0.0 111.178 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.648 ' H ' HG22 ' A' ' 86' ' ' THR . . . -63.0 -36.34 93.33 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 122.987 0.327 . . . . 0.0 113.138 173.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.47 ' HG2' ' HB ' ' A' ' 86' ' ' THR . 33.1 mm-40 -62.07 -47.03 86.47 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.691 0.797 . . . . 0.0 110.22 175.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.514 ' HG ' HG21 ' A' ' 73' ' ' VAL . 4.8 tt -50.48 -61.55 2.12 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.25 1.42 . . . . 0.0 109.932 173.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 47.1 mm -60.99 -27.48 41.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.448 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.09 -60.58 8.77 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 123.634 0.584 . . . . 0.0 113.48 175.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.1 mt -74.46 -32.7 62.69 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -82.19 -21.74 36.32 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.843 0.457 . . . . 0.0 112.176 -172.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.96 -17.28 63.11 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 168.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -132.45 69.3 79.94 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 124.651 1.18 . . . . 0.0 108.696 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.44 -81.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.233 1.955 . . . . 0.0 113.839 -168.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 90.08 -90.45 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.48 1.912 . . . . 0.0 106.821 -170.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -79.93 144.05 33.68 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 122.916 0.486 . . . . 0.0 111.912 170.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.82 -59.13 0.37 Allowed Glycine 0 C--N 1.35 1.315 0 C-N-CA 123.391 0.519 . . . . 0.0 113.176 166.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 24.7 mt -82.13 164.88 21.01 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.5 m -84.02 -24.37 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 CA-C-N 114.673 -1.148 . . . . 0.0 109.943 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 52.2 t -164.92 167.53 18.52 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 125.12 1.368 . . . . 0.0 108.745 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -77.36 170.68 16.12 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 120.93 0.395 . . . . 0.0 109.958 172.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.7 mt -81.53 97.46 7.83 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 175.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.9 mp -92.6 -57.93 2.52 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.017 0.927 . . . . 0.0 110.478 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 61.7 tp -131.09 107.06 14.96 Favored Pre-proline 0 N--CA 1.479 1.02 0 C-N-CA 123.379 0.671 . . . . 0.0 110.974 -165.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.99 124.12 10.3 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.368 2.045 . . . . 0.0 110.301 170.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 32.7 t . . . . . 0 CA--C 1.552 1.031 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -172.032 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.501 0.191 . . . . 0.0 110.65 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.09 70.74 1.12 Allowed Glycine 0 C--N 1.349 1.252 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.899 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -149.87 119.19 6.84 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.005 0.522 . . . . 0.0 109.77 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -158.7 113.6 2.54 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.098 0.559 . . . . 0.0 110.581 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -127.2 171.04 11.78 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.501 1.12 . . . . 0.0 108.907 166.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -164.1 102.1 0.87 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.309 0.643 . . . . 0.0 109.66 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -131.0 53.34 1.99 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.875 0.87 . . . . 0.0 108.729 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -86.22 -66.8 0.86 Allowed 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.862 -172.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 p -150.77 88.23 1.47 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.382 0.673 . . . . 0.0 110.762 -173.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 42.4 m170 -132.2 103.53 6.29 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.993 0.917 . . . . 0.0 109.971 177.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 56.9 ttp -120.65 -9.21 9.4 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.076 0.95 . . . . 0.0 109.461 170.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.9 p -72.47 166.3 22.88 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 123.474 0.709 . . . . 0.0 111.672 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.522 ' HB3' ' HB3' ' A' ' 108' ' ' PRO . 1.9 p-90 -86.3 10.4 14.93 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.889 0.876 . . . . 0.0 112.761 -176.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.421 ' HA ' ' HB ' ' A' ' 38' ' ' VAL . 17.8 t80 -118.03 134.82 54.62 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -174.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -137.18 171.89 13.82 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.739 0.816 . . . . 0.0 110.276 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.4 171.99 16.64 Favored 'General case' 0 C--O 1.245 0.817 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 164.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 74.55 3.95 4.35 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.677 1.191 . . . . 0.0 110.209 -172.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.3 tp -105.98 120.52 41.97 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 125.956 1.702 . . . . 0.0 107.999 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.4 m -82.49 170.15 15.57 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.524 0.73 . . . . 0.0 110.41 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.513 HH11 ' HG2' ' A' ' 24' ' ' GLU . 4.7 tmm_? -58.97 -55.88 29.48 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.408 0.683 . . . . 0.0 110.764 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.81 -44.01 73.43 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.121 0.888 . . . . 0.0 111.084 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.02 -36.06 82.77 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.521 0.729 . . . . 0.0 112.185 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.548 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -65.22 -56.5 12.46 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.824 0.85 . . . . 0.0 111.608 -176.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.513 ' HG2' HH11 ' A' ' 20' ' ' ARG . 0.0 OUTLIER -69.12 -24.64 64.13 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.879 -179.171 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 31.8 mt-10 -64.86 -55.66 18.11 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 169.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.12 -23.49 47.5 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.494 0.717 . . . . 0.0 112.828 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.9 mt -71.86 -52.79 15.63 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 168.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.98 -21.48 50.83 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -168.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 30.5 mmt180 -74.42 -42.25 59.49 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 118.246 0.475 . . . . 0.0 110.677 176.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.53 -53.45 4.8 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.945 -174.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.27 -159.59 8.41 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.974 -163.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 175.49 138.89 0.05 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.274 1.029 . . . . 0.0 110.493 -171.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.554 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 62.6 m-20 96.67 87.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.207 1.403 . . . . 0.0 109.184 159.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.24 16.7 73.55 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.708 -173.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 m -82.49 123.43 29.16 Favored 'General case' 0 C--N 1.346 0.456 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.448 ' CE1' ' HB3' ' A' ' 105' ' ' LEU . 30.9 p90 -131.7 159.22 39.02 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.41 0.624 . . . . 0.0 111.345 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.548 HD11 ' HB1' ' A' ' 23' ' ' ALA . 3.3 pp -150.63 159.99 44.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.165 165.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.421 ' HB ' ' HA ' ' A' ' 14' ' ' TYR . 46.9 t -116.75 150.54 18.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 175.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.501 HH22 ' HG2' ' A' ' 42' ' ' GLU . 20.6 ptt85 -146.59 -179.61 6.89 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -81.64 126.47 31.8 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 167.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 93.7 p -73.12 163.54 27.99 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.752 0.421 . . . . 0.0 110.703 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.501 ' HG2' HH22 ' A' ' 39' ' ' ARG . 10.8 pt-20 -124.61 -16.27 6.31 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.445 0.698 . . . . 0.0 110.6 -177.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.0 m -68.46 -30.17 68.97 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.884 0.874 . . . . 0.0 111.057 172.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.492 HG13 ' HB3' ' A' ' 47' ' ' ALA . 1.8 p -145.99 117.5 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 124.192 0.997 . . . . 0.0 109.683 -175.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.03 132.63 49.73 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.447 1.099 . . . . 0.0 112.056 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.84 11.94 80.66 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.347 0.404 . . . . 0.0 113.708 177.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.492 ' HB3' HG13 ' A' ' 44' ' ' VAL . . . -118.59 178.06 4.6 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.739 0.816 . . . . 0.0 111.717 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.474 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 32.9 m-85 -114.7 166.78 11.38 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.592 0.757 . . . . 0.0 111.286 -176.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.42 145.61 41.17 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.012 0.925 . . . . 0.0 110.233 169.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.491 ' HB2' HD11 ' A' ' 63' ' ' ILE . 51.7 tp -121.5 114.3 21.04 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.99 1.316 . . . . 0.0 108.33 -176.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 36.2 t -108.68 122.12 46.45 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.276 1.03 . . . . 0.0 108.62 -174.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.2 t -129.54 115.61 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 123.452 0.701 . . . . 0.0 110.366 -171.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.432 HD13 HG22 ' A' ' 58' ' ' VAL . 17.2 tp -94.83 136.89 34.6 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.564 1.146 . . . . 0.0 110.132 177.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 60.2 t80 -163.02 122.5 2.19 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.313 1.045 . . . . 0.0 109.206 175.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 40.58 61.12 1.71 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.327 1.851 . . . . 0.0 113.6 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 62.41 30.08 17.27 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.57 1.148 . . . . 0.0 113.042 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -138.33 106.88 5.85 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.236 0.614 . . . . 0.0 109.548 177.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.432 HG22 HD13 ' A' ' 53' ' ' LEU . 18.3 t -101.66 114.64 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -105.79 126.3 52.01 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.0 m -113.02 136.02 53.15 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -127.99 110.35 12.44 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.874 0.87 . . . . 0.0 109.107 -171.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.508 ' HD2' ' H ' ' A' ' 62' ' ' ARG . 0.1 OUTLIER -59.55 157.0 12.27 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 169.446 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.491 HD11 ' HB2' ' A' ' 50' ' ' LEU . 90.7 mt -146.19 102.66 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 103.686 -2.709 . . . . 0.0 103.686 -162.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.7 mp -114.97 140.65 25.81 Favored Pre-proline 0 N--CA 1.475 0.804 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -166.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 33.6 Cg_exo -58.58 -70.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 121.915 1.743 . . . . 0.0 109.274 164.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.0 t70 58.53 15.94 3.91 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.133 1.373 . . . . 0.0 112.639 167.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.38 137.38 3.77 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -34.08 -45.76 0.22 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 -165.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -113.21 -16.25 12.59 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -164.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.414 ' HB2' ' HB2' ' A' ' 83' ' ' ARG . 44.4 p90 -125.98 160.88 28.85 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.967 -0.458 . . . . 0.0 111.74 -167.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 3.9 pp -121.73 118.36 28.9 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.525 1.53 . . . . 0.0 107.144 166.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -111.95 148.48 33.65 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.735 0.779 . . . . 0.0 110.011 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.8 t -122.85 131.32 73.48 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -78.65 94.55 5.07 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.471 HG22 ' HA3' ' A' ' 100' ' ' GLY . 2.0 m -70.78 -63.06 1.17 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.059 -176.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.459 ' HB2' HG22 ' A' ' 79' ' ' VAL . 73.5 m -163.19 113.66 1.39 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.248 1.419 . . . . 0.0 107.62 170.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -68.62 97.41 0.79 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 170.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.16 -22.7 0.87 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -163.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.459 HG22 ' HB2' ' A' ' 76' ' ' SER . 22.5 m -129.84 153.21 80.87 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 125.375 1.47 . . . . 0.0 107.075 170.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -54.47 124.69 16.73 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.386 2.057 . . . . 0.0 112.8 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.6 t -86.09 140.32 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -102.11 136.21 42.35 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.031 0.533 . . . . 0.0 109.908 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.414 ' HB2' ' HB2' ' A' ' 70' ' ' PHE . 14.6 ptp180 -87.35 138.76 31.21 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 163.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -119.7 143.25 47.86 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.747 0.819 . . . . 0.0 109.277 176.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -84.66 -22.24 29.93 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.091 0.472 . . . . 0.0 110.43 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.677 ' HB ' ' HG2' ' A' ' 89' ' ' GLU . 51.0 m -141.79 149.01 39.83 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.74 0.816 . . . . 0.0 109.767 -177.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.24 -30.73 71.64 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.596 0.759 . . . . 0.0 109.525 176.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.66 ' H ' HG22 ' A' ' 86' ' ' THR . . . -53.92 -41.79 68.57 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-N 116.099 -0.501 . . . . 0.0 113.582 169.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.677 ' HG2' ' HB ' ' A' ' 86' ' ' THR . 31.0 mm-40 -71.45 -32.23 68.09 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.273 0.629 . . . . 0.0 110.7 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 46.5 tp -59.04 -59.25 5.77 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.318 0.647 . . . . 0.0 111.011 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 51.6 mm -62.25 -37.16 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.999 0.919 . . . . 0.0 111.004 -176.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.13 -51.73 53.91 Favored Glycine 0 CA--C 1.535 1.331 0 O-C-N 124.153 0.908 . . . . 0.0 113.292 174.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.0 mt -78.99 -23.17 44.6 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.091 0.556 . . . . 0.0 112.216 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -83.33 -18.31 39.39 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.03 -35.15 76.29 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.527 0.331 . . . . 0.0 110.539 170.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -127.0 76.42 76.0 Favored Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 124.371 1.068 . . . . 0.0 108.602 175.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -92.49 -66.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 123.363 2.708 . . . . 0.0 114.421 -169.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 59.66 55.84 3.85 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 124.845 1.258 . . . . 0.0 111.266 -173.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 160.45 97.87 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 126.734 2.014 . . . . 0.0 109.706 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.471 ' HA3' HG22 ' A' ' 75' ' ' THR . . . 104.33 -37.35 3.82 Favored Glycine 0 C--N 1.355 1.617 0 N-CA-C 113.758 0.263 . . . . 0.0 113.758 164.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -76.52 122.45 24.59 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.841 0.456 . . . . 0.0 110.829 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.2 m -52.73 -32.45 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 125.544 1.537 . . . . 0.0 114.19 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 36.4 t -153.54 3.31 0.28 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.108 0.563 . . . . 0.0 111.19 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 76.04 177.37 0.19 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.902 1.281 . . . . 0.0 110.669 -167.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.448 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 26.7 mt -93.05 103.39 15.7 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.51 -53.35 6.04 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.562 0.745 . . . . 0.0 111.03 -176.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.22 137.32 9.86 Favored Pre-proline 0 N--CA 1.483 1.222 0 C-N-CA 122.167 0.187 . . . . 0.0 111.199 -175.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.522 ' HB3' ' HB3' ' A' ' 13' ' ' TRP . 97.1 Cg_endo -78.79 137.08 13.9 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.333 2.022 . . . . 0.0 111.875 171.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 57.0 t . . . . . 0 CA--C 1.547 0.857 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.293 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 87.25 129.79 2.9 Favored Glycine 0 C--N 1.349 1.259 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -173.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -74.22 -25.43 59.66 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.82 0.448 . . . . 0.0 110.443 177.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 43.1 t60 63.81 15.83 9.35 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 125.299 1.44 . . . . 0.0 112.182 172.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -107.31 27.18 9.33 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -66.52 112.21 3.99 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 124.155 0.982 . . . . 0.0 110.504 -174.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -136.29 64.4 1.56 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.136 0.974 . . . . 0.0 108.445 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -141.81 119.06 11.42 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.762 0.825 . . . . 0.0 110.239 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 75.6 p -134.53 -14.84 2.18 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.342 1.057 . . . . 0.0 111.164 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.3 m170 65.6 107.68 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.487 1.515 . . . . 0.0 111.721 -176.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 43.2 ttm -95.54 21.65 8.0 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.793 0.806 . . . . 0.0 110.631 -177.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.6 p -75.14 -165.88 0.44 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 163.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -84.77 0.87 49.11 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.056 -1.027 . . . . 0.0 110.435 171.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -110.91 111.53 22.73 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -119.03 115.0 23.39 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 176.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -39.71 -49.31 2.26 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 125.565 1.546 . . . . 0.0 113.722 -172.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -156.96 70.55 0.64 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-O 122.312 1.053 . . . . 0.0 108.578 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 21.9 tp -64.77 -32.18 73.74 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 113.658 -1.61 . . . . 0.0 109.464 165.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.0 t 88.31 141.82 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 126.014 1.726 . . . . 0.0 107.944 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -60.83 -43.02 98.84 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.213 0.605 . . . . 0.0 112.079 -168.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.83 -48.01 73.09 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.507 0.723 . . . . 0.0 111.72 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -72.44 -22.58 61.07 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.316 178.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.476 ' O ' ' HG ' ' A' ' 27' ' ' LEU . . . -67.67 -49.83 60.87 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.594 ' HG3' HG21 ' A' ' 58' ' ' VAL . 34.8 tt0 -54.53 -41.24 69.48 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 124.885 1.366 . . . . 0.0 111.296 175.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.0 -50.6 47.39 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.437 -177.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.84 -33.98 73.87 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.091 0.957 . . . . 0.0 111.881 176.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 23' ' ' ALA . 75.4 mt -64.73 -52.84 54.94 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.1 0.56 . . . . 0.0 109.683 175.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.29 -42.47 98.71 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.17 0.988 . . . . 0.0 111.947 -176.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -69.33 -41.33 76.82 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.888 -175.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.35 -62.82 1.39 Allowed 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.02 -38.46 2.89 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 113.886 0.314 . . . . 0.0 113.886 -166.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.84 12.76 0.12 Allowed 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 128.011 2.524 . . . . 0.0 116.28 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 4.5 m-20 -174.37 118.51 0.23 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -166.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.429 ' HA2' ' SG ' ' A' ' 103' ' ' CYS . . . 63.16 11.02 37.01 Favored Glycine 0 C--N 1.352 1.44 0 N-CA-C 113.906 0.322 . . . . 0.0 113.906 -177.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.9 m -83.69 123.68 30.07 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.142 0.977 . . . . 0.0 110.039 -168.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -135.73 156.38 48.92 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 120.767 0.318 . . . . 0.0 111.439 -176.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.432 HD11 ' HB1' ' A' ' 23' ' ' ALA . 4.4 pp -159.9 158.74 31.41 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 124.709 1.255 . . . . 0.0 109.673 169.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.44 HG22 HD13 ' A' ' 50' ' ' LEU . 21.9 t -114.05 150.65 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.451 HH22 ' HB2' ' A' ' 42' ' ' GLU . 1.7 ptm180 -148.0 177.13 9.61 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.264 1.025 . . . . 0.0 109.207 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -84.4 129.28 34.88 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.3 t -61.18 142.38 56.79 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.48 0.712 . . . . 0.0 112.108 -174.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.451 ' HB2' HH22 ' A' ' 39' ' ' ARG . 32.2 tt0 -107.03 0.24 23.48 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.984 178.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.2 t -104.97 -41.72 5.52 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.207 1.003 . . . . 0.0 110.069 -177.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.5 HG21 HD21 ' A' ' 64' ' ' LEU . 44.7 t -128.11 115.18 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.902 0.881 . . . . 0.0 109.528 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.22 124.63 24.6 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.929 0.891 . . . . 0.0 110.817 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.36 12.06 65.75 Favored Glycine 0 C--N 1.344 0.979 0 O-C-N 123.345 0.403 . . . . 0.0 112.746 -174.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.32 177.0 5.07 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.794 0.838 . . . . 0.0 111.168 172.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.422 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 70.4 m-85 -124.21 166.83 15.16 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.832 1.253 . . . . 0.0 110.254 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.9 147.79 48.31 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.358 1.063 . . . . 0.0 109.526 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.561 ' HB2' HD11 ' A' ' 63' ' ' ILE . 50.2 tp -123.99 123.92 41.45 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.062 1.345 . . . . 0.0 107.51 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 37.1 t -112.29 123.85 51.17 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.9 t -128.73 143.7 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.545 HD13 HG22 ' A' ' 58' ' ' VAL . 48.9 tp -130.3 144.71 51.54 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.113 0.965 . . . . 0.0 108.942 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 84.6 t80 -164.28 122.77 1.83 Allowed 'General case' 0 CA--C 1.537 0.479 0 O-C-N 124.318 1.011 . . . . 0.0 109.005 178.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 17.3 tm0? 41.74 70.07 0.3 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 125.404 1.482 . . . . 0.0 111.561 -177.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt 48.67 25.23 0.93 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 125.586 1.555 . . . . 0.0 114.288 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -131.32 117.36 18.82 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.355 0.662 . . . . 0.0 109.299 -178.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.594 HG21 ' HG3' ' A' ' 24' ' ' GLU . 34.1 t -99.53 144.94 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.507 1.123 . . . . 0.0 109.623 -177.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -137.34 119.26 15.28 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 174.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 33.4 m -105.92 114.1 28.04 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -95.65 117.68 30.93 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -177.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 65.6 mtm-85 -62.25 158.37 17.32 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 170.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.561 HD11 ' HB2' ' A' ' 50' ' ' LEU . 76.2 mt -145.32 98.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 102.808 -3.034 . . . . 0.0 102.808 -175.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.5 HD21 HG21 ' A' ' 44' ' ' VAL . 10.6 mp -122.14 148.62 52.38 Favored Pre-proline 0 N--CA 1.477 0.923 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -172.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 70' ' ' PHE . 87.8 Cg_exo -44.29 -59.66 1.03 Allowed 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.53 2.153 . . . . 0.0 111.845 172.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.2 t70 47.33 71.5 0.32 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.857 1.263 . . . . 0.0 111.87 174.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.65 -75.95 0.24 Allowed Glycine 0 C--N 1.337 0.631 0 CA-C-O 119.459 -0.634 . . . . 0.0 111.626 -176.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 169.29 -40.44 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.051 1.34 . . . . 0.0 111.405 -175.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -131.35 -13.43 3.43 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -161.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 97.8 m-85 -117.91 163.81 15.99 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.425 1.09 . . . . 0.0 110.443 -167.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.1 mp -104.54 109.34 21.19 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 171.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.43 126.05 42.45 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.192 0.997 . . . . 0.0 109.57 -175.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.5 t -96.09 133.27 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -178.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -94.52 89.32 5.77 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -175.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.469 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 21.2 p -71.04 -66.59 0.59 Allowed 'General case' 0 C--O 1.248 1.006 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.325 175.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.3 t 176.39 174.67 0.34 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.089 1.355 . . . . 0.0 109.945 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -68.01 160.7 28.22 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 123.786 0.834 . . . . 0.0 109.185 167.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.51 -72.54 2.16 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-N 118.451 0.569 . . . . 0.0 112.99 -170.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.1 m -65.6 145.94 99.01 Favored Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 123.662 0.785 . . . . 0.0 110.538 176.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.79 137.56 27.36 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.482 2.121 . . . . 0.0 113.483 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.4 t -69.58 118.12 13.42 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 167.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -98.62 117.38 32.93 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.508 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -100.69 149.99 23.21 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.714 0.806 . . . . 0.0 110.271 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -134.29 162.29 32.59 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.42 0.688 . . . . 0.0 112.399 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -74.08 -46.5 42.62 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.511 170.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 37.9 p -138.34 169.12 18.35 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.618 0.767 . . . . 0.0 110.999 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.482 ' O ' HG12 ' A' ' 91' ' ' ILE . 4.3 mm? -62.21 -34.42 76.44 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.584 0.754 . . . . 0.0 111.058 171.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -53.86 -43.89 70.92 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 122.975 0.172 . . . . 0.0 113.029 175.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -66.38 -36.15 82.13 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.252 0.621 . . . . 0.0 110.611 175.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.424 HD13 HD13 ' A' ' 87' ' ' LEU . 7.8 tt -64.7 -38.6 91.54 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.342 1.057 . . . . 0.0 110.828 -178.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 87' ' ' LEU . 50.3 mm -85.04 -35.54 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -168.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.3 -44.93 32.61 Favored Glycine 0 C--N 1.35 1.331 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.877 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.1 tp -76.11 -32.73 59.32 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.712 0.405 . . . . 0.0 111.239 -178.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.616 ' HB3' ' HG ' ' A' ' 105' ' ' LEU . 3.9 m-30 -78.12 -16.46 57.95 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.757 174.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.42 -2.16 10.33 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.136 0.574 . . . . 0.0 112.102 171.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -128.37 152.14 77.65 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 169.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -28.93 103.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 124.819 3.679 . . . . 0.0 114.967 165.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.512 ' HB3' HD23 ' A' ' 101' ' ' LEU . 8.3 t30 -106.28 -44.7 4.48 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.533 -177.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 107.93 115.78 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 128.184 2.594 . . . . 0.0 108.644 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.469 ' HA3' ' HB ' ' A' ' 75' ' ' THR . . . 110.04 -13.28 31.61 Favored Glycine 0 C--N 1.345 1.04 0 O-C-N 123.747 0.654 . . . . 0.0 112.266 -175.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.512 HD23 ' HB3' ' A' ' 98' ' ' ASN . 3.9 mm? -84.36 138.72 32.72 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.183 0.993 . . . . 0.0 111.699 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.1 p -60.68 -35.64 65.27 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 C-N-CA 124.425 1.09 . . . . 0.0 112.421 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.429 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 29.0 p -163.98 13.62 0.05 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.377 0.671 . . . . 0.0 111.455 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.443 ' H ' ' HB3' ' A' ' 101' ' ' LEU . . . 74.15 176.96 0.24 Allowed 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 124.814 1.246 . . . . 0.0 109.771 -167.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.616 ' HG ' ' HB3' ' A' ' 94' ' ' TYR . 26.6 mt -92.88 113.87 26.27 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.412 ' HB3' ' HA3' ' A' ' 34' ' ' GLY . 56.1 tp -108.01 -63.32 1.33 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.513 0.725 . . . . 0.0 111.868 -173.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.459 HD22 HG22 ' A' ' 109' ' ' VAL . 5.0 tt -116.58 103.73 52.29 Favored Pre-proline 0 N--CA 1.479 0.999 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -170.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -73.74 119.24 5.8 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.56 2.173 . . . . 0.0 111.158 173.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.459 HG22 HD22 ' A' ' 107' ' ' LEU . 21.1 t . . . . . 0 CA--C 1.553 1.069 0 CA-C-O 118.038 -0.982 . . . . 0.0 108.371 -175.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -169.08 62.91 0.19 Allowed Glycine 0 C--N 1.344 1.025 0 N-CA-C 111.953 -0.459 . . . . 0.0 111.953 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -88.3 94.81 9.96 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 172.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 -70.83 117.7 12.67 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.779 0.832 . . . . 0.0 110.205 -176.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -136.98 46.05 2.21 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.71 0.804 . . . . 0.0 109.556 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -75.98 75.04 2.88 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 172.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -151.19 34.36 0.58 Allowed 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 122.594 1.188 . . . . 0.0 108.694 -172.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -80.62 84.41 6.2 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.359 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.1 m -139.93 88.41 2.23 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.482 0.713 . . . . 0.0 109.577 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 41.5 p-80 -171.42 152.46 3.28 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.884 1.273 . . . . 0.0 108.445 175.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.408 ' SD ' ' N ' ' A' ' 11' ' ' MET . 1.5 mpt? -70.8 83.18 0.64 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.871 0.843 . . . . 0.0 110.32 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.1 t -95.36 99.56 11.46 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.581 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -83.37 -29.1 28.47 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 172.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -74.67 122.75 23.69 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -138.41 93.36 2.73 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.371 0.669 . . . . 0.0 109.394 176.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -62.84 148.98 45.48 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 157.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.6 t70 81.41 -11.47 1.08 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.357 1.063 . . . . 0.0 111.736 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 tp -90.73 122.57 33.6 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.6 m -83.44 158.01 22.24 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.898 0.479 . . . . 0.0 109.851 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -62.58 -47.02 85.63 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -171.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.37 -45.32 80.58 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.416 0.686 . . . . 0.0 111.347 177.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.81 -34.39 76.66 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.86 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.594 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -66.23 -55.71 14.87 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.76 0.824 . . . . 0.0 111.422 -177.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.501 ' HG2' ' SG ' ' A' ' 51' ' ' CYS . 25.2 mt-10 -64.67 -28.77 69.83 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.521 1.128 . . . . 0.0 111.443 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -62.28 -50.99 69.51 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.462 0.705 . . . . 0.0 109.416 173.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.6 mt -66.77 -28.35 68.33 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.163 0.985 . . . . 0.0 112.077 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.503 HD21 ' HG ' ' A' ' 37' ' ' LEU . 75.0 mt -68.04 -45.01 75.15 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 118.058 0.39 . . . . 0.0 110.176 173.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.2 -26.78 63.09 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.653 0.781 . . . . 0.0 111.22 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -85.97 -60.54 1.98 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.369 0.668 . . . . 0.0 111.484 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.23 -54.92 5.49 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.626 0.771 . . . . 0.0 112.354 -166.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.595 ' HA3' ' HB3' ' A' ' 35' ' ' SER . . . -87.5 -34.1 10.78 Favored Glycine 0 N--CA 1.471 0.967 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 60.25 4.04 0.61 Allowed 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 126.445 1.898 . . . . 0.0 114.827 174.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.3 t70 164.52 133.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.09 1.356 . . . . 0.0 107.788 -171.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.61 -2.27 54.46 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 117.89 0.314 . . . . 0.0 113.579 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.595 ' HB3' ' HA3' ' A' ' 31' ' ' GLY . 1.9 p -82.54 130.37 35.1 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.406 1.082 . . . . 0.0 111.967 -169.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.411 ' CE1' ' HB3' ' A' ' 105' ' ' LEU . 46.2 p90 -127.33 151.93 48.12 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.031 0.532 . . . . 0.0 110.083 174.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.594 HD11 ' HB1' ' A' ' 23' ' ' ALA . 2.3 pp -144.9 160.89 40.59 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.718 0.807 . . . . 0.0 109.013 166.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.447 HG21 HD11 ' A' ' 87' ' ' LEU . 22.6 t -112.78 153.99 14.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.416 HH22 HG21 ' A' ' 60' ' ' THR . 30.1 mtm180 -139.99 170.43 15.87 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.075 0.95 . . . . 0.0 109.661 -176.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -87.78 134.54 33.66 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.296 168.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.5 m -62.96 135.45 57.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.911 0.386 . . . . 0.0 111.143 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -102.27 14.88 30.77 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.207 1.003 . . . . 0.0 111.286 -172.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.0 t -147.33 -62.28 0.28 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.374 0.669 . . . . 0.0 109.898 -177.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.9 m -89.32 125.39 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -171.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 24.78 -133.88 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 127.585 2.354 . . . . 0.0 116.466 171.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.45 57.63 0.44 Allowed Glycine 0 C--N 1.358 1.772 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.42 174.15 6.0 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.63 0.772 . . . . 0.0 111.107 -173.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.55 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 81.0 m-85 -114.82 158.73 21.5 Favored 'General case' 0 C--O 1.25 1.083 0 C-N-CA 123.905 0.882 . . . . 0.0 109.827 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.24 141.21 52.23 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.535 1.134 . . . . 0.0 109.214 173.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.573 HD22 HD21 ' A' ' 90' ' ' LEU . 58.9 tp -123.32 115.75 22.19 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.501 ' SG ' ' HG2' ' A' ' 24' ' ' GLU . 45.9 t -114.19 119.08 35.85 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -176.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 5.1 t -127.77 140.56 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.218 0.607 . . . . 0.0 109.4 -170.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.8 tp -122.92 138.47 54.66 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.722 1.209 . . . . 0.0 109.035 -177.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -169.32 136.63 1.78 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.002 0.921 . . . . 0.0 109.622 172.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 47.35 42.49 14.02 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.819 1.248 . . . . 0.0 112.096 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 56.62 45.47 22.09 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.739 1.216 . . . . 0.0 112.641 -173.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -129.6 103.85 7.11 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 171.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 61.6 t -97.65 105.45 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 170.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -112.78 134.12 54.45 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.416 HG21 HH22 ' A' ' 39' ' ' ARG . 55.5 m -117.8 142.34 47.4 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.412 0.685 . . . . 0.0 109.453 -175.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -124.74 154.85 40.24 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.54 1.136 . . . . 0.0 108.26 -177.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -102.39 160.98 14.07 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 166.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.658 HG12 HD11 ' A' ' 90' ' ' LEU . 3.7 mp -144.59 101.24 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 103.122 -2.918 . . . . 0.0 103.122 -163.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.1 mp -103.4 137.67 19.32 Favored Pre-proline 0 N--CA 1.481 1.119 0 CA-C-O 119.421 -0.323 . . . . 0.0 110.943 -163.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.63 -138.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 123.452 2.768 . . . . 0.0 111.081 175.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 68' ' ' GLU . 7.1 t70 169.47 -178.09 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 122.97 0.508 . . . . 0.0 110.323 -166.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -88.33 5.35 84.85 Favored Glycine 0 N--CA 1.491 2.342 0 CA-C-O 121.642 0.579 . . . . 0.0 112.337 167.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 66' ' ' ASP . 35.4 mt-10 -142.13 106.28 4.77 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 102.48 -3.156 . . . . 0.0 102.48 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -74.5 88.4 2.13 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 119.591 1.087 . . . . 0.0 111.287 -151.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.488 ' HB3' ' HB3' ' A' ' 83' ' ' ARG . 50.3 m-85 -116.24 138.27 51.44 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 124.398 1.079 . . . . 0.0 108.839 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 84' ' ' PHE . 8.7 mp -96.01 107.32 19.6 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 174.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -104.87 112.38 25.48 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.929 0.892 . . . . 0.0 110.013 -171.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.48 HG22 HG13 ' A' ' 63' ' ' ILE . 12.1 t -101.8 144.59 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.669 -175.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.2 86.9 2.51 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.452 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 4.3 p -80.86 -53.0 6.85 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.676 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.5 m -126.61 169.11 13.44 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.641 0.776 . . . . 0.0 110.536 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -88.11 -3.43 58.89 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.592 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -147.4 39.29 1.05 Allowed Glycine 0 C--N 1.35 1.306 0 CA-C-N 117.93 0.332 . . . . 0.0 113.086 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 m -120.34 151.18 53.17 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 123.73 0.812 . . . . 0.0 108.82 171.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.2 126.49 18.74 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 121.791 1.661 . . . . 0.0 110.557 170.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.6 t -68.95 127.45 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -177.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -98.48 117.97 34.11 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -171.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.488 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 88.3 mtm180 -99.0 126.73 44.77 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.036 0.934 . . . . 0.0 110.187 -173.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.519 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 71.1 m-85 -110.03 147.56 33.32 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.391 0.676 . . . . 0.0 111.781 -175.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -72.01 -38.59 69.58 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.263 0.625 . . . . 0.0 110.34 173.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.4 HG22 ' HG2' ' A' ' 89' ' ' GLU . 8.1 t -146.29 169.5 18.68 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.621 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.447 HD11 HG21 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -62.69 -29.65 70.81 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.937 174.182 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -55.22 -41.37 78.75 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 116.512 -0.313 . . . . 0.0 113.579 171.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 84' ' ' PHE . 53.3 mm-40 -67.9 -39.67 83.59 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.494 0.717 . . . . 0.0 110.644 176.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.658 HD11 HG12 ' A' ' 63' ' ' ILE . 7.1 tt -57.7 -54.96 40.99 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.334 -178.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 40.9 mm -66.26 -34.15 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.297 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.03 -56.92 22.48 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.636 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.36 -40.09 74.24 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.134 0.574 . . . . 0.0 111.016 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.666 ' HA ' HE22 ' A' ' 99' ' ' GLN . 6.5 m-30 -78.21 -7.25 56.88 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -173.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.03 -13.72 58.62 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 122.472 0.309 . . . . 0.0 111.584 164.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -92.25 137.54 24.77 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 124.477 1.111 . . . . 0.0 109.771 173.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.87 175.17 11.72 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.925 2.416 . . . . 0.0 113.917 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.4 t30 58.88 73.06 0.5 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.253 1.421 . . . . 0.0 112.228 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.666 HE22 ' HA ' ' A' ' 94' ' ' TYR . 48.1 mt-30 -142.4 -13.06 0.8 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.337 1.055 . . . . 0.0 111.029 174.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.452 ' HA3' ' HB ' ' A' ' 75' ' ' THR . . . 122.27 -2.63 10.52 Favored Glycine 0 N--CA 1.48 1.629 0 C-N-CA 123.694 0.664 . . . . 0.0 112.005 -169.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 88.5 mt -74.66 168.29 20.11 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.787 1.235 . . . . 0.0 111.114 176.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.5 m -67.26 -47.92 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.412 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.872 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 49.0 t -173.73 40.05 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.348 1.059 . . . . 0.0 109.63 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 78.37 -177.8 0.1 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.088 1.355 . . . . 0.0 111.346 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.411 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 21.9 mt -105.53 99.56 9.16 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 175.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 106' ' ' LEU . 0.8 OUTLIER -112.01 -48.79 3.02 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.907 0.883 . . . . 0.0 111.326 -171.754 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 35' ' ' SER . 10.5 mp -112.43 124.12 32.66 Favored Pre-proline 0 N--CA 1.484 1.247 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.49 -87.14 0.0 OUTLIER 'Trans proline' 0 CA--C 1.556 1.59 0 C-N-CA 121.203 1.268 . . . . 0.0 110.088 167.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 t . . . . . 0 C--O 1.25 1.128 0 C-N-CA 124.576 1.15 . . . . 0.0 108.137 177.782 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -140.52 142.47 12.41 Favored Glycine 0 C--N 1.343 0.917 0 N-CA-C 112.705 -0.158 . . . . 0.0 112.705 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -85.52 -157.63 0.33 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.377 1.071 . . . . 0.0 109.14 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -74.93 127.06 32.33 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 165.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -156.36 133.31 10.44 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.348 0.659 . . . . 0.0 109.848 -177.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -147.11 174.41 11.6 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.611 1.164 . . . . 0.0 108.911 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -156.58 86.69 1.0 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -83.94 94.8 8.34 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.143 0.577 . . . . 0.0 109.697 174.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.8 p -126.69 89.78 3.05 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.349 1.06 . . . . 0.0 109.383 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.97 140.07 48.96 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.05 176.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.6 ttt -78.28 -29.12 47.75 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.114 0.483 . . . . 0.0 110.318 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.3 m -155.82 173.45 16.74 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.388 1.075 . . . . 0.0 109.993 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 23.5 p-90 -93.27 -23.49 18.49 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 166.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 83.7 t80 -73.0 106.94 5.09 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 167.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -104.27 117.94 35.43 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -63.33 -46.3 87.27 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.946 0.899 . . . . 0.0 111.182 -170.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -114.47 81.7 1.59 Allowed 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.311 0.576 . . . . 0.0 109.585 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.7 tp -133.58 133.32 41.91 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.545 0.738 . . . . 0.0 110.376 176.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.6 m -99.17 170.28 8.8 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.673 0.789 . . . . 0.0 110.092 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.442 ' HG3' HG21 ' A' ' 60' ' ' THR . 38.8 ttt180 -62.1 -57.7 10.58 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -171.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.43 -42.96 78.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.149 0.58 . . . . 0.0 111.231 -178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.33 -30.71 70.61 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.172 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.26 -50.2 49.21 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.521 0.729 . . . . 0.0 111.356 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.489 ' HA ' HD12 ' A' ' 27' ' ' LEU . 10.2 pt-20 -69.68 -22.2 63.45 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.985 178.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -68.33 -49.59 59.31 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 167.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.405 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 43.7 mt -59.58 -30.11 68.42 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.752 0.421 . . . . 0.0 111.627 174.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 24' ' ' GLU . 48.1 mt -67.49 -47.07 71.09 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.49 0.316 . . . . 0.0 110.238 172.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.72 -42.71 97.89 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.4 0.68 . . . . 0.0 111.817 -173.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -87.0 -53.14 5.04 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.639 0.376 . . . . 0.0 110.643 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -78.29 -60.4 2.39 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 117.745 0.248 . . . . 0.0 111.127 -175.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.84 126.41 34.5 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-O 121.293 0.385 . . . . 0.0 114.029 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 71.2 mtp85 -79.47 -41.49 27.4 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.449 1.1 . . . . 0.0 113.159 -177.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 170.14 132.95 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.773 1.229 . . . . 0.0 107.988 -169.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.576 ' HA2' ' SG ' ' A' ' 103' ' ' CYS . . . 68.33 24.05 74.93 Favored Glycine 0 N--CA 1.479 1.519 0 CA-C-N 118.259 0.481 . . . . 0.0 111.929 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 7.6 m -88.73 145.77 25.43 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 124.141 0.976 . . . . 0.0 110.472 -171.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -142.05 151.6 42.56 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.197 0.599 . . . . 0.0 109.919 -176.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.492 HD23 HG21 ' A' ' 109' ' ' VAL . 4.6 pp -140.79 154.18 46.14 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.38 169.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 71.5 t -121.61 146.96 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 170.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 48.6 ptt85 -160.74 -170.25 2.68 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.801 1.24 . . . . 0.0 108.324 -173.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.71 144.25 25.93 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.572 0.749 . . . . 0.0 109.203 169.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.43 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . 35.6 t -70.41 160.84 31.6 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.972 0.909 . . . . 0.0 109.514 164.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -108.36 -14.57 14.65 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.8 m -81.11 -68.65 0.67 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.52 0.728 . . . . 0.0 109.975 -177.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.0 t -91.33 118.43 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.436 0.694 . . . . 0.0 109.444 -174.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 7.24 -82.17 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 127.791 2.436 . . . . 0.0 115.866 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.44 64.12 0.58 Allowed Glycine 0 C--N 1.346 1.12 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 174.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 41' ' ' SER . . . -90.11 164.41 14.48 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.935 0.494 . . . . 0.0 110.234 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.518 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 20.9 m-85 -104.16 122.19 44.83 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.027 0.931 . . . . 0.0 109.127 -177.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -108.23 130.74 55.14 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.445 0.698 . . . . 0.0 109.533 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.7 tp -117.79 108.13 14.99 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.495 ' SG ' HG22 ' A' ' 60' ' ' THR . 56.3 m -106.52 123.59 48.32 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -176.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 35' ' ' SER . 58.4 t -130.09 128.16 64.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 124.022 0.929 . . . . 0.0 109.596 -172.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 56.7 tp -108.29 143.45 37.12 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.28 1.032 . . . . 0.0 109.615 175.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -163.52 112.37 1.25 Allowed 'General case' 0 CA--C 1.543 0.689 0 O-C-N 123.839 0.712 . . . . 0.0 109.25 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 50.76 57.71 6.34 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.954 1.301 . . . . 0.0 113.018 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.7 tttm 52.6 28.03 5.71 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.925 1.29 . . . . 0.0 112.662 -175.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -106.6 104.13 13.74 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 173.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.0 t -86.19 128.71 39.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 173.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -140.07 134.69 31.71 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.495 HG22 ' SG ' ' A' ' 51' ' ' CYS . 37.7 p -112.62 135.9 52.81 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 173.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -114.1 99.93 8.0 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -82.16 97.73 8.35 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.518 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 63.4 mt -71.53 120.67 20.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.778 163.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.4 mp -101.78 126.87 32.65 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 172.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 11.6 Cg_endo -56.11 -62.59 0.23 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.146 1.897 . . . . 0.0 111.042 177.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.4 t70 105.64 -82.16 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.856 1.663 . . . . 0.0 107.733 161.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -88.93 25.82 9.34 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-O 119.171 -0.794 . . . . 0.0 113.579 174.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 59.9 -3.72 0.11 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 175.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -101.81 -44.04 5.65 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.524 0.73 . . . . 0.0 110.941 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -111.54 158.81 18.76 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.639 1.176 . . . . 0.0 109.104 -174.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 4.4 pp -110.49 112.97 25.24 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 165.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.14 125.14 49.71 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.977 0.511 . . . . 0.0 110.943 -176.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 81' ' ' VAL . 22.9 t -85.73 130.91 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.316 -175.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -96.79 93.02 6.44 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.3 p -81.93 -66.33 0.9 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 174.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.541 ' HB2' HG22 ' A' ' 79' ' ' VAL . 50.4 m -162.66 134.4 5.24 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.333 1.053 . . . . 0.0 109.884 172.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -71.65 99.31 2.08 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 164.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.44 -28.91 1.49 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -164.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.541 HG22 ' HB2' ' A' ' 76' ' ' SER . 17.4 m -126.43 152.52 74.25 Favored Pre-proline 0 N--CA 1.485 1.305 0 C-N-CA 124.154 0.981 . . . . 0.0 109.552 177.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -50.72 113.44 1.07 Allowed 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 123.117 2.545 . . . . 0.0 114.013 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 73' ' ' VAL . 7.3 p -71.08 141.38 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 124.72 1.208 . . . . 0.0 110.565 177.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -109.95 119.45 39.36 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.701 0.8 . . . . 0.0 109.656 175.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -102.06 146.94 27.2 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.025 0.93 . . . . 0.0 109.355 172.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -133.74 163.24 29.9 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.939 0.896 . . . . 0.0 108.849 174.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -100.15 -21.14 15.66 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 172.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.598 HG22 ' H ' ' A' ' 88' ' ' GLY . 57.9 m -138.5 141.59 39.38 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -170.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.478 ' O ' HG12 ' A' ' 91' ' ' ILE . 96.1 mt -61.82 -31.27 71.5 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.279 0.632 . . . . 0.0 111.353 177.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.598 ' H ' HG22 ' A' ' 86' ' ' THR . . . -58.21 -34.19 72.86 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 113.749 0.26 . . . . 0.0 113.749 173.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.86 -40.37 75.81 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.463 0.705 . . . . 0.0 110.295 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.3 tp -56.92 -61.07 2.7 Favored 'General case' 0 C--N 1.356 0.891 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.158 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.498 ' HA ' HD12 ' A' ' 105' ' ' LEU . 29.8 mm -60.29 -40.17 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 124.301 1.04 . . . . 0.0 110.573 -177.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.64 -55.54 28.25 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 124.073 0.858 . . . . 0.0 113.853 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 50.9 tp -73.82 -34.71 64.69 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 122.801 0.44 . . . . 0.0 110.939 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.417 ' HA ' ' OD1' ' A' ' 98' ' ' ASN . 3.1 m-30 -86.61 0.87 53.6 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -172.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.99 8.86 6.19 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.346 0.658 . . . . 0.0 112.497 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -137.92 162.18 55.66 Favored Pre-proline 0 CA--C 1.55 0.942 0 C-N-CA 124.888 1.275 . . . . 0.0 108.261 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -49.44 118.53 3.74 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 123.161 2.574 . . . . 0.0 113.243 171.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.417 ' OD1' ' HA ' ' A' ' 94' ' ' TYR . 21.8 m120 -106.93 -78.44 0.58 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.75 0.82 . . . . 0.0 110.923 -174.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 148.34 101.46 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.387 1.475 . . . . 0.0 108.089 -156.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 105.55 -29.06 12.05 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-O 119.742 -0.477 . . . . 0.0 112.832 172.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 15.2 mt -71.09 145.34 49.91 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.736 0.414 . . . . 0.0 111.339 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.5 m -66.01 -27.45 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.566 0.746 . . . . 0.0 111.421 172.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.576 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 29.3 p -168.22 172.89 8.23 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.337 1.055 . . . . 0.0 109.829 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.87 151.54 38.97 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.569 171.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 91' ' ' ILE . 29.9 mt -77.7 103.96 7.95 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 92.6 mt -118.95 -60.96 1.7 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.921 0.488 . . . . 0.0 112.153 -172.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -95.43 140.87 22.55 Favored Pre-proline 0 N--CA 1.484 1.271 0 C-N-CA 122.732 0.413 . . . . 0.0 111.17 -169.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -73.94 -163.46 0.17 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.965 2.444 . . . . 0.0 112.444 172.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.492 HG21 HD23 ' A' ' 37' ' ' LEU . 72.3 t . . . . . 0 C--O 1.254 1.32 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -175.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtt . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.79 37.28 0.08 OUTLIER Glycine 0 C--N 1.344 0.996 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -77.67 -5.32 50.05 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 123.484 0.714 . . . . 0.0 110.868 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -111.06 73.83 0.84 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 167.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -76.45 102.87 6.17 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -110.26 123.89 50.61 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.099 0.96 . . . . 0.0 109.32 172.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -79.41 23.81 0.38 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.684 0.794 . . . . 0.0 112.317 -176.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -123.51 49.87 1.66 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.301 1.041 . . . . 0.0 108.366 171.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.7 m -68.75 -2.25 8.9 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.538 1.135 . . . . 0.0 113.951 -173.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.8 m80 64.48 33.5 10.97 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.03 0.932 . . . . 0.0 110.329 -177.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.2 ptm -80.43 71.17 7.24 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.459 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 m -75.8 -61.37 1.95 Allowed 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.211 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.43 ' CD1' ' HB3' ' A' ' 108' ' ' PRO . 33.5 p-90 -91.95 3.82 54.37 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.908 0.483 . . . . 0.0 110.894 176.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.437 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 73.5 t80 -110.56 127.66 55.31 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -123.11 144.2 49.48 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.0 mtp-105 -63.07 -64.49 0.9 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.681 0.792 . . . . 0.0 110.13 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -84.74 -101.66 0.05 Allowed 'General case' 0 C--O 1.246 0.901 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -177.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.3 tp 65.05 113.56 0.03 OUTLIER 'General case' 0 C--N 1.363 1.182 0 C-N-CA 125.336 1.454 . . . . 0.0 110.661 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.2 t -72.91 147.81 44.95 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 170.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -63.81 -38.04 89.63 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.133 0.973 . . . . 0.0 110.151 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.23 -45.38 87.81 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.726 173.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.81 -33.59 66.31 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.606 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.576 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -66.87 -51.93 49.56 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.739 0.816 . . . . 0.0 110.255 -177.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -54.26 -43.66 71.17 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.013 1.325 . . . . 0.0 111.323 174.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.39 -50.3 66.02 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.821 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.1 mt -61.85 -34.32 75.76 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.69 0.796 . . . . 0.0 112.295 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.7 mt -70.54 -59.09 3.04 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.92 -29.01 68.08 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.297 1.039 . . . . 0.0 112.977 -172.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -78.21 -44.94 24.33 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.413 0.685 . . . . 0.0 110.904 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.64 -59.24 2.82 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.438 0.637 . . . . 0.0 112.408 -170.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.06 -169.62 16.05 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 114.685 -1.143 . . . . 0.0 113.808 -165.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.452 ' HB3' ' H ' ' A' ' 33' ' ' ASP . 6.4 mpt_? -119.47 -157.57 0.7 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 125.143 1.377 . . . . 0.0 109.716 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.452 ' H ' ' HB3' ' A' ' 32' ' ' ARG . 8.1 p-10 -57.0 132.87 54.16 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.959 0.904 . . . . 0.0 112.099 -176.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.55 0.59 64.65 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.932 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.43 ' HB2' ' HB3' ' A' ' 53' ' ' LEU . 56.8 m -71.64 116.58 12.17 Favored 'General case' 0 C--N 1.359 1.007 0 CA-C-N 117.764 0.782 . . . . 0.0 108.898 176.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 24.5 p90 -131.07 157.43 43.09 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.306 0.574 . . . . 0.0 111.639 -172.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.576 HD11 ' HB1' ' A' ' 23' ' ' ALA . 2.9 pp -150.93 164.11 37.12 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.69 169.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 49' ' ' ALA . 86.2 t -125.94 149.26 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 171.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.517 ' HG3' ' HB3' ' A' ' 49' ' ' ALA . 0.5 OUTLIER -153.17 169.07 23.91 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.739 1.215 . . . . 0.0 108.726 -175.383 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 13.7 t70 -93.18 120.8 33.87 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 172.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.4 m -69.19 101.15 1.4 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.027 0.931 . . . . 0.0 111.282 -169.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.454 ' HG2' HH21 ' A' ' 39' ' ' ARG . 16.6 mm-40 -49.78 -31.67 12.16 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.411 1.484 . . . . 0.0 114.315 173.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.5 p -79.23 -17.4 54.88 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.944 0.498 . . . . 0.0 112.279 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.6 t -108.81 -64.76 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 122.996 0.519 . . . . 0.0 109.7 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 95.84 122.07 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.871 2.469 . . . . 0.0 109.547 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 63.46 58.18 12.31 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.746 1.279 . . . . 0.0 111.643 -173.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 40' ' ' ASP . . . -153.08 150.4 29.09 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.461 1.104 . . . . 0.0 108.149 -174.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -113.53 125.1 53.82 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.388 0.994 . . . . 0.0 111.311 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.517 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . . . -104.4 127.27 52.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.52 0.728 . . . . 0.0 109.326 -177.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.4 tp -111.11 106.25 15.23 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 31.2 m -101.16 121.38 41.74 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -176.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.506 HG21 HD22 ' A' ' 101' ' ' LEU . 94.0 t -122.43 116.69 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.262 1.025 . . . . 0.0 109.37 -174.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 35' ' ' SER . 36.9 tp -85.24 135.13 34.06 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.189 0.996 . . . . 0.0 111.273 -173.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -141.7 102.3 4.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.525 0.73 . . . . 0.0 109.103 167.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 57.5 54.21 6.71 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.231 1.012 . . . . 0.0 111.369 172.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.419 ' H ' HD11 ' A' ' 53' ' ' LEU . 14.7 tmtt? 75.27 -23.06 0.24 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 125.681 1.592 . . . . 0.0 112.441 -177.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -88.8 101.35 13.94 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.902 0.858 . . . . 0.0 108.734 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 83.6 t -93.52 120.7 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.227 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -94.98 122.13 37.31 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 37.3 p -113.9 141.62 47.13 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -169.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -135.99 99.15 4.07 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -177.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -81.14 93.53 6.47 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.109 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.437 HG22 ' HB3' ' A' ' 71' ' ' LEU . 32.5 mt -79.9 136.63 23.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 124.494 1.117 . . . . 0.0 110.315 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.8 mp -121.2 141.22 32.56 Favored Pre-proline 0 N--CA 1.475 0.805 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -174.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 70' ' ' PHE . 52.5 Cg_exo -58.67 114.91 2.2 Favored 'Trans proline' 0 C--N 1.366 1.491 0 C-N-CA 122.038 1.826 . . . . 0.0 109.162 158.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -123.84 5.36 8.75 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 123.48 0.712 . . . . 0.0 110.44 -160.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.36 141.29 3.67 Favored Glycine 0 C--N 1.342 0.904 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -174.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 33.66 -76.75 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.016 2.228 . . . . 0.0 117.016 -166.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -163.02 22.37 0.09 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -163.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 72.1 m-85 -127.15 150.5 49.48 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.139 0.976 . . . . 0.0 109.717 -170.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.437 ' HB3' HG22 ' A' ' 63' ' ' ILE . 8.2 mp -99.11 150.05 22.42 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.28 1.032 . . . . 0.0 109.743 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -135.93 120.54 18.28 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.635 0.774 . . . . 0.0 109.836 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.8 t -84.93 128.04 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.27 1.028 . . . . 0.0 108.539 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -110.85 87.64 2.58 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -175.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.3 t -140.44 138.68 34.88 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.165 175.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.4 m 63.05 -2.12 0.44 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 165.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 60.71 -79.69 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 125.331 1.452 . . . . 0.0 112.429 -177.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.55 -28.48 62.52 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 -172.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.92 124.19 63.43 Favored Pre-proline 0 CA--C 1.561 1.392 0 CA-C-N 117.274 0.537 . . . . 0.0 110.632 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.413 ' HB2' HE22 ' A' ' 99' ' ' GLN . 81.3 Cg_exo -51.99 113.58 1.24 Allowed 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.653 2.235 . . . . 0.0 113.349 177.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 70.2 t -101.7 134.1 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.417 1.087 . . . . 0.0 108.751 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -105.29 151.6 23.94 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.471 ' O ' ' HD2' ' A' ' 83' ' ' ARG . 2.6 ppt_? -85.34 121.91 28.74 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 170.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -107.29 129.43 54.89 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.592 -0.693 . . . . 0.0 110.178 -176.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -84.64 -17.31 39.01 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.8 t -155.28 163.46 40.11 Favored 'General case' 0 C--O 1.248 0.99 0 C-N-CA 122.779 0.432 . . . . 0.0 110.372 172.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.424 ' O ' HG12 ' A' ' 91' ' ' ILE . 94.9 mt -60.22 -32.12 70.81 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.044 0.937 . . . . 0.0 111.677 177.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -55.86 -41.85 84.71 Favored Glycine 0 C--N 1.352 1.464 0 O-C-N 123.304 0.377 . . . . 0.0 112.762 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -65.85 -39.08 90.43 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.811 0.844 . . . . 0.0 111.033 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 47.7 tp -64.17 -41.72 97.02 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.191 0.996 . . . . 0.0 111.467 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 87' ' ' LEU . 49.8 mm -84.95 -28.18 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -168.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.42 -47.74 15.84 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.2 tt -61.28 -43.78 98.32 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.447 0.699 . . . . 0.0 110.325 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.492 ' HB3' HD11 ' A' ' 101' ' ' LEU . 3.0 m-85 -79.57 -9.76 59.68 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.509 0.724 . . . . 0.0 112.215 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.03 -0.72 19.85 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.734 0.413 . . . . 0.0 112.104 167.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -154.45 57.92 1.93 Allowed Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 124.465 1.106 . . . . 0.0 109.018 172.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.466 ' HG3' HD12 ' A' ' 101' ' ' LEU . 81.1 Cg_endo -75.35 -66.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.507 2.138 . . . . 0.0 113.706 -164.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.5 t30 57.77 39.24 27.29 Favored 'General case' 0 C--N 1.367 1.327 0 C-N-CA 124.325 1.05 . . . . 0.0 108.534 -170.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.413 HE22 ' HB2' ' A' ' 80' ' ' PRO . 20.9 mt-30 -177.75 86.38 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.243 1.017 . . . . 0.0 110.211 -162.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 103.93 -32.28 7.72 Favored Glycine 0 N--CA 1.474 1.187 0 C-N-CA 121.639 -0.315 . . . . 0.0 112.853 161.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.506 HD22 HG21 ' A' ' 52' ' ' VAL . 53.7 mt -87.64 123.96 33.04 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.675 0.39 . . . . 0.0 110.388 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.8 p -51.05 -32.83 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.457 0 C-N-CA 125.767 1.627 . . . . 0.0 113.514 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 26.2 p -153.64 16.07 0.51 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.979 0.512 . . . . 0.0 112.206 -175.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 67.26 -160.35 0.23 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.646 0.778 . . . . 0.0 110.891 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 56.9 mt -110.91 156.67 20.84 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 58.5 tp -164.94 -63.18 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.457 0.303 . . . . 0.0 111.051 -175.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 29.9 tp -111.52 102.56 53.56 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 122.792 0.437 . . . . 0.0 110.507 -167.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.43 ' HB3' ' CD1' ' A' ' 13' ' ' TRP . 12.3 Cg_exo -72.4 100.96 1.2 Allowed 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.587 2.192 . . . . 0.0 109.392 169.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 87.6 t . . . . . 0 C--O 1.245 0.852 0 CA-C-O 118.648 -0.691 . . . . 0.0 109.328 -171.433 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptp . . . . . 0 N--CA 1.481 1.096 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 167.55 -148.31 12.82 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.6 p-80 -160.01 92.11 0.99 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.974 0.91 . . . . 0.0 109.802 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -90.59 113.99 26.13 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.409 0.684 . . . . 0.0 109.909 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -106.87 134.08 50.57 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.884 0.873 . . . . 0.0 110.251 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -153.6 88.49 1.28 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.632 0.773 . . . . 0.0 109.568 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -143.25 153.65 43.01 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.287 1.035 . . . . 0.0 109.796 173.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -132.08 158.94 40.29 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.425 1.09 . . . . 0.0 109.133 172.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.0 t -64.36 155.71 31.5 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.353 0.661 . . . . 0.0 110.92 176.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -135.9 97.64 3.69 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.915 0.886 . . . . 0.0 110.293 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 67.7 mtm -128.41 123.97 35.11 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 172.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.6 m -61.29 -78.15 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.858 0.863 . . . . 0.0 111.765 -169.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -115.26 12.53 16.48 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.108 0.563 . . . . 0.0 111.929 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.415 ' HE2' ' HG2' ' A' ' 16' ' ' ARG . 53.8 t80 -108.36 116.57 32.22 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -177.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -115.51 117.15 29.55 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.415 ' HG2' ' HE2' ' A' ' 14' ' ' TYR . 80.9 mtt180 -64.24 -58.51 6.36 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.385 0.674 . . . . 0.0 111.524 -175.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -111.11 86.48 2.33 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.394 1.092 . . . . 0.0 108.461 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.9 tp -133.14 133.74 43.26 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.457 -1.247 . . . . 0.0 107.926 177.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.4 m -80.04 155.0 27.79 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.505 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 77.3 ttt180 -65.85 -43.35 88.7 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 119.233 -0.413 . . . . 0.0 110.774 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.85 -48.08 67.32 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.449 0.7 . . . . 0.0 111.252 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.47 -25.13 63.93 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.087 177.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.81 -49.55 20.33 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.49 0.716 . . . . 0.0 111.664 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 1.1 mm-40 -62.72 -38.65 91.31 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.234 0.614 . . . . 0.0 110.01 177.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.3 -47.24 80.22 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 124.377 1.048 . . . . 0.0 109.995 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -54.7 -37.92 66.41 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.89 0.876 . . . . 0.0 110.869 176.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 53' ' ' LEU . 86.5 mt -79.77 -36.1 37.65 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.375 -0.203 . . . . 0.0 111.061 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.63 -41.75 83.4 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 122.706 0.403 . . . . 0.0 110.45 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -89.22 -60.29 1.99 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.119 0.968 . . . . 0.0 111.621 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.26 -50.47 14.32 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.176 0.19 . . . . 0.0 111.347 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.32 122.11 28.62 Favored Glycine 0 C--N 1.353 1.505 0 O-C-N 123.544 0.527 . . . . 0.0 113.72 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -71.0 -45.04 64.67 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.089 0.556 . . . . 0.0 111.075 -177.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 160.98 131.94 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 125.405 1.482 . . . . 0.0 108.172 -174.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.12 20.45 79.05 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 111.924 -0.471 . . . . 0.0 111.924 -176.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 109' ' ' VAL . 13.7 m -83.48 144.94 29.22 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 124.377 1.071 . . . . 0.0 109.529 -178.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -141.75 150.49 41.84 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.96 0.409 . . . . 0.0 111.008 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -138.26 148.86 45.16 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.913 0.885 . . . . 0.0 109.869 170.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.468 HG22 HD13 ' A' ' 50' ' ' LEU . 48.7 t -114.39 136.55 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -135.73 165.2 26.13 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 124.54 1.136 . . . . 0.0 109.412 -174.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -86.32 131.96 34.09 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 175.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.444 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . 40.4 m -91.46 162.56 14.51 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.292 1.037 . . . . 0.0 108.251 172.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -143.7 75.28 1.46 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.6 t -165.48 -68.69 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.664 -174.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 76.2 t -82.18 82.35 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 174.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 46.72 -122.67 1.28 Allowed 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 124.352 1.061 . . . . 0.0 111.183 -170.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -108.77 79.69 0.25 Allowed Glycine 0 C--N 1.356 1.67 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 172.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 41' ' ' SER . . . -92.38 174.51 7.25 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.542 0.737 . . . . 0.0 111.445 -172.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.522 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 87.2 m-85 -113.37 155.05 25.9 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.214 1.006 . . . . 0.0 109.72 173.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.52 146.98 48.63 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.619 1.168 . . . . 0.0 108.989 171.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 61' ' ' TYR . 40.8 tp -124.82 108.95 12.47 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.182 0.993 . . . . 0.0 109.239 -176.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.505 ' SG ' HG22 ' A' ' 60' ' ' THR . 52.9 m -93.92 126.1 38.93 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.1 t -132.71 121.28 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 CA-C-N 118.273 0.488 . . . . 0.0 109.852 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 40.2 tp -86.93 139.84 30.21 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.72 0.808 . . . . 0.0 109.248 171.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -163.56 121.49 1.89 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 170.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 41.88 67.26 0.59 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 126.012 1.725 . . . . 0.0 113.732 177.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.465 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 10.8 mmpt? 59.21 27.73 16.83 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.76 1.224 . . . . 0.0 112.897 178.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -139.36 107.14 5.64 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.781 0.832 . . . . 0.0 108.984 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.9 t -93.47 122.12 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 166.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -117.97 138.61 52.06 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.064 0.946 . . . . 0.0 108.907 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.505 HG22 ' SG ' ' A' ' 51' ' ' CYS . 21.4 p -106.56 139.51 40.9 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.477 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 23.9 m-85 -119.0 107.56 13.67 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -70.58 150.37 46.14 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 171.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 96.7 mt -147.27 105.77 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 102.605 -3.109 . . . . 0.0 102.605 -158.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.8 mp -107.19 98.03 20.89 Favored Pre-proline 0 N--CA 1.48 1.051 0 CA-C-O 118.634 -0.698 . . . . 0.0 111.484 -160.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 70' ' ' PHE . 37.3 Cg_endo -66.22 95.58 0.32 Allowed 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 122.5 2.133 . . . . 0.0 109.268 162.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -166.76 164.26 16.56 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 124.446 1.098 . . . . 0.0 108.683 -158.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.72 -67.05 3.05 Favored Glycine 0 C--N 1.349 1.272 0 C-N-CA 123.076 0.369 . . . . 0.0 113.047 171.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -142.22 23.99 1.98 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.105 1.362 . . . . 0.0 108.108 -178.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 t70 61.49 58.71 2.03 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.262 1.425 . . . . 0.0 109.972 -170.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.439 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 23.1 p90 -127.8 151.99 48.35 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.394 1.078 . . . . 0.0 108.105 169.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.15 109.44 22.19 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 176.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . . . -98.56 127.11 44.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.793 0.837 . . . . 0.0 110.42 -175.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.3 t -99.26 129.15 50.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -94.04 90.72 6.53 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -174.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.5 p -71.66 -34.36 69.66 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.237 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.9 m 75.94 167.12 0.27 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.878 1.671 . . . . 0.0 112.745 173.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 67.57 -162.64 0.22 Allowed 'General case' 0 C--N 1.358 0.972 0 C-N-CA 124.47 1.108 . . . . 0.0 111.693 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -49.5 -24.38 5.42 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 114.756 -1.111 . . . . 0.0 113.965 170.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.69 120.9 80.4 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.573 0.749 . . . . 0.0 109.654 174.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.36 142.52 72.92 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.94 2.427 . . . . 0.0 113.266 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 37.1 t -78.29 118.88 26.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 C-N-CA 124.297 1.039 . . . . 0.0 108.278 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -107.03 127.76 53.76 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.852 0.358 . . . . 0.0 110.494 -173.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.545 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 27.9 ptt180 -98.05 154.33 17.79 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.311 1.044 . . . . 0.0 109.997 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -130.29 154.85 47.19 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.369 0.668 . . . . 0.0 111.399 -175.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -72.67 -46.42 53.92 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.502 172.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.0 t -145.76 166.74 24.99 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.517 0.727 . . . . 0.0 110.975 -177.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.6 mt -60.0 -32.57 70.98 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.712 0.805 . . . . 0.0 111.43 175.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -52.45 -41.26 55.44 Favored Glycine 0 N--CA 1.48 1.6 0 O-C-N 123.027 0.205 . . . . 0.0 113.357 172.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -65.63 -41.06 93.09 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.739 0.815 . . . . 0.0 111.232 173.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.5 tt -68.11 -40.09 82.65 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.226 1.01 . . . . 0.0 110.873 -174.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 44.6 mm -86.05 -42.11 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -166.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.88 -35.21 72.31 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.763 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.411 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 27.1 tp -77.49 -40.98 41.08 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-N 116.907 0.353 . . . . 0.0 110.821 177.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.3 m-30 -80.98 4.37 19.81 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 118.099 0.409 . . . . 0.0 111.83 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.63 -4.02 3.76 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.842 0.857 . . . . 0.0 112.538 163.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 93' ' ' LEU . 10.9 pt20 -125.27 144.35 47.27 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 171.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -84.42 -154.13 0.05 OUTLIER 'Trans proline' 0 CA--C 1.555 1.531 0 C-N-CA 123.32 2.68 . . . . 0.0 112.387 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.5 t30 62.68 57.54 1.77 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.64 1.176 . . . . 0.0 110.032 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -170.41 31.22 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.808 178.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.66 -10.36 72.42 Favored Glycine 0 N--CA 1.477 1.424 0 O-C-N 120.886 -1.134 . . . . 0.0 112.433 173.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.13 130.93 43.41 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 168.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.2 p -60.09 -31.67 48.5 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 123.984 0.914 . . . . 0.0 111.142 177.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 28.4 p -160.11 165.44 31.73 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.529 1.132 . . . . 0.0 108.876 176.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.2 150.73 46.16 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 122.727 0.411 . . . . 0.0 110.169 174.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 75.7 mt -73.16 95.85 2.14 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.2 tp -119.67 -61.37 1.62 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.673 -169.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.459 HD12 ' HD2' ' A' ' 108' ' ' PRO . 45.1 tp -100.42 123.78 45.12 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 123.081 0.552 . . . . 0.0 109.797 -172.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.459 ' HD2' HD12 ' A' ' 107' ' ' LEU . 19.4 Cg_endo -59.03 -47.61 17.21 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.399 2.066 . . . . 0.0 111.242 172.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.475 ' HA ' ' HB3' ' A' ' 35' ' ' SER . 0.3 OUTLIER . . . . . 0 C--O 1.245 0.836 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ttt . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.21 117.99 0.14 Allowed Glycine 0 C--N 1.35 1.336 0 O-C-N 123.573 0.546 . . . . 0.0 112.477 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -137.81 153.14 49.68 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 117.496 0.648 . . . . 0.0 109.836 177.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -109.68 -76.71 0.6 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 61.93 91.69 0.06 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.898 1.279 . . . . 0.0 112.6 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -108.52 -76.55 0.61 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.693 0.797 . . . . 0.0 108.949 174.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 52.91 -119.69 1.56 Allowed 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 124.716 1.206 . . . . 0.0 109.912 -172.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 63.1 m80 48.84 -165.79 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.523 1.129 . . . . 0.0 113.031 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.1 t 70.45 156.03 0.15 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.503 1.121 . . . . 0.0 112.802 169.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -157.3 -52.29 0.07 Allowed 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -178.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.435 ' SD ' HD11 ' A' ' 26' ' ' LEU . 65.7 mtt 53.99 34.36 19.55 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.938 1.295 . . . . 0.0 113.447 169.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t -84.44 55.75 3.52 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.697 1.199 . . . . 0.0 110.97 -176.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.524 ' HB3' ' HB3' ' A' ' 108' ' ' PRO 0.317 36.1 p-90 71.53 -54.56 0.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 128.569 2.748 . . . . 0.0 110.906 -177.89 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -76.35 123.83 26.57 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 173.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.407 ' CD2' ' HB2' ' A' ' 37' ' ' LEU . 93.3 m-70 -113.79 171.93 7.29 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.856 0.863 . . . . 0.0 110.797 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -81.95 -148.43 0.07 Allowed 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.601 169.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -65.04 106.04 1.18 Allowed 'General case' 0 CA--C 1.555 1.168 0 CA-C-O 121.786 0.803 . . . . 0.0 110.219 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 39' ' ' ARG . 26.2 tp -136.1 138.45 42.08 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 57.4 p -96.15 172.39 8.01 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.399 0.68 . . . . 0.0 110.225 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -63.42 -51.75 64.43 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.448 0.699 . . . . 0.0 112.568 -176.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.47 -35.95 80.93 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.872 0.469 . . . . 0.0 111.265 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.84 -37.25 81.65 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.385 0.674 . . . . 0.0 111.1 174.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.33 -55.31 12.52 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.816 0.846 . . . . 0.0 111.703 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.493 ' HB3' HG11 ' A' ' 58' ' ' VAL . 13.3 pt-20 -66.13 -26.37 67.42 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.005 0.922 . . . . 0.0 112.375 -177.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -64.81 -51.18 63.54 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 172.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.435 HD11 ' SD ' ' A' ' 11' ' ' MET . 25.9 tp -61.21 -40.16 92.91 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.974 178.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.0 mt -64.58 -52.34 58.08 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.705 0.802 . . . . 0.0 110.505 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.43 -33.48 75.64 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.866 0.867 . . . . 0.0 112.566 -172.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -87.75 -57.79 2.81 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.783 -0.189 . . . . 0.0 111.383 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.73 -59.44 3.32 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.14 0.576 . . . . 0.0 112.325 -170.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -123.12 77.04 0.36 Allowed Glycine 0 C--N 1.342 0.885 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -71.47 102.57 2.7 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 118.996 -0.525 . . . . 0.0 110.015 -171.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.5 t70 97.7 116.2 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.638 1.575 . . . . 0.0 109.877 164.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.72 3.79 68.23 Favored Glycine 0 N--CA 1.476 1.313 0 CA-C-N 115.879 -0.6 . . . . 0.0 113.543 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.7 p -78.09 158.56 29.1 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.416 0.687 . . . . 0.0 111.56 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -145.9 158.95 43.84 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 172.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.411 ' O ' HD12 ' A' ' 50' ' ' LEU . 4.1 pp -154.05 163.08 40.66 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.697 170.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.0 t -117.76 144.88 24.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 169.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.516 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 50.4 ptt85 -152.9 156.68 39.41 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.19 0.596 . . . . 0.0 110.051 -174.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -87.91 117.83 27.03 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 174.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.0 m -94.9 100.36 12.24 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 174.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -60.63 -39.45 88.28 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.196 0.598 . . . . 0.0 111.921 169.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.1 m -87.92 58.84 5.04 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.89 0.876 . . . . 0.0 112.183 -171.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.469 HG13 ' H ' ' A' ' 45' ' ' ALA . 2.1 p -155.49 -70.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.008 0.523 . . . . 0.0 110.17 172.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.469 ' H ' HG13 ' A' ' 44' ' ' VAL . . . -170.07 15.07 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.695 0.798 . . . . 0.0 110.539 -174.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.49 94.68 0.06 OUTLIER Glycine 0 C--N 1.344 1.026 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -161.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.583 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . . . -152.54 160.42 43.22 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -168.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.431 ' HD2' ' HB3' ' A' ' 65' ' ' PRO . 57.8 m-85 -109.58 137.12 47.87 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.932 0.493 . . . . 0.0 109.928 168.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -119.48 135.81 54.6 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.776 0.831 . . . . 0.0 109.816 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.535 HD21 HD21 ' A' ' 105' ' ' LEU . 66.8 tp -107.87 104.08 13.48 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 48.8 t -106.85 116.16 31.45 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -174.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.9 t -122.2 118.24 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.574 1.15 . . . . 0.0 109.151 -170.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 47.3 tp -91.75 131.91 36.78 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.768 0.827 . . . . 0.0 109.155 175.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.402 ' HD2' HG22 ' A' ' 102' ' ' VAL . 83.9 t80 -164.51 127.97 2.47 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.431 0.692 . . . . 0.0 110.32 172.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 47.69 53.23 11.55 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.351 1.46 . . . . 0.0 111.715 174.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 91.0 mttt 56.38 39.26 30.14 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.515 1.126 . . . . 0.0 112.05 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 59.2 m80 -136.77 105.8 5.96 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.334 1.054 . . . . 0.0 108.481 174.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.493 HG11 ' HB3' ' A' ' 24' ' ' GLU . 84.9 t -94.67 107.17 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 170.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -103.06 129.55 49.91 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 96.0 m -110.2 137.98 47.2 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.462 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 56.4 m-85 -120.64 101.47 7.77 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -86.13 96.47 9.9 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 119.082 0.855 . . . . 0.0 109.402 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.454 HD12 ' O ' ' A' ' 61' ' ' TYR . 4.9 mp -85.07 141.95 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 123.62 0.768 . . . . 0.0 110.805 171.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.9 mp -96.06 118.87 65.43 Favored Pre-proline 0 CA--C 1.557 1.219 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 172.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.598 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 92.3 Cg_endo -76.4 -51.98 0.09 OUTLIER 'Trans proline' 0 CA--C 1.556 1.589 0 C-N-CA 122.519 2.146 . . . . 0.0 116.361 -162.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -148.91 167.68 25.06 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 122.259 -0.276 . . . . 0.0 111.158 -158.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.15 -96.29 0.25 Allowed Glycine 0 C--N 1.35 1.323 0 C-N-CA 123.336 0.494 . . . . 0.0 111.898 178.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -126.05 30.31 5.68 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.983 0.913 . . . . 0.0 109.206 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -159.33 174.19 15.14 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.771 -162.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -120.26 158.19 27.55 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.598 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -93.42 111.49 23.17 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -170.636 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.781 ' HB2' ' HG2' ' A' ' 83' ' ' ARG . . . -117.95 142.23 47.59 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.86 0.864 . . . . 0.0 110.748 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.6 t -89.24 142.57 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -108.84 90.99 3.46 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.8 p -87.58 -71.35 0.57 Allowed 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 172.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.2 t 179.92 140.72 0.13 Allowed 'General case' 0 C--N 1.351 0.658 0 C-N-CA 124.616 1.167 . . . . 0.0 108.955 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -70.83 128.2 35.23 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 140.52 -76.96 0.31 Allowed Glycine 0 C--N 1.346 1.135 0 N-CA-C 108.067 -2.013 . . . . 0.0 108.067 -166.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.3 m -64.41 140.08 97.88 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 123.838 0.855 . . . . 0.0 110.043 162.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -64.58 121.28 8.8 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.75 2.3 . . . . 0.0 112.056 -176.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 72.6 t -99.47 141.85 16.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.197 0.999 . . . . 0.0 108.463 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.8 mmt85 -117.31 143.7 45.65 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.553 0.741 . . . . 0.0 111.109 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.781 ' HG2' ' HB2' ' A' ' 72' ' ' ALA . 86.2 mtt-85 -94.89 148.41 22.34 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 166.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -127.39 161.9 27.58 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.163 0.585 . . . . 0.0 110.395 -174.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -95.3 -19.39 20.02 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.313 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.401 HG23 ' H ' ' A' ' 89' ' ' GLU . 15.0 t -157.06 159.72 38.21 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 122.654 0.382 . . . . 0.0 111.592 -176.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.4 mt -61.27 -34.44 75.18 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.186 0.994 . . . . 0.0 112.143 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.41 -38.77 91.63 Favored Glycine 0 C--N 1.349 1.254 0 O-C-N 123.206 0.317 . . . . 0.0 112.952 174.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.401 ' H ' HG23 ' A' ' 86' ' ' THR . 26.2 tt0 -72.21 -37.16 69.3 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.649 0.78 . . . . 0.0 109.735 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.6 tt -54.28 -53.74 49.61 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.657 1.183 . . . . 0.0 110.428 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.9 mm -64.79 -36.3 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.414 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -53.89 -55.08 27.51 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 124.198 0.936 . . . . 0.0 113.298 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -76.47 -35.74 58.26 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 122.998 0.519 . . . . 0.0 111.843 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.531 ' CD2' HD21 ' A' ' 101' ' ' LEU . 7.4 m-85 -89.49 4.62 48.59 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -173.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.42 -6.82 48.72 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 122.719 0.408 . . . . 0.0 110.93 162.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -83.17 125.75 73.86 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.965 0.906 . . . . 0.0 110.337 174.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.94 179.78 6.18 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.387 2.058 . . . . 0.0 111.36 169.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 53.83 66.18 1.3 Allowed 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.877 0.871 . . . . 0.0 111.128 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -173.2 21.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.2 1.0 . . . . 0.0 110.383 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 107.52 -21.65 30.12 Favored Glycine 0 C--N 1.345 1.076 0 O-C-N 121.622 -0.674 . . . . 0.0 112.41 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.531 HD21 ' CD2' ' A' ' 94' ' ' TYR . 2.9 mm? -70.57 124.7 24.86 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.338 1.055 . . . . 0.0 110.582 177.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.402 HG22 ' HD2' ' A' ' 54' ' ' TYR . 13.9 p -52.96 -31.41 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.542 0 C-N-CA 124.21 1.004 . . . . 0.0 112.783 -178.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 27.2 p -156.25 6.41 0.19 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.003 0.521 . . . . 0.0 112.309 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 68.0 -179.62 0.22 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.727 0.811 . . . . 0.0 110.594 -166.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.535 HD21 HD21 ' A' ' 50' ' ' LEU . 46.1 mt -90.0 91.53 8.61 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 79.1 mt -93.86 -69.31 0.76 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.928 0.891 . . . . 0.0 111.321 -174.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.7 mp -104.01 128.25 27.6 Favored Pre-proline 0 N--CA 1.48 1.048 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -173.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.524 ' HB3' ' HB3' ' A' ' 13' ' ' TRP . 35.5 Cg_exo -63.38 -124.25 0.0 OUTLIER 'Trans proline' 0 CA--C 1.571 2.334 0 C-N-CA 122.623 2.215 . . . . 0.0 111.576 169.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.7 t . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 176.914 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -177.07 50.53 0.1 Allowed Glycine 0 C--N 1.349 1.264 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -68.01 100.96 1.04 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.381 0.672 . . . . 0.0 110.641 178.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -133.42 101.2 5.07 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.623 0.769 . . . . 0.0 108.967 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -73.45 111.33 8.48 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-O 121.192 0.52 . . . . 0.0 110.02 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -144.62 165.46 27.95 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.164 0.986 . . . . 0.0 109.406 177.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 66.77 7.88 5.56 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 123.969 0.908 . . . . 0.0 112.375 172.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -125.77 95.56 4.47 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.674 0.79 . . . . 0.0 109.086 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.6 m -146.05 -66.16 0.3 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.586 0.755 . . . . 0.0 109.267 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 54.75 56.35 6.82 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.337 1.055 . . . . 0.0 110.155 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 28.1 ttt -73.77 83.14 1.62 Allowed 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.937 -171.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.8 t 178.16 176.55 0.46 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.347 1.459 . . . . 0.0 109.142 178.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.5 ' HB3' ' O ' ' A' ' 108' ' ' PRO . 4.7 p-90 -94.77 -22.86 17.8 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.595 1.158 . . . . 0.0 109.341 166.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 84.6 t80 -71.68 109.05 5.33 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.862 173.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -128.27 120.29 26.84 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -59.06 -72.84 0.09 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.647 0.379 . . . . 0.0 110.937 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -85.48 59.05 5.39 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.72 0.808 . . . . 0.0 110.126 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 26.0 tp -88.2 -61.12 1.78 Allowed 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -176.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.2 m 93.81 145.94 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 127.125 2.17 . . . . 0.0 107.895 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.473 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 54.9 ttt180 -57.2 -46.83 82.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.112 0.565 . . . . 0.0 111.701 -177.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.523 ' O ' ' HB2' ' A' ' 25' ' ' GLU . . . -51.76 -47.92 63.93 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 124.173 0.92 . . . . 0.0 111.573 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.419 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -69.13 -38.04 78.63 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.459 177.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.447 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -61.4 -60.64 3.41 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.189 0.996 . . . . 0.0 112.114 -177.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 12.5 pt-20 -59.08 -29.58 67.44 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.246 1.019 . . . . 0.0 112.398 175.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.6 OUTLIER -67.1 -47.47 71.07 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.161 0.584 . . . . 0.0 109.522 178.119 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 22' ' ' ALA . 94.5 mt -59.59 -36.03 75.47 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.89 0.876 . . . . 0.0 111.341 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.3 mt -68.87 -54.55 15.0 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.24 -36.76 76.05 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.818 0.847 . . . . 0.0 112.748 -169.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -92.37 -59.47 2.08 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -73.35 -59.51 2.68 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -165.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.33 108.34 1.69 Allowed Glycine 0 C--N 1.349 1.304 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -175.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 50.8 ttt85 -57.75 -129.09 0.0 OUTLIER 'General case' 0 CA--C 1.581 2.173 0 C-N-CA 124.372 1.069 . . . . 0.0 113.236 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -74.68 148.83 40.24 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.282 -1.511 . . . . 0.0 111.442 -169.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.415 ' HA3' HD23 ' A' ' 106' ' ' LEU . . . 70.13 18.04 74.42 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.628 0.58 . . . . 0.0 114.207 -176.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.634 ' HB2' HG22 ' A' ' 109' ' ' VAL . 59.6 p -80.38 139.04 36.72 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -144.1 147.24 33.48 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.013 0.435 . . . . 0.0 110.255 177.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.447 HD11 ' HB1' ' A' ' 23' ' ' ALA . 1.6 pp -150.04 154.37 38.05 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.123 0.969 . . . . 0.0 108.701 168.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 79.6 t -114.73 131.02 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.496 ' HG3' ' HB3' ' A' ' 49' ' ' ALA . 5.9 ptm180 -116.79 168.64 10.04 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.214 1.005 . . . . 0.0 108.383 174.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -85.24 132.38 34.28 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 170.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 97.1 p -58.53 153.38 16.23 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 123.905 0.753 . . . . 0.0 111.596 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -71.73 79.58 0.85 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.711 0.804 . . . . 0.0 111.963 -172.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.3 m 53.55 28.31 7.63 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.954 1.301 . . . . 0.0 113.118 177.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.8 t -65.53 -73.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.499 0.72 . . . . 0.0 111.411 -172.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -172.41 34.7 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.238 0.615 . . . . 0.0 110.608 -177.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.39 35.49 33.14 Favored Glycine 0 N--CA 1.469 0.835 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.14 -174.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -97.08 169.77 9.58 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.568 0.747 . . . . 0.0 110.64 -177.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -124.16 157.49 34.59 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.049 0.94 . . . . 0.0 109.849 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.496 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . . . -133.64 144.77 49.42 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.295 0.638 . . . . 0.0 109.512 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.2 tp -123.9 124.21 42.12 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.447 ' SG ' HG22 ' A' ' 60' ' ' THR . 39.0 m -115.03 121.14 42.19 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -178.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 35' ' ' SER . 60.4 t -128.48 125.42 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.791 0.837 . . . . 0.0 109.038 -175.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.477 ' HB3' ' OG ' ' A' ' 35' ' ' SER . 60.7 tp -96.21 138.73 33.38 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.343 0.657 . . . . 0.0 109.905 177.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -161.57 125.05 3.2 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.9 0.88 . . . . 0.0 108.961 175.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 50.26 52.57 14.49 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.08 1.352 . . . . 0.0 112.391 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 80.3 tttt 55.9 39.11 30.64 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.737 1.215 . . . . 0.0 112.119 -176.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -140.69 106.03 5.05 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.94 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 85.4 t -87.36 112.06 22.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 168.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -97.4 130.34 44.54 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 170.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.447 HG22 ' SG ' ' A' ' 51' ' ' CYS . 41.1 p -108.29 130.26 55.19 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -113.59 98.9 7.34 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.3 mtm105 -83.54 91.69 7.47 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.506 HD13 HD11 ' A' ' 90' ' ' LEU . 61.7 mt -77.56 122.39 32.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.701 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.9 mp -93.96 149.86 37.61 Favored Pre-proline 0 CA--C 1.547 0.832 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -178.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -79.42 -143.05 0.02 OUTLIER 'Trans proline' 0 CA--C 1.565 2.061 0 C-N-CA 122.942 2.428 . . . . 0.0 112.498 -170.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.647 ' HB3' ' H ' ' A' ' 70' ' ' PHE . 31.0 t70 -169.74 151.43 4.25 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.646 0.778 . . . . 0.0 109.841 -172.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -55.33 -35.28 60.47 Favored Glycine 0 C--N 1.349 1.266 0 O-C-N 124.035 0.835 . . . . 0.0 114.112 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -102.59 25.13 9.48 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.646 0.778 . . . . 0.0 111.416 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 58.91 57.67 3.51 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.508 1.523 . . . . 0.0 114.098 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.647 ' H ' ' HB3' ' A' ' 66' ' ' ASP . 96.4 m-85 -118.86 151.65 37.72 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 169.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 mp -98.2 108.28 20.94 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.97 118.15 33.9 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.607 0.763 . . . . 0.0 109.628 -175.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 81' ' ' VAL . 12.9 t -99.72 140.96 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.918 0.887 . . . . 0.0 110.289 -176.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -108.09 89.73 3.08 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 176.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.3 m -90.82 125.51 35.74 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -171.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.2 m 59.01 -89.98 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.067 1.347 . . . . 0.0 112.061 177.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 176.75 -26.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.592 1.157 . . . . 0.0 111.057 -177.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -132.03 40.61 1.6 Allowed Glycine 0 N--CA 1.47 0.966 0 CA-C-N 116.694 -0.23 . . . . 0.0 112.861 -170.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.6 p -143.7 135.47 12.95 Favored Pre-proline 0 CA--C 1.555 1.168 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -40.14 135.06 1.76 Allowed 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 124.182 3.255 . . . . 0.0 115.091 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 73' ' ' VAL . 88.0 t -64.04 131.16 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.733 1.213 . . . . 0.0 109.473 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -105.32 116.48 32.02 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -174.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -93.34 146.12 23.97 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 172.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -125.56 146.57 49.62 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.695 0.798 . . . . 0.0 110.091 175.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -75.11 -40.04 60.18 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.764 0.425 . . . . 0.0 110.481 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.0 p -141.05 173.92 11.01 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.831 0.852 . . . . 0.0 109.854 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -68.37 -34.8 76.71 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.041 0.936 . . . . 0.0 109.455 175.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -60.66 -38.5 95.18 Favored Glycine 0 C--N 1.357 1.698 0 O-C-N 123.241 0.338 . . . . 0.0 113.341 175.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -64.93 -45.17 86.95 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.592 0.757 . . . . 0.0 111.096 174.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.506 HD11 HD13 ' A' ' 63' ' ' ILE . 8.2 tt -52.7 -50.34 63.53 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.426 1.09 . . . . 0.0 111.059 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.7 mm -70.3 -33.51 54.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.215 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.8 -57.31 20.09 Favored Glycine 0 CA--C 1.532 1.117 0 O-C-N 123.589 0.556 . . . . 0.0 114.163 178.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.1 mp -70.43 -31.17 68.25 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.098 0.559 . . . . 0.0 111.402 -178.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 -78.94 -18.87 53.05 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' A' ' 105' ' ' LEU . . . -61.01 -20.74 62.85 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.443 0.697 . . . . 0.0 112.707 174.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -110.9 166.32 10.98 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 123.643 0.777 . . . . 0.0 109.403 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -49.89 105.7 0.1 Allowed 'Trans proline' 0 C--N 1.386 2.518 0 C-N-CA 123.063 2.508 . . . . 0.0 112.327 168.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -90.97 -51.64 5.24 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.943 0.897 . . . . 0.0 111.521 -174.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 109.55 101.03 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 128.477 2.711 . . . . 0.0 108.673 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.15 -17.72 11.52 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.849 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 49.1 mt -77.31 143.95 38.43 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.821 0.448 . . . . 0.0 111.012 176.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.2 m -75.29 71.85 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 CA-C-O 121.826 0.822 . . . . 0.0 109.309 165.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 2.6 p 78.81 179.6 0.12 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.65 1.98 . . . . 0.0 110.761 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.06 -178.09 6.72 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.431 0.692 . . . . 0.0 110.895 -177.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 95' ' ' ALA . 29.0 mt -93.03 106.34 18.32 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 174.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.415 HD23 ' HA3' ' A' ' 34' ' ' GLY . 4.2 mm? -97.13 -56.89 2.41 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.379 0.672 . . . . 0.0 110.863 -176.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.5 pp -133.25 147.33 64.63 Favored Pre-proline 0 N--CA 1.486 1.333 0 C-N-CA 122.636 0.374 . . . . 0.0 111.407 -169.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.5 ' O ' ' HB3' ' A' ' 13' ' ' TRP . 65.0 Cg_endo -77.81 -11.99 16.56 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 123.155 2.57 . . . . 0.0 115.154 -171.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.634 HG22 ' HB2' ' A' ' 35' ' ' SER . 22.3 t . . . . . 0 N--CA 1.503 2.223 0 C-N-CA 124.994 1.318 . . . . 0.0 109.5 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 166.01 -25.86 0.16 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -77.17 123.41 26.38 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.647 0.779 . . . . 0.0 110.148 178.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -163.74 150.69 12.09 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.111 0.964 . . . . 0.0 109.199 173.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -85.22 175.52 8.9 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.684 0.754 . . . . 0.0 111.183 175.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -156.56 146.73 21.25 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.425 176.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -98.72 79.23 2.41 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -152.84 102.86 2.71 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.0 m -70.77 151.86 44.39 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.562 0.745 . . . . 0.0 111.285 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -125.59 137.19 53.89 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.643 0.777 . . . . 0.0 109.657 177.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -158.48 -45.3 0.06 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.138 0.975 . . . . 0.0 108.934 175.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.2 m 38.44 86.22 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.789 1.636 . . . . 0.0 112.781 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 108' ' ' PRO . 1.6 p-90 -80.37 3.47 21.11 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.459 0.704 . . . . 0.0 112.009 -172.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -110.82 102.33 10.86 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -172.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -118.22 119.1 33.68 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -67.56 -81.59 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.622 0.769 . . . . 0.0 111.477 -164.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -83.77 42.69 0.86 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 118.382 0.537 . . . . 0.0 111.761 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.441 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 35.8 tp -68.16 -48.0 66.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.839 0.456 . . . . 0.0 109.851 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.8 m 79.98 152.78 0.12 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.647 1.179 . . . . 0.0 110.684 170.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -56.58 -62.61 1.61 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.631 1.172 . . . . 0.0 112.546 -168.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.76 -50.66 67.89 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.598 0.759 . . . . 0.0 112.256 -178.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -65.46 -32.12 73.56 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.219 -178.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.75 -53.54 26.45 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.646 0.378 . . . . 0.0 111.629 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.26 -32.84 74.71 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 123.784 0.678 . . . . 0.0 111.619 -178.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -69.26 -43.65 73.51 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.228 0.33 . . . . 0.0 110.712 176.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.5 -27.0 66.64 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.515 0.726 . . . . 0.0 111.933 174.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.8 mt -66.96 -60.26 2.79 Favored 'General case' 0 C--N 1.348 0.52 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 170.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.79 -32.29 63.37 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.377 1.071 . . . . 0.0 112.951 -176.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.05 -58.0 3.49 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.74 0.816 . . . . 0.0 109.687 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.9 -55.18 5.16 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.295 -168.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -99.86 -58.28 0.89 Allowed Glycine 0 N--CA 1.47 0.96 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 -176.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.577 ' HA ' HD23 ' A' ' 53' ' ' LEU . 53.9 ttp180 51.9 104.86 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.083 2.153 . . . . 0.0 113.345 -170.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.8 t70 88.99 120.92 0.03 OUTLIER 'General case' 0 C--N 1.36 1.047 0 C-N-CA 124.778 1.231 . . . . 0.0 109.241 163.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.497 ' HA2' ' SG ' ' A' ' 103' ' ' CYS . . . 77.29 -0.43 68.39 Favored Glycine 0 C--N 1.352 1.43 0 CA-C-N 116.388 -0.369 . . . . 0.0 113.335 -168.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.0 m -82.91 141.22 32.35 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.903 0.881 . . . . 0.0 109.526 -175.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.455 ' HB2' HG22 ' A' ' 52' ' ' VAL . 20.6 p90 -144.76 158.21 43.87 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 175.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 pp -160.31 161.3 33.24 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.267 0.627 . . . . 0.0 109.944 168.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.472 HG21 HD11 ' A' ' 91' ' ' ILE . 40.2 t -110.91 145.55 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.412 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 17.6 mtm180 -132.33 165.52 24.02 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.829 0.851 . . . . 0.0 108.892 -176.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -89.18 119.2 29.46 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 158.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 56.4 m -58.97 147.64 33.57 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.456 0.473 . . . . 0.0 109.906 -175.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.431 ' CD ' ' H ' ' A' ' 42' ' ' GLU . 1.4 pm0 -77.05 77.23 3.59 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.279 1.032 . . . . 0.0 110.943 -162.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.5 t 50.13 54.61 10.79 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 125.497 1.519 . . . . 0.0 111.646 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 m -96.27 -55.5 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.904 -178.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -168.98 16.98 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.517 0.727 . . . . 0.0 111.305 -176.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.63 34.51 35.03 Favored Glycine 0 N--CA 1.474 1.168 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 -173.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -94.14 167.59 11.47 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.794 0.837 . . . . 0.0 112.194 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.537 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 79.0 m-85 -105.6 140.93 37.92 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.811 1.245 . . . . 0.0 109.309 171.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' A' ' 39' ' ' ARG . . . -117.42 126.19 52.22 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.946 0.498 . . . . 0.0 109.899 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.3 tp -108.81 104.08 13.28 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -177.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 53.5 t -102.55 120.21 40.15 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -176.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.455 HG22 ' HB2' ' A' ' 36' ' ' PHE . 56.3 t -128.05 121.42 56.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.373 1.069 . . . . 0.0 108.579 -175.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.577 HD23 ' HA ' ' A' ' 32' ' ' ARG . 43.1 tp -100.38 131.66 46.18 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.805 0.842 . . . . 0.0 109.013 174.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -167.0 145.53 5.08 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.167 0.917 . . . . 0.0 109.305 -177.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 47.82 41.45 14.33 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 125.852 1.661 . . . . 0.0 112.898 177.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.2 tttp 56.01 37.34 28.74 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.754 1.221 . . . . 0.0 111.684 -176.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -142.4 115.92 9.09 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.472 -174.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.4 HG22 HD13 ' A' ' 53' ' ' LEU . 45.2 t -83.82 139.03 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 173.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -139.21 123.85 18.45 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.8 m -114.16 129.97 56.61 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.502 ' HD2' ' HA ' ' A' ' 75' ' ' THR . 9.3 m-85 -115.22 100.58 8.24 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 -176.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -78.23 100.02 6.49 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 3.2 mp -70.02 118.65 14.8 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.764 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 165.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.478 ' H ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -120.88 131.17 24.55 Favored Pre-proline 0 C--O 1.241 0.611 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.52 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 7.1 Cg_exo -73.17 -74.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 122.241 1.961 . . . . 0.0 110.607 171.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.7 t70 71.36 124.94 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.733 1.213 . . . . 0.0 108.379 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 49.62 -143.99 9.69 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.593 -153.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -117.62 -154.2 0.55 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.268 0.627 . . . . 0.0 110.308 169.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.0 t70 88.02 -74.9 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 126.158 1.783 . . . . 0.0 110.491 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -129.65 158.91 38.02 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 121.408 0.623 . . . . 0.0 112.04 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 3.0 pp -110.49 123.31 49.67 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.416 1.086 . . . . 0.0 108.722 165.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.82 123.79 48.67 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.253 0.621 . . . . 0.0 111.008 -177.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 7.3 p -85.53 147.13 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -110.96 91.68 3.75 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.711 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 41.1 p -77.1 -58.88 3.03 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.13 -177.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.9 m -138.09 153.69 49.28 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.358 0.663 . . . . 0.0 110.343 -177.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -77.71 138.02 38.82 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.042 0.537 . . . . 0.0 110.043 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.57 32.49 67.59 Favored Glycine 0 CA--C 1.523 0.537 0 O-C-N 123.749 0.656 . . . . 0.0 114.029 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.7 m -133.78 144.43 51.81 Favored Pre-proline 0 N--CA 1.481 1.079 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.22 103.15 1.56 Allowed 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.273 1.982 . . . . 0.0 109.312 168.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.482 HG12 ' H ' ' A' ' 82' ' ' ARG . 4.7 t -79.75 174.14 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.26 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.482 ' H ' HG12 ' A' ' 81' ' ' VAL . 5.5 tpp180 -95.81 133.31 40.1 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -175.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -91.77 138.87 31.2 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -124.21 149.54 46.27 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.494 0.718 . . . . 0.0 109.468 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -96.17 -16.1 21.69 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 88' ' ' GLY . 25.5 m -144.33 140.2 28.99 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.936 0.895 . . . . 0.0 109.081 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -63.59 -31.83 73.11 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.433 1.093 . . . . 0.0 110.051 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.483 ' H ' HG22 ' A' ' 86' ' ' THR . . . -54.87 -42.03 78.14 Favored Glycine 0 CA--C 1.541 1.707 0 CA-C-N 116.409 -0.36 . . . . 0.0 113.923 172.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.39 -37.13 84.59 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.56 0.744 . . . . 0.0 110.791 176.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.406 HD11 ' HB ' ' A' ' 73' ' ' VAL . 9.3 tt -61.7 -55.0 35.12 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.265 1.026 . . . . 0.0 111.299 -176.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.472 HD11 HG21 ' A' ' 38' ' ' VAL . 49.8 mt -66.46 -37.53 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 123.44 0.463 . . . . 0.0 110.727 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.92 -52.39 46.85 Favored Glycine 0 C--N 1.342 0.913 0 O-C-N 123.769 0.668 . . . . 0.0 112.838 176.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 51.8 tp -72.15 -43.5 64.55 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.082 0.553 . . . . 0.0 111.412 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.484 ' HE2' HG11 ' A' ' 73' ' ' VAL . 18.6 m-85 -82.75 0.52 43.24 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -174.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.43 -25.41 64.32 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-O 121.472 0.653 . . . . 0.0 109.696 158.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -95.84 128.72 36.51 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.994 1.317 . . . . 0.0 107.565 171.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -80.55 -155.47 0.06 OUTLIER 'Trans proline' 0 CA--C 1.557 1.655 0 C-N-CA 122.837 2.358 . . . . 0.0 112.643 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 67.51 48.51 1.1 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.438 1.095 . . . . 0.0 111.842 171.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -163.32 10.69 0.06 Allowed 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.42 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.711 ' HA3' ' HB ' ' A' ' 75' ' ' THR . . . 127.28 -12.35 6.73 Favored Glycine 0 C--N 1.355 1.61 0 O-C-N 122.041 -0.412 . . . . 0.0 113.102 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.4 118.26 21.88 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.992 0.917 . . . . 0.0 111.422 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.7 p -55.55 -32.27 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.484 1.114 . . . . 0.0 111.24 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.497 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 53.8 t -138.31 145.18 40.89 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.003 0.921 . . . . 0.0 109.821 177.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.38 141.07 54.23 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 169.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 62.3 mt -76.17 92.86 3.29 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -174.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.433 ' HG ' ' HG ' ' A' ' 107' ' ' LEU . 47.4 tp -101.19 -58.14 1.95 Allowed 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.304 -171.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.433 ' HG ' ' HG ' ' A' ' 106' ' ' LEU . 58.6 mt -142.25 123.9 8.8 Favored Pre-proline 0 N--CA 1.485 1.302 0 C-N-CA 123.598 0.759 . . . . 0.0 109.336 -170.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.467 ' HB3' ' HB3' ' A' ' 13' ' ' TRP . 27.1 Cg_endo -61.06 -74.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 122.602 2.201 . . . . 0.0 112.906 -176.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 55.8 t . . . . . 0 CA--C 1.551 1.005 0 C-N-CA 124.242 1.017 . . . . 0.0 108.668 -177.577 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 ttp . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.21 10.27 85.65 Favored Glycine 0 C--N 1.347 1.184 0 O-C-N 123.509 0.505 . . . . 0.0 113.946 171.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -83.61 103.23 12.77 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -137.5 89.71 2.44 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -103.09 87.92 3.02 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 169.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -79.52 127.71 32.47 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 172.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -76.04 128.46 35.06 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.65 0.38 . . . . 0.0 110.134 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -70.99 161.87 30.39 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.362 0.665 . . . . 0.0 110.904 175.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.6 m -62.81 162.73 10.49 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.537 1.135 . . . . 0.0 113.374 -170.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -62.62 -30.41 71.34 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 168.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.464 ' SD ' ' N ' ' A' ' 12' ' ' SER . 1.6 tmt? 61.81 -88.78 0.03 OUTLIER 'General case' 0 C--N 1.355 0.847 0 C-N-CA 125.596 1.558 . . . . 0.0 110.573 170.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.464 ' N ' ' SD ' ' A' ' 11' ' ' MET . 67.1 m -168.86 124.39 0.91 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.165 1.386 . . . . 0.0 108.699 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -99.29 -18.82 17.38 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 161.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -75.53 104.51 6.12 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 166.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -113.59 96.27 5.78 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -54.45 -39.82 67.8 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 124.38 1.05 . . . . 0.0 113.178 -164.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -125.11 85.72 2.45 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.3 tp -115.82 -45.22 2.89 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.437 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.5 t 79.9 155.29 0.14 Allowed 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 124.746 1.218 . . . . 0.0 110.229 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -57.56 -50.66 72.37 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -172.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.07 -53.99 50.35 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.587 0.755 . . . . 0.0 111.948 -176.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.53 -30.93 68.88 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.24 0.616 . . . . 0.0 111.836 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.524 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -65.57 -58.96 4.51 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.685 0.794 . . . . 0.0 111.496 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.571 ' HG3' HG21 ' A' ' 58' ' ' VAL . 34.6 tt0 -56.97 -42.59 80.44 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.264 1.425 . . . . 0.0 111.976 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -67.8 -39.88 83.95 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.137 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.402 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 33.4 tp -63.16 -38.71 92.27 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.935 0.894 . . . . 0.0 111.667 175.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.495 HD21 ' HG ' ' A' ' 37' ' ' LEU . 95.6 mt -68.0 -29.36 68.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.256 0.622 . . . . 0.0 111.097 177.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.23 -54.39 5.78 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.81 0.844 . . . . 0.0 111.085 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.402 ' HG2' ' HA ' ' A' ' 26' ' ' LEU . 11.1 ptp180 -66.8 -46.01 76.57 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.419 0.688 . . . . 0.0 111.226 -174.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.4 ' N ' ' HG3' ' A' ' 29' ' ' ARG . . . -89.65 -60.59 1.9 Allowed 'General case' 0 C--N 1.349 0.551 0 C-N-CA 123.003 0.521 . . . . 0.0 110.803 -172.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.35 -36.97 19.16 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-O 119.799 -0.445 . . . . 0.0 113.704 -172.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? 74.79 -25.25 0.2 Allowed 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 125.273 1.429 . . . . 0.0 113.477 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.4 t70 174.93 141.69 0.05 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.661 0.784 . . . . 0.0 109.369 -165.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.56 9.82 65.72 Favored Glycine 0 C--N 1.358 1.787 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 12.4 m -84.71 146.73 27.27 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.295 1.038 . . . . 0.0 111.007 -168.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -150.83 151.88 32.92 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 174.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.524 HD11 ' HB1' ' A' ' 23' ' ' ALA . 2.9 pp -152.6 158.85 43.04 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 169.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.607 HG21 HD11 ' A' ' 87' ' ' LEU . 36.8 t -112.11 154.74 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.1 ptt85 -156.21 175.09 14.45 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.907 0.883 . . . . 0.0 109.039 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.17 145.2 24.87 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.5 m -56.17 148.63 17.68 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.658 0.783 . . . . 0.0 113.041 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -88.72 3.61 50.25 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.248 1.019 . . . . 0.0 112.048 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.0 m -134.48 -63.6 0.71 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.148 0.579 . . . . 0.0 111.101 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 47' ' ' ALA . 14.7 m -85.86 117.79 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 121.726 0.774 . . . . 0.0 110.672 -178.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.32 128.7 37.37 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.616 -1.174 . . . . 0.0 112.551 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.89 7.42 81.02 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 114.691 0.636 . . . . 0.0 114.691 177.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.478 ' HB3' HG23 ' A' ' 44' ' ' VAL . . . -100.81 173.78 6.35 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.149 0.58 . . . . 0.0 109.901 174.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -117.03 160.8 20.4 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-O 121.388 0.613 . . . . 0.0 112.027 -178.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.61 144.85 42.15 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.23 168.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.489 HD13 HG22 ' A' ' 38' ' ' VAL . 51.0 tp -125.05 110.59 14.35 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.695 1.198 . . . . 0.0 108.483 -174.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 35.5 t -104.23 123.02 46.59 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -175.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.2 t -130.48 121.8 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.636 0.774 . . . . 0.0 109.714 -172.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.424 HD13 HG22 ' A' ' 58' ' ' VAL . 16.1 tp -111.22 115.64 29.7 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.297 1.039 . . . . 0.0 109.685 175.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -145.79 144.77 30.49 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 166.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 53.45 36.56 23.47 Favored 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 124.536 1.134 . . . . 0.0 112.277 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 65.7 mttm 58.68 36.47 24.98 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.403 1.081 . . . . 0.0 112.412 -173.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -126.04 104.91 8.53 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.571 HG21 ' HG3' ' A' ' 24' ' ' GLU . 17.5 t -100.69 107.91 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.739 0.816 . . . . 0.0 108.877 174.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -112.14 140.63 46.67 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 171.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 89.2 m -106.63 135.75 47.62 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -117.1 100.04 7.46 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -63.48 155.28 29.74 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 168.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 92.3 mt -144.95 101.92 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 102.59 -3.115 . . . . 0.0 102.59 -158.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.1 mp -105.11 111.59 65.15 Favored Pre-proline 0 N--CA 1.472 0.649 0 O-C-N 123.351 0.407 . . . . 0.0 109.94 -161.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 70' ' ' PHE . 1.4 Cg_endo -81.76 108.55 1.89 Allowed 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.606 2.204 . . . . 0.0 109.422 162.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -82.15 137.24 35.01 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 174.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -46.73 77.57 0.0 OUTLIER Glycine 0 CA--C 1.538 1.49 0 N-CA-C 117.172 1.629 . . . . 0.0 117.172 -172.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -151.84 -83.29 0.09 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.366 1.866 . . . . 0.0 106.77 170.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -167.33 4.28 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 178.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 83.5 m-85 -115.81 140.29 49.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.237 -0.914 . . . . 0.0 110.899 -170.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.408 ' HG ' ' HG3' ' A' ' 65' ' ' PRO . 5.3 mp -111.07 112.3 24.02 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.964 0.905 . . . . 0.0 109.536 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.63 143.03 28.72 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.95 0.5 . . . . 0.0 112.17 -174.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 81' ' ' VAL . 39.1 t -109.38 137.46 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.212 1.005 . . . . 0.0 108.434 169.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -112.28 130.0 56.09 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -170.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.422 ' OG1' ' HA3' ' A' ' 100' ' ' GLY . 3.6 t -158.76 -41.8 0.06 Allowed 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.232 -175.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 65.9 m 58.68 -109.03 0.44 Allowed 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 117.777 -1.106 . . . . 0.0 111.808 -174.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 72.18 -42.14 0.52 Allowed 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.155 1.382 . . . . 0.0 113.427 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 148.01 -21.18 1.42 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 -166.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.515 HG11 ' HA ' ' A' ' 99' ' ' GLN . 14.0 m -84.44 134.25 43.06 Favored Pre-proline 0 CA--C 1.557 1.215 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 173.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.69 146.46 97.19 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.605 2.203 . . . . 0.0 112.015 175.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 73' ' ' VAL . 42.0 t -68.23 130.49 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -105.92 118.91 37.82 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -172.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -102.32 121.19 41.8 Favored 'General case' 0 C--N 1.344 0.355 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 54.5 p90 -109.0 153.62 23.34 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.472 0.709 . . . . 0.0 110.199 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -104.46 -9.6 18.28 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.778 0.831 . . . . 0.0 110.061 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.7 t -149.04 144.22 26.57 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.29 0.636 . . . . 0.0 109.403 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.607 HD11 HG21 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -60.73 -31.02 70.35 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.481 1.112 . . . . 0.0 111.232 -173.589 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -55.23 -34.42 58.93 Favored Glycine 0 CA--C 1.539 1.566 0 N-CA-C 113.984 0.354 . . . . 0.0 113.984 174.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 84' ' ' PHE . 46.9 mt-10 -68.28 -40.53 81.79 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.34 0.656 . . . . 0.0 110.982 175.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 51.0 tp -53.12 -55.54 23.27 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.336 0.589 . . . . 0.0 110.628 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.6 mm -66.97 -36.21 76.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.79 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.12 -52.34 53.06 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.754 0.659 . . . . 0.0 113.55 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.5 mt -65.74 -56.86 9.81 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.992 0.917 . . . . 0.0 111.102 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.616 ' HB3' HD11 ' A' ' 101' ' ' LEU . 83.8 m-85 -79.59 -4.25 50.68 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -170.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.32 -27.7 67.55 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.21 0.529 . . . . 0.0 110.513 164.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -84.17 131.52 50.67 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.146 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.446 ' HB3' ' HB2' ' A' ' 104' ' ' ALA . 81.7 Cg_endo -80.49 -172.97 1.67 Allowed 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.673 2.249 . . . . 0.0 113.598 -175.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 56.6 61.02 2.82 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.407 1.483 . . . . 0.0 111.33 -178.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.515 ' HA ' HG11 ' A' ' 79' ' ' VAL . 46.2 mt-30 -143.76 12.39 1.67 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.356 1.062 . . . . 0.0 111.441 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.422 ' HA3' ' OG1' ' A' ' 75' ' ' THR . . . 110.58 -5.79 29.69 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 112.16 -0.376 . . . . 0.0 112.16 178.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.616 HD11 ' HB3' ' A' ' 94' ' ' TYR . 94.4 mt -78.85 146.86 33.42 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.277 1.031 . . . . 0.0 111.234 -178.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.4 m -63.3 -26.72 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.391 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.83 171.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 31.9 p -162.61 171.85 16.29 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.514 1.126 . . . . 0.0 110.281 171.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.446 ' HB2' ' HB3' ' A' ' 97' ' ' PRO . . . -66.68 145.35 55.65 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 169.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 73.9 mt -64.38 103.39 0.64 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -177.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 62.5 tp -111.31 -60.25 1.86 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.589 0.756 . . . . 0.0 111.576 -166.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 35' ' ' SER . 5.8 tt -114.46 97.42 46.3 Favored Pre-proline 0 N--CA 1.474 0.741 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -169.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -81.44 130.34 6.98 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 122.232 1.955 . . . . 0.0 111.214 175.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.7 t . . . . . 0 C--O 1.251 1.174 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.186 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 66.3 43.96 91.71 Favored Glycine 0 C--N 1.345 1.029 0 O-C-N 123.722 0.639 . . . . 0.0 112.12 -173.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -62.65 141.32 58.57 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.07 0.948 . . . . 0.0 110.735 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -74.14 100.64 3.7 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.05 0.54 . . . . 0.0 110.427 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -133.47 94.04 3.25 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 124.219 1.008 . . . . 0.0 108.645 173.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -65.94 92.04 0.16 Allowed 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.315 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -87.16 55.49 3.58 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 122.146 0.974 . . . . 0.0 109.615 -177.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -139.99 163.75 31.85 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.334 -174.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.0 m 71.48 116.08 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.727 1.211 . . . . 0.0 110.611 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -71.89 171.62 11.4 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 123.068 0.547 . . . . 0.0 109.717 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 46.5 ttp 68.81 8.06 6.54 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.812 0.845 . . . . 0.0 111.188 177.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 t -72.14 -54.36 9.95 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.702 0.801 . . . . 0.0 110.199 -175.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 108' ' ' PRO . 77.2 t90 92.45 -43.9 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.938 1.295 . . . . 0.0 110.928 163.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.555 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 87.9 t80 -109.71 110.78 21.92 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -174.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -126.48 106.18 9.27 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -176.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.543 ' HA ' ' HB3' ' A' ' 40' ' ' ASP . 39.8 ttm180 -74.94 152.0 38.83 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.402 176.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.547 ' HA ' ' HG2' ' A' ' 42' ' ' GLU 0.291 11.3 p-10 36.82 51.8 0.97 Allowed 'General case' 0 C--N 1.37 1.494 0 C-N-CA 125.356 1.462 . . . . 0.0 114.527 -172.325 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.7 tp -114.73 124.54 52.05 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 169.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.7 m -69.06 156.4 38.71 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.945 0.498 . . . . 0.0 110.235 -178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.3 ttp85 -54.04 -52.14 61.8 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.775 0.43 . . . . 0.0 111.061 172.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.03 -45.26 71.52 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.33 1.052 . . . . 0.0 111.867 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.06 -29.85 64.56 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.578 0.751 . . . . 0.0 112.089 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.601 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -76.84 -47.53 21.13 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.571 0.748 . . . . 0.0 111.419 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.558 ' HG3' HG21 ' A' ' 58' ' ' VAL . 32.8 tt0 -51.79 -39.82 59.33 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.252 1.421 . . . . 0.0 111.187 169.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -63.96 -47.72 79.3 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.3 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.7 tp -57.86 -45.14 86.75 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.677 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.615 HD21 HD22 ' A' ' 37' ' ' LEU . 94.2 mt -63.45 -50.45 69.7 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.016 0.927 . . . . 0.0 110.623 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.16 -34.5 73.66 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.756 0.823 . . . . 0.0 111.681 -175.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -83.88 -32.71 25.04 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.493 0.717 . . . . 0.0 111.384 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.82 -65.8 0.98 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -174.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.91 -47.22 0.84 Allowed Glycine 0 C--N 1.356 1.666 0 CA-C-N 117.995 0.362 . . . . 0.0 113.422 -172.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 55.9 24.9 8.01 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 125.573 1.549 . . . . 0.0 114.924 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -174.4 100.15 0.1 Allowed 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.264 -0.897 . . . . 0.0 109.582 -174.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.03 15.83 80.89 Favored Glycine 0 N--CA 1.474 1.199 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.908 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.1 m -85.53 116.29 23.74 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.916 0.887 . . . . 0.0 109.684 -170.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -126.74 159.45 33.69 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.814 0.34 . . . . 0.0 111.672 -175.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.615 HD22 HD21 ' A' ' 27' ' ' LEU . 1.6 pt? -163.13 163.73 25.6 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.008 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 25.6 t -126.71 122.69 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 175.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.436 HH21 HD21 ' A' ' 37' ' ' LEU . 9.3 ptp85 -116.87 157.66 25.27 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -177.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.543 ' HB3' ' HA ' ' A' ' 16' ' ' ARG . 33.6 t70 -93.82 122.96 36.83 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 170.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.4 m -57.16 151.98 14.46 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.706 0.629 . . . . 0.0 111.403 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.547 ' HG2' ' HA ' ' A' ' 17' ' ' ASP . 32.5 mt-10 -81.93 -22.14 36.89 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -163.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.3 t -167.6 103.33 0.5 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 172.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.465 HG11 ' HB3' ' A' ' 47' ' ' ALA . 8.1 p -158.84 169.88 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 C-N-CA 123.9 0.88 . . . . 0.0 109.564 -178.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.99 23.21 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 175.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.446 ' H ' HG13 ' A' ' 44' ' ' VAL . . . 92.58 91.2 1.49 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -175.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.465 ' HB3' HG11 ' A' ' 44' ' ' VAL . . . -152.16 134.68 15.32 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.488 1.115 . . . . 0.0 109.5 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -110.62 143.39 41.12 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.002 0.921 . . . . 0.0 109.197 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.1 125.2 52.06 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.606 0.362 . . . . 0.0 110.86 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 37' ' ' LEU . 40.3 tp -105.51 131.62 52.69 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.724 ' SG ' HG22 ' A' ' 60' ' ' THR . 73.6 m -123.86 141.24 52.21 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 118.527 0.603 . . . . 0.0 110.126 171.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.6 t -125.47 114.72 40.88 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 170.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.709 HD13 HG22 ' A' ' 58' ' ' VAL . 13.8 tp -99.56 137.83 37.49 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.34 1.056 . . . . 0.0 108.921 176.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -149.44 102.87 3.23 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.003 1.321 . . . . 0.0 108.178 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 48.93 68.95 0.63 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.758 0.823 . . . . 0.0 112.808 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt 62.28 12.99 5.58 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -110.47 102.34 10.96 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.709 HG22 HD13 ' A' ' 53' ' ' LEU . 3.4 t -107.87 120.82 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -114.75 140.53 48.82 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 172.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.724 HG22 ' SG ' ' A' ' 51' ' ' CYS . 62.7 p -112.71 136.45 52.29 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.574 1.15 . . . . 0.0 109.072 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.29 96.91 4.43 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 178.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -80.94 100.7 9.05 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.471 HG21 HD12 ' A' ' 71' ' ' LEU . 15.6 mt -72.06 128.78 35.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.231 -1.35 . . . . 0.0 109.651 173.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.406 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -137.5 135.77 19.64 Favored Pre-proline 0 C--O 1.24 0.567 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 170.918 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 36.6 Cg_exo -62.1 -62.28 0.13 Allowed 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 122.786 2.324 . . . . 0.0 114.133 177.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.5 t70 87.91 -69.27 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.598 1.559 . . . . 0.0 109.2 175.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -85.5 16.71 38.54 Favored Glycine 0 C--N 1.357 1.698 0 CA-C-O 119.71 -0.495 . . . . 0.0 113.517 169.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 66.09 -30.76 0.14 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 174.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -76.5 -45.11 32.34 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.437 1.017 . . . . 0.0 111.131 -170.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 25.3 p90 -108.39 145.3 34.76 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 124.915 1.286 . . . . 0.0 108.504 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.496 HD23 ' H ' ' A' ' 71' ' ' LEU . 2.6 pt? -99.23 118.96 37.09 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 164.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.62 117.6 33.44 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.528 0.731 . . . . 0.0 110.713 -175.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.858 HG21 HD13 ' A' ' 90' ' ' LEU . 14.6 t -89.58 116.28 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.094 0.958 . . . . 0.0 110.342 177.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -90.39 92.11 8.76 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.422 HG23 ' HE2' ' A' ' 94' ' ' TYR . 0.2 OUTLIER -54.07 -58.61 6.69 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.419 177.961 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.0 m -155.3 131.19 10.01 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.454 1.502 . . . . 0.0 107.336 163.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -66.16 95.46 0.29 Allowed 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 165.51 -58.21 0.25 Allowed Glycine 0 C--N 1.343 0.93 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -172.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.38 140.83 82.54 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 124.051 0.94 . . . . 0.0 109.41 169.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -49.9 87.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.386 2.511 0 C-N-CA 123.599 2.866 . . . . 0.0 114.134 173.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 73' ' ' VAL . 7.4 p -36.72 143.78 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 126.262 1.825 . . . . 0.0 115.252 169.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -107.18 132.86 52.58 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 124.2 1.0 . . . . 0.0 109.505 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -99.12 146.87 25.66 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.078 0.951 . . . . 0.0 109.001 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -136.23 164.78 27.28 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.911 0.884 . . . . 0.0 109.038 -174.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -126.44 -13.31 6.06 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.847 0.459 . . . . 0.0 110.333 176.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 88' ' ' GLY . 20.8 m -140.15 140.7 36.01 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.631 0.772 . . . . 0.0 109.376 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 75.0 mt -58.36 -32.82 68.91 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.616 0.766 . . . . 0.0 111.551 172.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.582 ' H ' HG22 ' A' ' 86' ' ' THR . . . -60.39 -33.16 79.83 Favored Glycine 0 CA--C 1.532 1.154 0 O-C-N 123.493 0.496 . . . . 0.0 113.582 174.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.528 ' HG3' ' HB ' ' A' ' 86' ' ' THR . 47.6 mt-10 -71.83 -40.85 68.78 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.933 0.493 . . . . 0.0 110.168 176.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.858 HD13 HG21 ' A' ' 73' ' ' VAL . 42.2 tp -52.7 -51.59 59.67 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.553 0.741 . . . . 0.0 110.344 174.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.407 HD11 ' CZ2' ' A' ' 13' ' ' TRP . 49.7 mm -62.79 -39.28 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.432 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.15 -57.32 20.39 Favored Glycine 0 CA--C 1.529 0.911 0 O-C-N 123.621 0.576 . . . . 0.0 113.44 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.7 mp -70.74 -52.01 23.58 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.562 0.745 . . . . 0.0 112.006 -177.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.51 ' HB3' HD11 ' A' ' 101' ' ' LEU . 30.2 m-85 -68.66 -17.26 64.06 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -173.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.44 -19.93 51.22 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 171.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -77.99 124.13 86.13 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 123.396 0.678 . . . . 0.0 109.996 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -70.95 168.29 23.54 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.67 2.246 . . . . 0.0 111.724 173.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 53.8 58.11 5.41 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.85 0.86 . . . . 0.0 110.532 -174.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -142.52 -15.91 0.73 Allowed 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.701 -177.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 141.54 -18.06 2.64 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -175.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.51 HD11 ' HB3' ' A' ' 94' ' ' TYR . 17.7 mt -99.93 105.98 17.75 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.23 0.612 . . . . 0.0 110.105 175.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.6 m -44.96 -25.98 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 125.221 1.408 . . . . 0.0 114.538 174.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 36.7 t -124.27 -11.3 7.47 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.141 0.576 . . . . 0.0 112.444 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 64.11 178.57 0.17 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.122 0.969 . . . . 0.0 111.399 -167.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.1 mt -77.62 92.12 4.06 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.7 176.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.0 tt -81.78 -65.38 1.02 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.856 0.462 . . . . 0.0 109.906 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -146.22 130.05 8.48 Favored Pre-proline 0 N--CA 1.491 1.575 0 C-N-CA 122.295 0.238 . . . . 0.0 110.919 -174.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.487 ' HB2' ' HB2' ' A' ' 13' ' ' TRP . 80.8 Cg_endo -74.38 145.13 33.61 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.689 2.259 . . . . 0.0 111.779 177.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 57.2 t . . . . . 0 C--O 1.256 1.422 0 C-N-CA 123.799 0.84 . . . . 0.0 109.533 179.543 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.411 ' HB2' ' HA ' ' A' ' 37' ' ' LEU . 4.3 p-90 -85.41 -1.13 56.7 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.966 -0.459 . . . . 0.0 110.761 -177.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -107.33 113.57 27.04 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -173.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.431 ' NE2' ' HB2' ' A' ' 37' ' ' LEU . 1.9 p80 -138.97 109.95 6.78 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.518 1.127 . . . . 0.0 108.76 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -86.73 26.82 1.06 Allowed 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 124.17 0.988 . . . . 0.0 110.634 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -160.39 25.31 0.16 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.295 0.638 . . . . 0.0 111.098 -162.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 20.0 tp -108.99 -49.09 3.18 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.675 -0.64 . . . . 0.0 111.63 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.4 t 80.08 153.23 0.12 Allowed 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 124.856 1.262 . . . . 0.0 109.869 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HB2' ' NH1' ' A' ' 39' ' ' ARG . 74.5 ttt180 -64.21 -38.87 92.6 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 118.019 0.372 . . . . 0.0 111.512 -168.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.57 -54.82 23.56 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 123.652 0.595 . . . . 0.0 110.752 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.77 -22.55 43.02 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.9 -57.08 4.13 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 123.206 0.602 . . . . 0.0 111.542 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.429 ' HG3' HG11 ' A' ' 58' ' ' VAL . 36.7 tt0 -57.76 -37.08 73.03 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.076 1.351 . . . . 0.0 111.26 173.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -71.05 -38.18 72.53 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.365 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -55.13 -43.76 74.43 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.285 0.634 . . . . 0.0 110.083 173.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.569 HD22 ' HB3' ' A' ' 35' ' ' SER . 82.8 mt -71.92 -42.31 66.84 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 123.485 0.49 . . . . 0.0 110.413 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.36 -37.32 71.65 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.543 0.737 . . . . 0.0 112.21 -174.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.7 mtp180 -82.16 -50.56 8.89 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.024 0.53 . . . . 0.0 111.325 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.476 ' HB1' HG11 ' A' ' 109' ' ' VAL . . . -66.41 -46.8 75.35 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.559 0.344 . . . . 0.0 110.314 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.38 125.84 0.0 OUTLIER Glycine 0 CA--C 1.538 1.515 0 N-CA-C 118.854 2.302 . . . . 0.0 118.854 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 177.66 103.22 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 165.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -62.44 149.92 41.36 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -154.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.41 ' HA2' ' SG ' ' A' ' 103' ' ' CYS . . . 89.56 17.45 54.77 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -161.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.569 ' HB3' HD22 ' A' ' 27' ' ' LEU . 17.2 m -71.81 130.59 41.44 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 124.434 1.094 . . . . 0.0 108.895 -177.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 108' ' ' PRO . 50.9 p90 -141.74 155.14 45.65 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.118 0.485 . . . . 0.0 111.034 177.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.465 ' HG ' HD21 ' A' ' 27' ' ' LEU . 0.8 OUTLIER -158.58 153.47 25.0 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.612 166.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.6 t -105.28 117.41 50.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.543 ' HG3' ' HB3' ' A' ' 49' ' ' ALA . 2.1 ptm180 -113.58 168.49 9.72 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 122.168 0.985 . . . . 0.0 110.816 -178.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -54.44 127.91 29.57 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 113.122 -1.854 . . . . 0.0 110.838 165.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.0 m -74.48 143.99 44.38 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 162.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -78.48 83.58 4.67 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.3 m 67.29 -75.51 0.06 Allowed 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 126.201 1.8 . . . . 0.0 111.785 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.607 HG23 ' H ' ' A' ' 45' ' ' ALA 0.317 35.1 m 39.21 -84.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 126.996 2.118 . . . . 0.0 113.743 -167.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.607 ' H ' HG23 ' A' ' 44' ' ' VAL . . . -156.6 29.48 0.33 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.147 0.979 . . . . 0.0 109.309 -175.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.48 49.64 7.98 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.532 -175.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.53 176.51 5.01 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.44 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 59.0 m-85 -114.67 157.19 23.45 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.437 1.495 . . . . 0.0 107.447 174.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.543 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . . . -128.87 147.05 50.79 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.391 0.676 . . . . 0.0 110.098 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.4 tp -125.84 113.3 17.06 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.27 1.028 . . . . 0.0 108.577 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 52.6 t -100.58 123.23 44.51 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.0 t -128.54 126.09 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.781 0.832 . . . . 0.0 110.004 -174.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 35' ' ' SER . 54.7 tp -101.33 140.29 35.82 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.32 1.048 . . . . 0.0 110.844 177.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -156.29 115.61 3.51 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.01 1.324 . . . . 0.0 108.775 173.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 41.1 71.94 0.18 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.678 1.591 . . . . 0.0 113.881 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 81.9 tttt 58.72 27.47 15.96 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.155 0.982 . . . . 0.0 111.905 177.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -138.3 106.39 5.73 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.378 0.671 . . . . 0.0 109.455 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.429 HG11 ' HG3' ' A' ' 24' ' ' GLU . 41.4 t -99.71 112.75 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 174.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -101.53 132.18 47.31 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 170.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 22.9 m -113.51 128.0 56.29 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -108.39 154.51 21.75 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.875 1.27 . . . . 0.0 107.838 -172.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -105.12 160.2 15.25 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.698 0.799 . . . . 0.0 109.63 165.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.733 HG12 HD11 ' A' ' 90' ' ' LEU . 3.8 mp -146.62 100.68 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 102.578 -3.119 . . . . 0.0 102.578 -166.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.5 mp -113.63 133.7 22.16 Favored Pre-proline 0 N--CA 1.477 0.889 0 O-C-N 121.641 -0.662 . . . . 0.0 109.693 -168.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.09 -68.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.214 1.943 . . . . 0.0 110.256 160.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.9 t70 125.33 -66.1 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 C-N-CA 127.238 2.215 . . . . 0.0 107.743 163.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -171.04 25.72 0.1 OUTLIER Glycine 0 C--N 1.345 1.067 0 CA-C-N 115.515 -0.766 . . . . 0.0 113.203 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -135.69 -83.21 0.4 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 175.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -179.78 3.91 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.123 0.569 . . . . 0.0 111.925 -174.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.512 ' HB3' ' HB2' ' A' ' 83' ' ' ARG . 64.9 m-85 -106.77 134.94 49.14 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.41 0.684 . . . . 0.0 109.343 -169.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.2 mp -96.8 106.4 18.7 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 118.884 0.765 . . . . 0.0 109.348 -169.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.79 140.2 37.97 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.825 0.85 . . . . 0.0 110.13 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.504 HG22 HG13 ' A' ' 63' ' ' ILE . 22.7 t -114.99 124.51 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 176.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -93.56 97.29 10.41 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.404 HG21 ' ND2' ' A' ' 98' ' ' ASN . 76.6 p -87.53 -48.31 8.03 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.6 m -157.78 177.04 11.81 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.385 1.474 . . . . 0.0 108.134 166.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -85.45 -57.97 2.85 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.279 0.632 . . . . 0.0 110.436 -174.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.17 -31.2 61.81 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.821 0.701 . . . . 0.0 114.069 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.4 t -61.45 122.82 73.24 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 118.851 -0.595 . . . . 0.0 109.396 169.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -57.15 110.99 0.68 Allowed 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.5 2.133 . . . . 0.0 110.555 174.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.4 t -79.35 143.71 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.978 0.911 . . . . 0.0 109.115 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -114.89 130.75 56.96 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.512 ' HB2' ' HB3' ' A' ' 70' ' ' PHE . 32.0 ptt180 -94.81 134.07 37.83 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 171.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -113.74 149.44 34.82 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.257 1.023 . . . . 0.0 109.815 -174.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -92.1 -15.79 27.25 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.58 0.352 . . . . 0.0 110.354 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.9 p -142.53 151.12 41.3 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 124.371 1.068 . . . . 0.0 109.457 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 99.5 mt -62.87 -25.88 68.5 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.674 0.789 . . . . 0.0 111.497 172.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -59.85 -41.9 97.9 Favored Glycine 0 CA--C 1.537 1.456 0 N-CA-C 114.02 0.368 . . . . 0.0 114.02 174.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -63.27 -37.79 88.63 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.529 0.732 . . . . 0.0 110.979 176.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.733 HD11 HG12 ' A' ' 63' ' ' ILE . 6.6 tt -59.46 -57.33 13.46 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.814 1.246 . . . . 0.0 109.742 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.412 ' HA ' HD12 ' A' ' 105' ' ' LEU . 48.2 mm -59.79 -38.62 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.098 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.98 -44.88 54.23 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.568 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 42.0 tp -67.64 -50.67 56.79 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.084 0.554 . . . . 0.0 111.405 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -75.35 -8.02 55.55 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.13 -24.12 64.43 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.431 0.634 . . . . 0.0 111.06 163.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -94.71 139.58 22.29 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.499 1.12 . . . . 0.0 108.87 174.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -48.94 127.0 16.06 Favored 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 123.137 2.558 . . . . 0.0 112.433 165.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.404 ' ND2' HG21 ' A' ' 75' ' ' THR . 26.2 p-10 -111.62 -45.1 3.4 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.194 -174.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 111.05 94.29 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 128.051 2.54 . . . . 0.0 106.341 -163.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 135.2 -38.99 1.74 Allowed Glycine 0 C--N 1.343 0.97 0 CA-C-N 116.052 -0.522 . . . . 0.0 113.1 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.444 ' HB3' ' H ' ' A' ' 104' ' ' ALA . 2.6 mm? -69.41 136.93 52.29 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.859 0.464 . . . . 0.0 110.494 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.5 m -60.97 -28.31 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.585 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.41 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 25.4 p -163.06 -1.1 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.444 ' H ' ' HB3' ' A' ' 101' ' ' LEU . . . 70.27 166.81 0.29 Allowed 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.947 0.899 . . . . 0.0 111.284 -167.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 91' ' ' ILE . 37.3 mt -88.94 97.98 11.49 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.506 0.722 . . . . 0.0 109.804 -173.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.3 tp -82.86 -51.81 7.29 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.688 -175.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -165.71 146.46 5.77 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 123.726 0.81 . . . . 0.0 109.032 -172.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 42.4 Cg_exo -56.89 -54.95 3.05 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.22 1.947 . . . . 0.0 111.885 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.476 HG11 ' HB1' ' A' ' 30' ' ' ALA . 2.4 t . . . . . 0 N--CA 1.48 1.037 0 C-N-CA 125.717 1.607 . . . . 0.0 107.142 170.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.1 t . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 3.5 p-90 -90.55 12.9 17.31 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.528 0.731 . . . . 0.0 110.614 169.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 49.9 t80 -115.2 117.94 31.91 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -130.91 87.23 2.46 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.063 0.545 . . . . 0.0 109.865 -173.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -73.09 160.1 32.55 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 167.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.1 t70 63.61 26.11 14.54 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 122.064 0.935 . . . . 0.0 110.634 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.1 tt -131.87 123.57 27.78 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.597 1.559 . . . . 0.0 106.864 177.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.7 p -77.24 160.89 28.57 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.841 0.457 . . . . 0.0 110.281 -172.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -65.52 -34.43 78.25 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 117.952 0.342 . . . . 0.0 110.848 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.47 -47.59 81.47 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.796 0.838 . . . . 0.0 110.291 173.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.45 -32.72 73.78 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.615 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.25 -62.68 1.39 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.526 0.73 . . . . 0.0 111.184 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -62.66 -28.49 69.95 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.521 0.728 . . . . 0.0 112.465 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -68.27 -50.37 54.2 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 123.606 0.566 . . . . 0.0 109.485 175.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -58.52 -39.99 81.64 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.584 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.1 -48.26 74.31 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.926 0.89 . . . . 0.0 109.802 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.49 -31.98 73.3 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.121 0.968 . . . . 0.0 112.329 -175.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -81.65 -38.64 25.61 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.439 0.696 . . . . 0.0 110.592 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.26 -63.87 1.23 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -169.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.93 -41.34 1.57 Allowed Glycine 0 C--N 1.352 1.421 0 N-CA-C 112.12 -0.392 . . . . 0.0 112.12 -173.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.3 ttp85 58.02 17.58 4.52 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.902 1.281 . . . . 0.0 114.207 171.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -175.83 98.11 0.07 Allowed 'General case' 0 N--CA 1.479 0.978 0 O-C-N 121.552 -0.718 . . . . 0.0 109.626 -166.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.53 20.67 79.59 Favored Glycine 0 N--CA 1.478 1.493 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 11.2 m -90.05 119.64 30.57 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 124.487 1.115 . . . . 0.0 110.628 -172.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -126.16 159.12 33.8 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.033 0.444 . . . . 0.0 111.229 -173.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.6 pp -155.31 165.31 37.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.296 168.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 25.9 t -112.46 154.25 13.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 171.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.645 HH22 ' HG2' ' A' ' 42' ' ' GLU . 4.2 ptm180 -157.69 -177.82 6.86 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 123.205 0.602 . . . . 0.0 109.381 -176.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -90.77 125.57 35.74 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 172.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.2 m -57.43 147.65 25.68 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.382 0.673 . . . . 0.0 110.651 174.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.645 ' HG2' HH22 ' A' ' 39' ' ' ARG . 42.2 mt-10 -78.22 89.11 4.28 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.343 0.657 . . . . 0.0 111.967 -164.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.2 t 66.16 27.85 10.3 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.494 1.518 . . . . 0.0 111.57 173.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.2 t -71.89 -71.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.588 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -173.7 34.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.397 0.679 . . . . 0.0 110.786 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.21 35.78 56.68 Favored Glycine 0 N--CA 1.476 1.322 0 CA-C-N 116.618 -0.265 . . . . 0.0 112.96 -168.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 63' ' ' ILE . . . -90.87 164.2 14.13 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.66 0.784 . . . . 0.0 110.457 -173.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.519 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 97.2 m-85 -102.76 148.2 25.9 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.445 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . . . -128.23 137.53 52.05 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.0 tp -112.06 104.0 12.22 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 47.4 m -104.26 114.08 28.07 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -174.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.68 141.44 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 -175.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.416 HD13 HG22 ' A' ' 58' ' ' VAL . 47.3 tp -126.96 144.45 51.01 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.946 0.898 . . . . 0.0 109.463 -176.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.402 ' HB3' ' HB ' ' A' ' 102' ' ' VAL . 66.0 t80 -154.26 109.58 3.14 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 46.19 71.59 0.28 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.544 1.138 . . . . 0.0 112.739 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 56.51 20.61 4.98 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.413 1.085 . . . . 0.0 113.74 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -124.86 108.9 12.39 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 120.921 0.391 . . . . 0.0 110.088 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.416 HG22 HD13 ' A' ' 53' ' ' LEU . 31.7 t -94.4 147.72 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 124.423 1.089 . . . . 0.0 110.046 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.91 113.19 8.77 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.88 1.272 . . . . 0.0 107.599 174.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 66.5 p -107.93 138.38 44.28 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -126.24 100.41 6.29 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -77.67 95.57 4.64 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.639 0.733 . . . . 0.0 109.48 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.521 HG21 HD12 ' A' ' 71' ' ' LEU . 32.5 mt -71.32 133.94 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.216 171.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -90.04 128.0 51.48 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 174.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -81.06 -81.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 123.1 2.533 . . . . 0.0 115.13 -157.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -149.8 160.85 43.23 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 118.262 0.483 . . . . 0.0 110.261 -163.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.58 -46.62 1.02 Allowed Glycine 0 N--CA 1.468 0.819 0 N-CA-C 107.417 -2.273 . . . . 0.0 107.417 -169.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -65.02 -147.07 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.649 0 CA-C-N 113.321 -1.439 . . . . 0.0 111.314 155.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -112.37 -24.36 9.81 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.512 0.725 . . . . 0.0 110.289 173.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -130.13 162.42 28.88 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.902 1.281 . . . . 0.0 110.985 -169.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.521 HD12 HG21 ' A' ' 63' ' ' ILE . 0.5 OUTLIER -102.95 132.02 49.49 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.426 1.09 . . . . 0.0 110.186 178.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -105.26 113.9 27.76 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.529 0.731 . . . . 0.0 112.802 -172.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 81' ' ' VAL . 23.0 t -85.32 138.73 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.69 0.796 . . . . 0.0 109.281 177.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -99.89 91.97 5.07 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.3 m -72.41 -65.39 0.79 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.079 0.551 . . . . 0.0 112.248 -166.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.2 t -168.82 178.23 4.69 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.668 0.387 . . . . 0.0 111.207 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -61.49 -39.01 89.4 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.718 1.207 . . . . 0.0 114.17 -168.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -139.68 40.86 1.37 Allowed Glycine 0 N--CA 1.472 1.081 0 CA-C-O 120.758 0.088 . . . . 0.0 113.044 -171.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.5 m -122.92 155.23 64.1 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 123.848 0.859 . . . . 0.0 109.285 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -65.61 128.65 20.54 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.556 2.171 . . . . 0.0 111.24 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 73' ' ' VAL . 45.6 t -90.02 126.57 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -120.29 139.2 53.07 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.12 0.568 . . . . 0.0 109.528 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -101.99 157.67 16.7 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.348 1.059 . . . . 0.0 108.702 178.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.637 ' HE1' HD12 ' A' ' 93' ' ' LEU . 95.4 m-85 -130.99 160.67 33.89 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.815 0.846 . . . . 0.0 109.103 -173.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -99.35 -18.41 17.54 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.512 0.325 . . . . 0.0 110.489 174.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.8 p -146.7 154.0 40.91 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.764 0.826 . . . . 0.0 110.141 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.448 ' O ' ' HB3' ' A' ' 90' ' ' LEU . 96.1 mt -64.15 -25.56 68.14 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.154 0.982 . . . . 0.0 111.805 173.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -56.89 -42.65 92.43 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 116.574 -0.284 . . . . 0.0 113.026 172.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -68.09 -34.08 75.74 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.668 0.787 . . . . 0.0 111.095 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 22.7 tp -56.24 -58.97 5.71 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.896 0.878 . . . . 0.0 110.262 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 44.9 mm -62.77 -37.92 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.747 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.2 -55.64 28.36 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 115.032 -0.986 . . . . 0.0 113.747 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.637 HD12 ' HE1' ' A' ' 84' ' ' PHE . 34.5 mt -75.77 -42.58 49.92 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -177.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -72.42 -7.41 49.62 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.6 -3.38 4.51 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 171.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 93' ' ' LEU . 13.4 pt20 -95.98 141.01 22.55 Favored Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 123.008 0.523 . . . . 0.0 109.685 174.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 96' ' ' GLN . 4.2 Cg_exo -78.84 173.27 13.81 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.829 2.352 . . . . 0.0 112.706 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 54.16 82.79 0.08 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.478 1.511 . . . . 0.0 111.885 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -159.35 9.43 0.12 Allowed 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.738 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.31 -13.62 56.99 Favored Glycine 0 N--CA 1.476 1.316 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -175.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.418 ' HB3' ' O ' ' A' ' 103' ' ' CYS . 2.2 mm? -65.58 153.31 41.89 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.411 1.484 . . . . 0.0 111.849 175.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 54' ' ' TYR . 19.8 m -82.65 76.3 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 164.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 104' ' ' ALA . 42.8 t 75.75 170.95 0.26 Allowed 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 113.879 -1.509 . . . . 0.0 110.6 -174.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.44 ' N ' ' SG ' ' A' ' 103' ' ' CYS . . . -72.47 166.48 22.52 Favored 'General case' 0 C--O 1.249 1.033 0 C-N-CA 122.984 0.514 . . . . 0.0 109.677 176.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 29.1 mt -73.68 92.58 1.99 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -85.15 -59.91 2.19 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.953 -170.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.496 HD12 ' HD2' ' A' ' 108' ' ' PRO . 50.3 tp -147.58 127.55 6.66 Favored Pre-proline 0 N--CA 1.469 0.524 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -175.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.496 ' HD2' HD12 ' A' ' 107' ' ' LEU . 10.6 Cg_endo -54.16 -72.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.156 1.904 . . . . 0.0 111.37 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 50.2 t . . . . . 0 C--O 1.252 1.187 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 174.977 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.5 t . . . . . 0 N--CA 1.475 0.796 0 CA-C-O 121.404 0.621 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.586 ' HB2' ' HA ' ' A' ' 37' ' ' LEU . 1.9 p-90 -80.75 -23.17 39.59 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 28.4 t80 -75.53 105.41 6.55 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.034 0.933 . . . . 0.0 110.422 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -127.36 108.24 10.67 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -54.68 150.4 9.61 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 123.335 0.654 . . . . 0.0 111.334 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.599 ' H ' ' HB3' ' A' ' 40' ' ' ASP . 37.7 t70 -9.71 76.31 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -149.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.431 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 28.5 tp -62.14 -26.4 68.29 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.5 168.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.4 t 82.14 138.44 0.06 Allowed 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 125.587 1.555 . . . . 0.0 108.622 174.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -58.76 -45.39 89.86 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.111 0.564 . . . . 0.0 112.198 -168.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.42 -50.44 71.48 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.879 0.871 . . . . 0.0 111.516 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -73.7 -19.03 60.93 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.704 -178.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.605 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -74.38 -53.33 9.83 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.147 0.979 . . . . 0.0 110.545 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.567 ' HA ' HD12 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -68.95 -21.91 64.16 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 123.682 0.614 . . . . 0.0 110.916 178.155 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -71.54 -51.2 24.77 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.091 0.556 . . . . 0.0 110.501 172.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.4 tp -57.98 -31.69 67.14 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.339 0.656 . . . . 0.0 111.578 174.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.567 HD12 ' HA ' ' A' ' 24' ' ' GLU . 85.6 mt -62.48 -59.95 4.24 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.75 -40.31 66.08 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.833 0.853 . . . . 0.0 112.937 -176.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -77.85 -55.45 5.31 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.578 0.751 . . . . 0.0 111.951 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.3 -60.9 2.05 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.064 0.545 . . . . 0.0 111.257 -172.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.69 82.18 0.31 Allowed Glycine 0 C--N 1.335 0.523 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -70.61 14.39 0.14 Allowed 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -166.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 175.16 138.56 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.172 0.989 . . . . 0.0 108.695 -171.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.92 -4.57 29.89 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 115.088 0.795 . . . . 0.0 115.088 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.5 m -86.92 161.88 18.02 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -166.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -151.23 153.19 34.42 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.878 0.871 . . . . 0.0 109.346 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.605 HD11 ' HB1' ' A' ' 23' ' ' ALA . 3.2 pp -149.82 155.17 39.63 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.446 0.699 . . . . 0.0 109.836 170.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 70.9 t -112.77 131.72 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -119.82 170.37 9.3 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.908 0.883 . . . . 0.0 109.594 175.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.599 ' HB3' ' H ' ' A' ' 17' ' ' ASP . 35.0 t70 -83.63 130.23 34.98 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 172.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.0 t -68.18 152.3 45.69 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.488 0.715 . . . . 0.0 111.118 -176.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -110.77 -36.52 5.68 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.4 t -54.45 -45.05 73.03 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.624 1.17 . . . . 0.0 111.061 173.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 65.1 t -130.12 115.92 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.52 0.728 . . . . 0.0 109.379 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.13 130.41 42.63 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.431 0.692 . . . . 0.0 110.877 174.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.46 -0.63 68.37 Favored Glycine 0 C--N 1.352 1.443 0 C-N-CA 122.894 0.283 . . . . 0.0 112.757 -177.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.0 176.75 4.95 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.897 0.879 . . . . 0.0 112.0 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.437 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 48.7 m-85 -126.0 168.67 13.62 Favored 'General case' 0 C--O 1.249 1.04 0 C-N-CA 124.888 1.275 . . . . 0.0 110.434 -176.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.56 148.47 42.6 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.059 1.344 . . . . 0.0 109.686 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.8 tp -123.73 114.64 20.2 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.112 0.965 . . . . 0.0 108.996 -176.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 60.5 m -107.44 121.65 45.04 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.3 t -126.66 132.39 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -173.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 68.6 tp -123.84 118.15 26.46 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.93 0.892 . . . . 0.0 110.104 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -136.07 132.11 35.74 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 166.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 42.19 61.55 1.94 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 124.977 1.311 . . . . 0.0 113.562 -176.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm 62.92 2.34 0.99 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 125.194 1.398 . . . . 0.0 113.673 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -103.65 105.89 16.25 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -173.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.0 t -86.06 139.63 17.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.066 0.946 . . . . 0.0 109.413 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -135.16 115.52 13.48 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 173.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 51.5 m -109.66 130.79 55.48 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -110.59 156.43 20.95 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.895 1.278 . . . . 0.0 108.26 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -100.91 156.52 17.34 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 163.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.659 HG13 HG13 ' A' ' 73' ' ' VAL . 2.9 mp -144.47 100.5 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 101.564 -3.495 . . . . 0.0 101.564 -167.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.21 154.76 37.44 Favored Pre-proline 0 C--N 1.318 -0.781 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -169.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.97 -73.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 121.485 1.457 . . . . 0.0 111.302 163.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 43.82 73.85 0.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.762 1.225 . . . . 0.0 111.925 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.24 -100.65 0.15 Allowed Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.026 -174.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 158.97 -25.09 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 126.167 1.787 . . . . 0.0 108.271 -170.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -152.07 -2.89 0.27 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.704 0.801 . . . . 0.0 112.121 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -119.59 160.83 21.71 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.733 0.813 . . . . 0.0 109.495 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.408 ' H ' HD23 ' A' ' 71' ' ' LEU . 1.5 pt? -115.12 121.42 42.97 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.615 0.766 . . . . 0.0 109.377 173.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.14 117.9 33.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.56 0.744 . . . . 0.0 110.7 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.659 HG13 HG13 ' A' ' 63' ' ' ILE . 25.6 t -92.09 145.14 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.788 -177.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -101.13 90.12 4.03 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.68 173.22 10.09 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.762 178.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.4 t -65.54 108.32 1.98 Allowed 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -56.7 101.63 0.06 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.147 0.979 . . . . 0.0 110.293 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.32 -24.45 0.45 Allowed Glycine 0 CA--C 1.529 0.953 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -165.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.1 m -118.0 162.27 30.36 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 125.326 1.45 . . . . 0.0 107.654 168.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -63.01 132.12 35.5 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.247 1.965 . . . . 0.0 112.271 176.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 94.2 t -71.58 123.37 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.563 0.745 . . . . 0.0 109.746 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.509 ' HG2' HD13 ' A' ' 93' ' ' LEU . 10.6 tpt180 -111.97 121.75 45.87 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 123.17 0.294 . . . . 0.0 110.89 -175.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.67 155.79 16.62 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.938 0.895 . . . . 0.0 109.19 170.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -133.96 165.6 24.64 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.614 0.766 . . . . 0.0 110.374 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -89.36 -23.99 22.08 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.991 0.516 . . . . 0.0 111.049 168.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.1 t -147.95 155.39 41.5 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.774 0.43 . . . . 0.0 111.195 -175.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.489 ' O ' HG12 ' A' ' 91' ' ' ILE . 86.1 mt -60.14 -31.04 69.7 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.854 0.861 . . . . 0.0 112.132 175.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.94 -47.34 31.96 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 123.094 0.378 . . . . 0.0 114.021 176.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -69.69 -30.28 67.9 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.375 0.67 . . . . 0.0 111.318 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.2 tt -66.86 -36.67 82.85 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.699 0.8 . . . . 0.0 109.13 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 87' ' ' LEU . 47.2 mm -80.92 -40.14 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -169.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.97 -38.98 64.18 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.79 -0.641 . . . . 0.0 113.471 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.509 HD13 ' HG2' ' A' ' 82' ' ' ARG . 7.9 tt -73.42 -36.11 65.93 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.571 0.348 . . . . 0.0 110.189 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.494 ' CD2' HD21 ' A' ' 101' ' ' LEU . 2.0 m-85 -84.28 -9.39 58.53 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.871 0.468 . . . . 0.0 110.613 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.37 0.4 17.0 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.383 0.673 . . . . 0.0 111.287 165.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -92.63 125.69 54.79 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 169.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -66.24 172.64 8.53 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.776 2.317 . . . . 0.0 113.029 171.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.3 t30 55.4 39.62 31.22 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.661 1.185 . . . . 0.0 111.548 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -122.09 10.07 10.0 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.661 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 99.56 -14.01 60.88 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -174.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.494 HD21 ' CD2' ' A' ' 94' ' ' TYR . 4.1 mm? -72.56 150.73 42.89 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.19 1.396 . . . . 0.0 110.702 176.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.4 m -84.34 74.91 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-O 122.206 1.003 . . . . 0.0 109.558 172.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 39.6 t 72.59 27.83 2.27 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 113.438 -1.71 . . . . 0.0 111.25 172.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 77.85 165.5 0.23 Allowed 'General case' 0 C--N 1.354 0.781 0 C-N-CA 125.076 1.35 . . . . 0.0 112.937 172.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.8 mt -76.71 101.81 5.95 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.293 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 78.2 mt -104.78 -50.73 3.21 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 122.957 0.503 . . . . 0.0 112.091 -172.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 mp -113.05 130.16 23.82 Favored Pre-proline 0 N--CA 1.491 1.61 0 CA-C-O 118.776 -0.63 . . . . 0.0 109.766 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -83.48 9.4 4.12 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.79 2.326 . . . . 0.0 113.234 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.542 HG21 HD23 ' A' ' 37' ' ' LEU . 49.3 t . . . . . 0 C--O 1.252 1.214 0 C-N-CA 125.382 1.473 . . . . 0.0 109.396 -172.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.8 m . . . . . 0 CA--C 1.539 0.536 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -83.76 1.36 43.24 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -165.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -105.06 96.44 6.53 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -170.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -110.2 89.97 3.18 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.27 52.39 2.01 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.017 0.913 . . . . 0.0 110.558 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -146.77 -17.76 0.42 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.725 1.61 . . . . 0.0 109.748 -174.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 28.7 tp -112.36 100.34 8.71 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.457 0.703 . . . . 0.0 110.26 -164.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.2 p -47.07 157.25 0.18 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 125.161 1.384 . . . . 0.0 112.801 172.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.39 -37.1 86.34 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.255 0.622 . . . . 0.0 112.096 -172.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.29 -51.27 68.38 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.392 0.677 . . . . 0.0 111.014 177.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.77 -20.08 61.24 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.934 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.6 -55.58 9.7 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.296 0.638 . . . . 0.0 110.738 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.459 ' HB3' ' SG ' ' A' ' 51' ' ' CYS . 12.3 pt-20 -70.2 -26.54 63.92 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.259 0.623 . . . . 0.0 111.719 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -64.9 -51.98 59.0 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -61.9 -35.39 78.23 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.062 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.6 mt -68.47 -33.82 74.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.585 0.354 . . . . 0.0 110.382 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.18 -37.77 81.33 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.995 0.809 . . . . 0.0 111.652 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -83.46 -44.01 15.2 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.056 0.542 . . . . 0.0 112.22 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.39 -58.2 3.24 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.213 0.605 . . . . 0.0 112.018 -169.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -100.07 -35.76 4.4 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.751 -176.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 66.15 -7.72 0.38 Allowed 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 126.322 1.849 . . . . 0.0 114.452 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -171.18 127.79 0.7 Allowed 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 124.818 1.247 . . . . 0.0 107.647 -165.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.479 ' HA3' HD23 ' A' ' 106' ' ' LEU . . . 65.05 11.61 52.05 Favored Glycine 0 N--CA 1.478 1.467 0 N-CA-C 114.107 0.403 . . . . 0.0 114.107 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.8 m -83.35 143.47 30.31 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.83 0.852 . . . . 0.0 110.278 -168.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -152.92 154.59 35.35 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.06 0.457 . . . . 0.0 110.52 176.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -151.62 153.66 34.91 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.777 169.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.557 HG22 HD13 ' A' ' 50' ' ' LEU . 40.1 t -107.25 145.64 14.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.543 ' HG3' ' HB3' ' A' ' 49' ' ' ALA . 0.9 OUTLIER -138.94 -179.36 5.79 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 125.308 1.443 . . . . 0.0 108.312 -178.472 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -91.34 148.11 22.56 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 172.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.555 ' HB2' ' HB ' ' A' ' 44' ' ' VAL . 40.9 m -61.92 140.69 58.28 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.987 0.515 . . . . 0.0 110.412 173.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -35.35 -54.53 0.65 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 126.356 1.862 . . . . 0.0 114.168 -167.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.1 m -142.61 28.87 1.59 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.91 0.484 . . . . 0.0 110.045 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.555 ' HB ' ' HB2' ' A' ' 41' ' ' SER . 24.2 t -110.24 112.1 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.37 117.98 8.04 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.037 -177.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.89 -0.46 89.47 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 114.537 0.575 . . . . 0.0 114.537 172.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -92.92 155.24 17.71 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 117.161 0.481 . . . . 0.0 109.834 173.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.54 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 68.3 m-85 -110.67 158.24 18.83 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.647 0.736 . . . . 0.0 109.753 -175.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.543 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . . . -135.06 147.37 49.59 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 166.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.557 HD13 HG22 ' A' ' 38' ' ' VAL . 45.6 tp -125.77 139.24 53.68 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -177.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.459 ' SG ' ' HB3' ' A' ' 24' ' ' GLU . 44.6 t -124.84 128.55 48.87 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 175.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.661 HG12 ' SG ' ' A' ' 103' ' ' CYS . 12.8 t -137.0 140.41 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 123.538 0.735 . . . . 0.0 109.779 -176.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.7 tp -132.34 120.52 22.19 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.609 1.164 . . . . 0.0 110.148 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -147.77 146.14 29.07 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.473 0.709 . . . . 0.0 109.089 168.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 50.3 47.58 23.58 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.74 1.216 . . . . 0.0 111.837 -177.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt 54.75 27.68 9.14 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.641 1.177 . . . . 0.0 112.716 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -123.72 107.26 11.27 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.228 1.011 . . . . 0.0 108.888 -174.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.5 t -83.73 131.54 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -135.84 111.08 9.0 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 176.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.2 p -104.87 127.22 52.61 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.961 0.904 . . . . 0.0 108.614 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -113.25 101.02 9.01 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.033 0.933 . . . . 0.0 108.846 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 84.4 mtm180 -70.9 155.63 40.57 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 168.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 91.7 mt -145.86 100.92 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 102.601 -3.111 . . . . 0.0 102.601 -152.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 mp -113.36 101.71 53.9 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 122.814 0.446 . . . . 0.0 110.617 -161.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.716 ' HB2' ' HA ' ' A' ' 68' ' ' GLU . 39.7 Cg_endo -66.3 103.62 0.67 Allowed 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.086 1.857 . . . . 0.0 110.02 167.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.16 -52.8 62.35 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.849 0.86 . . . . 0.0 110.446 -169.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -116.86 34.04 4.8 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.577 174.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.716 ' HA ' ' HB2' ' A' ' 65' ' ' PRO . 46.5 mt-10 50.29 4.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 -173.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -84.85 -49.21 8.6 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 119.602 1.092 . . . . 0.0 109.695 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 31.3 m-85 -127.57 142.07 51.47 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.715 0.806 . . . . 0.0 109.933 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.23 114.9 27.95 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.7 1.2 . . . . 0.0 108.736 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.97 119.39 35.35 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.243 1.017 . . . . 0.0 111.277 -170.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.441 HG22 HG23 ' A' ' 63' ' ' ILE . 16.1 t -106.96 143.67 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.057 0.943 . . . . 0.0 108.956 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -113.49 91.89 3.8 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -172.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.62 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 30.7 p -108.26 28.36 8.38 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.897 0.879 . . . . 0.0 110.482 -177.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.4 m -68.66 94.52 0.59 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.975 0.91 . . . . 0.0 113.353 -167.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -118.41 2.02 11.82 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 124.229 1.012 . . . . 0.0 110.165 164.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.48 22.88 0.03 OUTLIER Glycine 0 N--CA 1.471 0.982 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.459 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.9 m -140.27 152.42 66.96 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.503 1.121 . . . . 0.0 108.969 -174.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -73.32 -175.19 1.88 Allowed 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.375 2.05 . . . . 0.0 111.903 172.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 62.9 t -76.63 123.92 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 176.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 39.8 tpt85 -100.7 116.07 31.74 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -175.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.447 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 32.2 mtp85 -95.33 145.07 25.37 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.292 1.037 . . . . 0.0 110.07 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.648 ' HE1' HD12 ' A' ' 93' ' ' LEU . 83.6 m-85 -126.93 152.87 46.55 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.905 0.882 . . . . 0.0 109.181 -178.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -85.7 -21.56 28.24 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 172.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.7 t -153.33 158.25 41.28 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 122.998 0.519 . . . . 0.0 110.725 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.98 -27.54 68.9 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.238 1.015 . . . . 0.0 109.979 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -52.83 -46.19 60.45 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-N 116.364 -0.38 . . . . 0.0 113.999 173.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -66.88 -30.7 70.93 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.442 0.697 . . . . 0.0 110.97 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.0 tt -62.53 -57.95 9.33 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.319 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.494 ' HA ' HD12 ' A' ' 105' ' ' LEU . 38.3 mm -54.41 -46.11 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.67 0.788 . . . . 0.0 111.206 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.05 -56.96 14.21 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 114.568 -1.196 . . . . 0.0 113.75 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.648 HD12 ' HE1' ' A' ' 84' ' ' PHE . 86.7 mt -74.0 -37.02 64.54 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.944 0.498 . . . . 0.0 111.675 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.425 ' HE2' HG11 ' A' ' 73' ' ' VAL . 5.9 m-30 -82.28 -5.51 58.6 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -169.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.13 -5.37 26.59 Favored 'General case' 0 CA--C 1.562 1.429 0 CA-C-O 120.805 0.336 . . . . 0.0 111.418 165.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -97.13 130.56 29.49 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 124.726 1.21 . . . . 0.0 109.095 173.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.47 -175.66 2.79 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.892 2.395 . . . . 0.0 113.311 173.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.6 t30 49.22 71.9 0.34 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 126.041 1.736 . . . . 0.0 112.277 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.568 ' HG3' HD23 ' A' ' 101' ' ' LEU . 12.7 pt20 -176.45 11.3 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.427 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.62 ' HA3' ' HB ' ' A' ' 75' ' ' THR . . . 122.94 -32.89 4.25 Favored Glycine 0 C--N 1.345 1.074 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -173.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.568 HD23 ' HG3' ' A' ' 99' ' ' GLN . 3.4 mm? -76.66 101.41 5.74 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.533 0.733 . . . . 0.0 109.287 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.462 HG23 ' SG ' ' A' ' 103' ' ' CYS . 4.7 m -69.74 -15.08 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.783 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.661 ' SG ' HG12 ' A' ' 52' ' ' VAL . 14.6 m -115.29 -47.38 2.85 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.582 1.153 . . . . 0.0 111.617 -174.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 69.94 139.34 0.04 OUTLIER 'General case' 0 C--N 1.357 0.906 0 O-C-N 125.27 1.606 . . . . 0.0 108.973 -158.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 91' ' ' ILE . 46.0 mt -69.94 101.42 1.77 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -170.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.479 HD23 ' HA3' ' A' ' 34' ' ' GLY . 57.7 tp -108.68 -60.49 1.74 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.346 1.058 . . . . 0.0 111.056 -169.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 60.6 tp -120.48 101.41 46.35 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 123.165 0.586 . . . . 0.0 109.999 -169.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.38 122.0 5.89 Favored 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 122.884 2.389 . . . . 0.0 110.352 174.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 C--O 1.244 0.81 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.57 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.7 p . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.449 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . 4.9 p-90 -79.54 -21.35 45.28 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -175.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.456 ' HH ' ' HE1' ' A' ' 48' ' ' PHE . 89.0 t80 -81.66 125.79 31.0 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.486 171.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -117.67 129.76 55.94 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.438 ' O ' ' HB3' ' A' ' 40' ' ' ASP . 1.6 mpp_? -75.08 -37.93 61.44 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -174.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -130.93 90.1 2.84 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.988 0.899 . . . . 0.0 109.897 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.9 tp -135.59 139.77 44.11 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.841 1.256 . . . . 0.0 107.764 175.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.3 t -99.0 167.09 10.95 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.312 0.645 . . . . 0.0 110.342 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -64.74 -40.08 94.7 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.875 0.87 . . . . 0.0 113.184 -172.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.89 -48.34 77.04 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.067 0.547 . . . . 0.0 110.801 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.55 -30.81 70.54 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.674 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.478 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -65.98 -57.26 8.21 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.123 0.569 . . . . 0.0 110.922 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -58.01 -38.74 76.72 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.877 1.271 . . . . 0.0 112.041 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -70.17 -45.04 67.55 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.395 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.2 tp -58.16 -34.28 70.13 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.981 0.912 . . . . 0.0 111.441 175.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 23' ' ' ALA . 96.5 mt -66.11 -53.05 42.82 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.62 -39.14 87.12 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.265 1.026 . . . . 0.0 112.695 -172.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -73.37 -52.09 15.06 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.748 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.21 -56.18 3.79 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -166.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -101.98 -46.69 1.57 Allowed Glycine 0 N--CA 1.475 1.267 0 N-CA-C 113.404 0.121 . . . . 0.0 113.404 -172.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 49.05 21.49 0.49 Allowed 'General case' 0 CA--C 1.57 1.747 0 C-N-CA 126.196 1.798 . . . . 0.0 114.827 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -170.64 100.43 0.24 Allowed 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.27 -0.894 . . . . 0.0 109.361 -168.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.407 ' HA3' ' HB2' ' A' ' 106' ' ' LEU . . . 66.44 19.05 68.36 Favored Glycine 0 C--N 1.353 1.488 0 CA-C-O 121.465 0.48 . . . . 0.0 112.394 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 9.2 m -84.55 122.8 29.53 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 124.533 1.133 . . . . 0.0 110.859 -167.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 36.7 p90 -129.76 156.7 43.89 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.986 0.422 . . . . 0.0 110.725 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.478 HD11 ' HB1' ' A' ' 23' ' ' ALA . 4.3 pp -150.2 160.11 43.93 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 167.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 57.4 t -114.23 148.54 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 174.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -149.05 151.94 35.37 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.308 0.643 . . . . 0.0 109.476 -174.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' A' ' 16' ' ' ARG . 25.3 t70 -91.11 118.33 30.34 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 174.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.3 m -92.69 97.33 10.72 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -173.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -55.29 -39.17 69.56 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.058 0.943 . . . . 0.0 112.325 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.6 m -58.31 -24.34 59.28 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.2 t -80.27 -87.0 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-O 119.476 -0.297 . . . . 0.0 110.913 -174.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -178.03 18.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 122.909 0.484 . . . . 0.0 111.595 -167.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.75 88.03 1.2 Allowed Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -159.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.3 163.75 39.71 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.717 0.807 . . . . 0.0 109.789 -170.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.596 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 21.2 m-85 -116.01 162.23 17.7 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.37 0.668 . . . . 0.0 109.69 168.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.55 149.38 43.81 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.169 0.988 . . . . 0.0 110.1 170.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.511 ' HB2' HD11 ' A' ' 63' ' ' ILE . 51.9 tp -117.2 111.29 19.24 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 55.4 m -101.17 121.52 41.98 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.4 t -125.19 143.52 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.532 HD13 HG22 ' A' ' 58' ' ' VAL . 51.0 tp -133.0 147.4 52.27 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.366 1.066 . . . . 0.0 109.214 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -162.33 115.88 1.77 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.9 tm0? 36.06 73.75 0.08 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 125.907 1.683 . . . . 0.0 112.612 -174.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 44.6 tptt 56.64 26.41 11.15 Favored 'General case' 0 CA--C 1.572 1.825 0 C-N-CA 124.391 1.076 . . . . 0.0 112.684 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -130.19 107.33 9.22 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 121.482 -0.761 . . . . 0.0 109.272 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.532 HG22 HD13 ' A' ' 53' ' ' LEU . 21.6 t -93.1 142.0 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.506 0.722 . . . . 0.0 109.995 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -137.14 112.77 9.43 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.639 1.576 . . . . 0.0 107.754 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.9 m -119.37 140.17 50.79 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -133.98 113.8 12.55 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.719 0.807 . . . . 0.0 109.41 -173.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -64.79 156.89 29.16 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 171.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.596 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 79.7 mt -148.33 104.32 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 -158.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -96.01 102.44 10.65 Favored Pre-proline 0 N--CA 1.478 0.93 0 CA-C-N 118.885 0.766 . . . . 0.0 109.453 -168.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.457 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 93.1 Cg_endo -76.73 -56.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 123.043 2.495 . . . . 0.0 115.99 -163.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -125.9 141.02 52.17 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 118.146 0.43 . . . . 0.0 111.081 -162.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.05 -16.44 0.24 Allowed Glycine 0 CA--C 1.534 1.236 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.161 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -146.84 -70.5 0.24 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.776 1.231 . . . . 0.0 108.592 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -166.62 -41.31 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.989 -175.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -110.16 151.18 27.6 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.766 0.426 . . . . 0.0 111.222 -167.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.457 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 3.8 pp -99.73 111.58 23.9 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 171.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -101.1 123.48 45.33 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.133 0.573 . . . . 0.0 110.541 -173.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.801 HG21 HD13 ' A' ' 90' ' ' LEU . 57.5 t -93.91 138.12 21.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -95.54 88.45 5.06 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.6 m -73.44 -77.95 0.1 Allowed 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.416 -173.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.433 ' HB2' HG22 ' A' ' 79' ' ' VAL . 66.6 m -161.15 128.29 4.1 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.799 0.84 . . . . 0.0 110.437 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.4 mp0 -70.07 92.87 0.76 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 169.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.53 -36.13 0.69 Allowed Glycine 0 C--N 1.346 1.099 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -170.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 99' ' ' GLN . 13.0 m -104.89 158.34 32.23 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 123.495 0.718 . . . . 0.0 109.171 177.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.36 111.05 1.18 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.256 1.971 . . . . 0.0 110.869 167.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 95.7 t -93.6 132.25 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.944 0.898 . . . . 0.0 108.675 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -112.13 136.13 51.91 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.948 0.499 . . . . 0.0 110.454 -173.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -89.92 140.97 29.1 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.303 1.041 . . . . 0.0 109.328 174.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -111.17 174.45 5.86 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.449 1.099 . . . . 0.0 110.207 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -120.08 -49.64 2.29 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -164.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.8 m -128.73 161.26 30.14 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 113.495 -1.684 . . . . 0.0 107.697 171.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.47 -26.13 67.7 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 118.647 0.658 . . . . 0.0 112.41 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -56.58 -34.93 64.93 Favored Glycine 0 N--CA 1.48 1.611 0 O-C-N 122.991 0.182 . . . . 0.0 113.47 169.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -67.45 -38.96 85.27 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.2 0.6 . . . . 0.0 110.677 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.801 HD13 HG21 ' A' ' 73' ' ' VAL . 37.6 tp -61.84 -64.71 0.85 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.855 0.862 . . . . 0.0 110.717 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.7 mm -59.68 -39.36 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.318 1.047 . . . . 0.0 111.063 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.18 -57.66 18.06 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.135 -0.939 . . . . 0.0 113.853 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.1 tt -67.63 -45.83 74.25 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.266 0.626 . . . . 0.0 110.101 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.469 ' HB3' ' HG ' ' A' ' 105' ' ' LEU . 5.7 m-30 -77.04 -12.15 59.9 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -170.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.42 -22.24 66.77 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.224 0.535 . . . . 0.0 110.835 169.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -94.45 139.25 22.31 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 174.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -46.3 117.75 2.13 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.105 2.537 . . . . 0.0 112.137 166.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -110.24 -58.37 2.08 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.518 -164.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.445 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . 9.4 mm-40 128.33 102.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 128.37 2.668 . . . . 0.0 107.595 -159.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 120.55 -39.91 2.31 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-O 120.117 -0.269 . . . . 0.0 113.432 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.438 HD11 ' HB3' ' A' ' 94' ' ' TYR . 76.2 mt -68.9 150.28 47.93 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.8 p -64.49 -36.83 78.41 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.174 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.4 ' SG ' HD11 ' A' ' 106' ' ' LEU . 49.0 t -165.25 20.64 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.268 0.627 . . . . 0.0 111.146 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 72.14 167.97 0.31 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.611 1.165 . . . . 0.0 110.664 -169.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.469 ' HG ' ' HB3' ' A' ' 94' ' ' TYR . 23.4 mt -81.18 98.91 8.28 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.167 0.587 . . . . 0.0 109.611 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.407 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 89.8 mt -93.95 -46.5 7.14 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.459 0.704 . . . . 0.0 112.404 -172.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 35' ' ' SER . 68.5 tp -141.54 116.68 7.06 Favored Pre-proline 0 N--CA 1.486 1.373 0 C-N-CA 123.079 0.552 . . . . 0.0 111.055 -174.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.449 ' HB2' ' HB3' ' A' ' 13' ' ' TRP . 73.2 Cg_endo -77.94 136.38 14.83 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.372 2.048 . . . . 0.0 111.581 174.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--O 1.25 1.086 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.407 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 CA--C 1.553 1.095 0 CA-C-O 119.57 -0.252 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.509 ' HB3' ' HB3' ' A' ' 108' ' ' PRO . 6.1 p-90 -99.23 15.5 25.9 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.813 0.845 . . . . 0.0 112.005 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 61.7 t80 -113.76 116.09 28.83 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -131.23 99.16 4.77 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.207 0.603 . . . . 0.0 110.373 -177.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.478 ' HD3' ' N ' ' A' ' 17' ' ' ASP . 1.0 OUTLIER -72.73 150.59 42.74 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 167.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.478 ' N ' ' HD3' ' A' ' 16' ' ' ARG . 36.6 t70 79.19 3.54 2.33 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.891 1.276 . . . . 0.0 111.389 -175.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.2 tp -99.44 123.25 43.55 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.082 -1.011 . . . . 0.0 109.042 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.2 p -80.85 160.84 24.66 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.663 0.785 . . . . 0.0 109.917 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.445 ' HB3' ' NH2' ' A' ' 39' ' ' ARG . 5.5 ppt_? -64.63 -35.47 81.13 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 118.458 0.572 . . . . 0.0 112.252 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.87 -48.86 78.63 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.538 0.735 . . . . 0.0 110.75 175.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.21 -26.56 62.99 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.849 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.462 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -71.97 -54.55 9.62 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.72 0.808 . . . . 0.0 110.768 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.578 ' HG2' HG21 ' A' ' 58' ' ' VAL . 5.5 tm-20 -56.97 -39.72 75.14 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.951 1.3 . . . . 0.0 111.52 175.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.82 -46.72 80.78 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 123.976 0.798 . . . . 0.0 110.156 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -60.63 -43.87 97.02 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 124.088 0.868 . . . . 0.0 110.411 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.4 mt -65.26 -42.18 93.52 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.368 0.667 . . . . 0.0 110.186 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.47 -35.87 80.03 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.764 0.826 . . . . 0.0 111.604 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 46.5 ttt85 -77.69 -30.77 52.06 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.573 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.53 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -87.91 -61.43 1.72 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -172.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -125.31 -48.05 0.21 Allowed Glycine 0 N--CA 1.474 1.195 0 C-N-CA 122.951 0.31 . . . . 0.0 112.7 -169.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.476 ' HG3' HD21 ' A' ' 53' ' ' LEU . 40.2 ttp180 45.57 41.96 7.55 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.343 1.857 . . . . 0.0 114.541 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -174.16 88.52 0.06 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -174.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.516 ' HA2' ' SG ' ' A' ' 103' ' ' CYS . . . 83.75 12.75 76.91 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.785 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 m -83.75 118.93 24.23 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 124.634 1.173 . . . . 0.0 110.563 -169.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -125.98 158.92 34.05 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.084 0.468 . . . . 0.0 110.178 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.462 HD11 ' HB1' ' A' ' 23' ' ' ALA . 3.8 pp -153.7 164.94 37.44 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.731 166.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.42 HG22 HD13 ' A' ' 50' ' ' LEU . 97.7 t -119.27 148.64 22.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 170.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.445 ' NH2' ' HB3' ' A' ' 20' ' ' ARG . 43.7 ptt85 -153.6 -178.31 6.94 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -93.29 141.54 28.32 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 165.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.4 m -65.65 146.22 55.08 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 163.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -66.6 81.37 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -158.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.6 m 51.12 30.88 5.96 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.96 1.304 . . . . 0.0 112.654 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.1 m -72.46 -44.04 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.892 -168.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -174.01 9.32 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.441 0.697 . . . . 0.0 111.454 -169.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.77 19.19 60.16 Favored Glycine 0 N--CA 1.474 1.183 0 N-CA-C 112.141 -0.384 . . . . 0.0 112.141 -171.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.79 155.3 18.88 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.989 0.916 . . . . 0.0 111.681 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -106.55 158.85 16.62 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.023 0.929 . . . . 0.0 110.398 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.88 141.19 51.36 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.986 0.514 . . . . 0.0 110.136 169.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.598 HD22 HD21 ' A' ' 90' ' ' LEU . 51.9 tp -114.32 107.09 15.11 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.136 1.374 . . . . 0.0 107.495 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 42.5 t -104.04 114.37 28.57 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -175.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.7 t -120.61 133.14 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.025 0.93 . . . . 0.0 108.724 -175.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.476 HD21 ' HG3' ' A' ' 32' ' ' ARG . 12.3 tp -128.98 140.89 51.45 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.858 1.263 . . . . 0.0 109.283 -173.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -155.3 115.54 3.79 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 41.75 71.05 0.23 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.001 1.32 . . . . 0.0 113.892 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.9 mttt 59.31 23.4 11.83 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.407 1.083 . . . . 0.0 113.714 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -131.82 105.68 7.62 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.578 HG21 ' HG2' ' A' ' 24' ' ' GLU . 40.1 t -103.9 109.0 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.823 0.849 . . . . 0.0 109.053 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -103.02 123.33 46.41 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 171.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 36.8 m -120.01 141.9 49.29 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.046 0.939 . . . . 0.0 108.687 -172.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -124.39 100.44 6.68 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -172.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.5 mtp-105 -81.97 98.61 8.67 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.52 HG12 HG22 ' A' ' 73' ' ' VAL . 6.1 mt -75.45 110.51 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.362 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.0 mp -112.06 103.12 55.06 Favored Pre-proline 0 C--O 1.241 0.639 0 C-N-CA 124.887 1.275 . . . . 0.0 107.566 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -58.05 -57.88 0.98 Allowed 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.259 1.972 . . . . 0.0 110.705 170.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.7 t70 56.01 36.09 26.74 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 122.788 1.28 . . . . 0.0 109.825 173.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.07 178.0 28.06 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.939 -165.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -108.9 -13.37 14.76 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 118.589 1.195 . . . . 0.0 111.029 -175.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -65.47 -85.0 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.451 0.701 . . . . 0.0 110.914 -174.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -131.04 155.68 46.46 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.675 0.75 . . . . 0.0 111.777 175.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.48 110.93 17.07 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.063 1.745 . . . . 0.0 107.578 169.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.12 132.0 43.33 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.147 0.579 . . . . 0.0 110.586 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.52 HG22 HG12 ' A' ' 63' ' ' ILE . 39.8 t -99.38 112.92 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -177.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -90.65 94.56 9.75 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.106 0.563 . . . . 0.0 109.923 -169.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.684 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 65.4 p -65.8 -27.88 68.6 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.612 0.765 . . . . 0.0 112.433 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.8 t -142.07 -169.97 3.05 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.006 0.922 . . . . 0.0 109.796 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -54.45 -55.3 30.28 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.473 1.109 . . . . 0.0 112.386 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.29 44.05 0.19 Allowed Glycine 0 CA--C 1.505 -0.536 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.855 176.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.0 m -69.32 166.3 31.01 Favored Pre-proline 0 CA--C 1.557 1.217 0 C-N-CA 123.347 0.659 . . . . 0.0 111.364 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.45 53.22 1.31 Allowed 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 122.89 2.393 . . . . 0.0 112.652 167.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.509 HG22 ' H ' ' A' ' 82' ' ' ARG . 4.3 p -55.85 176.44 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 C-N-CA 125.42 1.488 . . . . 0.0 111.989 162.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.509 ' H ' HG22 ' A' ' 81' ' ' VAL . 42.4 mmm-85 -108.93 140.49 42.34 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -169.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -95.18 126.44 40.5 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -112.18 166.01 11.65 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.447 0.467 . . . . 0.0 109.876 -175.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -132.27 -4.92 3.41 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.767 0.827 . . . . 0.0 109.006 169.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.529 HG22 ' H ' ' A' ' 88' ' ' GLY . 87.6 m -141.73 136.07 30.41 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.362 1.065 . . . . 0.0 109.645 -172.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 78.7 mt -66.35 -28.26 68.52 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.908 0.883 . . . . 0.0 111.125 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.529 ' H ' HG22 ' A' ' 86' ' ' THR . . . -57.65 -46.74 91.82 Favored Glycine 0 N--CA 1.475 1.234 0 N-CA-C 114.401 0.52 . . . . 0.0 114.401 174.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -65.56 -36.1 82.79 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.548 0.739 . . . . 0.0 111.01 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.598 HD21 HD22 ' A' ' 50' ' ' LEU . 6.5 tt -59.91 -63.68 1.21 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.937 1.295 . . . . 0.0 110.403 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 31.6 mm -60.67 -43.64 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.209 1.004 . . . . 0.0 110.94 -175.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.09 -48.69 66.44 Favored Glycine 0 C--N 1.343 0.955 0 O-C-N 124.219 0.95 . . . . 0.0 113.482 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.2 tt -67.04 -59.67 3.27 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.481 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . 20.2 m-85 -71.69 -5.9 37.19 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -166.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.67 -16.31 25.6 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.048 0.539 . . . . 0.0 111.867 165.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -90.76 146.46 34.08 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 173.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -91.72 -168.19 0.23 Allowed 'Trans proline' 0 C--N 1.363 1.338 0 C-N-CA 122.916 2.411 . . . . 0.0 111.939 172.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.4 t30 52.62 62.39 2.71 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.845 1.258 . . . . 0.0 111.868 176.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -174.31 5.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.985 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.684 ' HA3' ' HB ' ' A' ' 75' ' ' THR . . . 130.97 -31.49 3.17 Favored Glycine 0 N--CA 1.473 1.121 0 N-CA-C 112.221 -0.352 . . . . 0.0 112.221 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' A' ' 94' ' ' TYR . 3.9 mm? -83.17 97.34 8.77 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.5 m -46.63 -32.83 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 126.079 1.752 . . . . 0.0 114.533 -175.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.516 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 24.6 p -130.46 3.07 4.62 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.021 0.528 . . . . 0.0 111.731 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.404 ' HA ' ' HB3' ' A' ' 101' ' ' LEU . . . 66.6 -179.99 0.21 Allowed 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.344 1.028 . . . . 0.0 110.444 -171.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 60.9 mt -90.36 83.16 5.91 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 168.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.3 tp -110.3 -63.03 1.43 Allowed 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.161 -171.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.32 115.51 63.73 Favored Pre-proline 0 N--CA 1.485 1.305 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.509 ' HB3' ' HB3' ' A' ' 13' ' ' TRP . 4.9 Cg_exo -71.14 -90.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 121.805 1.67 . . . . 0.0 110.049 173.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.53 HG13 ' HB1' ' A' ' 30' ' ' ALA . 78.6 t . . . . . 0 C--O 1.254 1.342 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 172.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.7 t . . . . . 0 CA--C 1.556 1.195 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -70.68 -18.55 62.82 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.289 0.635 . . . . 0.0 110.033 172.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 76.2 t80 -85.54 130.42 34.58 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.129 0.572 . . . . 0.0 109.622 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -130.0 140.49 50.87 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -66.17 -53.53 36.35 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -169.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -155.67 72.34 0.79 Allowed 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 122.133 0.968 . . . . 0.0 111.44 175.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.71 HD22 HH21 ' A' ' 39' ' ' ARG . 8.7 tt -92.92 135.01 34.53 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 160.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.404 ' O ' HD23 ' A' ' 18' ' ' LEU . 48.1 t -66.97 146.47 54.34 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.776 0.831 . . . . 0.0 110.043 -173.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.47 ' NE ' ' H ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -64.84 -42.24 95.08 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.671 0.389 . . . . 0.0 110.956 -176.422 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.15 -51.2 67.22 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.56 0.744 . . . . 0.0 111.306 172.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.22 -29.3 70.4 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.659 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.433 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -69.59 -45.82 67.77 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.535 1.134 . . . . 0.0 111.893 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 43.9 mt-10 -56.73 -44.46 81.68 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.669 0.787 . . . . 0.0 110.898 175.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.28 -40.02 86.1 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.412 177.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.5 -42.41 92.12 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.315 1.046 . . . . 0.0 109.65 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.59 HD22 ' HB2' ' A' ' 35' ' ' SER . 93.7 mt -65.52 -43.64 89.4 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.511 0.724 . . . . 0.0 110.461 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.95 -34.91 70.43 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 124.066 0.854 . . . . 0.0 112.283 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -87.83 -43.06 12.12 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.85 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.86 -61.79 1.86 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -167.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.425 ' HA3' ' HB3' ' A' ' 35' ' ' SER . . . -95.29 -33.0 6.72 Favored Glycine 0 C--N 1.352 1.465 0 CA-C-O 121.277 0.376 . . . . 0.0 112.368 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 68.07 0.61 2.47 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 126.904 2.081 . . . . 0.0 114.405 175.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.2 t70 175.53 125.71 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.29 0.636 . . . . 0.0 109.381 -175.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.57 6.06 70.01 Favored Glycine 0 N--CA 1.477 1.417 0 O-C-N 123.285 0.366 . . . . 0.0 112.714 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.59 ' HB2' HD22 ' A' ' 27' ' ' LEU . 3.1 p -80.69 136.9 36.27 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.022 0.929 . . . . 0.0 109.639 -172.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.415 ' HB2' HG22 ' A' ' 52' ' ' VAL . 29.4 p90 -137.13 158.51 44.28 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.817 0.447 . . . . 0.0 110.577 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.447 HD11 ' HB3' ' A' ' 51' ' ' CYS . 1.2 pp -155.23 165.98 34.97 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.19 0.996 . . . . 0.0 109.729 174.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 89.2 t -132.64 130.54 59.48 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 173.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.71 HH21 HD22 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -121.59 179.16 4.55 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 169.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -92.18 140.24 29.82 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 171.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.8 m -71.89 162.65 29.14 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.305 1.042 . . . . 0.0 111.613 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.84 -29.91 8.8 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.142 0.577 . . . . 0.0 110.704 -178.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.8 p -89.63 -58.21 2.6 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 123.739 0.816 . . . . 0.0 110.425 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.5 t -86.68 106.06 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -175.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.8 117.63 7.19 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.957 0.903 . . . . 0.0 111.773 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.42 -0.07 74.02 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-O 119.856 -0.413 . . . . 0.0 113.365 176.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.04 151.64 20.96 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 117.455 0.628 . . . . 0.0 111.689 -177.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -110.82 130.19 55.65 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.875 0.87 . . . . 0.0 111.333 -175.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.419 ' HB3' ' HG2' ' A' ' 39' ' ' ARG . . . -100.51 114.48 28.12 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.904 0.882 . . . . 0.0 110.251 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.5 tp -106.24 108.49 20.02 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.447 ' HB3' HD11 ' A' ' 37' ' ' LEU . 43.3 t -111.39 124.49 52.36 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -177.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 36' ' ' PHE . 17.9 t -129.45 116.65 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.025 0.93 . . . . 0.0 109.675 -174.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.671 HD13 HG22 ' A' ' 58' ' ' VAL . 32.5 tp -86.34 142.83 28.2 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.058 0.943 . . . . 0.0 109.568 173.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -162.78 127.4 3.1 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.515 0.726 . . . . 0.0 109.719 167.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 47.35 62.78 2.25 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.5 1.52 . . . . 0.0 112.682 173.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.63 30.98 16.38 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.633 1.173 . . . . 0.0 111.949 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -141.52 105.93 4.84 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.265 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.671 HG22 HD13 ' A' ' 53' ' ' LEU . 2.7 t -92.98 122.8 44.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 172.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -114.98 140.29 49.15 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.9 p -111.76 136.58 50.83 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.842 0.857 . . . . 0.0 108.716 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -128.46 101.5 6.22 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -84.19 102.63 12.75 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.222 0.609 . . . . 0.0 109.825 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.1 mp -71.39 129.86 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.935 168.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.61 139.82 23.36 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 123.709 0.804 . . . . 0.0 109.533 171.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -83.11 111.51 1.9 Allowed 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.16 1.907 . . . . 0.0 111.129 169.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -69.43 -58.87 3.44 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.675 0.39 . . . . 0.0 110.185 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -96.74 33.04 5.98 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 119.543 -0.587 . . . . 0.0 112.548 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 69.49 -34.03 0.27 Allowed 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -89.11 -48.66 7.25 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.255 0.622 . . . . 0.0 111.094 -165.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -103.51 135.9 44.24 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp -106.68 151.1 25.54 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.557 ' HB2' ' HG2' ' A' ' 83' ' ' ARG . . . -138.93 134.23 32.92 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.163 -0.336 . . . . 0.0 111.481 -169.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.3 p -85.85 135.36 25.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 171.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -98.23 94.74 6.96 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.3 p -78.12 -63.84 1.3 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.407 0.683 . . . . 0.0 111.147 -170.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.538 ' HB3' HG22 ' A' ' 79' ' ' VAL . 41.3 t -177.37 140.15 0.27 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.916 0.886 . . . . 0.0 109.096 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -76.27 91.44 3.22 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 168.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.5 -27.15 0.42 Allowed Glycine 0 C--N 1.339 0.71 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -167.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 76' ' ' SER . 34.7 m -127.4 156.58 74.8 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 124.482 1.113 . . . . 0.0 108.449 174.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.12 136.57 61.34 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.525 2.15 . . . . 0.0 112.986 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 95.9 t -94.68 134.52 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.103 0.961 . . . . 0.0 108.589 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.4 tpt85 -113.78 130.9 56.39 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.68 0.792 . . . . 0.0 109.998 -176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.557 ' HG2' ' HB2' ' A' ' 72' ' ' ALA . 48.1 mtm105 -101.81 156.08 17.73 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.046 0.939 . . . . 0.0 108.83 173.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -137.52 160.85 37.98 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.729 0.812 . . . . 0.0 109.059 -172.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -88.99 -24.1 22.47 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 173.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 88' ' ' GLY . 33.2 m -154.6 154.48 33.09 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 124.289 1.036 . . . . 0.0 109.974 -175.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.8 mt -58.85 -32.28 69.29 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.407 1.083 . . . . 0.0 112.272 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.521 ' H ' HG22 ' A' ' 86' ' ' THR . . . -54.15 -38.72 61.93 Favored Glycine 0 N--CA 1.476 1.319 0 O-C-N 123.613 0.571 . . . . 0.0 114.08 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -66.78 -38.24 86.14 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.298 0.639 . . . . 0.0 110.437 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.9 tt -61.27 -57.58 11.77 Favored 'General case' 0 C--O 1.209 -1.068 0 O-C-N 124.088 0.867 . . . . 0.0 110.306 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 30.9 mm -55.83 -45.28 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 C-N-CA 123.171 0.588 . . . . 0.0 112.099 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.8 -52.23 49.95 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.854 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 61.2 tp -69.09 -43.62 74.18 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.897 0.879 . . . . 0.0 111.526 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.432 ' HB3' HD11 ' A' ' 101' ' ' LEU . 41.8 m-85 -86.69 9.35 19.06 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.547 1.139 . . . . 0.0 112.841 -175.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.88 2.01 2.94 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 157.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -102.82 126.77 31.71 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 124.135 0.974 . . . . 0.0 111.013 174.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -71.7 -178.03 2.84 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.99 2.46 . . . . 0.0 112.802 171.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.5 t30 55.55 28.58 12.03 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 125.049 1.34 . . . . 0.0 111.93 -177.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -141.95 23.76 2.04 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.168 0.587 . . . . 0.0 111.323 -172.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 122.43 -39.15 2.36 Favored Glycine 0 C--N 1.347 1.163 0 C-N-CA 123.018 0.342 . . . . 0.0 112.355 174.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.432 HD11 ' HB3' ' A' ' 94' ' ' TYR . 19.5 mt -90.56 126.57 35.98 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 122.837 0.455 . . . . 0.0 110.899 -174.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.6 m -24.48 -47.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 C-N-CA 126.944 2.098 . . . . 0.0 115.186 176.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.403 ' SG ' HD11 ' A' ' 106' ' ' LEU . 46.2 t -160.91 29.76 0.15 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.537 0.735 . . . . 0.0 109.343 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 69.92 -177.17 0.21 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.624 1.17 . . . . 0.0 112.211 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.4 mt -85.94 101.33 12.79 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.841 177.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.403 HD11 ' SG ' ' A' ' 103' ' ' CYS . 75.6 mt -99.03 -58.95 1.82 Allowed 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -173.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.4 mp -119.05 103.48 47.76 Favored Pre-proline 0 N--CA 1.5 2.031 0 CA-C-N 118.879 0.763 . . . . 0.0 111.001 -174.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.14 115.22 4.27 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.883 2.389 . . . . 0.0 112.439 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 C--O 1.251 1.143 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -176.943 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 p . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.764 0.316 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.512 ' HB2' ' HA ' ' A' ' 37' ' ' LEU . 4.3 p-90 -79.93 -18.57 50.14 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 170.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.445 ' HE2' ' HD3' ' A' ' 16' ' ' ARG . 37.3 t80 -80.82 97.35 7.32 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 18' ' ' LEU . 96.4 m-70 -98.04 119.42 36.65 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.511 0.724 . . . . 0.0 110.143 -175.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.445 ' HD3' ' HE2' ' A' ' 14' ' ' TYR . 21.1 mmm180 -92.26 -9.46 42.05 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.915 1.286 . . . . 0.0 111.748 -178.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -108.93 -9.42 15.13 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.55 0.74 . . . . 0.0 110.778 -174.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 15' ' ' HIS . 0.9 OUTLIER -113.27 131.07 56.06 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.317 1.047 . . . . 0.0 110.782 -166.686 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.5 p -88.92 -176.93 5.35 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.255 1.022 . . . . 0.0 111.128 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.649 ' HG3' HG21 ' A' ' 60' ' ' THR . 62.1 ttt180 -62.09 -50.38 72.15 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.997 0.919 . . . . 0.0 111.621 174.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.32 -43.99 92.62 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.125 0.57 . . . . 0.0 110.876 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.25 -30.12 70.97 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.86 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.4 -57.51 7.27 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.04 0.536 . . . . 0.0 109.882 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.42 ' HG2' HG11 ' A' ' 58' ' ' VAL . 36.5 mt-10 -53.45 -43.74 68.32 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.606 1.163 . . . . 0.0 111.674 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -67.29 -57.95 5.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.547 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.7 tt -61.86 -33.32 73.98 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.88 -174.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.488 HD22 ' HB2' ' A' ' 35' ' ' SER . 82.7 mt -67.68 -44.82 76.86 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.63 -27.58 69.04 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.71 0.804 . . . . 0.0 112.024 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -86.51 -48.97 7.92 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 122.997 0.519 . . . . 0.0 111.256 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.76 -59.2 2.87 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.598 0.759 . . . . 0.0 111.805 -170.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.53 ' HA3' ' HB3' ' A' ' 35' ' ' SER . . . -96.14 -46.35 2.63 Favored Glycine 0 C--N 1.346 1.084 0 O-C-N 123.044 0.215 . . . . 0.0 113.104 -175.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 50.48 26.04 2.2 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 125.842 1.657 . . . . 0.0 113.086 -175.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.0 t70 177.22 97.85 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -173.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.642 ' HA3' HD12 ' A' ' 106' ' ' LEU . . . 72.31 20.66 79.36 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-O 120.985 0.214 . . . . 0.0 113.332 174.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.53 ' HB3' ' HA3' ' A' ' 31' ' ' GLY . 5.7 p -81.59 124.08 29.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.961 0.904 . . . . 0.0 109.431 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -128.37 159.29 35.81 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.931 0.492 . . . . 0.0 110.016 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.512 ' HA ' ' HB2' ' A' ' 13' ' ' TRP . 4.1 pp -156.83 164.16 38.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.042 0.937 . . . . 0.0 109.842 169.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 47.3 t -122.81 154.34 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 173.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -155.77 -173.97 4.76 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.851 1.26 . . . . 0.0 108.803 -176.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -91.4 121.49 33.17 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 174.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.8 t -59.19 160.38 6.45 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 122.116 0.96 . . . . 0.0 113.271 -172.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.34 -29.64 4.11 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.209 1.804 . . . . 0.0 108.545 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.7 m -66.38 -38.71 88.16 Favored 'General case' 0 C--N 1.353 0.761 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.976 173.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.3 t -127.49 119.9 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.017 0.927 . . . . 0.0 108.76 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.45 134.07 51.73 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.435 0.694 . . . . 0.0 111.35 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.21 -1.82 88.06 Favored Glycine 0 C--N 1.348 1.214 0 O-C-N 123.176 0.298 . . . . 0.0 112.931 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -101.67 177.68 4.84 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.101 0.96 . . . . 0.0 111.615 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.601 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 44.7 m-85 -111.56 155.52 23.19 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.683 0.793 . . . . 0.0 109.328 175.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.66 142.94 50.63 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.821 0.848 . . . . 0.0 110.147 174.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.507 ' HB2' HD11 ' A' ' 63' ' ' ILE . 26.6 tp -117.09 113.48 22.36 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 42.2 t -103.99 118.85 37.66 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.8 t -125.28 137.09 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -176.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.531 HD13 HG22 ' A' ' 58' ' ' VAL . 27.0 tp -111.9 137.39 49.93 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.879 0.871 . . . . 0.0 110.216 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.547 ' HB2' ' HB2' ' A' ' 103' ' ' CYS . 88.8 t80 -142.0 103.42 4.31 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.395 1.078 . . . . 0.0 108.354 173.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 43.5 70.95 0.27 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.133 1.373 . . . . 0.0 113.212 172.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 79.9 tttt 55.68 38.23 29.87 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 124.891 1.276 . . . . 0.0 111.938 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -141.82 102.92 4.25 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 170.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.531 HG22 HD13 ' A' ' 53' ' ' LEU . 17.2 t -102.51 129.51 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -119.15 147.18 44.48 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.172 0.589 . . . . 0.0 109.578 170.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.649 HG21 ' HG3' ' A' ' 20' ' ' ARG . 17.7 p -117.37 132.82 56.51 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -123.54 107.03 11.1 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -171.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.574 ' HD3' ' H ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -59.83 155.35 16.42 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 171.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 77.4 mt -146.86 111.74 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 102.742 -3.058 . . . . 0.0 102.742 -162.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.1 mp -91.54 113.68 59.39 Favored Pre-proline 0 N--CA 1.468 0.462 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -165.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.84 -34.17 82.92 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.409 2.739 . . . . 0.0 111.392 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.8 t70 58.55 93.91 0.03 OUTLIER 'General case' 0 C--N 1.364 1.224 0 C-N-CA 125.101 1.361 . . . . 0.0 111.578 166.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -54.95 80.22 0.01 OUTLIER Glycine 0 C--N 1.35 1.322 0 N-CA-C 115.668 1.027 . . . . 0.0 115.668 -174.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -153.07 -85.69 0.07 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 170.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -160.42 6.04 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 174.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -131.09 147.6 52.64 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.202 -0.937 . . . . 0.0 112.513 -174.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.508 HD23 ' H ' ' A' ' 71' ' ' LEU . 2.5 pt? -120.73 129.8 53.78 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.947 1.299 . . . . 0.0 109.015 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.36 149.1 39.9 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.218 0.607 . . . . 0.0 110.271 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.7 t -89.23 130.11 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -108.13 130.81 55.09 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -171.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.9 t -137.47 -178.86 5.41 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.387 -170.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.2 t -69.8 6.22 1.25 Allowed 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -167.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 71.46 139.33 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.852 1.261 . . . . 0.0 111.127 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 113.73 -61.12 0.35 Allowed Glycine 0 C--N 1.342 0.863 0 N-CA-C 106.351 -2.7 . . . . 0.0 106.351 -175.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.476 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 4.3 m -63.63 116.47 26.48 Favored Pre-proline 0 CA--C 1.557 1.213 0 CA-C-N 113.891 -1.154 . . . . 0.0 109.327 156.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 4.7 Cg_exo -75.04 99.07 1.22 Allowed 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.362 2.708 . . . . 0.0 114.356 -168.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 75.4 t -35.8 120.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 123.936 0.895 . . . . 0.0 112.893 158.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 27.9 mmt85 -112.62 142.36 45.3 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 124.345 1.058 . . . . 0.0 108.869 176.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.8 ptt85 -97.81 142.59 29.38 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.544 0.738 . . . . 0.0 111.139 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.481 ' HE2' ' HE2' ' A' ' 94' ' ' TYR . 56.1 m-85 -133.97 163.26 29.93 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.679 1.192 . . . . 0.0 108.679 -176.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -140.15 62.89 1.49 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.095 0.474 . . . . 0.0 109.723 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.457 HG23 ' H ' ' A' ' 89' ' ' GLU . 7.6 t 149.76 133.75 0.0 OUTLIER 'General case' 0 C--N 1.362 1.151 0 C-N-CA 127.301 2.24 . . . . 0.0 106.969 -172.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.86 -29.46 68.31 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.698 0.799 . . . . 0.0 111.941 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -51.2 -46.57 51.23 Favored Glycine 0 C--N 1.353 1.477 0 O-C-N 123.872 0.732 . . . . 0.0 114.473 175.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.457 ' H ' HG23 ' A' ' 86' ' ' THR . 49.3 mm-40 -75.82 -29.85 58.81 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.637 0.375 . . . . 0.0 111.602 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.62 -63.29 1.1 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.438 0.695 . . . . 0.0 109.218 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.426 ' HA ' HD12 ' A' ' 105' ' ' LEU . 36.1 mm -60.28 -39.39 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.129 0.972 . . . . 0.0 111.177 178.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.84 -47.26 87.59 Favored Glycine 0 C--N 1.348 1.204 0 O-C-N 124.212 0.945 . . . . 0.0 113.753 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 34.8 tp -77.79 -43.36 30.89 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.58 0.352 . . . . 0.0 111.287 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.527 ' HB3' HD11 ' A' ' 101' ' ' LEU . 31.9 m-85 -80.74 -1.56 43.3 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -173.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.26 -8.87 56.52 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.174 0.511 . . . . 0.0 110.596 165.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.71 119.24 52.17 Favored Pre-proline 0 CA--C 1.56 1.346 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 175.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -72.69 -166.47 0.28 Allowed 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.128 2.552 . . . . 0.0 114.281 -171.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 56.98 44.56 22.69 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.921 1.288 . . . . 0.0 111.707 -175.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -131.95 8.46 4.44 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.114 -177.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 119.37 -19.6 9.86 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 112.214 -0.355 . . . . 0.0 112.214 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.527 HD11 ' HB3' ' A' ' 94' ' ' TYR . 64.8 mt -79.46 135.78 36.75 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.437 0.695 . . . . 0.0 111.869 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.2 m -59.74 -33.28 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.85 0.86 . . . . 0.0 110.617 171.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 53.9 t -144.55 151.02 38.48 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.401 1.08 . . . . 0.0 109.224 175.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.43 153.28 44.06 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 91' ' ' ILE . 69.5 mt -69.59 95.72 0.87 Allowed 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 120.801 0.334 . . . . 0.0 110.176 -178.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.642 HD12 ' HA3' ' A' ' 34' ' ' GLY . 84.0 mt -100.67 -67.14 0.87 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.309 1.044 . . . . 0.0 110.938 -176.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.431 HD22 HG22 ' A' ' 109' ' ' VAL . 2.0 tt -106.37 113.75 62.93 Favored Pre-proline 0 N--CA 1.481 1.108 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -166.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.22 -37.05 76.97 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 123.496 2.797 . . . . 0.0 113.128 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.431 HG22 HD22 ' A' ' 107' ' ' LEU . 29.4 t . . . . . 0 C--O 1.257 1.464 0 C-N-CA 124.699 1.2 . . . . 0.0 110.252 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.0 t . . . . . 0 C--O 1.239 0.53 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -74.9 -27.18 60.12 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.45 168.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -77.42 121.16 23.42 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.07 0.462 . . . . 0.0 109.803 -174.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.423 ' O ' ' HA ' ' A' ' 39' ' ' ARG . 91.4 m-70 -138.86 131.71 29.32 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 175.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.2 mtm180 -63.59 139.92 58.82 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 168.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.404 ' H ' ' HB3' ' A' ' 40' ' ' ASP . 27.2 t70 -26.25 83.16 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 116.635 2.087 . . . . 0.0 116.635 -166.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 pp -66.17 -19.0 65.7 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.107 165.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.4 t 100.24 138.87 0.01 OUTLIER 'General case' 0 C--N 1.372 1.548 0 C-N-CA 127.489 2.315 . . . . 0.0 110.198 173.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -63.47 -45.02 92.69 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.655 0.782 . . . . 0.0 112.156 -176.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.17 -49.96 65.59 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.142 0.577 . . . . 0.0 110.67 173.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.83 -24.2 63.42 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.68 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.467 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -68.44 -58.47 4.29 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.814 0.845 . . . . 0.0 110.887 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.462 ' HG2' HG11 ' A' ' 58' ' ' VAL . 45.8 mt-10 -53.38 -38.25 63.18 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.02 0.928 . . . . 0.0 111.706 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -71.23 -44.9 64.44 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.078 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 33.4 tp -59.98 -43.42 95.15 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.061 0.944 . . . . 0.0 111.068 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 23' ' ' ALA . 94.6 mt -65.85 -49.88 66.59 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.523 0.729 . . . . 0.0 109.235 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.21 -34.24 73.38 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.066 0.946 . . . . 0.0 112.388 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -82.79 -50.49 8.61 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.244 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.48 -61.85 1.87 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.318 -171.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.82 -60.02 0.56 Allowed Glycine 0 C--N 1.352 1.467 0 CA-C-N 117.902 0.319 . . . . 0.0 113.548 -171.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 50.09 40.7 22.21 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.943 1.697 . . . . 0.0 113.817 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -170.31 83.83 0.11 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -171.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.81 22.9 78.29 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -177.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.2 m -87.0 119.82 27.61 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.017 0.927 . . . . 0.0 109.073 -171.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.498 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 19.2 p90 -131.89 158.56 41.04 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.011 0.434 . . . . 0.0 110.695 -175.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.467 HD11 ' HB1' ' A' ' 23' ' ' ALA . 4.1 pp -156.86 165.28 36.64 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.256 170.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.3 t -121.58 129.33 75.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 15' ' ' HIS . 3.7 ptm180 -125.57 163.36 22.9 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.252 1.021 . . . . 0.0 109.365 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.404 ' HB3' ' H ' ' A' ' 17' ' ' ASP . 23.1 t70 -91.78 120.07 32.17 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.3 m -91.43 100.88 13.57 Favored 'General case' 0 C--O 1.247 0.953 0 C-N-CA 122.759 0.424 . . . . 0.0 110.565 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -62.64 94.92 0.07 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.47 0.652 . . . . 0.0 110.394 163.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.3 t -151.85 -55.88 0.14 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.9 m -125.66 149.2 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 165.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 8.79 -80.0 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 127.249 2.22 . . . . 0.0 115.334 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.18 79.88 0.21 Allowed Glycine 0 C--N 1.351 1.382 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.31 165.95 14.64 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 171.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -117.22 163.73 15.86 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.104 0.561 . . . . 0.0 111.031 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.62 146.75 46.4 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.052 0.941 . . . . 0.0 110.252 168.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.51 HD22 HD21 ' A' ' 90' ' ' LEU . 46.3 tp -116.7 114.91 24.69 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 176.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 61.0 m -101.05 116.26 32.43 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.4 t -119.17 124.07 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.418 ' HB2' HG22 ' A' ' 58' ' ' VAL . 23.5 tp -119.54 145.16 46.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.021 0.928 . . . . 0.0 110.335 -177.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.416 ' H ' HD12 ' A' ' 53' ' ' LEU . 25.1 t80 -154.74 126.14 7.37 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 172.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 35.79 73.71 0.08 Allowed 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 78.6 tttt 52.26 35.85 18.02 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 125.086 1.355 . . . . 0.0 113.768 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -143.58 104.39 4.21 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 121.759 -0.588 . . . . 0.0 110.49 165.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.462 HG11 ' HG2' ' A' ' 24' ' ' GLU . 20.1 t -93.05 129.25 43.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 172.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -118.24 133.37 55.95 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 168.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.8 m -120.99 141.99 50.2 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -174.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -128.67 99.7 5.45 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -170.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -76.95 103.57 6.96 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.514 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.0 mp -67.87 108.19 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.228 172.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.3 tp -110.1 108.95 59.04 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -174.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.514 ' HB2' ' HG2' ' A' ' 68' ' ' GLU . 14.5 Cg_exo -69.88 -57.39 0.12 Allowed 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.555 2.17 . . . . 0.0 112.439 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.8 t70 80.49 -70.39 0.09 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.965 1.306 . . . . 0.0 109.406 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.37 -38.35 80.66 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 168.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.514 ' HG2' ' HB2' ' A' ' 65' ' ' PRO . 48.7 mt-10 84.14 24.66 0.11 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.283 1.433 . . . . 0.0 113.304 164.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -103.82 -37.42 7.45 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 164.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -116.49 134.73 54.52 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.106 0.962 . . . . 0.0 109.256 170.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -105.71 111.92 24.79 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.965 0.906 . . . . 0.0 109.005 175.661 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . . . -99.01 132.42 44.33 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.92 0.488 . . . . 0.0 110.988 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.514 HG21 ' HG ' ' A' ' 90' ' ' LEU . 11.2 t -87.24 118.27 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.163 176.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -81.31 92.09 6.32 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.0 m -72.23 -42.85 65.24 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.794 -175.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.503 ' HB3' HG22 ' A' ' 79' ' ' VAL . 48.1 t 173.98 141.94 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.385 1.474 . . . . 0.0 109.019 169.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -74.63 86.82 2.14 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 168.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.95 -22.85 0.31 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -167.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.503 HG22 ' HB3' ' A' ' 76' ' ' SER . 32.6 m -128.31 157.84 73.25 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 124.033 0.933 . . . . 0.0 109.066 175.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.71 126.62 21.64 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.268 2.645 . . . . 0.0 113.312 172.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 73' ' ' VAL . 54.6 t -101.52 134.76 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.169 1.387 . . . . 0.0 108.521 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -111.5 137.77 48.89 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.336 0.654 . . . . 0.0 110.901 -172.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 48.4 ptt85 -96.5 150.44 20.62 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.805 0.842 . . . . 0.0 108.856 173.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -138.72 164.57 29.22 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.499 0.72 . . . . 0.0 109.442 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -111.63 -13.43 13.78 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.187 0.595 . . . . 0.0 110.142 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.648 HG22 ' H ' ' A' ' 88' ' ' GLY . 59.6 m -148.7 147.1 28.49 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.511 0.724 . . . . 0.0 109.214 -174.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.33 -28.68 69.87 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.179 0.592 . . . . 0.0 111.178 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.648 ' H ' HG22 ' A' ' 86' ' ' THR . . . -63.0 -36.34 93.33 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 122.987 0.327 . . . . 0.0 113.138 173.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.47 ' HG2' ' HB ' ' A' ' 86' ' ' THR . 33.1 mm-40 -62.07 -47.03 86.47 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.691 0.797 . . . . 0.0 110.22 175.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.514 ' HG ' HG21 ' A' ' 73' ' ' VAL . 4.8 tt -50.48 -61.55 2.12 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.25 1.42 . . . . 0.0 109.932 173.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 47.1 mm -60.99 -27.48 41.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.448 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.09 -60.58 8.77 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 123.634 0.584 . . . . 0.0 113.48 175.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.1 mt -74.46 -32.7 62.69 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -82.19 -21.74 36.32 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.843 0.457 . . . . 0.0 112.176 -172.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.96 -17.28 63.11 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 168.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -132.45 69.3 79.94 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 124.651 1.18 . . . . 0.0 108.696 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.44 -81.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.233 1.955 . . . . 0.0 113.839 -168.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 90.08 -90.45 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.48 1.912 . . . . 0.0 106.821 -170.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -79.93 144.05 33.68 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 122.916 0.486 . . . . 0.0 111.912 170.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.82 -59.13 0.37 Allowed Glycine 0 C--N 1.35 1.315 0 C-N-CA 123.391 0.519 . . . . 0.0 113.176 166.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 24.7 mt -82.13 164.88 21.01 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.5 m -84.02 -24.37 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 CA-C-N 114.673 -1.148 . . . . 0.0 109.943 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 52.2 t -164.92 167.53 18.52 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 125.12 1.368 . . . . 0.0 108.745 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -77.36 170.68 16.12 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 120.93 0.395 . . . . 0.0 109.958 172.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.7 mt -81.53 97.46 7.83 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 175.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.9 mp -92.6 -57.93 2.52 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.017 0.927 . . . . 0.0 110.478 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 61.7 tp -131.09 107.06 14.96 Favored Pre-proline 0 N--CA 1.479 1.02 0 C-N-CA 123.379 0.671 . . . . 0.0 110.974 -165.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.99 124.12 10.3 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.368 2.045 . . . . 0.0 110.301 170.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 32.7 t . . . . . 0 CA--C 1.552 1.031 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -172.032 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.9 p . . . . . 0 N--CA 1.472 0.645 0 CA-C-O 121.315 0.579 . . . . 0.0 111.672 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.522 ' HB3' ' HB3' ' A' ' 108' ' ' PRO . 1.9 p-90 -86.3 10.4 14.93 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.889 0.876 . . . . 0.0 112.761 -176.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.421 ' HA ' ' HB ' ' A' ' 38' ' ' VAL . 17.8 t80 -118.03 134.82 54.62 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -174.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -137.18 171.89 13.82 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.739 0.816 . . . . 0.0 110.276 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.4 171.99 16.64 Favored 'General case' 0 C--O 1.245 0.817 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 164.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 74.55 3.95 4.35 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.677 1.191 . . . . 0.0 110.209 -172.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.3 tp -105.98 120.52 41.97 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 125.956 1.702 . . . . 0.0 107.999 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.4 m -82.49 170.15 15.57 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.524 0.73 . . . . 0.0 110.41 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.513 HH11 ' HG2' ' A' ' 24' ' ' GLU . 4.7 tmm_? -58.97 -55.88 29.48 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.408 0.683 . . . . 0.0 110.764 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.81 -44.01 73.43 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.121 0.888 . . . . 0.0 111.084 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.02 -36.06 82.77 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.521 0.729 . . . . 0.0 112.185 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.548 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -65.22 -56.5 12.46 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.824 0.85 . . . . 0.0 111.608 -176.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.513 ' HG2' HH11 ' A' ' 20' ' ' ARG . 0.0 OUTLIER -69.12 -24.64 64.13 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.879 -179.171 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 31.8 mt-10 -64.86 -55.66 18.11 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 169.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.12 -23.49 47.5 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.494 0.717 . . . . 0.0 112.828 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.9 mt -71.86 -52.79 15.63 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 168.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.98 -21.48 50.83 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -168.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 30.5 mmt180 -74.42 -42.25 59.49 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 118.246 0.475 . . . . 0.0 110.677 176.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.53 -53.45 4.8 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.945 -174.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.27 -159.59 8.41 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.974 -163.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 175.49 138.89 0.05 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.274 1.029 . . . . 0.0 110.493 -171.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.554 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 62.6 m-20 96.67 87.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.207 1.403 . . . . 0.0 109.184 159.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.24 16.7 73.55 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.708 -173.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 m -82.49 123.43 29.16 Favored 'General case' 0 C--N 1.346 0.456 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.448 ' CE1' ' HB3' ' A' ' 105' ' ' LEU . 30.9 p90 -131.7 159.22 39.02 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.41 0.624 . . . . 0.0 111.345 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.548 HD11 ' HB1' ' A' ' 23' ' ' ALA . 3.3 pp -150.63 159.99 44.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.165 165.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.421 ' HB ' ' HA ' ' A' ' 14' ' ' TYR . 46.9 t -116.75 150.54 18.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 175.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.501 HH22 ' HG2' ' A' ' 42' ' ' GLU . 20.6 ptt85 -146.59 -179.61 6.89 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -81.64 126.47 31.8 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 167.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 93.7 p -73.12 163.54 27.99 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.752 0.421 . . . . 0.0 110.703 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.501 ' HG2' HH22 ' A' ' 39' ' ' ARG . 10.8 pt-20 -124.61 -16.27 6.31 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.445 0.698 . . . . 0.0 110.6 -177.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.0 m -68.46 -30.17 68.97 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.884 0.874 . . . . 0.0 111.057 172.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.492 HG13 ' HB3' ' A' ' 47' ' ' ALA . 1.8 p -145.99 117.5 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 124.192 0.997 . . . . 0.0 109.683 -175.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.03 132.63 49.73 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.447 1.099 . . . . 0.0 112.056 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.84 11.94 80.66 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.347 0.404 . . . . 0.0 113.708 177.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.492 ' HB3' HG13 ' A' ' 44' ' ' VAL . . . -118.59 178.06 4.6 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.739 0.816 . . . . 0.0 111.717 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.474 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 32.9 m-85 -114.7 166.78 11.38 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.592 0.757 . . . . 0.0 111.286 -176.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.42 145.61 41.17 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.012 0.925 . . . . 0.0 110.233 169.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.491 ' HB2' HD11 ' A' ' 63' ' ' ILE . 51.7 tp -121.5 114.3 21.04 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.99 1.316 . . . . 0.0 108.33 -176.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 36.2 t -108.68 122.12 46.45 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.276 1.03 . . . . 0.0 108.62 -174.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.2 t -129.54 115.61 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 123.452 0.701 . . . . 0.0 110.366 -171.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.432 HD13 HG22 ' A' ' 58' ' ' VAL . 17.2 tp -94.83 136.89 34.6 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.564 1.146 . . . . 0.0 110.132 177.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 60.2 t80 -163.02 122.5 2.19 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.313 1.045 . . . . 0.0 109.206 175.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 40.58 61.12 1.71 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.327 1.851 . . . . 0.0 113.6 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 62.41 30.08 17.27 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.57 1.148 . . . . 0.0 113.042 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -138.33 106.88 5.85 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.236 0.614 . . . . 0.0 109.548 177.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.432 HG22 HD13 ' A' ' 53' ' ' LEU . 18.3 t -101.66 114.64 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -105.79 126.3 52.01 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.0 m -113.02 136.02 53.15 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -127.99 110.35 12.44 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.874 0.87 . . . . 0.0 109.107 -171.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.508 ' HD2' ' H ' ' A' ' 62' ' ' ARG . 0.1 OUTLIER -59.55 157.0 12.27 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 169.446 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.491 HD11 ' HB2' ' A' ' 50' ' ' LEU . 90.7 mt -146.19 102.66 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 103.686 -2.709 . . . . 0.0 103.686 -162.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.7 mp -114.97 140.65 25.81 Favored Pre-proline 0 N--CA 1.475 0.804 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -166.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 33.6 Cg_exo -58.58 -70.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 121.915 1.743 . . . . 0.0 109.274 164.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.0 t70 58.53 15.94 3.91 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.133 1.373 . . . . 0.0 112.639 167.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.38 137.38 3.77 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -34.08 -45.76 0.22 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 -165.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -113.21 -16.25 12.59 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -164.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.414 ' HB2' ' HB2' ' A' ' 83' ' ' ARG . 44.4 p90 -125.98 160.88 28.85 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.967 -0.458 . . . . 0.0 111.74 -167.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 3.9 pp -121.73 118.36 28.9 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.525 1.53 . . . . 0.0 107.144 166.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -111.95 148.48 33.65 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.735 0.779 . . . . 0.0 110.011 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.8 t -122.85 131.32 73.48 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -78.65 94.55 5.07 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.471 HG22 ' HA3' ' A' ' 100' ' ' GLY . 2.0 m -70.78 -63.06 1.17 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.059 -176.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.459 ' HB2' HG22 ' A' ' 79' ' ' VAL . 73.5 m -163.19 113.66 1.39 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.248 1.419 . . . . 0.0 107.62 170.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -68.62 97.41 0.79 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 170.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.16 -22.7 0.87 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -163.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.459 HG22 ' HB2' ' A' ' 76' ' ' SER . 22.5 m -129.84 153.21 80.87 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 125.375 1.47 . . . . 0.0 107.075 170.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -54.47 124.69 16.73 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.386 2.057 . . . . 0.0 112.8 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.6 t -86.09 140.32 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -102.11 136.21 42.35 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.031 0.533 . . . . 0.0 109.908 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.414 ' HB2' ' HB2' ' A' ' 70' ' ' PHE . 14.6 ptp180 -87.35 138.76 31.21 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 163.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -119.7 143.25 47.86 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.747 0.819 . . . . 0.0 109.277 176.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -84.66 -22.24 29.93 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.091 0.472 . . . . 0.0 110.43 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.677 ' HB ' ' HG2' ' A' ' 89' ' ' GLU . 51.0 m -141.79 149.01 39.83 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.74 0.816 . . . . 0.0 109.767 -177.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.24 -30.73 71.64 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.596 0.759 . . . . 0.0 109.525 176.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.66 ' H ' HG22 ' A' ' 86' ' ' THR . . . -53.92 -41.79 68.57 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-N 116.099 -0.501 . . . . 0.0 113.582 169.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.677 ' HG2' ' HB ' ' A' ' 86' ' ' THR . 31.0 mm-40 -71.45 -32.23 68.09 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.273 0.629 . . . . 0.0 110.7 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 46.5 tp -59.04 -59.25 5.77 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.318 0.647 . . . . 0.0 111.011 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 51.6 mm -62.25 -37.16 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.999 0.919 . . . . 0.0 111.004 -176.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.13 -51.73 53.91 Favored Glycine 0 CA--C 1.535 1.331 0 O-C-N 124.153 0.908 . . . . 0.0 113.292 174.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.0 mt -78.99 -23.17 44.6 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.091 0.556 . . . . 0.0 112.216 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -83.33 -18.31 39.39 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.03 -35.15 76.29 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.527 0.331 . . . . 0.0 110.539 170.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -127.0 76.42 76.0 Favored Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 124.371 1.068 . . . . 0.0 108.602 175.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -92.49 -66.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 123.363 2.708 . . . . 0.0 114.421 -169.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 59.66 55.84 3.85 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 124.845 1.258 . . . . 0.0 111.266 -173.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 160.45 97.87 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 126.734 2.014 . . . . 0.0 109.706 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.471 ' HA3' HG22 ' A' ' 75' ' ' THR . . . 104.33 -37.35 3.82 Favored Glycine 0 C--N 1.355 1.617 0 N-CA-C 113.758 0.263 . . . . 0.0 113.758 164.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -76.52 122.45 24.59 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.841 0.456 . . . . 0.0 110.829 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.2 m -52.73 -32.45 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 125.544 1.537 . . . . 0.0 114.19 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 36.4 t -153.54 3.31 0.28 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.108 0.563 . . . . 0.0 111.19 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 76.04 177.37 0.19 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.902 1.281 . . . . 0.0 110.669 -167.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.448 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 26.7 mt -93.05 103.39 15.7 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.51 -53.35 6.04 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.562 0.745 . . . . 0.0 111.03 -176.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.22 137.32 9.86 Favored Pre-proline 0 N--CA 1.483 1.222 0 C-N-CA 122.167 0.187 . . . . 0.0 111.199 -175.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.522 ' HB3' ' HB3' ' A' ' 13' ' ' TRP . 97.1 Cg_endo -78.79 137.08 13.9 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.333 2.022 . . . . 0.0 111.875 171.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 57.0 t . . . . . 0 CA--C 1.547 0.857 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.293 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.6 p . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -84.77 0.87 49.11 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.056 -1.027 . . . . 0.0 110.435 171.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -110.91 111.53 22.73 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -119.03 115.0 23.39 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 176.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -39.71 -49.31 2.26 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 125.565 1.546 . . . . 0.0 113.722 -172.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -156.96 70.55 0.64 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-O 122.312 1.053 . . . . 0.0 108.578 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 21.9 tp -64.77 -32.18 73.74 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 113.658 -1.61 . . . . 0.0 109.464 165.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.0 t 88.31 141.82 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 126.014 1.726 . . . . 0.0 107.944 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -60.83 -43.02 98.84 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.213 0.605 . . . . 0.0 112.079 -168.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.83 -48.01 73.09 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.507 0.723 . . . . 0.0 111.72 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -72.44 -22.58 61.07 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.316 178.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.476 ' O ' ' HG ' ' A' ' 27' ' ' LEU . . . -67.67 -49.83 60.87 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.594 ' HG3' HG21 ' A' ' 58' ' ' VAL . 34.8 tt0 -54.53 -41.24 69.48 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 124.885 1.366 . . . . 0.0 111.296 175.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.0 -50.6 47.39 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.437 -177.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.84 -33.98 73.87 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.091 0.957 . . . . 0.0 111.881 176.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 23' ' ' ALA . 75.4 mt -64.73 -52.84 54.94 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.1 0.56 . . . . 0.0 109.683 175.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.29 -42.47 98.71 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.17 0.988 . . . . 0.0 111.947 -176.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -69.33 -41.33 76.82 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.888 -175.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.35 -62.82 1.39 Allowed 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.02 -38.46 2.89 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 113.886 0.314 . . . . 0.0 113.886 -166.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.84 12.76 0.12 Allowed 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 128.011 2.524 . . . . 0.0 116.28 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 4.5 m-20 -174.37 118.51 0.23 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -166.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.429 ' HA2' ' SG ' ' A' ' 103' ' ' CYS . . . 63.16 11.02 37.01 Favored Glycine 0 C--N 1.352 1.44 0 N-CA-C 113.906 0.322 . . . . 0.0 113.906 -177.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.9 m -83.69 123.68 30.07 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.142 0.977 . . . . 0.0 110.039 -168.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -135.73 156.38 48.92 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 120.767 0.318 . . . . 0.0 111.439 -176.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.432 HD11 ' HB1' ' A' ' 23' ' ' ALA . 4.4 pp -159.9 158.74 31.41 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 124.709 1.255 . . . . 0.0 109.673 169.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.44 HG22 HD13 ' A' ' 50' ' ' LEU . 21.9 t -114.05 150.65 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.451 HH22 ' HB2' ' A' ' 42' ' ' GLU . 1.7 ptm180 -148.0 177.13 9.61 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.264 1.025 . . . . 0.0 109.207 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -84.4 129.28 34.88 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.3 t -61.18 142.38 56.79 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.48 0.712 . . . . 0.0 112.108 -174.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.451 ' HB2' HH22 ' A' ' 39' ' ' ARG . 32.2 tt0 -107.03 0.24 23.48 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.984 178.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.2 t -104.97 -41.72 5.52 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.207 1.003 . . . . 0.0 110.069 -177.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.5 HG21 HD21 ' A' ' 64' ' ' LEU . 44.7 t -128.11 115.18 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.902 0.881 . . . . 0.0 109.528 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.22 124.63 24.6 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.929 0.891 . . . . 0.0 110.817 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.36 12.06 65.75 Favored Glycine 0 C--N 1.344 0.979 0 O-C-N 123.345 0.403 . . . . 0.0 112.746 -174.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.32 177.0 5.07 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.794 0.838 . . . . 0.0 111.168 172.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.422 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 70.4 m-85 -124.21 166.83 15.16 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.832 1.253 . . . . 0.0 110.254 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.9 147.79 48.31 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.358 1.063 . . . . 0.0 109.526 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.561 ' HB2' HD11 ' A' ' 63' ' ' ILE . 50.2 tp -123.99 123.92 41.45 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.062 1.345 . . . . 0.0 107.51 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 37.1 t -112.29 123.85 51.17 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.9 t -128.73 143.7 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.545 HD13 HG22 ' A' ' 58' ' ' VAL . 48.9 tp -130.3 144.71 51.54 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.113 0.965 . . . . 0.0 108.942 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 84.6 t80 -164.28 122.77 1.83 Allowed 'General case' 0 CA--C 1.537 0.479 0 O-C-N 124.318 1.011 . . . . 0.0 109.005 178.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 17.3 tm0? 41.74 70.07 0.3 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 125.404 1.482 . . . . 0.0 111.561 -177.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt 48.67 25.23 0.93 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 125.586 1.555 . . . . 0.0 114.288 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -131.32 117.36 18.82 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.355 0.662 . . . . 0.0 109.299 -178.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.594 HG21 ' HG3' ' A' ' 24' ' ' GLU . 34.1 t -99.53 144.94 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.507 1.123 . . . . 0.0 109.623 -177.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -137.34 119.26 15.28 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 174.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 33.4 m -105.92 114.1 28.04 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -95.65 117.68 30.93 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -177.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 65.6 mtm-85 -62.25 158.37 17.32 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 170.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.561 HD11 ' HB2' ' A' ' 50' ' ' LEU . 76.2 mt -145.32 98.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 102.808 -3.034 . . . . 0.0 102.808 -175.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.5 HD21 HG21 ' A' ' 44' ' ' VAL . 10.6 mp -122.14 148.62 52.38 Favored Pre-proline 0 N--CA 1.477 0.923 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -172.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 70' ' ' PHE . 87.8 Cg_exo -44.29 -59.66 1.03 Allowed 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.53 2.153 . . . . 0.0 111.845 172.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.2 t70 47.33 71.5 0.32 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.857 1.263 . . . . 0.0 111.87 174.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.65 -75.95 0.24 Allowed Glycine 0 C--N 1.337 0.631 0 CA-C-O 119.459 -0.634 . . . . 0.0 111.626 -176.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 169.29 -40.44 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.051 1.34 . . . . 0.0 111.405 -175.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -131.35 -13.43 3.43 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -161.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 97.8 m-85 -117.91 163.81 15.99 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.425 1.09 . . . . 0.0 110.443 -167.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.1 mp -104.54 109.34 21.19 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 171.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.43 126.05 42.45 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.192 0.997 . . . . 0.0 109.57 -175.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.5 t -96.09 133.27 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -178.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -94.52 89.32 5.77 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -175.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.469 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 21.2 p -71.04 -66.59 0.59 Allowed 'General case' 0 C--O 1.248 1.006 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.325 175.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.3 t 176.39 174.67 0.34 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.089 1.355 . . . . 0.0 109.945 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -68.01 160.7 28.22 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 123.786 0.834 . . . . 0.0 109.185 167.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.51 -72.54 2.16 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-N 118.451 0.569 . . . . 0.0 112.99 -170.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.1 m -65.6 145.94 99.01 Favored Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 123.662 0.785 . . . . 0.0 110.538 176.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.79 137.56 27.36 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.482 2.121 . . . . 0.0 113.483 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.4 t -69.58 118.12 13.42 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 167.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -98.62 117.38 32.93 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.508 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -100.69 149.99 23.21 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.714 0.806 . . . . 0.0 110.271 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -134.29 162.29 32.59 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.42 0.688 . . . . 0.0 112.399 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -74.08 -46.5 42.62 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.511 170.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 37.9 p -138.34 169.12 18.35 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.618 0.767 . . . . 0.0 110.999 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.482 ' O ' HG12 ' A' ' 91' ' ' ILE . 4.3 mm? -62.21 -34.42 76.44 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.584 0.754 . . . . 0.0 111.058 171.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -53.86 -43.89 70.92 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 122.975 0.172 . . . . 0.0 113.029 175.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -66.38 -36.15 82.13 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.252 0.621 . . . . 0.0 110.611 175.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.424 HD13 HD13 ' A' ' 87' ' ' LEU . 7.8 tt -64.7 -38.6 91.54 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.342 1.057 . . . . 0.0 110.828 -178.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 87' ' ' LEU . 50.3 mm -85.04 -35.54 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -168.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.3 -44.93 32.61 Favored Glycine 0 C--N 1.35 1.331 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.877 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.1 tp -76.11 -32.73 59.32 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.712 0.405 . . . . 0.0 111.239 -178.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.616 ' HB3' ' HG ' ' A' ' 105' ' ' LEU . 3.9 m-30 -78.12 -16.46 57.95 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.757 174.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.42 -2.16 10.33 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.136 0.574 . . . . 0.0 112.102 171.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -128.37 152.14 77.65 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 169.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -28.93 103.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 124.819 3.679 . . . . 0.0 114.967 165.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.512 ' HB3' HD23 ' A' ' 101' ' ' LEU . 8.3 t30 -106.28 -44.7 4.48 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.533 -177.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 107.93 115.78 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 128.184 2.594 . . . . 0.0 108.644 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.469 ' HA3' ' HB ' ' A' ' 75' ' ' THR . . . 110.04 -13.28 31.61 Favored Glycine 0 C--N 1.345 1.04 0 O-C-N 123.747 0.654 . . . . 0.0 112.266 -175.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.512 HD23 ' HB3' ' A' ' 98' ' ' ASN . 3.9 mm? -84.36 138.72 32.72 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.183 0.993 . . . . 0.0 111.699 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.1 p -60.68 -35.64 65.27 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 C-N-CA 124.425 1.09 . . . . 0.0 112.421 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.429 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 29.0 p -163.98 13.62 0.05 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.377 0.671 . . . . 0.0 111.455 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.443 ' H ' ' HB3' ' A' ' 101' ' ' LEU . . . 74.15 176.96 0.24 Allowed 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 124.814 1.246 . . . . 0.0 109.771 -167.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.616 ' HG ' ' HB3' ' A' ' 94' ' ' TYR . 26.6 mt -92.88 113.87 26.27 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.412 ' HB3' ' HA3' ' A' ' 34' ' ' GLY . 56.1 tp -108.01 -63.32 1.33 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.513 0.725 . . . . 0.0 111.868 -173.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.459 HD22 HG22 ' A' ' 109' ' ' VAL . 5.0 tt -116.58 103.73 52.29 Favored Pre-proline 0 N--CA 1.479 0.999 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -170.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -73.74 119.24 5.8 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.56 2.173 . . . . 0.0 111.158 173.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.459 HG22 HD22 ' A' ' 107' ' ' LEU . 21.1 t . . . . . 0 CA--C 1.553 1.069 0 CA-C-O 118.038 -0.982 . . . . 0.0 108.371 -175.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 C--O 1.239 0.515 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -83.37 -29.1 28.47 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 172.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -74.67 122.75 23.69 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -138.41 93.36 2.73 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.371 0.669 . . . . 0.0 109.394 176.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -62.84 148.98 45.48 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 157.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.6 t70 81.41 -11.47 1.08 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.357 1.063 . . . . 0.0 111.736 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 tp -90.73 122.57 33.6 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.6 m -83.44 158.01 22.24 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.898 0.479 . . . . 0.0 109.851 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -62.58 -47.02 85.63 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -171.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.37 -45.32 80.58 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.416 0.686 . . . . 0.0 111.347 177.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.81 -34.39 76.66 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.86 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.594 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -66.23 -55.71 14.87 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.76 0.824 . . . . 0.0 111.422 -177.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.501 ' HG2' ' SG ' ' A' ' 51' ' ' CYS . 25.2 mt-10 -64.67 -28.77 69.83 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.521 1.128 . . . . 0.0 111.443 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -62.28 -50.99 69.51 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.462 0.705 . . . . 0.0 109.416 173.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.6 mt -66.77 -28.35 68.33 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.163 0.985 . . . . 0.0 112.077 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.503 HD21 ' HG ' ' A' ' 37' ' ' LEU . 75.0 mt -68.04 -45.01 75.15 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 118.058 0.39 . . . . 0.0 110.176 173.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.2 -26.78 63.09 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.653 0.781 . . . . 0.0 111.22 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -85.97 -60.54 1.98 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.369 0.668 . . . . 0.0 111.484 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.23 -54.92 5.49 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.626 0.771 . . . . 0.0 112.354 -166.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.595 ' HA3' ' HB3' ' A' ' 35' ' ' SER . . . -87.5 -34.1 10.78 Favored Glycine 0 N--CA 1.471 0.967 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 60.25 4.04 0.61 Allowed 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 126.445 1.898 . . . . 0.0 114.827 174.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.3 t70 164.52 133.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.09 1.356 . . . . 0.0 107.788 -171.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.61 -2.27 54.46 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 117.89 0.314 . . . . 0.0 113.579 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.595 ' HB3' ' HA3' ' A' ' 31' ' ' GLY . 1.9 p -82.54 130.37 35.1 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.406 1.082 . . . . 0.0 111.967 -169.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.411 ' CE1' ' HB3' ' A' ' 105' ' ' LEU . 46.2 p90 -127.33 151.93 48.12 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.031 0.532 . . . . 0.0 110.083 174.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.594 HD11 ' HB1' ' A' ' 23' ' ' ALA . 2.3 pp -144.9 160.89 40.59 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.718 0.807 . . . . 0.0 109.013 166.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.447 HG21 HD11 ' A' ' 87' ' ' LEU . 22.6 t -112.78 153.99 14.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.416 HH22 HG21 ' A' ' 60' ' ' THR . 30.1 mtm180 -139.99 170.43 15.87 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.075 0.95 . . . . 0.0 109.661 -176.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -87.78 134.54 33.66 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.296 168.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.5 m -62.96 135.45 57.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.911 0.386 . . . . 0.0 111.143 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -102.27 14.88 30.77 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.207 1.003 . . . . 0.0 111.286 -172.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.0 t -147.33 -62.28 0.28 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.374 0.669 . . . . 0.0 109.898 -177.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.9 m -89.32 125.39 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -171.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 24.78 -133.88 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 127.585 2.354 . . . . 0.0 116.466 171.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.45 57.63 0.44 Allowed Glycine 0 C--N 1.358 1.772 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.42 174.15 6.0 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.63 0.772 . . . . 0.0 111.107 -173.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.55 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 81.0 m-85 -114.82 158.73 21.5 Favored 'General case' 0 C--O 1.25 1.083 0 C-N-CA 123.905 0.882 . . . . 0.0 109.827 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.24 141.21 52.23 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.535 1.134 . . . . 0.0 109.214 173.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.573 HD22 HD21 ' A' ' 90' ' ' LEU . 58.9 tp -123.32 115.75 22.19 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.501 ' SG ' ' HG2' ' A' ' 24' ' ' GLU . 45.9 t -114.19 119.08 35.85 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -176.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 5.1 t -127.77 140.56 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.218 0.607 . . . . 0.0 109.4 -170.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.8 tp -122.92 138.47 54.66 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.722 1.209 . . . . 0.0 109.035 -177.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -169.32 136.63 1.78 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.002 0.921 . . . . 0.0 109.622 172.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 47.35 42.49 14.02 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.819 1.248 . . . . 0.0 112.096 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 56.62 45.47 22.09 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.739 1.216 . . . . 0.0 112.641 -173.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -129.6 103.85 7.11 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 171.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 61.6 t -97.65 105.45 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 170.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -112.78 134.12 54.45 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.416 HG21 HH22 ' A' ' 39' ' ' ARG . 55.5 m -117.8 142.34 47.4 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.412 0.685 . . . . 0.0 109.453 -175.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -124.74 154.85 40.24 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.54 1.136 . . . . 0.0 108.26 -177.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -102.39 160.98 14.07 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 166.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.658 HG12 HD11 ' A' ' 90' ' ' LEU . 3.7 mp -144.59 101.24 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 103.122 -2.918 . . . . 0.0 103.122 -163.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.1 mp -103.4 137.67 19.32 Favored Pre-proline 0 N--CA 1.481 1.119 0 CA-C-O 119.421 -0.323 . . . . 0.0 110.943 -163.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.63 -138.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 123.452 2.768 . . . . 0.0 111.081 175.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 68' ' ' GLU . 7.1 t70 169.47 -178.09 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 122.97 0.508 . . . . 0.0 110.323 -166.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -88.33 5.35 84.85 Favored Glycine 0 N--CA 1.491 2.342 0 CA-C-O 121.642 0.579 . . . . 0.0 112.337 167.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 66' ' ' ASP . 35.4 mt-10 -142.13 106.28 4.77 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 102.48 -3.156 . . . . 0.0 102.48 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -74.5 88.4 2.13 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 119.591 1.087 . . . . 0.0 111.287 -151.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.488 ' HB3' ' HB3' ' A' ' 83' ' ' ARG . 50.3 m-85 -116.24 138.27 51.44 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 124.398 1.079 . . . . 0.0 108.839 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 84' ' ' PHE . 8.7 mp -96.01 107.32 19.6 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 174.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -104.87 112.38 25.48 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.929 0.892 . . . . 0.0 110.013 -171.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.48 HG22 HG13 ' A' ' 63' ' ' ILE . 12.1 t -101.8 144.59 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.669 -175.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.2 86.9 2.51 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.452 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 4.3 p -80.86 -53.0 6.85 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.676 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.5 m -126.61 169.11 13.44 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.641 0.776 . . . . 0.0 110.536 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -88.11 -3.43 58.89 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.592 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -147.4 39.29 1.05 Allowed Glycine 0 C--N 1.35 1.306 0 CA-C-N 117.93 0.332 . . . . 0.0 113.086 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 m -120.34 151.18 53.17 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 123.73 0.812 . . . . 0.0 108.82 171.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.2 126.49 18.74 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 121.791 1.661 . . . . 0.0 110.557 170.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.6 t -68.95 127.45 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -177.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -98.48 117.97 34.11 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -171.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.488 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 88.3 mtm180 -99.0 126.73 44.77 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.036 0.934 . . . . 0.0 110.187 -173.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.519 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 71.1 m-85 -110.03 147.56 33.32 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.391 0.676 . . . . 0.0 111.781 -175.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -72.01 -38.59 69.58 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.263 0.625 . . . . 0.0 110.34 173.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.4 HG22 ' HG2' ' A' ' 89' ' ' GLU . 8.1 t -146.29 169.5 18.68 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.621 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.447 HD11 HG21 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -62.69 -29.65 70.81 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.937 174.182 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -55.22 -41.37 78.75 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 116.512 -0.313 . . . . 0.0 113.579 171.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 84' ' ' PHE . 53.3 mm-40 -67.9 -39.67 83.59 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.494 0.717 . . . . 0.0 110.644 176.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.658 HD11 HG12 ' A' ' 63' ' ' ILE . 7.1 tt -57.7 -54.96 40.99 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.334 -178.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 40.9 mm -66.26 -34.15 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.297 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.03 -56.92 22.48 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.636 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.36 -40.09 74.24 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.134 0.574 . . . . 0.0 111.016 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.666 ' HA ' HE22 ' A' ' 99' ' ' GLN . 6.5 m-30 -78.21 -7.25 56.88 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -173.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.03 -13.72 58.62 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 122.472 0.309 . . . . 0.0 111.584 164.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -92.25 137.54 24.77 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 124.477 1.111 . . . . 0.0 109.771 173.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.87 175.17 11.72 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.925 2.416 . . . . 0.0 113.917 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.4 t30 58.88 73.06 0.5 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.253 1.421 . . . . 0.0 112.228 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.666 HE22 ' HA ' ' A' ' 94' ' ' TYR . 48.1 mt-30 -142.4 -13.06 0.8 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.337 1.055 . . . . 0.0 111.029 174.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.452 ' HA3' ' HB ' ' A' ' 75' ' ' THR . . . 122.27 -2.63 10.52 Favored Glycine 0 N--CA 1.48 1.629 0 C-N-CA 123.694 0.664 . . . . 0.0 112.005 -169.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 88.5 mt -74.66 168.29 20.11 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.787 1.235 . . . . 0.0 111.114 176.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.5 m -67.26 -47.92 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.412 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.872 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 49.0 t -173.73 40.05 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.348 1.059 . . . . 0.0 109.63 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 78.37 -177.8 0.1 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.088 1.355 . . . . 0.0 111.346 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.411 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 21.9 mt -105.53 99.56 9.16 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 175.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 106' ' ' LEU . 0.8 OUTLIER -112.01 -48.79 3.02 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.907 0.883 . . . . 0.0 111.326 -171.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 35' ' ' SER . 10.5 mp -112.43 124.12 32.66 Favored Pre-proline 0 N--CA 1.484 1.247 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.49 -87.14 0.0 OUTLIER 'Trans proline' 0 CA--C 1.556 1.59 0 C-N-CA 121.203 1.268 . . . . 0.0 110.088 167.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 t . . . . . 0 C--O 1.25 1.128 0 C-N-CA 124.576 1.15 . . . . 0.0 108.137 177.782 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 CA--C 1.54 0.573 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 23.5 p-90 -93.27 -23.49 18.49 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 166.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 83.7 t80 -73.0 106.94 5.09 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 167.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -104.27 117.94 35.43 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -63.33 -46.3 87.27 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.946 0.899 . . . . 0.0 111.182 -170.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -114.47 81.7 1.59 Allowed 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.311 0.576 . . . . 0.0 109.585 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.7 tp -133.58 133.32 41.91 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.545 0.738 . . . . 0.0 110.376 176.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.6 m -99.17 170.28 8.8 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.673 0.789 . . . . 0.0 110.092 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.442 ' HG3' HG21 ' A' ' 60' ' ' THR . 38.8 ttt180 -62.1 -57.7 10.58 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -171.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.43 -42.96 78.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.149 0.58 . . . . 0.0 111.231 -178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.33 -30.71 70.61 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.172 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.26 -50.2 49.21 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.521 0.729 . . . . 0.0 111.356 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.489 ' HA ' HD12 ' A' ' 27' ' ' LEU . 10.2 pt-20 -69.68 -22.2 63.45 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.985 178.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -68.33 -49.59 59.31 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 167.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.405 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 43.7 mt -59.58 -30.11 68.42 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.752 0.421 . . . . 0.0 111.627 174.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 24' ' ' GLU . 48.1 mt -67.49 -47.07 71.09 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.49 0.316 . . . . 0.0 110.238 172.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.72 -42.71 97.89 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.4 0.68 . . . . 0.0 111.817 -173.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -87.0 -53.14 5.04 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.639 0.376 . . . . 0.0 110.643 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -78.29 -60.4 2.39 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 117.745 0.248 . . . . 0.0 111.127 -175.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.84 126.41 34.5 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-O 121.293 0.385 . . . . 0.0 114.029 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 71.2 mtp85 -79.47 -41.49 27.4 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.449 1.1 . . . . 0.0 113.159 -177.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 170.14 132.95 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.773 1.229 . . . . 0.0 107.988 -169.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.576 ' HA2' ' SG ' ' A' ' 103' ' ' CYS . . . 68.33 24.05 74.93 Favored Glycine 0 N--CA 1.479 1.519 0 CA-C-N 118.259 0.481 . . . . 0.0 111.929 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 7.6 m -88.73 145.77 25.43 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 124.141 0.976 . . . . 0.0 110.472 -171.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -142.05 151.6 42.56 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.197 0.599 . . . . 0.0 109.919 -176.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.492 HD23 HG21 ' A' ' 109' ' ' VAL . 4.6 pp -140.79 154.18 46.14 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.38 169.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 71.5 t -121.61 146.96 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 170.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 48.6 ptt85 -160.74 -170.25 2.68 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.801 1.24 . . . . 0.0 108.324 -173.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.71 144.25 25.93 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.572 0.749 . . . . 0.0 109.203 169.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.43 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . 35.6 t -70.41 160.84 31.6 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.972 0.909 . . . . 0.0 109.514 164.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -108.36 -14.57 14.65 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.8 m -81.11 -68.65 0.67 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.52 0.728 . . . . 0.0 109.975 -177.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.0 t -91.33 118.43 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.436 0.694 . . . . 0.0 109.444 -174.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 7.24 -82.17 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 127.791 2.436 . . . . 0.0 115.866 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.44 64.12 0.58 Allowed Glycine 0 C--N 1.346 1.12 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 174.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 41' ' ' SER . . . -90.11 164.41 14.48 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.935 0.494 . . . . 0.0 110.234 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.518 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 20.9 m-85 -104.16 122.19 44.83 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.027 0.931 . . . . 0.0 109.127 -177.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -108.23 130.74 55.14 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.445 0.698 . . . . 0.0 109.533 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.7 tp -117.79 108.13 14.99 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.495 ' SG ' HG22 ' A' ' 60' ' ' THR . 56.3 m -106.52 123.59 48.32 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -176.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 35' ' ' SER . 58.4 t -130.09 128.16 64.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 124.022 0.929 . . . . 0.0 109.596 -172.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 56.7 tp -108.29 143.45 37.12 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.28 1.032 . . . . 0.0 109.615 175.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -163.52 112.37 1.25 Allowed 'General case' 0 CA--C 1.543 0.689 0 O-C-N 123.839 0.712 . . . . 0.0 109.25 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 50.76 57.71 6.34 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.954 1.301 . . . . 0.0 113.018 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.7 tttm 52.6 28.03 5.71 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.925 1.29 . . . . 0.0 112.662 -175.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -106.6 104.13 13.74 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 173.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.0 t -86.19 128.71 39.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 173.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -140.07 134.69 31.71 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.495 HG22 ' SG ' ' A' ' 51' ' ' CYS . 37.7 p -112.62 135.9 52.81 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 173.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -114.1 99.93 8.0 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -82.16 97.73 8.35 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.518 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 63.4 mt -71.53 120.67 20.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.778 163.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.4 mp -101.78 126.87 32.65 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 172.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 11.6 Cg_endo -56.11 -62.59 0.23 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.146 1.897 . . . . 0.0 111.042 177.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.4 t70 105.64 -82.16 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.856 1.663 . . . . 0.0 107.733 161.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -88.93 25.82 9.34 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-O 119.171 -0.794 . . . . 0.0 113.579 174.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 59.9 -3.72 0.11 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 175.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -101.81 -44.04 5.65 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.524 0.73 . . . . 0.0 110.941 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -111.54 158.81 18.76 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.639 1.176 . . . . 0.0 109.104 -174.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 4.4 pp -110.49 112.97 25.24 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 165.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.14 125.14 49.71 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.977 0.511 . . . . 0.0 110.943 -176.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 81' ' ' VAL . 22.9 t -85.73 130.91 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.316 -175.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -96.79 93.02 6.44 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.3 p -81.93 -66.33 0.9 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 174.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.541 ' HB2' HG22 ' A' ' 79' ' ' VAL . 50.4 m -162.66 134.4 5.24 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.333 1.053 . . . . 0.0 109.884 172.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -71.65 99.31 2.08 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 164.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.44 -28.91 1.49 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -164.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.541 HG22 ' HB2' ' A' ' 76' ' ' SER . 17.4 m -126.43 152.52 74.25 Favored Pre-proline 0 N--CA 1.485 1.305 0 C-N-CA 124.154 0.981 . . . . 0.0 109.552 177.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -50.72 113.44 1.07 Allowed 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 123.117 2.545 . . . . 0.0 114.013 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 73' ' ' VAL . 7.3 p -71.08 141.38 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 124.72 1.208 . . . . 0.0 110.565 177.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -109.95 119.45 39.36 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.701 0.8 . . . . 0.0 109.656 175.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -102.06 146.94 27.2 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.025 0.93 . . . . 0.0 109.355 172.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -133.74 163.24 29.9 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.939 0.896 . . . . 0.0 108.849 174.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -100.15 -21.14 15.66 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 172.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.598 HG22 ' H ' ' A' ' 88' ' ' GLY . 57.9 m -138.5 141.59 39.38 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -170.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.478 ' O ' HG12 ' A' ' 91' ' ' ILE . 96.1 mt -61.82 -31.27 71.5 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.279 0.632 . . . . 0.0 111.353 177.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.598 ' H ' HG22 ' A' ' 86' ' ' THR . . . -58.21 -34.19 72.86 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 113.749 0.26 . . . . 0.0 113.749 173.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.86 -40.37 75.81 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.463 0.705 . . . . 0.0 110.295 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.3 tp -56.92 -61.07 2.7 Favored 'General case' 0 C--N 1.356 0.891 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.158 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.498 ' HA ' HD12 ' A' ' 105' ' ' LEU . 29.8 mm -60.29 -40.17 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 124.301 1.04 . . . . 0.0 110.573 -177.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.64 -55.54 28.25 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 124.073 0.858 . . . . 0.0 113.853 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 50.9 tp -73.82 -34.71 64.69 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 122.801 0.44 . . . . 0.0 110.939 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.417 ' HA ' ' OD1' ' A' ' 98' ' ' ASN . 3.1 m-30 -86.61 0.87 53.6 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -172.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.99 8.86 6.19 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.346 0.658 . . . . 0.0 112.497 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -137.92 162.18 55.66 Favored Pre-proline 0 CA--C 1.55 0.942 0 C-N-CA 124.888 1.275 . . . . 0.0 108.261 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -49.44 118.53 3.74 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 123.161 2.574 . . . . 0.0 113.243 171.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.417 ' OD1' ' HA ' ' A' ' 94' ' ' TYR . 21.8 m120 -106.93 -78.44 0.58 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.75 0.82 . . . . 0.0 110.923 -174.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 148.34 101.46 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.387 1.475 . . . . 0.0 108.089 -156.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 105.55 -29.06 12.05 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-O 119.742 -0.477 . . . . 0.0 112.832 172.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 15.2 mt -71.09 145.34 49.91 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.736 0.414 . . . . 0.0 111.339 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.5 m -66.01 -27.45 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.566 0.746 . . . . 0.0 111.421 172.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.576 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 29.3 p -168.22 172.89 8.23 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.337 1.055 . . . . 0.0 109.829 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.87 151.54 38.97 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.569 171.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 91' ' ' ILE . 29.9 mt -77.7 103.96 7.95 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 92.6 mt -118.95 -60.96 1.7 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.921 0.488 . . . . 0.0 112.153 -172.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -95.43 140.87 22.55 Favored Pre-proline 0 N--CA 1.484 1.271 0 C-N-CA 122.732 0.413 . . . . 0.0 111.17 -169.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -73.94 -163.46 0.17 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.965 2.444 . . . . 0.0 112.444 172.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.492 HG21 HD23 ' A' ' 37' ' ' LEU . 72.3 t . . . . . 0 C--O 1.254 1.32 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -175.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 m . . . . . 0 C--O 1.24 0.6 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.43 ' CD1' ' HB3' ' A' ' 108' ' ' PRO . 33.5 p-90 -91.95 3.82 54.37 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.908 0.483 . . . . 0.0 110.894 176.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.437 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 73.5 t80 -110.56 127.66 55.31 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -123.11 144.2 49.48 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.0 mtp-105 -63.07 -64.49 0.9 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.681 0.792 . . . . 0.0 110.13 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -84.74 -101.66 0.05 Allowed 'General case' 0 C--O 1.246 0.901 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -177.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.3 tp 65.05 113.56 0.03 OUTLIER 'General case' 0 C--N 1.363 1.182 0 C-N-CA 125.336 1.454 . . . . 0.0 110.661 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.2 t -72.91 147.81 44.95 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 170.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -63.81 -38.04 89.63 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.133 0.973 . . . . 0.0 110.151 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.23 -45.38 87.81 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.726 173.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.81 -33.59 66.31 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.606 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.576 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -66.87 -51.93 49.56 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.739 0.816 . . . . 0.0 110.255 -177.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -54.26 -43.66 71.17 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.013 1.325 . . . . 0.0 111.323 174.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.39 -50.3 66.02 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.821 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.1 mt -61.85 -34.32 75.76 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.69 0.796 . . . . 0.0 112.295 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.7 mt -70.54 -59.09 3.04 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.92 -29.01 68.08 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.297 1.039 . . . . 0.0 112.977 -172.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -78.21 -44.94 24.33 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.413 0.685 . . . . 0.0 110.904 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.64 -59.24 2.82 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.438 0.637 . . . . 0.0 112.408 -170.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.06 -169.62 16.05 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 114.685 -1.143 . . . . 0.0 113.808 -165.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.452 ' HB3' ' H ' ' A' ' 33' ' ' ASP . 6.4 mpt_? -119.47 -157.57 0.7 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 125.143 1.377 . . . . 0.0 109.716 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.452 ' H ' ' HB3' ' A' ' 32' ' ' ARG . 8.1 p-10 -57.0 132.87 54.16 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.959 0.904 . . . . 0.0 112.099 -176.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.55 0.59 64.65 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.932 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.43 ' HB2' ' HB3' ' A' ' 53' ' ' LEU . 56.8 m -71.64 116.58 12.17 Favored 'General case' 0 C--N 1.359 1.007 0 CA-C-N 117.764 0.782 . . . . 0.0 108.898 176.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 24.5 p90 -131.07 157.43 43.09 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.306 0.574 . . . . 0.0 111.639 -172.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.576 HD11 ' HB1' ' A' ' 23' ' ' ALA . 2.9 pp -150.93 164.11 37.12 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.69 169.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 49' ' ' ALA . 86.2 t -125.94 149.26 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 171.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.517 ' HG3' ' HB3' ' A' ' 49' ' ' ALA . 0.5 OUTLIER -153.17 169.07 23.91 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.739 1.215 . . . . 0.0 108.726 -175.383 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 13.7 t70 -93.18 120.8 33.87 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 172.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.4 m -69.19 101.15 1.4 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.027 0.931 . . . . 0.0 111.282 -169.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.454 ' HG2' HH21 ' A' ' 39' ' ' ARG . 16.6 mm-40 -49.78 -31.67 12.16 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.411 1.484 . . . . 0.0 114.315 173.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.5 p -79.23 -17.4 54.88 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.944 0.498 . . . . 0.0 112.279 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.6 t -108.81 -64.76 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 122.996 0.519 . . . . 0.0 109.7 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 95.84 122.07 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.871 2.469 . . . . 0.0 109.547 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 63.46 58.18 12.31 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.746 1.279 . . . . 0.0 111.643 -173.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 40' ' ' ASP . . . -153.08 150.4 29.09 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.461 1.104 . . . . 0.0 108.149 -174.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -113.53 125.1 53.82 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.388 0.994 . . . . 0.0 111.311 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.517 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . . . -104.4 127.27 52.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.52 0.728 . . . . 0.0 109.326 -177.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.4 tp -111.11 106.25 15.23 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 31.2 m -101.16 121.38 41.74 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -176.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.506 HG21 HD22 ' A' ' 101' ' ' LEU . 94.0 t -122.43 116.69 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.262 1.025 . . . . 0.0 109.37 -174.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 35' ' ' SER . 36.9 tp -85.24 135.13 34.06 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.189 0.996 . . . . 0.0 111.273 -173.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -141.7 102.3 4.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.525 0.73 . . . . 0.0 109.103 167.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 57.5 54.21 6.71 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.231 1.012 . . . . 0.0 111.369 172.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.419 ' H ' HD11 ' A' ' 53' ' ' LEU . 14.7 tmtt? 75.27 -23.06 0.24 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 125.681 1.592 . . . . 0.0 112.441 -177.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -88.8 101.35 13.94 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.902 0.858 . . . . 0.0 108.734 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 83.6 t -93.52 120.7 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.227 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -94.98 122.13 37.31 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 37.3 p -113.9 141.62 47.13 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -169.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -135.99 99.15 4.07 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -177.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -81.14 93.53 6.47 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.109 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.437 HG22 ' HB3' ' A' ' 71' ' ' LEU . 32.5 mt -79.9 136.63 23.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 124.494 1.117 . . . . 0.0 110.315 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.8 mp -121.2 141.22 32.56 Favored Pre-proline 0 N--CA 1.475 0.805 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -174.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 70' ' ' PHE . 52.5 Cg_exo -58.67 114.91 2.2 Favored 'Trans proline' 0 C--N 1.366 1.491 0 C-N-CA 122.038 1.826 . . . . 0.0 109.162 158.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -123.84 5.36 8.75 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 123.48 0.712 . . . . 0.0 110.44 -160.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.36 141.29 3.67 Favored Glycine 0 C--N 1.342 0.904 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -174.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 33.66 -76.75 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.016 2.228 . . . . 0.0 117.016 -166.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -163.02 22.37 0.09 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -163.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 72.1 m-85 -127.15 150.5 49.48 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.139 0.976 . . . . 0.0 109.717 -170.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.437 ' HB3' HG22 ' A' ' 63' ' ' ILE . 8.2 mp -99.11 150.05 22.42 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.28 1.032 . . . . 0.0 109.743 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -135.93 120.54 18.28 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.635 0.774 . . . . 0.0 109.836 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.8 t -84.93 128.04 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.27 1.028 . . . . 0.0 108.539 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -110.85 87.64 2.58 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -175.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.3 t -140.44 138.68 34.88 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.165 175.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.4 m 63.05 -2.12 0.44 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 165.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 60.71 -79.69 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 125.331 1.452 . . . . 0.0 112.429 -177.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.55 -28.48 62.52 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 -172.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.92 124.19 63.43 Favored Pre-proline 0 CA--C 1.561 1.392 0 CA-C-N 117.274 0.537 . . . . 0.0 110.632 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.413 ' HB2' HE22 ' A' ' 99' ' ' GLN . 81.3 Cg_exo -51.99 113.58 1.24 Allowed 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.653 2.235 . . . . 0.0 113.349 177.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 70.2 t -101.7 134.1 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.417 1.087 . . . . 0.0 108.751 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -105.29 151.6 23.94 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.471 ' O ' ' HD2' ' A' ' 83' ' ' ARG . 2.6 ppt_? -85.34 121.91 28.74 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 170.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -107.29 129.43 54.89 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.592 -0.693 . . . . 0.0 110.178 -176.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -84.64 -17.31 39.01 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.8 t -155.28 163.46 40.11 Favored 'General case' 0 C--O 1.248 0.99 0 C-N-CA 122.779 0.432 . . . . 0.0 110.372 172.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.424 ' O ' HG12 ' A' ' 91' ' ' ILE . 94.9 mt -60.22 -32.12 70.81 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.044 0.937 . . . . 0.0 111.677 177.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -55.86 -41.85 84.71 Favored Glycine 0 C--N 1.352 1.464 0 O-C-N 123.304 0.377 . . . . 0.0 112.762 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -65.85 -39.08 90.43 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.811 0.844 . . . . 0.0 111.033 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 47.7 tp -64.17 -41.72 97.02 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.191 0.996 . . . . 0.0 111.467 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 87' ' ' LEU . 49.8 mm -84.95 -28.18 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -168.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.42 -47.74 15.84 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.2 tt -61.28 -43.78 98.32 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.447 0.699 . . . . 0.0 110.325 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.492 ' HB3' HD11 ' A' ' 101' ' ' LEU . 3.0 m-85 -79.57 -9.76 59.68 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.509 0.724 . . . . 0.0 112.215 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.03 -0.72 19.85 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.734 0.413 . . . . 0.0 112.104 167.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -154.45 57.92 1.93 Allowed Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 124.465 1.106 . . . . 0.0 109.018 172.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.466 ' HG3' HD12 ' A' ' 101' ' ' LEU . 81.1 Cg_endo -75.35 -66.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.507 2.138 . . . . 0.0 113.706 -164.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.5 t30 57.77 39.24 27.29 Favored 'General case' 0 C--N 1.367 1.327 0 C-N-CA 124.325 1.05 . . . . 0.0 108.534 -170.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.413 HE22 ' HB2' ' A' ' 80' ' ' PRO . 20.9 mt-30 -177.75 86.38 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.243 1.017 . . . . 0.0 110.211 -162.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 103.93 -32.28 7.72 Favored Glycine 0 N--CA 1.474 1.187 0 C-N-CA 121.639 -0.315 . . . . 0.0 112.853 161.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.506 HD22 HG21 ' A' ' 52' ' ' VAL . 53.7 mt -87.64 123.96 33.04 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.675 0.39 . . . . 0.0 110.388 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.8 p -51.05 -32.83 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.457 0 C-N-CA 125.767 1.627 . . . . 0.0 113.514 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 26.2 p -153.64 16.07 0.51 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.979 0.512 . . . . 0.0 112.206 -175.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 67.26 -160.35 0.23 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.646 0.778 . . . . 0.0 110.891 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 56.9 mt -110.91 156.67 20.84 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 58.5 tp -164.94 -63.18 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.457 0.303 . . . . 0.0 111.051 -175.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 29.9 tp -111.52 102.56 53.56 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 122.792 0.437 . . . . 0.0 110.507 -167.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.43 ' HB3' ' CD1' ' A' ' 13' ' ' TRP . 12.3 Cg_exo -72.4 100.96 1.2 Allowed 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.587 2.192 . . . . 0.0 109.392 169.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 87.6 t . . . . . 0 C--O 1.245 0.852 0 CA-C-O 118.648 -0.691 . . . . 0.0 109.328 -171.433 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.6 m . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -115.26 12.53 16.48 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.108 0.563 . . . . 0.0 111.929 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.415 ' HE2' ' HG2' ' A' ' 16' ' ' ARG . 53.8 t80 -108.36 116.57 32.22 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -177.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -115.51 117.15 29.55 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.415 ' HG2' ' HE2' ' A' ' 14' ' ' TYR . 80.9 mtt180 -64.24 -58.51 6.36 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.385 0.674 . . . . 0.0 111.524 -175.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -111.11 86.48 2.33 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.394 1.092 . . . . 0.0 108.461 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.9 tp -133.14 133.74 43.26 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.457 -1.247 . . . . 0.0 107.926 177.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.4 m -80.04 155.0 27.79 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.505 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 77.3 ttt180 -65.85 -43.35 88.7 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 119.233 -0.413 . . . . 0.0 110.774 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.85 -48.08 67.32 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.449 0.7 . . . . 0.0 111.252 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.47 -25.13 63.93 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.087 177.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.81 -49.55 20.33 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.49 0.716 . . . . 0.0 111.664 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 1.1 mm-40 -62.72 -38.65 91.31 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.234 0.614 . . . . 0.0 110.01 177.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.3 -47.24 80.22 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 124.377 1.048 . . . . 0.0 109.995 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -54.7 -37.92 66.41 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.89 0.876 . . . . 0.0 110.869 176.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 53' ' ' LEU . 86.5 mt -79.77 -36.1 37.65 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.375 -0.203 . . . . 0.0 111.061 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.63 -41.75 83.4 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 122.706 0.403 . . . . 0.0 110.45 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -89.22 -60.29 1.99 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.119 0.968 . . . . 0.0 111.621 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.26 -50.47 14.32 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.176 0.19 . . . . 0.0 111.347 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.32 122.11 28.62 Favored Glycine 0 C--N 1.353 1.505 0 O-C-N 123.544 0.527 . . . . 0.0 113.72 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -71.0 -45.04 64.67 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.089 0.556 . . . . 0.0 111.075 -177.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 160.98 131.94 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 125.405 1.482 . . . . 0.0 108.172 -174.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.12 20.45 79.05 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 111.924 -0.471 . . . . 0.0 111.924 -176.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 109' ' ' VAL . 13.7 m -83.48 144.94 29.22 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 124.377 1.071 . . . . 0.0 109.529 -178.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -141.75 150.49 41.84 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.96 0.409 . . . . 0.0 111.008 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -138.26 148.86 45.16 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.913 0.885 . . . . 0.0 109.869 170.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.468 HG22 HD13 ' A' ' 50' ' ' LEU . 48.7 t -114.39 136.55 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -135.73 165.2 26.13 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 124.54 1.136 . . . . 0.0 109.412 -174.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -86.32 131.96 34.09 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 175.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.444 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . 40.4 m -91.46 162.56 14.51 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.292 1.037 . . . . 0.0 108.251 172.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -143.7 75.28 1.46 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.6 t -165.48 -68.69 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.664 -174.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 76.2 t -82.18 82.35 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 174.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 46.72 -122.67 1.28 Allowed 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 124.352 1.061 . . . . 0.0 111.183 -170.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -108.77 79.69 0.25 Allowed Glycine 0 C--N 1.356 1.67 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 172.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 41' ' ' SER . . . -92.38 174.51 7.25 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.542 0.737 . . . . 0.0 111.445 -172.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.522 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 87.2 m-85 -113.37 155.05 25.9 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.214 1.006 . . . . 0.0 109.72 173.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.52 146.98 48.63 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.619 1.168 . . . . 0.0 108.989 171.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 61' ' ' TYR . 40.8 tp -124.82 108.95 12.47 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.182 0.993 . . . . 0.0 109.239 -176.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.505 ' SG ' HG22 ' A' ' 60' ' ' THR . 52.9 m -93.92 126.1 38.93 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.1 t -132.71 121.28 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 CA-C-N 118.273 0.488 . . . . 0.0 109.852 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 40.2 tp -86.93 139.84 30.21 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.72 0.808 . . . . 0.0 109.248 171.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -163.56 121.49 1.89 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 170.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 41.88 67.26 0.59 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 126.012 1.725 . . . . 0.0 113.732 177.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.465 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 10.8 mmpt? 59.21 27.73 16.83 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.76 1.224 . . . . 0.0 112.897 178.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -139.36 107.14 5.64 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.781 0.832 . . . . 0.0 108.984 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.9 t -93.47 122.12 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 166.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -117.97 138.61 52.06 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.064 0.946 . . . . 0.0 108.907 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.505 HG22 ' SG ' ' A' ' 51' ' ' CYS . 21.4 p -106.56 139.51 40.9 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.477 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 23.9 m-85 -119.0 107.56 13.67 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -70.58 150.37 46.14 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 171.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 96.7 mt -147.27 105.77 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 102.605 -3.109 . . . . 0.0 102.605 -158.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.8 mp -107.19 98.03 20.89 Favored Pre-proline 0 N--CA 1.48 1.051 0 CA-C-O 118.634 -0.698 . . . . 0.0 111.484 -160.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 70' ' ' PHE . 37.3 Cg_endo -66.22 95.58 0.32 Allowed 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 122.5 2.133 . . . . 0.0 109.268 162.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -166.76 164.26 16.56 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 124.446 1.098 . . . . 0.0 108.683 -158.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.72 -67.05 3.05 Favored Glycine 0 C--N 1.349 1.272 0 C-N-CA 123.076 0.369 . . . . 0.0 113.047 171.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -142.22 23.99 1.98 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.105 1.362 . . . . 0.0 108.108 -178.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 t70 61.49 58.71 2.03 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.262 1.425 . . . . 0.0 109.972 -170.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.439 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 23.1 p90 -127.8 151.99 48.35 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.394 1.078 . . . . 0.0 108.105 169.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.15 109.44 22.19 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 176.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . . . -98.56 127.11 44.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.793 0.837 . . . . 0.0 110.42 -175.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.3 t -99.26 129.15 50.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -94.04 90.72 6.53 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -174.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.5 p -71.66 -34.36 69.66 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.237 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.9 m 75.94 167.12 0.27 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.878 1.671 . . . . 0.0 112.745 173.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 67.57 -162.64 0.22 Allowed 'General case' 0 C--N 1.358 0.972 0 C-N-CA 124.47 1.108 . . . . 0.0 111.693 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -49.5 -24.38 5.42 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 114.756 -1.111 . . . . 0.0 113.965 170.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.69 120.9 80.4 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.573 0.749 . . . . 0.0 109.654 174.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.36 142.52 72.92 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.94 2.427 . . . . 0.0 113.266 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 37.1 t -78.29 118.88 26.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 C-N-CA 124.297 1.039 . . . . 0.0 108.278 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -107.03 127.76 53.76 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.852 0.358 . . . . 0.0 110.494 -173.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.545 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 27.9 ptt180 -98.05 154.33 17.79 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.311 1.044 . . . . 0.0 109.997 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -130.29 154.85 47.19 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.369 0.668 . . . . 0.0 111.399 -175.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -72.67 -46.42 53.92 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.502 172.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.0 t -145.76 166.74 24.99 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.517 0.727 . . . . 0.0 110.975 -177.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.6 mt -60.0 -32.57 70.98 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.712 0.805 . . . . 0.0 111.43 175.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -52.45 -41.26 55.44 Favored Glycine 0 N--CA 1.48 1.6 0 O-C-N 123.027 0.205 . . . . 0.0 113.357 172.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -65.63 -41.06 93.09 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.739 0.815 . . . . 0.0 111.232 173.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.5 tt -68.11 -40.09 82.65 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.226 1.01 . . . . 0.0 110.873 -174.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 44.6 mm -86.05 -42.11 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -166.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.88 -35.21 72.31 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.763 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.411 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 27.1 tp -77.49 -40.98 41.08 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-N 116.907 0.353 . . . . 0.0 110.821 177.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.3 m-30 -80.98 4.37 19.81 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 118.099 0.409 . . . . 0.0 111.83 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.63 -4.02 3.76 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.842 0.857 . . . . 0.0 112.538 163.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 93' ' ' LEU . 10.9 pt20 -125.27 144.35 47.27 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 171.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -84.42 -154.13 0.05 OUTLIER 'Trans proline' 0 CA--C 1.555 1.531 0 C-N-CA 123.32 2.68 . . . . 0.0 112.387 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.5 t30 62.68 57.54 1.77 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.64 1.176 . . . . 0.0 110.032 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -170.41 31.22 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.808 178.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.66 -10.36 72.42 Favored Glycine 0 N--CA 1.477 1.424 0 O-C-N 120.886 -1.134 . . . . 0.0 112.433 173.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.13 130.93 43.41 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 168.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.2 p -60.09 -31.67 48.5 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 123.984 0.914 . . . . 0.0 111.142 177.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 28.4 p -160.11 165.44 31.73 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.529 1.132 . . . . 0.0 108.876 176.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.2 150.73 46.16 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 122.727 0.411 . . . . 0.0 110.169 174.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 75.7 mt -73.16 95.85 2.14 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.2 tp -119.67 -61.37 1.62 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.673 -169.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.459 HD12 ' HD2' ' A' ' 108' ' ' PRO . 45.1 tp -100.42 123.78 45.12 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 123.081 0.552 . . . . 0.0 109.797 -172.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.459 ' HD2' HD12 ' A' ' 107' ' ' LEU . 19.4 Cg_endo -59.03 -47.61 17.21 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.399 2.066 . . . . 0.0 111.242 172.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.475 ' HA ' ' HB3' ' A' ' 35' ' ' SER . 0.3 OUTLIER . . . . . 0 C--O 1.245 0.836 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.483 1.22 0 CA-C-O 120.292 0.091 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.524 ' HB3' ' HB3' ' A' ' 108' ' ' PRO 0.317 36.1 p-90 71.53 -54.56 0.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 128.569 2.748 . . . . 0.0 110.906 -177.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -76.35 123.83 26.57 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 173.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.407 ' CD2' ' HB2' ' A' ' 37' ' ' LEU . 93.3 m-70 -113.79 171.93 7.29 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.856 0.863 . . . . 0.0 110.797 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -81.95 -148.43 0.07 Allowed 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.601 169.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -65.04 106.04 1.18 Allowed 'General case' 0 CA--C 1.555 1.168 0 CA-C-O 121.786 0.803 . . . . 0.0 110.219 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 39' ' ' ARG . 26.2 tp -136.1 138.45 42.08 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 57.4 p -96.15 172.39 8.01 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.399 0.68 . . . . 0.0 110.225 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -63.42 -51.75 64.43 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.448 0.699 . . . . 0.0 112.568 -176.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.47 -35.95 80.93 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.872 0.469 . . . . 0.0 111.265 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.84 -37.25 81.65 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.385 0.674 . . . . 0.0 111.1 174.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.33 -55.31 12.52 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.816 0.846 . . . . 0.0 111.703 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.493 ' HB3' HG11 ' A' ' 58' ' ' VAL . 13.3 pt-20 -66.13 -26.37 67.42 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.005 0.922 . . . . 0.0 112.375 -177.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -64.81 -51.18 63.54 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 172.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.9 tp -61.21 -40.16 92.91 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.974 178.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.0 mt -64.58 -52.34 58.08 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.705 0.802 . . . . 0.0 110.505 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.43 -33.48 75.64 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.866 0.867 . . . . 0.0 112.566 -172.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -87.75 -57.79 2.81 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.783 -0.189 . . . . 0.0 111.383 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.73 -59.44 3.32 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.14 0.576 . . . . 0.0 112.325 -170.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -123.12 77.04 0.36 Allowed Glycine 0 C--N 1.342 0.885 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -71.47 102.57 2.7 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 118.996 -0.525 . . . . 0.0 110.015 -171.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.5 t70 97.7 116.2 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.638 1.575 . . . . 0.0 109.877 164.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.72 3.79 68.23 Favored Glycine 0 N--CA 1.476 1.313 0 CA-C-N 115.879 -0.6 . . . . 0.0 113.543 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.7 p -78.09 158.56 29.1 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.416 0.687 . . . . 0.0 111.56 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -145.9 158.95 43.84 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 172.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.411 ' O ' HD12 ' A' ' 50' ' ' LEU . 4.1 pp -154.05 163.08 40.66 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.697 170.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.0 t -117.76 144.88 24.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 169.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.516 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 50.4 ptt85 -152.9 156.68 39.41 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.19 0.596 . . . . 0.0 110.051 -174.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -87.91 117.83 27.03 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 174.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.0 m -94.9 100.36 12.24 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 174.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -60.63 -39.45 88.28 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.196 0.598 . . . . 0.0 111.921 169.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.1 m -87.92 58.84 5.04 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.89 0.876 . . . . 0.0 112.183 -171.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.469 HG13 ' H ' ' A' ' 45' ' ' ALA . 2.1 p -155.49 -70.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.008 0.523 . . . . 0.0 110.17 172.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.469 ' H ' HG13 ' A' ' 44' ' ' VAL . . . -170.07 15.07 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.695 0.798 . . . . 0.0 110.539 -174.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.49 94.68 0.06 OUTLIER Glycine 0 C--N 1.344 1.026 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -161.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.583 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . . . -152.54 160.42 43.22 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -168.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.431 ' HD2' ' HB3' ' A' ' 65' ' ' PRO . 57.8 m-85 -109.58 137.12 47.87 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.932 0.493 . . . . 0.0 109.928 168.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -119.48 135.81 54.6 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.776 0.831 . . . . 0.0 109.816 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.535 HD21 HD21 ' A' ' 105' ' ' LEU . 66.8 tp -107.87 104.08 13.48 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 48.8 t -106.85 116.16 31.45 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -174.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.9 t -122.2 118.24 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.574 1.15 . . . . 0.0 109.151 -170.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 47.3 tp -91.75 131.91 36.78 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.768 0.827 . . . . 0.0 109.155 175.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.402 ' HD2' HG22 ' A' ' 102' ' ' VAL . 83.9 t80 -164.51 127.97 2.47 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.431 0.692 . . . . 0.0 110.32 172.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 47.69 53.23 11.55 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.351 1.46 . . . . 0.0 111.715 174.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 91.0 mttt 56.38 39.26 30.14 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.515 1.126 . . . . 0.0 112.05 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 59.2 m80 -136.77 105.8 5.96 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.334 1.054 . . . . 0.0 108.481 174.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.493 HG11 ' HB3' ' A' ' 24' ' ' GLU . 84.9 t -94.67 107.17 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 170.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -103.06 129.55 49.91 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 96.0 m -110.2 137.98 47.2 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.462 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 56.4 m-85 -120.64 101.47 7.77 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -86.13 96.47 9.9 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 119.082 0.855 . . . . 0.0 109.402 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.454 HD12 ' O ' ' A' ' 61' ' ' TYR . 4.9 mp -85.07 141.95 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 123.62 0.768 . . . . 0.0 110.805 171.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.9 mp -96.06 118.87 65.43 Favored Pre-proline 0 CA--C 1.557 1.219 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 172.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.598 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 92.3 Cg_endo -76.4 -51.98 0.09 OUTLIER 'Trans proline' 0 CA--C 1.556 1.589 0 C-N-CA 122.519 2.146 . . . . 0.0 116.361 -162.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -148.91 167.68 25.06 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 122.259 -0.276 . . . . 0.0 111.158 -158.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.15 -96.29 0.25 Allowed Glycine 0 C--N 1.35 1.323 0 C-N-CA 123.336 0.494 . . . . 0.0 111.898 178.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -126.05 30.31 5.68 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.983 0.913 . . . . 0.0 109.206 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -159.33 174.19 15.14 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.771 -162.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -120.26 158.19 27.55 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.598 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -93.42 111.49 23.17 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -170.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.781 ' HB2' ' HG2' ' A' ' 83' ' ' ARG . . . -117.95 142.23 47.59 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.86 0.864 . . . . 0.0 110.748 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.6 t -89.24 142.57 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -108.84 90.99 3.46 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.8 p -87.58 -71.35 0.57 Allowed 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 172.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.2 t 179.92 140.72 0.13 Allowed 'General case' 0 C--N 1.351 0.658 0 C-N-CA 124.616 1.167 . . . . 0.0 108.955 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -70.83 128.2 35.23 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 140.52 -76.96 0.31 Allowed Glycine 0 C--N 1.346 1.135 0 N-CA-C 108.067 -2.013 . . . . 0.0 108.067 -166.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.3 m -64.41 140.08 97.88 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 123.838 0.855 . . . . 0.0 110.043 162.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -64.58 121.28 8.8 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.75 2.3 . . . . 0.0 112.056 -176.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 72.6 t -99.47 141.85 16.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.197 0.999 . . . . 0.0 108.463 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.8 mmt85 -117.31 143.7 45.65 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.553 0.741 . . . . 0.0 111.109 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.781 ' HG2' ' HB2' ' A' ' 72' ' ' ALA . 86.2 mtt-85 -94.89 148.41 22.34 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 166.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -127.39 161.9 27.58 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.163 0.585 . . . . 0.0 110.395 -174.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -95.3 -19.39 20.02 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.313 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.401 HG23 ' H ' ' A' ' 89' ' ' GLU . 15.0 t -157.06 159.72 38.21 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 122.654 0.382 . . . . 0.0 111.592 -176.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.4 mt -61.27 -34.44 75.18 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.186 0.994 . . . . 0.0 112.143 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.41 -38.77 91.63 Favored Glycine 0 C--N 1.349 1.254 0 O-C-N 123.206 0.317 . . . . 0.0 112.952 174.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.401 ' H ' HG23 ' A' ' 86' ' ' THR . 26.2 tt0 -72.21 -37.16 69.3 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.649 0.78 . . . . 0.0 109.735 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.6 tt -54.28 -53.74 49.61 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.657 1.183 . . . . 0.0 110.428 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.9 mm -64.79 -36.3 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.414 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -53.89 -55.08 27.51 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 124.198 0.936 . . . . 0.0 113.298 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -76.47 -35.74 58.26 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 122.998 0.519 . . . . 0.0 111.843 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.531 ' CD2' HD21 ' A' ' 101' ' ' LEU . 7.4 m-85 -89.49 4.62 48.59 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -173.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.42 -6.82 48.72 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 122.719 0.408 . . . . 0.0 110.93 162.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -83.17 125.75 73.86 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.965 0.906 . . . . 0.0 110.337 174.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.94 179.78 6.18 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.387 2.058 . . . . 0.0 111.36 169.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 53.83 66.18 1.3 Allowed 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.877 0.871 . . . . 0.0 111.128 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -173.2 21.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.2 1.0 . . . . 0.0 110.383 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 107.52 -21.65 30.12 Favored Glycine 0 C--N 1.345 1.076 0 O-C-N 121.622 -0.674 . . . . 0.0 112.41 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.531 HD21 ' CD2' ' A' ' 94' ' ' TYR . 2.9 mm? -70.57 124.7 24.86 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.338 1.055 . . . . 0.0 110.582 177.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.402 HG22 ' HD2' ' A' ' 54' ' ' TYR . 13.9 p -52.96 -31.41 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.542 0 C-N-CA 124.21 1.004 . . . . 0.0 112.783 -178.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 27.2 p -156.25 6.41 0.19 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.003 0.521 . . . . 0.0 112.309 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 68.0 -179.62 0.22 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.727 0.811 . . . . 0.0 110.594 -166.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.535 HD21 HD21 ' A' ' 50' ' ' LEU . 46.1 mt -90.0 91.53 8.61 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 79.1 mt -93.86 -69.31 0.76 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.928 0.891 . . . . 0.0 111.321 -174.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.7 mp -104.01 128.25 27.6 Favored Pre-proline 0 N--CA 1.48 1.048 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -173.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.524 ' HB3' ' HB3' ' A' ' 13' ' ' TRP . 35.5 Cg_exo -63.38 -124.25 0.0 OUTLIER 'Trans proline' 0 CA--C 1.571 2.334 0 C-N-CA 122.623 2.215 . . . . 0.0 111.576 169.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.7 t . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 176.914 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.8 t . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.5 ' HB3' ' O ' ' A' ' 108' ' ' PRO . 4.7 p-90 -94.77 -22.86 17.8 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.595 1.158 . . . . 0.0 109.341 166.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 84.6 t80 -71.68 109.05 5.33 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.862 173.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -128.27 120.29 26.84 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -59.06 -72.84 0.09 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.647 0.379 . . . . 0.0 110.937 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -85.48 59.05 5.39 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.72 0.808 . . . . 0.0 110.126 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 26.0 tp -88.2 -61.12 1.78 Allowed 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -176.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.2 m 93.81 145.94 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 127.125 2.17 . . . . 0.0 107.895 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.473 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 54.9 ttt180 -57.2 -46.83 82.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.112 0.565 . . . . 0.0 111.701 -177.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.523 ' O ' ' HB2' ' A' ' 25' ' ' GLU . . . -51.76 -47.92 63.93 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 124.173 0.92 . . . . 0.0 111.573 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.419 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -69.13 -38.04 78.63 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.459 177.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.447 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -61.4 -60.64 3.41 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.189 0.996 . . . . 0.0 112.114 -177.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 12.5 pt-20 -59.08 -29.58 67.44 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.246 1.019 . . . . 0.0 112.398 175.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.6 OUTLIER -67.1 -47.47 71.07 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.161 0.584 . . . . 0.0 109.522 178.119 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 22' ' ' ALA . 94.5 mt -59.59 -36.03 75.47 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.89 0.876 . . . . 0.0 111.341 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.3 mt -68.87 -54.55 15.0 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.24 -36.76 76.05 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.818 0.847 . . . . 0.0 112.748 -169.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -92.37 -59.47 2.08 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -73.35 -59.51 2.68 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -165.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.33 108.34 1.69 Allowed Glycine 0 C--N 1.349 1.304 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -175.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 50.8 ttt85 -57.75 -129.09 0.0 OUTLIER 'General case' 0 CA--C 1.581 2.173 0 C-N-CA 124.372 1.069 . . . . 0.0 113.236 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -74.68 148.83 40.24 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.282 -1.511 . . . . 0.0 111.442 -169.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.415 ' HA3' HD23 ' A' ' 106' ' ' LEU . . . 70.13 18.04 74.42 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.628 0.58 . . . . 0.0 114.207 -176.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.634 ' HB2' HG22 ' A' ' 109' ' ' VAL . 59.6 p -80.38 139.04 36.72 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -144.1 147.24 33.48 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.013 0.435 . . . . 0.0 110.255 177.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.447 HD11 ' HB1' ' A' ' 23' ' ' ALA . 1.6 pp -150.04 154.37 38.05 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.123 0.969 . . . . 0.0 108.701 168.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 79.6 t -114.73 131.02 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.496 ' HG3' ' HB3' ' A' ' 49' ' ' ALA . 5.9 ptm180 -116.79 168.64 10.04 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.214 1.005 . . . . 0.0 108.383 174.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -85.24 132.38 34.28 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 170.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 97.1 p -58.53 153.38 16.23 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 123.905 0.753 . . . . 0.0 111.596 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -71.73 79.58 0.85 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.711 0.804 . . . . 0.0 111.963 -172.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.3 m 53.55 28.31 7.63 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.954 1.301 . . . . 0.0 113.118 177.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.8 t -65.53 -73.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.499 0.72 . . . . 0.0 111.411 -172.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -172.41 34.7 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.238 0.615 . . . . 0.0 110.608 -177.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.39 35.49 33.14 Favored Glycine 0 N--CA 1.469 0.835 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.14 -174.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -97.08 169.77 9.58 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.568 0.747 . . . . 0.0 110.64 -177.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -124.16 157.49 34.59 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.049 0.94 . . . . 0.0 109.849 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.496 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . . . -133.64 144.77 49.42 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.295 0.638 . . . . 0.0 109.512 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.2 tp -123.9 124.21 42.12 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.447 ' SG ' HG22 ' A' ' 60' ' ' THR . 39.0 m -115.03 121.14 42.19 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -178.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 35' ' ' SER . 60.4 t -128.48 125.42 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.791 0.837 . . . . 0.0 109.038 -175.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.477 ' HB3' ' OG ' ' A' ' 35' ' ' SER . 60.7 tp -96.21 138.73 33.38 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.343 0.657 . . . . 0.0 109.905 177.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -161.57 125.05 3.2 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.9 0.88 . . . . 0.0 108.961 175.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 50.26 52.57 14.49 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.08 1.352 . . . . 0.0 112.391 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 80.3 tttt 55.9 39.11 30.64 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.737 1.215 . . . . 0.0 112.119 -176.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -140.69 106.03 5.05 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.94 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 85.4 t -87.36 112.06 22.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 168.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -97.4 130.34 44.54 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 170.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.447 HG22 ' SG ' ' A' ' 51' ' ' CYS . 41.1 p -108.29 130.26 55.19 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -113.59 98.9 7.34 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.3 mtm105 -83.54 91.69 7.47 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.506 HD13 HD11 ' A' ' 90' ' ' LEU . 61.7 mt -77.56 122.39 32.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.701 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.9 mp -93.96 149.86 37.61 Favored Pre-proline 0 CA--C 1.547 0.832 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -178.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -79.42 -143.05 0.02 OUTLIER 'Trans proline' 0 CA--C 1.565 2.061 0 C-N-CA 122.942 2.428 . . . . 0.0 112.498 -170.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.647 ' HB3' ' H ' ' A' ' 70' ' ' PHE . 31.0 t70 -169.74 151.43 4.25 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.646 0.778 . . . . 0.0 109.841 -172.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -55.33 -35.28 60.47 Favored Glycine 0 C--N 1.349 1.266 0 O-C-N 124.035 0.835 . . . . 0.0 114.112 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -102.59 25.13 9.48 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.646 0.778 . . . . 0.0 111.416 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 58.91 57.67 3.51 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.508 1.523 . . . . 0.0 114.098 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.647 ' H ' ' HB3' ' A' ' 66' ' ' ASP . 96.4 m-85 -118.86 151.65 37.72 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 169.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 mp -98.2 108.28 20.94 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.97 118.15 33.9 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.607 0.763 . . . . 0.0 109.628 -175.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 81' ' ' VAL . 12.9 t -99.72 140.96 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.918 0.887 . . . . 0.0 110.289 -176.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -108.09 89.73 3.08 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 176.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.3 m -90.82 125.51 35.74 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -171.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.2 m 59.01 -89.98 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.067 1.347 . . . . 0.0 112.061 177.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 176.75 -26.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.592 1.157 . . . . 0.0 111.057 -177.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -132.03 40.61 1.6 Allowed Glycine 0 N--CA 1.47 0.966 0 CA-C-N 116.694 -0.23 . . . . 0.0 112.861 -170.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.6 p -143.7 135.47 12.95 Favored Pre-proline 0 CA--C 1.555 1.168 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -40.14 135.06 1.76 Allowed 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 124.182 3.255 . . . . 0.0 115.091 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 73' ' ' VAL . 88.0 t -64.04 131.16 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.733 1.213 . . . . 0.0 109.473 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -105.32 116.48 32.02 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -174.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -93.34 146.12 23.97 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 172.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -125.56 146.57 49.62 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.695 0.798 . . . . 0.0 110.091 175.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -75.11 -40.04 60.18 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.764 0.425 . . . . 0.0 110.481 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.0 p -141.05 173.92 11.01 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.831 0.852 . . . . 0.0 109.854 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -68.37 -34.8 76.71 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.041 0.936 . . . . 0.0 109.455 175.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -60.66 -38.5 95.18 Favored Glycine 0 C--N 1.357 1.698 0 O-C-N 123.241 0.338 . . . . 0.0 113.341 175.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -64.93 -45.17 86.95 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.592 0.757 . . . . 0.0 111.096 174.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.506 HD11 HD13 ' A' ' 63' ' ' ILE . 8.2 tt -52.7 -50.34 63.53 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.426 1.09 . . . . 0.0 111.059 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.7 mm -70.3 -33.51 54.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.215 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.8 -57.31 20.09 Favored Glycine 0 CA--C 1.532 1.117 0 O-C-N 123.589 0.556 . . . . 0.0 114.163 178.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.1 mp -70.43 -31.17 68.25 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.098 0.559 . . . . 0.0 111.402 -178.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 -78.94 -18.87 53.05 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' A' ' 105' ' ' LEU . . . -61.01 -20.74 62.85 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.443 0.697 . . . . 0.0 112.707 174.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -110.9 166.32 10.98 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 123.643 0.777 . . . . 0.0 109.403 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -49.89 105.7 0.1 Allowed 'Trans proline' 0 C--N 1.386 2.518 0 C-N-CA 123.063 2.508 . . . . 0.0 112.327 168.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -90.97 -51.64 5.24 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.943 0.897 . . . . 0.0 111.521 -174.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 109.55 101.03 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 128.477 2.711 . . . . 0.0 108.673 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.15 -17.72 11.52 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.849 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 49.1 mt -77.31 143.95 38.43 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.821 0.448 . . . . 0.0 111.012 176.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.2 m -75.29 71.85 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 CA-C-O 121.826 0.822 . . . . 0.0 109.309 165.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 2.6 p 78.81 179.6 0.12 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.65 1.98 . . . . 0.0 110.761 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.06 -178.09 6.72 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.431 0.692 . . . . 0.0 110.895 -177.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 95' ' ' ALA . 29.0 mt -93.03 106.34 18.32 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 174.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.415 HD23 ' HA3' ' A' ' 34' ' ' GLY . 4.2 mm? -97.13 -56.89 2.41 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.379 0.672 . . . . 0.0 110.863 -176.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.5 pp -133.25 147.33 64.63 Favored Pre-proline 0 N--CA 1.486 1.333 0 C-N-CA 122.636 0.374 . . . . 0.0 111.407 -169.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.5 ' O ' ' HB3' ' A' ' 13' ' ' TRP . 65.0 Cg_endo -77.81 -11.99 16.56 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 123.155 2.57 . . . . 0.0 115.154 -171.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.634 HG22 ' HB2' ' A' ' 35' ' ' SER . 22.3 t . . . . . 0 N--CA 1.503 2.223 0 C-N-CA 124.994 1.318 . . . . 0.0 109.5 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.2 m . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 108' ' ' PRO . 1.6 p-90 -80.37 3.47 21.11 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.459 0.704 . . . . 0.0 112.009 -172.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -110.82 102.33 10.86 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -172.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -118.22 119.1 33.68 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -67.56 -81.59 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.622 0.769 . . . . 0.0 111.477 -164.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -83.77 42.69 0.86 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 118.382 0.537 . . . . 0.0 111.761 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.441 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 35.8 tp -68.16 -48.0 66.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.839 0.456 . . . . 0.0 109.851 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.8 m 79.98 152.78 0.12 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.647 1.179 . . . . 0.0 110.684 170.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -56.58 -62.61 1.61 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.631 1.172 . . . . 0.0 112.546 -168.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.76 -50.66 67.89 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.598 0.759 . . . . 0.0 112.256 -178.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -65.46 -32.12 73.56 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.219 -178.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.75 -53.54 26.45 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.646 0.378 . . . . 0.0 111.629 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.26 -32.84 74.71 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 123.784 0.678 . . . . 0.0 111.619 -178.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -69.26 -43.65 73.51 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.228 0.33 . . . . 0.0 110.712 176.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.5 -27.0 66.64 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.515 0.726 . . . . 0.0 111.933 174.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.8 mt -66.96 -60.26 2.79 Favored 'General case' 0 C--N 1.348 0.52 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 170.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.79 -32.29 63.37 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.377 1.071 . . . . 0.0 112.951 -176.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.05 -58.0 3.49 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.74 0.816 . . . . 0.0 109.687 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.9 -55.18 5.16 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.295 -168.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -99.86 -58.28 0.89 Allowed Glycine 0 N--CA 1.47 0.96 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 -176.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.577 ' HA ' HD23 ' A' ' 53' ' ' LEU . 53.9 ttp180 51.9 104.86 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.083 2.153 . . . . 0.0 113.345 -170.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.8 t70 88.99 120.92 0.03 OUTLIER 'General case' 0 C--N 1.36 1.047 0 C-N-CA 124.778 1.231 . . . . 0.0 109.241 163.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.497 ' HA2' ' SG ' ' A' ' 103' ' ' CYS . . . 77.29 -0.43 68.39 Favored Glycine 0 C--N 1.352 1.43 0 CA-C-N 116.388 -0.369 . . . . 0.0 113.335 -168.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.0 m -82.91 141.22 32.35 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.903 0.881 . . . . 0.0 109.526 -175.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.455 ' HB2' HG22 ' A' ' 52' ' ' VAL . 20.6 p90 -144.76 158.21 43.87 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 175.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 pp -160.31 161.3 33.24 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.267 0.627 . . . . 0.0 109.944 168.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.472 HG21 HD11 ' A' ' 91' ' ' ILE . 40.2 t -110.91 145.55 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.412 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 17.6 mtm180 -132.33 165.52 24.02 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.829 0.851 . . . . 0.0 108.892 -176.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -89.18 119.2 29.46 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 158.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 56.4 m -58.97 147.64 33.57 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.456 0.473 . . . . 0.0 109.906 -175.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.431 ' CD ' ' H ' ' A' ' 42' ' ' GLU . 1.4 pm0 -77.05 77.23 3.59 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.279 1.032 . . . . 0.0 110.943 -162.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.5 t 50.13 54.61 10.79 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 125.497 1.519 . . . . 0.0 111.646 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 m -96.27 -55.5 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.904 -178.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -168.98 16.98 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.517 0.727 . . . . 0.0 111.305 -176.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.63 34.51 35.03 Favored Glycine 0 N--CA 1.474 1.168 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 -173.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -94.14 167.59 11.47 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.794 0.837 . . . . 0.0 112.194 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.537 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 79.0 m-85 -105.6 140.93 37.92 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.811 1.245 . . . . 0.0 109.309 171.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' A' ' 39' ' ' ARG . . . -117.42 126.19 52.22 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.946 0.498 . . . . 0.0 109.899 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.3 tp -108.81 104.08 13.28 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -177.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 53.5 t -102.55 120.21 40.15 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -176.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.455 HG22 ' HB2' ' A' ' 36' ' ' PHE . 56.3 t -128.05 121.42 56.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.373 1.069 . . . . 0.0 108.579 -175.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.577 HD23 ' HA ' ' A' ' 32' ' ' ARG . 43.1 tp -100.38 131.66 46.18 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.805 0.842 . . . . 0.0 109.013 174.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -167.0 145.53 5.08 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.167 0.917 . . . . 0.0 109.305 -177.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 47.82 41.45 14.33 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 125.852 1.661 . . . . 0.0 112.898 177.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.2 tttp 56.01 37.34 28.74 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.754 1.221 . . . . 0.0 111.684 -176.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -142.4 115.92 9.09 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.472 -174.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.4 HG22 HD13 ' A' ' 53' ' ' LEU . 45.2 t -83.82 139.03 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 173.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -139.21 123.85 18.45 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.8 m -114.16 129.97 56.61 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.502 ' HD2' ' HA ' ' A' ' 75' ' ' THR . 9.3 m-85 -115.22 100.58 8.24 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 -176.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -78.23 100.02 6.49 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 3.2 mp -70.02 118.65 14.8 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.764 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 165.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.478 ' H ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -120.88 131.17 24.55 Favored Pre-proline 0 C--O 1.241 0.611 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.52 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 7.1 Cg_exo -73.17 -74.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 122.241 1.961 . . . . 0.0 110.607 171.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.7 t70 71.36 124.94 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.733 1.213 . . . . 0.0 108.379 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 49.62 -143.99 9.69 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.593 -153.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -117.62 -154.2 0.55 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.268 0.627 . . . . 0.0 110.308 169.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.0 t70 88.02 -74.9 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 126.158 1.783 . . . . 0.0 110.491 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -129.65 158.91 38.02 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 121.408 0.623 . . . . 0.0 112.04 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 3.0 pp -110.49 123.31 49.67 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.416 1.086 . . . . 0.0 108.722 165.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.82 123.79 48.67 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.253 0.621 . . . . 0.0 111.008 -177.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 7.3 p -85.53 147.13 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -110.96 91.68 3.75 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.711 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 41.1 p -77.1 -58.88 3.03 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.13 -177.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.9 m -138.09 153.69 49.28 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.358 0.663 . . . . 0.0 110.343 -177.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -77.71 138.02 38.82 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.042 0.537 . . . . 0.0 110.043 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.57 32.49 67.59 Favored Glycine 0 CA--C 1.523 0.537 0 O-C-N 123.749 0.656 . . . . 0.0 114.029 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.7 m -133.78 144.43 51.81 Favored Pre-proline 0 N--CA 1.481 1.079 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.22 103.15 1.56 Allowed 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.273 1.982 . . . . 0.0 109.312 168.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.482 HG12 ' H ' ' A' ' 82' ' ' ARG . 4.7 t -79.75 174.14 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.26 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.482 ' H ' HG12 ' A' ' 81' ' ' VAL . 5.5 tpp180 -95.81 133.31 40.1 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -175.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -91.77 138.87 31.2 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -124.21 149.54 46.27 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.494 0.718 . . . . 0.0 109.468 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -96.17 -16.1 21.69 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 88' ' ' GLY . 25.5 m -144.33 140.2 28.99 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.936 0.895 . . . . 0.0 109.081 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -63.59 -31.83 73.11 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.433 1.093 . . . . 0.0 110.051 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.483 ' H ' HG22 ' A' ' 86' ' ' THR . . . -54.87 -42.03 78.14 Favored Glycine 0 CA--C 1.541 1.707 0 CA-C-N 116.409 -0.36 . . . . 0.0 113.923 172.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.39 -37.13 84.59 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.56 0.744 . . . . 0.0 110.791 176.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.406 HD11 ' HB ' ' A' ' 73' ' ' VAL . 9.3 tt -61.7 -55.0 35.12 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.265 1.026 . . . . 0.0 111.299 -176.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.472 HD11 HG21 ' A' ' 38' ' ' VAL . 49.8 mt -66.46 -37.53 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 123.44 0.463 . . . . 0.0 110.727 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.92 -52.39 46.85 Favored Glycine 0 C--N 1.342 0.913 0 O-C-N 123.769 0.668 . . . . 0.0 112.838 176.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 51.8 tp -72.15 -43.5 64.55 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.082 0.553 . . . . 0.0 111.412 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.484 ' HE2' HG11 ' A' ' 73' ' ' VAL . 18.6 m-85 -82.75 0.52 43.24 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -174.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.43 -25.41 64.32 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-O 121.472 0.653 . . . . 0.0 109.696 158.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -95.84 128.72 36.51 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.994 1.317 . . . . 0.0 107.565 171.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -80.55 -155.47 0.06 OUTLIER 'Trans proline' 0 CA--C 1.557 1.655 0 C-N-CA 122.837 2.358 . . . . 0.0 112.643 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 67.51 48.51 1.1 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.438 1.095 . . . . 0.0 111.842 171.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -163.32 10.69 0.06 Allowed 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.42 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.711 ' HA3' ' HB ' ' A' ' 75' ' ' THR . . . 127.28 -12.35 6.73 Favored Glycine 0 C--N 1.355 1.61 0 O-C-N 122.041 -0.412 . . . . 0.0 113.102 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.4 118.26 21.88 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.992 0.917 . . . . 0.0 111.422 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.7 p -55.55 -32.27 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.484 1.114 . . . . 0.0 111.24 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.497 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 53.8 t -138.31 145.18 40.89 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.003 0.921 . . . . 0.0 109.821 177.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.38 141.07 54.23 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 169.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 62.3 mt -76.17 92.86 3.29 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -174.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.433 ' HG ' ' HG ' ' A' ' 107' ' ' LEU . 47.4 tp -101.19 -58.14 1.95 Allowed 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.304 -171.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.433 ' HG ' ' HG ' ' A' ' 106' ' ' LEU . 58.6 mt -142.25 123.9 8.8 Favored Pre-proline 0 N--CA 1.485 1.302 0 C-N-CA 123.598 0.759 . . . . 0.0 109.336 -170.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.467 ' HB3' ' HB3' ' A' ' 13' ' ' TRP . 27.1 Cg_endo -61.06 -74.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 122.602 2.201 . . . . 0.0 112.906 -176.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 55.8 t . . . . . 0 CA--C 1.551 1.005 0 C-N-CA 124.242 1.017 . . . . 0.0 108.668 -177.577 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.1 m . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -99.29 -18.82 17.38 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 161.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -75.53 104.51 6.12 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 166.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -113.59 96.27 5.78 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -54.45 -39.82 67.8 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 124.38 1.05 . . . . 0.0 113.178 -164.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -125.11 85.72 2.45 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.3 tp -115.82 -45.22 2.89 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.437 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.5 t 79.9 155.29 0.14 Allowed 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 124.746 1.218 . . . . 0.0 110.229 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -57.56 -50.66 72.37 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -172.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.07 -53.99 50.35 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.587 0.755 . . . . 0.0 111.948 -176.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.53 -30.93 68.88 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.24 0.616 . . . . 0.0 111.836 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.524 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -65.57 -58.96 4.51 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.685 0.794 . . . . 0.0 111.496 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.571 ' HG3' HG21 ' A' ' 58' ' ' VAL . 34.6 tt0 -56.97 -42.59 80.44 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.264 1.425 . . . . 0.0 111.976 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -67.8 -39.88 83.95 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.137 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.402 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 33.4 tp -63.16 -38.71 92.27 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.935 0.894 . . . . 0.0 111.667 175.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.495 HD21 ' HG ' ' A' ' 37' ' ' LEU . 95.6 mt -68.0 -29.36 68.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.256 0.622 . . . . 0.0 111.097 177.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.23 -54.39 5.78 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.81 0.844 . . . . 0.0 111.085 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.402 ' HG2' ' HA ' ' A' ' 26' ' ' LEU . 11.1 ptp180 -66.8 -46.01 76.57 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.419 0.688 . . . . 0.0 111.226 -174.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.4 ' N ' ' HG3' ' A' ' 29' ' ' ARG . . . -89.65 -60.59 1.9 Allowed 'General case' 0 C--N 1.349 0.551 0 C-N-CA 123.003 0.521 . . . . 0.0 110.803 -172.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.35 -36.97 19.16 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-O 119.799 -0.445 . . . . 0.0 113.704 -172.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? 74.79 -25.25 0.2 Allowed 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 125.273 1.429 . . . . 0.0 113.477 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.4 t70 174.93 141.69 0.05 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.661 0.784 . . . . 0.0 109.369 -165.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.56 9.82 65.72 Favored Glycine 0 C--N 1.358 1.787 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 12.4 m -84.71 146.73 27.27 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.295 1.038 . . . . 0.0 111.007 -168.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -150.83 151.88 32.92 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 174.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.524 HD11 ' HB1' ' A' ' 23' ' ' ALA . 2.9 pp -152.6 158.85 43.04 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 169.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.607 HG21 HD11 ' A' ' 87' ' ' LEU . 36.8 t -112.11 154.74 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.1 ptt85 -156.21 175.09 14.45 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.907 0.883 . . . . 0.0 109.039 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.17 145.2 24.87 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.5 m -56.17 148.63 17.68 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.658 0.783 . . . . 0.0 113.041 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -88.72 3.61 50.25 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.248 1.019 . . . . 0.0 112.048 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.0 m -134.48 -63.6 0.71 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.148 0.579 . . . . 0.0 111.101 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 47' ' ' ALA . 14.7 m -85.86 117.79 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 121.726 0.774 . . . . 0.0 110.672 -178.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.32 128.7 37.37 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.616 -1.174 . . . . 0.0 112.551 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.89 7.42 81.02 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 114.691 0.636 . . . . 0.0 114.691 177.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.478 ' HB3' HG23 ' A' ' 44' ' ' VAL . . . -100.81 173.78 6.35 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.149 0.58 . . . . 0.0 109.901 174.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -117.03 160.8 20.4 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-O 121.388 0.613 . . . . 0.0 112.027 -178.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.61 144.85 42.15 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.23 168.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.489 HD13 HG22 ' A' ' 38' ' ' VAL . 51.0 tp -125.05 110.59 14.35 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.695 1.198 . . . . 0.0 108.483 -174.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 35.5 t -104.23 123.02 46.59 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -175.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.2 t -130.48 121.8 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.636 0.774 . . . . 0.0 109.714 -172.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.424 HD13 HG22 ' A' ' 58' ' ' VAL . 16.1 tp -111.22 115.64 29.7 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.297 1.039 . . . . 0.0 109.685 175.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -145.79 144.77 30.49 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 166.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 53.45 36.56 23.47 Favored 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 124.536 1.134 . . . . 0.0 112.277 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 65.7 mttm 58.68 36.47 24.98 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.403 1.081 . . . . 0.0 112.412 -173.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -126.04 104.91 8.53 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.571 HG21 ' HG3' ' A' ' 24' ' ' GLU . 17.5 t -100.69 107.91 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.739 0.816 . . . . 0.0 108.877 174.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -112.14 140.63 46.67 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 171.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 89.2 m -106.63 135.75 47.62 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -117.1 100.04 7.46 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -63.48 155.28 29.74 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 168.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 92.3 mt -144.95 101.92 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 102.59 -3.115 . . . . 0.0 102.59 -158.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.1 mp -105.11 111.59 65.15 Favored Pre-proline 0 N--CA 1.472 0.649 0 O-C-N 123.351 0.407 . . . . 0.0 109.94 -161.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 70' ' ' PHE . 1.4 Cg_endo -81.76 108.55 1.89 Allowed 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.606 2.204 . . . . 0.0 109.422 162.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -82.15 137.24 35.01 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 174.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -46.73 77.57 0.0 OUTLIER Glycine 0 CA--C 1.538 1.49 0 N-CA-C 117.172 1.629 . . . . 0.0 117.172 -172.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -151.84 -83.29 0.09 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.366 1.866 . . . . 0.0 106.77 170.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -167.33 4.28 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 178.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 83.5 m-85 -115.81 140.29 49.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.237 -0.914 . . . . 0.0 110.899 -170.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.408 ' HG ' ' HG3' ' A' ' 65' ' ' PRO . 5.3 mp -111.07 112.3 24.02 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.964 0.905 . . . . 0.0 109.536 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.63 143.03 28.72 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.95 0.5 . . . . 0.0 112.17 -174.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 81' ' ' VAL . 39.1 t -109.38 137.46 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.212 1.005 . . . . 0.0 108.434 169.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -112.28 130.0 56.09 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -170.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.422 ' OG1' ' HA3' ' A' ' 100' ' ' GLY . 3.6 t -158.76 -41.8 0.06 Allowed 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.232 -175.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 65.9 m 58.68 -109.03 0.44 Allowed 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 117.777 -1.106 . . . . 0.0 111.808 -174.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 72.18 -42.14 0.52 Allowed 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.155 1.382 . . . . 0.0 113.427 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 148.01 -21.18 1.42 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 -166.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.515 HG11 ' HA ' ' A' ' 99' ' ' GLN . 14.0 m -84.44 134.25 43.06 Favored Pre-proline 0 CA--C 1.557 1.215 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 173.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.69 146.46 97.19 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.605 2.203 . . . . 0.0 112.015 175.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 73' ' ' VAL . 42.0 t -68.23 130.49 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -105.92 118.91 37.82 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -172.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -102.32 121.19 41.8 Favored 'General case' 0 C--N 1.344 0.355 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 54.5 p90 -109.0 153.62 23.34 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.472 0.709 . . . . 0.0 110.199 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -104.46 -9.6 18.28 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.778 0.831 . . . . 0.0 110.061 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.7 t -149.04 144.22 26.57 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.29 0.636 . . . . 0.0 109.403 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.607 HD11 HG21 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -60.73 -31.02 70.35 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.481 1.112 . . . . 0.0 111.232 -173.589 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -55.23 -34.42 58.93 Favored Glycine 0 CA--C 1.539 1.566 0 N-CA-C 113.984 0.354 . . . . 0.0 113.984 174.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 84' ' ' PHE . 46.9 mt-10 -68.28 -40.53 81.79 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.34 0.656 . . . . 0.0 110.982 175.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 51.0 tp -53.12 -55.54 23.27 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.336 0.589 . . . . 0.0 110.628 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.6 mm -66.97 -36.21 76.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.79 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.12 -52.34 53.06 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.754 0.659 . . . . 0.0 113.55 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.5 mt -65.74 -56.86 9.81 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.992 0.917 . . . . 0.0 111.102 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.616 ' HB3' HD11 ' A' ' 101' ' ' LEU . 83.8 m-85 -79.59 -4.25 50.68 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -170.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.32 -27.7 67.55 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.21 0.529 . . . . 0.0 110.513 164.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -84.17 131.52 50.67 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.146 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.446 ' HB3' ' HB2' ' A' ' 104' ' ' ALA . 81.7 Cg_endo -80.49 -172.97 1.67 Allowed 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.673 2.249 . . . . 0.0 113.598 -175.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 56.6 61.02 2.82 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.407 1.483 . . . . 0.0 111.33 -178.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.515 ' HA ' HG11 ' A' ' 79' ' ' VAL . 46.2 mt-30 -143.76 12.39 1.67 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.356 1.062 . . . . 0.0 111.441 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.422 ' HA3' ' OG1' ' A' ' 75' ' ' THR . . . 110.58 -5.79 29.69 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 112.16 -0.376 . . . . 0.0 112.16 178.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.616 HD11 ' HB3' ' A' ' 94' ' ' TYR . 94.4 mt -78.85 146.86 33.42 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.277 1.031 . . . . 0.0 111.234 -178.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.4 m -63.3 -26.72 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.391 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.83 171.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 31.9 p -162.61 171.85 16.29 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.514 1.126 . . . . 0.0 110.281 171.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.446 ' HB2' ' HB3' ' A' ' 97' ' ' PRO . . . -66.68 145.35 55.65 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 169.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 73.9 mt -64.38 103.39 0.64 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -177.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 62.5 tp -111.31 -60.25 1.86 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.589 0.756 . . . . 0.0 111.576 -166.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 35' ' ' SER . 5.8 tt -114.46 97.42 46.3 Favored Pre-proline 0 N--CA 1.474 0.741 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -169.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -81.44 130.34 6.98 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 122.232 1.955 . . . . 0.0 111.214 175.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.7 t . . . . . 0 C--O 1.251 1.174 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.186 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 t . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 108' ' ' PRO . 77.2 t90 92.45 -43.9 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.938 1.295 . . . . 0.0 110.928 163.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.555 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 87.9 t80 -109.71 110.78 21.92 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -174.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -126.48 106.18 9.27 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -176.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.543 ' HA ' ' HB3' ' A' ' 40' ' ' ASP . 39.8 ttm180 -74.94 152.0 38.83 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.402 176.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.547 ' HA ' ' HG2' ' A' ' 42' ' ' GLU 0.291 11.3 p-10 36.82 51.8 0.97 Allowed 'General case' 0 C--N 1.37 1.494 0 C-N-CA 125.356 1.462 . . . . 0.0 114.527 -172.325 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.7 tp -114.73 124.54 52.05 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 169.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.7 m -69.06 156.4 38.71 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.945 0.498 . . . . 0.0 110.235 -178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.3 ttp85 -54.04 -52.14 61.8 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.775 0.43 . . . . 0.0 111.061 172.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.03 -45.26 71.52 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.33 1.052 . . . . 0.0 111.867 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.06 -29.85 64.56 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.578 0.751 . . . . 0.0 112.089 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.601 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -76.84 -47.53 21.13 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.571 0.748 . . . . 0.0 111.419 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.558 ' HG3' HG21 ' A' ' 58' ' ' VAL . 32.8 tt0 -51.79 -39.82 59.33 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.252 1.421 . . . . 0.0 111.187 169.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -63.96 -47.72 79.3 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.3 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.7 tp -57.86 -45.14 86.75 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.677 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.615 HD21 HD22 ' A' ' 37' ' ' LEU . 94.2 mt -63.45 -50.45 69.7 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.016 0.927 . . . . 0.0 110.623 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.16 -34.5 73.66 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.756 0.823 . . . . 0.0 111.681 -175.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -83.88 -32.71 25.04 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.493 0.717 . . . . 0.0 111.384 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.82 -65.8 0.98 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -174.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.91 -47.22 0.84 Allowed Glycine 0 C--N 1.356 1.666 0 CA-C-N 117.995 0.362 . . . . 0.0 113.422 -172.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 55.9 24.9 8.01 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 125.573 1.549 . . . . 0.0 114.924 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -174.4 100.15 0.1 Allowed 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.264 -0.897 . . . . 0.0 109.582 -174.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.03 15.83 80.89 Favored Glycine 0 N--CA 1.474 1.199 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.908 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.1 m -85.53 116.29 23.74 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.916 0.887 . . . . 0.0 109.684 -170.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -126.74 159.45 33.69 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.814 0.34 . . . . 0.0 111.672 -175.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.615 HD22 HD21 ' A' ' 27' ' ' LEU . 1.6 pt? -163.13 163.73 25.6 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.008 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 25.6 t -126.71 122.69 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 175.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.436 HH21 HD21 ' A' ' 37' ' ' LEU . 9.3 ptp85 -116.87 157.66 25.27 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -177.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.543 ' HB3' ' HA ' ' A' ' 16' ' ' ARG . 33.6 t70 -93.82 122.96 36.83 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 170.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.4 m -57.16 151.98 14.46 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.706 0.629 . . . . 0.0 111.403 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.547 ' HG2' ' HA ' ' A' ' 17' ' ' ASP . 32.5 mt-10 -81.93 -22.14 36.89 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -163.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.3 t -167.6 103.33 0.5 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 172.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.465 HG11 ' HB3' ' A' ' 47' ' ' ALA . 8.1 p -158.84 169.88 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 C-N-CA 123.9 0.88 . . . . 0.0 109.564 -178.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.99 23.21 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 175.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.446 ' H ' HG13 ' A' ' 44' ' ' VAL . . . 92.58 91.2 1.49 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -175.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.465 ' HB3' HG11 ' A' ' 44' ' ' VAL . . . -152.16 134.68 15.32 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.488 1.115 . . . . 0.0 109.5 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -110.62 143.39 41.12 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.002 0.921 . . . . 0.0 109.197 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.1 125.2 52.06 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.606 0.362 . . . . 0.0 110.86 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 37' ' ' LEU . 40.3 tp -105.51 131.62 52.69 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.724 ' SG ' HG22 ' A' ' 60' ' ' THR . 73.6 m -123.86 141.24 52.21 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 118.527 0.603 . . . . 0.0 110.126 171.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.6 t -125.47 114.72 40.88 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 170.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.709 HD13 HG22 ' A' ' 58' ' ' VAL . 13.8 tp -99.56 137.83 37.49 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.34 1.056 . . . . 0.0 108.921 176.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -149.44 102.87 3.23 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.003 1.321 . . . . 0.0 108.178 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 48.93 68.95 0.63 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.758 0.823 . . . . 0.0 112.808 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt 62.28 12.99 5.58 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -110.47 102.34 10.96 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.709 HG22 HD13 ' A' ' 53' ' ' LEU . 3.4 t -107.87 120.82 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -114.75 140.53 48.82 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 172.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.724 HG22 ' SG ' ' A' ' 51' ' ' CYS . 62.7 p -112.71 136.45 52.29 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.574 1.15 . . . . 0.0 109.072 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.29 96.91 4.43 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 178.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -80.94 100.7 9.05 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.471 HG21 HD12 ' A' ' 71' ' ' LEU . 15.6 mt -72.06 128.78 35.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.231 -1.35 . . . . 0.0 109.651 173.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.406 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -137.5 135.77 19.64 Favored Pre-proline 0 C--O 1.24 0.567 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 170.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 36.6 Cg_exo -62.1 -62.28 0.13 Allowed 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 122.786 2.324 . . . . 0.0 114.133 177.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.5 t70 87.91 -69.27 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.598 1.559 . . . . 0.0 109.2 175.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -85.5 16.71 38.54 Favored Glycine 0 C--N 1.357 1.698 0 CA-C-O 119.71 -0.495 . . . . 0.0 113.517 169.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 66.09 -30.76 0.14 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 174.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -76.5 -45.11 32.34 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.437 1.017 . . . . 0.0 111.131 -170.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 25.3 p90 -108.39 145.3 34.76 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 124.915 1.286 . . . . 0.0 108.504 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.496 HD23 ' H ' ' A' ' 71' ' ' LEU . 2.6 pt? -99.23 118.96 37.09 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 164.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.62 117.6 33.44 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.528 0.731 . . . . 0.0 110.713 -175.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.858 HG21 HD13 ' A' ' 90' ' ' LEU . 14.6 t -89.58 116.28 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.094 0.958 . . . . 0.0 110.342 177.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -90.39 92.11 8.76 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.422 HG23 ' HE2' ' A' ' 94' ' ' TYR . 0.2 OUTLIER -54.07 -58.61 6.69 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.419 177.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.0 m -155.3 131.19 10.01 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.454 1.502 . . . . 0.0 107.336 163.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -66.16 95.46 0.29 Allowed 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 165.51 -58.21 0.25 Allowed Glycine 0 C--N 1.343 0.93 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -172.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.38 140.83 82.54 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 124.051 0.94 . . . . 0.0 109.41 169.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -49.9 87.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.386 2.511 0 C-N-CA 123.599 2.866 . . . . 0.0 114.134 173.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 73' ' ' VAL . 7.4 p -36.72 143.78 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 126.262 1.825 . . . . 0.0 115.252 169.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -107.18 132.86 52.58 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 124.2 1.0 . . . . 0.0 109.505 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -99.12 146.87 25.66 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.078 0.951 . . . . 0.0 109.001 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -136.23 164.78 27.28 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.911 0.884 . . . . 0.0 109.038 -174.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -126.44 -13.31 6.06 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.847 0.459 . . . . 0.0 110.333 176.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 88' ' ' GLY . 20.8 m -140.15 140.7 36.01 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.631 0.772 . . . . 0.0 109.376 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 75.0 mt -58.36 -32.82 68.91 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.616 0.766 . . . . 0.0 111.551 172.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.582 ' H ' HG22 ' A' ' 86' ' ' THR . . . -60.39 -33.16 79.83 Favored Glycine 0 CA--C 1.532 1.154 0 O-C-N 123.493 0.496 . . . . 0.0 113.582 174.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.528 ' HG3' ' HB ' ' A' ' 86' ' ' THR . 47.6 mt-10 -71.83 -40.85 68.78 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.933 0.493 . . . . 0.0 110.168 176.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.858 HD13 HG21 ' A' ' 73' ' ' VAL . 42.2 tp -52.7 -51.59 59.67 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.553 0.741 . . . . 0.0 110.344 174.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.407 HD11 ' CZ2' ' A' ' 13' ' ' TRP . 49.7 mm -62.79 -39.28 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.432 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.15 -57.32 20.39 Favored Glycine 0 CA--C 1.529 0.911 0 O-C-N 123.621 0.576 . . . . 0.0 113.44 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.7 mp -70.74 -52.01 23.58 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.562 0.745 . . . . 0.0 112.006 -177.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.51 ' HB3' HD11 ' A' ' 101' ' ' LEU . 30.2 m-85 -68.66 -17.26 64.06 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -173.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.44 -19.93 51.22 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 171.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -77.99 124.13 86.13 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 123.396 0.678 . . . . 0.0 109.996 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -70.95 168.29 23.54 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.67 2.246 . . . . 0.0 111.724 173.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 53.8 58.11 5.41 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.85 0.86 . . . . 0.0 110.532 -174.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -142.52 -15.91 0.73 Allowed 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.701 -177.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 141.54 -18.06 2.64 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -175.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.51 HD11 ' HB3' ' A' ' 94' ' ' TYR . 17.7 mt -99.93 105.98 17.75 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.23 0.612 . . . . 0.0 110.105 175.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.6 m -44.96 -25.98 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 125.221 1.408 . . . . 0.0 114.538 174.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 36.7 t -124.27 -11.3 7.47 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.141 0.576 . . . . 0.0 112.444 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 64.11 178.57 0.17 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.122 0.969 . . . . 0.0 111.399 -167.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.1 mt -77.62 92.12 4.06 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.7 176.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.0 tt -81.78 -65.38 1.02 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.856 0.462 . . . . 0.0 109.906 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -146.22 130.05 8.48 Favored Pre-proline 0 N--CA 1.491 1.575 0 C-N-CA 122.295 0.238 . . . . 0.0 110.919 -174.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.487 ' HB2' ' HB2' ' A' ' 13' ' ' TRP . 80.8 Cg_endo -74.38 145.13 33.61 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.689 2.259 . . . . 0.0 111.779 177.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 57.2 t . . . . . 0 C--O 1.256 1.422 0 C-N-CA 123.799 0.84 . . . . 0.0 109.533 179.543 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.5 mtp . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 123.14 144.81 6.71 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -136.41 97.91 3.69 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.314 1.046 . . . . 0.0 108.523 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -135.92 99.4 4.15 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.32 0.648 . . . . 0.0 110.226 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.3 t60 -154.83 96.07 1.83 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -73.54 165.21 25.5 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.329 0.585 . . . . 0.0 111.991 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -83.14 -169.57 2.6 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.292 174.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 37.7 m80 63.91 32.74 13.02 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.04 0.936 . . . . 0.0 109.754 -174.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.5 t -82.58 68.05 8.87 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 122.027 0.918 . . . . 0.0 109.748 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -139.59 139.27 36.75 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.686 -1.143 . . . . 0.0 107.995 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.618 ' SD ' ' HB2' ' A' ' 108' ' ' PRO . 44.1 ttm -72.14 -48.19 45.41 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 172.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.6 m 62.08 108.61 0.02 OUTLIER 'General case' 0 C--N 1.359 0.984 0 O-C-N 124.87 1.356 . . . . 0.0 109.569 -168.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.411 ' HB2' ' HA ' ' A' ' 37' ' ' LEU . 4.3 p-90 -85.41 -1.13 56.7 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.966 -0.459 . . . . 0.0 110.761 -177.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -107.33 113.57 27.04 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -173.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.431 ' NE2' ' HB2' ' A' ' 37' ' ' LEU . 1.9 p80 -138.97 109.95 6.78 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.518 1.127 . . . . 0.0 108.76 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -86.73 26.82 1.06 Allowed 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 124.17 0.988 . . . . 0.0 110.634 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -160.39 25.31 0.16 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.295 0.638 . . . . 0.0 111.098 -162.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 20.0 tp -108.99 -49.09 3.18 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.675 -0.64 . . . . 0.0 111.63 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.4 t 80.08 153.23 0.12 Allowed 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 124.856 1.262 . . . . 0.0 109.869 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HB2' ' NH1' ' A' ' 39' ' ' ARG . 74.5 ttt180 -64.21 -38.87 92.6 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 118.019 0.372 . . . . 0.0 111.512 -168.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.57 -54.82 23.56 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 123.652 0.595 . . . . 0.0 110.752 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.77 -22.55 43.02 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.9 -57.08 4.13 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 123.206 0.602 . . . . 0.0 111.542 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.429 ' HG3' HG11 ' A' ' 58' ' ' VAL . 36.7 tt0 -57.76 -37.08 73.03 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.076 1.351 . . . . 0.0 111.26 173.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -71.05 -38.18 72.53 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.365 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -55.13 -43.76 74.43 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.285 0.634 . . . . 0.0 110.083 173.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.569 HD22 ' HB3' ' A' ' 35' ' ' SER . 82.8 mt -71.92 -42.31 66.84 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 123.485 0.49 . . . . 0.0 110.413 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.36 -37.32 71.65 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.543 0.737 . . . . 0.0 112.21 -174.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.7 mtp180 -82.16 -50.56 8.89 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.024 0.53 . . . . 0.0 111.325 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.476 ' HB1' HG11 ' A' ' 109' ' ' VAL . . . -66.41 -46.8 75.35 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.559 0.344 . . . . 0.0 110.314 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.38 125.84 0.0 OUTLIER Glycine 0 CA--C 1.538 1.515 0 N-CA-C 118.854 2.302 . . . . 0.0 118.854 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 177.66 103.22 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 165.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -62.44 149.92 41.36 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -154.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.41 ' HA2' ' SG ' ' A' ' 103' ' ' CYS . . . 89.56 17.45 54.77 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -161.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.569 ' HB3' HD22 ' A' ' 27' ' ' LEU . 17.2 m -71.81 130.59 41.44 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 124.434 1.094 . . . . 0.0 108.895 -177.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 108' ' ' PRO . 50.9 p90 -141.74 155.14 45.65 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.118 0.485 . . . . 0.0 111.034 177.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.465 ' HG ' HD21 ' A' ' 27' ' ' LEU . 0.8 OUTLIER -158.58 153.47 25.0 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.612 166.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.6 t -105.28 117.41 50.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.543 ' HG3' ' HB3' ' A' ' 49' ' ' ALA . 2.1 ptm180 -113.58 168.49 9.72 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 122.168 0.985 . . . . 0.0 110.816 -178.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -54.44 127.91 29.57 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 113.122 -1.854 . . . . 0.0 110.838 165.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.0 m -74.48 143.99 44.38 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 162.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -78.48 83.58 4.67 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.3 m 67.29 -75.51 0.06 Allowed 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 126.201 1.8 . . . . 0.0 111.785 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.607 HG23 ' H ' ' A' ' 45' ' ' ALA 0.317 35.1 m 39.21 -84.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 126.996 2.118 . . . . 0.0 113.743 -167.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.607 ' H ' HG23 ' A' ' 44' ' ' VAL . . . -156.6 29.48 0.33 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.147 0.979 . . . . 0.0 109.309 -175.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.48 49.64 7.98 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.532 -175.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.53 176.51 5.01 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.44 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 59.0 m-85 -114.67 157.19 23.45 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.437 1.495 . . . . 0.0 107.447 174.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.543 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . . . -128.87 147.05 50.79 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.391 0.676 . . . . 0.0 110.098 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.4 tp -125.84 113.3 17.06 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.27 1.028 . . . . 0.0 108.577 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 52.6 t -100.58 123.23 44.51 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.0 t -128.54 126.09 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.781 0.832 . . . . 0.0 110.004 -174.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 35' ' ' SER . 54.7 tp -101.33 140.29 35.82 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.32 1.048 . . . . 0.0 110.844 177.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -156.29 115.61 3.51 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.01 1.324 . . . . 0.0 108.775 173.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 41.1 71.94 0.18 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.678 1.591 . . . . 0.0 113.881 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 81.9 tttt 58.72 27.47 15.96 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.155 0.982 . . . . 0.0 111.905 177.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -138.3 106.39 5.73 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.378 0.671 . . . . 0.0 109.455 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.429 HG11 ' HG3' ' A' ' 24' ' ' GLU . 41.4 t -99.71 112.75 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 174.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -101.53 132.18 47.31 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 170.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 22.9 m -113.51 128.0 56.29 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -108.39 154.51 21.75 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.875 1.27 . . . . 0.0 107.838 -172.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -105.12 160.2 15.25 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.698 0.799 . . . . 0.0 109.63 165.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.733 HG12 HD11 ' A' ' 90' ' ' LEU . 3.8 mp -146.62 100.68 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 102.578 -3.119 . . . . 0.0 102.578 -166.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.5 mp -113.63 133.7 22.16 Favored Pre-proline 0 N--CA 1.477 0.889 0 O-C-N 121.641 -0.662 . . . . 0.0 109.693 -168.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.09 -68.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.214 1.943 . . . . 0.0 110.256 160.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.9 t70 125.33 -66.1 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 C-N-CA 127.238 2.215 . . . . 0.0 107.743 163.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -171.04 25.72 0.1 OUTLIER Glycine 0 C--N 1.345 1.067 0 CA-C-N 115.515 -0.766 . . . . 0.0 113.203 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -135.69 -83.21 0.4 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 175.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -179.78 3.91 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.123 0.569 . . . . 0.0 111.925 -174.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.512 ' HB3' ' HB2' ' A' ' 83' ' ' ARG . 64.9 m-85 -106.77 134.94 49.14 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.41 0.684 . . . . 0.0 109.343 -169.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.2 mp -96.8 106.4 18.7 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 118.884 0.765 . . . . 0.0 109.348 -169.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.79 140.2 37.97 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.825 0.85 . . . . 0.0 110.13 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.504 HG22 HG13 ' A' ' 63' ' ' ILE . 22.7 t -114.99 124.51 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 176.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -93.56 97.29 10.41 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.404 HG21 ' ND2' ' A' ' 98' ' ' ASN . 76.6 p -87.53 -48.31 8.03 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.6 m -157.78 177.04 11.81 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.385 1.474 . . . . 0.0 108.134 166.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -85.45 -57.97 2.85 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.279 0.632 . . . . 0.0 110.436 -174.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.17 -31.2 61.81 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.821 0.701 . . . . 0.0 114.069 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.4 t -61.45 122.82 73.24 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 118.851 -0.595 . . . . 0.0 109.396 169.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -57.15 110.99 0.68 Allowed 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.5 2.133 . . . . 0.0 110.555 174.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.4 t -79.35 143.71 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.978 0.911 . . . . 0.0 109.115 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -114.89 130.75 56.96 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.512 ' HB2' ' HB3' ' A' ' 70' ' ' PHE . 32.0 ptt180 -94.81 134.07 37.83 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 171.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -113.74 149.44 34.82 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.257 1.023 . . . . 0.0 109.815 -174.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -92.1 -15.79 27.25 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.58 0.352 . . . . 0.0 110.354 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.9 p -142.53 151.12 41.3 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 124.371 1.068 . . . . 0.0 109.457 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 99.5 mt -62.87 -25.88 68.5 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.674 0.789 . . . . 0.0 111.497 172.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -59.85 -41.9 97.9 Favored Glycine 0 CA--C 1.537 1.456 0 N-CA-C 114.02 0.368 . . . . 0.0 114.02 174.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -63.27 -37.79 88.63 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.529 0.732 . . . . 0.0 110.979 176.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.733 HD11 HG12 ' A' ' 63' ' ' ILE . 6.6 tt -59.46 -57.33 13.46 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.814 1.246 . . . . 0.0 109.742 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.412 ' HA ' HD12 ' A' ' 105' ' ' LEU . 48.2 mm -59.79 -38.62 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.098 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.98 -44.88 54.23 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.568 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 42.0 tp -67.64 -50.67 56.79 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.084 0.554 . . . . 0.0 111.405 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -75.35 -8.02 55.55 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.13 -24.12 64.43 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.431 0.634 . . . . 0.0 111.06 163.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -94.71 139.58 22.29 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.499 1.12 . . . . 0.0 108.87 174.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -48.94 127.0 16.06 Favored 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 123.137 2.558 . . . . 0.0 112.433 165.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.404 ' ND2' HG21 ' A' ' 75' ' ' THR . 26.2 p-10 -111.62 -45.1 3.4 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.194 -174.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 111.05 94.29 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 128.051 2.54 . . . . 0.0 106.341 -163.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 135.2 -38.99 1.74 Allowed Glycine 0 C--N 1.343 0.97 0 CA-C-N 116.052 -0.522 . . . . 0.0 113.1 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.444 ' HB3' ' H ' ' A' ' 104' ' ' ALA . 2.6 mm? -69.41 136.93 52.29 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.859 0.464 . . . . 0.0 110.494 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.5 m -60.97 -28.31 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.585 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.41 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 25.4 p -163.06 -1.1 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.444 ' H ' ' HB3' ' A' ' 101' ' ' LEU . . . 70.27 166.81 0.29 Allowed 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.947 0.899 . . . . 0.0 111.284 -167.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 91' ' ' ILE . 37.3 mt -88.94 97.98 11.49 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.506 0.722 . . . . 0.0 109.804 -173.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.3 tp -82.86 -51.81 7.29 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.688 -175.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -165.71 146.46 5.77 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 123.726 0.81 . . . . 0.0 109.032 -172.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.618 ' HB2' ' SD ' ' A' ' 11' ' ' MET . 42.4 Cg_exo -56.89 -54.95 3.05 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.22 1.947 . . . . 0.0 111.885 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.476 HG11 ' HB1' ' A' ' 30' ' ' ALA . 2.4 t . . . . . 0 N--CA 1.48 1.037 0 C-N-CA 125.717 1.607 . . . . 0.0 107.142 170.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptp . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.61 -44.31 0.42 Allowed Glycine 0 C--N 1.338 0.662 0 N-CA-C 111.746 -0.542 . . . . 0.0 111.746 -177.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 63.65 -163.43 0.27 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.26 1.024 . . . . 0.0 110.749 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -142.11 112.49 7.1 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.846 0.355 . . . . 0.0 110.308 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -83.35 -172.54 4.2 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.416 0.686 . . . . 0.0 109.834 169.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 70.36 90.31 0.1 Allowed 'General case' 0 C--N 1.358 0.964 0 C-N-CA 124.261 1.025 . . . . 0.0 110.137 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -66.08 -50.87 62.58 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.336 1.054 . . . . 0.0 109.295 175.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -172.76 -79.57 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.9 p 175.9 128.8 0.04 OUTLIER 'General case' 0 C--O 1.241 0.649 0 C-N-CA 125.412 1.485 . . . . 0.0 107.842 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -91.34 58.95 3.77 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.218 1.009 . . . . 0.0 109.502 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -165.95 52.23 0.09 Allowed 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 114.4 -1.273 . . . . 0.0 109.105 -175.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.1 t -62.28 152.43 33.67 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.663 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 3.5 p-90 -90.55 12.9 17.31 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.528 0.731 . . . . 0.0 110.614 169.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 49.9 t80 -115.2 117.94 31.91 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -130.91 87.23 2.46 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.063 0.545 . . . . 0.0 109.865 -173.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -73.09 160.1 32.55 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 167.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.1 t70 63.61 26.11 14.54 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 122.064 0.935 . . . . 0.0 110.634 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.1 tt -131.87 123.57 27.78 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.597 1.559 . . . . 0.0 106.864 177.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.7 p -77.24 160.89 28.57 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.841 0.457 . . . . 0.0 110.281 -172.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -65.52 -34.43 78.25 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 117.952 0.342 . . . . 0.0 110.848 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.47 -47.59 81.47 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.796 0.838 . . . . 0.0 110.291 173.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.45 -32.72 73.78 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.615 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.25 -62.68 1.39 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.526 0.73 . . . . 0.0 111.184 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -62.66 -28.49 69.95 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.521 0.728 . . . . 0.0 112.465 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -68.27 -50.37 54.2 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 123.606 0.566 . . . . 0.0 109.485 175.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -58.52 -39.99 81.64 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.584 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.1 -48.26 74.31 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.926 0.89 . . . . 0.0 109.802 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.49 -31.98 73.3 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.121 0.968 . . . . 0.0 112.329 -175.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -81.65 -38.64 25.61 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.439 0.696 . . . . 0.0 110.592 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.26 -63.87 1.23 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -169.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.93 -41.34 1.57 Allowed Glycine 0 C--N 1.352 1.421 0 N-CA-C 112.12 -0.392 . . . . 0.0 112.12 -173.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.3 ttp85 58.02 17.58 4.52 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.902 1.281 . . . . 0.0 114.207 171.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -175.83 98.11 0.07 Allowed 'General case' 0 N--CA 1.479 0.978 0 O-C-N 121.552 -0.718 . . . . 0.0 109.626 -166.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.53 20.67 79.59 Favored Glycine 0 N--CA 1.478 1.493 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 11.2 m -90.05 119.64 30.57 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 124.487 1.115 . . . . 0.0 110.628 -172.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -126.16 159.12 33.8 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.033 0.444 . . . . 0.0 111.229 -173.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.6 pp -155.31 165.31 37.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.296 168.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 25.9 t -112.46 154.25 13.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 171.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.645 HH22 ' HG2' ' A' ' 42' ' ' GLU . 4.2 ptm180 -157.69 -177.82 6.86 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 123.205 0.602 . . . . 0.0 109.381 -176.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -90.77 125.57 35.74 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 172.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.2 m -57.43 147.65 25.68 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.382 0.673 . . . . 0.0 110.651 174.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.645 ' HG2' HH22 ' A' ' 39' ' ' ARG . 42.2 mt-10 -78.22 89.11 4.28 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.343 0.657 . . . . 0.0 111.967 -164.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.2 t 66.16 27.85 10.3 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.494 1.518 . . . . 0.0 111.57 173.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.2 t -71.89 -71.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.588 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -173.7 34.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.397 0.679 . . . . 0.0 110.786 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.21 35.78 56.68 Favored Glycine 0 N--CA 1.476 1.322 0 CA-C-N 116.618 -0.265 . . . . 0.0 112.96 -168.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 63' ' ' ILE . . . -90.87 164.2 14.13 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.66 0.784 . . . . 0.0 110.457 -173.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.519 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 97.2 m-85 -102.76 148.2 25.9 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.445 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . . . -128.23 137.53 52.05 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.0 tp -112.06 104.0 12.22 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 47.4 m -104.26 114.08 28.07 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -174.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.68 141.44 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 -175.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.416 HD13 HG22 ' A' ' 58' ' ' VAL . 47.3 tp -126.96 144.45 51.01 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.946 0.898 . . . . 0.0 109.463 -176.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.402 ' HB3' ' HB ' ' A' ' 102' ' ' VAL . 66.0 t80 -154.26 109.58 3.14 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 46.19 71.59 0.28 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.544 1.138 . . . . 0.0 112.739 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 56.51 20.61 4.98 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.413 1.085 . . . . 0.0 113.74 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -124.86 108.9 12.39 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 120.921 0.391 . . . . 0.0 110.088 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.416 HG22 HD13 ' A' ' 53' ' ' LEU . 31.7 t -94.4 147.72 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 124.423 1.089 . . . . 0.0 110.046 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.91 113.19 8.77 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.88 1.272 . . . . 0.0 107.599 174.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 66.5 p -107.93 138.38 44.28 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -126.24 100.41 6.29 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -77.67 95.57 4.64 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.639 0.733 . . . . 0.0 109.48 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.521 HG21 HD12 ' A' ' 71' ' ' LEU . 32.5 mt -71.32 133.94 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.216 171.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -90.04 128.0 51.48 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 174.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -81.06 -81.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 123.1 2.533 . . . . 0.0 115.13 -157.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -149.8 160.85 43.23 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 118.262 0.483 . . . . 0.0 110.261 -163.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.58 -46.62 1.02 Allowed Glycine 0 N--CA 1.468 0.819 0 N-CA-C 107.417 -2.273 . . . . 0.0 107.417 -169.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -65.02 -147.07 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.649 0 CA-C-N 113.321 -1.439 . . . . 0.0 111.314 155.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -112.37 -24.36 9.81 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.512 0.725 . . . . 0.0 110.289 173.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -130.13 162.42 28.88 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.902 1.281 . . . . 0.0 110.985 -169.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.521 HD12 HG21 ' A' ' 63' ' ' ILE . 0.5 OUTLIER -102.95 132.02 49.49 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.426 1.09 . . . . 0.0 110.186 178.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -105.26 113.9 27.76 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.529 0.731 . . . . 0.0 112.802 -172.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 81' ' ' VAL . 23.0 t -85.32 138.73 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.69 0.796 . . . . 0.0 109.281 177.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -99.89 91.97 5.07 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.3 m -72.41 -65.39 0.79 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.079 0.551 . . . . 0.0 112.248 -166.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.2 t -168.82 178.23 4.69 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.668 0.387 . . . . 0.0 111.207 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -61.49 -39.01 89.4 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.718 1.207 . . . . 0.0 114.17 -168.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -139.68 40.86 1.37 Allowed Glycine 0 N--CA 1.472 1.081 0 CA-C-O 120.758 0.088 . . . . 0.0 113.044 -171.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.5 m -122.92 155.23 64.1 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 123.848 0.859 . . . . 0.0 109.285 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -65.61 128.65 20.54 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.556 2.171 . . . . 0.0 111.24 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 73' ' ' VAL . 45.6 t -90.02 126.57 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -120.29 139.2 53.07 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.12 0.568 . . . . 0.0 109.528 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -101.99 157.67 16.7 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.348 1.059 . . . . 0.0 108.702 178.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.637 ' HE1' HD12 ' A' ' 93' ' ' LEU . 95.4 m-85 -130.99 160.67 33.89 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.815 0.846 . . . . 0.0 109.103 -173.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -99.35 -18.41 17.54 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.512 0.325 . . . . 0.0 110.489 174.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.8 p -146.7 154.0 40.91 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.764 0.826 . . . . 0.0 110.141 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.448 ' O ' ' HB3' ' A' ' 90' ' ' LEU . 96.1 mt -64.15 -25.56 68.14 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.154 0.982 . . . . 0.0 111.805 173.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -56.89 -42.65 92.43 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 116.574 -0.284 . . . . 0.0 113.026 172.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -68.09 -34.08 75.74 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.668 0.787 . . . . 0.0 111.095 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 22.7 tp -56.24 -58.97 5.71 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.896 0.878 . . . . 0.0 110.262 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 44.9 mm -62.77 -37.92 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.747 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.2 -55.64 28.36 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 115.032 -0.986 . . . . 0.0 113.747 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.637 HD12 ' HE1' ' A' ' 84' ' ' PHE . 34.5 mt -75.77 -42.58 49.92 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -177.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -72.42 -7.41 49.62 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.6 -3.38 4.51 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 171.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 93' ' ' LEU . 13.4 pt20 -95.98 141.01 22.55 Favored Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 123.008 0.523 . . . . 0.0 109.685 174.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 96' ' ' GLN . 4.2 Cg_exo -78.84 173.27 13.81 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.829 2.352 . . . . 0.0 112.706 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 54.16 82.79 0.08 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.478 1.511 . . . . 0.0 111.885 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -159.35 9.43 0.12 Allowed 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.738 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.31 -13.62 56.99 Favored Glycine 0 N--CA 1.476 1.316 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -175.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.418 ' HB3' ' O ' ' A' ' 103' ' ' CYS . 2.2 mm? -65.58 153.31 41.89 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.411 1.484 . . . . 0.0 111.849 175.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 54' ' ' TYR . 19.8 m -82.65 76.3 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 164.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 104' ' ' ALA . 42.8 t 75.75 170.95 0.26 Allowed 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 113.879 -1.509 . . . . 0.0 110.6 -174.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.44 ' N ' ' SG ' ' A' ' 103' ' ' CYS . . . -72.47 166.48 22.52 Favored 'General case' 0 C--O 1.249 1.033 0 C-N-CA 122.984 0.514 . . . . 0.0 109.677 176.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 29.1 mt -73.68 92.58 1.99 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -85.15 -59.91 2.19 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.953 -170.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.496 HD12 ' HD2' ' A' ' 108' ' ' PRO . 50.3 tp -147.58 127.55 6.66 Favored Pre-proline 0 N--CA 1.469 0.524 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -175.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.496 ' HD2' HD12 ' A' ' 107' ' ' LEU . 10.6 Cg_endo -54.16 -72.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.156 1.904 . . . . 0.0 111.37 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 50.2 t . . . . . 0 C--O 1.252 1.187 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 174.977 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptp . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 120.806 0.336 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.31 103.92 0.23 Allowed Glycine 0 C--N 1.344 1.0 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -133.13 -12.82 2.81 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.834 0.853 . . . . 0.0 110.516 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -81.9 85.31 6.7 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 122.975 0.51 . . . . 0.0 110.242 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -154.16 144.78 22.39 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.322 1.049 . . . . 0.0 108.281 175.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -49.5 115.47 1.36 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.42 1.088 . . . . 0.0 112.274 -172.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -99.23 114.59 27.48 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-O 121.014 0.435 . . . . 0.0 110.127 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -74.53 147.77 41.52 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.563 170.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.2 p -58.39 156.51 10.1 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.831 0.852 . . . . 0.0 110.872 175.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 63.3 t-80 -49.76 135.03 19.85 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.259 1.024 . . . . 0.0 111.88 -174.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 88.5 mtp -63.0 175.84 0.81 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.612 0.765 . . . . 0.0 111.901 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.5 t 71.33 141.37 0.05 Allowed 'General case' 0 C--N 1.355 0.838 0 C-N-CA 124.532 1.133 . . . . 0.0 109.848 -172.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.586 ' HB2' ' HA ' ' A' ' 37' ' ' LEU . 1.9 p-90 -80.75 -23.17 39.59 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 28.4 t80 -75.53 105.41 6.55 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.034 0.933 . . . . 0.0 110.422 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -127.36 108.24 10.67 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -54.68 150.4 9.61 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 123.335 0.654 . . . . 0.0 111.334 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.599 ' H ' ' HB3' ' A' ' 40' ' ' ASP . 37.7 t70 -9.71 76.31 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -149.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.431 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 28.5 tp -62.14 -26.4 68.29 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.5 168.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.4 t 82.14 138.44 0.06 Allowed 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 125.587 1.555 . . . . 0.0 108.622 174.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -58.76 -45.39 89.86 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.111 0.564 . . . . 0.0 112.198 -168.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.42 -50.44 71.48 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.879 0.871 . . . . 0.0 111.516 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -73.7 -19.03 60.93 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.704 -178.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.605 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -74.38 -53.33 9.83 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.147 0.979 . . . . 0.0 110.545 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.567 ' HA ' HD12 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -68.95 -21.91 64.16 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 123.682 0.614 . . . . 0.0 110.916 178.155 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -71.54 -51.2 24.77 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.091 0.556 . . . . 0.0 110.501 172.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.4 tp -57.98 -31.69 67.14 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.339 0.656 . . . . 0.0 111.578 174.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.567 HD12 ' HA ' ' A' ' 24' ' ' GLU . 85.6 mt -62.48 -59.95 4.24 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.75 -40.31 66.08 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.833 0.853 . . . . 0.0 112.937 -176.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -77.85 -55.45 5.31 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.578 0.751 . . . . 0.0 111.951 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.3 -60.9 2.05 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.064 0.545 . . . . 0.0 111.257 -172.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.69 82.18 0.31 Allowed Glycine 0 C--N 1.335 0.523 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -70.61 14.39 0.14 Allowed 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -166.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 175.16 138.56 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.172 0.989 . . . . 0.0 108.695 -171.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.92 -4.57 29.89 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 115.088 0.795 . . . . 0.0 115.088 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.5 m -86.92 161.88 18.02 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -166.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -151.23 153.19 34.42 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.878 0.871 . . . . 0.0 109.346 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.605 HD11 ' HB1' ' A' ' 23' ' ' ALA . 3.2 pp -149.82 155.17 39.63 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.446 0.699 . . . . 0.0 109.836 170.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 70.9 t -112.77 131.72 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -119.82 170.37 9.3 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.908 0.883 . . . . 0.0 109.594 175.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.599 ' HB3' ' H ' ' A' ' 17' ' ' ASP . 35.0 t70 -83.63 130.23 34.98 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 172.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.0 t -68.18 152.3 45.69 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.488 0.715 . . . . 0.0 111.118 -176.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -110.77 -36.52 5.68 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.4 t -54.45 -45.05 73.03 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.624 1.17 . . . . 0.0 111.061 173.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 65.1 t -130.12 115.92 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.52 0.728 . . . . 0.0 109.379 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.13 130.41 42.63 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.431 0.692 . . . . 0.0 110.877 174.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.46 -0.63 68.37 Favored Glycine 0 C--N 1.352 1.443 0 C-N-CA 122.894 0.283 . . . . 0.0 112.757 -177.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.0 176.75 4.95 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.897 0.879 . . . . 0.0 112.0 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.437 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 48.7 m-85 -126.0 168.67 13.62 Favored 'General case' 0 C--O 1.249 1.04 0 C-N-CA 124.888 1.275 . . . . 0.0 110.434 -176.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.56 148.47 42.6 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.059 1.344 . . . . 0.0 109.686 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.8 tp -123.73 114.64 20.2 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.112 0.965 . . . . 0.0 108.996 -176.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 60.5 m -107.44 121.65 45.04 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.3 t -126.66 132.39 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -173.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 68.6 tp -123.84 118.15 26.46 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.93 0.892 . . . . 0.0 110.104 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -136.07 132.11 35.74 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 166.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 42.19 61.55 1.94 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 124.977 1.311 . . . . 0.0 113.562 -176.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm 62.92 2.34 0.99 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 125.194 1.398 . . . . 0.0 113.673 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -103.65 105.89 16.25 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -173.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.0 t -86.06 139.63 17.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.066 0.946 . . . . 0.0 109.413 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -135.16 115.52 13.48 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 173.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 51.5 m -109.66 130.79 55.48 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -110.59 156.43 20.95 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.895 1.278 . . . . 0.0 108.26 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -100.91 156.52 17.34 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 163.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.659 HG13 HG13 ' A' ' 73' ' ' VAL . 2.9 mp -144.47 100.5 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 101.564 -3.495 . . . . 0.0 101.564 -167.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.21 154.76 37.44 Favored Pre-proline 0 C--N 1.318 -0.781 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -169.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.97 -73.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 121.485 1.457 . . . . 0.0 111.302 163.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 43.82 73.85 0.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.762 1.225 . . . . 0.0 111.925 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.24 -100.65 0.15 Allowed Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.026 -174.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 158.97 -25.09 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 126.167 1.787 . . . . 0.0 108.271 -170.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -152.07 -2.89 0.27 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.704 0.801 . . . . 0.0 112.121 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -119.59 160.83 21.71 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.733 0.813 . . . . 0.0 109.495 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.408 ' H ' HD23 ' A' ' 71' ' ' LEU . 1.5 pt? -115.12 121.42 42.97 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.615 0.766 . . . . 0.0 109.377 173.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.14 117.9 33.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.56 0.744 . . . . 0.0 110.7 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.659 HG13 HG13 ' A' ' 63' ' ' ILE . 25.6 t -92.09 145.14 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.788 -177.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -101.13 90.12 4.03 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.68 173.22 10.09 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.762 178.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.4 t -65.54 108.32 1.98 Allowed 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -56.7 101.63 0.06 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.147 0.979 . . . . 0.0 110.293 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.32 -24.45 0.45 Allowed Glycine 0 CA--C 1.529 0.953 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -165.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.1 m -118.0 162.27 30.36 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 125.326 1.45 . . . . 0.0 107.654 168.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -63.01 132.12 35.5 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.247 1.965 . . . . 0.0 112.271 176.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 94.2 t -71.58 123.37 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.563 0.745 . . . . 0.0 109.746 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.509 ' HG2' HD13 ' A' ' 93' ' ' LEU . 10.6 tpt180 -111.97 121.75 45.87 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 123.17 0.294 . . . . 0.0 110.89 -175.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.67 155.79 16.62 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.938 0.895 . . . . 0.0 109.19 170.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -133.96 165.6 24.64 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.614 0.766 . . . . 0.0 110.374 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -89.36 -23.99 22.08 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.991 0.516 . . . . 0.0 111.049 168.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.1 t -147.95 155.39 41.5 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.774 0.43 . . . . 0.0 111.195 -175.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.489 ' O ' HG12 ' A' ' 91' ' ' ILE . 86.1 mt -60.14 -31.04 69.7 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.854 0.861 . . . . 0.0 112.132 175.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.94 -47.34 31.96 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 123.094 0.378 . . . . 0.0 114.021 176.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -69.69 -30.28 67.9 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.375 0.67 . . . . 0.0 111.318 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.2 tt -66.86 -36.67 82.85 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.699 0.8 . . . . 0.0 109.13 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 87' ' ' LEU . 47.2 mm -80.92 -40.14 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -169.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.97 -38.98 64.18 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.79 -0.641 . . . . 0.0 113.471 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.509 HD13 ' HG2' ' A' ' 82' ' ' ARG . 7.9 tt -73.42 -36.11 65.93 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.571 0.348 . . . . 0.0 110.189 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.494 ' CD2' HD21 ' A' ' 101' ' ' LEU . 2.0 m-85 -84.28 -9.39 58.53 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.871 0.468 . . . . 0.0 110.613 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.37 0.4 17.0 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.383 0.673 . . . . 0.0 111.287 165.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -92.63 125.69 54.79 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 169.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -66.24 172.64 8.53 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.776 2.317 . . . . 0.0 113.029 171.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.3 t30 55.4 39.62 31.22 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.661 1.185 . . . . 0.0 111.548 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -122.09 10.07 10.0 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.661 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 99.56 -14.01 60.88 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -174.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.494 HD21 ' CD2' ' A' ' 94' ' ' TYR . 4.1 mm? -72.56 150.73 42.89 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.19 1.396 . . . . 0.0 110.702 176.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.4 m -84.34 74.91 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-O 122.206 1.003 . . . . 0.0 109.558 172.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 39.6 t 72.59 27.83 2.27 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 113.438 -1.71 . . . . 0.0 111.25 172.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 77.85 165.5 0.23 Allowed 'General case' 0 C--N 1.354 0.781 0 C-N-CA 125.076 1.35 . . . . 0.0 112.937 172.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.8 mt -76.71 101.81 5.95 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.293 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 78.2 mt -104.78 -50.73 3.21 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 122.957 0.503 . . . . 0.0 112.091 -172.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 mp -113.05 130.16 23.82 Favored Pre-proline 0 N--CA 1.491 1.61 0 CA-C-O 118.776 -0.63 . . . . 0.0 109.766 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -83.48 9.4 4.12 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.79 2.326 . . . . 0.0 113.234 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.542 HG21 HD23 ' A' ' 37' ' ' LEU . 49.3 t . . . . . 0 C--O 1.252 1.214 0 C-N-CA 125.382 1.473 . . . . 0.0 109.396 -172.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.785 0.326 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -142.39 132.9 5.36 Favored Glycine 0 C--N 1.341 0.831 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 175.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -72.39 120.98 18.76 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.881 0.472 . . . . 0.0 110.418 -173.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -98.53 149.96 22.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.927 0.891 . . . . 0.0 109.796 174.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -70.29 158.68 35.46 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.029 0.532 . . . . 0.0 110.101 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -66.29 152.93 43.91 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.863 0.465 . . . . 0.0 110.916 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -71.42 152.19 43.34 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 170.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -65.73 165.54 12.5 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.643 0.377 . . . . 0.0 110.933 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.4 m -62.01 120.39 10.73 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 122.662 0.385 . . . . 0.0 110.729 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -65.02 102.65 0.64 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 173.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 95.9 mmm -69.21 82.47 0.35 Allowed 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.813 0.816 . . . . 0.0 112.183 -168.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.8 m -155.6 103.02 2.26 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -83.76 1.36 43.24 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -165.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -105.06 96.44 6.53 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -170.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -110.2 89.97 3.18 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.27 52.39 2.01 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.017 0.913 . . . . 0.0 110.558 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -146.77 -17.76 0.42 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.725 1.61 . . . . 0.0 109.748 -174.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 28.7 tp -112.36 100.34 8.71 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.457 0.703 . . . . 0.0 110.26 -164.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.2 p -47.07 157.25 0.18 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 125.161 1.384 . . . . 0.0 112.801 172.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.39 -37.1 86.34 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.255 0.622 . . . . 0.0 112.096 -172.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.29 -51.27 68.38 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.392 0.677 . . . . 0.0 111.014 177.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.77 -20.08 61.24 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.934 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.6 -55.58 9.7 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.296 0.638 . . . . 0.0 110.738 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.459 ' HB3' ' SG ' ' A' ' 51' ' ' CYS . 12.3 pt-20 -70.2 -26.54 63.92 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.259 0.623 . . . . 0.0 111.719 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -64.9 -51.98 59.0 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -61.9 -35.39 78.23 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.062 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.6 mt -68.47 -33.82 74.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.585 0.354 . . . . 0.0 110.382 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.18 -37.77 81.33 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.995 0.809 . . . . 0.0 111.652 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -83.46 -44.01 15.2 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.056 0.542 . . . . 0.0 112.22 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.39 -58.2 3.24 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.213 0.605 . . . . 0.0 112.018 -169.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -100.07 -35.76 4.4 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.751 -176.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 66.15 -7.72 0.38 Allowed 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 126.322 1.849 . . . . 0.0 114.452 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -171.18 127.79 0.7 Allowed 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 124.818 1.247 . . . . 0.0 107.647 -165.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.479 ' HA3' HD23 ' A' ' 106' ' ' LEU . . . 65.05 11.61 52.05 Favored Glycine 0 N--CA 1.478 1.467 0 N-CA-C 114.107 0.403 . . . . 0.0 114.107 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.8 m -83.35 143.47 30.31 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.83 0.852 . . . . 0.0 110.278 -168.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -152.92 154.59 35.35 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.06 0.457 . . . . 0.0 110.52 176.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -151.62 153.66 34.91 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.777 169.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.557 HG22 HD13 ' A' ' 50' ' ' LEU . 40.1 t -107.25 145.64 14.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.543 ' HG3' ' HB3' ' A' ' 49' ' ' ALA . 0.9 OUTLIER -138.94 -179.36 5.79 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 125.308 1.443 . . . . 0.0 108.312 -178.472 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -91.34 148.11 22.56 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 172.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.555 ' HB2' ' HB ' ' A' ' 44' ' ' VAL . 40.9 m -61.92 140.69 58.28 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.987 0.515 . . . . 0.0 110.412 173.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -35.35 -54.53 0.65 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 126.356 1.862 . . . . 0.0 114.168 -167.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.1 m -142.61 28.87 1.59 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.91 0.484 . . . . 0.0 110.045 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.555 ' HB ' ' HB2' ' A' ' 41' ' ' SER . 24.2 t -110.24 112.1 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.37 117.98 8.04 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.037 -177.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.89 -0.46 89.47 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 114.537 0.575 . . . . 0.0 114.537 172.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -92.92 155.24 17.71 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 117.161 0.481 . . . . 0.0 109.834 173.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.54 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 68.3 m-85 -110.67 158.24 18.83 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.647 0.736 . . . . 0.0 109.753 -175.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.543 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . . . -135.06 147.37 49.59 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 166.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.557 HD13 HG22 ' A' ' 38' ' ' VAL . 45.6 tp -125.77 139.24 53.68 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -177.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.459 ' SG ' ' HB3' ' A' ' 24' ' ' GLU . 44.6 t -124.84 128.55 48.87 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 175.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.661 HG12 ' SG ' ' A' ' 103' ' ' CYS . 12.8 t -137.0 140.41 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 123.538 0.735 . . . . 0.0 109.779 -176.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.7 tp -132.34 120.52 22.19 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.609 1.164 . . . . 0.0 110.148 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -147.77 146.14 29.07 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.473 0.709 . . . . 0.0 109.089 168.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 50.3 47.58 23.58 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.74 1.216 . . . . 0.0 111.837 -177.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt 54.75 27.68 9.14 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.641 1.177 . . . . 0.0 112.716 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -123.72 107.26 11.27 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.228 1.011 . . . . 0.0 108.888 -174.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.5 t -83.73 131.54 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -135.84 111.08 9.0 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 176.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.2 p -104.87 127.22 52.61 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.961 0.904 . . . . 0.0 108.614 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -113.25 101.02 9.01 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.033 0.933 . . . . 0.0 108.846 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 84.4 mtm180 -70.9 155.63 40.57 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 168.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 91.7 mt -145.86 100.92 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 102.601 -3.111 . . . . 0.0 102.601 -152.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 mp -113.36 101.71 53.9 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 122.814 0.446 . . . . 0.0 110.617 -161.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.716 ' HB2' ' HA ' ' A' ' 68' ' ' GLU . 39.7 Cg_endo -66.3 103.62 0.67 Allowed 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.086 1.857 . . . . 0.0 110.02 167.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.16 -52.8 62.35 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.849 0.86 . . . . 0.0 110.446 -169.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -116.86 34.04 4.8 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.577 174.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.716 ' HA ' ' HB2' ' A' ' 65' ' ' PRO . 46.5 mt-10 50.29 4.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 -173.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -84.85 -49.21 8.6 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 119.602 1.092 . . . . 0.0 109.695 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 31.3 m-85 -127.57 142.07 51.47 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.715 0.806 . . . . 0.0 109.933 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.23 114.9 27.95 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.7 1.2 . . . . 0.0 108.736 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.97 119.39 35.35 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.243 1.017 . . . . 0.0 111.277 -170.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.441 HG22 HG23 ' A' ' 63' ' ' ILE . 16.1 t -106.96 143.67 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.057 0.943 . . . . 0.0 108.956 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -113.49 91.89 3.8 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -172.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.62 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 30.7 p -108.26 28.36 8.38 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.897 0.879 . . . . 0.0 110.482 -177.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.4 m -68.66 94.52 0.59 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.975 0.91 . . . . 0.0 113.353 -167.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -118.41 2.02 11.82 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 124.229 1.012 . . . . 0.0 110.165 164.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.48 22.88 0.03 OUTLIER Glycine 0 N--CA 1.471 0.982 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.459 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.9 m -140.27 152.42 66.96 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.503 1.121 . . . . 0.0 108.969 -174.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -73.32 -175.19 1.88 Allowed 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.375 2.05 . . . . 0.0 111.903 172.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 62.9 t -76.63 123.92 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 176.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 39.8 tpt85 -100.7 116.07 31.74 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -175.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.447 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 32.2 mtp85 -95.33 145.07 25.37 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.292 1.037 . . . . 0.0 110.07 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.648 ' HE1' HD12 ' A' ' 93' ' ' LEU . 83.6 m-85 -126.93 152.87 46.55 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.905 0.882 . . . . 0.0 109.181 -178.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -85.7 -21.56 28.24 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 172.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.7 t -153.33 158.25 41.28 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 122.998 0.519 . . . . 0.0 110.725 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.98 -27.54 68.9 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.238 1.015 . . . . 0.0 109.979 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -52.83 -46.19 60.45 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-N 116.364 -0.38 . . . . 0.0 113.999 173.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -66.88 -30.7 70.93 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.442 0.697 . . . . 0.0 110.97 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.0 tt -62.53 -57.95 9.33 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.319 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.494 ' HA ' HD12 ' A' ' 105' ' ' LEU . 38.3 mm -54.41 -46.11 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.67 0.788 . . . . 0.0 111.206 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.05 -56.96 14.21 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 114.568 -1.196 . . . . 0.0 113.75 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.648 HD12 ' HE1' ' A' ' 84' ' ' PHE . 86.7 mt -74.0 -37.02 64.54 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.944 0.498 . . . . 0.0 111.675 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.425 ' HE2' HG11 ' A' ' 73' ' ' VAL . 5.9 m-30 -82.28 -5.51 58.6 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -169.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.13 -5.37 26.59 Favored 'General case' 0 CA--C 1.562 1.429 0 CA-C-O 120.805 0.336 . . . . 0.0 111.418 165.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -97.13 130.56 29.49 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 124.726 1.21 . . . . 0.0 109.095 173.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.47 -175.66 2.79 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.892 2.395 . . . . 0.0 113.311 173.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.6 t30 49.22 71.9 0.34 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 126.041 1.736 . . . . 0.0 112.277 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.568 ' HG3' HD23 ' A' ' 101' ' ' LEU . 12.7 pt20 -176.45 11.3 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.427 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.62 ' HA3' ' HB ' ' A' ' 75' ' ' THR . . . 122.94 -32.89 4.25 Favored Glycine 0 C--N 1.345 1.074 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -173.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.568 HD23 ' HG3' ' A' ' 99' ' ' GLN . 3.4 mm? -76.66 101.41 5.74 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.533 0.733 . . . . 0.0 109.287 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.462 HG23 ' SG ' ' A' ' 103' ' ' CYS . 4.7 m -69.74 -15.08 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.783 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.661 ' SG ' HG12 ' A' ' 52' ' ' VAL . 14.6 m -115.29 -47.38 2.85 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.582 1.153 . . . . 0.0 111.617 -174.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 69.94 139.34 0.04 OUTLIER 'General case' 0 C--N 1.357 0.906 0 O-C-N 125.27 1.606 . . . . 0.0 108.973 -158.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 91' ' ' ILE . 46.0 mt -69.94 101.42 1.77 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -170.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.479 HD23 ' HA3' ' A' ' 34' ' ' GLY . 57.7 tp -108.68 -60.49 1.74 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.346 1.058 . . . . 0.0 111.056 -169.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 60.6 tp -120.48 101.41 46.35 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 123.165 0.586 . . . . 0.0 109.999 -169.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.38 122.0 5.89 Favored 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 122.884 2.389 . . . . 0.0 110.352 174.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 C--O 1.244 0.81 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.57 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.001 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.62 158.72 35.8 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.888 -177.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -170.74 161.49 7.39 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.372 1.069 . . . . 0.0 109.523 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -143.62 127.32 17.12 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -176.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -103.57 156.65 17.62 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -166.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -141.13 130.8 24.1 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.697 1.199 . . . . 0.0 108.813 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -145.31 99.04 3.25 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -62.69 99.78 0.17 Allowed 'General case' 0 N--CA 1.48 1.068 0 O-C-N 123.709 0.631 . . . . 0.0 110.714 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.8 p -155.92 107.76 2.56 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.795 0.838 . . . . 0.0 109.077 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -111.92 159.81 18.03 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 123.653 0.781 . . . . 0.0 109.161 178.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 75.2 mtp -73.33 145.48 45.95 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.683 0.793 . . . . 0.0 109.973 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.7 p -65.8 149.14 50.64 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.281 0.632 . . . . 0.0 110.438 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.449 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . 4.9 p-90 -79.54 -21.35 45.28 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -175.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.456 ' HH ' ' HE1' ' A' ' 48' ' ' PHE . 89.0 t80 -81.66 125.79 31.0 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.486 171.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -117.67 129.76 55.94 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.438 ' O ' ' HB3' ' A' ' 40' ' ' ASP . 1.6 mpp_? -75.08 -37.93 61.44 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -174.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -130.93 90.1 2.84 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.988 0.899 . . . . 0.0 109.897 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.9 tp -135.59 139.77 44.11 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.841 1.256 . . . . 0.0 107.764 175.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.3 t -99.0 167.09 10.95 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.312 0.645 . . . . 0.0 110.342 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -64.74 -40.08 94.7 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.875 0.87 . . . . 0.0 113.184 -172.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.89 -48.34 77.04 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.067 0.547 . . . . 0.0 110.801 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.55 -30.81 70.54 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.674 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.478 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -65.98 -57.26 8.21 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.123 0.569 . . . . 0.0 110.922 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -58.01 -38.74 76.72 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.877 1.271 . . . . 0.0 112.041 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -70.17 -45.04 67.55 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.395 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.2 tp -58.16 -34.28 70.13 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.981 0.912 . . . . 0.0 111.441 175.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 23' ' ' ALA . 96.5 mt -66.11 -53.05 42.82 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.62 -39.14 87.12 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.265 1.026 . . . . 0.0 112.695 -172.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -73.37 -52.09 15.06 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.748 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.21 -56.18 3.79 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -166.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -101.98 -46.69 1.57 Allowed Glycine 0 N--CA 1.475 1.267 0 N-CA-C 113.404 0.121 . . . . 0.0 113.404 -172.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 49.05 21.49 0.49 Allowed 'General case' 0 CA--C 1.57 1.747 0 C-N-CA 126.196 1.798 . . . . 0.0 114.827 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -170.64 100.43 0.24 Allowed 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.27 -0.894 . . . . 0.0 109.361 -168.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.407 ' HA3' ' HB2' ' A' ' 106' ' ' LEU . . . 66.44 19.05 68.36 Favored Glycine 0 C--N 1.353 1.488 0 CA-C-O 121.465 0.48 . . . . 0.0 112.394 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 9.2 m -84.55 122.8 29.53 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 124.533 1.133 . . . . 0.0 110.859 -167.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 36.7 p90 -129.76 156.7 43.89 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.986 0.422 . . . . 0.0 110.725 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.478 HD11 ' HB1' ' A' ' 23' ' ' ALA . 4.3 pp -150.2 160.11 43.93 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 167.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 57.4 t -114.23 148.54 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 174.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -149.05 151.94 35.37 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.308 0.643 . . . . 0.0 109.476 -174.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' A' ' 16' ' ' ARG . 25.3 t70 -91.11 118.33 30.34 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 174.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.3 m -92.69 97.33 10.72 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -173.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -55.29 -39.17 69.56 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.058 0.943 . . . . 0.0 112.325 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.6 m -58.31 -24.34 59.28 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.2 t -80.27 -87.0 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-O 119.476 -0.297 . . . . 0.0 110.913 -174.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -178.03 18.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 122.909 0.484 . . . . 0.0 111.595 -167.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.75 88.03 1.2 Allowed Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -159.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.3 163.75 39.71 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.717 0.807 . . . . 0.0 109.789 -170.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.596 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 21.2 m-85 -116.01 162.23 17.7 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.37 0.668 . . . . 0.0 109.69 168.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.55 149.38 43.81 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.169 0.988 . . . . 0.0 110.1 170.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.511 ' HB2' HD11 ' A' ' 63' ' ' ILE . 51.9 tp -117.2 111.29 19.24 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 55.4 m -101.17 121.52 41.98 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.4 t -125.19 143.52 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.532 HD13 HG22 ' A' ' 58' ' ' VAL . 51.0 tp -133.0 147.4 52.27 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.366 1.066 . . . . 0.0 109.214 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -162.33 115.88 1.77 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.9 tm0? 36.06 73.75 0.08 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 125.907 1.683 . . . . 0.0 112.612 -174.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 44.6 tptt 56.64 26.41 11.15 Favored 'General case' 0 CA--C 1.572 1.825 0 C-N-CA 124.391 1.076 . . . . 0.0 112.684 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -130.19 107.33 9.22 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 121.482 -0.761 . . . . 0.0 109.272 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.532 HG22 HD13 ' A' ' 53' ' ' LEU . 21.6 t -93.1 142.0 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.506 0.722 . . . . 0.0 109.995 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -137.14 112.77 9.43 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.639 1.576 . . . . 0.0 107.754 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.9 m -119.37 140.17 50.79 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -133.98 113.8 12.55 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.719 0.807 . . . . 0.0 109.41 -173.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -64.79 156.89 29.16 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 171.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.596 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 79.7 mt -148.33 104.32 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 -158.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -96.01 102.44 10.65 Favored Pre-proline 0 N--CA 1.478 0.93 0 CA-C-N 118.885 0.766 . . . . 0.0 109.453 -168.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.457 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 93.1 Cg_endo -76.73 -56.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 123.043 2.495 . . . . 0.0 115.99 -163.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -125.9 141.02 52.17 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 118.146 0.43 . . . . 0.0 111.081 -162.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.05 -16.44 0.24 Allowed Glycine 0 CA--C 1.534 1.236 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.161 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -146.84 -70.5 0.24 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.776 1.231 . . . . 0.0 108.592 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -166.62 -41.31 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.989 -175.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -110.16 151.18 27.6 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.766 0.426 . . . . 0.0 111.222 -167.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.457 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 3.8 pp -99.73 111.58 23.9 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 171.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -101.1 123.48 45.33 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.133 0.573 . . . . 0.0 110.541 -173.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.801 HG21 HD13 ' A' ' 90' ' ' LEU . 57.5 t -93.91 138.12 21.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -95.54 88.45 5.06 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.6 m -73.44 -77.95 0.1 Allowed 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.416 -173.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.433 ' HB2' HG22 ' A' ' 79' ' ' VAL . 66.6 m -161.15 128.29 4.1 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.799 0.84 . . . . 0.0 110.437 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.4 mp0 -70.07 92.87 0.76 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 169.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.53 -36.13 0.69 Allowed Glycine 0 C--N 1.346 1.099 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -170.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 99' ' ' GLN . 13.0 m -104.89 158.34 32.23 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 123.495 0.718 . . . . 0.0 109.171 177.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.36 111.05 1.18 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.256 1.971 . . . . 0.0 110.869 167.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 95.7 t -93.6 132.25 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.944 0.898 . . . . 0.0 108.675 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -112.13 136.13 51.91 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.948 0.499 . . . . 0.0 110.454 -173.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -89.92 140.97 29.1 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.303 1.041 . . . . 0.0 109.328 174.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -111.17 174.45 5.86 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.449 1.099 . . . . 0.0 110.207 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -120.08 -49.64 2.29 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -164.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.8 m -128.73 161.26 30.14 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 113.495 -1.684 . . . . 0.0 107.697 171.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.47 -26.13 67.7 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 118.647 0.658 . . . . 0.0 112.41 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -56.58 -34.93 64.93 Favored Glycine 0 N--CA 1.48 1.611 0 O-C-N 122.991 0.182 . . . . 0.0 113.47 169.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -67.45 -38.96 85.27 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.2 0.6 . . . . 0.0 110.677 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.801 HD13 HG21 ' A' ' 73' ' ' VAL . 37.6 tp -61.84 -64.71 0.85 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.855 0.862 . . . . 0.0 110.717 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.7 mm -59.68 -39.36 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.318 1.047 . . . . 0.0 111.063 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.18 -57.66 18.06 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.135 -0.939 . . . . 0.0 113.853 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.1 tt -67.63 -45.83 74.25 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.266 0.626 . . . . 0.0 110.101 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.469 ' HB3' ' HG ' ' A' ' 105' ' ' LEU . 5.7 m-30 -77.04 -12.15 59.9 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -170.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.42 -22.24 66.77 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.224 0.535 . . . . 0.0 110.835 169.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -94.45 139.25 22.31 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 174.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -46.3 117.75 2.13 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.105 2.537 . . . . 0.0 112.137 166.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -110.24 -58.37 2.08 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.518 -164.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.445 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . 9.4 mm-40 128.33 102.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 128.37 2.668 . . . . 0.0 107.595 -159.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 120.55 -39.91 2.31 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-O 120.117 -0.269 . . . . 0.0 113.432 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.438 HD11 ' HB3' ' A' ' 94' ' ' TYR . 76.2 mt -68.9 150.28 47.93 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.8 p -64.49 -36.83 78.41 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.174 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.4 ' SG ' HD11 ' A' ' 106' ' ' LEU . 49.0 t -165.25 20.64 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.268 0.627 . . . . 0.0 111.146 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 72.14 167.97 0.31 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.611 1.165 . . . . 0.0 110.664 -169.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.469 ' HG ' ' HB3' ' A' ' 94' ' ' TYR . 23.4 mt -81.18 98.91 8.28 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.167 0.587 . . . . 0.0 109.611 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.407 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 89.8 mt -93.95 -46.5 7.14 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.459 0.704 . . . . 0.0 112.404 -172.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 35' ' ' SER . 68.5 tp -141.54 116.68 7.06 Favored Pre-proline 0 N--CA 1.486 1.373 0 C-N-CA 123.079 0.552 . . . . 0.0 111.055 -174.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.449 ' HB2' ' HB3' ' A' ' 13' ' ' TRP . 73.2 Cg_endo -77.94 136.38 14.83 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.372 2.048 . . . . 0.0 111.581 174.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--O 1.25 1.086 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.407 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.9 mtt . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 132.21 119.56 2.07 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 112.387 -0.285 . . . . 0.0 112.387 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -141.46 112.04 7.05 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -94.42 97.79 10.43 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.083 0.468 . . . . 0.0 110.374 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -98.65 126.3 44.2 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.695 1.198 . . . . 0.0 108.486 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -96.84 147.6 23.78 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.099 0.56 . . . . 0.0 110.778 -178.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 -160.37 125.58 3.9 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.467 1.107 . . . . 0.0 109.318 174.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -142.07 157.8 44.49 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.25 1.02 . . . . 0.0 110.369 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.4 m -122.53 101.68 7.62 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.026 0.931 . . . . 0.0 108.593 171.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -108.83 90.45 3.3 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.262 1.025 . . . . 0.0 108.882 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -83.47 62.68 6.91 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 175.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.8 t 55.67 -107.52 0.39 Allowed 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 124.177 0.991 . . . . 0.0 110.56 -171.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.509 ' HB3' ' HB3' ' A' ' 108' ' ' PRO . 6.1 p-90 -99.23 15.5 25.9 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.813 0.845 . . . . 0.0 112.005 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 61.7 t80 -113.76 116.09 28.83 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -131.23 99.16 4.77 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.207 0.603 . . . . 0.0 110.373 -177.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.478 ' HD3' ' N ' ' A' ' 17' ' ' ASP . 1.0 OUTLIER -72.73 150.59 42.74 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 167.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.478 ' N ' ' HD3' ' A' ' 16' ' ' ARG . 36.6 t70 79.19 3.54 2.33 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.891 1.276 . . . . 0.0 111.389 -175.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.2 tp -99.44 123.25 43.55 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.082 -1.011 . . . . 0.0 109.042 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.2 p -80.85 160.84 24.66 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.663 0.785 . . . . 0.0 109.917 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.445 ' HB3' ' NH2' ' A' ' 39' ' ' ARG . 5.5 ppt_? -64.63 -35.47 81.13 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 118.458 0.572 . . . . 0.0 112.252 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.87 -48.86 78.63 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.538 0.735 . . . . 0.0 110.75 175.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.21 -26.56 62.99 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.849 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.462 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -71.97 -54.55 9.62 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.72 0.808 . . . . 0.0 110.768 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.578 ' HG2' HG21 ' A' ' 58' ' ' VAL . 5.5 tm-20 -56.97 -39.72 75.14 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.951 1.3 . . . . 0.0 111.52 175.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.82 -46.72 80.78 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 123.976 0.798 . . . . 0.0 110.156 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -60.63 -43.87 97.02 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 124.088 0.868 . . . . 0.0 110.411 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.4 mt -65.26 -42.18 93.52 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.368 0.667 . . . . 0.0 110.186 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.47 -35.87 80.03 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.764 0.826 . . . . 0.0 111.604 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 46.5 ttt85 -77.69 -30.77 52.06 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.573 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.53 ' HB1' HG13 ' A' ' 109' ' ' VAL . . . -87.91 -61.43 1.72 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -172.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -125.31 -48.05 0.21 Allowed Glycine 0 N--CA 1.474 1.195 0 C-N-CA 122.951 0.31 . . . . 0.0 112.7 -169.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.476 ' HG3' HD21 ' A' ' 53' ' ' LEU . 40.2 ttp180 45.57 41.96 7.55 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.343 1.857 . . . . 0.0 114.541 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -174.16 88.52 0.06 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -174.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.516 ' HA2' ' SG ' ' A' ' 103' ' ' CYS . . . 83.75 12.75 76.91 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.785 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 m -83.75 118.93 24.23 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 124.634 1.173 . . . . 0.0 110.563 -169.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -125.98 158.92 34.05 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.084 0.468 . . . . 0.0 110.178 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.462 HD11 ' HB1' ' A' ' 23' ' ' ALA . 3.8 pp -153.7 164.94 37.44 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.731 166.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.42 HG22 HD13 ' A' ' 50' ' ' LEU . 97.7 t -119.27 148.64 22.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 170.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.445 ' NH2' ' HB3' ' A' ' 20' ' ' ARG . 43.7 ptt85 -153.6 -178.31 6.94 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -93.29 141.54 28.32 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 165.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.4 m -65.65 146.22 55.08 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 163.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -66.6 81.37 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -158.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.6 m 51.12 30.88 5.96 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.96 1.304 . . . . 0.0 112.654 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.1 m -72.46 -44.04 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.892 -168.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -174.01 9.32 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.441 0.697 . . . . 0.0 111.454 -169.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.77 19.19 60.16 Favored Glycine 0 N--CA 1.474 1.183 0 N-CA-C 112.141 -0.384 . . . . 0.0 112.141 -171.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.79 155.3 18.88 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.989 0.916 . . . . 0.0 111.681 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -106.55 158.85 16.62 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.023 0.929 . . . . 0.0 110.398 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.88 141.19 51.36 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.986 0.514 . . . . 0.0 110.136 169.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.598 HD22 HD21 ' A' ' 90' ' ' LEU . 51.9 tp -114.32 107.09 15.11 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.136 1.374 . . . . 0.0 107.495 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 42.5 t -104.04 114.37 28.57 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -175.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.7 t -120.61 133.14 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.025 0.93 . . . . 0.0 108.724 -175.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.476 HD21 ' HG3' ' A' ' 32' ' ' ARG . 12.3 tp -128.98 140.89 51.45 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.858 1.263 . . . . 0.0 109.283 -173.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -155.3 115.54 3.79 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 41.75 71.05 0.23 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.001 1.32 . . . . 0.0 113.892 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.9 mttt 59.31 23.4 11.83 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.407 1.083 . . . . 0.0 113.714 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -131.82 105.68 7.62 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.578 HG21 ' HG2' ' A' ' 24' ' ' GLU . 40.1 t -103.9 109.0 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.823 0.849 . . . . 0.0 109.053 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -103.02 123.33 46.41 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 171.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 36.8 m -120.01 141.9 49.29 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.046 0.939 . . . . 0.0 108.687 -172.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -124.39 100.44 6.68 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -172.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.5 mtp-105 -81.97 98.61 8.67 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.52 HG12 HG22 ' A' ' 73' ' ' VAL . 6.1 mt -75.45 110.51 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.362 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.0 mp -112.06 103.12 55.06 Favored Pre-proline 0 C--O 1.241 0.639 0 C-N-CA 124.887 1.275 . . . . 0.0 107.566 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -58.05 -57.88 0.98 Allowed 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.259 1.972 . . . . 0.0 110.705 170.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.7 t70 56.01 36.09 26.74 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 122.788 1.28 . . . . 0.0 109.825 173.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.07 178.0 28.06 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.939 -165.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -108.9 -13.37 14.76 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 118.589 1.195 . . . . 0.0 111.029 -175.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -65.47 -85.0 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.451 0.701 . . . . 0.0 110.914 -174.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -131.04 155.68 46.46 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.675 0.75 . . . . 0.0 111.777 175.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.48 110.93 17.07 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.063 1.745 . . . . 0.0 107.578 169.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.12 132.0 43.33 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.147 0.579 . . . . 0.0 110.586 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.52 HG22 HG12 ' A' ' 63' ' ' ILE . 39.8 t -99.38 112.92 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -177.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -90.65 94.56 9.75 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.106 0.563 . . . . 0.0 109.923 -169.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.684 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 65.4 p -65.8 -27.88 68.6 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.612 0.765 . . . . 0.0 112.433 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.8 t -142.07 -169.97 3.05 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.006 0.922 . . . . 0.0 109.796 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -54.45 -55.3 30.28 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.473 1.109 . . . . 0.0 112.386 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.29 44.05 0.19 Allowed Glycine 0 CA--C 1.505 -0.536 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.855 176.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.0 m -69.32 166.3 31.01 Favored Pre-proline 0 CA--C 1.557 1.217 0 C-N-CA 123.347 0.659 . . . . 0.0 111.364 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.45 53.22 1.31 Allowed 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 122.89 2.393 . . . . 0.0 112.652 167.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.509 HG22 ' H ' ' A' ' 82' ' ' ARG . 4.3 p -55.85 176.44 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 C-N-CA 125.42 1.488 . . . . 0.0 111.989 162.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.509 ' H ' HG22 ' A' ' 81' ' ' VAL . 42.4 mmm-85 -108.93 140.49 42.34 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -169.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -95.18 126.44 40.5 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -112.18 166.01 11.65 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.447 0.467 . . . . 0.0 109.876 -175.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -132.27 -4.92 3.41 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.767 0.827 . . . . 0.0 109.006 169.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.529 HG22 ' H ' ' A' ' 88' ' ' GLY . 87.6 m -141.73 136.07 30.41 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.362 1.065 . . . . 0.0 109.645 -172.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 78.7 mt -66.35 -28.26 68.52 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.908 0.883 . . . . 0.0 111.125 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.529 ' H ' HG22 ' A' ' 86' ' ' THR . . . -57.65 -46.74 91.82 Favored Glycine 0 N--CA 1.475 1.234 0 N-CA-C 114.401 0.52 . . . . 0.0 114.401 174.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -65.56 -36.1 82.79 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.548 0.739 . . . . 0.0 111.01 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.598 HD21 HD22 ' A' ' 50' ' ' LEU . 6.5 tt -59.91 -63.68 1.21 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.937 1.295 . . . . 0.0 110.403 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 31.6 mm -60.67 -43.64 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.209 1.004 . . . . 0.0 110.94 -175.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.09 -48.69 66.44 Favored Glycine 0 C--N 1.343 0.955 0 O-C-N 124.219 0.95 . . . . 0.0 113.482 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.2 tt -67.04 -59.67 3.27 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.481 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . 20.2 m-85 -71.69 -5.9 37.19 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -166.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.67 -16.31 25.6 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.048 0.539 . . . . 0.0 111.867 165.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -90.76 146.46 34.08 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 173.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -91.72 -168.19 0.23 Allowed 'Trans proline' 0 C--N 1.363 1.338 0 C-N-CA 122.916 2.411 . . . . 0.0 111.939 172.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.4 t30 52.62 62.39 2.71 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.845 1.258 . . . . 0.0 111.868 176.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -174.31 5.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.985 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.684 ' HA3' ' HB ' ' A' ' 75' ' ' THR . . . 130.97 -31.49 3.17 Favored Glycine 0 N--CA 1.473 1.121 0 N-CA-C 112.221 -0.352 . . . . 0.0 112.221 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' A' ' 94' ' ' TYR . 3.9 mm? -83.17 97.34 8.77 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.5 m -46.63 -32.83 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 126.079 1.752 . . . . 0.0 114.533 -175.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.516 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 24.6 p -130.46 3.07 4.62 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.021 0.528 . . . . 0.0 111.731 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.404 ' HA ' ' HB3' ' A' ' 101' ' ' LEU . . . 66.6 -179.99 0.21 Allowed 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.344 1.028 . . . . 0.0 110.444 -171.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 60.9 mt -90.36 83.16 5.91 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 168.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.3 tp -110.3 -63.03 1.43 Allowed 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.161 -171.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.32 115.51 63.73 Favored Pre-proline 0 N--CA 1.485 1.305 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.509 ' HB3' ' HB3' ' A' ' 13' ' ' TRP . 4.9 Cg_exo -71.14 -90.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 121.805 1.67 . . . . 0.0 110.049 173.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.53 HG13 ' HB1' ' A' ' 30' ' ' ALA . 78.6 t . . . . . 0 C--O 1.254 1.342 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 172.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 tpp . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.95 -42.14 3.13 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 115.313 0.885 . . . . 0.0 115.313 166.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -54.33 98.84 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.168 0.987 . . . . 0.0 113.267 -170.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -136.39 -67.16 0.52 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 170.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.1 t60 51.41 55.34 9.57 Favored 'General case' 0 C--N 1.363 1.177 0 C-N-CA 125.082 1.353 . . . . 0.0 111.0 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -150.04 129.91 13.36 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.139 0.976 . . . . 0.0 109.553 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -132.72 146.14 51.61 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.186 0.994 . . . . 0.0 108.813 172.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -62.87 87.31 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.946 0.899 . . . . 0.0 111.562 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.7 p -78.61 98.86 6.32 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.865 176.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -82.61 70.14 9.52 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 122.062 0.934 . . . . 0.0 110.84 -175.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 10.1 tpt -92.65 128.45 38.51 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.716 176.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.7 t -172.78 -141.53 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 124.129 0.971 . . . . 0.0 108.681 -176.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -70.68 -18.55 62.82 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.289 0.635 . . . . 0.0 110.033 172.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 76.2 t80 -85.54 130.42 34.58 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.129 0.572 . . . . 0.0 109.622 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -130.0 140.49 50.87 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -66.17 -53.53 36.35 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -169.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -155.67 72.34 0.79 Allowed 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 122.133 0.968 . . . . 0.0 111.44 175.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.71 HD22 HH21 ' A' ' 39' ' ' ARG . 8.7 tt -92.92 135.01 34.53 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 160.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.404 ' O ' HD23 ' A' ' 18' ' ' LEU . 48.1 t -66.97 146.47 54.34 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.776 0.831 . . . . 0.0 110.043 -173.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.47 ' NE ' ' H ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -64.84 -42.24 95.08 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.671 0.389 . . . . 0.0 110.956 -176.422 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.15 -51.2 67.22 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.56 0.744 . . . . 0.0 111.306 172.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.22 -29.3 70.4 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.659 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.433 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -69.59 -45.82 67.77 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.535 1.134 . . . . 0.0 111.893 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 43.9 mt-10 -56.73 -44.46 81.68 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.669 0.787 . . . . 0.0 110.898 175.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.28 -40.02 86.1 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.412 177.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.5 -42.41 92.12 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.315 1.046 . . . . 0.0 109.65 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.59 HD22 ' HB2' ' A' ' 35' ' ' SER . 93.7 mt -65.52 -43.64 89.4 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.511 0.724 . . . . 0.0 110.461 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.95 -34.91 70.43 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 124.066 0.854 . . . . 0.0 112.283 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -87.83 -43.06 12.12 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.85 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.86 -61.79 1.86 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -167.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.425 ' HA3' ' HB3' ' A' ' 35' ' ' SER . . . -95.29 -33.0 6.72 Favored Glycine 0 C--N 1.352 1.465 0 CA-C-O 121.277 0.376 . . . . 0.0 112.368 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 68.07 0.61 2.47 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 126.904 2.081 . . . . 0.0 114.405 175.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.2 t70 175.53 125.71 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.29 0.636 . . . . 0.0 109.381 -175.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.57 6.06 70.01 Favored Glycine 0 N--CA 1.477 1.417 0 O-C-N 123.285 0.366 . . . . 0.0 112.714 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.59 ' HB2' HD22 ' A' ' 27' ' ' LEU . 3.1 p -80.69 136.9 36.27 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.022 0.929 . . . . 0.0 109.639 -172.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.415 ' HB2' HG22 ' A' ' 52' ' ' VAL . 29.4 p90 -137.13 158.51 44.28 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.817 0.447 . . . . 0.0 110.577 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.447 HD11 ' HB3' ' A' ' 51' ' ' CYS . 1.2 pp -155.23 165.98 34.97 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.19 0.996 . . . . 0.0 109.729 174.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 89.2 t -132.64 130.54 59.48 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 173.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.71 HH21 HD22 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -121.59 179.16 4.55 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 169.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -92.18 140.24 29.82 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 171.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.8 m -71.89 162.65 29.14 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.305 1.042 . . . . 0.0 111.613 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.84 -29.91 8.8 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.142 0.577 . . . . 0.0 110.704 -178.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.8 p -89.63 -58.21 2.6 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 123.739 0.816 . . . . 0.0 110.425 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.5 t -86.68 106.06 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -175.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.8 117.63 7.19 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.957 0.903 . . . . 0.0 111.773 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.42 -0.07 74.02 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-O 119.856 -0.413 . . . . 0.0 113.365 176.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.04 151.64 20.96 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 117.455 0.628 . . . . 0.0 111.689 -177.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -110.82 130.19 55.65 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.875 0.87 . . . . 0.0 111.333 -175.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.419 ' HB3' ' HG2' ' A' ' 39' ' ' ARG . . . -100.51 114.48 28.12 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.904 0.882 . . . . 0.0 110.251 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.5 tp -106.24 108.49 20.02 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.447 ' HB3' HD11 ' A' ' 37' ' ' LEU . 43.3 t -111.39 124.49 52.36 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -177.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 36' ' ' PHE . 17.9 t -129.45 116.65 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.025 0.93 . . . . 0.0 109.675 -174.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.671 HD13 HG22 ' A' ' 58' ' ' VAL . 32.5 tp -86.34 142.83 28.2 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.058 0.943 . . . . 0.0 109.568 173.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -162.78 127.4 3.1 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.515 0.726 . . . . 0.0 109.719 167.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 47.35 62.78 2.25 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.5 1.52 . . . . 0.0 112.682 173.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.63 30.98 16.38 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.633 1.173 . . . . 0.0 111.949 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -141.52 105.93 4.84 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.265 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.671 HG22 HD13 ' A' ' 53' ' ' LEU . 2.7 t -92.98 122.8 44.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 172.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -114.98 140.29 49.15 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.9 p -111.76 136.58 50.83 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.842 0.857 . . . . 0.0 108.716 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -128.46 101.5 6.22 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -84.19 102.63 12.75 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.222 0.609 . . . . 0.0 109.825 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.1 mp -71.39 129.86 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.935 168.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.61 139.82 23.36 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 123.709 0.804 . . . . 0.0 109.533 171.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -83.11 111.51 1.9 Allowed 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.16 1.907 . . . . 0.0 111.129 169.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -69.43 -58.87 3.44 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.675 0.39 . . . . 0.0 110.185 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -96.74 33.04 5.98 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 119.543 -0.587 . . . . 0.0 112.548 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 69.49 -34.03 0.27 Allowed 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -89.11 -48.66 7.25 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.255 0.622 . . . . 0.0 111.094 -165.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -103.51 135.9 44.24 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp -106.68 151.1 25.54 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.557 ' HB2' ' HG2' ' A' ' 83' ' ' ARG . . . -138.93 134.23 32.92 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.163 -0.336 . . . . 0.0 111.481 -169.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.3 p -85.85 135.36 25.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 171.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -98.23 94.74 6.96 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.3 p -78.12 -63.84 1.3 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.407 0.683 . . . . 0.0 111.147 -170.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.538 ' HB3' HG22 ' A' ' 79' ' ' VAL . 41.3 t -177.37 140.15 0.27 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.916 0.886 . . . . 0.0 109.096 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -76.27 91.44 3.22 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 168.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.5 -27.15 0.42 Allowed Glycine 0 C--N 1.339 0.71 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -167.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 76' ' ' SER . 34.7 m -127.4 156.58 74.8 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 124.482 1.113 . . . . 0.0 108.449 174.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.12 136.57 61.34 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.525 2.15 . . . . 0.0 112.986 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 95.9 t -94.68 134.52 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.103 0.961 . . . . 0.0 108.589 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.4 tpt85 -113.78 130.9 56.39 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.68 0.792 . . . . 0.0 109.998 -176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.557 ' HG2' ' HB2' ' A' ' 72' ' ' ALA . 48.1 mtm105 -101.81 156.08 17.73 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.046 0.939 . . . . 0.0 108.83 173.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -137.52 160.85 37.98 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.729 0.812 . . . . 0.0 109.059 -172.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -88.99 -24.1 22.47 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 173.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 88' ' ' GLY . 33.2 m -154.6 154.48 33.09 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 124.289 1.036 . . . . 0.0 109.974 -175.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.8 mt -58.85 -32.28 69.29 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.407 1.083 . . . . 0.0 112.272 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.521 ' H ' HG22 ' A' ' 86' ' ' THR . . . -54.15 -38.72 61.93 Favored Glycine 0 N--CA 1.476 1.319 0 O-C-N 123.613 0.571 . . . . 0.0 114.08 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -66.78 -38.24 86.14 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.298 0.639 . . . . 0.0 110.437 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.9 tt -61.27 -57.58 11.77 Favored 'General case' 0 C--O 1.209 -1.068 0 O-C-N 124.088 0.867 . . . . 0.0 110.306 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 30.9 mm -55.83 -45.28 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 C-N-CA 123.171 0.588 . . . . 0.0 112.099 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.8 -52.23 49.95 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.854 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 61.2 tp -69.09 -43.62 74.18 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.897 0.879 . . . . 0.0 111.526 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.432 ' HB3' HD11 ' A' ' 101' ' ' LEU . 41.8 m-85 -86.69 9.35 19.06 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.547 1.139 . . . . 0.0 112.841 -175.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.88 2.01 2.94 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 157.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -102.82 126.77 31.71 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 124.135 0.974 . . . . 0.0 111.013 174.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -71.7 -178.03 2.84 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.99 2.46 . . . . 0.0 112.802 171.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.5 t30 55.55 28.58 12.03 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 125.049 1.34 . . . . 0.0 111.93 -177.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -141.95 23.76 2.04 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.168 0.587 . . . . 0.0 111.323 -172.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 122.43 -39.15 2.36 Favored Glycine 0 C--N 1.347 1.163 0 C-N-CA 123.018 0.342 . . . . 0.0 112.355 174.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.432 HD11 ' HB3' ' A' ' 94' ' ' TYR . 19.5 mt -90.56 126.57 35.98 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 122.837 0.455 . . . . 0.0 110.899 -174.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.6 m -24.48 -47.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 C-N-CA 126.944 2.098 . . . . 0.0 115.186 176.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.403 ' SG ' HD11 ' A' ' 106' ' ' LEU . 46.2 t -160.91 29.76 0.15 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.537 0.735 . . . . 0.0 109.343 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 69.92 -177.17 0.21 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.624 1.17 . . . . 0.0 112.211 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.4 mt -85.94 101.33 12.79 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.841 177.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.403 HD11 ' SG ' ' A' ' 103' ' ' CYS . 75.6 mt -99.03 -58.95 1.82 Allowed 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -173.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.4 mp -119.05 103.48 47.76 Favored Pre-proline 0 N--CA 1.5 2.031 0 CA-C-N 118.879 0.763 . . . . 0.0 111.001 -174.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.14 115.22 4.27 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.883 2.389 . . . . 0.0 112.439 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 C--O 1.251 1.143 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -176.943 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.4 ttm . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.08 61.94 0.93 Allowed Glycine 0 C--N 1.349 1.25 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 -70.48 85.88 0.62 Allowed 'General case' 0 CA--C 1.553 1.087 0 CA-C-O 121.411 0.624 . . . . 0.0 111.002 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -169.59 100.61 0.33 Allowed 'General case' 0 C--N 1.349 0.56 0 C-N-CA 124.131 0.972 . . . . 0.0 109.102 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -125.57 13.63 8.12 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.677 0.791 . . . . 0.0 110.784 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -96.65 104.91 16.94 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 173.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -139.99 74.46 1.47 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 172.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.7 t60 -99.94 113.08 25.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.804 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.4 p -110.88 156.17 21.55 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.89 0.876 . . . . 0.0 109.502 174.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -171.71 -40.78 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.554 0.742 . . . . 0.0 109.222 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.4 mpt? 60.89 -175.86 0.12 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.096 1.358 . . . . 0.0 112.031 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 p -168.8 160.67 10.58 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.815 0.446 . . . . 0.0 111.709 -173.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.512 ' HB2' ' HA ' ' A' ' 37' ' ' LEU . 4.3 p-90 -79.93 -18.57 50.14 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 170.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.445 ' HE2' ' HD3' ' A' ' 16' ' ' ARG . 37.3 t80 -80.82 97.35 7.32 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 18' ' ' LEU . 96.4 m-70 -98.04 119.42 36.65 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.511 0.724 . . . . 0.0 110.143 -175.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.445 ' HD3' ' HE2' ' A' ' 14' ' ' TYR . 21.1 mmm180 -92.26 -9.46 42.05 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.915 1.286 . . . . 0.0 111.748 -178.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -108.93 -9.42 15.13 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.55 0.74 . . . . 0.0 110.778 -174.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 15' ' ' HIS . 0.9 OUTLIER -113.27 131.07 56.06 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.317 1.047 . . . . 0.0 110.782 -166.686 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.5 p -88.92 -176.93 5.35 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.255 1.022 . . . . 0.0 111.128 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.649 ' HG3' HG21 ' A' ' 60' ' ' THR . 62.1 ttt180 -62.09 -50.38 72.15 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.997 0.919 . . . . 0.0 111.621 174.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.32 -43.99 92.62 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.125 0.57 . . . . 0.0 110.876 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.25 -30.12 70.97 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.86 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.4 -57.51 7.27 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.04 0.536 . . . . 0.0 109.882 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.42 ' HG2' HG11 ' A' ' 58' ' ' VAL . 36.5 mt-10 -53.45 -43.74 68.32 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.606 1.163 . . . . 0.0 111.674 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -67.29 -57.95 5.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.547 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.7 tt -61.86 -33.32 73.98 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.88 -174.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.488 HD22 ' HB2' ' A' ' 35' ' ' SER . 82.7 mt -67.68 -44.82 76.86 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.63 -27.58 69.04 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.71 0.804 . . . . 0.0 112.024 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -86.51 -48.97 7.92 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 122.997 0.519 . . . . 0.0 111.256 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.76 -59.2 2.87 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.598 0.759 . . . . 0.0 111.805 -170.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.53 ' HA3' ' HB3' ' A' ' 35' ' ' SER . . . -96.14 -46.35 2.63 Favored Glycine 0 C--N 1.346 1.084 0 O-C-N 123.044 0.215 . . . . 0.0 113.104 -175.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 50.48 26.04 2.2 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 125.842 1.657 . . . . 0.0 113.086 -175.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.0 t70 177.22 97.85 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -173.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.642 ' HA3' HD12 ' A' ' 106' ' ' LEU . . . 72.31 20.66 79.36 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-O 120.985 0.214 . . . . 0.0 113.332 174.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.53 ' HB3' ' HA3' ' A' ' 31' ' ' GLY . 5.7 p -81.59 124.08 29.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.961 0.904 . . . . 0.0 109.431 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -128.37 159.29 35.81 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.931 0.492 . . . . 0.0 110.016 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.512 ' HA ' ' HB2' ' A' ' 13' ' ' TRP . 4.1 pp -156.83 164.16 38.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.042 0.937 . . . . 0.0 109.842 169.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 47.3 t -122.81 154.34 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 173.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -155.77 -173.97 4.76 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.851 1.26 . . . . 0.0 108.803 -176.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -91.4 121.49 33.17 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 174.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.8 t -59.19 160.38 6.45 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 122.116 0.96 . . . . 0.0 113.271 -172.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.34 -29.64 4.11 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.209 1.804 . . . . 0.0 108.545 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.7 m -66.38 -38.71 88.16 Favored 'General case' 0 C--N 1.353 0.761 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.976 173.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.3 t -127.49 119.9 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.017 0.927 . . . . 0.0 108.76 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.45 134.07 51.73 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.435 0.694 . . . . 0.0 111.35 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.21 -1.82 88.06 Favored Glycine 0 C--N 1.348 1.214 0 O-C-N 123.176 0.298 . . . . 0.0 112.931 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -101.67 177.68 4.84 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.101 0.96 . . . . 0.0 111.615 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.601 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 44.7 m-85 -111.56 155.52 23.19 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.683 0.793 . . . . 0.0 109.328 175.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.66 142.94 50.63 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.821 0.848 . . . . 0.0 110.147 174.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.507 ' HB2' HD11 ' A' ' 63' ' ' ILE . 26.6 tp -117.09 113.48 22.36 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 42.2 t -103.99 118.85 37.66 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.8 t -125.28 137.09 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -176.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.531 HD13 HG22 ' A' ' 58' ' ' VAL . 27.0 tp -111.9 137.39 49.93 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.879 0.871 . . . . 0.0 110.216 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.547 ' HB2' ' HB2' ' A' ' 103' ' ' CYS . 88.8 t80 -142.0 103.42 4.31 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.395 1.078 . . . . 0.0 108.354 173.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 43.5 70.95 0.27 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.133 1.373 . . . . 0.0 113.212 172.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 79.9 tttt 55.68 38.23 29.87 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 124.891 1.276 . . . . 0.0 111.938 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -141.82 102.92 4.25 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 170.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.531 HG22 HD13 ' A' ' 53' ' ' LEU . 17.2 t -102.51 129.51 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -119.15 147.18 44.48 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.172 0.589 . . . . 0.0 109.578 170.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.649 HG21 ' HG3' ' A' ' 20' ' ' ARG . 17.7 p -117.37 132.82 56.51 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -123.54 107.03 11.1 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -171.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.574 ' HD3' ' H ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -59.83 155.35 16.42 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 171.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 77.4 mt -146.86 111.74 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 102.742 -3.058 . . . . 0.0 102.742 -162.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.1 mp -91.54 113.68 59.39 Favored Pre-proline 0 N--CA 1.468 0.462 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -165.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.84 -34.17 82.92 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.409 2.739 . . . . 0.0 111.392 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.8 t70 58.55 93.91 0.03 OUTLIER 'General case' 0 C--N 1.364 1.224 0 C-N-CA 125.101 1.361 . . . . 0.0 111.578 166.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -54.95 80.22 0.01 OUTLIER Glycine 0 C--N 1.35 1.322 0 N-CA-C 115.668 1.027 . . . . 0.0 115.668 -174.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -153.07 -85.69 0.07 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 170.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -160.42 6.04 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 174.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -131.09 147.6 52.64 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.202 -0.937 . . . . 0.0 112.513 -174.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.508 HD23 ' H ' ' A' ' 71' ' ' LEU . 2.5 pt? -120.73 129.8 53.78 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.947 1.299 . . . . 0.0 109.015 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -116.36 149.1 39.9 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.218 0.607 . . . . 0.0 110.271 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.7 t -89.23 130.11 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -108.13 130.81 55.09 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -171.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.9 t -137.47 -178.86 5.41 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.387 -170.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.2 t -69.8 6.22 1.25 Allowed 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -167.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 71.46 139.33 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.852 1.261 . . . . 0.0 111.127 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 113.73 -61.12 0.35 Allowed Glycine 0 C--N 1.342 0.863 0 N-CA-C 106.351 -2.7 . . . . 0.0 106.351 -175.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.476 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 4.3 m -63.63 116.47 26.48 Favored Pre-proline 0 CA--C 1.557 1.213 0 CA-C-N 113.891 -1.154 . . . . 0.0 109.327 156.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 4.7 Cg_exo -75.04 99.07 1.22 Allowed 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.362 2.708 . . . . 0.0 114.356 -168.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 75.4 t -35.8 120.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 123.936 0.895 . . . . 0.0 112.893 158.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 27.9 mmt85 -112.62 142.36 45.3 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 124.345 1.058 . . . . 0.0 108.869 176.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.8 ptt85 -97.81 142.59 29.38 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.544 0.738 . . . . 0.0 111.139 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.481 ' HE2' ' HE2' ' A' ' 94' ' ' TYR . 56.1 m-85 -133.97 163.26 29.93 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.679 1.192 . . . . 0.0 108.679 -176.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -140.15 62.89 1.49 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.095 0.474 . . . . 0.0 109.723 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.457 HG23 ' H ' ' A' ' 89' ' ' GLU . 7.6 t 149.76 133.75 0.0 OUTLIER 'General case' 0 C--N 1.362 1.151 0 C-N-CA 127.301 2.24 . . . . 0.0 106.969 -172.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.86 -29.46 68.31 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.698 0.799 . . . . 0.0 111.941 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -51.2 -46.57 51.23 Favored Glycine 0 C--N 1.353 1.477 0 O-C-N 123.872 0.732 . . . . 0.0 114.473 175.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.457 ' H ' HG23 ' A' ' 86' ' ' THR . 49.3 mm-40 -75.82 -29.85 58.81 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.637 0.375 . . . . 0.0 111.602 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.62 -63.29 1.1 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.438 0.695 . . . . 0.0 109.218 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.426 ' HA ' HD12 ' A' ' 105' ' ' LEU . 36.1 mm -60.28 -39.39 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.129 0.972 . . . . 0.0 111.177 178.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.84 -47.26 87.59 Favored Glycine 0 C--N 1.348 1.204 0 O-C-N 124.212 0.945 . . . . 0.0 113.753 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 34.8 tp -77.79 -43.36 30.89 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.58 0.352 . . . . 0.0 111.287 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.527 ' HB3' HD11 ' A' ' 101' ' ' LEU . 31.9 m-85 -80.74 -1.56 43.3 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -173.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.26 -8.87 56.52 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.174 0.511 . . . . 0.0 110.596 165.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.71 119.24 52.17 Favored Pre-proline 0 CA--C 1.56 1.346 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 175.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -72.69 -166.47 0.28 Allowed 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.128 2.552 . . . . 0.0 114.281 -171.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 56.98 44.56 22.69 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.921 1.288 . . . . 0.0 111.707 -175.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -131.95 8.46 4.44 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.114 -177.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 119.37 -19.6 9.86 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 112.214 -0.355 . . . . 0.0 112.214 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.527 HD11 ' HB3' ' A' ' 94' ' ' TYR . 64.8 mt -79.46 135.78 36.75 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.437 0.695 . . . . 0.0 111.869 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.2 m -59.74 -33.28 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.85 0.86 . . . . 0.0 110.617 171.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 54' ' ' TYR . 53.9 t -144.55 151.02 38.48 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.401 1.08 . . . . 0.0 109.224 175.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.43 153.28 44.06 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 91' ' ' ILE . 69.5 mt -69.59 95.72 0.87 Allowed 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 120.801 0.334 . . . . 0.0 110.176 -178.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.642 HD12 ' HA3' ' A' ' 34' ' ' GLY . 84.0 mt -100.67 -67.14 0.87 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.309 1.044 . . . . 0.0 110.938 -176.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.431 HD22 HG22 ' A' ' 109' ' ' VAL . 2.0 tt -106.37 113.75 62.93 Favored Pre-proline 0 N--CA 1.481 1.108 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -166.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.22 -37.05 76.97 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 123.496 2.797 . . . . 0.0 113.128 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.431 HG22 HD22 ' A' ' 107' ' ' LEU . 29.4 t . . . . . 0 C--O 1.257 1.464 0 C-N-CA 124.699 1.2 . . . . 0.0 110.252 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -117.78 76.9 0.29 Allowed Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.4 m170 -110.23 149.36 30.25 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.758 0.823 . . . . 0.0 110.527 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.7 p-80 -157.93 -73.47 0.09 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.828 0.851 . . . . 0.0 109.528 172.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 47.0 t60 39.89 78.8 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 125.637 1.575 . . . . 0.0 113.906 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -137.52 146.31 44.0 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.345 0.658 . . . . 0.0 109.803 176.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -105.48 62.79 0.68 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 172.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -92.13 143.72 26.16 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.567 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.3 t 69.49 121.19 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.961 1.304 . . . . 0.0 111.863 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 59.2 m80 -137.16 101.98 4.7 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.963 0.905 . . . . 0.0 108.715 174.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.2 ttt -74.4 95.02 2.64 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.0 t -169.59 163.18 10.15 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.936 0.894 . . . . 0.0 109.523 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -74.9 -27.18 60.12 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.45 168.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -77.42 121.16 23.42 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.07 0.462 . . . . 0.0 109.803 -174.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.423 ' O ' ' HA ' ' A' ' 39' ' ' ARG . 91.4 m-70 -138.86 131.71 29.32 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 175.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.2 mtm180 -63.59 139.92 58.82 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 168.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.404 ' H ' ' HB3' ' A' ' 40' ' ' ASP . 27.2 t70 -26.25 83.16 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 116.635 2.087 . . . . 0.0 116.635 -166.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 pp -66.17 -19.0 65.7 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.107 165.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.4 t 100.24 138.87 0.01 OUTLIER 'General case' 0 C--N 1.372 1.548 0 C-N-CA 127.489 2.315 . . . . 0.0 110.198 173.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -63.47 -45.02 92.69 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.655 0.782 . . . . 0.0 112.156 -176.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.17 -49.96 65.59 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.142 0.577 . . . . 0.0 110.67 173.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.83 -24.2 63.42 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.68 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.467 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -68.44 -58.47 4.29 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.814 0.845 . . . . 0.0 110.887 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.462 ' HG2' HG11 ' A' ' 58' ' ' VAL . 45.8 mt-10 -53.38 -38.25 63.18 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.02 0.928 . . . . 0.0 111.706 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -71.23 -44.9 64.44 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.078 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 33.4 tp -59.98 -43.42 95.15 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.061 0.944 . . . . 0.0 111.068 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 23' ' ' ALA . 94.6 mt -65.85 -49.88 66.59 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.523 0.729 . . . . 0.0 109.235 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.21 -34.24 73.38 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.066 0.946 . . . . 0.0 112.388 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -82.79 -50.49 8.61 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.244 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.48 -61.85 1.87 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.318 -171.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.82 -60.02 0.56 Allowed Glycine 0 C--N 1.352 1.467 0 CA-C-N 117.902 0.319 . . . . 0.0 113.548 -171.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 50.09 40.7 22.21 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.943 1.697 . . . . 0.0 113.817 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -170.31 83.83 0.11 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -171.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.81 22.9 78.29 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -177.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.2 m -87.0 119.82 27.61 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.017 0.927 . . . . 0.0 109.073 -171.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.498 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 19.2 p90 -131.89 158.56 41.04 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.011 0.434 . . . . 0.0 110.695 -175.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.467 HD11 ' HB1' ' A' ' 23' ' ' ALA . 4.1 pp -156.86 165.28 36.64 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.256 170.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.3 t -121.58 129.33 75.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 15' ' ' HIS . 3.7 ptm180 -125.57 163.36 22.9 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.252 1.021 . . . . 0.0 109.365 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.404 ' HB3' ' H ' ' A' ' 17' ' ' ASP . 23.1 t70 -91.78 120.07 32.17 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.3 m -91.43 100.88 13.57 Favored 'General case' 0 C--O 1.247 0.953 0 C-N-CA 122.759 0.424 . . . . 0.0 110.565 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -62.64 94.92 0.07 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.47 0.652 . . . . 0.0 110.394 163.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.3 t -151.85 -55.88 0.14 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.9 m -125.66 149.2 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 165.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 8.79 -80.0 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 127.249 2.22 . . . . 0.0 115.334 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.18 79.88 0.21 Allowed Glycine 0 C--N 1.351 1.382 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.31 165.95 14.64 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 171.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -117.22 163.73 15.86 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.104 0.561 . . . . 0.0 111.031 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.62 146.75 46.4 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.052 0.941 . . . . 0.0 110.252 168.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.51 HD22 HD21 ' A' ' 90' ' ' LEU . 46.3 tp -116.7 114.91 24.69 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 176.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 61.0 m -101.05 116.26 32.43 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.4 t -119.17 124.07 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.418 ' HB2' HG22 ' A' ' 58' ' ' VAL . 23.5 tp -119.54 145.16 46.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.021 0.928 . . . . 0.0 110.335 -177.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.416 ' H ' HD12 ' A' ' 53' ' ' LEU . 25.1 t80 -154.74 126.14 7.37 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 172.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 35.79 73.71 0.08 Allowed 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 78.6 tttt 52.26 35.85 18.02 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 125.086 1.355 . . . . 0.0 113.768 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -143.58 104.39 4.21 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 121.759 -0.588 . . . . 0.0 110.49 165.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.462 HG11 ' HG2' ' A' ' 24' ' ' GLU . 20.1 t -93.05 129.25 43.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 172.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -118.24 133.37 55.95 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 168.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.8 m -120.99 141.99 50.2 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -174.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -128.67 99.7 5.45 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -170.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -76.95 103.57 6.96 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.514 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.0 mp -67.87 108.19 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.228 172.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.3 tp -110.1 108.95 59.04 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -174.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.514 ' HB2' ' HG2' ' A' ' 68' ' ' GLU . 14.5 Cg_exo -69.88 -57.39 0.12 Allowed 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.555 2.17 . . . . 0.0 112.439 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.8 t70 80.49 -70.39 0.09 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.965 1.306 . . . . 0.0 109.406 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.37 -38.35 80.66 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 168.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.514 ' HG2' ' HB2' ' A' ' 65' ' ' PRO . 48.7 mt-10 84.14 24.66 0.11 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.283 1.433 . . . . 0.0 113.304 164.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -103.82 -37.42 7.45 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 164.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -116.49 134.73 54.52 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.106 0.962 . . . . 0.0 109.256 170.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -105.71 111.92 24.79 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.965 0.906 . . . . 0.0 109.005 175.661 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . . . -99.01 132.42 44.33 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.92 0.488 . . . . 0.0 110.988 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.514 HG21 ' HG ' ' A' ' 90' ' ' LEU . 11.2 t -87.24 118.27 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.163 176.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -81.31 92.09 6.32 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.0 m -72.23 -42.85 65.24 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.794 -175.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.503 ' HB3' HG22 ' A' ' 79' ' ' VAL . 48.1 t 173.98 141.94 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.385 1.474 . . . . 0.0 109.019 169.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -74.63 86.82 2.14 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 168.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.95 -22.85 0.31 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -167.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.503 HG22 ' HB3' ' A' ' 76' ' ' SER . 32.6 m -128.31 157.84 73.25 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 124.033 0.933 . . . . 0.0 109.066 175.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.71 126.62 21.64 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.268 2.645 . . . . 0.0 113.312 172.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 73' ' ' VAL . 54.6 t -101.52 134.76 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.169 1.387 . . . . 0.0 108.521 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -111.5 137.77 48.89 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.336 0.654 . . . . 0.0 110.901 -172.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 48.4 ptt85 -96.5 150.44 20.62 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.805 0.842 . . . . 0.0 108.856 173.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -138.72 164.57 29.22 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.499 0.72 . . . . 0.0 109.442 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -111.63 -13.43 13.78 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.187 0.595 . . . . 0.0 110.142 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.648 HG22 ' H ' ' A' ' 88' ' ' GLY . 59.6 m -148.7 147.1 28.49 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.511 0.724 . . . . 0.0 109.214 -174.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.33 -28.68 69.87 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.179 0.592 . . . . 0.0 111.178 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.648 ' H ' HG22 ' A' ' 86' ' ' THR . . . -63.0 -36.34 93.33 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 122.987 0.327 . . . . 0.0 113.138 173.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.47 ' HG2' ' HB ' ' A' ' 86' ' ' THR . 33.1 mm-40 -62.07 -47.03 86.47 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.691 0.797 . . . . 0.0 110.22 175.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.514 ' HG ' HG21 ' A' ' 73' ' ' VAL . 4.8 tt -50.48 -61.55 2.12 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.25 1.42 . . . . 0.0 109.932 173.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 47.1 mm -60.99 -27.48 41.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.448 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.09 -60.58 8.77 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 123.634 0.584 . . . . 0.0 113.48 175.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.1 mt -74.46 -32.7 62.69 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -82.19 -21.74 36.32 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.843 0.457 . . . . 0.0 112.176 -172.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.96 -17.28 63.11 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 168.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -132.45 69.3 79.94 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 124.651 1.18 . . . . 0.0 108.696 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.44 -81.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.233 1.955 . . . . 0.0 113.839 -168.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 90.08 -90.45 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.48 1.912 . . . . 0.0 106.821 -170.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -79.93 144.05 33.68 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 122.916 0.486 . . . . 0.0 111.912 170.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.82 -59.13 0.37 Allowed Glycine 0 C--N 1.35 1.315 0 C-N-CA 123.391 0.519 . . . . 0.0 113.176 166.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 24.7 mt -82.13 164.88 21.01 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.5 m -84.02 -24.37 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 CA-C-N 114.673 -1.148 . . . . 0.0 109.943 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 52.2 t -164.92 167.53 18.52 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 125.12 1.368 . . . . 0.0 108.745 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -77.36 170.68 16.12 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 120.93 0.395 . . . . 0.0 109.958 172.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.7 mt -81.53 97.46 7.83 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 175.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.9 mp -92.6 -57.93 2.52 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.017 0.927 . . . . 0.0 110.478 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 61.7 tp -131.09 107.06 14.96 Favored Pre-proline 0 N--CA 1.479 1.02 0 C-N-CA 123.379 0.671 . . . . 0.0 110.974 -165.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.99 124.12 10.3 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.368 2.045 . . . . 0.0 110.301 170.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 32.7 t . . . . . 0 CA--C 1.552 1.031 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -172.032 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.501 0.191 . . . . 0.0 110.65 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.09 70.74 1.12 Allowed Glycine 0 C--N 1.349 1.252 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.899 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -149.87 119.19 6.84 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.005 0.522 . . . . 0.0 109.77 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -158.7 113.6 2.54 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.098 0.559 . . . . 0.0 110.581 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -127.2 171.04 11.78 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.501 1.12 . . . . 0.0 108.907 166.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -164.1 102.1 0.87 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.309 0.643 . . . . 0.0 109.66 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -131.0 53.34 1.99 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.875 0.87 . . . . 0.0 108.729 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -86.22 -66.8 0.86 Allowed 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.862 -172.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 p -150.77 88.23 1.47 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.382 0.673 . . . . 0.0 110.762 -173.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 42.4 m170 -132.2 103.53 6.29 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.993 0.917 . . . . 0.0 109.971 177.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 56.9 ttp -120.65 -9.21 9.4 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.076 0.95 . . . . 0.0 109.461 170.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.9 p -72.47 166.3 22.88 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 123.474 0.709 . . . . 0.0 111.672 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.522 ' HB3' ' HB3' ' A' ' 108' ' ' PRO . 1.9 p-90 -86.3 10.4 14.93 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.889 0.876 . . . . 0.0 112.761 -176.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.421 ' HA ' ' HB ' ' A' ' 38' ' ' VAL . 17.8 t80 -118.03 134.82 54.62 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -174.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -137.18 171.89 13.82 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.739 0.816 . . . . 0.0 110.276 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.4 171.99 16.64 Favored 'General case' 0 C--O 1.245 0.817 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 164.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 74.55 3.95 4.35 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.677 1.191 . . . . 0.0 110.209 -172.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.3 tp -105.98 120.52 41.97 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 125.956 1.702 . . . . 0.0 107.999 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.4 m -82.49 170.15 15.57 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.524 0.73 . . . . 0.0 110.41 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.513 HH11 ' HG2' ' A' ' 24' ' ' GLU . 4.7 tmm_? -58.97 -55.88 29.48 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.408 0.683 . . . . 0.0 110.764 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.81 -44.01 73.43 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.121 0.888 . . . . 0.0 111.084 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.02 -36.06 82.77 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.521 0.729 . . . . 0.0 112.185 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.548 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -65.22 -56.5 12.46 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.824 0.85 . . . . 0.0 111.608 -176.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.513 ' HG2' HH11 ' A' ' 20' ' ' ARG . 0.0 OUTLIER -69.12 -24.64 64.13 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.879 -179.171 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 31.8 mt-10 -64.86 -55.66 18.11 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 169.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.12 -23.49 47.5 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.494 0.717 . . . . 0.0 112.828 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.9 mt -71.86 -52.79 15.63 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 168.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.98 -21.48 50.83 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -168.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 30.5 mmt180 -74.42 -42.25 59.49 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 118.246 0.475 . . . . 0.0 110.677 176.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.53 -53.45 4.8 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.945 -174.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.27 -159.59 8.41 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.974 -163.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 175.49 138.89 0.05 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.274 1.029 . . . . 0.0 110.493 -171.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.554 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 62.6 m-20 96.67 87.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.207 1.403 . . . . 0.0 109.184 159.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.24 16.7 73.55 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.708 -173.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 m -82.49 123.43 29.16 Favored 'General case' 0 C--N 1.346 0.456 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.448 ' CE1' ' HB3' ' A' ' 105' ' ' LEU . 30.9 p90 -131.7 159.22 39.02 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.41 0.624 . . . . 0.0 111.345 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.548 HD11 ' HB1' ' A' ' 23' ' ' ALA . 3.3 pp -150.63 159.99 44.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.165 165.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.421 ' HB ' ' HA ' ' A' ' 14' ' ' TYR . 46.9 t -116.75 150.54 18.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 175.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.501 HH22 ' HG2' ' A' ' 42' ' ' GLU . 20.6 ptt85 -146.59 -179.61 6.89 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -81.64 126.47 31.8 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 167.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 93.7 p -73.12 163.54 27.99 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.752 0.421 . . . . 0.0 110.703 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.501 ' HG2' HH22 ' A' ' 39' ' ' ARG . 10.8 pt-20 -124.61 -16.27 6.31 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.445 0.698 . . . . 0.0 110.6 -177.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.0 m -68.46 -30.17 68.97 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.884 0.874 . . . . 0.0 111.057 172.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.492 HG13 ' HB3' ' A' ' 47' ' ' ALA . 1.8 p -145.99 117.5 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 124.192 0.997 . . . . 0.0 109.683 -175.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.03 132.63 49.73 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.447 1.099 . . . . 0.0 112.056 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.84 11.94 80.66 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.347 0.404 . . . . 0.0 113.708 177.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.492 ' HB3' HG13 ' A' ' 44' ' ' VAL . . . -118.59 178.06 4.6 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.739 0.816 . . . . 0.0 111.717 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.474 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 32.9 m-85 -114.7 166.78 11.38 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.592 0.757 . . . . 0.0 111.286 -176.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.42 145.61 41.17 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.012 0.925 . . . . 0.0 110.233 169.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.491 ' HB2' HD11 ' A' ' 63' ' ' ILE . 51.7 tp -121.5 114.3 21.04 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.99 1.316 . . . . 0.0 108.33 -176.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 36.2 t -108.68 122.12 46.45 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.276 1.03 . . . . 0.0 108.62 -174.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.2 t -129.54 115.61 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 123.452 0.701 . . . . 0.0 110.366 -171.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.432 HD13 HG22 ' A' ' 58' ' ' VAL . 17.2 tp -94.83 136.89 34.6 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.564 1.146 . . . . 0.0 110.132 177.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 60.2 t80 -163.02 122.5 2.19 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.313 1.045 . . . . 0.0 109.206 175.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 40.58 61.12 1.71 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.327 1.851 . . . . 0.0 113.6 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 62.41 30.08 17.27 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.57 1.148 . . . . 0.0 113.042 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -138.33 106.88 5.85 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.236 0.614 . . . . 0.0 109.548 177.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.432 HG22 HD13 ' A' ' 53' ' ' LEU . 18.3 t -101.66 114.64 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -105.79 126.3 52.01 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.0 m -113.02 136.02 53.15 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -127.99 110.35 12.44 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.874 0.87 . . . . 0.0 109.107 -171.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.508 ' HD2' ' H ' ' A' ' 62' ' ' ARG . 0.1 OUTLIER -59.55 157.0 12.27 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 169.446 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.491 HD11 ' HB2' ' A' ' 50' ' ' LEU . 90.7 mt -146.19 102.66 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 103.686 -2.709 . . . . 0.0 103.686 -162.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.7 mp -114.97 140.65 25.81 Favored Pre-proline 0 N--CA 1.475 0.804 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -166.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 33.6 Cg_exo -58.58 -70.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 121.915 1.743 . . . . 0.0 109.274 164.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.0 t70 58.53 15.94 3.91 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.133 1.373 . . . . 0.0 112.639 167.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.38 137.38 3.77 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -34.08 -45.76 0.22 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 -165.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -113.21 -16.25 12.59 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -164.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.414 ' HB2' ' HB2' ' A' ' 83' ' ' ARG . 44.4 p90 -125.98 160.88 28.85 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.967 -0.458 . . . . 0.0 111.74 -167.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 3.9 pp -121.73 118.36 28.9 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.525 1.53 . . . . 0.0 107.144 166.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -111.95 148.48 33.65 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.735 0.779 . . . . 0.0 110.011 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.8 t -122.85 131.32 73.48 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -78.65 94.55 5.07 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.471 HG22 ' HA3' ' A' ' 100' ' ' GLY . 2.0 m -70.78 -63.06 1.17 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.059 -176.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.459 ' HB2' HG22 ' A' ' 79' ' ' VAL . 73.5 m -163.19 113.66 1.39 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.248 1.419 . . . . 0.0 107.62 170.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -68.62 97.41 0.79 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 170.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.16 -22.7 0.87 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -163.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.459 HG22 ' HB2' ' A' ' 76' ' ' SER . 22.5 m -129.84 153.21 80.87 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 125.375 1.47 . . . . 0.0 107.075 170.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -54.47 124.69 16.73 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.386 2.057 . . . . 0.0 112.8 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.6 t -86.09 140.32 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -102.11 136.21 42.35 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.031 0.533 . . . . 0.0 109.908 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.414 ' HB2' ' HB2' ' A' ' 70' ' ' PHE . 14.6 ptp180 -87.35 138.76 31.21 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 163.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -119.7 143.25 47.86 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.747 0.819 . . . . 0.0 109.277 176.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -84.66 -22.24 29.93 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.091 0.472 . . . . 0.0 110.43 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.677 ' HB ' ' HG2' ' A' ' 89' ' ' GLU . 51.0 m -141.79 149.01 39.83 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.74 0.816 . . . . 0.0 109.767 -177.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.24 -30.73 71.64 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.596 0.759 . . . . 0.0 109.525 176.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.66 ' H ' HG22 ' A' ' 86' ' ' THR . . . -53.92 -41.79 68.57 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-N 116.099 -0.501 . . . . 0.0 113.582 169.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.677 ' HG2' ' HB ' ' A' ' 86' ' ' THR . 31.0 mm-40 -71.45 -32.23 68.09 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.273 0.629 . . . . 0.0 110.7 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 46.5 tp -59.04 -59.25 5.77 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.318 0.647 . . . . 0.0 111.011 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 51.6 mm -62.25 -37.16 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.999 0.919 . . . . 0.0 111.004 -176.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.13 -51.73 53.91 Favored Glycine 0 CA--C 1.535 1.331 0 O-C-N 124.153 0.908 . . . . 0.0 113.292 174.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.0 mt -78.99 -23.17 44.6 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.091 0.556 . . . . 0.0 112.216 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -83.33 -18.31 39.39 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.03 -35.15 76.29 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.527 0.331 . . . . 0.0 110.539 170.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -127.0 76.42 76.0 Favored Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 124.371 1.068 . . . . 0.0 108.602 175.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -92.49 -66.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 123.363 2.708 . . . . 0.0 114.421 -169.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 59.66 55.84 3.85 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 124.845 1.258 . . . . 0.0 111.266 -173.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 160.45 97.87 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 126.734 2.014 . . . . 0.0 109.706 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.471 ' HA3' HG22 ' A' ' 75' ' ' THR . . . 104.33 -37.35 3.82 Favored Glycine 0 C--N 1.355 1.617 0 N-CA-C 113.758 0.263 . . . . 0.0 113.758 164.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -76.52 122.45 24.59 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.841 0.456 . . . . 0.0 110.829 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.2 m -52.73 -32.45 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 125.544 1.537 . . . . 0.0 114.19 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 36.4 t -153.54 3.31 0.28 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.108 0.563 . . . . 0.0 111.19 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 76.04 177.37 0.19 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.902 1.281 . . . . 0.0 110.669 -167.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.448 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 26.7 mt -93.05 103.39 15.7 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.51 -53.35 6.04 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.562 0.745 . . . . 0.0 111.03 -176.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.22 137.32 9.86 Favored Pre-proline 0 N--CA 1.483 1.222 0 C-N-CA 122.167 0.187 . . . . 0.0 111.199 -175.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.522 ' HB3' ' HB3' ' A' ' 13' ' ' TRP . 97.1 Cg_endo -78.79 137.08 13.9 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.333 2.022 . . . . 0.0 111.875 171.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 57.0 t . . . . . 0 CA--C 1.547 0.857 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.293 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 87.25 129.79 2.9 Favored Glycine 0 C--N 1.349 1.259 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -173.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -74.22 -25.43 59.66 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.82 0.448 . . . . 0.0 110.443 177.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 43.1 t60 63.81 15.83 9.35 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 125.299 1.44 . . . . 0.0 112.182 172.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -107.31 27.18 9.33 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -66.52 112.21 3.99 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 124.155 0.982 . . . . 0.0 110.504 -174.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -136.29 64.4 1.56 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.136 0.974 . . . . 0.0 108.445 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -141.81 119.06 11.42 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.762 0.825 . . . . 0.0 110.239 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 75.6 p -134.53 -14.84 2.18 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.342 1.057 . . . . 0.0 111.164 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.3 m170 65.6 107.68 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.487 1.515 . . . . 0.0 111.721 -176.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 43.2 ttm -95.54 21.65 8.0 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.793 0.806 . . . . 0.0 110.631 -177.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.6 p -75.14 -165.88 0.44 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 163.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -84.77 0.87 49.11 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.056 -1.027 . . . . 0.0 110.435 171.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -110.91 111.53 22.73 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -119.03 115.0 23.39 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 176.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -39.71 -49.31 2.26 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 125.565 1.546 . . . . 0.0 113.722 -172.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -156.96 70.55 0.64 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-O 122.312 1.053 . . . . 0.0 108.578 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 21.9 tp -64.77 -32.18 73.74 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 113.658 -1.61 . . . . 0.0 109.464 165.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.0 t 88.31 141.82 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 126.014 1.726 . . . . 0.0 107.944 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -60.83 -43.02 98.84 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.213 0.605 . . . . 0.0 112.079 -168.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.83 -48.01 73.09 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.507 0.723 . . . . 0.0 111.72 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -72.44 -22.58 61.07 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.316 178.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.476 ' O ' ' HG ' ' A' ' 27' ' ' LEU . . . -67.67 -49.83 60.87 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.594 ' HG3' HG21 ' A' ' 58' ' ' VAL . 34.8 tt0 -54.53 -41.24 69.48 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 124.885 1.366 . . . . 0.0 111.296 175.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.0 -50.6 47.39 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.437 -177.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.84 -33.98 73.87 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.091 0.957 . . . . 0.0 111.881 176.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 23' ' ' ALA . 75.4 mt -64.73 -52.84 54.94 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.1 0.56 . . . . 0.0 109.683 175.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.29 -42.47 98.71 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.17 0.988 . . . . 0.0 111.947 -176.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -69.33 -41.33 76.82 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.888 -175.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.35 -62.82 1.39 Allowed 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.02 -38.46 2.89 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 113.886 0.314 . . . . 0.0 113.886 -166.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.84 12.76 0.12 Allowed 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 128.011 2.524 . . . . 0.0 116.28 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 4.5 m-20 -174.37 118.51 0.23 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -166.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.429 ' HA2' ' SG ' ' A' ' 103' ' ' CYS . . . 63.16 11.02 37.01 Favored Glycine 0 C--N 1.352 1.44 0 N-CA-C 113.906 0.322 . . . . 0.0 113.906 -177.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.9 m -83.69 123.68 30.07 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.142 0.977 . . . . 0.0 110.039 -168.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -135.73 156.38 48.92 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 120.767 0.318 . . . . 0.0 111.439 -176.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.432 HD11 ' HB1' ' A' ' 23' ' ' ALA . 4.4 pp -159.9 158.74 31.41 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 124.709 1.255 . . . . 0.0 109.673 169.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.44 HG22 HD13 ' A' ' 50' ' ' LEU . 21.9 t -114.05 150.65 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.451 HH22 ' HB2' ' A' ' 42' ' ' GLU . 1.7 ptm180 -148.0 177.13 9.61 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.264 1.025 . . . . 0.0 109.207 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -84.4 129.28 34.88 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.3 t -61.18 142.38 56.79 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.48 0.712 . . . . 0.0 112.108 -174.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.451 ' HB2' HH22 ' A' ' 39' ' ' ARG . 32.2 tt0 -107.03 0.24 23.48 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.984 178.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.2 t -104.97 -41.72 5.52 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.207 1.003 . . . . 0.0 110.069 -177.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.5 HG21 HD21 ' A' ' 64' ' ' LEU . 44.7 t -128.11 115.18 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.902 0.881 . . . . 0.0 109.528 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.22 124.63 24.6 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.929 0.891 . . . . 0.0 110.817 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.36 12.06 65.75 Favored Glycine 0 C--N 1.344 0.979 0 O-C-N 123.345 0.403 . . . . 0.0 112.746 -174.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.32 177.0 5.07 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.794 0.838 . . . . 0.0 111.168 172.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.422 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 70.4 m-85 -124.21 166.83 15.16 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.832 1.253 . . . . 0.0 110.254 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.9 147.79 48.31 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.358 1.063 . . . . 0.0 109.526 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.561 ' HB2' HD11 ' A' ' 63' ' ' ILE . 50.2 tp -123.99 123.92 41.45 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.062 1.345 . . . . 0.0 107.51 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 37.1 t -112.29 123.85 51.17 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.9 t -128.73 143.7 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.545 HD13 HG22 ' A' ' 58' ' ' VAL . 48.9 tp -130.3 144.71 51.54 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.113 0.965 . . . . 0.0 108.942 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 84.6 t80 -164.28 122.77 1.83 Allowed 'General case' 0 CA--C 1.537 0.479 0 O-C-N 124.318 1.011 . . . . 0.0 109.005 178.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 17.3 tm0? 41.74 70.07 0.3 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 125.404 1.482 . . . . 0.0 111.561 -177.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt 48.67 25.23 0.93 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 125.586 1.555 . . . . 0.0 114.288 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -131.32 117.36 18.82 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.355 0.662 . . . . 0.0 109.299 -178.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.594 HG21 ' HG3' ' A' ' 24' ' ' GLU . 34.1 t -99.53 144.94 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.507 1.123 . . . . 0.0 109.623 -177.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -137.34 119.26 15.28 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 174.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 33.4 m -105.92 114.1 28.04 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -95.65 117.68 30.93 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -177.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 65.6 mtm-85 -62.25 158.37 17.32 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 170.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.561 HD11 ' HB2' ' A' ' 50' ' ' LEU . 76.2 mt -145.32 98.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 102.808 -3.034 . . . . 0.0 102.808 -175.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.5 HD21 HG21 ' A' ' 44' ' ' VAL . 10.6 mp -122.14 148.62 52.38 Favored Pre-proline 0 N--CA 1.477 0.923 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -172.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 70' ' ' PHE . 87.8 Cg_exo -44.29 -59.66 1.03 Allowed 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.53 2.153 . . . . 0.0 111.845 172.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.2 t70 47.33 71.5 0.32 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.857 1.263 . . . . 0.0 111.87 174.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.65 -75.95 0.24 Allowed Glycine 0 C--N 1.337 0.631 0 CA-C-O 119.459 -0.634 . . . . 0.0 111.626 -176.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 169.29 -40.44 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.051 1.34 . . . . 0.0 111.405 -175.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -131.35 -13.43 3.43 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -161.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 97.8 m-85 -117.91 163.81 15.99 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.425 1.09 . . . . 0.0 110.443 -167.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.1 mp -104.54 109.34 21.19 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 171.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.43 126.05 42.45 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.192 0.997 . . . . 0.0 109.57 -175.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.5 t -96.09 133.27 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -178.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -94.52 89.32 5.77 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -175.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.469 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 21.2 p -71.04 -66.59 0.59 Allowed 'General case' 0 C--O 1.248 1.006 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.325 175.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.3 t 176.39 174.67 0.34 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.089 1.355 . . . . 0.0 109.945 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -68.01 160.7 28.22 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 123.786 0.834 . . . . 0.0 109.185 167.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.51 -72.54 2.16 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-N 118.451 0.569 . . . . 0.0 112.99 -170.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.1 m -65.6 145.94 99.01 Favored Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 123.662 0.785 . . . . 0.0 110.538 176.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.79 137.56 27.36 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.482 2.121 . . . . 0.0 113.483 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.4 t -69.58 118.12 13.42 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 167.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -98.62 117.38 32.93 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.508 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -100.69 149.99 23.21 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.714 0.806 . . . . 0.0 110.271 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -134.29 162.29 32.59 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.42 0.688 . . . . 0.0 112.399 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -74.08 -46.5 42.62 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.511 170.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 37.9 p -138.34 169.12 18.35 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.618 0.767 . . . . 0.0 110.999 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.482 ' O ' HG12 ' A' ' 91' ' ' ILE . 4.3 mm? -62.21 -34.42 76.44 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.584 0.754 . . . . 0.0 111.058 171.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -53.86 -43.89 70.92 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 122.975 0.172 . . . . 0.0 113.029 175.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -66.38 -36.15 82.13 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.252 0.621 . . . . 0.0 110.611 175.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.424 HD13 HD13 ' A' ' 87' ' ' LEU . 7.8 tt -64.7 -38.6 91.54 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.342 1.057 . . . . 0.0 110.828 -178.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 87' ' ' LEU . 50.3 mm -85.04 -35.54 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -168.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.3 -44.93 32.61 Favored Glycine 0 C--N 1.35 1.331 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.877 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.1 tp -76.11 -32.73 59.32 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.712 0.405 . . . . 0.0 111.239 -178.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.616 ' HB3' ' HG ' ' A' ' 105' ' ' LEU . 3.9 m-30 -78.12 -16.46 57.95 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.757 174.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.42 -2.16 10.33 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.136 0.574 . . . . 0.0 112.102 171.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -128.37 152.14 77.65 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 169.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -28.93 103.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 124.819 3.679 . . . . 0.0 114.967 165.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.512 ' HB3' HD23 ' A' ' 101' ' ' LEU . 8.3 t30 -106.28 -44.7 4.48 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.533 -177.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 107.93 115.78 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 128.184 2.594 . . . . 0.0 108.644 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.469 ' HA3' ' HB ' ' A' ' 75' ' ' THR . . . 110.04 -13.28 31.61 Favored Glycine 0 C--N 1.345 1.04 0 O-C-N 123.747 0.654 . . . . 0.0 112.266 -175.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.512 HD23 ' HB3' ' A' ' 98' ' ' ASN . 3.9 mm? -84.36 138.72 32.72 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.183 0.993 . . . . 0.0 111.699 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.1 p -60.68 -35.64 65.27 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 C-N-CA 124.425 1.09 . . . . 0.0 112.421 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.429 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 29.0 p -163.98 13.62 0.05 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.377 0.671 . . . . 0.0 111.455 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.443 ' H ' ' HB3' ' A' ' 101' ' ' LEU . . . 74.15 176.96 0.24 Allowed 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 124.814 1.246 . . . . 0.0 109.771 -167.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.616 ' HG ' ' HB3' ' A' ' 94' ' ' TYR . 26.6 mt -92.88 113.87 26.27 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.412 ' HB3' ' HA3' ' A' ' 34' ' ' GLY . 56.1 tp -108.01 -63.32 1.33 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.513 0.725 . . . . 0.0 111.868 -173.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.459 HD22 HG22 ' A' ' 109' ' ' VAL . 5.0 tt -116.58 103.73 52.29 Favored Pre-proline 0 N--CA 1.479 0.999 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -170.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -73.74 119.24 5.8 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.56 2.173 . . . . 0.0 111.158 173.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.459 HG22 HD22 ' A' ' 107' ' ' LEU . 21.1 t . . . . . 0 CA--C 1.553 1.069 0 CA-C-O 118.038 -0.982 . . . . 0.0 108.371 -175.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -169.08 62.91 0.19 Allowed Glycine 0 C--N 1.344 1.025 0 N-CA-C 111.953 -0.459 . . . . 0.0 111.953 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -88.3 94.81 9.96 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 172.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 -70.83 117.7 12.67 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.779 0.832 . . . . 0.0 110.205 -176.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -136.98 46.05 2.21 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.71 0.804 . . . . 0.0 109.556 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -75.98 75.04 2.88 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 172.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -151.19 34.36 0.58 Allowed 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 122.594 1.188 . . . . 0.0 108.694 -172.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -80.62 84.41 6.2 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.359 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.1 m -139.93 88.41 2.23 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.482 0.713 . . . . 0.0 109.577 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -171.42 152.46 3.28 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.884 1.273 . . . . 0.0 108.445 175.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.408 ' SD ' ' N ' ' A' ' 11' ' ' MET . 1.5 mpt? -70.8 83.18 0.64 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.871 0.843 . . . . 0.0 110.32 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.1 t -95.36 99.56 11.46 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.581 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -83.37 -29.1 28.47 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 172.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -74.67 122.75 23.69 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -138.41 93.36 2.73 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.371 0.669 . . . . 0.0 109.394 176.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -62.84 148.98 45.48 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 157.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.6 t70 81.41 -11.47 1.08 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.357 1.063 . . . . 0.0 111.736 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 tp -90.73 122.57 33.6 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.6 m -83.44 158.01 22.24 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.898 0.479 . . . . 0.0 109.851 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -62.58 -47.02 85.63 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -171.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.37 -45.32 80.58 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.416 0.686 . . . . 0.0 111.347 177.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.81 -34.39 76.66 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.86 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.594 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -66.23 -55.71 14.87 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.76 0.824 . . . . 0.0 111.422 -177.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.501 ' HG2' ' SG ' ' A' ' 51' ' ' CYS . 25.2 mt-10 -64.67 -28.77 69.83 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.521 1.128 . . . . 0.0 111.443 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -62.28 -50.99 69.51 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.462 0.705 . . . . 0.0 109.416 173.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.6 mt -66.77 -28.35 68.33 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.163 0.985 . . . . 0.0 112.077 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.503 HD21 ' HG ' ' A' ' 37' ' ' LEU . 75.0 mt -68.04 -45.01 75.15 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 118.058 0.39 . . . . 0.0 110.176 173.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.2 -26.78 63.09 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.653 0.781 . . . . 0.0 111.22 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -85.97 -60.54 1.98 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.369 0.668 . . . . 0.0 111.484 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.23 -54.92 5.49 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.626 0.771 . . . . 0.0 112.354 -166.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.595 ' HA3' ' HB3' ' A' ' 35' ' ' SER . . . -87.5 -34.1 10.78 Favored Glycine 0 N--CA 1.471 0.967 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 60.25 4.04 0.61 Allowed 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 126.445 1.898 . . . . 0.0 114.827 174.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.3 t70 164.52 133.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.09 1.356 . . . . 0.0 107.788 -171.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.61 -2.27 54.46 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 117.89 0.314 . . . . 0.0 113.579 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.595 ' HB3' ' HA3' ' A' ' 31' ' ' GLY . 1.9 p -82.54 130.37 35.1 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.406 1.082 . . . . 0.0 111.967 -169.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.411 ' CE1' ' HB3' ' A' ' 105' ' ' LEU . 46.2 p90 -127.33 151.93 48.12 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.031 0.532 . . . . 0.0 110.083 174.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.594 HD11 ' HB1' ' A' ' 23' ' ' ALA . 2.3 pp -144.9 160.89 40.59 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.718 0.807 . . . . 0.0 109.013 166.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.447 HG21 HD11 ' A' ' 87' ' ' LEU . 22.6 t -112.78 153.99 14.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.416 HH22 HG21 ' A' ' 60' ' ' THR . 30.1 mtm180 -139.99 170.43 15.87 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.075 0.95 . . . . 0.0 109.661 -176.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -87.78 134.54 33.66 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.296 168.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.5 m -62.96 135.45 57.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.911 0.386 . . . . 0.0 111.143 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -102.27 14.88 30.77 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.207 1.003 . . . . 0.0 111.286 -172.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.0 t -147.33 -62.28 0.28 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.374 0.669 . . . . 0.0 109.898 -177.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.9 m -89.32 125.39 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -171.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 24.78 -133.88 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 127.585 2.354 . . . . 0.0 116.466 171.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.45 57.63 0.44 Allowed Glycine 0 C--N 1.358 1.772 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.42 174.15 6.0 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.63 0.772 . . . . 0.0 111.107 -173.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.55 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 81.0 m-85 -114.82 158.73 21.5 Favored 'General case' 0 C--O 1.25 1.083 0 C-N-CA 123.905 0.882 . . . . 0.0 109.827 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.24 141.21 52.23 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.535 1.134 . . . . 0.0 109.214 173.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.573 HD22 HD21 ' A' ' 90' ' ' LEU . 58.9 tp -123.32 115.75 22.19 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.501 ' SG ' ' HG2' ' A' ' 24' ' ' GLU . 45.9 t -114.19 119.08 35.85 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -176.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 5.1 t -127.77 140.56 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.218 0.607 . . . . 0.0 109.4 -170.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.8 tp -122.92 138.47 54.66 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.722 1.209 . . . . 0.0 109.035 -177.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -169.32 136.63 1.78 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.002 0.921 . . . . 0.0 109.622 172.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 47.35 42.49 14.02 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.819 1.248 . . . . 0.0 112.096 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 56.62 45.47 22.09 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.739 1.216 . . . . 0.0 112.641 -173.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -129.6 103.85 7.11 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 171.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 61.6 t -97.65 105.45 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 170.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -112.78 134.12 54.45 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.416 HG21 HH22 ' A' ' 39' ' ' ARG . 55.5 m -117.8 142.34 47.4 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.412 0.685 . . . . 0.0 109.453 -175.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -124.74 154.85 40.24 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.54 1.136 . . . . 0.0 108.26 -177.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -102.39 160.98 14.07 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 166.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.658 HG12 HD11 ' A' ' 90' ' ' LEU . 3.7 mp -144.59 101.24 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 103.122 -2.918 . . . . 0.0 103.122 -163.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.1 mp -103.4 137.67 19.32 Favored Pre-proline 0 N--CA 1.481 1.119 0 CA-C-O 119.421 -0.323 . . . . 0.0 110.943 -163.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.63 -138.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 123.452 2.768 . . . . 0.0 111.081 175.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 68' ' ' GLU . 7.1 t70 169.47 -178.09 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 122.97 0.508 . . . . 0.0 110.323 -166.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -88.33 5.35 84.85 Favored Glycine 0 N--CA 1.491 2.342 0 CA-C-O 121.642 0.579 . . . . 0.0 112.337 167.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 66' ' ' ASP . 35.4 mt-10 -142.13 106.28 4.77 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 102.48 -3.156 . . . . 0.0 102.48 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -74.5 88.4 2.13 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 119.591 1.087 . . . . 0.0 111.287 -151.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.488 ' HB3' ' HB3' ' A' ' 83' ' ' ARG . 50.3 m-85 -116.24 138.27 51.44 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 124.398 1.079 . . . . 0.0 108.839 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 84' ' ' PHE . 8.7 mp -96.01 107.32 19.6 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 174.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -104.87 112.38 25.48 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.929 0.892 . . . . 0.0 110.013 -171.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.48 HG22 HG13 ' A' ' 63' ' ' ILE . 12.1 t -101.8 144.59 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.669 -175.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.2 86.9 2.51 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.452 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 4.3 p -80.86 -53.0 6.85 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.676 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.5 m -126.61 169.11 13.44 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.641 0.776 . . . . 0.0 110.536 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -88.11 -3.43 58.89 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.592 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -147.4 39.29 1.05 Allowed Glycine 0 C--N 1.35 1.306 0 CA-C-N 117.93 0.332 . . . . 0.0 113.086 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 m -120.34 151.18 53.17 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 123.73 0.812 . . . . 0.0 108.82 171.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.2 126.49 18.74 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 121.791 1.661 . . . . 0.0 110.557 170.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.6 t -68.95 127.45 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -177.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -98.48 117.97 34.11 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -171.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.488 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 88.3 mtm180 -99.0 126.73 44.77 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.036 0.934 . . . . 0.0 110.187 -173.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.519 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 71.1 m-85 -110.03 147.56 33.32 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.391 0.676 . . . . 0.0 111.781 -175.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -72.01 -38.59 69.58 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.263 0.625 . . . . 0.0 110.34 173.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.4 HG22 ' HG2' ' A' ' 89' ' ' GLU . 8.1 t -146.29 169.5 18.68 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.621 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.447 HD11 HG21 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -62.69 -29.65 70.81 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.937 174.182 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -55.22 -41.37 78.75 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 116.512 -0.313 . . . . 0.0 113.579 171.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 84' ' ' PHE . 53.3 mm-40 -67.9 -39.67 83.59 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.494 0.717 . . . . 0.0 110.644 176.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.658 HD11 HG12 ' A' ' 63' ' ' ILE . 7.1 tt -57.7 -54.96 40.99 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.334 -178.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 40.9 mm -66.26 -34.15 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.297 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.03 -56.92 22.48 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.636 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.36 -40.09 74.24 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.134 0.574 . . . . 0.0 111.016 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.666 ' HA ' HE22 ' A' ' 99' ' ' GLN . 6.5 m-30 -78.21 -7.25 56.88 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -173.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.03 -13.72 58.62 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 122.472 0.309 . . . . 0.0 111.584 164.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -92.25 137.54 24.77 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 124.477 1.111 . . . . 0.0 109.771 173.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.87 175.17 11.72 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.925 2.416 . . . . 0.0 113.917 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.4 t30 58.88 73.06 0.5 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.253 1.421 . . . . 0.0 112.228 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.666 HE22 ' HA ' ' A' ' 94' ' ' TYR . 48.1 mt-30 -142.4 -13.06 0.8 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.337 1.055 . . . . 0.0 111.029 174.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.452 ' HA3' ' HB ' ' A' ' 75' ' ' THR . . . 122.27 -2.63 10.52 Favored Glycine 0 N--CA 1.48 1.629 0 C-N-CA 123.694 0.664 . . . . 0.0 112.005 -169.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 88.5 mt -74.66 168.29 20.11 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.787 1.235 . . . . 0.0 111.114 176.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.5 m -67.26 -47.92 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.412 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.872 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 49.0 t -173.73 40.05 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.348 1.059 . . . . 0.0 109.63 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 78.37 -177.8 0.1 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.088 1.355 . . . . 0.0 111.346 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.411 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 21.9 mt -105.53 99.56 9.16 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 175.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 106' ' ' LEU . 0.8 OUTLIER -112.01 -48.79 3.02 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.907 0.883 . . . . 0.0 111.326 -171.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 35' ' ' SER . 10.5 mp -112.43 124.12 32.66 Favored Pre-proline 0 N--CA 1.484 1.247 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.49 -87.14 0.0 OUTLIER 'Trans proline' 0 CA--C 1.556 1.59 0 C-N-CA 121.203 1.268 . . . . 0.0 110.088 167.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 t . . . . . 0 C--O 1.25 1.128 0 C-N-CA 124.576 1.15 . . . . 0.0 108.137 177.782 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -140.52 142.47 12.41 Favored Glycine 0 C--N 1.343 0.917 0 N-CA-C 112.705 -0.158 . . . . 0.0 112.705 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -85.52 -157.63 0.33 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.377 1.071 . . . . 0.0 109.14 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -74.93 127.06 32.33 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 165.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -156.36 133.31 10.44 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.348 0.659 . . . . 0.0 109.848 -177.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -147.11 174.41 11.6 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.611 1.164 . . . . 0.0 108.911 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -156.58 86.69 1.0 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -83.94 94.8 8.34 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.143 0.577 . . . . 0.0 109.697 174.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.8 p -126.69 89.78 3.05 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.349 1.06 . . . . 0.0 109.383 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.97 140.07 48.96 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.05 176.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.6 ttt -78.28 -29.12 47.75 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.114 0.483 . . . . 0.0 110.318 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.3 m -155.82 173.45 16.74 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.388 1.075 . . . . 0.0 109.993 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 23.5 p-90 -93.27 -23.49 18.49 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 166.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 83.7 t80 -73.0 106.94 5.09 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 167.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -104.27 117.94 35.43 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -63.33 -46.3 87.27 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.946 0.899 . . . . 0.0 111.182 -170.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -114.47 81.7 1.59 Allowed 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.311 0.576 . . . . 0.0 109.585 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.7 tp -133.58 133.32 41.91 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.545 0.738 . . . . 0.0 110.376 176.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.6 m -99.17 170.28 8.8 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.673 0.789 . . . . 0.0 110.092 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.442 ' HG3' HG21 ' A' ' 60' ' ' THR . 38.8 ttt180 -62.1 -57.7 10.58 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -171.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.43 -42.96 78.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.149 0.58 . . . . 0.0 111.231 -178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.33 -30.71 70.61 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.172 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.26 -50.2 49.21 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.521 0.729 . . . . 0.0 111.356 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.489 ' HA ' HD12 ' A' ' 27' ' ' LEU . 10.2 pt-20 -69.68 -22.2 63.45 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.985 178.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -68.33 -49.59 59.31 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 167.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.405 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 43.7 mt -59.58 -30.11 68.42 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.752 0.421 . . . . 0.0 111.627 174.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 24' ' ' GLU . 48.1 mt -67.49 -47.07 71.09 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.49 0.316 . . . . 0.0 110.238 172.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.72 -42.71 97.89 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.4 0.68 . . . . 0.0 111.817 -173.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -87.0 -53.14 5.04 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.639 0.376 . . . . 0.0 110.643 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -78.29 -60.4 2.39 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 117.745 0.248 . . . . 0.0 111.127 -175.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.84 126.41 34.5 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-O 121.293 0.385 . . . . 0.0 114.029 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 71.2 mtp85 -79.47 -41.49 27.4 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.449 1.1 . . . . 0.0 113.159 -177.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 170.14 132.95 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.773 1.229 . . . . 0.0 107.988 -169.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.576 ' HA2' ' SG ' ' A' ' 103' ' ' CYS . . . 68.33 24.05 74.93 Favored Glycine 0 N--CA 1.479 1.519 0 CA-C-N 118.259 0.481 . . . . 0.0 111.929 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 7.6 m -88.73 145.77 25.43 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 124.141 0.976 . . . . 0.0 110.472 -171.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -142.05 151.6 42.56 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.197 0.599 . . . . 0.0 109.919 -176.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.492 HD23 HG21 ' A' ' 109' ' ' VAL . 4.6 pp -140.79 154.18 46.14 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.38 169.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 71.5 t -121.61 146.96 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 170.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 48.6 ptt85 -160.74 -170.25 2.68 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.801 1.24 . . . . 0.0 108.324 -173.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.71 144.25 25.93 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.572 0.749 . . . . 0.0 109.203 169.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.43 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . 35.6 t -70.41 160.84 31.6 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.972 0.909 . . . . 0.0 109.514 164.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -108.36 -14.57 14.65 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.8 m -81.11 -68.65 0.67 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.52 0.728 . . . . 0.0 109.975 -177.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.0 t -91.33 118.43 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.436 0.694 . . . . 0.0 109.444 -174.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 7.24 -82.17 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 127.791 2.436 . . . . 0.0 115.866 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.44 64.12 0.58 Allowed Glycine 0 C--N 1.346 1.12 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 174.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 41' ' ' SER . . . -90.11 164.41 14.48 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.935 0.494 . . . . 0.0 110.234 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.518 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 20.9 m-85 -104.16 122.19 44.83 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.027 0.931 . . . . 0.0 109.127 -177.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -108.23 130.74 55.14 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.445 0.698 . . . . 0.0 109.533 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.7 tp -117.79 108.13 14.99 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.495 ' SG ' HG22 ' A' ' 60' ' ' THR . 56.3 m -106.52 123.59 48.32 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -176.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 35' ' ' SER . 58.4 t -130.09 128.16 64.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 124.022 0.929 . . . . 0.0 109.596 -172.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 56.7 tp -108.29 143.45 37.12 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.28 1.032 . . . . 0.0 109.615 175.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -163.52 112.37 1.25 Allowed 'General case' 0 CA--C 1.543 0.689 0 O-C-N 123.839 0.712 . . . . 0.0 109.25 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 50.76 57.71 6.34 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.954 1.301 . . . . 0.0 113.018 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.7 tttm 52.6 28.03 5.71 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.925 1.29 . . . . 0.0 112.662 -175.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -106.6 104.13 13.74 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 173.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.0 t -86.19 128.71 39.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 173.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -140.07 134.69 31.71 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.495 HG22 ' SG ' ' A' ' 51' ' ' CYS . 37.7 p -112.62 135.9 52.81 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 173.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -114.1 99.93 8.0 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -82.16 97.73 8.35 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.518 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 63.4 mt -71.53 120.67 20.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.778 163.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.4 mp -101.78 126.87 32.65 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 172.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 11.6 Cg_endo -56.11 -62.59 0.23 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.146 1.897 . . . . 0.0 111.042 177.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.4 t70 105.64 -82.16 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.856 1.663 . . . . 0.0 107.733 161.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -88.93 25.82 9.34 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-O 119.171 -0.794 . . . . 0.0 113.579 174.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 59.9 -3.72 0.11 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 175.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -101.81 -44.04 5.65 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.524 0.73 . . . . 0.0 110.941 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -111.54 158.81 18.76 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.639 1.176 . . . . 0.0 109.104 -174.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 4.4 pp -110.49 112.97 25.24 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 165.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.14 125.14 49.71 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.977 0.511 . . . . 0.0 110.943 -176.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 81' ' ' VAL . 22.9 t -85.73 130.91 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.316 -175.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -96.79 93.02 6.44 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.3 p -81.93 -66.33 0.9 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 174.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.541 ' HB2' HG22 ' A' ' 79' ' ' VAL . 50.4 m -162.66 134.4 5.24 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.333 1.053 . . . . 0.0 109.884 172.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -71.65 99.31 2.08 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 164.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.44 -28.91 1.49 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -164.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.541 HG22 ' HB2' ' A' ' 76' ' ' SER . 17.4 m -126.43 152.52 74.25 Favored Pre-proline 0 N--CA 1.485 1.305 0 C-N-CA 124.154 0.981 . . . . 0.0 109.552 177.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -50.72 113.44 1.07 Allowed 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 123.117 2.545 . . . . 0.0 114.013 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 73' ' ' VAL . 7.3 p -71.08 141.38 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 124.72 1.208 . . . . 0.0 110.565 177.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -109.95 119.45 39.36 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.701 0.8 . . . . 0.0 109.656 175.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -102.06 146.94 27.2 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.025 0.93 . . . . 0.0 109.355 172.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -133.74 163.24 29.9 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.939 0.896 . . . . 0.0 108.849 174.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -100.15 -21.14 15.66 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 172.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.598 HG22 ' H ' ' A' ' 88' ' ' GLY . 57.9 m -138.5 141.59 39.38 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -170.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.478 ' O ' HG12 ' A' ' 91' ' ' ILE . 96.1 mt -61.82 -31.27 71.5 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.279 0.632 . . . . 0.0 111.353 177.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.598 ' H ' HG22 ' A' ' 86' ' ' THR . . . -58.21 -34.19 72.86 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 113.749 0.26 . . . . 0.0 113.749 173.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.86 -40.37 75.81 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.463 0.705 . . . . 0.0 110.295 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.3 tp -56.92 -61.07 2.7 Favored 'General case' 0 C--N 1.356 0.891 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.158 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.498 ' HA ' HD12 ' A' ' 105' ' ' LEU . 29.8 mm -60.29 -40.17 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 124.301 1.04 . . . . 0.0 110.573 -177.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.64 -55.54 28.25 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 124.073 0.858 . . . . 0.0 113.853 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 50.9 tp -73.82 -34.71 64.69 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 122.801 0.44 . . . . 0.0 110.939 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.417 ' HA ' ' OD1' ' A' ' 98' ' ' ASN . 3.1 m-30 -86.61 0.87 53.6 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -172.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.99 8.86 6.19 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.346 0.658 . . . . 0.0 112.497 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -137.92 162.18 55.66 Favored Pre-proline 0 CA--C 1.55 0.942 0 C-N-CA 124.888 1.275 . . . . 0.0 108.261 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -49.44 118.53 3.74 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 123.161 2.574 . . . . 0.0 113.243 171.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.417 ' OD1' ' HA ' ' A' ' 94' ' ' TYR . 21.8 m120 -106.93 -78.44 0.58 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.75 0.82 . . . . 0.0 110.923 -174.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 148.34 101.46 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.387 1.475 . . . . 0.0 108.089 -156.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 105.55 -29.06 12.05 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-O 119.742 -0.477 . . . . 0.0 112.832 172.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 15.2 mt -71.09 145.34 49.91 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.736 0.414 . . . . 0.0 111.339 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.5 m -66.01 -27.45 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.566 0.746 . . . . 0.0 111.421 172.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.576 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 29.3 p -168.22 172.89 8.23 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.337 1.055 . . . . 0.0 109.829 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.87 151.54 38.97 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.569 171.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 91' ' ' ILE . 29.9 mt -77.7 103.96 7.95 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 92.6 mt -118.95 -60.96 1.7 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.921 0.488 . . . . 0.0 112.153 -172.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -95.43 140.87 22.55 Favored Pre-proline 0 N--CA 1.484 1.271 0 C-N-CA 122.732 0.413 . . . . 0.0 111.17 -169.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -73.94 -163.46 0.17 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.965 2.444 . . . . 0.0 112.444 172.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.492 HG21 HD23 ' A' ' 37' ' ' LEU . 72.3 t . . . . . 0 C--O 1.254 1.32 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -175.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtt . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.79 37.28 0.08 OUTLIER Glycine 0 C--N 1.344 0.996 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -77.67 -5.32 50.05 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 123.484 0.714 . . . . 0.0 110.868 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -111.06 73.83 0.84 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 167.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -76.45 102.87 6.17 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -110.26 123.89 50.61 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.099 0.96 . . . . 0.0 109.32 172.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -79.41 23.81 0.38 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.684 0.794 . . . . 0.0 112.317 -176.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -123.51 49.87 1.66 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.301 1.041 . . . . 0.0 108.366 171.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.7 m -68.75 -2.25 8.9 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.538 1.135 . . . . 0.0 113.951 -173.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.8 m80 64.48 33.5 10.97 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.03 0.932 . . . . 0.0 110.329 -177.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.2 ptm -80.43 71.17 7.24 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.459 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 m -75.8 -61.37 1.95 Allowed 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.211 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.43 ' CD1' ' HB3' ' A' ' 108' ' ' PRO . 33.5 p-90 -91.95 3.82 54.37 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.908 0.483 . . . . 0.0 110.894 176.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.437 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 73.5 t80 -110.56 127.66 55.31 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -123.11 144.2 49.48 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.0 mtp-105 -63.07 -64.49 0.9 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.681 0.792 . . . . 0.0 110.13 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -84.74 -101.66 0.05 Allowed 'General case' 0 C--O 1.246 0.901 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -177.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.3 tp 65.05 113.56 0.03 OUTLIER 'General case' 0 C--N 1.363 1.182 0 C-N-CA 125.336 1.454 . . . . 0.0 110.661 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.2 t -72.91 147.81 44.95 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 170.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -63.81 -38.04 89.63 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.133 0.973 . . . . 0.0 110.151 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.23 -45.38 87.81 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.726 173.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.81 -33.59 66.31 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.606 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.576 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -66.87 -51.93 49.56 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.739 0.816 . . . . 0.0 110.255 -177.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -54.26 -43.66 71.17 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.013 1.325 . . . . 0.0 111.323 174.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.39 -50.3 66.02 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.821 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.1 mt -61.85 -34.32 75.76 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.69 0.796 . . . . 0.0 112.295 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.7 mt -70.54 -59.09 3.04 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.92 -29.01 68.08 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.297 1.039 . . . . 0.0 112.977 -172.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -78.21 -44.94 24.33 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.413 0.685 . . . . 0.0 110.904 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.64 -59.24 2.82 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.438 0.637 . . . . 0.0 112.408 -170.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.06 -169.62 16.05 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 114.685 -1.143 . . . . 0.0 113.808 -165.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.452 ' HB3' ' H ' ' A' ' 33' ' ' ASP . 6.4 mpt_? -119.47 -157.57 0.7 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 125.143 1.377 . . . . 0.0 109.716 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.452 ' H ' ' HB3' ' A' ' 32' ' ' ARG . 8.1 p-10 -57.0 132.87 54.16 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.959 0.904 . . . . 0.0 112.099 -176.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.55 0.59 64.65 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.932 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.43 ' HB2' ' HB3' ' A' ' 53' ' ' LEU . 56.8 m -71.64 116.58 12.17 Favored 'General case' 0 C--N 1.359 1.007 0 CA-C-N 117.764 0.782 . . . . 0.0 108.898 176.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 24.5 p90 -131.07 157.43 43.09 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.306 0.574 . . . . 0.0 111.639 -172.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.576 HD11 ' HB1' ' A' ' 23' ' ' ALA . 2.9 pp -150.93 164.11 37.12 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.69 169.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 49' ' ' ALA . 86.2 t -125.94 149.26 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 171.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.517 ' HG3' ' HB3' ' A' ' 49' ' ' ALA . 0.5 OUTLIER -153.17 169.07 23.91 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.739 1.215 . . . . 0.0 108.726 -175.383 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 13.7 t70 -93.18 120.8 33.87 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 172.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.4 m -69.19 101.15 1.4 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.027 0.931 . . . . 0.0 111.282 -169.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.454 ' HG2' HH21 ' A' ' 39' ' ' ARG . 16.6 mm-40 -49.78 -31.67 12.16 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.411 1.484 . . . . 0.0 114.315 173.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.5 p -79.23 -17.4 54.88 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.944 0.498 . . . . 0.0 112.279 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.6 t -108.81 -64.76 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 122.996 0.519 . . . . 0.0 109.7 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 95.84 122.07 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.871 2.469 . . . . 0.0 109.547 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 63.46 58.18 12.31 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.746 1.279 . . . . 0.0 111.643 -173.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 40' ' ' ASP . . . -153.08 150.4 29.09 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.461 1.104 . . . . 0.0 108.149 -174.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -113.53 125.1 53.82 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.388 0.994 . . . . 0.0 111.311 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.517 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . . . -104.4 127.27 52.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.52 0.728 . . . . 0.0 109.326 -177.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.4 tp -111.11 106.25 15.23 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 31.2 m -101.16 121.38 41.74 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -176.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.506 HG21 HD22 ' A' ' 101' ' ' LEU . 94.0 t -122.43 116.69 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.262 1.025 . . . . 0.0 109.37 -174.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 35' ' ' SER . 36.9 tp -85.24 135.13 34.06 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.189 0.996 . . . . 0.0 111.273 -173.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -141.7 102.3 4.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.525 0.73 . . . . 0.0 109.103 167.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 57.5 54.21 6.71 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.231 1.012 . . . . 0.0 111.369 172.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.419 ' H ' HD11 ' A' ' 53' ' ' LEU . 14.7 tmtt? 75.27 -23.06 0.24 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 125.681 1.592 . . . . 0.0 112.441 -177.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -88.8 101.35 13.94 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.902 0.858 . . . . 0.0 108.734 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 83.6 t -93.52 120.7 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.227 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -94.98 122.13 37.31 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 37.3 p -113.9 141.62 47.13 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -169.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -135.99 99.15 4.07 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -177.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -81.14 93.53 6.47 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.109 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.437 HG22 ' HB3' ' A' ' 71' ' ' LEU . 32.5 mt -79.9 136.63 23.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 124.494 1.117 . . . . 0.0 110.315 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.8 mp -121.2 141.22 32.56 Favored Pre-proline 0 N--CA 1.475 0.805 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -174.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 70' ' ' PHE . 52.5 Cg_exo -58.67 114.91 2.2 Favored 'Trans proline' 0 C--N 1.366 1.491 0 C-N-CA 122.038 1.826 . . . . 0.0 109.162 158.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -123.84 5.36 8.75 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 123.48 0.712 . . . . 0.0 110.44 -160.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.36 141.29 3.67 Favored Glycine 0 C--N 1.342 0.904 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -174.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 33.66 -76.75 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.016 2.228 . . . . 0.0 117.016 -166.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -163.02 22.37 0.09 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -163.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 72.1 m-85 -127.15 150.5 49.48 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.139 0.976 . . . . 0.0 109.717 -170.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.437 ' HB3' HG22 ' A' ' 63' ' ' ILE . 8.2 mp -99.11 150.05 22.42 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.28 1.032 . . . . 0.0 109.743 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -135.93 120.54 18.28 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.635 0.774 . . . . 0.0 109.836 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.8 t -84.93 128.04 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.27 1.028 . . . . 0.0 108.539 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -110.85 87.64 2.58 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -175.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.3 t -140.44 138.68 34.88 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.165 175.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.4 m 63.05 -2.12 0.44 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 165.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 60.71 -79.69 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 125.331 1.452 . . . . 0.0 112.429 -177.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.55 -28.48 62.52 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 -172.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.92 124.19 63.43 Favored Pre-proline 0 CA--C 1.561 1.392 0 CA-C-N 117.274 0.537 . . . . 0.0 110.632 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.413 ' HB2' HE22 ' A' ' 99' ' ' GLN . 81.3 Cg_exo -51.99 113.58 1.24 Allowed 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.653 2.235 . . . . 0.0 113.349 177.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 70.2 t -101.7 134.1 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.417 1.087 . . . . 0.0 108.751 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -105.29 151.6 23.94 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.471 ' O ' ' HD2' ' A' ' 83' ' ' ARG . 2.6 ppt_? -85.34 121.91 28.74 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 170.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -107.29 129.43 54.89 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.592 -0.693 . . . . 0.0 110.178 -176.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -84.64 -17.31 39.01 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.8 t -155.28 163.46 40.11 Favored 'General case' 0 C--O 1.248 0.99 0 C-N-CA 122.779 0.432 . . . . 0.0 110.372 172.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.424 ' O ' HG12 ' A' ' 91' ' ' ILE . 94.9 mt -60.22 -32.12 70.81 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.044 0.937 . . . . 0.0 111.677 177.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -55.86 -41.85 84.71 Favored Glycine 0 C--N 1.352 1.464 0 O-C-N 123.304 0.377 . . . . 0.0 112.762 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -65.85 -39.08 90.43 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.811 0.844 . . . . 0.0 111.033 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 47.7 tp -64.17 -41.72 97.02 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.191 0.996 . . . . 0.0 111.467 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 87' ' ' LEU . 49.8 mm -84.95 -28.18 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -168.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.42 -47.74 15.84 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.2 tt -61.28 -43.78 98.32 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.447 0.699 . . . . 0.0 110.325 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.492 ' HB3' HD11 ' A' ' 101' ' ' LEU . 3.0 m-85 -79.57 -9.76 59.68 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.509 0.724 . . . . 0.0 112.215 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.03 -0.72 19.85 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.734 0.413 . . . . 0.0 112.104 167.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -154.45 57.92 1.93 Allowed Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 124.465 1.106 . . . . 0.0 109.018 172.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.466 ' HG3' HD12 ' A' ' 101' ' ' LEU . 81.1 Cg_endo -75.35 -66.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.507 2.138 . . . . 0.0 113.706 -164.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.5 t30 57.77 39.24 27.29 Favored 'General case' 0 C--N 1.367 1.327 0 C-N-CA 124.325 1.05 . . . . 0.0 108.534 -170.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.413 HE22 ' HB2' ' A' ' 80' ' ' PRO . 20.9 mt-30 -177.75 86.38 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.243 1.017 . . . . 0.0 110.211 -162.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 103.93 -32.28 7.72 Favored Glycine 0 N--CA 1.474 1.187 0 C-N-CA 121.639 -0.315 . . . . 0.0 112.853 161.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.506 HD22 HG21 ' A' ' 52' ' ' VAL . 53.7 mt -87.64 123.96 33.04 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.675 0.39 . . . . 0.0 110.388 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.8 p -51.05 -32.83 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.457 0 C-N-CA 125.767 1.627 . . . . 0.0 113.514 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 26.2 p -153.64 16.07 0.51 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.979 0.512 . . . . 0.0 112.206 -175.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 67.26 -160.35 0.23 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.646 0.778 . . . . 0.0 110.891 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 56.9 mt -110.91 156.67 20.84 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 58.5 tp -164.94 -63.18 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.457 0.303 . . . . 0.0 111.051 -175.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 29.9 tp -111.52 102.56 53.56 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 122.792 0.437 . . . . 0.0 110.507 -167.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.43 ' HB3' ' CD1' ' A' ' 13' ' ' TRP . 12.3 Cg_exo -72.4 100.96 1.2 Allowed 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.587 2.192 . . . . 0.0 109.392 169.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 87.6 t . . . . . 0 C--O 1.245 0.852 0 CA-C-O 118.648 -0.691 . . . . 0.0 109.328 -171.433 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptp . . . . . 0 N--CA 1.481 1.096 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 167.55 -148.31 12.82 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.6 p-80 -160.01 92.11 0.99 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.974 0.91 . . . . 0.0 109.802 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -90.59 113.99 26.13 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.409 0.684 . . . . 0.0 109.909 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -106.87 134.08 50.57 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.884 0.873 . . . . 0.0 110.251 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -153.6 88.49 1.28 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.632 0.773 . . . . 0.0 109.568 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -143.25 153.65 43.01 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.287 1.035 . . . . 0.0 109.796 173.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -132.08 158.94 40.29 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.425 1.09 . . . . 0.0 109.133 172.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.0 t -64.36 155.71 31.5 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.353 0.661 . . . . 0.0 110.92 176.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -135.9 97.64 3.69 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.915 0.886 . . . . 0.0 110.293 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 67.7 mtm -128.41 123.97 35.11 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 172.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.6 m -61.29 -78.15 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.858 0.863 . . . . 0.0 111.765 -169.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -115.26 12.53 16.48 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.108 0.563 . . . . 0.0 111.929 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.415 ' HE2' ' HG2' ' A' ' 16' ' ' ARG . 53.8 t80 -108.36 116.57 32.22 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -177.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -115.51 117.15 29.55 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.415 ' HG2' ' HE2' ' A' ' 14' ' ' TYR . 80.9 mtt180 -64.24 -58.51 6.36 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.385 0.674 . . . . 0.0 111.524 -175.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -111.11 86.48 2.33 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.394 1.092 . . . . 0.0 108.461 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.9 tp -133.14 133.74 43.26 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.457 -1.247 . . . . 0.0 107.926 177.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.4 m -80.04 155.0 27.79 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.505 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 77.3 ttt180 -65.85 -43.35 88.7 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 119.233 -0.413 . . . . 0.0 110.774 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.85 -48.08 67.32 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.449 0.7 . . . . 0.0 111.252 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.47 -25.13 63.93 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.087 177.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.81 -49.55 20.33 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.49 0.716 . . . . 0.0 111.664 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 1.1 mm-40 -62.72 -38.65 91.31 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.234 0.614 . . . . 0.0 110.01 177.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.3 -47.24 80.22 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 124.377 1.048 . . . . 0.0 109.995 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -54.7 -37.92 66.41 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.89 0.876 . . . . 0.0 110.869 176.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 53' ' ' LEU . 86.5 mt -79.77 -36.1 37.65 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.375 -0.203 . . . . 0.0 111.061 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.63 -41.75 83.4 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 122.706 0.403 . . . . 0.0 110.45 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -89.22 -60.29 1.99 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.119 0.968 . . . . 0.0 111.621 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.26 -50.47 14.32 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.176 0.19 . . . . 0.0 111.347 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.32 122.11 28.62 Favored Glycine 0 C--N 1.353 1.505 0 O-C-N 123.544 0.527 . . . . 0.0 113.72 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -71.0 -45.04 64.67 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.089 0.556 . . . . 0.0 111.075 -177.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 160.98 131.94 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 125.405 1.482 . . . . 0.0 108.172 -174.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.12 20.45 79.05 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 111.924 -0.471 . . . . 0.0 111.924 -176.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 109' ' ' VAL . 13.7 m -83.48 144.94 29.22 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 124.377 1.071 . . . . 0.0 109.529 -178.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -141.75 150.49 41.84 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.96 0.409 . . . . 0.0 111.008 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -138.26 148.86 45.16 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.913 0.885 . . . . 0.0 109.869 170.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.468 HG22 HD13 ' A' ' 50' ' ' LEU . 48.7 t -114.39 136.55 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -135.73 165.2 26.13 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 124.54 1.136 . . . . 0.0 109.412 -174.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -86.32 131.96 34.09 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 175.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.444 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . 40.4 m -91.46 162.56 14.51 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.292 1.037 . . . . 0.0 108.251 172.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -143.7 75.28 1.46 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.6 t -165.48 -68.69 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.664 -174.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 76.2 t -82.18 82.35 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 174.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 46.72 -122.67 1.28 Allowed 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 124.352 1.061 . . . . 0.0 111.183 -170.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -108.77 79.69 0.25 Allowed Glycine 0 C--N 1.356 1.67 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 172.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 41' ' ' SER . . . -92.38 174.51 7.25 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.542 0.737 . . . . 0.0 111.445 -172.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.522 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 87.2 m-85 -113.37 155.05 25.9 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.214 1.006 . . . . 0.0 109.72 173.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.52 146.98 48.63 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.619 1.168 . . . . 0.0 108.989 171.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 61' ' ' TYR . 40.8 tp -124.82 108.95 12.47 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.182 0.993 . . . . 0.0 109.239 -176.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.505 ' SG ' HG22 ' A' ' 60' ' ' THR . 52.9 m -93.92 126.1 38.93 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.1 t -132.71 121.28 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 CA-C-N 118.273 0.488 . . . . 0.0 109.852 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 40.2 tp -86.93 139.84 30.21 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.72 0.808 . . . . 0.0 109.248 171.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -163.56 121.49 1.89 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 170.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 41.88 67.26 0.59 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 126.012 1.725 . . . . 0.0 113.732 177.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.465 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 10.8 mmpt? 59.21 27.73 16.83 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.76 1.224 . . . . 0.0 112.897 178.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -139.36 107.14 5.64 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.781 0.832 . . . . 0.0 108.984 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.9 t -93.47 122.12 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 166.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -117.97 138.61 52.06 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.064 0.946 . . . . 0.0 108.907 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.505 HG22 ' SG ' ' A' ' 51' ' ' CYS . 21.4 p -106.56 139.51 40.9 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.477 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 23.9 m-85 -119.0 107.56 13.67 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -70.58 150.37 46.14 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 171.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 96.7 mt -147.27 105.77 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 102.605 -3.109 . . . . 0.0 102.605 -158.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.8 mp -107.19 98.03 20.89 Favored Pre-proline 0 N--CA 1.48 1.051 0 CA-C-O 118.634 -0.698 . . . . 0.0 111.484 -160.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 70' ' ' PHE . 37.3 Cg_endo -66.22 95.58 0.32 Allowed 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 122.5 2.133 . . . . 0.0 109.268 162.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -166.76 164.26 16.56 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 124.446 1.098 . . . . 0.0 108.683 -158.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.72 -67.05 3.05 Favored Glycine 0 C--N 1.349 1.272 0 C-N-CA 123.076 0.369 . . . . 0.0 113.047 171.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -142.22 23.99 1.98 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.105 1.362 . . . . 0.0 108.108 -178.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 t70 61.49 58.71 2.03 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.262 1.425 . . . . 0.0 109.972 -170.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.439 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 23.1 p90 -127.8 151.99 48.35 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.394 1.078 . . . . 0.0 108.105 169.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.15 109.44 22.19 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 176.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . . . -98.56 127.11 44.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.793 0.837 . . . . 0.0 110.42 -175.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.3 t -99.26 129.15 50.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -94.04 90.72 6.53 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -174.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.5 p -71.66 -34.36 69.66 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.237 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.9 m 75.94 167.12 0.27 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.878 1.671 . . . . 0.0 112.745 173.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 67.57 -162.64 0.22 Allowed 'General case' 0 C--N 1.358 0.972 0 C-N-CA 124.47 1.108 . . . . 0.0 111.693 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -49.5 -24.38 5.42 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 114.756 -1.111 . . . . 0.0 113.965 170.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.69 120.9 80.4 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.573 0.749 . . . . 0.0 109.654 174.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.36 142.52 72.92 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.94 2.427 . . . . 0.0 113.266 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 37.1 t -78.29 118.88 26.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 C-N-CA 124.297 1.039 . . . . 0.0 108.278 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -107.03 127.76 53.76 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.852 0.358 . . . . 0.0 110.494 -173.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.545 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 27.9 ptt180 -98.05 154.33 17.79 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.311 1.044 . . . . 0.0 109.997 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -130.29 154.85 47.19 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.369 0.668 . . . . 0.0 111.399 -175.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -72.67 -46.42 53.92 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.502 172.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.0 t -145.76 166.74 24.99 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.517 0.727 . . . . 0.0 110.975 -177.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.6 mt -60.0 -32.57 70.98 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.712 0.805 . . . . 0.0 111.43 175.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -52.45 -41.26 55.44 Favored Glycine 0 N--CA 1.48 1.6 0 O-C-N 123.027 0.205 . . . . 0.0 113.357 172.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -65.63 -41.06 93.09 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.739 0.815 . . . . 0.0 111.232 173.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.5 tt -68.11 -40.09 82.65 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.226 1.01 . . . . 0.0 110.873 -174.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 44.6 mm -86.05 -42.11 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -166.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.88 -35.21 72.31 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.763 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.411 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 27.1 tp -77.49 -40.98 41.08 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-N 116.907 0.353 . . . . 0.0 110.821 177.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.3 m-30 -80.98 4.37 19.81 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 118.099 0.409 . . . . 0.0 111.83 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.63 -4.02 3.76 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.842 0.857 . . . . 0.0 112.538 163.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 93' ' ' LEU . 10.9 pt20 -125.27 144.35 47.27 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 171.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -84.42 -154.13 0.05 OUTLIER 'Trans proline' 0 CA--C 1.555 1.531 0 C-N-CA 123.32 2.68 . . . . 0.0 112.387 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.5 t30 62.68 57.54 1.77 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.64 1.176 . . . . 0.0 110.032 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -170.41 31.22 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.808 178.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.66 -10.36 72.42 Favored Glycine 0 N--CA 1.477 1.424 0 O-C-N 120.886 -1.134 . . . . 0.0 112.433 173.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.13 130.93 43.41 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 168.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.2 p -60.09 -31.67 48.5 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 123.984 0.914 . . . . 0.0 111.142 177.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 28.4 p -160.11 165.44 31.73 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.529 1.132 . . . . 0.0 108.876 176.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.2 150.73 46.16 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 122.727 0.411 . . . . 0.0 110.169 174.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 75.7 mt -73.16 95.85 2.14 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.2 tp -119.67 -61.37 1.62 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.673 -169.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.459 HD12 ' HD2' ' A' ' 108' ' ' PRO . 45.1 tp -100.42 123.78 45.12 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 123.081 0.552 . . . . 0.0 109.797 -172.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.459 ' HD2' HD12 ' A' ' 107' ' ' LEU . 19.4 Cg_endo -59.03 -47.61 17.21 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.399 2.066 . . . . 0.0 111.242 172.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.475 ' HA ' ' HB3' ' A' ' 35' ' ' SER . 0.3 OUTLIER . . . . . 0 C--O 1.245 0.836 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ttt . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.21 117.99 0.14 Allowed Glycine 0 C--N 1.35 1.336 0 O-C-N 123.573 0.546 . . . . 0.0 112.477 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -137.81 153.14 49.68 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 117.496 0.648 . . . . 0.0 109.836 177.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -109.68 -76.71 0.6 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 61.93 91.69 0.06 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.898 1.279 . . . . 0.0 112.6 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -108.52 -76.55 0.61 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.693 0.797 . . . . 0.0 108.949 174.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 52.91 -119.69 1.56 Allowed 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 124.716 1.206 . . . . 0.0 109.912 -172.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 48.84 -165.79 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.523 1.129 . . . . 0.0 113.031 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.1 t 70.45 156.03 0.15 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.503 1.121 . . . . 0.0 112.802 169.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -157.3 -52.29 0.07 Allowed 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -178.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.435 ' SD ' HD11 ' A' ' 26' ' ' LEU . 65.7 mtt 53.99 34.36 19.55 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.938 1.295 . . . . 0.0 113.447 169.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t -84.44 55.75 3.52 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.697 1.199 . . . . 0.0 110.97 -176.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.524 ' HB3' ' HB3' ' A' ' 108' ' ' PRO 0.317 36.1 p-90 71.53 -54.56 0.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 128.569 2.748 . . . . 0.0 110.906 -177.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -76.35 123.83 26.57 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 173.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.407 ' CD2' ' HB2' ' A' ' 37' ' ' LEU . 93.3 m-70 -113.79 171.93 7.29 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.856 0.863 . . . . 0.0 110.797 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -81.95 -148.43 0.07 Allowed 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.601 169.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -65.04 106.04 1.18 Allowed 'General case' 0 CA--C 1.555 1.168 0 CA-C-O 121.786 0.803 . . . . 0.0 110.219 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 39' ' ' ARG . 26.2 tp -136.1 138.45 42.08 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 57.4 p -96.15 172.39 8.01 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.399 0.68 . . . . 0.0 110.225 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -63.42 -51.75 64.43 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.448 0.699 . . . . 0.0 112.568 -176.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.47 -35.95 80.93 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.872 0.469 . . . . 0.0 111.265 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.84 -37.25 81.65 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.385 0.674 . . . . 0.0 111.1 174.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.33 -55.31 12.52 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.816 0.846 . . . . 0.0 111.703 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.493 ' HB3' HG11 ' A' ' 58' ' ' VAL . 13.3 pt-20 -66.13 -26.37 67.42 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.005 0.922 . . . . 0.0 112.375 -177.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -64.81 -51.18 63.54 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 172.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.435 HD11 ' SD ' ' A' ' 11' ' ' MET . 25.9 tp -61.21 -40.16 92.91 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.974 178.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.0 mt -64.58 -52.34 58.08 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.705 0.802 . . . . 0.0 110.505 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.43 -33.48 75.64 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.866 0.867 . . . . 0.0 112.566 -172.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -87.75 -57.79 2.81 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.783 -0.189 . . . . 0.0 111.383 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.73 -59.44 3.32 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.14 0.576 . . . . 0.0 112.325 -170.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -123.12 77.04 0.36 Allowed Glycine 0 C--N 1.342 0.885 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -71.47 102.57 2.7 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 118.996 -0.525 . . . . 0.0 110.015 -171.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.5 t70 97.7 116.2 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.638 1.575 . . . . 0.0 109.877 164.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.72 3.79 68.23 Favored Glycine 0 N--CA 1.476 1.313 0 CA-C-N 115.879 -0.6 . . . . 0.0 113.543 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.7 p -78.09 158.56 29.1 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.416 0.687 . . . . 0.0 111.56 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -145.9 158.95 43.84 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 172.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.411 ' O ' HD12 ' A' ' 50' ' ' LEU . 4.1 pp -154.05 163.08 40.66 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.697 170.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.0 t -117.76 144.88 24.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 169.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.516 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 50.4 ptt85 -152.9 156.68 39.41 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.19 0.596 . . . . 0.0 110.051 -174.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -87.91 117.83 27.03 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 174.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.0 m -94.9 100.36 12.24 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 174.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -60.63 -39.45 88.28 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.196 0.598 . . . . 0.0 111.921 169.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.1 m -87.92 58.84 5.04 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.89 0.876 . . . . 0.0 112.183 -171.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.469 HG13 ' H ' ' A' ' 45' ' ' ALA . 2.1 p -155.49 -70.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.008 0.523 . . . . 0.0 110.17 172.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.469 ' H ' HG13 ' A' ' 44' ' ' VAL . . . -170.07 15.07 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.695 0.798 . . . . 0.0 110.539 -174.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.49 94.68 0.06 OUTLIER Glycine 0 C--N 1.344 1.026 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -161.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.583 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . . . -152.54 160.42 43.22 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -168.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.431 ' HD2' ' HB3' ' A' ' 65' ' ' PRO . 57.8 m-85 -109.58 137.12 47.87 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.932 0.493 . . . . 0.0 109.928 168.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -119.48 135.81 54.6 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.776 0.831 . . . . 0.0 109.816 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.535 HD21 HD21 ' A' ' 105' ' ' LEU . 66.8 tp -107.87 104.08 13.48 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 48.8 t -106.85 116.16 31.45 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -174.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.9 t -122.2 118.24 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.574 1.15 . . . . 0.0 109.151 -170.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 47.3 tp -91.75 131.91 36.78 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.768 0.827 . . . . 0.0 109.155 175.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.402 ' HD2' HG22 ' A' ' 102' ' ' VAL . 83.9 t80 -164.51 127.97 2.47 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.431 0.692 . . . . 0.0 110.32 172.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 47.69 53.23 11.55 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.351 1.46 . . . . 0.0 111.715 174.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 91.0 mttt 56.38 39.26 30.14 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.515 1.126 . . . . 0.0 112.05 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 59.2 m80 -136.77 105.8 5.96 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.334 1.054 . . . . 0.0 108.481 174.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.493 HG11 ' HB3' ' A' ' 24' ' ' GLU . 84.9 t -94.67 107.17 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 170.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -103.06 129.55 49.91 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 96.0 m -110.2 137.98 47.2 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.462 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 56.4 m-85 -120.64 101.47 7.77 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -86.13 96.47 9.9 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 119.082 0.855 . . . . 0.0 109.402 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.454 HD12 ' O ' ' A' ' 61' ' ' TYR . 4.9 mp -85.07 141.95 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 123.62 0.768 . . . . 0.0 110.805 171.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.9 mp -96.06 118.87 65.43 Favored Pre-proline 0 CA--C 1.557 1.219 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 172.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.598 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 92.3 Cg_endo -76.4 -51.98 0.09 OUTLIER 'Trans proline' 0 CA--C 1.556 1.589 0 C-N-CA 122.519 2.146 . . . . 0.0 116.361 -162.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -148.91 167.68 25.06 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 122.259 -0.276 . . . . 0.0 111.158 -158.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.15 -96.29 0.25 Allowed Glycine 0 C--N 1.35 1.323 0 C-N-CA 123.336 0.494 . . . . 0.0 111.898 178.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -126.05 30.31 5.68 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.983 0.913 . . . . 0.0 109.206 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -159.33 174.19 15.14 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.771 -162.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -120.26 158.19 27.55 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.598 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -93.42 111.49 23.17 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -170.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.781 ' HB2' ' HG2' ' A' ' 83' ' ' ARG . . . -117.95 142.23 47.59 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.86 0.864 . . . . 0.0 110.748 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.6 t -89.24 142.57 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -108.84 90.99 3.46 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.8 p -87.58 -71.35 0.57 Allowed 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 172.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.2 t 179.92 140.72 0.13 Allowed 'General case' 0 C--N 1.351 0.658 0 C-N-CA 124.616 1.167 . . . . 0.0 108.955 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -70.83 128.2 35.23 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 140.52 -76.96 0.31 Allowed Glycine 0 C--N 1.346 1.135 0 N-CA-C 108.067 -2.013 . . . . 0.0 108.067 -166.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.3 m -64.41 140.08 97.88 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 123.838 0.855 . . . . 0.0 110.043 162.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -64.58 121.28 8.8 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.75 2.3 . . . . 0.0 112.056 -176.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 72.6 t -99.47 141.85 16.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.197 0.999 . . . . 0.0 108.463 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.8 mmt85 -117.31 143.7 45.65 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.553 0.741 . . . . 0.0 111.109 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.781 ' HG2' ' HB2' ' A' ' 72' ' ' ALA . 86.2 mtt-85 -94.89 148.41 22.34 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 166.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -127.39 161.9 27.58 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.163 0.585 . . . . 0.0 110.395 -174.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -95.3 -19.39 20.02 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.313 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.401 HG23 ' H ' ' A' ' 89' ' ' GLU . 15.0 t -157.06 159.72 38.21 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 122.654 0.382 . . . . 0.0 111.592 -176.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.4 mt -61.27 -34.44 75.18 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.186 0.994 . . . . 0.0 112.143 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.41 -38.77 91.63 Favored Glycine 0 C--N 1.349 1.254 0 O-C-N 123.206 0.317 . . . . 0.0 112.952 174.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.401 ' H ' HG23 ' A' ' 86' ' ' THR . 26.2 tt0 -72.21 -37.16 69.3 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.649 0.78 . . . . 0.0 109.735 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.6 tt -54.28 -53.74 49.61 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.657 1.183 . . . . 0.0 110.428 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.9 mm -64.79 -36.3 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.414 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -53.89 -55.08 27.51 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 124.198 0.936 . . . . 0.0 113.298 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -76.47 -35.74 58.26 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 122.998 0.519 . . . . 0.0 111.843 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.531 ' CD2' HD21 ' A' ' 101' ' ' LEU . 7.4 m-85 -89.49 4.62 48.59 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -173.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.42 -6.82 48.72 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 122.719 0.408 . . . . 0.0 110.93 162.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -83.17 125.75 73.86 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.965 0.906 . . . . 0.0 110.337 174.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.94 179.78 6.18 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.387 2.058 . . . . 0.0 111.36 169.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 53.83 66.18 1.3 Allowed 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.877 0.871 . . . . 0.0 111.128 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -173.2 21.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.2 1.0 . . . . 0.0 110.383 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 107.52 -21.65 30.12 Favored Glycine 0 C--N 1.345 1.076 0 O-C-N 121.622 -0.674 . . . . 0.0 112.41 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.531 HD21 ' CD2' ' A' ' 94' ' ' TYR . 2.9 mm? -70.57 124.7 24.86 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.338 1.055 . . . . 0.0 110.582 177.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.402 HG22 ' HD2' ' A' ' 54' ' ' TYR . 13.9 p -52.96 -31.41 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.542 0 C-N-CA 124.21 1.004 . . . . 0.0 112.783 -178.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 27.2 p -156.25 6.41 0.19 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.003 0.521 . . . . 0.0 112.309 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 68.0 -179.62 0.22 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.727 0.811 . . . . 0.0 110.594 -166.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.535 HD21 HD21 ' A' ' 50' ' ' LEU . 46.1 mt -90.0 91.53 8.61 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 79.1 mt -93.86 -69.31 0.76 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.928 0.891 . . . . 0.0 111.321 -174.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.7 mp -104.01 128.25 27.6 Favored Pre-proline 0 N--CA 1.48 1.048 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -173.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.524 ' HB3' ' HB3' ' A' ' 13' ' ' TRP . 35.5 Cg_exo -63.38 -124.25 0.0 OUTLIER 'Trans proline' 0 CA--C 1.571 2.334 0 C-N-CA 122.623 2.215 . . . . 0.0 111.576 169.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.7 t . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 176.914 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -177.07 50.53 0.1 Allowed Glycine 0 C--N 1.349 1.264 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -68.01 100.96 1.04 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.381 0.672 . . . . 0.0 110.641 178.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -133.42 101.2 5.07 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.623 0.769 . . . . 0.0 108.967 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -73.45 111.33 8.48 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-O 121.192 0.52 . . . . 0.0 110.02 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -144.62 165.46 27.95 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.164 0.986 . . . . 0.0 109.406 177.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 66.77 7.88 5.56 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 123.969 0.908 . . . . 0.0 112.375 172.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -125.77 95.56 4.47 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.674 0.79 . . . . 0.0 109.086 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.6 m -146.05 -66.16 0.3 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.586 0.755 . . . . 0.0 109.267 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 54.75 56.35 6.82 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.337 1.055 . . . . 0.0 110.155 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 28.1 ttt -73.77 83.14 1.62 Allowed 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.937 -171.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.8 t 178.16 176.55 0.46 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.347 1.459 . . . . 0.0 109.142 178.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.5 ' HB3' ' O ' ' A' ' 108' ' ' PRO . 4.7 p-90 -94.77 -22.86 17.8 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.595 1.158 . . . . 0.0 109.341 166.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 84.6 t80 -71.68 109.05 5.33 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.862 173.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -128.27 120.29 26.84 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -59.06 -72.84 0.09 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.647 0.379 . . . . 0.0 110.937 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -85.48 59.05 5.39 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.72 0.808 . . . . 0.0 110.126 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 26.0 tp -88.2 -61.12 1.78 Allowed 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -176.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.2 m 93.81 145.94 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 127.125 2.17 . . . . 0.0 107.895 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.473 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 54.9 ttt180 -57.2 -46.83 82.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.112 0.565 . . . . 0.0 111.701 -177.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.523 ' O ' ' HB2' ' A' ' 25' ' ' GLU . . . -51.76 -47.92 63.93 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 124.173 0.92 . . . . 0.0 111.573 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.419 ' O ' ' HG ' ' A' ' 26' ' ' LEU . . . -69.13 -38.04 78.63 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.459 177.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.447 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -61.4 -60.64 3.41 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.189 0.996 . . . . 0.0 112.114 -177.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 12.5 pt-20 -59.08 -29.58 67.44 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.246 1.019 . . . . 0.0 112.398 175.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.6 OUTLIER -67.1 -47.47 71.07 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.161 0.584 . . . . 0.0 109.522 178.119 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 22' ' ' ALA . 94.5 mt -59.59 -36.03 75.47 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.89 0.876 . . . . 0.0 111.341 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.3 mt -68.87 -54.55 15.0 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.24 -36.76 76.05 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.818 0.847 . . . . 0.0 112.748 -169.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -92.37 -59.47 2.08 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -73.35 -59.51 2.68 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -165.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.33 108.34 1.69 Allowed Glycine 0 C--N 1.349 1.304 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -175.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 50.8 ttt85 -57.75 -129.09 0.0 OUTLIER 'General case' 0 CA--C 1.581 2.173 0 C-N-CA 124.372 1.069 . . . . 0.0 113.236 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -74.68 148.83 40.24 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.282 -1.511 . . . . 0.0 111.442 -169.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.415 ' HA3' HD23 ' A' ' 106' ' ' LEU . . . 70.13 18.04 74.42 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.628 0.58 . . . . 0.0 114.207 -176.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.634 ' HB2' HG22 ' A' ' 109' ' ' VAL . 59.6 p -80.38 139.04 36.72 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -144.1 147.24 33.48 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.013 0.435 . . . . 0.0 110.255 177.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.447 HD11 ' HB1' ' A' ' 23' ' ' ALA . 1.6 pp -150.04 154.37 38.05 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.123 0.969 . . . . 0.0 108.701 168.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 79.6 t -114.73 131.02 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.496 ' HG3' ' HB3' ' A' ' 49' ' ' ALA . 5.9 ptm180 -116.79 168.64 10.04 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.214 1.005 . . . . 0.0 108.383 174.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -85.24 132.38 34.28 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 170.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 97.1 p -58.53 153.38 16.23 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 123.905 0.753 . . . . 0.0 111.596 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -71.73 79.58 0.85 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.711 0.804 . . . . 0.0 111.963 -172.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.3 m 53.55 28.31 7.63 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.954 1.301 . . . . 0.0 113.118 177.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.8 t -65.53 -73.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.499 0.72 . . . . 0.0 111.411 -172.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -172.41 34.7 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.238 0.615 . . . . 0.0 110.608 -177.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.39 35.49 33.14 Favored Glycine 0 N--CA 1.469 0.835 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.14 -174.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -97.08 169.77 9.58 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.568 0.747 . . . . 0.0 110.64 -177.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -124.16 157.49 34.59 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.049 0.94 . . . . 0.0 109.849 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.496 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . . . -133.64 144.77 49.42 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.295 0.638 . . . . 0.0 109.512 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.2 tp -123.9 124.21 42.12 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.447 ' SG ' HG22 ' A' ' 60' ' ' THR . 39.0 m -115.03 121.14 42.19 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -178.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 35' ' ' SER . 60.4 t -128.48 125.42 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.791 0.837 . . . . 0.0 109.038 -175.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.477 ' HB3' ' OG ' ' A' ' 35' ' ' SER . 60.7 tp -96.21 138.73 33.38 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.343 0.657 . . . . 0.0 109.905 177.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -161.57 125.05 3.2 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.9 0.88 . . . . 0.0 108.961 175.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 50.26 52.57 14.49 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.08 1.352 . . . . 0.0 112.391 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 80.3 tttt 55.9 39.11 30.64 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.737 1.215 . . . . 0.0 112.119 -176.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -140.69 106.03 5.05 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.94 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 85.4 t -87.36 112.06 22.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 168.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -97.4 130.34 44.54 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 170.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.447 HG22 ' SG ' ' A' ' 51' ' ' CYS . 41.1 p -108.29 130.26 55.19 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -113.59 98.9 7.34 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.3 mtm105 -83.54 91.69 7.47 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.506 HD13 HD11 ' A' ' 90' ' ' LEU . 61.7 mt -77.56 122.39 32.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.701 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.9 mp -93.96 149.86 37.61 Favored Pre-proline 0 CA--C 1.547 0.832 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -178.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -79.42 -143.05 0.02 OUTLIER 'Trans proline' 0 CA--C 1.565 2.061 0 C-N-CA 122.942 2.428 . . . . 0.0 112.498 -170.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.647 ' HB3' ' H ' ' A' ' 70' ' ' PHE . 31.0 t70 -169.74 151.43 4.25 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.646 0.778 . . . . 0.0 109.841 -172.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -55.33 -35.28 60.47 Favored Glycine 0 C--N 1.349 1.266 0 O-C-N 124.035 0.835 . . . . 0.0 114.112 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -102.59 25.13 9.48 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.646 0.778 . . . . 0.0 111.416 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 58.91 57.67 3.51 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.508 1.523 . . . . 0.0 114.098 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.647 ' H ' ' HB3' ' A' ' 66' ' ' ASP . 96.4 m-85 -118.86 151.65 37.72 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 169.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 mp -98.2 108.28 20.94 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.97 118.15 33.9 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.607 0.763 . . . . 0.0 109.628 -175.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 81' ' ' VAL . 12.9 t -99.72 140.96 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.918 0.887 . . . . 0.0 110.289 -176.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -108.09 89.73 3.08 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 176.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.3 m -90.82 125.51 35.74 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -171.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.2 m 59.01 -89.98 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.067 1.347 . . . . 0.0 112.061 177.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 176.75 -26.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.592 1.157 . . . . 0.0 111.057 -177.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -132.03 40.61 1.6 Allowed Glycine 0 N--CA 1.47 0.966 0 CA-C-N 116.694 -0.23 . . . . 0.0 112.861 -170.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.6 p -143.7 135.47 12.95 Favored Pre-proline 0 CA--C 1.555 1.168 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -40.14 135.06 1.76 Allowed 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 124.182 3.255 . . . . 0.0 115.091 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 73' ' ' VAL . 88.0 t -64.04 131.16 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.733 1.213 . . . . 0.0 109.473 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -105.32 116.48 32.02 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -174.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -93.34 146.12 23.97 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 172.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -125.56 146.57 49.62 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.695 0.798 . . . . 0.0 110.091 175.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -75.11 -40.04 60.18 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.764 0.425 . . . . 0.0 110.481 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.0 p -141.05 173.92 11.01 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.831 0.852 . . . . 0.0 109.854 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -68.37 -34.8 76.71 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.041 0.936 . . . . 0.0 109.455 175.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -60.66 -38.5 95.18 Favored Glycine 0 C--N 1.357 1.698 0 O-C-N 123.241 0.338 . . . . 0.0 113.341 175.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -64.93 -45.17 86.95 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.592 0.757 . . . . 0.0 111.096 174.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.506 HD11 HD13 ' A' ' 63' ' ' ILE . 8.2 tt -52.7 -50.34 63.53 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.426 1.09 . . . . 0.0 111.059 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.7 mm -70.3 -33.51 54.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.215 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.8 -57.31 20.09 Favored Glycine 0 CA--C 1.532 1.117 0 O-C-N 123.589 0.556 . . . . 0.0 114.163 178.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.1 mp -70.43 -31.17 68.25 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.098 0.559 . . . . 0.0 111.402 -178.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 -78.94 -18.87 53.05 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' A' ' 105' ' ' LEU . . . -61.01 -20.74 62.85 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.443 0.697 . . . . 0.0 112.707 174.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -110.9 166.32 10.98 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 123.643 0.777 . . . . 0.0 109.403 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -49.89 105.7 0.1 Allowed 'Trans proline' 0 C--N 1.386 2.518 0 C-N-CA 123.063 2.508 . . . . 0.0 112.327 168.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -90.97 -51.64 5.24 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.943 0.897 . . . . 0.0 111.521 -174.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 109.55 101.03 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 128.477 2.711 . . . . 0.0 108.673 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.15 -17.72 11.52 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.849 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 49.1 mt -77.31 143.95 38.43 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.821 0.448 . . . . 0.0 111.012 176.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.2 m -75.29 71.85 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 CA-C-O 121.826 0.822 . . . . 0.0 109.309 165.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 2.6 p 78.81 179.6 0.12 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.65 1.98 . . . . 0.0 110.761 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.06 -178.09 6.72 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.431 0.692 . . . . 0.0 110.895 -177.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 95' ' ' ALA . 29.0 mt -93.03 106.34 18.32 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 174.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.415 HD23 ' HA3' ' A' ' 34' ' ' GLY . 4.2 mm? -97.13 -56.89 2.41 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.379 0.672 . . . . 0.0 110.863 -176.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.5 pp -133.25 147.33 64.63 Favored Pre-proline 0 N--CA 1.486 1.333 0 C-N-CA 122.636 0.374 . . . . 0.0 111.407 -169.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.5 ' O ' ' HB3' ' A' ' 13' ' ' TRP . 65.0 Cg_endo -77.81 -11.99 16.56 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 123.155 2.57 . . . . 0.0 115.154 -171.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.634 HG22 ' HB2' ' A' ' 35' ' ' SER . 22.3 t . . . . . 0 N--CA 1.503 2.223 0 C-N-CA 124.994 1.318 . . . . 0.0 109.5 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 166.01 -25.86 0.16 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -77.17 123.41 26.38 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.647 0.779 . . . . 0.0 110.148 178.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -163.74 150.69 12.09 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.111 0.964 . . . . 0.0 109.199 173.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -85.22 175.52 8.9 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.684 0.754 . . . . 0.0 111.183 175.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -156.56 146.73 21.25 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.425 176.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -98.72 79.23 2.41 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -152.84 102.86 2.71 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.0 m -70.77 151.86 44.39 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.562 0.745 . . . . 0.0 111.285 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -125.59 137.19 53.89 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.643 0.777 . . . . 0.0 109.657 177.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -158.48 -45.3 0.06 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.138 0.975 . . . . 0.0 108.934 175.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.2 m 38.44 86.22 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.789 1.636 . . . . 0.0 112.781 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 108' ' ' PRO . 1.6 p-90 -80.37 3.47 21.11 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.459 0.704 . . . . 0.0 112.009 -172.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -110.82 102.33 10.86 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -172.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -118.22 119.1 33.68 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -67.56 -81.59 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.622 0.769 . . . . 0.0 111.477 -164.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -83.77 42.69 0.86 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 118.382 0.537 . . . . 0.0 111.761 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.441 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 35.8 tp -68.16 -48.0 66.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.839 0.456 . . . . 0.0 109.851 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.8 m 79.98 152.78 0.12 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.647 1.179 . . . . 0.0 110.684 170.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -56.58 -62.61 1.61 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.631 1.172 . . . . 0.0 112.546 -168.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.76 -50.66 67.89 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.598 0.759 . . . . 0.0 112.256 -178.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 18' ' ' LEU . . . -65.46 -32.12 73.56 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.219 -178.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.75 -53.54 26.45 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.646 0.378 . . . . 0.0 111.629 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.26 -32.84 74.71 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 123.784 0.678 . . . . 0.0 111.619 -178.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -69.26 -43.65 73.51 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.228 0.33 . . . . 0.0 110.712 176.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.5 -27.0 66.64 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.515 0.726 . . . . 0.0 111.933 174.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.8 mt -66.96 -60.26 2.79 Favored 'General case' 0 C--N 1.348 0.52 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 170.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.79 -32.29 63.37 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.377 1.071 . . . . 0.0 112.951 -176.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.05 -58.0 3.49 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.74 0.816 . . . . 0.0 109.687 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.9 -55.18 5.16 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.295 -168.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -99.86 -58.28 0.89 Allowed Glycine 0 N--CA 1.47 0.96 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 -176.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.577 ' HA ' HD23 ' A' ' 53' ' ' LEU . 53.9 ttp180 51.9 104.86 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.083 2.153 . . . . 0.0 113.345 -170.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.8 t70 88.99 120.92 0.03 OUTLIER 'General case' 0 C--N 1.36 1.047 0 C-N-CA 124.778 1.231 . . . . 0.0 109.241 163.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.497 ' HA2' ' SG ' ' A' ' 103' ' ' CYS . . . 77.29 -0.43 68.39 Favored Glycine 0 C--N 1.352 1.43 0 CA-C-N 116.388 -0.369 . . . . 0.0 113.335 -168.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.0 m -82.91 141.22 32.35 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.903 0.881 . . . . 0.0 109.526 -175.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.455 ' HB2' HG22 ' A' ' 52' ' ' VAL . 20.6 p90 -144.76 158.21 43.87 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 175.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 pp -160.31 161.3 33.24 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.267 0.627 . . . . 0.0 109.944 168.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.472 HG21 HD11 ' A' ' 91' ' ' ILE . 40.2 t -110.91 145.55 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.412 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 17.6 mtm180 -132.33 165.52 24.02 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.829 0.851 . . . . 0.0 108.892 -176.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -89.18 119.2 29.46 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 158.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 56.4 m -58.97 147.64 33.57 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.456 0.473 . . . . 0.0 109.906 -175.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.431 ' CD ' ' H ' ' A' ' 42' ' ' GLU . 1.4 pm0 -77.05 77.23 3.59 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.279 1.032 . . . . 0.0 110.943 -162.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.5 t 50.13 54.61 10.79 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 125.497 1.519 . . . . 0.0 111.646 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 m -96.27 -55.5 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.904 -178.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -168.98 16.98 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.517 0.727 . . . . 0.0 111.305 -176.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.63 34.51 35.03 Favored Glycine 0 N--CA 1.474 1.168 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 -173.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -94.14 167.59 11.47 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.794 0.837 . . . . 0.0 112.194 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.537 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 79.0 m-85 -105.6 140.93 37.92 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.811 1.245 . . . . 0.0 109.309 171.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' A' ' 39' ' ' ARG . . . -117.42 126.19 52.22 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.946 0.498 . . . . 0.0 109.899 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.3 tp -108.81 104.08 13.28 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -177.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 53.5 t -102.55 120.21 40.15 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -176.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.455 HG22 ' HB2' ' A' ' 36' ' ' PHE . 56.3 t -128.05 121.42 56.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.373 1.069 . . . . 0.0 108.579 -175.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.577 HD23 ' HA ' ' A' ' 32' ' ' ARG . 43.1 tp -100.38 131.66 46.18 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.805 0.842 . . . . 0.0 109.013 174.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -167.0 145.53 5.08 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.167 0.917 . . . . 0.0 109.305 -177.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 47.82 41.45 14.33 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 125.852 1.661 . . . . 0.0 112.898 177.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.2 tttp 56.01 37.34 28.74 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.754 1.221 . . . . 0.0 111.684 -176.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -142.4 115.92 9.09 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.472 -174.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.4 HG22 HD13 ' A' ' 53' ' ' LEU . 45.2 t -83.82 139.03 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 173.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -139.21 123.85 18.45 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.8 m -114.16 129.97 56.61 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.502 ' HD2' ' HA ' ' A' ' 75' ' ' THR . 9.3 m-85 -115.22 100.58 8.24 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 -176.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -78.23 100.02 6.49 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 48' ' ' PHE . 3.2 mp -70.02 118.65 14.8 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.764 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 165.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.478 ' H ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -120.88 131.17 24.55 Favored Pre-proline 0 C--O 1.241 0.611 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.52 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 7.1 Cg_exo -73.17 -74.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 122.241 1.961 . . . . 0.0 110.607 171.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.7 t70 71.36 124.94 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.733 1.213 . . . . 0.0 108.379 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 49.62 -143.99 9.69 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.593 -153.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -117.62 -154.2 0.55 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.268 0.627 . . . . 0.0 110.308 169.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.0 t70 88.02 -74.9 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 126.158 1.783 . . . . 0.0 110.491 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -129.65 158.91 38.02 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 121.408 0.623 . . . . 0.0 112.04 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 3.0 pp -110.49 123.31 49.67 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.416 1.086 . . . . 0.0 108.722 165.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.82 123.79 48.67 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.253 0.621 . . . . 0.0 111.008 -177.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 63' ' ' ILE . 7.3 p -85.53 147.13 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -110.96 91.68 3.75 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.711 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 41.1 p -77.1 -58.88 3.03 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.13 -177.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.9 m -138.09 153.69 49.28 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.358 0.663 . . . . 0.0 110.343 -177.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -77.71 138.02 38.82 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.042 0.537 . . . . 0.0 110.043 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.57 32.49 67.59 Favored Glycine 0 CA--C 1.523 0.537 0 O-C-N 123.749 0.656 . . . . 0.0 114.029 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.7 m -133.78 144.43 51.81 Favored Pre-proline 0 N--CA 1.481 1.079 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.22 103.15 1.56 Allowed 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.273 1.982 . . . . 0.0 109.312 168.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.482 HG12 ' H ' ' A' ' 82' ' ' ARG . 4.7 t -79.75 174.14 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.26 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.482 ' H ' HG12 ' A' ' 81' ' ' VAL . 5.5 tpp180 -95.81 133.31 40.1 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -175.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -91.77 138.87 31.2 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -124.21 149.54 46.27 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.494 0.718 . . . . 0.0 109.468 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -96.17 -16.1 21.69 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 88' ' ' GLY . 25.5 m -144.33 140.2 28.99 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.936 0.895 . . . . 0.0 109.081 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -63.59 -31.83 73.11 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.433 1.093 . . . . 0.0 110.051 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.483 ' H ' HG22 ' A' ' 86' ' ' THR . . . -54.87 -42.03 78.14 Favored Glycine 0 CA--C 1.541 1.707 0 CA-C-N 116.409 -0.36 . . . . 0.0 113.923 172.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.39 -37.13 84.59 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.56 0.744 . . . . 0.0 110.791 176.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.406 HD11 ' HB ' ' A' ' 73' ' ' VAL . 9.3 tt -61.7 -55.0 35.12 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.265 1.026 . . . . 0.0 111.299 -176.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.472 HD11 HG21 ' A' ' 38' ' ' VAL . 49.8 mt -66.46 -37.53 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 123.44 0.463 . . . . 0.0 110.727 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.92 -52.39 46.85 Favored Glycine 0 C--N 1.342 0.913 0 O-C-N 123.769 0.668 . . . . 0.0 112.838 176.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 51.8 tp -72.15 -43.5 64.55 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.082 0.553 . . . . 0.0 111.412 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.484 ' HE2' HG11 ' A' ' 73' ' ' VAL . 18.6 m-85 -82.75 0.52 43.24 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -174.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.43 -25.41 64.32 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-O 121.472 0.653 . . . . 0.0 109.696 158.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -95.84 128.72 36.51 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.994 1.317 . . . . 0.0 107.565 171.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -80.55 -155.47 0.06 OUTLIER 'Trans proline' 0 CA--C 1.557 1.655 0 C-N-CA 122.837 2.358 . . . . 0.0 112.643 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 67.51 48.51 1.1 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.438 1.095 . . . . 0.0 111.842 171.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -163.32 10.69 0.06 Allowed 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.42 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.711 ' HA3' ' HB ' ' A' ' 75' ' ' THR . . . 127.28 -12.35 6.73 Favored Glycine 0 C--N 1.355 1.61 0 O-C-N 122.041 -0.412 . . . . 0.0 113.102 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.4 118.26 21.88 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.992 0.917 . . . . 0.0 111.422 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.7 p -55.55 -32.27 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.484 1.114 . . . . 0.0 111.24 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.497 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 53.8 t -138.31 145.18 40.89 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.003 0.921 . . . . 0.0 109.821 177.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.38 141.07 54.23 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 169.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 62.3 mt -76.17 92.86 3.29 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -174.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.433 ' HG ' ' HG ' ' A' ' 107' ' ' LEU . 47.4 tp -101.19 -58.14 1.95 Allowed 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.304 -171.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.433 ' HG ' ' HG ' ' A' ' 106' ' ' LEU . 58.6 mt -142.25 123.9 8.8 Favored Pre-proline 0 N--CA 1.485 1.302 0 C-N-CA 123.598 0.759 . . . . 0.0 109.336 -170.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.467 ' HB3' ' HB3' ' A' ' 13' ' ' TRP . 27.1 Cg_endo -61.06 -74.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 122.602 2.201 . . . . 0.0 112.906 -176.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 55.8 t . . . . . 0 CA--C 1.551 1.005 0 C-N-CA 124.242 1.017 . . . . 0.0 108.668 -177.577 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 ttp . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.21 10.27 85.65 Favored Glycine 0 C--N 1.347 1.184 0 O-C-N 123.509 0.505 . . . . 0.0 113.946 171.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -83.61 103.23 12.77 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -137.5 89.71 2.44 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -103.09 87.92 3.02 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 169.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -79.52 127.71 32.47 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 172.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -76.04 128.46 35.06 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.65 0.38 . . . . 0.0 110.134 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -70.99 161.87 30.39 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.362 0.665 . . . . 0.0 110.904 175.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.6 m -62.81 162.73 10.49 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.537 1.135 . . . . 0.0 113.374 -170.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -62.62 -30.41 71.34 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 168.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.464 ' SD ' ' N ' ' A' ' 12' ' ' SER . 1.6 tmt? 61.81 -88.78 0.03 OUTLIER 'General case' 0 C--N 1.355 0.847 0 C-N-CA 125.596 1.558 . . . . 0.0 110.573 170.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.464 ' N ' ' SD ' ' A' ' 11' ' ' MET . 67.1 m -168.86 124.39 0.91 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.165 1.386 . . . . 0.0 108.699 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -99.29 -18.82 17.38 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 161.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -75.53 104.51 6.12 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 166.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -113.59 96.27 5.78 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -54.45 -39.82 67.8 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 124.38 1.05 . . . . 0.0 113.178 -164.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -125.11 85.72 2.45 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.3 tp -115.82 -45.22 2.89 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.437 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.5 t 79.9 155.29 0.14 Allowed 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 124.746 1.218 . . . . 0.0 110.229 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -57.56 -50.66 72.37 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -172.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.07 -53.99 50.35 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.587 0.755 . . . . 0.0 111.948 -176.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.53 -30.93 68.88 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.24 0.616 . . . . 0.0 111.836 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.524 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -65.57 -58.96 4.51 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.685 0.794 . . . . 0.0 111.496 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.571 ' HG3' HG21 ' A' ' 58' ' ' VAL . 34.6 tt0 -56.97 -42.59 80.44 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.264 1.425 . . . . 0.0 111.976 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -67.8 -39.88 83.95 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.137 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.402 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 33.4 tp -63.16 -38.71 92.27 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.935 0.894 . . . . 0.0 111.667 175.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.495 HD21 ' HG ' ' A' ' 37' ' ' LEU . 95.6 mt -68.0 -29.36 68.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.256 0.622 . . . . 0.0 111.097 177.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.23 -54.39 5.78 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.81 0.844 . . . . 0.0 111.085 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.402 ' HG2' ' HA ' ' A' ' 26' ' ' LEU . 11.1 ptp180 -66.8 -46.01 76.57 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.419 0.688 . . . . 0.0 111.226 -174.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.4 ' N ' ' HG3' ' A' ' 29' ' ' ARG . . . -89.65 -60.59 1.9 Allowed 'General case' 0 C--N 1.349 0.551 0 C-N-CA 123.003 0.521 . . . . 0.0 110.803 -172.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.35 -36.97 19.16 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-O 119.799 -0.445 . . . . 0.0 113.704 -172.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? 74.79 -25.25 0.2 Allowed 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 125.273 1.429 . . . . 0.0 113.477 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.4 t70 174.93 141.69 0.05 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.661 0.784 . . . . 0.0 109.369 -165.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.56 9.82 65.72 Favored Glycine 0 C--N 1.358 1.787 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 12.4 m -84.71 146.73 27.27 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.295 1.038 . . . . 0.0 111.007 -168.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -150.83 151.88 32.92 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 174.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.524 HD11 ' HB1' ' A' ' 23' ' ' ALA . 2.9 pp -152.6 158.85 43.04 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 169.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.607 HG21 HD11 ' A' ' 87' ' ' LEU . 36.8 t -112.11 154.74 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.1 ptt85 -156.21 175.09 14.45 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.907 0.883 . . . . 0.0 109.039 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.17 145.2 24.87 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.5 m -56.17 148.63 17.68 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.658 0.783 . . . . 0.0 113.041 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -88.72 3.61 50.25 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.248 1.019 . . . . 0.0 112.048 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.0 m -134.48 -63.6 0.71 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.148 0.579 . . . . 0.0 111.101 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 47' ' ' ALA . 14.7 m -85.86 117.79 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 121.726 0.774 . . . . 0.0 110.672 -178.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.32 128.7 37.37 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.616 -1.174 . . . . 0.0 112.551 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.89 7.42 81.02 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 114.691 0.636 . . . . 0.0 114.691 177.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.478 ' HB3' HG23 ' A' ' 44' ' ' VAL . . . -100.81 173.78 6.35 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.149 0.58 . . . . 0.0 109.901 174.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -117.03 160.8 20.4 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-O 121.388 0.613 . . . . 0.0 112.027 -178.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.61 144.85 42.15 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.23 168.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.489 HD13 HG22 ' A' ' 38' ' ' VAL . 51.0 tp -125.05 110.59 14.35 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.695 1.198 . . . . 0.0 108.483 -174.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 35.5 t -104.23 123.02 46.59 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -175.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.2 t -130.48 121.8 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.636 0.774 . . . . 0.0 109.714 -172.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.424 HD13 HG22 ' A' ' 58' ' ' VAL . 16.1 tp -111.22 115.64 29.7 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.297 1.039 . . . . 0.0 109.685 175.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -145.79 144.77 30.49 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 166.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 53.45 36.56 23.47 Favored 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 124.536 1.134 . . . . 0.0 112.277 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 65.7 mttm 58.68 36.47 24.98 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.403 1.081 . . . . 0.0 112.412 -173.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -126.04 104.91 8.53 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.571 HG21 ' HG3' ' A' ' 24' ' ' GLU . 17.5 t -100.69 107.91 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.739 0.816 . . . . 0.0 108.877 174.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -112.14 140.63 46.67 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 171.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 89.2 m -106.63 135.75 47.62 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -117.1 100.04 7.46 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -63.48 155.28 29.74 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 168.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 92.3 mt -144.95 101.92 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 102.59 -3.115 . . . . 0.0 102.59 -158.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.1 mp -105.11 111.59 65.15 Favored Pre-proline 0 N--CA 1.472 0.649 0 O-C-N 123.351 0.407 . . . . 0.0 109.94 -161.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 70' ' ' PHE . 1.4 Cg_endo -81.76 108.55 1.89 Allowed 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.606 2.204 . . . . 0.0 109.422 162.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -82.15 137.24 35.01 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 174.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -46.73 77.57 0.0 OUTLIER Glycine 0 CA--C 1.538 1.49 0 N-CA-C 117.172 1.629 . . . . 0.0 117.172 -172.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -151.84 -83.29 0.09 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.366 1.866 . . . . 0.0 106.77 170.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -167.33 4.28 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 178.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 83.5 m-85 -115.81 140.29 49.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.237 -0.914 . . . . 0.0 110.899 -170.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.408 ' HG ' ' HG3' ' A' ' 65' ' ' PRO . 5.3 mp -111.07 112.3 24.02 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.964 0.905 . . . . 0.0 109.536 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.63 143.03 28.72 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.95 0.5 . . . . 0.0 112.17 -174.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 81' ' ' VAL . 39.1 t -109.38 137.46 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.212 1.005 . . . . 0.0 108.434 169.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -112.28 130.0 56.09 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -170.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.422 ' OG1' ' HA3' ' A' ' 100' ' ' GLY . 3.6 t -158.76 -41.8 0.06 Allowed 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.232 -175.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 65.9 m 58.68 -109.03 0.44 Allowed 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 117.777 -1.106 . . . . 0.0 111.808 -174.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 72.18 -42.14 0.52 Allowed 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.155 1.382 . . . . 0.0 113.427 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 148.01 -21.18 1.42 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 -166.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.515 HG11 ' HA ' ' A' ' 99' ' ' GLN . 14.0 m -84.44 134.25 43.06 Favored Pre-proline 0 CA--C 1.557 1.215 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 173.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.69 146.46 97.19 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.605 2.203 . . . . 0.0 112.015 175.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 73' ' ' VAL . 42.0 t -68.23 130.49 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -105.92 118.91 37.82 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -172.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -102.32 121.19 41.8 Favored 'General case' 0 C--N 1.344 0.355 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 54.5 p90 -109.0 153.62 23.34 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.472 0.709 . . . . 0.0 110.199 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -104.46 -9.6 18.28 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.778 0.831 . . . . 0.0 110.061 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.7 t -149.04 144.22 26.57 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.29 0.636 . . . . 0.0 109.403 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.607 HD11 HG21 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -60.73 -31.02 70.35 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.481 1.112 . . . . 0.0 111.232 -173.589 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -55.23 -34.42 58.93 Favored Glycine 0 CA--C 1.539 1.566 0 N-CA-C 113.984 0.354 . . . . 0.0 113.984 174.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 84' ' ' PHE . 46.9 mt-10 -68.28 -40.53 81.79 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.34 0.656 . . . . 0.0 110.982 175.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 51.0 tp -53.12 -55.54 23.27 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.336 0.589 . . . . 0.0 110.628 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.6 mm -66.97 -36.21 76.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.79 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.12 -52.34 53.06 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.754 0.659 . . . . 0.0 113.55 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.5 mt -65.74 -56.86 9.81 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.992 0.917 . . . . 0.0 111.102 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.616 ' HB3' HD11 ' A' ' 101' ' ' LEU . 83.8 m-85 -79.59 -4.25 50.68 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -170.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.32 -27.7 67.55 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.21 0.529 . . . . 0.0 110.513 164.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -84.17 131.52 50.67 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.146 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.446 ' HB3' ' HB2' ' A' ' 104' ' ' ALA . 81.7 Cg_endo -80.49 -172.97 1.67 Allowed 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.673 2.249 . . . . 0.0 113.598 -175.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 56.6 61.02 2.82 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.407 1.483 . . . . 0.0 111.33 -178.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.515 ' HA ' HG11 ' A' ' 79' ' ' VAL . 46.2 mt-30 -143.76 12.39 1.67 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.356 1.062 . . . . 0.0 111.441 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.422 ' HA3' ' OG1' ' A' ' 75' ' ' THR . . . 110.58 -5.79 29.69 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 112.16 -0.376 . . . . 0.0 112.16 178.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.616 HD11 ' HB3' ' A' ' 94' ' ' TYR . 94.4 mt -78.85 146.86 33.42 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.277 1.031 . . . . 0.0 111.234 -178.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.4 m -63.3 -26.72 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.391 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.83 171.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 31.9 p -162.61 171.85 16.29 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.514 1.126 . . . . 0.0 110.281 171.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.446 ' HB2' ' HB3' ' A' ' 97' ' ' PRO . . . -66.68 145.35 55.65 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 169.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 73.9 mt -64.38 103.39 0.64 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -177.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 62.5 tp -111.31 -60.25 1.86 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.589 0.756 . . . . 0.0 111.576 -166.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 35' ' ' SER . 5.8 tt -114.46 97.42 46.3 Favored Pre-proline 0 N--CA 1.474 0.741 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -169.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -81.44 130.34 6.98 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 122.232 1.955 . . . . 0.0 111.214 175.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.7 t . . . . . 0 C--O 1.251 1.174 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.186 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 66.3 43.96 91.71 Favored Glycine 0 C--N 1.345 1.029 0 O-C-N 123.722 0.639 . . . . 0.0 112.12 -173.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -62.65 141.32 58.57 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.07 0.948 . . . . 0.0 110.735 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -74.14 100.64 3.7 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.05 0.54 . . . . 0.0 110.427 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -133.47 94.04 3.25 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 124.219 1.008 . . . . 0.0 108.645 173.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -65.94 92.04 0.16 Allowed 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.315 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -87.16 55.49 3.58 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 122.146 0.974 . . . . 0.0 109.615 -177.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -139.99 163.75 31.85 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.334 -174.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.0 m 71.48 116.08 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.727 1.211 . . . . 0.0 110.611 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -71.89 171.62 11.4 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 123.068 0.547 . . . . 0.0 109.717 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 46.5 ttp 68.81 8.06 6.54 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.812 0.845 . . . . 0.0 111.188 177.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 t -72.14 -54.36 9.95 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.702 0.801 . . . . 0.0 110.199 -175.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 108' ' ' PRO . 77.2 t90 92.45 -43.9 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.938 1.295 . . . . 0.0 110.928 163.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.555 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 87.9 t80 -109.71 110.78 21.92 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -174.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -126.48 106.18 9.27 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -176.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.543 ' HA ' ' HB3' ' A' ' 40' ' ' ASP . 39.8 ttm180 -74.94 152.0 38.83 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.402 176.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.547 ' HA ' ' HG2' ' A' ' 42' ' ' GLU 0.291 11.3 p-10 36.82 51.8 0.97 Allowed 'General case' 0 C--N 1.37 1.494 0 C-N-CA 125.356 1.462 . . . . 0.0 114.527 -172.325 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.7 tp -114.73 124.54 52.05 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 169.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.7 m -69.06 156.4 38.71 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.945 0.498 . . . . 0.0 110.235 -178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.3 ttp85 -54.04 -52.14 61.8 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.775 0.43 . . . . 0.0 111.061 172.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.03 -45.26 71.52 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.33 1.052 . . . . 0.0 111.867 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.06 -29.85 64.56 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.578 0.751 . . . . 0.0 112.089 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.601 ' HB1' HD11 ' A' ' 37' ' ' LEU . . . -76.84 -47.53 21.13 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.571 0.748 . . . . 0.0 111.419 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.558 ' HG3' HG21 ' A' ' 58' ' ' VAL . 32.8 tt0 -51.79 -39.82 59.33 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.252 1.421 . . . . 0.0 111.187 169.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -63.96 -47.72 79.3 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.3 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.7 tp -57.86 -45.14 86.75 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.677 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.615 HD21 HD22 ' A' ' 37' ' ' LEU . 94.2 mt -63.45 -50.45 69.7 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.016 0.927 . . . . 0.0 110.623 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.16 -34.5 73.66 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.756 0.823 . . . . 0.0 111.681 -175.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -83.88 -32.71 25.04 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.493 0.717 . . . . 0.0 111.384 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.82 -65.8 0.98 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -174.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.91 -47.22 0.84 Allowed Glycine 0 C--N 1.356 1.666 0 CA-C-N 117.995 0.362 . . . . 0.0 113.422 -172.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 55.9 24.9 8.01 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 125.573 1.549 . . . . 0.0 114.924 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -174.4 100.15 0.1 Allowed 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.264 -0.897 . . . . 0.0 109.582 -174.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.03 15.83 80.89 Favored Glycine 0 N--CA 1.474 1.199 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.908 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.1 m -85.53 116.29 23.74 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.916 0.887 . . . . 0.0 109.684 -170.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -126.74 159.45 33.69 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.814 0.34 . . . . 0.0 111.672 -175.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.615 HD22 HD21 ' A' ' 27' ' ' LEU . 1.6 pt? -163.13 163.73 25.6 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.008 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 25.6 t -126.71 122.69 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 175.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.436 HH21 HD21 ' A' ' 37' ' ' LEU . 9.3 ptp85 -116.87 157.66 25.27 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -177.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.543 ' HB3' ' HA ' ' A' ' 16' ' ' ARG . 33.6 t70 -93.82 122.96 36.83 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 170.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.4 m -57.16 151.98 14.46 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.706 0.629 . . . . 0.0 111.403 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.547 ' HG2' ' HA ' ' A' ' 17' ' ' ASP . 32.5 mt-10 -81.93 -22.14 36.89 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -163.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.3 t -167.6 103.33 0.5 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 172.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.465 HG11 ' HB3' ' A' ' 47' ' ' ALA . 8.1 p -158.84 169.88 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 C-N-CA 123.9 0.88 . . . . 0.0 109.564 -178.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.99 23.21 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 175.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.446 ' H ' HG13 ' A' ' 44' ' ' VAL . . . 92.58 91.2 1.49 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -175.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.465 ' HB3' HG11 ' A' ' 44' ' ' VAL . . . -152.16 134.68 15.32 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.488 1.115 . . . . 0.0 109.5 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -110.62 143.39 41.12 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.002 0.921 . . . . 0.0 109.197 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.1 125.2 52.06 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.606 0.362 . . . . 0.0 110.86 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 37' ' ' LEU . 40.3 tp -105.51 131.62 52.69 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.724 ' SG ' HG22 ' A' ' 60' ' ' THR . 73.6 m -123.86 141.24 52.21 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 118.527 0.603 . . . . 0.0 110.126 171.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.6 t -125.47 114.72 40.88 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 170.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.709 HD13 HG22 ' A' ' 58' ' ' VAL . 13.8 tp -99.56 137.83 37.49 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.34 1.056 . . . . 0.0 108.921 176.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -149.44 102.87 3.23 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.003 1.321 . . . . 0.0 108.178 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 48.93 68.95 0.63 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.758 0.823 . . . . 0.0 112.808 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt 62.28 12.99 5.58 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -110.47 102.34 10.96 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.709 HG22 HD13 ' A' ' 53' ' ' LEU . 3.4 t -107.87 120.82 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -114.75 140.53 48.82 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 172.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.724 HG22 ' SG ' ' A' ' 51' ' ' CYS . 62.7 p -112.71 136.45 52.29 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.574 1.15 . . . . 0.0 109.072 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.29 96.91 4.43 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 178.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -80.94 100.7 9.05 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.471 HG21 HD12 ' A' ' 71' ' ' LEU . 15.6 mt -72.06 128.78 35.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.231 -1.35 . . . . 0.0 109.651 173.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.406 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -137.5 135.77 19.64 Favored Pre-proline 0 C--O 1.24 0.567 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 170.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 36.6 Cg_exo -62.1 -62.28 0.13 Allowed 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 122.786 2.324 . . . . 0.0 114.133 177.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.5 t70 87.91 -69.27 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.598 1.559 . . . . 0.0 109.2 175.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -85.5 16.71 38.54 Favored Glycine 0 C--N 1.357 1.698 0 CA-C-O 119.71 -0.495 . . . . 0.0 113.517 169.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 66.09 -30.76 0.14 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 174.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -76.5 -45.11 32.34 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.437 1.017 . . . . 0.0 111.131 -170.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 65' ' ' PRO . 25.3 p90 -108.39 145.3 34.76 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 124.915 1.286 . . . . 0.0 108.504 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.496 HD23 ' H ' ' A' ' 71' ' ' LEU . 2.6 pt? -99.23 118.96 37.09 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 164.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.62 117.6 33.44 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.528 0.731 . . . . 0.0 110.713 -175.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.858 HG21 HD13 ' A' ' 90' ' ' LEU . 14.6 t -89.58 116.28 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.094 0.958 . . . . 0.0 110.342 177.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -90.39 92.11 8.76 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.422 HG23 ' HE2' ' A' ' 94' ' ' TYR . 0.2 OUTLIER -54.07 -58.61 6.69 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.419 177.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.0 m -155.3 131.19 10.01 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.454 1.502 . . . . 0.0 107.336 163.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -66.16 95.46 0.29 Allowed 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 165.51 -58.21 0.25 Allowed Glycine 0 C--N 1.343 0.93 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -172.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.38 140.83 82.54 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 124.051 0.94 . . . . 0.0 109.41 169.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -49.9 87.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.386 2.511 0 C-N-CA 123.599 2.866 . . . . 0.0 114.134 173.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 73' ' ' VAL . 7.4 p -36.72 143.78 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 126.262 1.825 . . . . 0.0 115.252 169.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -107.18 132.86 52.58 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 124.2 1.0 . . . . 0.0 109.505 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -99.12 146.87 25.66 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.078 0.951 . . . . 0.0 109.001 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -136.23 164.78 27.28 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.911 0.884 . . . . 0.0 109.038 -174.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -126.44 -13.31 6.06 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.847 0.459 . . . . 0.0 110.333 176.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 88' ' ' GLY . 20.8 m -140.15 140.7 36.01 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.631 0.772 . . . . 0.0 109.376 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 75.0 mt -58.36 -32.82 68.91 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.616 0.766 . . . . 0.0 111.551 172.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.582 ' H ' HG22 ' A' ' 86' ' ' THR . . . -60.39 -33.16 79.83 Favored Glycine 0 CA--C 1.532 1.154 0 O-C-N 123.493 0.496 . . . . 0.0 113.582 174.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.528 ' HG3' ' HB ' ' A' ' 86' ' ' THR . 47.6 mt-10 -71.83 -40.85 68.78 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.933 0.493 . . . . 0.0 110.168 176.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.858 HD13 HG21 ' A' ' 73' ' ' VAL . 42.2 tp -52.7 -51.59 59.67 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.553 0.741 . . . . 0.0 110.344 174.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.407 HD11 ' CZ2' ' A' ' 13' ' ' TRP . 49.7 mm -62.79 -39.28 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.432 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.15 -57.32 20.39 Favored Glycine 0 CA--C 1.529 0.911 0 O-C-N 123.621 0.576 . . . . 0.0 113.44 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.7 mp -70.74 -52.01 23.58 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.562 0.745 . . . . 0.0 112.006 -177.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.51 ' HB3' HD11 ' A' ' 101' ' ' LEU . 30.2 m-85 -68.66 -17.26 64.06 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -173.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.44 -19.93 51.22 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 171.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -77.99 124.13 86.13 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 123.396 0.678 . . . . 0.0 109.996 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -70.95 168.29 23.54 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.67 2.246 . . . . 0.0 111.724 173.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 53.8 58.11 5.41 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.85 0.86 . . . . 0.0 110.532 -174.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -142.52 -15.91 0.73 Allowed 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.701 -177.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 141.54 -18.06 2.64 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -175.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.51 HD11 ' HB3' ' A' ' 94' ' ' TYR . 17.7 mt -99.93 105.98 17.75 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.23 0.612 . . . . 0.0 110.105 175.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.6 m -44.96 -25.98 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 125.221 1.408 . . . . 0.0 114.538 174.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 36.7 t -124.27 -11.3 7.47 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.141 0.576 . . . . 0.0 112.444 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 64.11 178.57 0.17 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.122 0.969 . . . . 0.0 111.399 -167.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.1 mt -77.62 92.12 4.06 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.7 176.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.0 tt -81.78 -65.38 1.02 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.856 0.462 . . . . 0.0 109.906 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -146.22 130.05 8.48 Favored Pre-proline 0 N--CA 1.491 1.575 0 C-N-CA 122.295 0.238 . . . . 0.0 110.919 -174.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.487 ' HB2' ' HB2' ' A' ' 13' ' ' TRP . 80.8 Cg_endo -74.38 145.13 33.61 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.689 2.259 . . . . 0.0 111.779 177.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 57.2 t . . . . . 0 C--O 1.256 1.422 0 C-N-CA 123.799 0.84 . . . . 0.0 109.533 179.543 . . . . . . . . 0 0 . 1 stop_ save_